
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8">	
		<style type="text/css">
			table {
			    border-collapse: collapse;
				font-family: arial, helvetica, sans-serif;
			}

			table, th, td {
			    border: 1px solid #C0C0C0;
				font-family: arial, helvetica, sans-serif;
			}
		</style>
	</head>
	<body><table class="tablesorter">
<thead><tr><th>Document Date</th><th>Contributor</th><th>Headline</th><th>Language</th><th>Pages</th><th>Tickers</th><th>Company Names</th><th>Category</th><th>Countries</th><th>Industries</th><th>Regions</th><th>Subjects</th><th>Report Styles</th><th>Author</th></tr>
</thead><tbody><tr class="even"><td class="leftalignment">01/17/2022</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">What Should BIIB Do Next? Whatever Route, It's Not What Should They Buy...</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/15/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">01/15/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 582</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / 65487U108 / N90064101 / 14147L108 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102 / 09063M205</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Nkarta Inc / Uniqure NV / Cardiff Oncology Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc / Bionomics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Emily Ozpinar / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">01/14/2022</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 1/7/22</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Coverage Report : A summary of credit analyst recommendations in the Healthcare sector</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMGN.O / BSX.N / BAX.N / BDX.N / BMY.N / CAH.N / CI.N / CVS.N / JNJ.N / LLY.N / MCK.N / MRK.N / TMO.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / ABC.N / BIIB.O / ABBV.N / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amgen Inc / Boston Scientific Corp / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Amerisourcebergen Corp / Biogen Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">01/13/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">0925288 / 2126335 / 2486813 / 2050832 / 2219224 / 2270726 / 2542049 / 2317087 / 2670519 / 2455965 / 2689560 / 2684703 / 2048804 / 2799351 / 2900335 / 2857817 / B03PGL4 / B7TL820 / B65SQW4 / B7VD3F2 / BFLR866 / BVVN4Q8 / BYY8XK8 / BK0VHF6 / BJ1FD74 / BKVDFF7 / BFZ1K46 / BLGJ610 / BJJMGL2 / BYXJQG9 / BZ1LFG7 / BD5GSZ4 / BWC52Q6</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Kellogg Co / Ameren Corp / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Exelon Corp / Biogen Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Sinclair Broadcast Group Inc / Tractor Supply Co / Netflix Inc / NorthWestern Corp / Meta Platforms Inc / Enphase Energy Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / WEC Energy Group Inc / IDEAYA Biosciences Inc / Revolve Group Inc / Oric Pharmaceuticals Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / Spire Inc / Roku Inc / Infrastructure and Energy Alternatives Inc / Solaredge Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Downgrading to Neutral While We Wait for Additional Clarity on CED Study Details and Competitor Cognition Data - PT Lowered to $202</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - KOL Call in 15 MINUTES to Discuss NCD Draft Memo and Implications for Amyloid Therapies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - KOL Call in 1 HOUR to Discuss NCD Draft Memo and Implications for Amyloid Therapies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - REMINDER KOL Call TODAY at 1PM ET to Discuss NCD Draft Memo and Implications for Amyloid Therapies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jan 12 2022</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">DE0007164600 / US00724F1012 / US0079731008 / US0116591092 / US0126531013 / US02553E1064 / US0382221051 / US1266501006 / US1925761066 / US4824801009 / US5012421013 / US5128071082 / US55306N1046 / US5949181045 / US62855J1043 / US68389X1054 / US8030542042 / US8740391003 / US8807701029 / US91347P1057 / AU000000LYC6 / US3463751087 / US09062X1037 / CA8676EP1086 / US90385V1070 / US25754A2015 / US79466L3024 / US5500211090 / US88076W1036 / US75972A3014 / NL0010273215 / US81762P1021 / US98138H1014 / US8486371045 / US00847X1046 / US98936J1016 / US4435731009 / US3580391056 / US64829B1008 / US8190471016 / US72703H1014 / GB00BZ09BD16 / US90138F1021 / KYG4740B1059 / US02156B1035 / US03782L1017 / CA53680Q2071 / US76674Q1076 / US55910K1088 / US2575541055 / US88688T1007 / US53814L1089 / US69553P1003 / US09203E1055 / US76155X1000 / US96684W1009 / US8334451098 / US86646P1030 / US5533681012 / US83089J1088 / IL0011762130 / US20717M1036 / US92747V1061 / US0536041041 / US1263271058 / US30322L1017 / US74276L1052 / US1095041000 / US2297901009 / KYG393871085 / US37637K1088 / US10576N1028</td><td class="leftalignment">SAP SE / Adobe Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / Albemarle Corp / American Eagle Outfitters Inc / Applied Materials Inc / CVS Health Corp / Cohu Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / MKS Instruments Inc / Microsoft Corp / Myriad Genetics Inc / Oracle Corp / SAP SE / Taiwan Semiconductor Manufacturing Co Ltd / Teradyne Inc / Universal Display Corp / Lynas Rare Earths Ltd / FormFactor Inc / Biogen Inc / Sunopta Inc / Ultra Clean Holdings Inc / Domino's Pizza Inc / Salesforce.Com Inc / Lululemon Athletica Inc / Teradata Corp / Renewable Energy Group Inc / ASML Holding NV / ServiceNow Inc / Workday Inc / Splunk Inc / Agios Pharmaceuticals Inc / Zendesk Inc / HubSpot Inc / Freshpet Inc / New Relic Inc / Shake Shack Inc / Planet Fitness Inc / Atlassian Corporation PLC / Twilio Inc / Ichor Holdings Ltd / Alteryx Inc / Appian Corp / Lithium Americas Corp / Rimini Street Inc / Magenta Therapeutics Inc / Domo Inc / Tilray Brands Inc / Livent Corp / PagerDuty Inc / Black Diamond Therapeutics Inc / Revolution Medicines Inc / Whole Earth Brands Inc / Snowflake Inc. / Sumo Logic Inc / Mp Materials Corp / Skywater Technology Inc / Monday.Com Ltd / Confluent Inc / Vintage Wine Estates Inc / AvePoint Inc / CS Disco Inc / F45 Training Holdings Inc / Procept Biorobotics Corp / Brilliant Earth Group Inc / Cue Health Inc / Globalfoundries Inc / GitLab Inc / Braze Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Cayman Islands / Germany / United Kingdom / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Jan 12 2022 6:41AM</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">2303.TW / 2330.TW / ACN / DBD / IBM / INTC.O / KBH / KMX / MSFT.O / QCOM.O / NVDA.O / AMD.O / NTAP.O / CTSH.O / BMRN.O / INFY.NS / WIPR.NS / MU.O / HPE / UFPI.O / SWKS.O / BIIB.O / DENN.O / STX.O / SIMO.O / 37045V100 / WDC.O / QRVO.O / SHAK.K / PSTG.K / CVNA.K / RDFN.O / DELL.K / AXLA.O / VRM.O / 88338K103</td><td class="leftalignment">United Microelectronics Corp / Taiwan Semiconductor Manufacturing Co Ltd / Accenture PLC / Diebold Nixdorf Inc / International Business Machines Corp / Intel Corp / KB Home / Carmax Inc / Microsoft Corp / Qualcomm Inc / NVIDIA Corp / Advanced Micro Devices Inc / NetApp Inc / Cognizant Technology Solutions Corp / Biomarin Pharmaceutical Inc / Infosys Ltd / Wipro Ltd / Micron Technology Inc / Hewlett Packard Enterprise Co / Ufp Industries Inc / Skyworks Solutions Inc / Biogen Inc / Denny's Corp / Seagate Technology Holdings PLC / Silicon Motion Technology Corp / General Motors Co / Western Digital Corp / Qorvo Inc / Shake Shack Inc / Pure Storage Inc / Carvana Co / Redfin Corp / Dell Technologies Inc / Axcella Health Inc / Vroom Inc / One Group Hospitality Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / India / Ireland / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="even"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Tell Me You're Not Covering Our Drug Without Telling Me; CMS to BIIB --> CED</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/12/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Aduhelm Draft NCD Highly Restrictive; Will CMS Ease CED Requirements by April? Lecanamab Phase III Now Make or Break</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Sarah Schram / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0925288 / 2516152 / 2023607 / 2050832 / 2222631 / 2270726 / 2542049 / 2317087 / 2670519 / 2455965 / 2457864 / 2471950 / 2689560 / 2048804 / 2440637 / 2799351 / 2829601 / 2980906 / B3D7K31 / B03PGL4 / 2390817 / B783TY6 / B7VD3F2 / BFDV8K0 / BVVN4Q8 / BYY8XK8 / BJ1FD74 / BGCYWN8 / BFZ1K46 / BLGJ610 / BJJMGL2 / BKTNTR9 / BYQHPK7 / BWY52P3 / BYY88Y7 / BL71K91 / BYNQ369 / BMXXBD9 / BMYRFV6 / BMFPHK2 / BMBSNX0</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Eli Lilly and Co / Amgen Inc / Ameren Corp / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Exelon Corp / Biogen Inc / ImmunoGen Inc / Incyte Corp / PG&E Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / Southern Co / Foot Locker Inc / Discovery Inc / NorthWestern Corp / Gray Television Inc / Aptiv PLC / Duke Energy Corp / MacroGenics Inc / Eversource Energy / WEC Energy Group Inc / Revolve Group Inc / Xencor Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Zymeworks Inc / Blueprint Medicines Corp / Alphabet Inc / Revolution Medicines Inc / Albertsons Companies Inc / Figs Inc / Procept Biorobotics Corp / ThredUp Inc / IronNet Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Downgrade to Neutral – Hard to See a Way Forward</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">01/12/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : Adu-justing to a New Reality; Draft NCD Significantly Dims Near Term Outlook for Aduhelm and A-Beta Class</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">our take on CMS NCD on alzh</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - INVITE - KOL Call to Discuss NCD Draft Memo and Implications for Amyloid Therapies Tomorrow at 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Aduhelm/CMS reimbursement relationship status: it's complicated</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">CMS Proposes Limiting Coverage Of Beta Amyloid Antibodies To Randomized Trials</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">CMS decision appears worse than expected, in our view; we spoke with BIIB mgmt for more color</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / LLY=US / BIIB=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Implications for CMS Proposal of CED</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB / SAGE</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Jay Olson, CFA, III / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - CMS Wants to See Cognition Benefit, Proposes Rigorous CED Study - 2H22 Cognition Data from Competing Products to Decide Fate of the Aβ Class</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">It's really no meaningful reimbursement; sending waves across biotech</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US / BIIB=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">NCD Proposed Decision Memo; Let's See What's Next With CED Proposal</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">CMS Proposal, If Finalized, Could Effectively Spell The End For Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BIIB/LLY—Could CMS Decision Make the FDA Rethink the Early approval of Other Anti-Amyloid Drugs?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O / LLY.N</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">CMS Says COVERAGE WITH EVIDENCE DETERMINATION --- But They Mean Another Trial</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACI / BAC / DHI / DIS / INTC.O / KBH / LEN / LLY.N / NVR / PFE.N / RKT / TOL / AMD.O / MU.O / NFLX.O / BIIB.O / DISCA.O / CCS.N / STAG.K / ABBV.N / PFSI.K / OMF / INSP.K / FTCH.K / RAPT.O / HMPT.O / AOMR.N</td><td class="leftalignment">Albertsons Companies Inc / Bank of America Corp / D R Horton Inc / Walt Disney Co / Intel Corp / KB Home / Lennar Corp / Eli Lilly and Co / NVR Inc / Pfizer Inc / Rocket Companies Inc / Toll Brothers Inc / Advanced Micro Devices Inc / Micron Technology Inc / Netflix Inc / Biogen Inc / Discovery Inc / Century Communities Inc / STAG Industrial Inc / Abbvie Inc / PennyMac Financial Services Inc / OneMain Holdings Inc / Inspire Medical Systems Inc / Farfetch Ltd / Rapt Therapeutics Inc / Home Point Capital Inc / Angel Oak Mortgage Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BIIB NCD TMRW—When to Look, Where to Look, and What to Look For?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O / LLY.N</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">AGTC-501 Exceeds Enrollment in SKYLINE; Key Interim Updates in XLRP in 2Q22 and Beyond</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03820J100 / BIIB / 68906L105</td><td class="leftalignment">Applied Genetic Technologies Corp / Biogen Inc / Otonomy Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">NCD scenarios and potential stock movements; 2H2022 lecanemab data most important, in our view.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB=US / LLY=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CARS / AN=US / MRK=US / LLY=US / PFE=US / BMY=US / HD=US / MCD=US / WEN=US / AGL=US / BLDP=US / AMZN=US / BLD=US / INCY=US / RUN=US / GILD=US / PLUG=US / NOVA=US / LOW=US / THC=US / TTWO=US / LEG=US / VMC=US / HUM=US / CVS=US / CI=US / MLM=US / UNH=US / KFY=US / AMED=US / AMN=US / SWIM=US / ARRY=US / BMRN=US / CBRL=US / KIDS=US / DRI=US / EXEL=US / FCN=US / GFF=US / ABG=US / IBP=US / MAS=US / MHK=US / ASGN=US / REGI=US / TRGP=US / TRUE=US / VRTX=US / EPD=US / CCRN=US / CNC=US / R=US / CNM=US / JAZZ=US / BE=US / DIN=US / ACVA=US / BCO=US / MOH=US / BIIB=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / SPWR=US / CMG=US / REX=US / PGTI=US / GPRE=US / ICFI=US / AWI=US / OC=US / CPRX=US / TAST=US / QSR=US / PRPL=US / LULU=US / IAA=US / ATSG=US / JACK=US / RCUS=US / TREX=US / GNRC=US / FBHS=US / ZNGA=US / ENPH=US / TILE=US / NDLS=US / PTCT=US / FATE=US / CNCE=US / 00770K202 / LOCO=US / OSH=US / UPLD=US / ANTM=US / SHAK=US / GDDY=US / SEDG=US / WING=US / SPNE=US / NVCR=US / 82982L103 / GXO=US / IRTC=US / CRSP=US / ANAB=US / JELD=US / DCPH=US / ALLO=US / FERG=US / AHCO=US / AZEK=US / SHLS=US / PRVA=US / SNPO=US / ROIV=US</td><td class="leftalignment">Cars.com Inc / AutoNation Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / agilon health Inc / Ballard Power Systems Inc / Amazon.com Inc / TopBuild Corp / Incyte Corp / Sunrun Inc / Gilead Sciences Inc / Plug Power Inc / Sunnova Energy International Inc / Lowe's Companies Inc / Tenet Healthcare Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / Vulcan Materials Co / Humana Inc / CVS Health Corp / Cigna Corp / Martin Marietta Materials Inc / UnitedHealth Group Inc / Korn Ferry / Amedisys Inc / AMN Healthcare Services Inc / Latham Group Inc / Array Technologies Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / OrthoPediatrics Corp / Darden Restaurants Inc / Exelixis Inc / FTI Consulting Inc / Griffon Corp / Asbury Automotive Group Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Targa Resources Corp / TrueCar Inc / Vertex Pharmaceuticals Inc / Enterprise Products Partners LP / Cross Country Healthcare Inc / Centene Corp / Ryder System Inc / Core & Main Inc / Jazz Pharmaceuticals PLC / Bloom Energy Corp / Dine Brands Global Inc / ACV Auctions Inc / Brinks Co / Molina Healthcare Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / SunPower Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / ICF International Inc / Armstrong World Industries Inc / Owens Corning / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lululemon Athletica Inc / IAA Inc / Air Transport Services Group Inc / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / Generac Holdings Inc / Fortune Brands Home & Security Inc / Zynga Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Oak Street Health Inc / Upland Software Inc / Anthem Inc / Shake Shack Inc / GoDaddy Inc / Solaredge Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Novocure Ltd / SiteOne Landscape Supply Inc / GXO Logistics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / AnaptysBio Inc / JELD-WEN Holding Inc / Deciphera Pharmaceuticals Inc / Allogene Therapeutics Inc / Ferguson PLC / Adapthealth Corp / Azek Company Inc / Shoals Technologies Group Inc / Privia Health Group Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US7665596034 / US09062X1037 / US8036071004 / US69366J2006 / US46116X1019 / IL0011313900 / CA68620P1018 / CA1380351009 / US8162121045 / US4834971032 / US03753U1060 / US03969F1093 / US03836N1037 / US88688T1007 / CA39342L1085 / ZAE000185005 / CA22587M1068 / CA89788C1041 / US12482W1018 / CA16106R1091 / US86150R1077 / CA23126M1023 / US1266541028 / CA05156X8843 / CA4283043079 / CA00489Y6001</td><td class="leftalignment">Rigel Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Intra-Cellular Therapies Inc / Galmed Pharmaceuticals Ltd / OrganiGram Holdings Inc / Canopy Growth Corp / Selecta Biosciences Inc / Kalvista Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Arcus Biosciences Inc / Aptinyx Inc / Tilray Brands Inc / Green Thumb Industries Inc / Ascendis Health Ltd / Cresco Labs Inc / Trulieve Cannabis Corp / cbdMD Inc / Charlotte's Web Holdings Inc / Stoke Therapeutics Inc / Curaleaf Holdings Inc / CV Sciences Inc / Aurora Cannabis Inc / Hexo Corp / Acreage Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2002305 / 2050832 / 2219224 / 2270726 / 2542049 / 2576941 / 2670519 / 2100920 / 2455965 / 2471950 / 2645409 / 2689560 / 2684703 / 7103065 / B00FWN1 / B19FQ48 / 2713317 / 2969637 / B3D7K31 / B23FN39 / B1XGNW4 / B0796X4 / B7TL820 / B7254K9 / B7VD3F2 / B85KFY9 / B8DPDT7 / BFLR866 / BS7K7C9 / BYZLV46 / BFZNYB7 / BK0VHF6 / BD9GVY0 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BYSGPK2 / BDD1B07 / BMXXBD9 / BNKGXX2 / BJ62Z18 / BL53KF5 / BK6L288 / BMBSNX0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Abbott Laboratories / Ameren Corp / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Exelon Corp / FirstEnergy Corp / Biogen Inc / Incyte Corp / NiSource Inc / PG&E Corp / Pfizer Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / DICK'S Sporting Goods Inc / Discovery Inc / Lululemon Athletica Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / AxoGen Inc / Duke Energy Corp / Five Below Inc / Sarepta Therapeutics Inc / Twitter Inc / Nevro Corp / InflaRx NV / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / Evergy Inc / Fox Corp / ViacomCBS Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / ViewRay Inc / Rubius Therapeutics Inc / Figs Inc / Verve Therapeutics Inc / Ultragenyx Pharmaceutical Inc / F45 Training Holdings Inc / Beam Therapeutics Inc / IronNet Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">2022 HC Conf Day 1 Recap : Credit Takeaways from the 40th Annual J.P. Morgan Conference</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BAX.N / BMY.N / CAH.N / HUM.N / GILD.O / ABC.N / BIIB.O / ZTS.N</td><td class="leftalignment">Baxter International Inc / Bristol-Myers Squibb Co / Cardinal Health Inc / Humana Inc / Gilead Sciences Inc / Amerisourcebergen Corp / Biogen Inc / Zoetis Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Day 1 Takes and the Biggest One is We Miss Seeing You Guys in Person</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US03753U1060 / US09062X1037 / US8036071004 / US69366J2006 / AKBA / US03969F1093 / ZAE000185005 / US86150R1077</td><td class="leftalignment">Apellis Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Akebia Therapeutics Inc / Arcus Biosciences Inc / Ascendis Health Ltd / Stoke Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 31, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB — With A Draft Proposal Memo Due From CMS on Jan 12th, We Caught Up With Our Payer Expert To Discuss Possible NCD Scenarios - CED Study Likely</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech Nightcap: Partnerships are good for Pharma/LC biotech but investors looking for M&A</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / INCY=US / GILD=US / BMRN=US / VRTX=US / BIIB=US / RCUS=US / PTCT=US / FATE=US / ROIV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Arcus Biosciences Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ABT / AME / BAC / BSX / CP / IEX / IOT / MDT / NOC.N / NSC / PEN / PFE.N / PNC / ROP / TFC / USB / GILD.O / GD.N / EPC / REGN.O / VRTX.O / NDSN.O / BIIB.O / DXCM.O / TNDM.OQ / FIVE.O / MEIP.O / NVRO.K / SMAR.K / SWAV.O / LHX.N / BEAM.O</td><td class="leftalignment">Abbott Laboratories / AMETEK Inc / Bank of America Corp / Boston Scientific Corp / Canadian Pacific Railway Ltd / IDEX Corp / Samsara Inc / Medtronic PLC / Northrop Grumman Corp / Norfolk Southern Corp / Penumbra Inc / Pfizer Inc / PNC Financial Services Group Inc / Roper Technologies Inc / Truist Financial Corp / US Bancorp / Gilead Sciences Inc / General Dynamics Corp / Edgewell Personal Care Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nordson Corp / Biogen Inc / Dexcom Inc / Tandem Diabetes Care Inc / Five Below Inc / MEI Pharma Inc / Nevro Corp / Smartsheet Inc / Shockwave Medical Inc / L3harris Technologies Inc / Beam Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : Live from The J.P. Morgan Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - CALL IN 15 MIN - Discussion on National Coverage Determination Scenarios for Aduhelm @ 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - CALL IN 1 HOUR - Discussion on National Coverage Determination Scenarios for Aduhelm @ 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BIIB: Key NCD Takeaways from BIIB Call and Our Risk/Reward Thoughts</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BIIB: Takeaways From Presentation; All Eyes on Wednesday's CMS Draft Decision</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - KOL CALL TODAY AT 1PM ET - Discussion on National Coverage Determination Scenarios for Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 10, 2022</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US0188021085 / US0236081024 / US0255371017 / US0311621009 / US1101221083 / US1258961002 / US1264081035 / US1270971039 / US1475281036 / US22160K1051 / US2333311072 / US25179M1036 / US25746U1097 / US26875P1012 / US29364G1031 / US30161N1019 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US4592001014 / US5010441013 / US5324571083 / US56418H1005 / US6267171022 / US64125C1099 / US65473P1057 / US6558441084 / US6745991058 / US7170811035 / US7237871071 / US7445731067 / US75281A1097 / US75886F1075 / US7703231032 / AN8068571086 / US8168511090 / US8425871071 / US8454671095 / US87612E1064 / US8851601018 / US9078181081 / US92276F1003 / US92532F1003 / US9746371007 / US98389B1008 / CA1363751027 / CA4530384086 / CA5649051078 / CA1363851017 / US1667641005 / US5658491064 / CA0636711016 / US0017441017 / US20825C1045 / US15189T1079 / US2274831047 / US09062X1037 / CA67072Q1046 / CA2265331074 / US6293775085 / US0534841012 / US1011211018 / US2644115055 / CA6993202069 / CA0906971035 / CA4495861060 / US42809H1077 / BMG383271050 / US4219461047 / US49427F1084 / US89785X1019 / US2120151012 / US38500T1016 / US26884L1098 / CA22576C1014 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / CA00829Q1019 / US26441C2044 / CA89156V1067 / US69327R1014 / US72919P2020 / CA4013393042 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA3565001086 / US70509V1008 / CA04682R1073 / US5764852050 / US29355A1079 / US25278X1090 / CA4882951060 / US71943U1043 / US60468T1051 / US03674X1063 / CA14150G4007 / CA7397211086 / US65341B1061 / US29444U7000 / US30040W1080 / US83417M1045 / US4278255009 / US92939U1060 / US86771W1053 / US0130911037 / US2057683029 / US13462K1097 / US15136A1025 / GB00BDSFG982 / CA46016U1084 / US92840M1027 / US05722G1004 / US12653C1080 / CA35905B1076 / US00191U1025 / US83200N1037 / US87484T1088 / US0937121079 / US08579X1019 / CA7241121077 / CA6744822033 / US86745K1043 / US69047Q1022 / CA4220961078 / CA84678A1021 / US5168062058 / US13123X5086 / CA89055A2039 / US0412421085 / US62955J1034 / US1651677353 / US03743Q1085 / CA00791P1071 / US1374041093</td><td class="leftalignment">Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Amgen Inc / Bristol-Myers Squibb Co / CMS Energy Corp / CSX Corp / Coterra Energy Inc / Caseys General Stores Inc / Costco Wholesale Corp / DTE Energy Co / Devon Energy Corp / Dominion Energy Inc / EOG Resources Inc / Entergy Corp / Exelon Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / International Business Machines Corp / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Murphy Oil Corp / Neurocrine Biosciences Inc / NiSource Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Public Service Enterprise Group Inc / Range Resources Corp / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Schlumberger NV / Sempra Energy / Southern Co / Southwestern Energy Co / Target Corp / Thor Industries Inc / Union Pacific Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Xcel Energy Inc / Canadian National Railway Co / Imperial Oil Ltd / Maple Leaf Foods Inc / Canadian Natural Resources Ltd / Chevron Corp / Marathon Oil Corp / Bank of Montreal / AMN Healthcare Services Inc / Conocophillips / CenterPoint Energy Inc / Cross Country Healthcare Inc / Biogen Inc / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Avalonbay Communities Inc / Boston Properties Inc / Duke Realty Corp / Paramount Resources Ltd / Birchcliff Energy Ltd / IGM Financial Inc / Hess Corp / GeoPark Ltd / Healthcare Realty Trust Inc / Kilroy Realty Corp / TrueBlue Inc / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Crescent Point Energy Corp / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Africa Oil Corp / Duke Energy Corp / Tourmaline Oil Corp / PDC Energy Inc / Plug Power Inc / Guardian Capital Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Freehold Royalties Ltd / Pebblebrook Hotel Trust / Athabasca Oil Corp / Matador Resources Co / Enphase Energy Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Physicians Realty Trust / Mirati Therapeutics Inc / Antero Resources Corp / Cardinal Energy Ltd (Alberta) / Prairiesky Royalty Ltd / Nextera Energy Partners LP / Equinix Inc / Eversource Energy / Solaredge Technologies Inc / Hersha Hospitality Trust / WEC Energy Group Inc / Sunrun Inc / Albertsons Companies Inc / Comstock Resources Inc / Camping World Holdings Inc / Centennial Resource Development Inc / TechnipFMC PLC / International Petroleum Corp / Vistra Corp / Baker Hughes Co / CNX Resources Corp / Frontera Energy Corp / ASGN Inc / Smartsheet Inc / Talos Energy Inc / Bloom Energy Corp / Berry Corporation (Bry) / Pipestone Energy Corp / Obsidian Energy Ltd / Sunnova Energy International Inc / Ovintiv Inc / Headwater Exploration Inc / Spartan Delta Corp / Laredo Petroleum Inc / Callon Petroleum Co / Topaz Energy Corp / Arko Corp. / Nov Inc / Chesapeake Energy Corp / APA Corp (US) / Advantage Energy Ltd / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">NCD Proposal Anticipated Wednesday; We Expect CED With A Registry Requirement</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="even"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - INVITE - Discussion on National Coverage Determination Scenarios for Aduhelm; KOL Call Tomorrow at 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: General & Physician Outsourcing Outperform; Nurse Employment during the First 15 Months of the Pandemic</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="even"><td class="leftalignment">01/08/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 581</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / 65487U108 / N90064101 / 14147L108 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Nkarta Inc / Uniqure NV / Cardiff Oncology Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">TENX-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">TENX.O / JNJ / PTN / NBY / BIIB.O / CYTK.O / ANIP.O / XNCR.O</td><td class="leftalignment">Tenax Therapeutics Inc / Johnson & Johnson / Palatin Technologies Inc / NovaBay Pharmaceuticals Inc / Biogen Inc / Cytokinetics Inc / ANI Pharmaceuticals Inc / Xencor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SYN-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SYN / ABT / MRK / PFE / AZN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Synthetic Biologics Inc / Abbott Laboratories / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BCLI-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BCLI.O / GILD.O / AGEN.O / SGEN.O / BIIB.O / CYTK.O / IDRA.O / BIEI.PK</td><td class="leftalignment">Brainstorm Cell Therapeutics Inc / Gilead Sciences Inc / Agenus Inc / Seagen Inc / Biogen Inc / Cytokinetics Inc / Idera Pharmaceuticals Inc / Premier Biomedical Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SPPI-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SPPI.O / ABT / BMY / JNJ / NVS / PFE / GSK / CRIS.O / SGEN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Spectrum Pharmaceuticals Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Curis Inc / Seagen Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ACA / ORCL / RAD / WMT / ONEM.O / AYI / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / ANGO.O / 156782104 / LHCG.O / ENSG.O / 483548103 / ADUS.O / 92857F107 / EVH / CFMS.O / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Oracle Corp / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / Acuity Brands Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / AngioDynamics Inc / Cerner Corp / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Vocera Communications Inc / Evolent Health Inc / Conformis Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Costa Rica / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">The Cowen Edge - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0028241000 / US00846U1016 / US00971T1016 / US0116591092 / US0231351067 / US0378331005 / US0382221051 / US0463531089 / US0718131099 / US0758871091 / US1011371077 / US1101221083 / US1266501006 / US1727551004 / US22284P1057 / US28176E1082 / US3021301094 / US3156161024 / US37733W1053 / US4364401012 / US4433201062 / US4456581077 / US4781601046 / US5150981018 / US5324571083 / US5951121038 / US66987V1098 / US6701002056 / US6795801009 / US7140461093 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US8168501018 / US8308791024 / US8447411088 / US8610121027 / US8740391003 / US8807701029 / US9029251066 / US91347P1057 / US92343V1044 / US9507551086 / US9581021055 / TW0002330008 / US87157D1090 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US20030N1019 / US6402681083 / US09062X1037 / US1572101053 / US0042251084 / US02043Q1076 / US2538681030 / US19239V3024 / US2090341072 / US12541W2098 / US00206R1023 / ACOR.OQ / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US53261M1045 / US25470M1099 / US58933Y1055 / US34959E1091 / US1920051067 / US9100471096 / US03027X1000 / US30303M1027 / US9837931008 / US00287Y1091 / NL0010273215 / US81762P1021 / US8725901040 / US6974351057 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US22822V1017 / US74736K1016 / US29444U7000 / IE00BTN1Y115 / US00653A1079 / US12685J1051 / US02079K1079 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / CA87241L1094 / US78410G1040 / US83304A1060 / US91325V1089 / US23753F1075 / US80689H1023 / US02156K1034 / US4990491049 / US87105L1044 / US57777K1060 / US11135F1012 / US5904791358 / US0197701065 / US0144421072 / US90353T1007 / US18915M1071 / US09203E1055 / CH0499880968 / KYG3902L1095 / US5502411037 / US35909R1086 / US25401T1088 / US20717M1036 / US1920031010 / US02080L1026 / US35909D1090 / US23284C1027 / US2935941078 / KYG393871085 / KYG4701H1092 / US86337R1032 / US10576N1028 / US4181001037 / AU0000185993</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Abbott Laboratories / Agilent Technologies Inc / Akamai Technologies Inc / Alaska Air Group Inc / Amazon.com Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Bristol-Myers Squibb Co / CVS Health Corp / Cirrus Logic Inc / Covenant Logistics Group Inc / Edwards Lifesciences Corp / Expeditors International of Washington Inc / F5 Inc / GlaxoSmithKline PLC / Hologic Inc / Hub Group Inc / J B Hunt Transport Services Inc / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Micron Technology Inc / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / PerkinElmer Inc / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Semtech Corp / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Taiwan Semiconductor Manufacturing Co Ltd / Teradyne Inc / USA Truck Inc / Universal Display Corp / Verizon Communications Inc / Werner Enterprises Inc / Western Digital Corp / Taiwan Semiconductor Manufacturing Co Ltd / Synaptics Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / Comcast Corp / Nektar Therapeutics / Biogen Inc / CEVA Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / CH Robinson Worldwide Inc / AT&T Inc / Acorda Therapeutics Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / DISH Network Corp / Merck & Co Inc / Fortinet Inc / Codexis Inc / United Airlines Holdings Inc / American Tower Corp / Meta Platforms Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / ServiceNow Inc / T-Mobile US Inc / Palo Alto Networks Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Crown Castle International Corp / Qorvo Inc / Equinix Inc / Medtronic PLC / Adaptimmune Therapeutics PLC / Cable One Inc / Alphabet Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / TFI International Inc / SBA Communications Corp / Snap Inc / Uniti Group Inc / Daseke Inc / Schneider National Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Switch Inc / MaxCyte Inc / Broadcom Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Uber Technologies Inc / Cloudflare Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / GDS Holdings Ltd / Lumen Technologies Inc / Frontier Group Holdings Inc / DigitalBridge Group Inc / Confluent Inc / Codex DNA Inc / Alpha Teknova Inc / Frontier Communications Parent Inc / Cyxtera Technologies Inc / Enovix Corp / Globalfoundries Inc / IHS Holding Ltd / Stronghold Digital Mining Inc / Braze Inc / Hashicorp Inc / Iris Energy Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - CMS AD NCD & JPM Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 24, 2021 to January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US8336351056 / US0091581068 / US0126531013 / US0234361089 / US0311621009 / US0536111091 / US1101221083 / US2017231034 / US2788651006 / US3755581036 / US3976241071 / US4128221086 / US4180561072 / US4282911084 / US4448591028 / US45337C1027 / US4601461035 / US5324571083 / US5463471053 / US56418H1005 / US5719032022 / US5770811025 / US64125C1099 / US6516391066 / US6703461052 / US6935061076 / US6951561090 / US7170811035 / US7310681025 / US7496851038 / US7549071030 / US75886F1075 / US7703231032 / US7802871084 / US8243481061 / US8581191009 / US9113121068 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA25822C2058 / CA1469001053 / CA0679011084 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US37940X1028 / US2274831047 / US09062X1037 / US46625H1005 / US0605051046 / US20451N1019 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2971781057 / US1331311027 / US1508701034 / US2538681030 / CA8911605092 / CA1360691010 / US1011211018 / US2644115055 / US9290421091 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / US57636Q1040 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US59522J1034 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US5021751020 / US63633D1046 / US5500211090 / US89785X1019 / CA3518581051 / US92826C8394 / US58502B1061 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / CA55903Q1046 / US76131N1019 / US70509V1008 / CA38045Y1025 / US16208T1025 / US78573L1061 / US74965L1017 / US23283R1005 / CA05577W2004 / US71943U1043 / US60468T1051 / US9660842041 / US02665T3068 / US45378A1060 / US11120U1051 / US02005N1000 / US1785871013 / CA45868C1095 / US14174T1079 / BMG0750C1082 / US8621211007 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US9741551033 / US1638511089 / US4278255009 / US96145D1054 / US70450Y1038 / CA8485101031 / US95040Q1040 / US8522341036 / 100607060 / US45688C1071 / US53223X1072 / US0441861046 / CA26829L1076 / US7005171050 / US43300A2033 / US46187W1071 / CA9628791027 / GB00BF3ZNS54 / US87105L1044 / CA53680Q2071 / US46590V1008 / CA2960061091 / US3610081057 / CA8585221051 / US29261A1007 / US00191U1025 / US83200N1037 / US48251W1045 / CA4039254079 / US53814L1089 / IE00BZ12WP82 / CA13000C2058 / US2605571031 / GB00BJT16S69 / US73757R1023 / US26614N1028 / US5012701026 / US42250P1030 / CA92625W5072 / US14316J1088 / US47012E4035 / US69526K1051 / CA67079A1021 / US15202L1070 / CA00076T1057 / US11135E2037 / US00848J1043 / BMG6964L1072 / US0708301041 / US71844V2016 / US27923Q1094 / AU0000193666 / US4576791085</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Air Products and Chemicals Inc / Albemarle Corp / Amedisys Inc / Amgen Inc / Avery Dennison Corp / Bristol-Myers Squibb Co / Commercial Metals Co / Ecolab Inc / Gilead Sciences Inc / Greif Inc / Harley-Davidson Inc / Hasbro Inc / Hexcel Corp / Humana Inc / Incyte Corp / International Paper Co / Eli Lilly and Co / Louisiana-Pacific Corp / ManpowerGroup Inc / Marriott International Inc / Mattel Inc / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / PPG Industries Inc / Packaging Corp of America / Pfizer Inc / Polaris Inc / RPM International Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Royal Gold Inc / Sherwin-Williams Co / Steel Dynamics Inc / United Parcel Service Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Dorel Industries Inc / Cascades Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Global Payments Inc / Cross Country Healthcare Inc / Biogen Inc / JPMorgan Chase & Co / Bank of America Corp / Compass Minerals International Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Essex Property Trust Inc / Camden Property Trust / Celanese Corp / Digital Realty Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Mastercard Inc / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / Mid-America Apartment Communities Inc / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / Lululemon Athletica Inc / TrueBlue Inc / Franco-Nevada Corp / Visa Inc / MEDNAX Inc / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / MAG Silver Corp / Retail Opportunity Investments Corp / Pebblebrook Hotel Trust / GoGold Resources Inc / Chatham Lodging Trust / Sabra Health Care REIT Inc / RLJ Lodging Trust / CyrusOne Inc / BRP Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Whitestone REIT / American Homes 4 Rent / Independence Realty Trust Inc / Brixmor Property Group Inc / Ally Financial Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Axalta Coating Systems Ltd / STORE Capital Corp / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Wingstop Inc / Chemours Co / Hersha Hospitality Trust / Westrock Co / PayPal Holdings Inc / Spin Master Corp / Welltower Inc / Block Inc / First-Citizens Bank & Trust Co / Ingevity Corp / Life Storage Inc / Ashland Global Holdings Inc / ECN Capital Corp / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Invitation Homes Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Switch Inc / Lithium Americas Corp / JBG SMITH Properties / Ero Copper Corp / Funko Inc / Stelco Holdings Inc / Encompass Health Corp / ASGN Inc / Smartsheet Inc / KKR & Co Inc / H&R Real Estate Investment Trust / Livent Corp / Linde PLC / Calibre Mining Corp / Dow Inc / Tronox Holdings PLC / Postal Realty Trust Inc / Dupont De Nemours Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Carlyle Group Inc / JAKKS Pacific Inc / Pactiv Evergreen Inc / Nuvei Corp / Centerspace / Abc Technologies Holdings Inc / Broadstone Net Lease Inc / Agiliti Inc / Paysafe Ltd / Bath & Body Works Inc / Phillips Edison & Co Inc / Ecovyst Inc / Allkem Ltd / Innovid Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Chile / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 31, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Jan. 07, 2022</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACA / ATRC / INSP / IRTC / NBIX / ORCL / RAD / WMT / EW / ONEM.O / SSNC.O / CCRN.O / ICAD.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / ANGO.O / 156782104 / LHCG.O / CYCC.O / INFI.O / ENSG.O / 483548103 / 771195104 / ADUS.O / SLP.O / SPRO.O / 92857F107 / SRPT.O / OTIC.O / VBLT.O / EVH / CFMS.O / 100063846 / EDIT / VRAY / NTLA / ATNX.O / SLDB.O / 720795103 / TMDX / PSNL.O / NBSE.O / PNTG.O / HGEN.O / EVAX.O</td><td class="leftalignment">Arcosa Inc / AtriCure Inc / Inspire Medical Systems Inc / iRhythm Technologies Inc / Neurocrine Biosciences Inc / Oracle Corp / Rite Aid Corp / Walmart Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / ICAD Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / AngioDynamics Inc / Cerner Corp / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Roche Holding AG / Addus Homecare Corp / Simulations Plus Inc / Spero Therapeutics Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Otonomy Inc / Vascular Biogenics Ltd / Evolent Health Inc / Conformis Inc / Truist Financial Corp / Editas Medicine Inc / ViewRay Inc / Intellia Therapeutics Inc / Athenex Inc / Solid Biosciences Inc / Pieris Pharmaceuticals Inc / Transmedics Group Inc / Personalis Inc / NeuBase Therapeutics Inc / Pennant Group Inc / Humanigen Inc / Evaxion Biotech A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / ORCL / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / 156782104 / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Oracle Corp / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Cerner Corp / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 12/31/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AIN / CARS / FISV=US / LLY=US / AMGN=US / BMY=US / TWTR=US / AMZN=US / EBAY=US / GILD=US / PEB=US / H=US / CRM=US / V=US / MTN=US / VRM=US / MAR=US / EXPE=US / TNL=US / HLT=US / HUM=US / CVS=US / W=US / STZ=US / DV=US / AIR=US / ATRO=US / BLL=US / B=US / BMRN=US / CHH=US / CCK=US / CW=US / DRH=US / DCO=US / EEFT=US / HEI=US / HXL=US / TREE=US / MRCY=US / NRDS=US / REGN=US / ROLL=US / SHOP=US / SFT=US / SNAP=US / TRIP=US / TGI=US / TRUE=US / VSEC=US / VRTX=US / WIX=US / WEX=US / FOUR=US / GPN=US / PYPL=US / BKNG=US / PRI=US / FB=US / MTCH=US / SPR=US / EVOP=US / MQ / DKS=US / PTON=US / BIIB=US / FLT=US / MOG.A=US / APP=US / SHO=US / BLDR=US / FIS=US / TDG=US / HST=US / MA=US / WU=US / KTOS=US / WH=US / IAC=US / 45665G303 / HGV=US / GDOT=US / WWD=US / PCRX=US / RLJ=US / VAC=US / ANGI=US / RHP=US / SSTK=US / ABBV=US / GOOGL=US / BABA=US / AFMD=US / CMPR=US / BVH=US / WBA=US / GDDY=US / ETSY=US / AJRD=US / BWXT=US / ZG=US / SQ=US / IBEX=US / NTLA=US / TTD=US / CRSP=US / TRVG=US / PK=US / PLYA=US / AYX=US / CVNA=US / YEXT=US / RDFN=US / CARG=US / SFIX=US / ROOT=US / MAXR=US / GSKY=US / FTDR=US / EB=US / AXNX=US / LYFT=US / UBER=US / LSPD=US / APLT=US / LHX=US / RPAY=US / ONEW=US / SPCE=US / AZEK=US / TSHA / PAYA=US / ABNB=US / DASH=US / AFRM=US / VMEO=US / MNTV=US / SQSP=US / 00152K101</td><td class="leftalignment">Albany International Corp / Cars.com Inc / Fiserv Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Twitter Inc / Amazon.com Inc / eBay Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Visa Inc / Vail Resorts Inc / Vroom Inc / Marriott International Inc / Expedia Group Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Humana Inc / CVS Health Corp / Wayfair Inc / Constellation Brands Inc / DoubleVerify Holdings Inc / AAR Corp / Astronics Corp / Ball Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Crown Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / Euronet Worldwide Inc / HEICO Corp / Hexcel Corp / Lendingtree Inc / Mercury Systems Inc / Nerdwallet Inc / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Shopify Inc / Shift Technologies Inc / Snap Inc / Tripadvisor Inc / Triumph Group Inc / TrueCar Inc / VSE Corp / Vertex Pharmaceuticals Inc / Wix.Com Ltd / WEX Inc / Shift4 Payments Inc / Global Payments Inc / PayPal Holdings Inc / Booking Holdings Inc / Primerica Inc / Meta Platforms Inc / Match Group Inc / Spirit AeroSystems Holdings Inc / EVO Payments Inc / Marqeta Inc / DICK'S Sporting Goods Inc / Peloton Interactive Inc / Biogen Inc / Fleetcor Technologies Inc / Moog Inc / Applovin Corp / Sunstone Hotel Investors Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Host Hotels & Resorts Inc / Mastercard Inc / Western Union Co / Kratos Defense and Security Solutions Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / Green Dot Corp / Woodward Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Shutterstock Inc / Abbvie Inc / Alphabet Inc / Alibaba Group Holding Ltd / Affimed NV / Cimpress PLC / Bluegreen Vacations Holding Corp / Walgreens Boots Alliance Inc / GoDaddy Inc / ETSY Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Zillow Group Inc / Block Inc / Ibex Ltd / Intellia Therapeutics Inc / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Alteryx Inc / Carvana Co / Yext Inc / Redfin Corp / CarGurus Inc / Stitch Fix Inc / Root Inc / Maxar Technologies Inc / GreenSky Inc / Frontdoor Inc / Eventbrite Inc / Axonics Inc / Lyft Inc / Uber Technologies Inc / Lightspeed Commerce Inc / Applied Therapeutics Inc / L3harris Technologies Inc / Repay Holdings Corp / OneWater Marine Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Taysha Gene Therapies Inc / Paya Holdings Inc / Airbnb Inc / DoorDash Inc / Affirm Holdings Inc / Vimeo Inc / Momentive Global Inc / Squarespace Inc / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US8336351056 / US0126531013 / US0311621009 / US1101221083 / US3755581036 / US4448591028 / US45337C1027 / US5324571083 / US5463471053 / US5719032022 / US64125C1099 / US6516391066 / US7170811035 / US7549071030 / US75886F1075 / US7802871084 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA0679011084 / CA9528451052 / US09062X1037 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2538681030 / US1011211018 / US2644115055 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US63633D1046 / CA3518581051 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / US70509V1008 / US16208T1025 / US78573L1061 / US71943U1043 / US60468T1051 / CA45868C1095 / US14174T1079 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / CA9628791027 / US87105L1044 / CA53680Q2071 / CA2960061091 / US53814L1089 / CA13000C2058 / US2605571031 / US73757R1023 / US5012701026 / US42250P1030 / CA92625W5072 / US15202L1070 / US11135E2037 / US0708301041 / AU0000193666</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Albemarle Corp / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Humana Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Marriott International Inc / Neurocrine Biosciences Inc / Newmont Corporation / Pfizer Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Biogen Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Digital Realty Trust Inc / Boston Properties Inc / Duke Realty Corp / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / National Health Investors Inc / Franco-Nevada Corp / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Sabra Health Care REIT Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Interfor Corp / CareTrust REIT Inc / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Wheaton Precious Metals Corp / Switch Inc / Lithium Americas Corp / Ero Copper Corp / Livent Corp / Calibre Mining Corp / Dow Inc / Postal Realty Trust Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Centerspace / Broadstone Net Lease Inc / Bath & Body Works Inc / Allkem Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Chile / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ALTR.O / BOX.N / CNA.L / CP.TO / CRM.N / MSFT.O / NSC.N / PD.N / RWEG.DE / HUM.N / GILD.O / CHKP.O / INCY.O / CNR.TO / DRI.N / DT.N / CSX.N / ADBE.O / UNP.N / CTXS.O / NICE.O / EAT.N / MCD.N / CAG.N / YUM.N / DV.N / SYK.N / DVN.N / JAZZ.O / EXEL.O / AKAM.O / SBUX.O / ARNA.O / STZ.N / RRC.N / ADSK.O / ARE.N / NBIX.O / VTR.N / BMRN.O / VRTX.O / NET.N / VRNT.O / BLU.N / LTC.N / PEGA.OQ / NTCT.OQ / IMGN.O / HOOK.O / BCRX.O / ANSS.O / ICPT.O / FFIV.O / BIIB.O / MNKD.OQ / DPZ.N / TXRH.O / ACAD.O / MPW.N / CMG.N / CVLT.O / VMW.N / TDC.N / ABCA.L / INO.OQ / JACK.OQ / SWI.N / FTNT.O / RXDX.OQ / PCRX.O / MSP.N / WEN.O / SPLK.OQ / SRPT.O / PANW.N / QLYS.O / ABBV.N / INFA.N / ENTA.O / TMUS.N / PTCT.O / DOC.N / AGIO.O / 81762P102 / PTC.O / KPTI.O / XNCR.OQ / ITCI.O / COUP.N / VRNS.O / 922475108 / SAGE.OQ / HUBS.N / XENE.O / NEWR.N / CTRE.O / QSR.N / WBA.N / 03835T200 / CRBP.OQ / GLPG.O / PYPL.OQ / GBT.OQ / RPD.O / ZG.O / SQ.N / SCWX.O / NTLA.O / TWLO.N / TTD.O / NTNX.O / CRSP.OQ / OKTA.OQ / ATNX.O / SAIL.N / WELL.N / ZS.OQ / SMAR.N / DBX.O / VRCA.OQ / PRVB.O / ESTC.N / ALLO.OQ / SG.N / NBSE.OQ / ZM.O / FSLY.N / KRTX.OQ / MORF.OQ / CRWD.O / DOCU.N / PING.N / DDOG.O / APRE.OQ / IGMS.O / PEAK.N / NLOK.O / ETNB.O / DHC.O / PLRX.OQ / FOUR.N / ZI.O / MGNI.OQ / JAMF.O / DCT.O / PLTR.N / ASAN.N / SPRB.OQ / MTCR.O / SUMO.O / BSY.O / MCFE.OQ / LSPD.N / PUBM.O / AFRM.O / OLO.N / COUR.N / PATH.N / WING.N / XMTR.OQ / 9VC.F / TRMR.OQ / EVCM.O / NABL.N / PWSC.N / BASE.OQ / AVTX.OQ / CWAN.N / GTLB.OQ / ZD.OQ</td><td class="leftalignment">Altair Engineering Inc / Box Inc / Centrica PLC / Canadian Pacific Railway Ltd / Salesforce.Com Inc / Microsoft Corp / Norfolk Southern Corp / PagerDuty Inc / Rwe AG / Humana Inc / Gilead Sciences Inc / Check Point Software Technologies Ltd / Incyte Corp / Canadian National Railway Co / Darden Restaurants Inc / Dynatrace Inc / CSX Corp / Adobe Inc / Union Pacific Corp / Citrix Systems Inc / Nice Ltd / Brinker International Inc / McDonald's Corp / Conagra Brands Inc / Yum! Brands Inc / DoubleVerify Holdings Inc / Stryker Corp / Devon Energy Corp / Jazz Pharmaceuticals PLC / Exelixis Inc / Akamai Technologies Inc / Starbucks Corp / Arena Pharmaceuticals Inc / Constellation Brands Inc / Range Resources Corp / Autodesk Inc / Alexandria Real Estate Equities Inc / Neurocrine Biosciences Inc / Ventas Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Cloudflare Inc / Verint Systems Inc / BELLUS Health Inc / LTC Properties Inc / Pegasystems Inc / Netscout Systems Inc / ImmunoGen Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / ANSYS Inc / Intercept Pharmaceuticals Inc / F5 Inc / Biogen Inc / MannKind Corp / Domino's Pizza Inc / Texas Roadhouse Inc / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / Chipotle Mexican Grill Inc / Commvault Systems Inc / VMware Inc / Teradata Corp / Abcam PLC / Inovio Pharmaceuticals Inc / Jack in the Box Inc / SolarWinds Corp / Fortinet Inc / Prometheus Biosciences Inc / Pacira Biosciences Inc / Datto Holding Corp / Wendys Co / Splunk Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Qualys Inc / Abbvie Inc / Informatica Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Physicians Realty Trust / Agios Pharmaceuticals Inc / ServiceNow Inc / PTC Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Coupa Software Inc / Varonis Systems Inc / Veeva Systems Inc / SAGE Therapeutics Inc / HubSpot Inc / Xenon Pharmaceuticals Inc / New Relic Inc / CareTrust REIT Inc / Restaurant Brands International Inc / Walgreens Boots Alliance Inc / Aptose Biosciences Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / Global Blood Therapeutics Inc / Rapid7 Inc / Zillow Group Inc / Block Inc / SecureWorks Corp / Intellia Therapeutics Inc / Twilio Inc / Trade Desk Inc / Nutanix Inc / CRISPR Therapeutics AG / Okta Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Welltower Inc / Zscaler Inc / Smartsheet Inc / Dropbox Inc / Verrica Pharmaceuticals Inc / Provention Bio Inc / Elastic NV / Allogene Therapeutics Inc / Sweetgreen Inc / NeuBase Therapeutics Inc / Zoom Video Communications Inc / Fastly Inc / Karuna Therapeutics Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / DocuSign Inc / Ping Identity Holding Corp / Datadog Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / Healthpeak Properties Inc / NortonLifeLock Inc / 89Bio Inc / Diversified Healthcare Trust / Pliant Therapeutics Inc / Shift4 Payments Inc / ZoomInfo Technologies Inc / Magnite Inc / Jamf Holding Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Asana Inc / Spruce Biosciences Inc / Metacrine Inc / Sumo Logic Inc / Bentley Systems Inc / Mcafee Corp / Lightspeed Commerce Inc / PubMatic Inc / Affirm Holdings Inc / Olo Inc / Coursera Inc / UiPath Inc / Wingstop Inc / Xometry Inc / ATAI Life Sciences NV / Tremor International Ltd / EverCommerce Inc / N-Able Inc / PowerSchool Holdings Inc / Couchbase Inc / Avalo Therapeutics Inc / Clearwater Analytics Holdings Inc / GitLab Inc / Ziff Davis Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FY2022 Large-Cap Biotech Preview</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">BIIB=US / AMGN=US / LLY=US / BMY=US / GILD=US / BMRN=US / REGN=US / VRTX=US / ABBV=US</td><td class="leftalignment">Biogen Inc / Amgen Inc / Eli Lilly and Co / Bristol-Myers Squibb Co / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Top Catalysts in Our Universe to Watch In 1H2022</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / EXEL.O / ARNA.O / BMRN.O / VRTX.O / BLU.N / IMGN.O / ICPT.O / BIIB.O / MNKD.OQ / ACAD.O / SRPT.O / AGIO.O / SAGE.OQ / NTLA.O / CRSP.OQ / ATNX.O / VRCA.OQ / PRVB.O / ALLO.OQ</td><td class="leftalignment">Gilead Sciences Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / ImmunoGen Inc / Intercept Pharmaceuticals Inc / Biogen Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / SAGE Therapeutics Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Athenex Inc / Verrica Pharmaceuticals Inc / Provention Bio Inc / Allogene Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Gregory J. Renza, MD / Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Luca Issi, PHD / Yinglu Zhang / Leonid Timashev / Stephen Mallon / Jackie Yan / Lisa Walter</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech “Prep Pack” for Company Meetings</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / HOOK.O / BCRX.O / ICPT.O / BIIB.O / SRPT.O / ABBV.N / ENTA.O / PTCT.O / KPTI.O / ITCI.O / SAGE.OQ / XENE.O / CRBP.OQ / GLPG.O / NBSE.OQ / KRTX.OQ / IGMS.O / ETNB.O / PLRX.OQ / MTCR.O / 9VC.F</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Xenon Pharmaceuticals Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Pliant Therapeutics Inc / Metacrine Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Navigating the Virtual Circus: Expectations and Mgmt Qs for Next Week's Conf.</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">LLY/BIIB: Expectations Into CMS's Draft NCD for Anti-a-Beta Antibodies for AD</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US09062X1037 / US5324571083</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Starting With a Bang: Fund Flows Positive Into 2022</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105 / 670703107</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 6, 2022</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AES.N / BP.L / CCO.TO / CMS.N / DGE.L / EIX.N / ENI.MI / NA / REP.MC / SRCL.O / AMZN.O / GILD.O / INCY.O / AAL.L / REE.MC / XOM.N / ENEI.MI / JAZZ.O / MDRX.O / XEL.N / EXC.N / IG.MI / EXPE.O / NBIX.O / VRTX.O / CVX.N / SRG.MI / ENAG.MC / BLU.N / DCO.N / MTCH.OQ / HCSG.O / BCRX.O / ICPT.O / BIIB.O / FM.TO / 878742204 / TRN.MI / ACAD.O / RDSb.L / CS.TO / 443628102 / GALP.LS / PHR.N / SFR.AX / ADUS.OQ / RXDX.OQ / NEE.N / PCRX.O / GLEN.L / ANGI.OQ / VCRA.N / FB.O / SRPT.O / ADT.N / ENTA.O / PTCT.O / 46579R104 / WIX.O / KPTI.O / XNCR.OQ / ITCI.O / GOOGL.O / CIA.TO / NESF.L / CTLT.N / HQY.OQ / 03835T200 / GLPG.O / TDOC.N / GBT.OQ / ZG.O / TRHC.OQ / SNAP.N / RCM.OQ / CVNA.N / RDFN.O / CARG.O / CDMO.OQ / BKNG.O / OPRX.OQ / NXGN.O / LYFT.O / PINS.N / UBER.N / FVRR.N / HCAT.OQ / APRE.OQ / IGMS.O / VVNT.N / PLRX.OQ / OTRK.OQ / AEP.OQ / GDRX.O / TLMD.OQ / SHC.OQ / ABNB.OQ / DASH.N / SKLZ.N / BMBL.OQ / SQSP.N / TTEF.PA / 9VC.F / THRN.OQ / ASCU.TO</td><td class="leftalignment">AES Corp / BP PLC / Cameco Corp / CMS Energy Corp / Diageo PLC / Edison International / Eni SpA / National Bank of Canada / Repsol SA / Stericycle Inc / Amazon.com Inc / Gilead Sciences Inc / Incyte Corp / Anglo American PLC / Red Electrica Corporacion SA / Exxon Mobil Corp / Enel SpA / Jazz Pharmaceuticals PLC / Allscripts Healthcare Solutions Inc / Xcel Energy Inc / Exelon Corp / Italgas SpA / Expedia Group Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Snam SpA / Enagas SA / BELLUS Health Inc / Ducommun Inc / Match Group Inc / Healthcare Services Group Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / First Quantum Minerals Ltd / Teck Resources Ltd / Terna Rete Elettrica Nazionale SpA / ACADIA Pharmaceuticals Inc / Royal Dutch Shell PLC / Capstone Mining Corp / Hudbay Minerals Inc / Galp Energia SGPS SA / Phreesia Inc / Sandfire Resources Ltd / Addus Homecare Corp / Prometheus Biosciences Inc / Nextera Energy Inc / Pacira Biosciences Inc / Glencore PLC / Angi Inc / Vocera Communications Inc / Meta Platforms Inc / Sarepta Therapeutics Inc / ADT Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Ivanhoe Mines Ltd / Wix.Com Ltd / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Alphabet Inc / Champion Iron Ltd / NextEnergy Solar Fund Ltd / Catalent Inc / Healthequity Inc / Aptose Biosciences Inc / Galapagos NV / Teladoc Health Inc / Global Blood Therapeutics Inc / Zillow Group Inc / Tabula Rasa HealthCare Inc / Snap Inc / R1 RCM Inc / Carvana Co / Redfin Corp / CarGurus Inc / Avid Bioservices Inc / Booking Holdings Inc / OPTIMIZERx Corp / NextGen Healthcare Inc / Lyft Inc / Pinterest Inc / Uber Technologies Inc / Fiverr International Ltd / Health Catalyst Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / Vivint Smart Home Inc / Pliant Therapeutics Inc / Ontrak Inc / American Electric Power Company Inc / Goodrx Holdings Inc / Soc Telemed Inc / Sotera Health Co / Airbnb Inc / DoorDash Inc / Skillz Inc / Bumble Inc / Squarespace Inc / TotalEnergies SE / ATAI Life Sciences NV / Thorne Healthtech Inc / Arizona Sonoran Copper Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Spain / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">01/06/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / JAZZ.O / BLU.N / BIIB.O / ACAD.O / RXDX.OQ / SRPT.O / XNCR.OQ / ITCI.O / 03835T200 / GBT.OQ / APRE.OQ / IGMS.O / PLRX.OQ</td><td class="leftalignment">Gilead Sciences Inc / Jazz Pharmaceuticals PLC / BELLUS Health Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Prometheus Biosciences Inc / Sarepta Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / Pliant Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">4Q21/2022 Earnings Preview On Select Biotechs</td><td class="leftalignment">English</td><td class="rightalignment">90</td><td class="leftalignment">GILD.O / INCY.O / JAZZ.O / NBIX.O / VRTX.O / BLU.N / BCRX.O / ICPT.O / BIIB.O / ACAD.O / PCRX.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / 03835T200 / GLPG.O / GBT.OQ / 9VC.F</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Jazz Pharmaceuticals PLC / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Aptose Biosciences Inc / Galapagos NV / Global Blood Therapeutics Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Japan Outlook 2022: What to Own; What to Avoid</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">1301.TW / 2267.T / 2317.TW / 2502.T / 2503.T / 2593.T / 2810.T / 2815.T / 4063.T / 4185.T / 4186.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / 4901.T / 5101.T / 5108.T / 5110.T / 6361.T / 6407.T / 6501.T / 6502.T / 6503.T / 6701.T / 6702.T / 6752.T / 6753.T / 6758.T / 6806.T / 6902.T / 6952.T / 6976.T / 6981.T / 6988.T / 7201.T / 7203.T / 7259.T / 7267.T / 7282.T / 7453.T / 7532.T / 7733.T / 7751.T / 7752.T / 7762.T / 7951.T / 8282.T / 9432.T / 9433.T / 9434.T / 9613.T / 9983.T / ASML.AS / ATCOA.ST / BSX.N / DOW.N / ERICB.ST / FLS.N / MDT.N / PHG.AS / PLOF.PA / SAPJ.J / T.N / VOD.L / WAT.N / 6920.T / 4684.T / 7701.T / 4716.T / 4516.T / 2602.T / 9831.T / 4506.T / 4536.T / 6861.T / 9719.T / ROG.S / 6146.T / 5105.T / 7606.T / 2801.T / 4704.T / SIEGN.DE / SPOT.N / 6871.T / 4151.T / 4552.T / SYK.N / 4553.T / 9989.T / MGA.N / 8056.T / 4755.T / 4739.T / 2651.T / VZ.N / 6951.T / 2811.T / ORCL.N / KSBG.DE / 4768.T / 4902.T / 7649.T / 7518.T / 2201.T / 4540.T / 6869.T / 8050.T / 6995.T / 2264.T / 2590.T / 2670.T / 4307.T / 3116.T / 600690.SS / 4541.T / 2327.T / 000921.SZ / INTC.OQ / 000651.SZ / AMAT.OQ / SGEN.OQ / 6723.T / 005930.KS / 066570.KS / 2371.T / BIIB.OQ / 5949.T / 2413.T / 3349.T / 3774.T / 3382.T / 4568.T / 3436.T / WCHG.DE / ERIC.OQ / 3064.T / 3088.T / 3092.T / 3626.T / 3141.T / 6632.T / 2269.T / SHLG.DE / 4578.T / 2607.HK / 2282.HK / 4581.T / 3046.T / 2587.T / 4587.T / 2782.T / 7564.T / 3038.T / 000333.SZ / 6488.TWO / 3697.T / 6027.T / TMUS.OQ / 2296.T / 3563.T / 6690.HK / 4887.T</td><td class="leftalignment">Formosa Plastics Corp / Yakult Honsha Co Ltd / Hon Hai Precision Industry Co Ltd / Asahi Group Holdings Ltd / Kirin Holdings Co Ltd / Ito En Ltd / House Foods Group Inc / Ariake Japan Co Ltd / Shin-Etsu Chemical Co Ltd / JSR Corp / Tokyo Ohka Kogyo Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Fujifilm Holdings Corp / Yokohama Rubber Co Ltd / Bridgestone Corp / Sumitomo Rubber Industries Ltd / Ebara Corp / CKD Corp / Hitachi Ltd / Toshiba Corp / Mitsubishi Electric Corp / NEC Corp / Fujitsu Ltd / Panasonic Corp / Sharp Corp / Sony Group Corp / Hirose Electric Co Ltd / Denso Corp / Casio Computer Co Ltd / Taiyo Yuden Co Ltd / Murata Manufacturing Co Ltd / Nitto Denko Corp / Nissan Motor Co Ltd / Toyota Motor Corp / Aisin Corp / Honda Motor Co Ltd / Toyoda Gosei Co Ltd / Ryohin Keikaku Co Ltd / Pan Pacific International Holdings Corp / Olympus Corp / Canon Inc / Ricoh Co Ltd / Citizen Watch Co Ltd / Yamaha Corp / K'S Holdings Corp / Nippon Telegraph and Telephone Corp / KDDI Corp / SoftBank Corp / NTT Data Corp / Fast Retailing Co Ltd / ASML Holding NV / Atlas Copco AB / Boston Scientific Corp / Dow Inc / Telefonaktiebolaget LM Ericsson / Flowserve Corp / Medtronic PLC / Koninklijke Philips NV / Compagnie Plastic Omnium SE / Sappi Ltd / AT&T Inc / Vodafone Group PLC / Waters Corp / Lasertec Corp / Obic Co Ltd / Shimadzu Corp / Oracle Corp Japan / Nippon Shinyaku Co Ltd / Nisshin OilliO Group Ltd / Yamada Holdings Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Keyence Corp / SCSK Corp / Roche Holding AG / Disco Corp / Toyo Tire Corp / United Arrows Ltd / Kikkoman Corp / Trend Micro Inc / Siemens AG / Spotify Technology SA / Micronics Japan Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Stryker Corp / Towa Pharmaceutical Co Ltd / Sundrug Co Ltd / Magna International Inc / Nihon Unisys Ltd / Rakuten Group Inc / Itochu Techno-Solutions Corp / Lawson Inc / Verizon Communications Inc / JEOL Ltd / Kagome Co Ltd / Oracle Corp / KSB SE & Co KGaA / Otsuka Corp / Konica Minolta Inc / Sugi Holdings Co Ltd / Net One Systems Co Ltd / Morinaga & Co Ltd / Tsumura & Co / Sysmex Corp / Seiko Holdings Corp / Tokai Rika Co Ltd / Morinaga Milk Industry Co Ltd / DyDo Group Holdings Inc / ABC-Mart Inc / Nomura Research Institute Ltd / Toyota Boshoku Corp / Haier Smart Home Co Ltd / Nichi-Iko Pharmaceutical Co Ltd / NS Solutions Corp / Hisense Home Appliances Group Co Ltd / Intel Corp / Gree Electric Appliances Inc of Zhuhai / Applied Materials Inc / Seagen Inc / Renesas Electronics Corp / Samsung Electronics Co Ltd / LG Electronics Inc / Kakaku.com Inc / Biogen Inc / Unipres Corp / M3 Inc / Cosmos Pharmaceutical Corp / Internet Initiative Japan Inc / Seven & i Holdings Co Ltd / Daiichi Sankyo Co Ltd / Sumco Corp / Wacker Chemie AG / Telefonaktiebolaget LM Ericsson / MonotaRO Co Ltd / MatsukiyoCocokara & Co / ZOZO Inc / TIS Inc / Welcia Holdings Co Ltd / JVCkenwood Corp / Meiji Holdings Co Ltd / Siemens Healthineers AG / Otsuka Holdings Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / MGM China Holdings Ltd / Taisho Pharmaceutical Holdings Co Ltd / Jins Holdings Inc / Suntory Beverage & Food Ltd / PeptiDream Inc / Seria Co Ltd / Workman Co Ltd / Kobe Bussan Co Ltd / Midea Group Co Ltd / Globalwafers Co Ltd / Shift Inc / Bengo4.com Inc / T-Mobile US Inc / Itoham Yonekyu Holdings Inc / Food & Life Companies Ltd / Haier Smart Home Co Ltd / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Ireland / Japan / Korea, Republic of / Luxembourg / Netherlands / Sweden / Taiwan / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Hideyuki Maekawa / Mr. Takahiro Kazahaya</td></tr>
<tr class="odd"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">日本市場の2022年の展望: 持つべき銘柄・避けるべき銘柄</td><td class="leftalignment">Japanese</td><td class="rightalignment">59</td><td class="leftalignment">1301.TW / 2267.T / 2317.TW / 2502.T / 2503.T / 2593.T / 2810.T / 2815.T / 4063.T / 4185.T / 4186.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / 4901.T / 5101.T / 5108.T / 5110.T / 6361.T / 6407.T / 6501.T / 6502.T / 6503.T / 6701.T / 6702.T / 6752.T / 6753.T / 6758.T / 6806.T / 6902.T / 6952.T / 6976.T / 6981.T / 6988.T / 7201.T / 7203.T / 7259.T / 7267.T / 7282.T / 7453.T / 7532.T / 7733.T / 7751.T / 7752.T / 7762.T / 7951.T / 8282.T / 9432.T / 9433.T / 9434.T / 9613.T / 9983.T / ASML.AS / ATCOA.ST / BSX.N / DOW.N / ERICB.ST / FLS.N / MDT.N / PHG.AS / PLOF.PA / SAPJ.J / T.N / VOD.L / WAT.N / 6920.T / 4684.T / 7701.T / 4716.T / 4516.T / 2602.T / 9831.T / 4506.T / 4536.T / 6861.T / 9719.T / ROG.S / 6146.T / 5105.T / 7606.T / 2801.T / 4704.T / SIEGN.DE / SPOT.N / 6871.T / 4151.T / 4552.T / SYK.N / 4553.T / 9989.T / MGA.N / 8056.T / 4755.T / 4739.T / 2651.T / VZ.N / 6951.T / 2811.T / ORCL.N / KSBG.DE / 4768.T / 4902.T / 7649.T / 7518.T / 2201.T / 4540.T / 6869.T / 8050.T / 6995.T / 2264.T / 2590.T / 2670.T / 4307.T / 3116.T / 600690.SS / 4541.T / 2327.T / 000921.SZ / INTC.OQ / 000651.SZ / AMAT.OQ / SGEN.OQ / 6723.T / 005930.KS / 066570.KS / 2371.T / BIIB.OQ / 5949.T / 2413.T / 3349.T / 3774.T / 3382.T / 4568.T / 3436.T / WCHG.DE / ERIC.OQ / 3064.T / 3088.T / 3092.T / 3626.T / 3141.T / 6632.T / 2269.T / SHLG.DE / 4578.T / 2607.HK / 2282.HK / 4581.T / 3046.T / 2587.T / 4587.T / 2782.T / 7564.T / 3038.T / 000333.SZ / 6488.TWO / 3697.T / 6027.T / TMUS.OQ / 2296.T / 3563.T / 6690.HK / 4887.T</td><td class="leftalignment">Formosa Plastics Corp / Yakult Honsha Co Ltd / Hon Hai Precision Industry Co Ltd / Asahi Group Holdings Ltd / Kirin Holdings Co Ltd / Ito En Ltd / House Foods Group Inc / Ariake Japan Co Ltd / Shin-Etsu Chemical Co Ltd / JSR Corp / Tokyo Ohka Kogyo Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Fujifilm Holdings Corp / Yokohama Rubber Co Ltd / Bridgestone Corp / Sumitomo Rubber Industries Ltd / Ebara Corp / CKD Corp / Hitachi Ltd / Toshiba Corp / Mitsubishi Electric Corp / NEC Corp / Fujitsu Ltd / Panasonic Corp / Sharp Corp / Sony Group Corp / Hirose Electric Co Ltd / Denso Corp / Casio Computer Co Ltd / Taiyo Yuden Co Ltd / Murata Manufacturing Co Ltd / Nitto Denko Corp / Nissan Motor Co Ltd / Toyota Motor Corp / Aisin Corp / Honda Motor Co Ltd / Toyoda Gosei Co Ltd / Ryohin Keikaku Co Ltd / Pan Pacific International Holdings Corp / Olympus Corp / Canon Inc / Ricoh Co Ltd / Citizen Watch Co Ltd / Yamaha Corp / K'S Holdings Corp / Nippon Telegraph and Telephone Corp / KDDI Corp / SoftBank Corp / NTT Data Corp / Fast Retailing Co Ltd / ASML Holding NV / Atlas Copco AB / Boston Scientific Corp / Dow Inc / Telefonaktiebolaget LM Ericsson / Flowserve Corp / Medtronic PLC / Koninklijke Philips NV / Compagnie Plastic Omnium SE / Sappi Ltd / AT&T Inc / Vodafone Group PLC / Waters Corp / Lasertec Corp / Obic Co Ltd / Shimadzu Corp / Oracle Corp Japan / Nippon Shinyaku Co Ltd / Nisshin OilliO Group Ltd / Yamada Holdings Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Keyence Corp / SCSK Corp / Roche Holding AG / Disco Corp / Toyo Tire Corp / United Arrows Ltd / Kikkoman Corp / Trend Micro Inc / Siemens AG / Spotify Technology SA / Micronics Japan Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Stryker Corp / Towa Pharmaceutical Co Ltd / Sundrug Co Ltd / Magna International Inc / Nihon Unisys Ltd / Rakuten Group Inc / Itochu Techno-Solutions Corp / Lawson Inc / Verizon Communications Inc / JEOL Ltd / Kagome Co Ltd / Oracle Corp / KSB SE & Co KGaA / Otsuka Corp / Konica Minolta Inc / Sugi Holdings Co Ltd / Net One Systems Co Ltd / Morinaga & Co Ltd / Tsumura & Co / Sysmex Corp / Seiko Holdings Corp / Tokai Rika Co Ltd / Morinaga Milk Industry Co Ltd / DyDo Group Holdings Inc / ABC-Mart Inc / Nomura Research Institute Ltd / Toyota Boshoku Corp / Haier Smart Home Co Ltd / Nichi-Iko Pharmaceutical Co Ltd / NS Solutions Corp / Hisense Home Appliances Group Co Ltd / Intel Corp / Gree Electric Appliances Inc of Zhuhai / Applied Materials Inc / Seagen Inc / Renesas Electronics Corp / Samsung Electronics Co Ltd / LG Electronics Inc / Kakaku.com Inc / Biogen Inc / Unipres Corp / M3 Inc / Cosmos Pharmaceutical Corp / Internet Initiative Japan Inc / Seven & i Holdings Co Ltd / Daiichi Sankyo Co Ltd / Sumco Corp / Wacker Chemie AG / Telefonaktiebolaget LM Ericsson / MonotaRO Co Ltd / MatsukiyoCocokara & Co / ZOZO Inc / TIS Inc / Welcia Holdings Co Ltd / JVCkenwood Corp / Meiji Holdings Co Ltd / Siemens Healthineers AG / Otsuka Holdings Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / MGM China Holdings Ltd / Taisho Pharmaceutical Holdings Co Ltd / Jins Holdings Inc / Suntory Beverage & Food Ltd / PeptiDream Inc / Seria Co Ltd / Workman Co Ltd / Kobe Bussan Co Ltd / Midea Group Co Ltd / Globalwafers Co Ltd / Shift Inc / Bengo4.com Inc / T-Mobile US Inc / Itoham Yonekyu Holdings Inc / Food & Life Companies Ltd / Haier Smart Home Co Ltd / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Ireland / Japan / Korea, Republic of / Luxembourg / Netherlands / Sweden / Taiwan / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Hideyuki Maekawa / Mr. Takahiro Kazahaya</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US64125C1099 / US09062X1037 / US0042251084 / US40637H1095 / US23282W6057 / US46116X1019 / US45773H2013 / US68906L1052 / CA68620P1018 / US98986X1090 / CA1380351009 / US05464T1043 / US0327973006 / US75615P1030 / US24823R1059 / US03836N1037 / US22663K1079 / US88688T1007 / CA39342L1085 / CA22587M1068 / CA89788C1041 / US12482W1018 / US6700024010 / CA16106R1091 / CA23126M1023 / US1266541028 / CA05156X8843 / CA4283043079 / CA00489Y6001</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / Cytokinetics Inc / Intra-Cellular Therapies Inc / Inovio Pharmaceuticals Inc / Otonomy Inc / OrganiGram Holdings Inc / Zynerba Pharmaceuticals Inc / Canopy Growth Corp / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Reata Pharmaceuticals Inc / Denali Therapeutics Inc / Aptinyx Inc / Crinetics Pharmaceuticals Inc / Tilray Brands Inc / Green Thumb Industries Inc / Cresco Labs Inc / Trulieve Cannabis Corp / cbdMD Inc / Novavax Inc / Charlotte's Web Holdings Inc / Curaleaf Holdings Inc / CV Sciences Inc / Aurora Cannabis Inc / Hexo Corp / Acreage Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EA / INSP / INTC.O / MSFT / SONY / T / TTWO / ATVI.O / NVDA.O / HEAR / AMBA / VZ / NFLX / ICAD.O / BIIB / 78442P106 / 36467W109 / ZNGA / SRPT.O / FDEV.L / 82655M107 / EDIT / NTLA / SLDB.O / BILI.O / CRWD.O / GRWG / HUYA.K</td><td class="leftalignment">Electronic Arts Inc / Inspire Medical Systems Inc / Intel Corp / Microsoft Corp / Sony Group Corp / AT&T Inc / Take-Two Interactive Software Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Ambarella Inc / Verizon Communications Inc / Netflix Inc / ICAD Inc / Biogen Inc / SLM Corp / GameStop Corp / Zynga Inc / Sarepta Therapeutics Inc / Frontier Developments PLC / Sify Technologies Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Solid Biosciences Inc / Bilibili Inc / CrowdStrike Holdings Inc / GrowGeneration Corp / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAP / AR / AZO / BBY / BMY.N / BP.N / CHD / CL / CLR / CLX / CNX / COP / CPE / CVX / DVN / EL / EOG / EQT / FND / HD / HES / KMB / KO / LLY.N / LOW / MGY / MRK.N / MRO / MUR / OLN / OXY / PFE.N / PG / PXD / RH / RRC / SLB.N / SM / SPB / STZ / SWN / TAP.N / W / WLK / WLL / WSM / CNQ.TO / GILD.O / AMGN.O / HAL.N / EPC / MGM.N / SU.TO / BBBY.O / XOM / LBRT.N / PENN.O / LPI / REGN.O / VRTX.O / TSCO.O / COCO.O / SMG.N / WYNN.O / MNST.O / ORLY.O / WOOF.O / BIIB.O / NOV.N / RDSb / NOG.A / CZR.O / BKR.N / ESTE.K / MTDR.K / PDCE.O / AMBA.O / FANG.O / ABBV.N / GTLS.N / COTY.K / CIVI.K / TCON.O / CDEV.O / CVNA.K / IOVA.O / EYE.O / PEP.O / INSP.K / KDP.N / AVRO.O / BRY.O / NWL.O / FLTRF.L / OAS.O / OVV.N / DKNG.O / VRM.O / CTRA.K / GRWG.O / SFT.O / BALY.N / RSI.N / HYFM.O / CHK.O / JOAN.O / ZVIA.N / WEBR.N</td><td class="leftalignment">Advance Auto Parts Inc / Antero Resources Corp / Autozone Inc / Best Buy Co Inc / Bristol-Myers Squibb Co / BP PLC / Church & Dwight Co Inc / Colgate-Palmolive Co / Continental Resources Inc / Clorox Co / CNX Resources Corp / Conocophillips / Callon Petroleum Co / Chevron Corp / Devon Energy Corp / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Floor & Decor Holdings Inc / Home Depot Inc / Hess Corp / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lowe's Companies Inc / Magnolia Oil & Gas Corp / Merck & Co Inc / Marathon Oil Corp / Murphy Oil Corp / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Procter & Gamble Co / Pioneer Natural Resources Co / RH / Range Resources Corp / Schlumberger NV / SM Energy Co / Spectrum Brands Holdings Inc / Constellation Brands Inc / Southwestern Energy Co / Molson Coors Beverage Co / Wayfair Inc / Westlake Chemical Corp / Whiting Petroleum Corp / Williams-Sonoma Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Halliburton Co / Edgewell Personal Care Co / MGM Resorts International / Suncor Energy Inc / Bed Bath & Beyond Inc / Exxon Mobil Corp / Liberty Oilfield Services Inc / Penn National Gaming Inc / Laredo Petroleum Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Tractor Supply Co / Vita Coco Company Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / Monster Beverage Corp / O'Reilly Automotive Inc / Petco Health and Wellness Company Inc / Biogen Inc / Nov Inc / Royal Dutch Shell PLC / Northern Oil and Gas Inc / Caesars Entertainment Inc / Baker Hughes Co / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / Abbvie Inc / Chart Industries Inc / Coty Inc / Civitas Resources Inc / TRACON Pharmaceuticals Inc / Centennial Resource Development Inc / Carvana Co / Iovance Biotherapeutics Inc / National Vision Holdings Inc / PepsiCo Inc / Inspire Medical Systems Inc / Keurig Dr Pepper Inc / AVROBIO Inc / Berry Corporation (Bry) / Newell Brands Inc / Flutter Entertainment PLC / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Vroom Inc / Coterra Energy Inc / GrowGeneration Corp / Shift Technologies Inc / Bally's Corp / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Joann Inc / Zevia PBC / Weber Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Biopharma—Feedback From our Recent Launch; Slides attached–CC TMRW (1/5) 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">The Future of Genetic Medicine in Ophthalmology</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB / EDIT / NTLA</td><td class="leftalignment">Biogen Inc / Editas Medicine Inc / Intellia Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Jay Olson, CFA, III / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Donanemab Is On Our Mind; How We Think About Next Week's NCD Initial Determination</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">January "Monthly Controversies" report & '22 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">163</td><td class="leftalignment">US09062X1037 / US0311621009 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Biogen Inc / Amgen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Omicron Drives Unprecedented Number of Infections, Potentially Offsetting Decreased Severity; Oral Antivirals Get EUAs</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AGR / AIG / AJG / ALL / AME / AON / APO / AXP / AZO / BAC / CB / CCO / CMS / COF / DFS / DIS / DOW / DVN / FNB / FRC / GPS / HIG / IPG / JNJ / KKR / LLY.N / LNC / MA / MET / MMC / NSC / NTB / OLN / OMC / PGR / PNC / PNM / PRU / RE / RNR / SNV / SO / STZ / SYY / T / TFC / TRV / USB / V / WAL / AMZN.O / AUD.N / CMCSA.O / WWE / ASB / BRO / AAPL.O / CSCO.O / SBGI.O / GTN / SIRI.O / PACW.O / SYF / SNPS.O / CHTR.O / EXPE.O / CBSH.O / AXS / WBS / FBP.N / OFG.N / PBCT.O / SIVB.O / UMBF.O / BPOP.O / BOKF.O / ACGL.O / UMPQ.O / EWBC.O / PNFP.O / NFLX.O / BIIB.O / NXST.O / FHN / SBNY.O / VIAC.O / DISCA.O / ISBC.O / CNK.N / WRB.N / FTNT.O / IMAX.N / NXPI.O / FIBK.O / CZR.O / BKU / STAG.K / AMCX.O / FB.O / UIHC.O / ABBV.N / VOYA.K / FOXA.O / HMTV.O / MAR.O / GOOGL.O / ARES.K / BANC.K / TBK.O / QRVO.O / CABO.N / ZBH / TGNA.K / WLTW.O / FHB.O / LGFb.N / ATUS.N / BHF.O / BOMN.O / ROKU.O / EQH / SPOT.K / SSP.O / OZK.O / UBER.K / IHRT.O / AVTR.K / BRP.O / ROOT.O / VZIO.N / RYAN.N</td><td class="leftalignment">Avangrid Inc / American International Group Inc / Arthur J Gallagher & Co / Allstate Corp / AMETEK Inc / Aon PLC / Apollo Global Management Inc / American Express Co / Autozone Inc / Bank of America Corp / Chubb Ltd / Clear Channel Outdoor Holdings Inc / CMS Energy Corp / Capital One Financial Corp / Discover Financial Services / Walt Disney Co / Dow Inc / Devon Energy Corp / FNB Corp / First Republic Bank / Gap Inc / Hartford Financial Services Group Inc / Interpublic Group of Companies Inc / Johnson & Johnson / KKR & Co Inc / Eli Lilly and Co / Lincoln National Corp / Mastercard Inc / MetLife Inc / Marsh & McLennan Companies Inc / Norfolk Southern Corp / Bank of N T Butterfield & Son Ltd / Olin Corp / Omnicom Group Inc / Progressive Corp / PNC Financial Services Group Inc / PNM Resources Inc / Prudential Financial Inc / Everest Re Group Ltd / Renaissancere Holdings Ltd / Synovus Financial Corp / Southern Co / Constellation Brands Inc / Sysco Corp / AT&T Inc / Truist Financial Corp / Travelers Companies Inc / US Bancorp / Visa Inc / Western Alliance Bancorp / Amazon.com Inc / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Associated Banc-Corp / Brown & Brown Inc / Apple Inc / Cisco Systems Inc / Sinclair Broadcast Group Inc / Gray Television Inc / Sirius XM Holdings Inc / PacWest Bancorp / Synchrony Financial / Synopsys Inc / Charter Communications Inc / Expedia Group Inc / Commerce Bancshares Inc / AXIS Capital Holdings Ltd / Webster Financial Corp / First Bancorp / OFG Bancorp / People's United Financial Inc / SVB Financial Group / UMB Financial Corp / Popular Inc / BOK Financial Corp / Arch Capital Group Ltd / Umpqua Holdings Corp / East West Bancorp Inc / Pinnacle Financial Partners Inc / Netflix Inc / Biogen Inc / Nexstar Media Group Inc / First Horizon Corp / Signature Bank / ViacomCBS Inc / Discovery Inc / Investors Bancorp Inc / Cinemark Holdings Inc / W R Berkley Corp / Fortinet Inc / Imax Corp / NXP Semiconductors NV / First Interstate BancSystem Inc / Caesars Entertainment Inc / BankUnited Inc / STAG Industrial Inc / AMC Networks Inc / Meta Platforms Inc / United Insurance Holdings Corp / Abbvie Inc / Voya Financial Inc / Fox Corp / Hemisphere Media Group Inc / Marriott International Inc / Alphabet Inc / Ares Management Corp / Banc of California Inc / Triumph Bancorp Inc / Qorvo Inc / Cable One Inc / Zimmer Biomet Holdings Inc / Tegna Inc / Willis Towers Watson PLC / First Hawaiian Inc / Lions Gate Entertainment Corp / Altice USA Inc / Brighthouse Financial Inc / Boston Omaha Corp / Roku Inc / Equitable Holdings Inc / Spotify Technology SA / E W Scripps Co / Bank Ozk / Uber Technologies Inc / iHeartMedia Inc / Avantor Inc / BRP Group Inc / Root Inc / Vizio Holding Corp / Ryan Specialty Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Luxembourg / Netherlands / Puerto Rico / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Jan. 2022</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ABT.N / BA.N / BAC.N / C.N / CCL.N / CF.N / CNC.N / COF.N / CRM.N / EOG.N / F.N / FLT.N / GE.N / GPS.N / JPM.N / LLY.N / LUV.N / MDT.N / PFE.N / RHI.N / T.N / TMO.N / WFC.N / DRE.N / SPG.N / PG.N / NUE.N / DIS.N / UNH.N / TFX.N / HD.N / LOW.N / MRO.N / XOM.N / DVN.N / IT.N / GWW.N / VZ.N / V.N / ACN.N / PLD.N / TWTR.N / MAA.N / HPQ.N / COP.N / AOS.N / AAPL.OQ / AMAT.OQ / CERN.OQ / CSCO.OQ / FISV.OQ / ATVI.OQ / MSFT.OQ / XLNX.OQ / ODFL.OQ / QCOM.OQ / COST.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / CTXS.OQ / NVDA.OQ / CHTR.OQ / MTCH.OQ / GPN.N / VRTX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / EXR.N / MKTX.OQ / LVS.N / VIAC.OQ / DISCA.OQ / FIS.N / STX.AX / WU.N / IPGP.OQ / MRNA.OQ / AVGO.OQ / FTNT.OQ / TSLA.OQ / CZR.OQ / AMD.OQ / FANG.OQ / ABBV.N / LEGN.DE / NCLH.N / GOOGL.OQ / PAYC.N / ANET.N / ZBH.N / PYPL.OQ / TMUS.OQ / LW.N / FB.PS / TER.OQ / APA.OQ / VTRS.OQ</td><td class="leftalignment">Abbott Laboratories / Boeing Co / Bank of America Corp / Citigroup Inc / Carnival Corp / CF Industries Holdings Inc / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / Gap Inc / JPMorgan Chase & Co / Eli Lilly and Co / Southwest Airlines Co / Medtronic PLC / Pfizer Inc / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Duke Realty Corp / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Exxon Mobil Corp / Devon Energy Corp / Gartner Inc / W W Grainger Inc / Verizon Communications Inc / Visa Inc / Accenture PLC / Prologis Inc / Twitter Inc / Mid-America Apartment Communities Inc / HP Inc / Conocophillips / A O Smith Corp / Apple Inc / Applied Materials Inc / Cerner Corp / Cisco Systems Inc / Fiserv Inc / Activision Blizzard Inc / Microsoft Corp / Xilinx Inc / Old Dominion Freight Line Inc / Qualcomm Inc / Costco Wholesale Corp / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / Citrix Systems Inc / NVIDIA Corp / Charter Communications Inc / Match Group Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Extra Space Storage Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Western Union Co / IPG Photonics Corp / Moderna Inc / Broadcom Inc / Fortinet Inc / Tesla Inc / Caesars Entertainment Inc / Advanced Micro Devices Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Paycom Software Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / San Miguel Food and Beverage Inc / Teradyne Inc / APA Corp (US) / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Germany / Ireland / Panama / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BIIB/LLY—Recasting Our Alz Scenarios for Aduhelm Price Cut</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BIIB.O / LLY.N</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch First Quarter 2022</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">014442107 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Alector Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / John Boyle / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 12/24/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jan 4 2022</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">FR0000120271 / GB0007980591 / US00971T1016 / US0116591092 / US0463531089 / US0556221044 / US1101221083 / US30231G1022 / US37733W1053 / US4062161017 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / AN8068571086 / US8308791024 / US8447411088 / US91913Y1001 / US92343V1044 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US80105N1054 / US20030N1019 / LU0156801721 / US6402681083 / US88031M1099 / US09062X1037 / US0042251084 / US02043Q1076 / GB00B03MLX29 / US2538681030 / US19239V3024 / RDSa.AS / US2090341072 / US00206R1023 / US1314761032 / PAP310761054 / US01748X1028 / US2473617023 / US53261M1045 / US25470M1099 / US00507V1098 / US58933Y1055 / US88160R1014 / US9100471096 / US0995021062 / US4361061082 / US56585A1025 / US03027X1000 / US7185461040 / US69318G1067 / US00287Y1091 / US98978V1035 / US81762P1021 / US8725901040 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / US69888T2078 / US0465131078 / CA0089118776 / US22822V1017 / US29444U7000 / US00653A1079 / US12685J1051 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / GB00BDSFG982 / US78410G1040 / US91325V1089 / US05722G1004 / US24665A1034 / US02156K1034 / US87105L1044 / US5904791358 / US28414H1032 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968 / US15872M1045 / KYG3902L1095 / US62955J1034 / US5502411037 / US25401T1088 / US20717M1036 / US35909D1090 / KYG4701H1092 / US10576N1028 / US4181001037</td><td class="leftalignment">TotalEnergies SE / BP PLC / Akamai Technologies Inc / Alaska Air Group Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Exxon Mobil Corp / GlaxoSmithKline PLC / Halliburton Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Schlumberger NV / SkyWest Inc / Southwest Airlines Co / Valero Energy Corp / Verizon Communications Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Comcast Corp / Tenaris SA / Nektar Therapeutics / Tenaris SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Royal Dutch Shell PLC / Consolidated Communications Holdings Inc / AT&T Inc / Calumet Specialty Products Partners LP / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / DISH Network Corp / Activision Blizzard Inc / Merck & Co Inc / Tesla Inc / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / HollyFrontier Corp / Marathon Petroleum Corp / American Tower Corp / Phillips 66 / PBF Energy Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / T-Mobile US Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Air Canada / Crown Castle International Corp / Equinix Inc / Adaptimmune Therapeutics PLC / Cable One Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / TechnipFMC PLC / SBA Communications Corp / Uniti Group Inc / Baker Hughes Co / Delek US Holdings Inc / Altice USA Inc / Switch Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / ChampionX Corp / GDS Holdings Ltd / Nov Inc / Lumen Technologies Inc / DigitalBridge Group Inc / Confluent Inc / Frontier Communications Parent Inc / IHS Holding Ltd / Braze Inc / Hashicorp Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Luxembourg / Mexico / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GBT=US / GILD=US / H=US / CRM=US / MTN=US / HSII=US / MAR=US / TNL=US / KFRC=US / HLT=US / KFY=US / AMN=US / PATH=US / CHH=US / COLL=US / MAN=US / ASGN=US / RARE=US / REGN=US / RHI=US / VRTX=US / SAGE=US / CCRN=US / JAZZ=US / COP=US / APPN=US / INST=US / BDSI=US / MRNS=US / BIIB=US / RNG=US / APTX=US / XM=US / NSP=US / HST=US / CPRX=US / WH=US / HGV=US / VAC=US / RHP=US / FATE=US / CNCE=US / FIVN=US / AFMD=US / HUBS=US / BVH=US / WK=US / RLMD=US / VKTX=US / ARGX=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / PK=US / ANAB=US / PLYA=US / VRNA=US / ARVN=US / CYCN=US / TSHA / COUR=US / UDMY=US / USER=US</td><td class="leftalignment">Global Blood Therapeutics Inc / Gilead Sciences Inc / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Heidrick & Struggles International Inc / Marriott International Inc / Travel + Leisure Co / Kforce Inc / Hilton Worldwide Holdings Inc / Korn Ferry / AMN Healthcare Services Inc / UiPath Inc / Choice Hotels International Inc / Collegium Pharmaceutical Inc / ManpowerGroup Inc / ASGN Inc / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Vertex Pharmaceuticals Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Jazz Pharmaceuticals PLC / Conocophillips / Appian Corp / Instructure Holdings Inc / BioDelivery Sciences International Inc / Marinus Pharmaceuticals Inc / Biogen Inc / RingCentral Inc / Aptinyx Inc / Qualtrics International Inc / Insperity Inc / Host Hotels & Resorts Inc / Catalyst Pharmaceuticals Inc / Wyndham Hotels & Resorts Inc / Hilton Grand Vacations Inc / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Five9 Inc / Affimed NV / HubSpot Inc / Bluegreen Vacations Holding Corp / Workiva Inc / Relmada Therapeutics Inc / Viking Therapeutics Inc / argenx SE / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / AnaptysBio Inc / Playa Hotels & Resorts NV / Verona Pharma PLC / Arvinas Inc / Cyclerion Therapeutics Inc / Taysha Gene Therapies Inc / Coursera Inc / Udemy Inc / UserTesting Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">2000019 / 2023607 / 2437071 / 2216850 / 2222631 / 2542049 / 2576941 / 2328915 / 2455965 / 2457864 / 2657802 / 2989301 / 4595739 / 2713317 / B616C79 / BCZS820 / BFDV8K0 / BBPK0J0 / B3V9F12 / BP4GNK9 / BYZLV46 / BF4VBS8 / BK0VHF6 / BDHF4K6 / BZBY005 / BJLKVS6 / BYZR4X4 / BGCYWN8 / BJXBP30 / BYQHPK7 / BYYWPW6 / BDVLM39 / BDZ30Q0 / BJMLSD2 / BYTJZL1 / BK71LV3 / BMPRZV5 / BMC5RV6 / BNG3RZ7 / BMZ9Z11 / BMXXBD9 / BLF0CW7 / BFYVZ75 / BJLV8T9 / BMW5084 / BP0TJN7 / BMW5LX6</td><td class="leftalignment">Amazon.com Inc / Amgen Inc / Biomarin Pharmaceutical Inc / Consolidated Edison Inc / Cooper Companies Inc / Dominion Energy Inc / Exelixis Inc / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / OGE Energy Corp / TJX Companies Inc / Genmab A/S / ACADIA Pharmaceuticals Inc / Tesla Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / PVH Corp / SAGE Therapeutics Inc / InflaRx NV / BioXcel Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Phathom Pharmaceuticals Inc / Axsome Therapeutics Inc / Xencor Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / argenx SE / Arvinas Inc / Karuna Therapeutics Inc / Zogenix Inc / Relmada Therapeutics Inc / Kymera Therapeutics Inc / Adicet Bio Inc / Leslie's Inc / Prometheus Biosciences Inc / Figs Inc / Repare Therapeutics Inc / Seelos Therapeutics Inc / Celldex Therapeutics Inc / PMV Pharmaceuticals Inc / Xponential Fitness Inc / Eliem Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, January 3, 2022</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0231351067 / US64110L1061 / US09062X1037 / TSLA.OQ / US30303M1027 / GOOGL.OQ / US8982021060 / 94419L101 / US98954M1018 / 83304A106 / G11196105 / APRN.N / 860897107 / 92915B106 / L8681T102 / EVER.OQ / 54738L109 / 29786A106 / 55087P104 / 90353T100 / 70614W100 / 26142R104 / 34380C102 / 25401G106 / 58450V104 / 009066101 / 75724T103</td><td class="leftalignment">Amazon.com Inc / Netflix Inc / Biogen Inc / Tesla Inc / Meta Platforms Inc / Alphabet Inc / Trupanion Inc / Wayfair Inc / Zillow Group Inc / Snap Inc / Biohaven Pharmaceutical Holding Company Ltd / Blue Apron Holdings Inc / Stitch Fix Inc / Voyager Therapeutics Inc / Spotify Technology SA / EverQuote Inc / Lovesac Co / ETSY Inc / Lyft Inc / Uber Technologies Inc / Peloton Interactive Inc / DraftKings Inc / Fluent Inc / Digital Media Solutions Inc / Mediaalpha Inc / Airbnb Inc / Redbox Entertainment Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Previewing 2022 — We See Several Opportunities Within the Neurology and Immunology Therapeutics Categories</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">2713317 / BDRW1L7 / 2455965 / 2623911 / 2730190 / BQPVQZ6 / BP4GNK9 / BYZLV46 / BF4VBS8 / BJLKVS6 / BYZR4X4 / BZ05388 / BDVLM39 / BJMLSD2 / BYTJZL1 / BRJ3GY4 / BG0Q4Y1 / BK71LV3 / BF3N4P3 / BJRFSB7 / BN0XTW4 / BMZ9Z11 / BLR6S36 / BMHR7K6 / BFYVZ75 / BJLV8T9 / BMW5LX6 / BP96C52</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / AnaptysBio Inc / Biogen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Horizon Therapeutics PLC / SAGE Therapeutics Inc / InflaRx NV / BioXcel Therapeutics Inc / Phathom Pharmaceuticals Inc / Axsome Therapeutics Inc / Global Blood Therapeutics Inc / argenx SE / Karuna Therapeutics Inc / Zogenix Inc / Xenon Pharmaceuticals Inc / Exicure Inc / Relmada Therapeutics Inc / Arena Pharmaceuticals Inc / Immunovant Inc / Orphazyme A/S / Prometheus Biosciences Inc / Longboard Pharmaceuticals Inc / Impel Neuropharma Inc / Seelos Therapeutics Inc / Celldex Therapeutics Inc / Eliem Therapeutics Inc / Surrozen Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Denmark / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Retail Pharmacy & General Outsourcing Outperform; Foregone Care by Medicare Beneficiaries During Pandemic</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen's Biotech Thermometer</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US0465131078 / US00653A1079 / US05464T1043 / US00773U1088 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / China / Germany / Denmark / United Kingdom / Ireland / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">01/02/2022</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Aduhelm albatross means BIIB is at an interesting point; PT from $390 to $335, maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sumant Kulkarni / Kyle Qian</td></tr>
<tr class="even"><td class="leftalignment">01/02/2022</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">1H22 Biopharma Catalyst Calendar</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">375558103 / 031162100 / 766559603 / 09062X103 / 92532F100 / 09061G101 / 75886F107 / 30161Q104 / 02043Q107 / 036642106 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 68375N103 / 00287Y109 / 29251M106 / 23282W605 / G50871105 / 03835T200 / 78667J108 / 03209R103 / 16383L106 / 868459108 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 52187K101 / G11196105 / 81750R102 / 462260100 / 558868105 / 68404V100 / 98401F105 / 23284F105 / 03168L105 / 80706P103 / 29014R103 / 039697107 / 140755109 / H17182108 / 67576A100 / 761330109 / 41358P106 / 87808K106 / 483347100 / 37890U108 / 29668H708 / 68906L105 / 04016X101 / 87184Q107 / 481116101 / 59935V107 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 64049K104 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 05454B105 / 729139105 / 00972D105 / 760273102 / 00973J101 / 282559103 / 02155H200 / 03969T109 / 24344T101 / 80810D103 / 92243A200 / 74366E102 / 00166B105 / 45790W108 / 04335A105 / 23257D103 / 76029N106 / 4525EP101 / 46565G104 / 52490G102 / 75382E109 / 38341P102 / 501575104 / 14147L108 / 53272L103 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 83422E105 / 50107A104 / 01626L105 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 92556V106 / 03890D108 / 03835L207 / 413197104 / 002120202 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 00288U106 / 38406L103 / 92941V209 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 75974E103 / 09077A106 / 75082Q105 / 23954D109 / 15673T100 / 61225M102 / 730541109 / 670703107 / 68217N105 / 87978U108 / 00032Q104</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / Alnylam Pharmaceuticals Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / OPKO Health Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Jazz Pharmaceuticals PLC / Aptose Biosciences Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Supernus Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Xencor Inc / CytomX Therapeutics Inc / Amneal Pharmaceuticals Inc / Scholar Rock Holding Corp / Eloxx Pharmaceuticals Inc / Ardelyx Inc / Cara Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / ESSA Pharma Inc / Otonomy Inc / argenx SE / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Milestone Pharmaceuticals Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Neoleukin Therapeutics Inc / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Axcella Health Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / Akouos Inc / 89Bio Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Schrodinger Inc / Vaxart Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Replimune Group Inc / Immunic Inc / Iteos Therapeutics Inc / Legend Biotech Corp / Rapt Therapeutics Inc / Gossamer Bio Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Liminal BioSciences Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Solid Biosciences Inc / Kronos Bio Inc / Aligos Therapeutics Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Viatris Inc / Aravive Inc / Aptevo Therapeutics Inc / Harmony Biosciences Holdings Inc / aTyr Pharma Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Abcellera Biologics Inc / Gracell Biotechnologies Inc / Vyne Therapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Reneo Pharmaceuticals Inc / Biomea Fusion Inc / Rain Therapeutics Inc / Day One Biopharmaceuticals Inc / Century Therapeutics Inc / Monte Rosa Therapeutics Inc / POINT Biopharma Global Inc / Nuvalent Inc / Omega Therapeutics Inc / Tempest Therapeutics Inc / Aadi Bioscience Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Mr. Do G. Kim / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff / Mr. Allison M. Bratzel, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/02/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Large Cap Biotech: Price Increases as of Jan 1, 2022 for BIIB, GILD, REGN and VRTX products</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / GILD.OQ / REGN.OQ / VRTX.OQ / GILD=US / REGN=US / VRTX=US / BIIB=US</td><td class="leftalignment">Biogen Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/01/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/01/2022</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 580</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Biogen decreases 2.0% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Biogen tumbles 16% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">M&A Event Not Implausible, Though Seems Relatively Unlikely At This Time Without Substantial CVRs</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB: Updating model to reflect lower Alz Ds forecasts</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Ending the Year on a Positive Note - Biotech Inflows Close Out 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105 / 670703107</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Biogen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report</td><td class="leftalignment">English</td><td class="rightalignment">250</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Biogen, Inc.</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MGY=US / MUR=US / MRO=US / MGM=US / BIIB=US / CZR=US / OAS=US / ROCC=US</td><td class="leftalignment">Magnolia Oil & Gas Corp / Murphy Oil Corp / Marathon Oil Corp / MGM Resorts International / Biogen Inc / Caesars Entertainment Inc / Oasis Petroleum Inc / Ranger Oil Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BP.N / COP / CVX / DK / HES / HFC / MPC / MUR / OXY / PSX / RKT / SLB.N / VLO / CNQ.TO / HAL.N / SU.TO / XOM / PBF / LBRT.N / BIIB.O / NOV.N / RDSb / CLMT.O / BKR.N / GTLS.N / PFSI.K / HMPT.O</td><td class="leftalignment">BP PLC / Conocophillips / Chevron Corp / Delek US Holdings Inc / Hess Corp / HollyFrontier Corp / Marathon Petroleum Corp / Murphy Oil Corp / Occidental Petroleum Corp / Phillips 66 / Rocket Companies Inc / Schlumberger NV / Valero Energy Corp / Canadian Natural Resources Ltd / Halliburton Co / Suncor Energy Inc / Exxon Mobil Corp / PBF Energy Inc / Liberty Oilfield Services Inc / Biogen Inc / Nov Inc / Royal Dutch Shell PLC / Calumet Specialty Products Partners LP / Baker Hughes Co / Chart Industries Inc / PennyMac Financial Services Inc / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">2328915 / 2455965 / 2689560 / B7VD3F2</td><td class="leftalignment">Nextera Energy Inc / Biogen Inc / PG&E Corp / Duke Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">207940.KS: Samsung Biologics Co., Ltd. - The Biogen news turns out to be untrue; still, Samsung on the verge of making a long-term strategic decision</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / 207940.KS</td><td class="leftalignment">Biogen Inc / Samsung Biologics Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB + Samsung? Now THAT takes some nerve....</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Andrew Galler / Dr. Tim M. Anderson, MD</td></tr>
<tr class="even"><td class="leftalignment">12/29/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Samsung for Biogen = smart thing(s) or not? Maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sumant Kulkarni / Kyle Qian</td></tr>
<tr class="odd"><td class="leftalignment">12/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Christmas Miracle on Binney St?  Maybe in 2022, but a Samsung Deal Would be Surprising</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar</td></tr>
<tr class="even"><td class="leftalignment">12/29/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">top 4 Q's on Samsung</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">12/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Let the Games Begin</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB / SAGE</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Jay Olson, CFA, III / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">12/29/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">survey time</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">12/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BIIB: Is Buyout of Biosimilar JV More Likely than M&A? BIIB's JV Stake Could Be Worth $5B</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Relevant questions around a potential acquisition</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">12/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Samsung Coming to BIIB's Rescue? Is the Price Fair? Depends On Your Optimism Around BIIB's Amyloid Beta Franchise</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Samsung for Biogen Wouldn’t be the Craziest Deal Ever</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Biotech 2021 Recap and Predictions for 2022</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">04683R106 / 09061G101 / 03116210 / 64125C109 / 110122108 / 09062X103 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Atea Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">RARE / BIIB / ALNY.O / IONS.O / ATXS.O</td><td class="leftalignment">Ultragenyx Pharmaceutical Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Thoughts on Angelman; Weakness Associated with Competitor ATTR Failure Seems Misplaced</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">IONS.O / RARE / BIIB / ALNY.O</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Biogen Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter / Zhiqi He, Ph.D., CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Race to the Bottom? Which Biopharma Has Most LOE Risk in 2025-30 Period?</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Medical Staffing & Physician Outsourcing Outperform; Healthcare Workers COVID-19 and Work Intentions Survey</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">CAH.N / CI.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / CYH.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / LHCG.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N / CLOV.OQ / OSCR.N / AVAH.N</td><td class="leftalignment">Cardinal Health Inc / Cigna Corp / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Community Health Systems Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / LHC Group Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp / Clover Health Investments Corp / Oscar Health Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="odd"><td class="leftalignment">12/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Nice Stocking Stuffer - Fund Flows Decidedly Positive This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">12/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 17 to 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US02553E1064 / US0311621009 / US0530151036 / US0584981064 / US0936711052 / US1101221083 / US2017231034 / US2371941053 / US3647601083 / US3703341046 / US3755581036 / US45337C1027 / US5324571083 / US5951121038 / US64125C1099 / US6541061031 / US6556641008 / US6703461052 / US7043261079 / US7170811035 / US75886F1075 / US7782961038 / US8000131040 / US8168511090 / US8270481091 / US8354951027 / US8581191009 / US8589121081 / US8725401090 / US9170471026 / US9182041080 / US92276F1003 / US92532F1003 / US9746371007 / CA1249003098 / CA8029121057 / CA30150P1099 / CA1469001053 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / US2283681060 / US2274831047 / US09062X1037 / US0534841012 / US29476L1070 / US2971781057 / CA8911605092 / CA1360691010 / US74144T1088 / US1011211018 / US2644115055 / US9290421091 / CA6445351068 / US9043111072 / US7376301039 / CA1375761048 / US9026531049 / US25960P1093 / US49427F1084 / CA3499151080 / US5500211090 / US02913V1035 / US90384S3031 / US3886891015 / US58933Y1055 / US18538R1032 / US74340W1036 / US6936561009 / US7512121010 / CA07380N1042 / CA96145A2002 / US4440971095 / US78573L1061 / GB00B11DNM70 / US60468T1051 / US1220171060 / US2921041065 / US1785871013 / CA45868C1095 / US14174T1079 / US96145D1054 / US72703H1014 / US95040Q1040 / CA26829L1076 / US7495271071 / CA9628791027 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / US03843E1047 / KYG370921069 / VGG1890L1076 / US73757R1023 / US76156B1070 / US88339P1012 / CA29446Y5020 / US70614W1009 / CA04302L1004 / US82575P1075 / US26484T1060 / US15202L1070 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027 / US1374041093</td><td class="leftalignment">American Eagle Outfitters Inc / Amgen Inc / Automatic Data Processing Inc / Ball Corp / H & R Block Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darden Restaurants Inc / Gap Inc / General Mills Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Micron Technology Inc / Neurocrine Biosciences Inc / Nike Inc / Nordstrom Inc / Nucor Corp / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sanderson Farms Inc / Sempra Energy / Silgan Holdings Inc / Sonoco Products Co / Steel Dynamics Inc / Stericycle Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / CCL Industries Inc / Saputo Inc / Exco Technologies Ltd / Cascades Inc / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Crown Holdings Inc / Cross Country Healthcare Inc / Biogen Inc / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / T Rowe Price Group Inc / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / New Gold Inc / Under Armour Inc / Potlatchdeltic Corp / Canfor Corp / UDR Inc / Douglas Emmett Inc / Kilroy Realty Corp / Fortuna Silver Mines Inc / Lululemon Athletica Inc / American Public Education Inc / Ulta Beauty Inc / Graphic Packaging Holding Co / Merck & Co Inc / Clearwater Paper Corp / Prologis Inc / PVH Corp / Ralph Lauren Corp / Bear Creek Mining Corp / Westshore Terminals Investment Corp / Hudson Pacific Properties Inc / Sabra Health Care REIT Inc / Horizonte Minerals PLC / Mirati Therapeutics Inc / Burlington Stores Inc / Empire State Realty Trust Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Westrock Co / Planet Fitness Inc / Welltower Inc / ECN Capital Corp / REV Group Inc / Wheaton Precious Metals Corp / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Aquestive Therapeutics Inc / Galaxy Digital Holdings Ltd / Capri Holdings Ltd / Postal Realty Trust Inc / Revolve Group Inc / RealReal Inc / Equinox Gold Corp / Peloton Interactive Inc / Artemis Gold Inc / Sibanye Stillwater Ltd / Dun & Bradstreet Holdings Inc / Centerspace / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States / Virgin Islands, British / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 579</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">12/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">There’s No Biopharma Without M&A; Dip in Deals in 2021 Does Not Make a Trend</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / INCY.O / JAZZ.O / CTAS.O / KMX.N / NBIX.O / COP.N / CRC.N / BCRX.O / ICPT.O / BIIB.O / ACAD.O / ALNY.O / CFR.S / PCH.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / ZALG.DE / GLPG.O / GBT.OQ / CARR.N</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Jazz Pharmaceuticals PLC / Cintas Corp / Carmax Inc / Neurocrine Biosciences Inc / Conocophillips / California Resources Corp / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Compagnie Financiere Richemont SA / Potlatchdeltic Corp / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Zalando SE / Galapagos NV / Global Blood Therapeutics Inc / Carrier Global Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / China / Germany / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: 4Q21 - Reimbursement Radar</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">GILD.O / INCY.O / JAZZ.O / NBIX.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GLPG.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Jazz Pharmaceuticals PLC / Neurocrine Biosciences Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Galapagos NV / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Stephen Mallon / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ACA / CTAS / ORCL / RAD / WMT / PFX / ONEM.O / DRRX.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / 156782104 / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O / MDNA.O</td><td class="leftalignment">Arcosa Inc / Cintas Corp / Oracle Corp / Rite Aid Corp / Walmart Inc / PhenixFIN Corp / 1Life Healthcare Inc / DURECT Corp / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Cerner Corp / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / Medicenna Therapeutics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / ORCL / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / 156782104 / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Oracle Corp / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Cerner Corp / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE0006969603 / US09061G1013 / US0311621009 / US0718131099 / US1101221083 / US1311931042 / US1985161066 / US2435371073 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US6541061031 / US66987V1098 / US75886F1075 / US7782961038 / US8006771062 / US8305661055 / US8725401090 / US87612E1064 / US9021041085 / US9139031002 / US9182041080 / US92532F1003 / US3448491049 / US6402681083 / US21036P1084 / US2533931026 / US09062X1037 / US0042251084 / US02043Q1076 / US9043111072 / BREMBRACNOR4 / US4103451021 / US03152W1099 / US5500211090 / US36315X1019 / US58933Y1055 / US46333X1081 / US13100M5094 / DE000A1EWWW0 / US29082A1079 / US40412C1018 / US6936561009 / US7512121010 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US1220171060 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US74967X1037 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US89610F1012 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US98585X1046 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US0843101017 / US75943R1023 / US02875D1090 / US07373B1098 / US56854Q2003 / US81181C1045 / US74006W1080 / US55406W1036 / US30260D1037 / US38870X1046 / KYG7614L1095 / US98422T1007 / US01675A1097</td><td class="leftalignment">Puma SE / Biomarin Pharmaceutical Inc / Amgen Inc / Baxter International Inc / Bristol-Myers Squibb Co / Callaway Golf Co / Columbia Sportswear Co / Deckers Outdoor Corp / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Nike Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sangamo Therapeutics Inc / Skechers USA Inc / TJX Companies Inc / Target Corp / II-VI Inc / Universal Health Services Inc / VF Corp / Vertex Pharmaceuticals Inc / Foot Locker Inc / Nektar Therapeutics / Constellation Brands Inc / DICK'S Sporting Goods Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Embraer SA / HanesBrands Inc / Amicus Therapeutics Inc / Lululemon Athletica Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Calix Inc / Adidas AG / Embraer SA / HCA Healthcare Inc / PVH Corp / Ralph Lauren Corp / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Burlington Stores Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / RH / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Tricida Inc / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Yeti Holdings Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Berkeley Lights Inc / Relay Therapeutics Inc / American Outdoor Brands Inc / Beam Global / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / MYT Netherlands Parent BV / Figs Inc / Graphite Bio Inc / Rockley Photonics Holdings Ltd / Xilio Therapeutics Inc / Allbirds Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Brazil / Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAPL / AGCO / ALLO / AMGN / AMT / APPS / AXP / BYND / C.N / CCI / CHTR / CME / COF / CSII / DISH / DNLI / EA / FISV / FOCS / GE / GS / ICE / INTC.O / JPM.N / MA / MCO / MS / MSFT / NET / ORCL / RNG / RXT / SAGE / SAP / SEIC / SONY / T / TTWO / V / VCTR / AMZN.O / CMCSA.O / NICE / MSCI / CSCO.O / FIS / ATVI.O / TRIT / NVDA.O / EGAN / RDWR / HEAR / KLR / SQ / AKAM / EQIX / VZ / NFLX / LUMN / FDS.N / GPN / LFUS.O / DOX.O / PYPL / VRNT / NDAQ / OSIS.O / CALM.OQ / ABMD.O / TEAM.O / SIVB.O / ALCO.O / BIIB / 459200101 / 316773100 / CYTK.O / GOOG.O / SPGI / ACAD.O / G02602103 / 029899101 / 36467W109 / CCOI / COIN / 02043Q107 / STX.OQ / VFF.TO / SWAV / LMNR.O / 695127100 / ZNGA / FB.O / WDAY / TMUS / FDEV.L / FIVN.O / 82655M107 / 83587F202 / 174610105 / IONS.O / RMR.O / ACST.V / CLLS.O / ATUS.K / APLS.O / EGHT.K / ZS.O / BILI.O / AVYA.K / CBOE.K / FSLY / KRTX / CMBM / ONDS.OQ / APPH / DOCN / HUYA.K / HON.O / CLNN.O / OTLY / LOCL.k</td><td class="leftalignment">Apple Inc / AGCO Corp / Allogene Therapeutics Inc / Amgen Inc / American Tower Corp / Digital Turbine Inc / American Express Co / Beyond Meat Inc / Citigroup Inc / Crown Castle International Corp / Charter Communications Inc / CME Group Inc / Capital One Financial Corp / Cardiovascular Systems Inc / DISH Network Corp / Denali Therapeutics Inc / Electronic Arts Inc / Fiserv Inc / Focus Financial Partners Inc / General Electric Co / Goldman Sachs Group Inc / Intercontinental Exchange Inc / Intel Corp / JPMorgan Chase & Co / Mastercard Inc / Moody's Corp / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Oracle Corp / RingCentral Inc / Rackspace Technology Inc / SAGE Therapeutics Inc / SAP SE / SEI Investments Co / Sony Group Corp / AT&T Inc / Take-Two Interactive Software Inc / Visa Inc / Victory Capital Holdings Inc / Amazon.com Inc / Comcast Corp / Nice Ltd / MSCI Inc / Cisco Systems Inc / Fidelity National Information Services Inc / Activision Blizzard Inc / Triterras Inc / NVIDIA Corp / eGain Corp / Radware Ltd / Turtle Beach Corp / Kaleyra Inc / Block Inc / Akamai Technologies Inc / Equinix Inc / Verizon Communications Inc / Netflix Inc / Lumen Technologies Inc / Factset Research Systems Inc / Global Payments Inc / Littelfuse Inc / Amdocs Ltd / PayPal Holdings Inc / Verint Systems Inc / Nasdaq Inc / OSI Systems Inc / Cal-Maine Foods Inc / ABIOMED Inc / Atlassian Corporation PLC / SVB Financial Group / Alico Inc / Biogen Inc / International Business Machines Corp / Fifth Third Bancorp / Cytokinetics Inc / Alphabet Inc / S&P Global Inc / ACADIA Pharmaceuticals Inc / Amdocs Ltd / American States Water Co / GameStop Corp / Cogent Communications Holdings Inc / Coinbase Global Inc / Alnylam Pharmaceuticals Inc / Seagate Technology Holdings PLC / Village Farms International Inc / Shockwave Medical Inc / Limoneira Co / Pacira Biosciences Inc / Zynga Inc / Meta Platforms Inc / Workday Inc / T-Mobile US Inc / Frontier Developments PLC / Five9 Inc / Sify Technologies Ltd / Sorrento Therapeutics Inc / Citizens Financial Group Inc / Ionis Pharmaceuticals Inc / RMR Group Inc / Acasti Pharma Inc / Cellectis SA / Altice USA Inc / Apellis Pharmaceuticals Inc / 8x8 Inc / Zscaler Inc / Bilibili Inc / Avaya Holdings Corp / Cboe Global Markets Inc / Fastly Inc / Karuna Therapeutics Inc / Cambium Networks Corp / Ondas Holdings Inc / AppHarvest Inc / DigitalOcean Holdings Inc / HUYA Inc / Honeywell International Inc / Clene Inc. / Oatly Group AB / Local Bounti Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / India / Ireland / Israel / Japan / Sweden / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AIR.N / ALB.N / BAC.N / BB.N / BK.N / C.N / CC.N / CCK.N / CE.N / DD.N / DOW.N / ED.N / EMN.N / F.N / FITB.O / FMC.N / GM.N / JPM.N / KEY.N / NTRS.O / PNC.N / PPG.N / RIO.L / SEE.N / USB.N / WFC.N / GILD.O / INCY.O / AAL.L / WLK.N / GS.N / GIS.N / OLN.N / SHW.N / OI.N / BLL.N / STT.N / FDS.N / RPM.N / SLGN.O / MTB.N / VRTX.O / GPK.N / RF.N / BLU.N / HOOK.O / BPOP.O / BIIB.O / IGO.AX / TFC.N / HUN.N / WSA.AX / MS.N / CS.TO / 443628102 / 550372106 / INO.OQ / VALE.N / LYB.N / BERY.N / 505440107 / TSLA.N / KPTI.O / CFG.N / AXTA.N / XENE.O / GLPG.O / VNTR.N / EAF.N / CTVA.N / KRTX.OQ / EPAC.N / IGMS.O / ETNB.O / SPRB.OQ / MTCR.O / PTVE.O / CLVT.N / AMBP.N</td><td class="leftalignment">AAR Corp / Albemarle Corp / Bank of America Corp / BlackBerry Ltd / Bank of New York Mellon Corp / Citigroup Inc / Chemours Co / Crown Holdings Inc / Celanese Corp / Dupont De Nemours Inc / Dow Inc / Consolidated Edison Inc / Eastman Chemical Co / Ford Motor Co / Fifth Third Bancorp / FMC Corp / General Motors Co / JPMorgan Chase & Co / KeyCorp / Northern Trust Corp / PNC Financial Services Group Inc / PPG Industries Inc / Rio Tinto PLC / Sealed Air Corp / US Bancorp / Wells Fargo & Co / Gilead Sciences Inc / Incyte Corp / Anglo American PLC / Westlake Chemical Corp / Goldman Sachs Group Inc / General Mills Inc / Olin Corp / Sherwin-Williams Co / O-I Glass Inc / Ball Corp / State Street Corp / Factset Research Systems Inc / RPM International Inc / Silgan Holdings Inc / M&T Bank Corp / Vertex Pharmaceuticals Inc / Graphic Packaging Holding Co / Regions Financial Corp / BELLUS Health Inc / HOOKIPA Pharma Inc / Popular Inc / Biogen Inc / IGO Ltd / Truist Financial Corp / Huntsman Corp / Western Areas Ltd / Morgan Stanley / Capstone Mining Corp / Hudbay Minerals Inc / Lundin Mining Corp / Inovio Pharmaceuticals Inc / Vale SA / LyondellBasell Industries NV / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / Tesla Inc / Karyopharm Therapeutics Inc / Citizens Financial Group Inc / Axalta Coating Systems Ltd / Xenon Pharmaceuticals Inc / Galapagos NV / Venator Materials PLC / GrafTech International Ltd / Corteva Inc / Karuna Therapeutics Inc / Enerpac Tool Group Corp / IGM Biosciences Inc / 89Bio Inc / Spruce Biosciences Inc / Metacrine Inc / Pactiv Evergreen Inc / CLARIVATE PLC / Ardagh Metal Packaging SA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / United Kingdom / Luxembourg / Netherlands / Puerto Rico / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">And The Nominees For Our Best 2021 Note Titles Are...</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O / INCY.O / VRTX.O / BLU.N / HOOK.O / BIIB.O / INO.OQ / KPTI.O / XENE.O / GLPG.O / KRTX.OQ / IGMS.O / ETNB.O / SPRB.OQ / MTCR.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / BELLUS Health Inc / HOOKIPA Pharma Inc / Biogen Inc / Inovio Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xenon Pharmaceuticals Inc / Galapagos NV / Karuna Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Spruce Biosciences Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Stephen Mallon / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Top 10 Potential Surprises Of 2022</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US09062X1037 / US89610F1012 / US09061G1013 / US0311621009 / US1101221083 / US3755581036 / US45253H1014 / US45337C1027 / US4781601046 / US64125C1099 / US66987V1098 / US75886F1075 / US8006771062 / US92532F1003 / US6402681083 / US21036P1084 / US0042251084 / US02043Q1076 / US03152W1099 / US36315X1019 / US58933Y1055 / US46333X1081 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US00847X1046 / US60468T1051 / US4277461020 / US90400D1081 / NL0010696654 / US0396971071 / US78667J1088 / US2681582019 / US09627Y1091 / US81750R1023 / US37890U1088 / US50127T1097 / US05464T1043 / US4622221004 / US28106W1036 / US87164F1057 / US00773U1088 / US5588681057 / CH0334081137 / BMG637AM1024 / US01345P1066 / US6904691010 / US04016X1019 / US76243J1051 / US4622601007 / US5011471027 / US03753U1060 / US77313F1066 / US4380831077 / US2997341035 / US80706P1030 / US01671P1003 / US9842411095 / US39868T1051 / US0197701065 / US68570P1012 / US85205L1070 / US92764N1028 / US7027121000 / US75943R1023 / US56854Q2003 / US81181C1045 / US74006W1080 / US38870X1046 / US98422T1007</td><td class="leftalignment">Biogen Inc / Tricida Inc / Biomarin Pharmaceutical Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / ImmunoGen Inc / Incyte Corp / Johnson & Johnson / Neurocrine Biosciences Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Constellation Brands Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / Galapagos NV / Merck & Co Inc / Ironwood Pharmaceuticals Inc / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Ardelyx Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / Blueprint Medicines Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / Kura Oncology Inc / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Syndax Pharmaceuticals Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Myovant Sciences Ltd / Albireo Pharma Inc / Ovid Therapeutics Inc / argenx SE / Rhythm Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Krystal Biotech Inc / Apellis Pharmaceuticals Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Allakos Inc / Y-mAbs Therapeutics Inc / Gritstone bio Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / SpringWorks Therapeutics Inc / Vir Biotechnology Inc / Passage Bio Inc / Relay Therapeutics Inc / Marinus Pharmaceuticals Inc / Seagen Inc / Praxis Precision Medicines Inc / Graphite Bio Inc / Xilio Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Aduhelm Dynamics Continue to Evolve</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB / SAGE</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Jay Olson, CFA, III / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BSX=US / NKE=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / MDT=US / BLD=US / PEB=US / H=US / CRM=US / MTN=US / LOW=US / IART=US / MAR=US / LEG=US / TNL=US / VMC=US / HLT=US / MANH=US / MLM=US / PATH=US / SWIM=US / CBRL=US / CCL=US / KIDS=US / CHH=US / DRI=US / DRH=US / GFF=US / IBP=US / MAS=US / MHK=US / VRTX=US / PYPL=US / CNM=US / APPN=US / DIN=US / BDSI=US / DKS=US / OGN / BIIB=US / TPX=US / EXP=US / NUVA=US / BECN=US / TXRH=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / HST=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / WH=US / JACK=US / TREX=US / OLO=US / HGV=US / RLJ=US / VAC=US / FBHS=US / GMED=US / RHP=US / TILE=US / NDLS=US / LOCO=US / VCEL=US / NVRO=US / SHAK=US / ZBH=US / WING=US / SPNE=US / PEN=US / 82982L103 / EVBG=US / IRTC=US / CRSP=US / PK=US / JELD=US / PLYA=US / SMAR=US / AXNX=US / LYFT=US / UBER=US / FERG=US / AZEK=US / AZYO=US / VTRS=US / DASH=US / DNUT=US / SNPO=US / ROIV=US</td><td class="leftalignment">Boston Scientific Corp / Nike Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Lowe's Companies Inc / Integra Lifesciences Holdings Corp / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Manhattan Associates Inc / Martin Marietta Materials Inc / UiPath Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Carnival Corp / OrthoPediatrics Corp / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Vertex Pharmaceuticals Inc / PayPal Holdings Inc / Core & Main Inc / Appian Corp / Dine Brands Global Inc / BioDelivery Sciences International Inc / DICK'S Sporting Goods Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / NuVasive Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / Host Hotels & Resorts Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Olo Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Vericel Corp / Nevro Corp / Shake Shack Inc / Zimmer Biomet Holdings Inc / Wingstop Inc / SeaSpine Holdings Corp / Penumbra Inc / SiteOne Landscape Supply Inc / Everbridge Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / Smartsheet Inc / Axonics Inc / Lyft Inc / Uber Technologies Inc / Ferguson PLC / Azek Company Inc / Aziyo Biologics Inc / Viatris Inc / DoorDash Inc / Krispy Kreme Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Omicron Eclipses Delta to Become Dominant in U.S., Increased Transmissibility a Concern but Boosters Remain Effective</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2640147 / 2778844 / 2219224 / 2270726 / 2542049 / 2317087 / 2455965 / 2689560 / 2684703 / 7103065 / 2713317 / 2857817 / B125XQ6 / BHC8X90 / BJJMGL2 / BKTNTR9 / BJXBP30 / BYYWPW6 / BZ1LFG7 / BYY88Y7 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Nike Inc / Merck & Co Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Biogen Inc / PG&E Corp / Pfizer Inc / Novartis AG / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / Novo Nordisk A/S / Fox Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Beigene Ltd / Roku Inc / Alphabet Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AIR.N / BA.N / BAC.N / BK.N / BMO.TO / BOX.N / C.N / COF.N / CRM.N / FITB.O / JPM.N / KEY.N / L.TO / MSFT.O / NTRS.O / PNC.N / USB.N / WFC.N / CERN.O / CMA.N / AMGN.O / HEI.N / HBAN.O / GS.N / NICE.O / MRU.TO / STT.N / AKAM.O / HXL.N / MRCY.O / MTB.N / WN.TO / NET.N / GPK.N / RF.N / DCO.N / DOL.TO / FRC.N / VSEC.OQ / SIVB.O / BLUE.O / CASY.O / EMPA.TO / BIIB.O / SAP.TO / MFI.TO / TFC.N / ACAD.O / MS.N / TDG.N / CTCa.TO / SPR.N / AVAV.OQ / KTOS.OQ / CLW.N / PANW.N / ITCI.O / PLC.TO / COUP.N / RYAM.N / CFG.N / HUBS.N / WRK.N / ATZ.TO / DBX.O / ZM.O / FSLY.N / CRWD.O / PTVE.O / NBLY.TO / PET.TO</td><td class="leftalignment">AAR Corp / Boeing Co / Bank of America Corp / Bank of New York Mellon Corp / Bank of Montreal / Box Inc / Citigroup Inc / Capital One Financial Corp / Salesforce.Com Inc / Fifth Third Bancorp / JPMorgan Chase & Co / KeyCorp / Loblaw Companies Ltd / Microsoft Corp / Northern Trust Corp / PNC Financial Services Group Inc / US Bancorp / Wells Fargo & Co / Cerner Corp / Comerica Inc / Amgen Inc / HEICO Corp / Huntington Bancshares Inc / Goldman Sachs Group Inc / Nice Ltd / Metro Inc / State Street Corp / Akamai Technologies Inc / Hexcel Corp / Mercury Systems Inc / M&T Bank Corp / George Weston Ltd / Cloudflare Inc / Graphic Packaging Holding Co / Regions Financial Corp / Ducommun Inc / Dollarama Inc / First Republic Bank / VSE Corp / SVB Financial Group / bluebird bio Inc / Caseys General Stores Inc / Empire Company Ltd / Biogen Inc / Saputo Inc / Maple Leaf Foods Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Morgan Stanley / TransDigm Group Inc / Canadian Tire Corporation Ltd / Spirit AeroSystems Holdings Inc / AeroVironment Inc / Kratos Defense and Security Solutions Inc / Clearwater Paper Corp / Palo Alto Networks Inc / Intra-Cellular Therapies Inc / Park Lawn Corp / Coupa Software Inc / Rayonier Advanced Materials Inc / Citizens Financial Group Inc / HubSpot Inc / Westrock Co / Aritzia Inc / Dropbox Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Pactiv Evergreen Inc / Neighbourly Pharmacy Inc / Pet Valu Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Model update: Adu Pricing And Staff Cuts Likely Necessary; Our Scenario Analyses Suggests Shares Near Floor But Upside Limited</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : Aduhelm Holiday Sale...Price Reduced But Outlook Remains Challenged</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">BIIB Lowers Aduhelm's Price; Restructuring Underway</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Too Little Too Late? Aduhelm Pricing Cut in Half</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Biogen Cuts Controversial Aduhelm Price in Half Starting January 1, 2022, Ahead of CMS NCD Decision</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Sarah Schram / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Lower Aducanumab Price Step in the Right Direction, Paves Way for a Smooth NCD in January</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O / LLY.N</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - 50% Price Cut May Give Aduhelm Launch a Boost, But We Think 50K Patient Estimate For 2022 Is Too High</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB: Tidbits From Our Discussion With BIIB's Senior Mgmt Following This Morning's Announced Adu Price and Opex Cuts - Important Though Likely Not Needle-Moving Changes</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Throwing In The Towel - BIIB Cuts Aduhelm Price, Workforce</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Reducing Aduhelm by half could increase uptake; focus remains on NCD coverage</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GBT=US / T=US / TXN=US / GPK=US / MPWR=US / MTN=US / DIOD=US / KFY=US / COLL=US / DRI=US / PDM=US / WGO=US / HIW=US / CPT=US / CUZ=US / MAA=US / EVOP=US / INST=US / BDSI=US / BIIB=US / FRPT=US / XM=US / APTS=US / ESTE=US / 00770K202 / BABA=US / ON=US / NXRT=US / ARGX=US / EVBG=US / CELU=US</td><td class="leftalignment">Global Blood Therapeutics Inc / AT&T Inc / Texas Instruments Inc / Graphic Packaging Holding Co / Monolithic Power Systems Inc / Vail Resorts Inc / Diodes Inc / Korn Ferry / Collegium Pharmaceutical Inc / Darden Restaurants Inc / Piedmont Office Realty Trust Inc / Winnebago Industries Inc / Highwoods Properties Inc / Camden Property Trust / Cousins Properties Inc / Mid-America Apartment Communities Inc / EVO Payments Inc / Instructure Holdings Inc / BioDelivery Sciences International Inc / Biogen Inc / Freshpet Inc / Qualtrics International Inc / Preferred Apartment Communities Inc / Earthstone Energy Inc / Aemetis Inc / Alibaba Group Holding Ltd / ON Semiconductor Corp / NexPoint Residential Trust Inc / argenx SE / Everbridge Inc / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AES.N / AFL.N / AIG.N / ALV.N / CB.N / CCI.N / CI.N / CL.N / CVS.N / DD.N / ECL.N / EIX.N / EL.N / F.N / FSR.N / GM.N / KO.N / MDT.N / MO.N / PNC.N / PPG.N / SLB.N / SO.N / T.N / USB.N / VC.N / PG.N / HUM.N / GILD.O / CPB.N / TEN.N / INCY.O / DUK.N / BWA.N / LEA.N / DRI.N / ADBE.O / IMO.TO / MCD.N / VLO.N / DV.N / PCG.N / MGA.N / AMT.N / JAZZ.O / SHW.N / VZ.N / EXEL.O / XEL.N / ARNA.O / AMP.N / LNC.N / APH.N / SRE.N / EXC.N / FISV.O / AXL.N / ACN.N / PLD.N / NBIX.O / AME.N / BC.N / AJG.N / BMRN.O / REGN.O / VRTX.O / PRU.N / NCR.N / TEL.N / COP.N / CPK.N / PII.N / ST.N / DFS.N / PLUG.OQ / SGEN.OQ / GPN.N / MNST.O / IMGN.O / ACGL.O / ICPT.O / EQIX.O / BIIB.O / TFC.N / ACAD.O / 416515104 / ALNY.O / BKD.N / MA.N / HOG.N / AON.N / DAN.N / MSCI.N / CVE.TO / SPB.N / NEE.N / MTOR.N / SRPT.O / FFHu.TO / MDLZ.OQ / TSLA.N / TMUS.N / BEP.N / AGIO.O / PTC.O / QTWO.N / NEP.N / GBT.OQ / MESO.O / SPGI.N / ADNT.N / ATNX.O / CNNE.N / APTV.N / ITRM.O / VNE.N / GMDA.OQ / GMAB.O / CRNC.OQ / WTRG.N / CARR.N / OTIS.N / NKLA.OQ / FOUR.N / NRIX.OQ / LUMN.N / AEP.OQ / RIDE.OQ / LSPD.N / NUVB.N / TSP.OQ / FLYW.O / DBRG.N / BHG.N / RYAN.N / BASE.OQ / FLNC.OQ / RIVN.OQ</td><td class="leftalignment">AES Corp / Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fisker Inc / General Motors Co / Coca-Cola Co / Medtronic PLC / Altria Group Inc / PNC Financial Services Group Inc / PPG Industries Inc / Schlumberger NV / Southern Co / AT&T Inc / US Bancorp / Visteon Corp / Procter & Gamble Co / Humana Inc / Gilead Sciences Inc / Campbell Soup Co / Tenneco Inc / Incyte Corp / Duke Energy Corp / Borgwarner Inc / Lear Corp / Darden Restaurants Inc / Adobe Inc / Imperial Oil Ltd / McDonald's Corp / Valero Energy Corp / DoubleVerify Holdings Inc / PG&E Corp / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / Sherwin-Williams Co / Verizon Communications Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Lincoln National Corp / Amphenol Corp / Sempra Energy / Exelon Corp / Fiserv Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Prologis Inc / Neurocrine Biosciences Inc / AMETEK Inc / Brunswick Corp / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Conocophillips / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Discover Financial Services / Plug Power Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / ImmunoGen Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / Equinix Inc / Biogen Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Alnylam Pharmaceuticals Inc / Brookdale Senior Living Inc / Mastercard Inc / Harley-Davidson Inc / Aon PLC / Dana Inc / MSCI Inc / Cenovus Energy Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Meritor Inc / Sarepta Therapeutics Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Tesla Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / PTC Inc / Q2 Holdings Inc / Nextera Energy Partners LP / Global Blood Therapeutics Inc / Mesoblast Ltd / S&P Global Inc / Adient PLC / Athenex Inc / Cannae Holdings Inc / Aptiv PLC / Iterum Therapeutics PLC / Veoneer Inc / Gamida Cell Ltd / Genmab A/S / Cerence Inc / Essential Utilities Inc / Carrier Global Corp / Otis Worldwide Corp / Nikola Corp / Shift4 Payments Inc / Nurix Therapeutics Inc / Lumen Technologies Inc / American Electric Power Company Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Nuvation Bio Inc / TuSimple Holdings Inc / Flywire Corp / DigitalBridge Group Inc / Bright Health Group Inc / Ryan Specialty Group Holdings Inc / Couchbase Inc / Fluence Energy Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Imagine™: Game Changers: Disruptive Forces in Biotech</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">GILD.O / INCY.O / JAZZ.O / NBIX.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Jazz Pharmaceuticals PLC / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech Outlook Survey: Investors Are Bullish and Plan to Increase Exposure into 2022</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ARNA.O / BMRN.O / VRTX.O / SGEN.OQ / BIIB.O / ALNY.O / GBT.OQ</td><td class="leftalignment">Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Seagen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Luca Issi, PHD / Lisa Walter / Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Leonid Timashev / Stephen Mallon / Jackie Yan / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Clinical Labs & Medical Staffing Outperform; National Health Spending in 2020</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">CAH.N / CI.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / CYH.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / LHCG.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N / CLOV.OQ / AVAH.N</td><td class="leftalignment">Cardinal Health Inc / Cigna Corp / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Community Health Systems Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / LHC Group Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp / Clover Health Investments Corp / Aveanna Healthcare Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (20 December-): Trading sluggish and lacking direction, likely to be range-bound during holiday season</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / GILD.OQ / NVAX.OQ / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Gilead Sciences Inc / Novavax Inc / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品・医療機器セクター: 週間レビューと見通し（12月20日～）: 薄商いで方向感欠く、ホリデーシーズン入りでレンジ相場か</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / GILD.OQ / NVAX.OQ / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Gilead Sciences Inc / Novavax Inc / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">12/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 578</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Sarah Schram / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Moving into 2022 and Rolling SOTP Valuation Models Forward</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">00422510 / H0026310 / 64125C10 / 09062X10 / G0176710 / G5087110 / 05337M104 / 38942Q10 / 98420N10 / 30052C10 / 05464T10 / 01438T10 / G1119610 / 40422M10 / 98978L20 / 78667J10 / 46116X10 / 80405P10 / 75955J40 / 03836N10 / 56854Q20 / 36870G10 / 28658R10</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / AC Immune SA / Neurocrine Biosciences Inc / Biogen Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Avadel Pharmaceuticals PLC / Graybug Vision Inc / Xenon Pharmaceuticals Inc / Evolus Inc / Axsome Therapeutics Inc / Aldeyra Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / SAGE Therapeutics Inc / Intra-Cellular Therapies Inc / Satsuma Pharmaceuticals Inc / Relmada Therapeutics Inc / Aptinyx Inc / Marinus Pharmaceuticals Inc / Gemini Therapeutics Inc / Eliem Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACA / DRI / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Darden Restaurants Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - ASH & 2022 Outlook Edition</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 10 to 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / GB0000456144 / US00724F1012 / US0236081024 / US0311621009 / US0351282068 / US0383361039 / US0394831020 / US0536111091 / US0584981064 / US1101221083 / US1264081035 / US1564311082 / US2017231034 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4227041062 / US5324571083 / US5463471053 / US6516391066 / US65473P1057 / US6703461052 / US7170811035 / US7445731067 / US7802871084 / US8581191009 / US92276F1003 / US9746371007 / US98389B1008 / CA13321L1085 / CA6979001089 / CA8787422044 / CA2918434077 / CA0679011084 / US9129091081 / CA51925D1069 / CA13677F1018 / CA1349211054 / CA0636711016 / CA0641491075 / CA8765111064 / CA3359341052 / US20825C1045 / US35671D8570 / AU000000FMG4 / US09062X1037 / CA98462Y1007 / US02043Q1076 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / CA39138C1068 / CA4436281022 / CA1360691010 / US3546131018 / US74144T1088 / US09247X1019 / US44107P1049 / CA95083R1001 / US40637H1095 / CA1375761048 / US74460D1090 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / US30225T1025 / CA0966311064 / CA29258Y1034 / CA1999101001 / CA2271071094 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA46071W2058 / BMG491BT1088 / CA3518581051 / GB00B2QPKJ12 / GB0004300496 / US26884L1098 / US91912E1055 / US1921085049 / IE00B4BNMY34 / CA69946Q1046 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US2296631094 / CA54928Q1081 / AU000000EVN4 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09739D1000 / JE00B5TT1872 / US09609G1004 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA1348082035 / CA3874371147 / CA3807381049 / CA87505Y4094 / CA0805581091 / CA9323971023 / CA0158571053 / CA0213611001 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA8661201167 / CA38045Y1025 / US16208T1025 / CA5054401073 / US45845P1084 / CA0266951064 / CA33812R1091 / CA17039A1066 / CA46579R1047 / US45378A1060 / CA65340P1062 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / CA45868C1095 / CA26153P1045 / CA1264621006 / CA7397211086 / US14174T1079 / CA68827L1013 / US78667J1088 / CA30606C1086 / IE00BQPVQZ61 / CA5503711080 / US30040W1080 / CA74273V1067 / US6378701063 / AU000000S320 / US4278255009 / CA0115321089 / CA05329M1041 / US95040Q1040 / CA8283631015 / CY0106002112 / AU000000NST8 / CA4991131083 / CA6882811046 / CA8910546032 / US53223X1072 / CA31730E1016 / CA89621C1059 / US0138721065 / CA68634K1066 / US43300A2033 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US23355L1061 / US93627C1018 / US7045511000 / CA9628791027 / CY0103562118 / CA7847301032 / LU1701428291 / US03753U1060 / CA2960061091 / CA7766521099 / CA8585221051 / US92645B1035 / US3843135084 / US03168L1052 / US2997341035 / CA05585D1033 / US03836N1037 / CA0717341071 / US03843E1047 / CA4039254079 / US04335A1051 / CA38119T8077 / CA13000C2058 / US03990B1017 / CA72765Q8829 / US1255231003 / CA2849025093 / CA45075E1043 / US63253R2013 / AU0000018236 / CA7426943006 / CA57776F4050 / US09260D1072 / CA5625684025 / CA48086P1009 / US30205M1018 / CA29446Y5020 / US03768E1055 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / CA31890B1031 / US14316J1088 / US82575P1075 / CA36352H1001 / US03940R1077 / CA70137W1086 / US44862P1093 / CA83419D2014 / CA67079A1021 / US12529R1077 / US3773201062 / CA9004352071 / US3680361090 / CA64782A1075 / CA00288U1066 / CA36261G1028 / US15202L1070 / US24343R1068 / CA65401N1078 / US90364P1057 / AU0000143729 / CA65532M6062 / GB00BL6K5J42 / CA50202P1053 / CA65343M2094 / US1374041093 / CA0156581070 / CA24477T1003 / CA22289D1078 / CA89531J7868</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Antofagasta PLC / Adobe Inc / Ameren Corp / Amgen Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Ball Corp / Bristol-Myers Squibb Co / CSX Corp / Century Aluminum Co / Commercial Metals Co / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hecla Mining Co / Eli Lilly and Co / Louisiana-Pacific Corp / Newmont Corporation / NiSource Inc / Nucor Corp / Pfizer Inc / Public Service Enterprise Group Inc / Royal Gold Inc / Steel Dynamics Inc / Ventas Inc / Winnebago Industries Inc / Xcel Energy Inc / Cameco Corp / Pan American Silver Corp / Teck Resources Ltd / Empire Company Ltd / Barrick Gold Corp / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Canadian Apartment Properties Real Estate Investment Trust / Bank of Montreal / Bank of Nova Scotia / Taseko Mines Ltd / First Quantum Minerals Ltd / Conocophillips / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Great-West Lifeco Inc / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Host Hotels & Resorts Inc / Wesdome Gold Mines Ltd / Halozyme Therapeutics Inc / Canfor Corp / Public Storage / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Extra Space Storage Inc / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Cominar Real Estate Investment Trust / Crombie Real Estate Investment Trust / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / InterRent Real Estate Investment Trust / Invesco Ltd / Franco-Nevada Corp / Fresnillo PLC / Pan African Resources PLC / EQT Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Parex Resources Inc / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / CubeSmart / Lucara Diamond Corp / Evolution Mining Ltd / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / Boise Cascade Co / Centamin PLC / bluebird bio Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Canacol Energy Ltd / Granite Real Estate Investment Trust / Gold Standard Ventures Corp / Tamarack Valley Energy Ltd / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Algonquin Power & Utilities Corp / AltaGas Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / Summit Industrial Income REIT / GoGold Resources Inc / Chatham Lodging Trust / Labrador Iron Ore Royalty Corp / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Fission Uranium Corp / Choice Properties Real Estate Investment Trust / Ivanhoe Mines Ltd / Independence Realty Trust Inc / Nexgen Energy Ltd / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / Interfor Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / Prairiesky Royalty Ltd / CareTrust REIT Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Falco Resources Ltd / Horizon Therapeutics PLC / Lundin Gold Inc / Eversource Energy / Probe Metals Inc / National Storage Affiliates Trust / South32 Ltd / Hersha Hospitality Trust / Alamos Gold Inc / Automotive Properties Real Estate Investment Trust / Welltower Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Northern Star Resources Ltd / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Life Storage Inc / Filo Mining Corp / Trilogy Metals Inc / Alcoa Corp / Orla Mining Ltd / Hilton Worldwide Holdings Inc / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / DXC Technology Co / Warrior Met Coal Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / Nexa Resources SA / Apellis Pharmaceuticals Inc / Ero Copper Corp / Roots Corp / Stelco Holdings Inc / Victory Capital Holdings Inc / GrafTech International Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Aptinyx Inc / Bausch Health Companies Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Golden Star Resources Ltd / Calibre Mining Corp / Ares Management Corp / Platinum Group Metals Ltd / Cigna Corp / Eldorado Gold Corp / iA Financial Corporation Inc / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / Maverix Metals Inc / Blackstone Inc / Mandalay Resources Corp / Josemaria Resources Inc / Exicure Inc / Equinox Gold Corp / Apollo Global Management Inc / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / First Capital Real Estate Investment Trust / Carlyle Group Inc / Sibanye Stillwater Ltd / Galiano Gold Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Solaris Resources Inc / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Abcellera Biologics Inc / G Mining Ventures Corp / Centerspace / Decibel Therapeutics Inc / Nickel 28 Capital Corp / UiPath Inc / Sunrise Energy Metals Ltd / Nomad Royalty Company Ltd / Endeavour Mining PLC / Li-Cycle Holdings Corp / NextSource Materials Inc / Candel Therapeutics Inc / Algoma Steel Group Inc / Definity Financial Corp / Coveo Solutions Inc / Trevali Mining Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">CHMP Adopts Negative Opinion On Adu's MAA; BIIB To Seek Re-Examination</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ACA / ALLO / ATRC / GBT / INCY / INSP / MBIO / NBIX / RAD / SAGE / WMT / GILD.O / EW / ONEM.O / RMD / FMTX / ISRG / ALPN / SGEN / REGN.O / VRTX.O / SSNC.O / NKTR / CCRN.O / AMED.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / LHCG.O / INFI.O / TMDI / TNDM.O / ENSG.O / 483548103 / MRNA.O / BLRX / ADUS.O / AGIO / FATE.O / 02005N100 / RXDX.O / VBLT.O / APTO.O / EVH / 100063846 / IONS.O / 04280A100 / EDIT / VRAY / CRSP / SRRA / ATNX.O / APLS.O / 720795103 / ELOX.OQ / ARVN / XFOR.O / TMDX / KRTX / PSNL.O / 50127T109 / 87164F105 / PNTG.O / GMDA / ZNTL.O / ORIC.O / SPRB.OQ / TARS.O / VOR.O / NKTX.O / BMEA.O / CLNN.O / RZLT.O / CRBU.O / MDNA.O / JSPR.O</td><td class="leftalignment">Arcosa Inc / Allogene Therapeutics Inc / AtriCure Inc / Global Blood Therapeutics Inc / Incyte Corp / Inspire Medical Systems Inc / Mustang Bio Inc / Neurocrine Biosciences Inc / Rite Aid Corp / SAGE Therapeutics Inc / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Resmed Inc / Forma Therapeutics Holdings Inc / Intuitive Surgical Inc / Alpine Immune Sciences Inc / Seagen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Nektar Therapeutics / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Infinity Pharmaceuticals Inc / Titan Medical Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / BioLine RX Ltd / Addus Homecare Corp / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Ally Financial Inc / Prometheus Biosciences Inc / Vascular Biogenics Ltd / Aptose Biosciences Inc / Evolent Health Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Editas Medicine Inc / ViewRay Inc / CRISPR Therapeutics AG / Sierra Oncology Inc / Athenex Inc / Apellis Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Eloxx Pharmaceuticals Inc / Arvinas Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Karuna Therapeutics Inc / Personalis Inc / Kura Oncology Inc / Syndax Pharmaceuticals Inc / Pennant Group Inc / Gamida Cell Ltd / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Spruce Biosciences Inc / Tarsus Pharmaceuticals Inc / Vor Biopharma Inc / Nkarta Inc / Biomea Fusion Inc / Clene Inc. / Rezolute Inc / Caribou Biosciences Inc / Medicenna Therapeutics Corp / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">EU opportunity not in our model; focus is on lecanemab (BAN2401) with data in 2H22</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 12/10/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">IL0006290147 / US00724F1012 / US0311621009 / US0383361039 / US0584981064 / US1101221083 / US31428X1063 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US81211K1007 / US8581191009 / US92532F1003 / CA59162N1096 / CA5394811015 / CA2918434077 / US9129091081 / CA1349211054 / US7665596034 / US09062X1037 / US02043Q1076 / US3546131018 / US74144T1088 / US09247X1019 / US40637H1095 / CA1375761048 / CA0966311064 / CA6179141065 / CA1999101001 / CA7669101031 / CA2271071094 / CA46071W2058 / BMG491BT1088 / IE00B4BNMY34 / US58933Y1055 / CA0985461049 / JE00B4T3BW64 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09609G1004 / CA3874371147 / CA16141A1030 / IE00B4Q5ZN47 / CA8661201167 / CA38045Y1025 / CA6674951059 / US6951271005 / US45845P1084 / CA0266951064 / CA58546R1091 / CA17039A1066 / US60468T1051 / US45378A1060 / US31189P1021 / CA72820F1036 / IE00BJ3V9050 / US03820J1007 / CA26153P1045 / CA1264621006 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / CA8310211005 / CA82621K1021 / CA83179X1087 / CA05329M1041 / US4622221004 / CA49410M1023 / US5588681057 / US68404V1008 / US03753U1060 / CA46136U1030 / IL0011417206 / US92645B1035 / US03168L1052 / US2997341035 / CA05585D1033 / US80706P1030 / US03836N1037 / US48251W1045 / CA0717341071 / CA60448E1034 / US76029N1063 / US03843E1047 / CA4039254079 / US04335A1051 / US50015M1099 / US03990B1017 / CA2849025093 / US62921N1054 / CA7426943006 / US61775R1059 / US09260D1072 / US03768E1055 / US71722W1071 / CA92625W5072 / CA31890B1031 / US14316J1088 / US80810D1037 / US6544051096 / IL0011326795 / CA67079A1021 / US12529R1077 / US3773201062 / CA33843T1084 / US92556V1061 / CA00288U1066 / CA65342N3159 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Adobe Inc / Amgen Inc / Aptargroup Inc / Ball Corp / Bristol-Myers Squibb Co / FedEx Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sealed Air Corp / Steel Dynamics Inc / Vertex Pharmaceuticals Inc / Metro Inc / Loblaw Companies Ltd / Empire Company Ltd / United States Steel Corp / Canadian Apartment Properties Real Estate Investment Trust / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Halozyme Therapeutics Inc / Canfor Corp / Boardwalk Real Estate Investment Trust / Morguard Real Estate Investment Trust / Cominar Real Estate Investment Trust / RioCan Real Estate Investment Trust / Crombie Real Estate Investment Trust / InterRent Real Estate Investment Trust / Invesco Ltd / Accenture PLC / Merck & Co Inc / Bonterra Energy Corp / Glencore PLC / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / bluebird bio Inc / Granite Real Estate Investment Trust / Chartwell Retirement Residences / Jazz Pharmaceuticals PLC / Summit Industrial Income REIT / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Mirati Therapeutics Inc / Independence Realty Trust Inc / Fate Therapeutics Inc / Plaza Retail REIT / Endo International PLC / Applied Genetic Technologies Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Slate Office REIT / Sienna Senior Living Inc / SmartCentres Real Estate Investment Trust / Automotive Properties Real Estate Investment Trust / Ionis Pharmaceuticals Inc / Killam Apartment REIT / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Invesque Inc / Sol Gel Technologies Ltd / Victory Capital Holdings Inc / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Scholar Rock Holding Corp / Aptinyx Inc / KKR & Co Inc / Bausch Health Companies Inc / Minto Apartment Real Estate Investment Trust / Replimune Group Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Kodiak Sciences Inc / Ares Management Corp / Eldorado Gold Corp / NGM Biopharmaceuticals Inc / PRO Real Estate Investment Trust / Morphic Holding Inc / Blackstone Inc / Apollo Global Management Inc / Phathom Pharmaceuticals Inc / Victoria Gold Corp / First Capital Real Estate Investment Trust / Carlyle Group Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Flagship Communities Real Estate Investment Trust / Viatris Inc / Abcellera Biologics Inc / Nexus Real Estate Investment Trust / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biopharma Growth Crisis? Lower & Slower Growth Ahead as Major LOEs Loom</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">92532F10 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Healthcare: Key takeaways from our Pharma & Medtech virtual bus trip</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVN.S / FMEG.DE / FREG.DE / GSK.L / UCB.BR / COLOB.CO / STMN.S / BIIB.OQ / YPSN.S / IPN.PA / DEMANT.CO</td><td class="leftalignment">Eli Lilly and Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novartis AG / Fresenius Medical Care AG & Co KGaA / Fresenius SE & Co KGaA / GlaxoSmithKline PLC / Ucb SA / Coloplast A/S / Straumann Holding AG / Biogen Inc / Ypsomed Holding AG / Ipsen SA / Demant A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Herr. Christoph Gretler / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2022 BioPharma Outlook: A Light at the End of the Tunnel as Sector Sentiment Likely to Improve</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">IL0006290147 / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US7665596034 / US09062X1037 / US02043Q1076 / US40637H1095 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US6951271005 / US45845P1084 / US60468T1051 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / US4622221004 / US5588681057 / US68404V1008 / US03753U1060 / IL0011417206 / US03168L1052 / US2997341035 / US80706P1030 / US03836N1037 / CA0717341071 / US76029N1063 / US03843E1047 / US04335A1051 / US50015M1099 / US62921N1054 / US61775R1059 / US71722W1071 / US80810D1037 / US6544051096 / IL0011326795 / US12529R1077 / US92556V1061 / CA00288U1066 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Sol Gel Technologies Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Aptinyx Inc / Bausch Health Companies Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Arvinas Inc / Kodiak Sciences Inc / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Phathom Pharmaceuticals Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / C4 Therapeutics Inc / Viatris Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Flip the Script - Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ALLO / EA / EVER / GGG / IEX / INTC.O / LECO / LOW / MSFT / PNR / SAGE / SONY / TTWO / ATVI.O / NVDA.O / HEAR / NFLX / LFUS.O / REGN.O / BIIB / 36467W109 / ZNGA / SPLK.O / CG.O / FDEV.L / FATE.O / 82655M107 / CRSP / BILI.O / DDOG.O / GMDA / APPH / VOR.O / NKTX.O / HUYA.K / CRBU.O</td><td class="leftalignment">Allogene Therapeutics Inc / Electronic Arts Inc / EverQuote Inc / Graco Inc / IDEX Corp / Intel Corp / Lincoln Electric Holdings Inc / Lowe's Companies Inc / Microsoft Corp / Pentair PLC / SAGE Therapeutics Inc / Sony Group Corp / Take-Two Interactive Software Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Netflix Inc / Littelfuse Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / GameStop Corp / Zynga Inc / Splunk Inc / Carlyle Group Inc / Frontier Developments PLC / Fate Therapeutics Inc / Sify Technologies Ltd / CRISPR Therapeutics AG / Bilibili Inc / Datadog Inc / Gamida Cell Ltd / AppHarvest Inc / Vor Biopharma Inc / Nkarta Inc / HUYA Inc / Caribou Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">PRAX-114 Poised to Fulfill Neurosteroid's Potential in Depression; Initiate at Buy and $48 PT</td><td class="leftalignment">English</td><td class="rightalignment">59</td><td class="leftalignment">PRAX.OQ / BIIB / 64125C109 / CERE.OQ / G50871105 / 78667J108</td><td class="leftalignment">Praxis Precision Medicines Inc / Biogen Inc / Neurocrine Biosciences Inc / Cerevel Therapeutics Holdings Inc / Jazz Pharmaceuticals PLC / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Douglas D. Tsao</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4519.T: Chugai Pharmaceutical - Virtual pharma tour update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4519.T / ROG.S / BIIB.OQ</td><td class="leftalignment">Chugai Pharmaceutical Co Ltd / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4519.T: 中外製薬 - バーチャルファーマツアー・アップデート</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4519.T / ROG.S / BIIB.OQ</td><td class="leftalignment">Chugai Pharmaceutical Co Ltd / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Pipeline Review and Guidance Event Supports Positive Momentum For the Stock in 2022+, Increasing PT to $335 From $315</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">R&D Event Highlights Key Opportunities</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">SAGE / BIIB</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">A Dash Of Sugar And Spice This Morning, First Look At 2022 Financial Guidance That Beat Expectations</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Dec 15 2021 6:27AM</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ASND.O / DNLI.O / AMD.O / NBIX.O / ARGX.O / UTHR.O / BMRN.O / SWTX.O / ACET.O / RARE.O / ICPT.O / BIIB.O / LXRX.O / IDRA.O / OMER.O / VIRC.O / PCRX.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / SAGE.O / PRTK.O / XENE.O / CDTX.O / GBT.O / RGNX / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / CLSD.O / SYRS.O / ALBO.O / VRNA.O / GTHX.O / MRSN.O / KALA.O / OBSV.O / FENC.O / SURF.O / KNSA.O / SRRK.O / LQDA.O / REPL.O / YMAB.O / STRO.O / BHVN.K / ETTX.O / HARP.O / TPTX.O / ISEE.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BDTX.O / GBIO.O / FUSN.O / 91381U101 / ITOS.O / KDNY / RCUS.K / GRAY.O / INZY.O / 23284P103 / 20454B104</td><td class="leftalignment">Ascendis Pharma A/S / Denali Therapeutics Inc / Advanced Micro Devices Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / Biomarin Pharmaceutical Inc / SpringWorks Therapeutics Inc / Adicet Bio Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Omeros Corp / Virco Mfg Corp / Pacira Biosciences Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / SAGE Therapeutics Inc / Paratek Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Global Blood Therapeutics Inc / Regenxbio Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Clearside Biomedical Inc / Syros Pharmaceuticals Inc / Albireo Pharma Inc / Verona Pharma PLC / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Liquidia Corp / Replimune Group Inc / Y-mAbs Therapeutics Inc / Sutro Biopharma Inc / Biohaven Pharmaceutical Holding Company Ltd / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Turning Point Therapeutics Inc / Iveric Bio Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Black Diamond Therapeutics Inc / Generation Bio Co / Fusion Pharmaceuticals Inc / UNITY Biotechnology Inc / Iteos Therapeutics Inc / Chinook Therapeutics Inc / Arcus Biosciences Inc / Graybug Vision Inc / Inozyme Pharma Inc / Cyteir Therapeutics Inc / Compass Therapeutics Inc.</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">2021 - No Gains... Lot of Pain [2022 Outlook]</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">ASND.O / DNLI.O / NBIX.O / ARGX.O / UTHR.O / BMRN.O / SWTX.O / ACET.O / RARE.O / ICPT.O / BIIB.O / LXRX.O / IDRA.O / OMER.O / PCRX.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / SAGE.O / PRTK.O / XENE.O / CDTX.O / GBT.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / CLSD.O / SYRS.O / ALBO.O / VRNA.O / GTHX.O / MRSN.O / KALA.O / OBSV.O / FENC.O / SURF.O / KNSA.O / SRRK.O / LQDA.O / REPL.O / YMAB.O / STRO.O / BHVN.K / ETTX.O / HARP.O / TPTX.O / ISEE.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BDTX.O / FUSN.O / ITOS.O / KDNY / RCUS.K / INZY.O / 23284P103</td><td class="leftalignment">Ascendis Pharma A/S / Denali Therapeutics Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / Biomarin Pharmaceutical Inc / SpringWorks Therapeutics Inc / Adicet Bio Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / SAGE Therapeutics Inc / Paratek Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Clearside Biomedical Inc / Syros Pharmaceuticals Inc / Albireo Pharma Inc / Verona Pharma PLC / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Liquidia Corp / Replimune Group Inc / Y-mAbs Therapeutics Inc / Sutro Biopharma Inc / Biohaven Pharmaceutical Holding Company Ltd / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Turning Point Therapeutics Inc / Iveric Bio Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Black Diamond Therapeutics Inc / Fusion Pharmaceuticals Inc / Iteos Therapeutics Inc / Chinook Therapeutics Inc / Arcus Biosciences Inc / Inozyme Pharma Inc / Cyteir Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Mr. Andreas Argyrides / Dennis Pak</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Eyes Wide Open: Setting Our Sights on a New Frontier in Ocular Disease</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">AMD.O / BIIB.O / RGNX / CLSD.O / KALA.O / GBIO.O / 91381U101 / GRAY.O</td><td class="leftalignment">Advanced Micro Devices Inc / Biogen Inc / Regenxbio Inc / Clearside Biomedical Inc / Kala Pharmaceuticals Inc / Generation Bio Co / UNITY Biotechnology Inc / Graybug Vision Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Andreas Argyrides / Ms. Liana Moussatos, PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US -  Dividend Quality Analysis, for the period ended September 13,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 3, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">US0311621009 / US0394831020 / US0536111091 / US1101221083 / US1266501006 / US3755581036 / US3976241071 / US45337C1027 / US5324571083 / US5719032022 / US64125C1099 / US65473P1057 / US7170811035 / US7445731067 / US75886F1075 / US92276F1003 / US92532F1003 / US98389B1008 / CA51925D1069 / US09062X1037 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US44107P1049 / US74460D1090 / US9026531049 / US30225T1025 / US58933Y1055 / US65339F1012 / US2296631094 / US09609G1004 / US70509V1008 / US16208T1025 / US60468T1051 / US14174T1079 / US9840171030 / US30040W1080 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / US03753U1060 / US04335A1051 / US15202L1070 / US4718711033 / US1374041093 / CA24477T1003 / CA22289D1078</td><td class="leftalignment">Amgen Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Bristol-Myers Squibb Co / CVS Health Corp / Gilead Sciences Inc / Greif Inc / Incyte Corp / Eli Lilly and Co / Marriott International Inc / Neurocrine Biosciences Inc / NiSource Inc / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Xcel Energy Inc / Laurentian Bank of Canada / Biogen Inc / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Host Hotels & Resorts Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Merck & Co Inc / Nextera Energy Inc / CubeSmart / bluebird bio Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Mirati Therapeutics Inc / CareTrust REIT Inc / Xenia Hotels & Resorts Inc / Eversource Energy / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Apellis Pharmaceuticals Inc / Arvinas Inc / Centerspace / Jasper Therapeutics Inc / Candel Therapeutics Inc / Definity Financial Corp / Coveo Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AJG / ALL / AM / AMT / AR / AXP / BA.N / BAX / BMY.N / CB / CCI / CLR / CNC.N / CNX / COO / CPE / CPK / CRM.N / CVS.N / D / DG / DGX / DK / DLR / DVN / DY / EOG / EQT / HD / HEP / HIG / IFF / KNX / LOW / MCHP.O / MGY / MMP / MRK.N / MRO / OKE / OLN / OXY / PFE.N / PGR / PNM / PXD / QCOM.O / RKT / RMBS.O / RNG / RRC / SJI / SLG / SM / SWN / T / TFX / TOL / USM / WES / WLK / WLL / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / IRM / MGM.N / ADBE.O / PAA.N / SBAC.O / MXL / ADI.O / VZ / NWN / ARNA.O / SMTC.O / SLAB.O / SNPS.O / DLTR.O / BYD.N / ARGX.O / PENN.O / ISRG.O / LPI / CHDN.O / REGN.O / VRTX.O / MRVL.O / SMG.N / WYNN.O / SIVB.O / DIOD.O / ACGL.O / EQIX.O / OMCL.O / SWKS.O / BIIB.O / DKL / LVS.N / CDNS.O / CNSL.O / CLMT.O / CCOI.O / NOG.A / WRB.N / TSLA.O / NXPI.O / CZR.O / HZNP.O / ESTE.K / MTDR.K / TRGP.K / PDCE.O / AMBA.O / FANG.O / MPLX.K / ABBV.N / PFSI.K / PSXP.K / LGIH.O / FIVN.O / RXDX.O / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / CYAD.O / GBT.O / TMUS.O / RRR.O / EVBG.O / UNIT.O / CLLS.O / CDEV.O / WDAY.O / HESM.K / RYTM.O / SWCH.K / APLS.O / EGHT.K / AUTL.O / BRY.O / KZR.O / AXNX.O / SWAV.O / ZM.O / FLTRF.L / RTLR.O / MORF.O / CABA.O / OAS.O / OVV.N / PGEN.O / BEAM.O / DKNG.O / ZI.O / CTRA.K / GRWG.O / 45258J102 / NWE.O / LUMN.K / BALY.N / ALGM.O / RSI.N / HYFM.O / GRCL.O / CHK.O / HMPT.O / DBRG.N / BLND.N / YOU.N / WKME.O / KLTR.O / WOLF.N / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / American Tower Corp / Antero Resources Corp / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Continental Resources Inc / Centene Corp / CNX Resources Corp / Cooper Companies Inc / Callon Petroleum Co / Chesapeake Utilities Corp / Salesforce.Com Inc / CVS Health Corp / Dominion Energy Inc / Dollar General Corp / Quest Diagnostics Inc / Delek US Holdings Inc / Digital Realty Trust Inc / Devon Energy Corp / Dycom Industries Inc / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / International Flavors & Fragrances Inc / Knight-Swift Transportation Holdings Inc / Lowe's Companies Inc / Microchip Technology Inc / Magnolia Oil & Gas Corp / Magellan Midstream Partners LP / Merck & Co Inc / Marathon Oil Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / PNM Resources Inc / Pioneer Natural Resources Co / Qualcomm Inc / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / SM Energy Co / Southwestern Energy Co / AT&T Inc / Teleflex Inc / Toll Brothers Inc / United States Cellular Corp / Western Midstream Partners LP / Westlake Chemical Corp / Whiting Petroleum Corp / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Iron Mountain Inc / MGM Resorts International / Adobe Inc / Plains All American Pipeline LP / SBA Communications Corp / Maxlinear Inc / Analog Devices Inc / Verizon Communications Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Dollar Tree Inc / Boyd Gaming Corp / argenx SE / Penn National Gaming Inc / Intuitive Surgical Inc / Laredo Petroleum Inc / Churchill Downs Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / SVB Financial Group / Diodes Inc / Arch Capital Group Ltd / Equinix Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / Las Vegas Sands Corp / Cadence Design Systems Inc / Consolidated Communications Holdings Inc / Calumet Specialty Products Partners LP / Cogent Communications Holdings Inc / Northern Oil and Gas Inc / W R Berkley Corp / Tesla Inc / NXP Semiconductors NV / Caesars Entertainment Inc / Horizon Therapeutics PLC / Earthstone Energy Inc / Matador Resources Co / Targa Resources Corp / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / MPLX LP / Abbvie Inc / PennyMac Financial Services Inc / Phillips 66 Partners LP / LGI Homes Inc / Five9 Inc / Prometheus Biosciences Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Celyad Oncology SA / Global Blood Therapeutics Inc / T-Mobile US Inc / Red Rock Resorts Inc / Everbridge Inc / Uniti Group Inc / Cellectis SA / Centennial Resource Development Inc / Workday Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Switch Inc / Apellis Pharmaceuticals Inc / 8x8 Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Zoom Video Communications Inc / Flutter Entertainment PLC / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Oasis Petroleum Inc / Ovintiv Inc / Precigen Inc / Beam Therapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / NorthWestern Corp / Lumen Technologies Inc / Bally's Corp / Allegro Microsystems Inc / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / DigitalBridge Group Inc / Blend Labs Inc / Clear Secure Inc / Walkme Ltd / Kaltura Inc / Wolfspeed Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AES.N / AFL.N / AIG.N / ALV.N / CB.N / CCI.N / CL.N / CRM.N / CVS.N / EIX.N / F.N / FSR.N / GM.N / GOG.L / PD.N / SO.N / T.N / VC.N / GILD.O / TEN.N / CMCSA.O / INCY.O / RBA.N / DUK.N / DIS.N / BWA.N / LEA.N / DT.N / DISH.O / PCG.N / AMT.N / KGC.N / JAZZ.O / VZ.N / XEL.N / LNC.N / APH.N / AXL.N / ACN.N / AJG.N / NBR.N / REGN.O / PRU.N / NCR.N / TEL.N / CPK.N / ST.N / PLUG.OQ / SGEN.OQ / IMGN.O / CASY.O / ACGL.O / EQIX.O / BIIB.O / DLR.N / 416515104 / BKD.N / MA.N / AON.N / DAN.N / INPP.L / NEE.N / NXT.AX / PKI.TO / MSP.N / MTOR.N / FFHu.TO / TSLA.N / TMUS.N / BEP.N / AGIO.O / KPTI.O / XNCR.OQ / COUP.N / NEP.N / HUBS.N / 03835T200 / GBT.OQ / MESO.O / ADNT.N / GDS.O / ATUS.N / ATNX.O / APTV.N / VNE.N / FOCS.O / ESTC.N / GMDA.OQ / SG.N / CRWD.O / GMAB.O / APRE.OQ / CRNC.OQ / IGMS.O / WTRG.N / NKLA.OQ / NRIX.OQ / LUMN.N / AEP.OQ / SUMO.O / RIDE.OQ / NUVB.N / COUR.N / PATH.N / TSP.OQ / BHG.N / XMTR.OQ / RYAN.N / BASE.OQ / GTLB.OQ / ZD.OQ / FLNC.OQ / RIVN.OQ</td><td class="leftalignment">AES Corp / Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Salesforce.Com Inc / CVS Health Corp / Edison International / Ford Motor Co / Fisker Inc / General Motors Co / Go-Ahead Group PLC / PagerDuty Inc / Southern Co / AT&T Inc / Visteon Corp / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / Incyte Corp / Ritchie Bros Auctioneers Inc / Duke Energy Corp / Walt Disney Co / Borgwarner Inc / Lear Corp / Dynatrace Inc / DISH Network Corp / PG&E Corp / American Tower Corp / Kinross Gold Corp / Jazz Pharmaceuticals PLC / Verizon Communications Inc / Xcel Energy Inc / Lincoln National Corp / Amphenol Corp / American Axle & Manufacturing Holdings Inc / Accenture PLC / Arthur J Gallagher & Co / Nabors Industries Ltd / Regeneron Pharmaceuticals Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / Plug Power Inc / Seagen Inc / ImmunoGen Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Equinix Inc / Biogen Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / Brookdale Senior Living Inc / Mastercard Inc / Aon PLC / Dana Inc / International Public Partnerships Ltd / Nextera Energy Inc / NEXTDC Ltd / Parkland Corp / Datto Holding Corp / Meritor Inc / Fairfax Financial Holdings Ltd / Tesla Inc / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xencor Inc / Coupa Software Inc / Nextera Energy Partners LP / HubSpot Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Mesoblast Ltd / Adient PLC / GDS Holdings Ltd / Altice USA Inc / Athenex Inc / Aptiv PLC / Veoneer Inc / Focus Financial Partners Inc / Elastic NV / Gamida Cell Ltd / Sweetgreen Inc / CrowdStrike Holdings Inc / Genmab A/S / Aprea Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / Essential Utilities Inc / Nikola Corp / Nurix Therapeutics Inc / Lumen Technologies Inc / American Electric Power Company Inc / Sumo Logic Inc / Lordstown Motors Corp / Nuvation Bio Inc / Coursera Inc / UiPath Inc / TuSimple Holdings Inc / Bright Health Group Inc / Xometry Inc / Ryan Specialty Group Holdings Inc / Couchbase Inc / GitLab Inc / Ziff Davis Inc / Fluence Energy Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Alto Neuroscience Inc.: Our Q&A With Management</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Sarah Schram</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Retail Pharmacy & Managed Care Outperform; No Surprises Act Expectations for 2022</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 577</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Weekly Highlights—December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AJG / ALL / AM / AR / BA.N / BAX / BMY.N / CB / CLR / CNX / COO / CPK / CRM.N / D / DG / DK / DVN / EOG / EQT / HD / HEP / HIG / LOW / MMP / MRK.N / OKE / OLN / OXY / PFE.N / PGR / RRC / SJI / SLG / SWN / WES / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / PAA.N / ADI.O / NWN / ARNA.O / ARGX.O / ISRG.O / REGN.O / VRTX.O / SMG.N / SIVB.O / ACGL.O / OMCL.O / BIIB.O / DKL / CLMT.O / WRB.N / TSLA.O / HZNP.O / TRGP.K / FANG.O / MPLX.K / ABBV.N / PSXP.K / LGIH.O / RXDX.O / SHLX.K / NVRO.K / CIVI.K / PBFX.K / CDEV.O / HESM.K / RYTM.O / APLS.O / BRY.O / KZR.O / AXNX.O / SWAV.O / RTLR.O / MORF.O / CABA.O / CTRA.K / GRWG.O / 45258J102 / HYFM.O / CHK.O / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / Antero Resources Corp / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Continental Resources Inc / CNX Resources Corp / Cooper Companies Inc / Chesapeake Utilities Corp / Salesforce.Com Inc / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / Lowe's Companies Inc / Magellan Midstream Partners LP / Merck & Co Inc / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / Southwestern Energy Co / Western Midstream Partners LP / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Plains All American Pipeline LP / Analog Devices Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / argenx SE / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Scotts Miracle-Gro Co / SVB Financial Group / Arch Capital Group Ltd / Omnicell Inc / Biogen Inc / Delek Logistics Partners LP / Calumet Specialty Products Partners LP / W R Berkley Corp / Tesla Inc / Horizon Therapeutics PLC / Targa Resources Corp / Diamondback Energy Inc / MPLX LP / Abbvie Inc / Phillips 66 Partners LP / LGI Homes Inc / Prometheus Biosciences Inc / Shell Midstream Partners LP / Nevro Corp / Civitas Resources Inc / PBF Logistics LP / Centennial Resource Development Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Rivian Automotive Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Denmark / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT / ACI / AIG / AJG / ALC / ALL / AM / AMAT.O / AMT / AON / AR / ARW / BA.N / BAX / BDX / BEP / BK / BMY.N / BP.N / BSX / CB / CLR / CMA / CNX / COO / COP / COST.O / CPK / CRM.N / CVX / D / DG / DK / DVN / EOG / EQT / F.N / FITB.O / GM.N / HD / HEP / HES / HFC / HIG / INTC.O / JNJ / KLAC.O / KR / LNC / LOW / LRCX.O / MCHP.O / MDT / MET / MMC / MMP / MPC / MRK.N / MUR / NTRS.O / OGE / OKE / OLN / OXY / PEN / PFE.N / PGR / PNC / PRU / PSX / QCOM.O / RE / RKT / RMBS.O / RNG / RNR / RRC / SJI / SLB.N / SLG / STT / SWN / SYK / TFC / TFX / TRV / VLO / WES / WMB / WMT / XLNX.O / ASND.O / AMZN.O / CNQ.TO / GILD.O / ET / AMGN.O / EW / BRO / AAPL.O / CSCO.O / HAL.N / NVDA.O / SU.TO / XOM / PAA.N / PBF / MXL / LBRT.N / IART.O / AMD.O / ADI.O / NWN / NTAP.O / ARNA.O / BJ.N / SMTC.O / SLAB.O / SNPS.O / ARGX.O / AXS / ISRG.O / REGN.O / VRTX.O / MU.O / MRVL.O / HPQ / HPE / AVGO.O / BE.N / SMG.N / FCEL.OQ / PLUG.OQ / SIVB.O / BLUE.O / DIOD.O / MMSI.O / ACGL.O / MKSI.O / OMCL.O / SWKS.O / BIIB.O / DKL / VIAC.O / NOV.N / BLDP.OQ / RDSb / DXCM.O / CDNS.O / STX.O / CLMT.O / CVLT.O / PODD.O / TNDM.OQ / WRB.N / JNPR.K / TSLA.O / NXPI.O / LUNG.O / BKR.N / HZNP.O / WDC.O / TRGP.K / AMBA.O / FANG.O / MPLX.K / UIHC.O / ABBV.N / GTLS.N / VOYA.K / PFSI.K / RNA.O / PSXP.K / FATE.O / LGIH.O / RXDX.O / ANET.K / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / GKOS.K / ZBH / CYAD.O / PSTG.K / NVCR.O / IONS.O / WLTW.O / EDIT.O / NTLA.O / NTNX.O / CLLS.O / CDEV.O / BHF.O / IOVA.O / HESM.K / RYTM.O / APLS.O / EQH / AVT.O / INSP.K / AUTL.O / BRY.O / KZR.O / STRO.O / AXNX.O / DELL.K / SWAV.O / RTLR.O / MORF.O / CHWY.K / BRP.O / CABA.O / PGEN.O / NARI.O / AVNT.K / CTRA.K / BEPC.K / GRWG.O / 45258J102 / ASO.O / EAR.O / ROOT.O / ALGM.O / HYFM.O / GRCL.O / CHK.O / HMPT.O / NPCE.O / RYAN.N / RXST.O / WOLF.N / ARBE.O / RIVN.O</td><td class="leftalignment">Abbott Laboratories / Albertsons Companies Inc / American International Group Inc / Arthur J Gallagher & Co / Alcon AG / Allstate Corp / Antero Midstream Corp / Applied Materials Inc / American Tower Corp / Aon PLC / Antero Resources Corp / Arrow Electronics Inc / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Brookfield Renewable Partners LP / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / BP PLC / Boston Scientific Corp / Chubb Ltd / Continental Resources Inc / Comerica Inc / CNX Resources Corp / Cooper Companies Inc / Conocophillips / Costco Wholesale Corp / Chesapeake Utilities Corp / Salesforce.Com Inc / Chevron Corp / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Ford Motor Co / Fifth Third Bancorp / General Motors Co / Home Depot Inc / Holly Energy Partners LP / Hess Corp / HollyFrontier Corp / Hartford Financial Services Group Inc / Intel Corp / Johnson & Johnson / KLA Corp / Kroger Co / Lincoln National Corp / Lowe's Companies Inc / Lam Research Corp / Microchip Technology Inc / Medtronic PLC / MetLife Inc / Marsh & McLennan Companies Inc / Magellan Midstream Partners LP / Marathon Petroleum Corp / Merck & Co Inc / Murphy Oil Corp / Northern Trust Corp / OGE Energy Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Penumbra Inc / Pfizer Inc / Progressive Corp / PNC Financial Services Group Inc / Prudential Financial Inc / Phillips 66 / Qualcomm Inc / Everest Re Group Ltd / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Renaissancere Holdings Ltd / Range Resources Corp / South Jersey Industries Inc / Schlumberger NV / SL Green Realty Corp / State Street Corp / Southwestern Energy Co / Stryker Corp / Truist Financial Corp / Teleflex Inc / Travelers Companies Inc / Valero Energy Corp / Western Midstream Partners LP / Williams Companies Inc / Walmart Inc / Xilinx Inc / Ascendis Pharma A/S / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Brown & Brown Inc / Apple Inc / Cisco Systems Inc / Halliburton Co / NVIDIA Corp / Suncor Energy Inc / Exxon Mobil Corp / Plains All American Pipeline LP / PBF Energy Inc / Maxlinear Inc / Liberty Oilfield Services Inc / Integra Lifesciences Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Northwest Natural Holding Co / NetApp Inc / Arena Pharmaceuticals Inc / BJ's Wholesale Club Holdings Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / argenx SE / AXIS Capital Holdings Ltd / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Micron Technology Inc / Marvell Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Bloom Energy Corp / Scotts Miracle-Gro Co / Fuelcell Energy Inc / Plug Power Inc / SVB Financial Group / bluebird bio Inc / Diodes Inc / Merit Medical Systems Inc / Arch Capital Group Ltd / MKS Instruments Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / ViacomCBS Inc / Nov Inc / Ballard Power Systems Inc / Royal Dutch Shell PLC / Dexcom Inc / Cadence Design Systems Inc / Seagate Technology Holdings PLC / Calumet Specialty Products Partners LP / Commvault Systems Inc / Insulet Corp / Tandem Diabetes Care Inc / W R Berkley Corp / Juniper Networks Inc / Tesla Inc / NXP Semiconductors NV / Pulmonx Corp / Baker Hughes Co / Horizon Therapeutics PLC / Western Digital Corp / Targa Resources Corp / Ambarella Inc / Diamondback Energy Inc / MPLX LP / United Insurance Holdings Corp / Abbvie Inc / Chart Industries Inc / Voya Financial Inc / PennyMac Financial Services Inc / Avidity Biosciences Inc / Phillips 66 Partners LP / Fate Therapeutics Inc / LGI Homes Inc / Prometheus Biosciences Inc / Arista Networks Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Glaukos Corp / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Pure Storage Inc / Novocure Ltd / Ionis Pharmaceuticals Inc / Willis Towers Watson PLC / Editas Medicine Inc / Intellia Therapeutics Inc / Nutanix Inc / Cellectis SA / Centennial Resource Development Inc / Brighthouse Financial Inc / Iovance Biotherapeutics Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Equitable Holdings Inc / Avnet Inc / Inspire Medical Systems Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Sutro Biopharma Inc / Axonics Inc / Dell Technologies Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Chewy Inc / BRP Group Inc / Cabaletta Bio Inc / Precigen Inc / Inari Medical Inc / Avient Corp / Coterra Energy Inc / Brookfield Renewable Corp / GrowGeneration Corp / Immunovant Inc / Academy Sports and Outdoors Inc / Eargo Inc / Root Inc / Allegro Microsystems Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / Neuropace Inc / Ryan Specialty Group Holdings Inc / Rxsight Inc / Wolfspeed Inc / Arbe Robotics Ltd / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video Link - ASH & Launch Feedback</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">INCY.O / BIIB.O</td><td class="leftalignment">Incyte Corp / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 3 to 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AU000000CIA2 / US0079031078 / US0091581068 / US0311621009 / US0383361039 / US1101221083 / US1264081035 / US1266501006 / US1270971039 / US1475281036 / US1844961078 / US2017231034 / US22160K1051 / US2372661015 / US25179M1036 / US26875P1012 / US30231G1022 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4404521001 / US4433201062 / US4456581077 / US45337C1027 / US4581401001 / US4601461035 / US5324571083 / US56418H1005 / US5962781010 / US6267171022 / US64125C1099 / US6558441084 / US6703461052 / US6745991058 / US6819191064 / US68389X1054 / US7170811035 / US7237871071 / US75281A1097 / US8454671095 / US8851601018 / US9024941034 / US9078181081 / US9113121068 / CA53278L1076 / CA1363751027 / CA29250N1050 / CA0977512007 / CA4530384086 / CA8787422044 / CA1247651088 / CA2918434077 / CA1469001053 / CA0679011084 / CA1363851017 / CA0099051009 / CA7029251088 / CA8959451037 / US1667641005 / CA13645T1003 / US5658491064 / CA13677F1018 / US0017441017 / US20825C1045 / US2274831047 / US09062X1037 / CA8676EP1086 / CA2052491057 / US14040H1059 / BMG169621056 / CA67072Q1046 / CA2265331074 / US6293775085 / CA98462Y1007 / US02043Q1076 / CA4969024047 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US1331311027 / CA8935781044 / CA2935701078 / US12008R1077 / CA6993202069 / US8288061091 / US1252691001 / US12541W2098 / CA1125851040 / CA0906971035 / US42809H1077 / US57636Q1040 / CA30041N1078 / US59522J1034 / BMG383271050 / US9026531049 / CA2945051027 / CA6179141065 / CA14068G1046 / US5500211090 / US3932221043 / US3886891015 / US2120151012 / US38500T1016 / US26884L1098 / CA6252841045 / CA89154B1022 / CA9838911027 / CA22576C1014 / CA8672241079 / CA25675T1075 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / US98986T1088 / CA00829Q1019 / US30303M1027 / US4571871023 / CA7063271034 / US6092071058 / US00287Y1091 / CA89156V1067 / US1091941005 / JE00B5TT1872 / US09609G1004 / US69327R1014 / CA04364G1063 / CA02215R1073 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA8204391079 / CA0805581091 / CA0213611001 / CA3565001086 / CA69338U1012 / CA74061A1084 / CA96145A2002 / CA09202D2077 / IE00B4Q5ZN47 / CA38045Y1025 / CA81373C1023 / CA04682R1073 / CA29269R1055 / CA3748252069 / US5764852050 / US25278X1090 / CA4882951060 / CA46579R1047 / US31189P1021 / US03674X1063 / US2267181046 / US1630921096 / CA14150G4007 / US02005N1000 / US14174T1079 / IE00BQPVQZ61 / US2383371091 / CA0089118776 / BMG0750C1082 / CA8310211005 / US1638511089 / CA83179X1087 / US95040Q1040 / US4622221004 / CA17040T3001 / US2057683029 / BMG162341090 / US13462K1097 / US15136A1025 / CA87241L1094 / CA46016U1084 / CA85859H1055 / CA6632782083 / CA15713J1049 / US12653C1080 / US8608971078 / CA35905B1076 / US03753U1060 / CA2960061091 / US00191U1025 / US11135F1012 / US87484T1088 / US76029N1063 / US34417P1003 / US08579X1019 / US04335A1051 / VGG1890L1076 / CA7241121077 / CA14179V5036 / US22052L1044 / CA6744822033 / US03768E1055 / US70614W1009 / US91734M1036 / CA31890B1031 / US69047Q1022 / US80810D1037 / MHY0436Q1098 / CA36168Q1046 / CA4220961078 / US03940R1077 / CA84678A1021 / US5168062058 / US05478C1053 / CA2674881040 / US13123X5086 / CA67079A1021 / CA89055A2039 / US23821D1000 / CA74022D4075 / US03750L1098 / US86333M1080 / US15202L1070 / CA83615X4075 / CA1295844056 / US78440X8048 / US1651677353 / US03743Q1085 / US90364P1057 / CA5362211040 / US44891N2080 / US92719V1008 / CA65532M6062 / CA00791P1071 / CA24874B1085 / US60646V1052 / CA03253E1079 / IE0003LFZ4U7 / CA53229C1077 / US98955K1043 / US4718711033 / US1374041093 / CA23344V1085 / CA0156581070</td><td class="leftalignment">Champion Iron Ltd / Advanced Micro Devices Inc / Air Products and Chemicals Inc / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / CSX Corp / CVS Health Corp / Coterra Energy Inc / Caseys General Stores Inc / Clean Harbors Inc / Commercial Metals Co / Costco Wholesale Corp / Darling Ingredients Inc / Devon Energy Corp / EOG Resources Inc / Exxon Mobil Corp / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hormel Foods Corp / Hub Group Inc / J B Hunt Transport Services Inc / Incyte Corp / Intel Corp / International Paper Co / Eli Lilly and Co / ManpowerGroup Inc / Middleby Corp / Murphy Oil Corp / Neurocrine Biosciences Inc / Norfolk Southern Corp / Nucor Corp / Occidental Petroleum Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Southwestern Energy Co / Thor Industries Inc / Tyson Foods Inc / Union Pacific Corp / United Parcel Service Inc / Linamar Corp / Canadian National Railway Co / Enbridge Inc / Bombardier Inc / Imperial Oil Ltd / Teck Resources Ltd / CAE Inc / Empire Company Ltd / Cascades Inc / Barrick Gold Corp / Canadian Natural Resources Ltd / AKITA Drilling Ltd / Pason Systems Inc / Trican Well Service Ltd / Chevron Corp / Canadian Pacific Railway Ltd / Marathon Oil Corp / Canadian Western Bank / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Biogen Inc / Sunopta Inc / Computer Modelling Group Ltd / Capital One Financial Corp / Bunge Ltd / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Kinross Gold Corp / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Camden Property Trust / Transcontinental Inc / Ensign Energy Services Inc / Builders FirstSource Inc / Paramount Resources Ltd / Simon Property Group Inc / CF Industries Holdings Inc / CH Robinson Worldwide Inc / Brookfield Asset Management Inc / Birchcliff Energy Ltd / Hess Corp / Mastercard Inc / Evertz Technologies Ltd / Mid-America Apartment Communities Inc / GeoPark Ltd / UDR Inc / Equitable Group Inc / Morguard Real Estate Investment Trust / Capstone Mining Corp / Lululemon Athletica Inc / Green Plains Inc / Graphic Packaging Holding Co / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Mullen Group Ltd / Total Energy Services Inc / Xebec Adsorption Inc / Crescent Point Energy Corp / Suncor Energy Inc / Dollarama Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Zynga Inc / Africa Oil Corp / Meta Platforms Inc / Ingredion Inc / Pembina Pipeline Corp / Mondelez International Inc / Abbvie Inc / Tourmaline Oil Corp / Bright Horizons Family Solutions Inc / Centamin PLC / bluebird bio Inc / PDC Energy Inc / Ascot Resources Ltd / Altus Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Shawcor Ltd / Belo Sun Mining Corp / AltaGas Ltd / Freehold Royalties Ltd / PHX Energy Services Corp / Premium Brands Holdings Corp / Westshore Terminals Investment Corp / Black Diamond Group Ltd / Jazz Pharmaceuticals PLC / GoGold Resources Inc / Secure Energy Services Inc / Athabasca Oil Corp / Enerflex Ltd / Gibson Energy Inc / Matador Resources Co / Diamondback Energy Inc / Kelt Exploration Ltd / Ivanhoe Mines Ltd / Fate Therapeutics Inc / Antero Resources Corp / Criteo SA / Chegg Inc / Cardinal Energy Ltd (Alberta) / Ally Financial Inc / CareTrust REIT Inc / Horizon Therapeutics PLC / Dave & Buster's Entertainment Inc / Air Canada / Axalta Coating Systems Ltd / Slate Office REIT / Chemours Co / SmartCentres Real Estate Investment Trust / Welltower Inc / Ionis Pharmaceuticals Inc / Chorus Aviation Inc / Comstock Resources Inc / Brookfield Business Partners LP / Camping World Holdings Inc / Centennial Resource Development Inc / TFI International Inc / International Petroleum Corp / Step Energy Services Ltd / North West Company Inc / CES Energy Solutions Corp / CNX Resources Corp / Stitch Fix Inc / Frontera Energy Corp / Apellis Pharmaceuticals Inc / Ero Copper Corp / ASGN Inc / Broadcom Inc / Talos Energy Inc / Replimune Group Inc / Focus Financial Partners Inc / Berry Corporation (Bry) / Arvinas Inc / Capri Holdings Ltd / Pipestone Energy Corp / Cargojet Inc / Corteva Inc / Obsidian Energy Ltd / Apollo Global Management Inc / Peloton Interactive Inc / US Ecology Inc / First Capital Real Estate Investment Trust / Ovintiv Inc / Schrodinger Inc / Atlas Corp / GFL Environmental Inc / Headwater Exploration Inc / Arch Resources Inc / Spartan Delta Corp / Laredo Petroleum Inc / Azek Company Inc / Dye & Durham Ltd / Callon Petroleum Co / Nuvei Corp / Topaz Energy Corp / Datto Holding Corp / Precision Drilling Corp / Apartment Income REIT Corp / Stride Inc / Centerspace / Source Energy Services Ltd / Calfrac Well Services Ltd / SL Green Realty Corp / Chesapeake Energy Corp / APA Corp (US) / UiPath Inc / Lion Electric Co / IAC/Interactivecorp / Vimeo Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Mister Car Wash Inc / Anaergia Inc / Dole PLC / Lightspeed Commerce Inc / Zevia PBC / Jasper Therapeutics Inc / Candel Therapeutics Inc / D2L Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / France / Ireland / United States / Virgin Islands, British / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">ACA / BAX / DNLI / EBS / ICPT / INMD / NBIX / OM / PRGO / RAD / SAGE / SVA / WMT / GILD.O / EW / ONEM.O / ALKS.O / OPNT.O / REGN.O / SSNC.O / MRNS / NKTR / NOVN.O / CCRN.O / BCRX.O / AMED.O / EXAS.O / ANGN.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / CMMB / FREQ / ACAD.O / ALNY.O / DXCM.O / LHCG.O / MBRX.O / CBAY / CYCC.O / INFI.O / HUMA / 02043Q107 / TNDM.O / ENSG.O / 483548103 / MRNA.O / VERO / 771195104 / ADUS.O / GLAXOSM.LG / SPRO.O / 695127100 / SRPT.O / AERI.O / MDWD.O / 02005N100 / RXDX.O / INO.O / VBLT.O / NVRO / AUPH.O / GLPG.O / EVH / NVCR.O / 100063846 / IONS.O / CLRB.O / VRAY / NTLA / FLGT.O / IOVA / MTEM.O / ATNX.O / PTGX.O / 720795103 / ORTX.O / BNGO.O / IMUX.O / ZM.O / TMDX / IDYA.O / PSNL.O / DMTK.O / XAIR / PNTG.O / BCYC / NMTR.O / ORIC.O / PHGE.K / PLRX.O / NNOX / HGEN.O / TSHA.O / FSTX.O / PRTG.O / SNSE.O / IMCR.O / PHVS.O / 03823M100 / 390320109 / EVAX.O / RZLT.O / SERA.OQ / CGTX.OQ / ATXS.O</td><td class="leftalignment">Arcosa Inc / Baxter International Inc / Denali Therapeutics Inc / Emergent BioSolutions Inc / Intercept Pharmaceuticals Inc / Inmode Ltd / Neurocrine Biosciences Inc / Outset Medical Inc / Perrigo Company PLC / Rite Aid Corp / SAGE Therapeutics Inc / Sinovac Biotech Ltd / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Alkermes Plc / Opiant Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Marinus Pharmaceuticals Inc / Nektar Therapeutics / Novan Inc / Cross Country Healthcare Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Exact Sciences Corp / Angion Biomedica Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Chemomab Therapeutics Ltd / Frequency Therapeutics Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / Cymabay Therapeutics Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Humacyte Inc / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Venus Concept Inc / Roche Holding AG / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Spero Therapeutics Inc / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / Ally Financial Inc / Prometheus Biosciences Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Aurinia Pharmaceuticals Inc / Galapagos NV / Evolent Health Inc / Novocure Ltd / Truist Financial Corp / Ionis Pharmaceuticals Inc / Cellectar Biosciences Inc / ViewRay Inc / Intellia Therapeutics Inc / Fulgent Genetics Inc / Iovance Biotherapeutics Inc / Molecular Templates Inc / Athenex Inc / Protagonist Therapeutics Inc / Pieris Pharmaceuticals Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Immunic Inc / Zoom Video Communications Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / Personalis Inc / DermTech Inc / Beyond Air Inc / Pennant Group Inc / Bicycle Therapeutics PLC / 9 Meters Biopharma Inc / Oric Pharmaceuticals Inc / Biomx Inc / Pliant Therapeutics Inc / Nano-X Imaging Ltd / Humanigen Inc / Taysha Gene Therapies Inc / F-Star Therapeutics Inc / Portage Biotech Inc / Sensei Biotherapeutics Inc / Immunocore Holdings PLC / Pharvaris NV / Applied Minerals Inc / Great Elm Capital Corp / Evaxion Biotech A/S / Rezolute Inc / Sera Prognostics Inc / Cognition Therapeutics Inc / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Antigua and Barbuda / Belgium / Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / Nigeria / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 71708110 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 12/3/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AAPL / ACA / AMT / APP / APPS / BBY / C.N / CCI / CHTR / CME / COST / DISH / DLR / EA / FOCS / GLW / GS / ICE / ICPT / INTC.O / IS / MCD / MCO / MS / MSFT / NET / NKE / ORCL / QCOM.O / QUIK / RAD / RH / RNG / RXT / SAP / SEIC / SONY / SPOT / T / TTWO / U / UPS / V / WMT / AMZN.O / GILD.O / CMCSA.O / NICE / CSCO.O / ATVI.O / ONEM.O / TRIT / NVDA.O / EGAN / RDWR / HEAR / KLR / SQ / AKAM / CSGS.O / SBAC.O / VG / AMD.O / ADI.O / EQIX / VZ / NFLX / CEVA / CRNT.O / LUMN / SMTC.O / FDS.N / TXN.O / DOX.O / REGN.O / MRVL.O / VRNT / SSNC.O / AVGO.O / NDAQ / XLNX.OQ / NOVN.O / CCRN.O / BCRX.O / AMED.O / EXAS.O / SWKS.O / ANGN.O / BIIB / 00846U101 / 868168105 / GOOG.O / CMMB / FREQ / SPGI / DXCM.O / LHCG.O / MBRX.O / 36467W109 / CBAY / CCOI / CYCC.O / INFI.O / COIN / IVZ / 02043Q107 / ENSG.O / 483548103 / 00826A109 / 771195104 / ADUS.O / GLAXOSM.LG / TSLA.O / NXPI.O / SPRO.O / ZNGA / FB.O / WDAY / TMUS / FDEV.L / WIX.O / ARMK / FIVN.O / 82655M107 / MDWD.O / VBLT.O / QRVO.O / CXDO / AUPH.O / GLPG.O / EVH / NVCR.O / 100063846 / IONS.O / CLRB.O / NTLA / TTD.O / FLGT.O / OKTA.O / MTEM.O / ATNX.O / ROKU.O / MDB.O / EGHT.K / PTGX.O / 720795103 / BILI.O / ORTX.O / BNGO.O / IMUX.O / ZM.O / IDYA.O / FSLY / PSNL.O / DMTK.O / CMBM / PNTG.O / BCYC / DKNG / NMTR.O / ORIC.O / PHGE.K / PLRX.O / FUBO / HGEN.O / TSHA.O / TEUM.PK / ONDS.OQ / PRTG.O / SNSE.O / PHVS.O / DOCN / HUYA.K / EVAX.O / RZLT.O / 975657107 / SERA.OQ / MNDY.O / ATXS.O / NN.O</td><td class="leftalignment">Apple Inc / Arcosa Inc / American Tower Corp / Applovin Corp / Digital Turbine Inc / Best Buy Co Inc / Citigroup Inc / Crown Castle International Corp / Charter Communications Inc / CME Group Inc / Costco Wholesale Corp / DISH Network Corp / Digital Realty Trust Inc / Electronic Arts Inc / Focus Financial Partners Inc / Corning Inc / Goldman Sachs Group Inc / Intercontinental Exchange Inc / Intercept Pharmaceuticals Inc / Intel Corp / Ironsource Ltd / McDonald's Corp / Moody's Corp / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Nike Inc / Oracle Corp / Qualcomm Inc / QuickLogic Corp / Rite Aid Corp / RH / RingCentral Inc / Rackspace Technology Inc / SAP SE / SEI Investments Co / Sony Group Corp / Spotify Technology SA / AT&T Inc / Take-Two Interactive Software Inc / Unity Software Inc / United Parcel Service Inc / Visa Inc / Walmart Inc / Amazon.com Inc / Gilead Sciences Inc / Comcast Corp / Nice Ltd / Cisco Systems Inc / Activision Blizzard Inc / 1Life Healthcare Inc / Triterras Inc / NVIDIA Corp / eGain Corp / Radware Ltd / Turtle Beach Corp / Kaleyra Inc / Block Inc / Akamai Technologies Inc / CSG Systems International Inc / SBA Communications Corp / Vonage Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Equinix Inc / Verizon Communications Inc / Netflix Inc / CEVA Inc / Ceragon Networks Ltd / Lumen Technologies Inc / Semtech Corp / Factset Research Systems Inc / Texas Instruments Inc / Amdocs Ltd / Regeneron Pharmaceuticals Inc / Marvell Technology Inc / Verint Systems Inc / SS&C Technologies Holdings Inc / Broadcom Inc / Nasdaq Inc / Xilinx Inc / Novan Inc / Cross Country Healthcare Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Exact Sciences Corp / Skyworks Solutions Inc / Angion Biomedica Corp / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Chemomab Therapeutics Ltd / Frequency Therapeutics Inc / S&P Global Inc / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / GameStop Corp / Cymabay Therapeutics Inc / Cogent Communications Holdings Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Coinbase Global Inc / Invesco Ltd / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Affymax Inc / Roche Holding AG / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / NXP Semiconductors NV / Spero Therapeutics Inc / Zynga Inc / Meta Platforms Inc / Workday Inc / T-Mobile US Inc / Frontier Developments PLC / Wix.Com Ltd / Aramark / Five9 Inc / Sify Technologies Ltd / Mediwound Ltd / Vascular Biogenics Ltd / Qorvo Inc / Crexendo Inc / Aurinia Pharmaceuticals Inc / Galapagos NV / Evolent Health Inc / Novocure Ltd / Truist Financial Corp / Ionis Pharmaceuticals Inc / Cellectar Biosciences Inc / Intellia Therapeutics Inc / Trade Desk Inc / Fulgent Genetics Inc / Okta Inc / Molecular Templates Inc / Athenex Inc / Roku Inc / MongoDB Inc / 8x8 Inc / Protagonist Therapeutics Inc / Pieris Pharmaceuticals Inc / Bilibili Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Immunic Inc / Zoom Video Communications Inc / IDEAYA Biosciences Inc / Fastly Inc / Personalis Inc / DermTech Inc / Cambium Networks Corp / Pennant Group Inc / Bicycle Therapeutics PLC / DraftKings Inc / 9 Meters Biopharma Inc / Oric Pharmaceuticals Inc / Biomx Inc / Pliant Therapeutics Inc / Fubotv Inc / Humanigen Inc / Taysha Gene Therapies Inc / Pareteum Corp / Ondas Holdings Inc / Portage Biotech Inc / Sensei Biotherapeutics Inc / Pharvaris NV / DigitalOcean Holdings Inc / HUYA Inc / Evaxion Biotech A/S / Rezolute Inc / Winston Pharmaceuticals Inc / Sera Prognostics Inc / Monday.Com Ltd / Astria Therapeutics Inc / NextNav Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / India / Israel / Japan / Luxembourg / Nigeria / Netherlands / United States / Virgin Islands, British / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Biogen Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Let it Bleed; Four Straight Weeks of Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Institutional ownership of BIIB at Sep 30: 315 (31%) exits from Biogen</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / LH / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / AFMD.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Laboratory Corporation of America Holdings / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Affimed NV / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—December 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US64125C1099 / US09062X1037 / CA68620P1018 / CA1380351009 / US88688T1007 / CA39342L1085 / CA58507M1077 / CA22587M1068 / CA89788C1041 / US12482W1018 / CA16106R1091 / US86150R1077 / CA23126M1023 / US1266541028 / CA05156X8843 / US56854Q2003 / CA00489Y6001</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / OrganiGram Holdings Inc / Canopy Growth Corp / Tilray Brands Inc / Green Thumb Industries Inc / Medmen Enterprises Inc / Cresco Labs Inc / Trulieve Cannabis Corp / cbdMD Inc / Charlotte's Web Holdings Inc / Stoke Therapeutics Inc / Curaleaf Holdings Inc / CV Sciences Inc / Aurora Cannabis Inc / Marinus Pharmaceuticals Inc / Acreage Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AJG / BMY.N / EMN / H / KO / LLY.N / MRK.N / OLN / PFE.N / PK / RKT / S.N / SWK / ASND.O / AMZN.O / HT / GILD.O / AMGN.O / EW / ARNA.O / CHH.N / GSK.N / ARGX.O / BMRN.O / REGN.O / VRTX.O / DOL.TO / SIVB.O / BIIB.O / SHO.N / HST.N / HZNP.O / SRPT.O / RHP.N / ABBV.N / PFSI.K / QURE.O / RXDX.O / XHR.N / APLE.N / RYTM.O / SFIX.O / APLS.O / KZR.O / MORF.O / CABA.O / 45258J102 / HMPT.O</td><td class="leftalignment">Arthur J Gallagher & Co / Bristol-Myers Squibb Co / Eastman Chemical Co / Hyatt Hotels Corp / Coca-Cola Co / Eli Lilly and Co / Merck & Co Inc / Olin Corp / Pfizer Inc / Park Hotels & Resorts Inc / Rocket Companies Inc / SentinelOne Inc / Stanley Black & Decker Inc / Ascendis Pharma A/S / Amazon.com Inc / Hersha Hospitality Trust / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Arena Pharmaceuticals Inc / Choice Hotels International Inc / GlaxoSmithKline PLC / argenx SE / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Dollarama Inc / SVB Financial Group / Biogen Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Horizon Therapeutics PLC / Sarepta Therapeutics Inc / Ryman Hospitality Properties Inc / Abbvie Inc / PennyMac Financial Services Inc / Uniqure NV / Prometheus Biosciences Inc / Xenia Hotels & Resorts Inc / Apple Hospitality REIT Inc / Rhythm Pharmaceuticals Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / Kezar Life Sciences Inc / Morphic Holding Inc / Cabaletta Bio Inc / Immunovant Inc / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">The Skies Are Clearing but Stock Selection Still Important</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Correction: BIIB—Between a Rock and a Hard Place; BAN2401 Key to Recovery; Initiating at Equal Weight</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">December 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">US09062X1037 / US0311621009 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Biogen Inc / Amgen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">US0091581068 / US0311621009 / US1101221083 / US2017231034 / US2372661015 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US8718291078 / US8851601018 / US9078181081 / US9111631035 / US92532F1003 / US9746371007 / CA29250N1050 / CA1247651088 / CA2918434077 / US09062X1037 / BMG169621056 / US6293775085 / US12008R1077 / US1252691001 / CA6179141065 / US58933Y1055 / US65339F1012 / CA04364G1063 / CA0805581091 / CA38045Y1025 / US85208M1027 / US60468T1051 / US2383371091 / US1638511089 / US4622221004 / US13462K1097 / US8608971078 / US80810D1037 / US92719V1008 / US1374041093</td><td class="leftalignment">Air Products and Chemicals Inc / Amgen Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sysco Corp / Thor Industries Inc / Union Pacific Corp / United Natural Foods Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Enbridge Inc / CAE Inc / Empire Company Ltd / Biogen Inc / Bunge Ltd / NRG Energy Inc / Builders FirstSource Inc / CF Industries Holdings Inc / Morguard Real Estate Investment Trust / Merck & Co Inc / Nextera Energy Inc / Ascot Resources Ltd / Belo Sun Mining Corp / GoGold Resources Inc / Sprouts Farmers Market Inc / Mirati Therapeutics Inc / Dave & Buster's Entertainment Inc / Chemours Co / Ionis Pharmaceuticals Inc / Camping World Holdings Inc / Stitch Fix Inc / Schrodinger Inc / Vimeo Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Feedback From Our Launch: PFE’s Longer-Term COVID Benefit Clearer w/ Omicron</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended September 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Model Update: Tweaking our Aduhelm accounting model</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Amid Seasonal Delta-Driven Wave; Clarity on Omicron’s Impact on Vaccines, Trajectory, and Disease Severity in Near Term</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Medical Technology</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">85231230 / 002824100 / 09062X103 / 101137107 / 457985208 / 863667101 / 98956P102 / 30063P105 / 28176E108 / 46120E602 / 883556102 / 436440101 / 670704105 / 003654100 / 04963C209 / 252131107 / 574795100 / 45784P101 / 004397105 / 379577208 / 05463X106 / 44934S206 / 46071F103 / 92346J108 / G5960L103 / 81727U105 / 87357P100 / 450056106 / 92672L107 / 377322102 / 81255T108 / 922107107 / 68752L100 / 68621F102 / H01301128 / 45332Y109 / 92332W105 / G31249108 / 64131A105 / 05380C102 / 005111109 / M6883010 / 70975L10 / 24661P807 / 52634L10 / 78349D10 / 44486Q10 / 92561V10</td><td class="leftalignment">STAAR Surgical Co / Abbott Laboratories / Biogen Inc / Boston Scientific Corp / Integra Lifesciences Holdings Corp / Stryker Corp / Zimmer Biomet Holdings Inc / Exact Sciences Corp / Edwards Lifesciences Corp / Intuitive Surgical Inc / Thermo Fisher Scientific Inc / Hologic Inc / NuVasive Inc / ABIOMED Inc / AtriCure Inc / Dexcom Inc / Masimo Corp / Insulet Corp / Accuray Inc / Globus Medical Inc / AxoGen Inc / ICAD Inc / Intersect Ent Inc / Vericel Corp / Medtronic PLC / Senseonics Holdings Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / ViewRay Inc / Glaukos Corp / SeaSpine Holdings Corp / Vapotherm Inc / OrthoPediatrics Corp / Organogenesis Holdings Inc / Alcon AG / Inari Medical Inc / Venus Concept Inc / Establishment Labs Holdings Inc / Neuronetics Inc / AVITA Medical Inc / Acutus Medical Inc / Mediwound Ltd / Penumbra Inc / Delcath Systems Inc / LENSAR Inc / Rxsight Inc / Humacyte Inc / Vicarious Surgical Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / Israel / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ryan Zimmerman / Ms. Marie Thibault / Sam Eiber / Phillip Dantoin</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">465</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / INCY.O / JAZZ.O / NBIX.O / BLU.N / BIIB.O / SRPT.O / ENTA.O / KPTI.O / XNCR.OQ / 03835T200 / GBT.OQ / KRTX.OQ / IGMS.O / ETNB.O / PLRX.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Jazz Pharmaceuticals PLC / Neurocrine Biosciences Inc / BELLUS Health Inc / Biogen Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xencor Inc / Aptose Biosciences Inc / Global Blood Therapeutics Inc / Karuna Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Pliant Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AGCO / BAX / DCI / DE / EA / HD / INMD / LOW / MSFT / NBIX / NET / OM / QCOM.O / ROK / SAGE / TRMB / AMZN.O / EW / NVDA.O / AKAM / NTAP.O / PLUG.O / FCEL.O / OTEX.O / BLK.N / AMSC.O / HPE / SIVB.O / ITRI.O / BIIB / 983919101 / GOOG.O / CDNS.O / SPWR.O / CSIQ.O / FSLR.O / HUMA / VERO / WPRT.O / TWIN.O / TSLA.O / PCYO.O / AMRS.O / ENPH.O / CG.O / CNHI / NVRO / SEDG.O / RUN.O / WKHS.O / AQMS.O / VRAY / AQB / 720795103 / ZM.O / TMDX / KERN.O / FSLY / NLOK.O / 02081G201 / NNOX / VLDR.O / SHLS.O / APPH / DOCN / TSP.O / 010196103 / ENVX.O / LILM.O / BLZE.O</td><td class="leftalignment">AGCO Corp / Baxter International Inc / Donaldson Company Inc / Deere & Co / Electronic Arts Inc / Home Depot Inc / Inmode Ltd / Lowe's Companies Inc / Microsoft Corp / Neurocrine Biosciences Inc / Cloudflare Inc / Outset Medical Inc / Qualcomm Inc / Rockwell Automation Inc / SAGE Therapeutics Inc / Trimble Inc / Amazon.com Inc / Edwards Lifesciences Corp / NVIDIA Corp / Akamai Technologies Inc / NetApp Inc / Plug Power Inc / Fuelcell Energy Inc / Open Text Corp / BlackRock Inc / American Superconductor Corp / Hewlett Packard Enterprise Co / SVB Financial Group / Itron Inc / Biogen Inc / Xilinx Inc / Alphabet Inc / Cadence Design Systems Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / Humacyte Inc / Venus Concept Inc / Westport Fuel Systems Inc / Twin Disc Inc / Tesla Inc / Pure Cycle Corp / Amyris Inc / Enphase Energy Inc / Carlyle Group Inc / CNH Industrial NV / Nevro Corp / Solaredge Technologies Inc / Sunrun Inc / Workhorse Group Inc / Aqua Metals Inc / ViewRay Inc / AquaBounty Technologies Inc / Pieris Pharmaceuticals Inc / Zoom Video Communications Inc / Transmedics Group Inc / Akerna Corp / Fastly Inc / NortonLifeLock Inc / Alphatec Holdings Inc / Nano-X Imaging Ltd / Velodyne Lidar Inc / Shoals Technologies Group Inc / AppHarvest Inc / DigitalOcean Holdings Inc / TuSimple Holdings Inc / Aksys Ltd / Enovix Corp / Lilium NV / Backblaze Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Clinical Labs & Death Care Outperform; Paying for Medicaid Expansion in Mississippi</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="even"><td class="leftalignment">12/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">SHORELINE Update Highlights Differentiated Profile</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SAGE / BIIB</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">12/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 576</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ACA / MCO / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / DOCU.O / PNTG.O</td><td class="leftalignment">Arcosa Inc / Moody's Corp / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / DocuSign Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">China / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">The Cowen Edge - December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">FR0000121014 / NL0000226223 / DE0006231004 / DE0006969603 / US0079031078 / US0079731008 / US00971T1016 / US02553E1064 / US0378331005 / US0382221051 / US1265011056 / US1311931042 / US1727551004 / US1925761066 / US1985161066 / US22160K1051 / US2435371073 / US2545431015 / US4581401001 / US4824801009 / US5002551043 / US5128071082 / US5184151042 / US5370081045 / US55306N1046 / US5950171042 / US5951121038 / US6541061031 / US67066G1040 / US6821891057 / US7392761034 / US7475251036 / US7782961038 / US8168501018 / US8269191024 / US8305661055 / US8610121027 / US8725401090 / US8740391003 / US87612E1064 / US8807701029 / US91347P1057 / US9182041080 / US92343V1044 / US9282981086 / US9311421039 / US9581021055 / DE0005664809 / TW0002330008 / US3448491049 / US87157D1090 / US83088M1027 / US20030N1019 / US3463751087 / US2533931026 / US09062X1037 / US1572101053 / US90385V1070 / US0042251084 / US02043Q1076 / US6098391054 / US2538681030 / US19239V3024 / US2090341072 / US00206R1023 / US9043111072 / US82706C1080 / US4103451021 / US55616P1049 / US53261M1045 / US5500211090 / US90384S3031 / US25470M1099 / US64110D1046 / US30050E1055 / DE000A1EWWW0 / US6936561009 / US7512121010 / US03027X1000 / NL0010273215 / US8725901040 / US55405Y1001 / US23283R1005 / US1220171060 / US0465131078 / US22822V1017 / US74736K1016 / US29444U7000 / US00653A1079 / US12685J1051 / US6323071042 / CA1380351009 / US74624M1027 / US05464T1043 / US90041L1052 / US00773U1088 / US16119P1084 / US36165L1089 / KYG4740B1059 / US78410G1040 / CA22717L1013 / US91325V1089 / US02156K1034 / IL0011063760 / US87105L1044 / US74766Q1013 / US57777K1060 / US11135F1012 / CA88105E1088 / US88688T1007 / CA39342L1085 / US0197701065 / US98585X1046 / CA22587M1068 / US0144421072 / CA89788C1041 / US3953301039 / CA23126M1023 / CA86730L1094 / US09203E1055 / CA1973091079 / CA05156X8843 / CH0499880968 / US02875D1090 / ACRGau.CD / KYG3902L1095 / CA1867601041 / US5502411037 / US5738741041 / IE00BKVD2N49 / US30260D1037 / US25401T1088 / US35909D1090 / US1095041000 / KYG4701H1092 / US01675A1097</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / STMicroelectronics NV / Infineon Technologies AG / Puma SE / Advanced Micro Devices Inc / Advanced Energy Industries Inc / Akamai Technologies Inc / American Eagle Outfitters Inc / Apple Inc / Applied Materials Inc / CTS Corp / Callaway Golf Co / Cirrus Logic Inc / Cohu Inc / Columbia Sportswear Co / Costco Wholesale Corp / Deckers Outdoor Corp / Diodes Inc / Intel Corp / KLA Corp / Kohls Corp / Lam Research Corp / Lattice Semiconductor Corp / Littelfuse Inc / MKS Instruments Inc / Microchip Technology Inc / Micron Technology Inc / Nike Inc / NVIDIA Corp / ON Semiconductor Corp / Power Integrations Inc / Qualcomm Inc / Ross Stores Inc / Semtech Corp / Silicon Laboratories Inc / Skechers USA Inc / STMicroelectronics NV / TJX Companies Inc / Taiwan Semiconductor Manufacturing Co Ltd / Target Corp / Teradyne Inc / Universal Display Corp / VF Corp / Verizon Communications Inc / Vishay Intertechnology Inc / Walmart Inc / Western Digital Corp / Evotec SE / Taiwan Semiconductor Manufacturing Co Ltd / Foot Locker Inc / Synaptics Inc / Skyworks Solutions Inc / Comcast Corp / FormFactor Inc / DICK'S Sporting Goods Inc / Biogen Inc / CEVA Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Monolithic Power Systems Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / AT&T Inc / Under Armour Inc / Silicon Motion Technology Corp / HanesBrands Inc / Macy's Inc / Limelight Networks Inc / Lululemon Athletica Inc / Ulta Beauty Inc / DISH Network Corp / NetApp Inc / Evotec SE / Adidas AG / PVH Corp / Ralph Lauren Corp / American Tower Corp / ASML Holding NV / T-Mobile US Inc / MACOM Technology Solutions Holdings Inc / CyrusOne Inc / Burlington Stores Inc / Atara Biotherapeutics Inc / Crown Castle International Corp / Qorvo Inc / Equinix Inc / Adaptimmune Therapeutics PLC / Cable One Inc / Natera Inc / Canopy Growth Corp / Pure Storage Inc / Axsome Therapeutics Inc / Turning Point Brands Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / Ichor Holdings Ltd / SBA Communications Corp / Cronos Group Inc / Uniti Group Inc / Altice USA Inc / InterCure Ltd / Switch Inc / Quanterix Corp / MaxCyte Inc / Broadcom Inc / Terrascend Corp / Tilray Brands Inc / Green Thumb Industries Inc / Allogene Therapeutics Inc / Yeti Holdings Inc / Cresco Labs Inc / Alector Inc / Trulieve Cannabis Corp / Greenlane Holdings Inc / Curaleaf Holdings Inc / Sundial Growers Inc / Black Diamond Therapeutics Inc / Columbia Care Inc / Aurora Cannabis Inc / ADC Therapeutics SA / American Outdoor Brands Inc / Acreage Holdings Inc / GDS Holdings Ltd / Clever Leaves Holdings Inc / Lumen Technologies Inc / Marvell Technology Inc / Seagate Technology Holdings PLC / Figs Inc / DigitalBridge Group Inc / Frontier Communications Parent Inc / Brilliant Earth Group Inc / IHS Holding Ltd / Allbirds Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 26 to December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0002810146 / IL0006290147 / US0091581068 / US02553E1064 / US0383361039 / US0536111091 / US0584981064 / US1264081035 / US2017231034 / US2441991054 / US25179M1036 / US2788651006 / US30231G1022 / US31428X1063 / US3154051003 / US3647601083 / US4180561072 / US4282911084 / US4433201062 / US4456581077 / US4523081093 / US5010441013 / US5324571083 / US56418H1005 / US5770811025 / US5949181045 / US64125C1099 / US6516391066 / US6541061031 / US6556641008 / US6558441084 / US6703461052 / US6935061076 / US7170811035 / US7496851038 / US75886F1075 / US7703231032 / US7782961038 / US7802871084 / US81211K1007 / US8243481061 / US8581191009 / US8725401090 / US9078181081 / US9113121068 / US91324P1021 / US9170471026 / US9182041080 / US92532F1003 / CA53278L1076 / CA1363751027 / CA59162N1096 / CA29250N1050 / CA5394811015 / CA0977512007 / CA30150P1099 / CA1247651088 / CA2908761018 / CA5592224011 / CA0084741085 / CA0679011084 / CA1363851017 / CA2499061083 / US1667641005 / CA13645T1003 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US20825C1045 / US2274831047 / CA5734591046 / US09062X1037 / NO0010208051 / US49446R1095 / CA98462Y1007 / US79466L3024 / US9604131022 / CA5503721063 / US29476L1070 / US7588491032 / US1508701034 / CA8911605092 / CA1360691010 / CA8935781044 / US8288061091 / US44107P1049 / US12541W2098 / US9043111072 / US3137472060 / US29472R1086 / US8666741041 / CA32076V1031 / GB00B1FW5029 / US5021751020 / US63633D1046 / CA14068G1046 / US5500211090 / US89785X1019 / US90384S3031 / CA3518581051 / US91912E1055 / CA8672241079 / US58933Y1055 / CA25675T1075 / CA15135U1093 / US2566771059 / CA14042M1023 / NL0009434992 / CA9237251058 / CA07317Q1054 / US18538R1032 / CA00208D4084 / CA2927661025 / US61945C1036 / JE00B4T3BW64 / US6936561009 / US7512121010 / US71922G2093 / CA7063271034 / CA4932711001 / CA89156V1067 / CA55903Q1046 / CA96145A2002 / US70509V1008 / CA04682R1073 / US78573L1061 / US8486371045 / CA87262K1057 / US08579W1036 / US23283R1005 / CA05577W2004 / US1220171060 / US11120U1051 / CA68827L1013 / US78667J1088 / CA0089118776 / BMG0750C1082 / US1638511089 / US92939U1060 / CA8485101031 / US86771W1053 / US72703H1014 / US4622221004 / US45688C1071 / US0441861046 / US7005171050 / CA87241L1094 / US6792951054 / CA9628791027 / GB00BF3ZNS54 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / CA67077M1086 / US98980G1022 / US00191U1025 / US83200N1037 / IE00BZ12WP82 / VGG1890L1076 / US28618M1062 / US2605571031 / GB00BJT16S69 / CA87807B1076 / CA14179V5036 / US26614N1028 / US76156B1070 / JE00BJ1F3079 / US88339P1012 / US86745K1043 / US70614W1009 / US69047Q1022 / MHY0436Q1098 / US03750L1098 / JE00BMVMZ478 / US1651677353 / US24343R1068 / CA00076T1057 / US90364P1057 / US11135E2037 / US5738741041 / US60646V1052 / US0708301041 / US9264001028 / US27923Q1094 / US89269P1030 / US94770D1028 / US53190C1027 / US04302A1043</td><td class="leftalignment">Icl Group Ltd / Teva Pharmaceutical Industries Ltd / Air Products and Chemicals Inc / American Eagle Outfitters Inc / Aptargroup Inc / Avery Dennison Corp / Ball Corp / CSX Corp / Commercial Metals Co / Deere & Co / Devon Energy Corp / Ecolab Inc / Exxon Mobil Corp / FedEx Corp / Ferro Corp / Gap Inc / Hasbro Inc / Hexcel Corp / Hub Group Inc / J B Hunt Transport Services Inc / Illinois Tool Works Inc / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Mattel Inc / Microsoft Corp / Neurocrine Biosciences Inc / Newmont Corporation / Nike Inc / Nordstrom Inc / Norfolk Southern Corp / Nucor Corp / PPG Industries Inc / Pfizer Inc / RPM International Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Ross Stores Inc / Royal Gold Inc / Sealed Air Corp / Sherwin-Williams Co / Steel Dynamics Inc / TJX Companies Inc / Union Pacific Corp / United Parcel Service Inc / UnitedHealth Group Inc / Urban Outfitters Inc / VF Corp / Vertex Pharmaceuticals Inc / Linamar Corp / Canadian National Railway Co / Metro Inc / Enbridge Inc / Loblaw Companies Ltd / Bombardier Inc / Exco Technologies Ltd / CAE Inc / Emera Inc / Magna International Inc / Agnico Eagle Mines Ltd / Barrick Gold Corp / Canadian Natural Resources Ltd / Descartes Systems Group Inc / Chevron Corp / Canadian Pacific Railway Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Martinrea International Inc / Biogen Inc / Yara International ASA / Kimco Realty Corp / Yamana Gold Inc / Salesforce.Com Inc / Westlake Chemical Corp / Lundin Mining Corp / Equity Residential / Regency Centers Corp / Celanese Corp / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Transcontinental Inc / Simon Property Group Inc / Host Hotels & Resorts Inc / CH Robinson Worldwide Inc / Under Armour Inc / Federal Realty Investment Trust / Equity LifeStyle Properties Inc / Sun Communities Inc / First Majestic Silver Corp / Hochschild Mining PLC / LTC Properties Inc / National Health Investors Inc / Capstone Mining Corp / Lululemon Athletica Inc / TrueBlue Inc / Ulta Beauty Inc / Franco-Nevada Corp / Vale SA / Suncor Energy Inc / Merck & Co Inc / Dollarama Inc / Cenovus Energy Inc / Dollar General Corp / Capital Power Corp / LyondellBasell Industries NV / Vermilion Energy Inc / Baytex Energy Corp / Clearwater Paper Corp / ARC Resources Ltd / Enerplus Corp / Mosaic Co / Glencore PLC / PVH Corp / Ralph Lauren Corp / PhosAgro PAO / Pembina Pipeline Corp / Keyera Corp / Tourmaline Oil Corp / MAG Silver Corp / Westshore Terminals Investment Corp / Pebblebrook Hotel Trust / Athabasca Oil Corp / Sabra Health Care REIT Inc / Splunk Inc / TMX Group Ltd / Berry Global Group Inc / CyrusOne Inc / BRP Inc / Burlington Stores Inc / Brixmor Property Group Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Air Canada / Axalta Coating Systems Ltd / Chemours Co / WEC Energy Group Inc / Spin Master Corp / Sunrun Inc / Planet Fitness Inc / Ionis Pharmaceuticals Inc / Ingevity Corp / Ashland Global Holdings Inc / Park Hotels & Resorts Inc / TFI International Inc / Okta Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Nutrien Ltd / Zscaler Inc / ASGN Inc / Smartsheet Inc / Linde PLC / Capri Holdings Ltd / Element Solutions Inc / Dow Inc / Tronox Holdings PLC / TC Energy Corp / Cargojet Inc / Dupont De Nemours Inc / Revolve Group Inc / Amcor PLC / RealReal Inc / Sunnova Energy International Inc / Peloton Interactive Inc / Ovintiv Inc / Atlas Corp / Apartment Income REIT Corp / Atotech Ltd / Chesapeake Energy Corp / Decibel Therapeutics Inc / Abc Technologies Holdings Inc / UiPath Inc / Broadstone Net Lease Inc / Marvell Technology Inc / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Ecovyst Inc / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Arteris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / United Kingdom / Ireland / Israel / Netherlands / Norway / Russian Federation / United States / Virgin Islands, British / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 11012210 / 71708110 / 00846U10 / 88162420 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 80105N10 / NOVO B / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Sanofi SA / Novo Nordisk A/S / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Dec. 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACA / ALLO / MBIO / RAD / WMT / GILD.O / EW / ONEM.O / ISRG / BMRN.O / REGN.O / VRTX.O / CYAD / SSNC.O / CCRN.O / CSTL.O / AMED.O / EXAS.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / ALNY.O / LHCG.O / TMDI / ENSG.O / 483548103 / MRNA.O / ADUS.O / GLAXOSM.LG / FATE.O / VBIV.O / INO.O / EVH / 100063846 / NVTA.K / 04280A100 / CRSP / CLLS.O / MTEM.O / VERU.O / 720795103 / MOTS.O / TMDX / DMTK.O / PNTG.O / HRMY.O / HGEN.O / VOR.O / 03823M100 / CRBU.O / ATXS.O</td><td class="leftalignment">Arcosa Inc / Allogene Therapeutics Inc / Mustang Bio Inc / Rite Aid Corp / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Intuitive Surgical Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Celyad Oncology SA / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Castle Biosciences Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / Alnylam Pharmaceuticals Inc / LHC Group Inc / Titan Medical Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Fate Therapeutics Inc / VBI Vaccines Inc / Inovio Pharmaceuticals Inc / Evolent Health Inc / Truist Financial Corp / Invitae Corp / Arrowhead Pharmaceuticals Inc / CRISPR Therapeutics AG / Cellectis SA / Molecular Templates Inc / Veru Inc / Pieris Pharmaceuticals Inc / Motus GI Holdings Inc / Transmedics Group Inc / DermTech Inc / Pennant Group Inc / Harmony Biosciences Holdings Inc / Humanigen Inc / Vor Biopharma Inc / Applied Minerals Inc / Caribou Biosciences Inc / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 11/26/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">US0584981064 / US1264081035 / US31428X1063 / US4433201062 / US4456581077 / US5010441013 / US5324571083 / US6516391066 / US6558441084 / US7170811035 / US7802871084 / US9078181081 / US9113121068 / CA53278L1076 / CA1363751027 / CA59162N1096 / CA5394811015 / CA0977512007 / CA30150P1099 / CA1247651088 / CA5592224011 / CA0679011084 / CA13645T1003 / CA5734591046 / US09062X1037 / CA5503721063 / CA8911605092 / CA1360691010 / CA8935781044 / US12541W2098 / CA32076V1031 / US90384S3031 / US2566771059 / CA14042M1023 / JE00B4T3BW64 / CA96145A2002 / CA0089118776 / US4622221004 / CA87241L1094 / CA9628791027 / US83200N1037 / CA14179V5036 / MHY0436Q1098 / CA00076T1057 / US5738741041</td><td class="leftalignment">Ball Corp / CSX Corp / FedEx Corp / Hub Group Inc / J B Hunt Transport Services Inc / Kroger Co / Eli Lilly and Co / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Royal Gold Inc / Union Pacific Corp / United Parcel Service Inc / Linamar Corp / Canadian National Railway Co / Metro Inc / Loblaw Companies Ltd / Bombardier Inc / Exco Technologies Ltd / CAE Inc / Magna International Inc / Barrick Gold Corp / Canadian Pacific Railway Ltd / Martinrea International Inc / Biogen Inc / Lundin Mining Corp / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Transcontinental Inc / CH Robinson Worldwide Inc / First Majestic Silver Corp / Ulta Beauty Inc / Dollar General Corp / Capital Power Corp / Glencore PLC / Westshore Terminals Investment Corp / Air Canada / Ionis Pharmaceuticals Inc / TFI International Inc / Wheaton Precious Metals Corp / Smartsheet Inc / Cargojet Inc / Atlas Corp / Abc Technologies Holdings Inc / Marvell Technology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Bleeding Continues - Third Straight Week of Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 04016X101 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / argenx SE / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Transcript: Expert Call on Alzheimer's Disease</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US5324571083 / US7170811035 / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / BMY=US / IP=US / GILD=US / PEB=US / H=US / CRM=US / MTN=US / MAR=US / TNL=US / HLT=US / AKR=US / APH=US / CHH=US / CSTR=US / DRH=US / REGN=US / ROLL=US / VRTX=US / CVX=US / PSA=US / SPG=US / SNOW=US / SGMS=US / FBK=US / MTCH=US / SRC=US / AUTL=US / BRX=US / PNFP=US / IGMS=US / STRO=US / BIIB=US / EXR=US / BECN=US / SHO=US / PLAY=US / HST=US / WH=US / IAC=US / EPRT=US / HGV=US / RLJ=US / VAC=US / CUBE=US / SPLK=US / RHP=US / ABBV=US / FATE=US / 00770K202 / AFMD=US / BVH=US / NSA=US / EDIT=US / NTLA=US / PK=US / PLYA=US / OKTA=US / ALLO=US / ESTC=US / HARP=US / CRWD=US / GMAB=US / NCNO=US / CELU=US / DHT.UN=CA / REPX=US / ROIV=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Bristol-Myers Squibb Co / International Paper Co / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Amphenol Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Public Storage / Simon Property Group Inc / Snowflake Inc. / Scientific Games Corp / FB Financial Corp / Match Group Inc / Spirit Realty Capital Inc / Autolus Therapeutics PLC / Brixmor Property Group Inc / Pinnacle Financial Partners Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / CubeSmart / Splunk Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Fate Therapeutics Inc / Aemetis Inc / Affimed NV / Bluegreen Vacations Holding Corp / National Storage Affiliates Trust / Editas Medicine Inc / Intellia Therapeutics Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Allogene Therapeutics Inc / Elastic NV / Harpoon Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / nCino Inc / Celularity Inc / Dri Healthcare Trust / Riley Exploration Permian Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US30231G1022 / US4523081093 / US5324571083 / US91324P1021 / US92532F1003 / CA2908761018 / CA0084741085 / CA2499061083 / US1667641005 / CA6330671034 / CA7800871021 / US09062X1037 / CA98462Y1007 / GB00B1FW5029 / CA25675T1075 / CA07317Q1054 / US18538R1032 / CA04682R1073 / US8486371045 / CA05577W2004 / US78667J1088 / US6792951054 / CA87807B1076</td><td class="leftalignment">Exxon Mobil Corp / Illinois Tool Works Inc / Eli Lilly and Co / UnitedHealth Group Inc / Vertex Pharmaceuticals Inc / Emera Inc / Agnico Eagle Mines Ltd / Descartes Systems Group Inc / Chevron Corp / National Bank of Canada / Royal Bank of Canada / Biogen Inc / Yamana Gold Inc / Hochschild Mining PLC / Dollarama Inc / Baytex Energy Corp / Clearwater Paper Corp / Athabasca Oil Corp / Splunk Inc / BRP Inc / SAGE Therapeutics Inc / Okta Inc / TC Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 2026242 / 2270726 / 2317087 / 2455965 / 2931034 / 2857817 / B7TL820 / B4MG4Z6 / B7VD3F2 / B85KFY9 / B3V9F12 / BFH3N85 / B3NXMJ9 / BP4GNK9 / BF4VBS8 / BD8DJ71 / BWTN5N1 / BYZR4X4 / BJ2Z0H2 / BJJMGL2 / BKTNTR9 / BDFZSP1 / BZ1LFG7 / BYTJZL1 / BNTB3N8</td><td class="leftalignment">Sanofi SA / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Biogen Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Five Below Inc / PVH Corp / Veeva Systems Inc / Wendys Co / SAGE Therapeutics Inc / BioXcel Therapeutics Inc / Snap Inc / ETSY Inc / Axsome Therapeutics Inc / Pinterest Inc / Fox Corp / ViacomCBS Inc / Okta Inc / Roku Inc / Zogenix Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Repercussions from the high price of Aduhelm treatment for Alzheimer's</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - アルツハイマー病治療薬アデュヘルムの高薬価の波紋</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Alzheimer's Call Bullish for Positive CMS Decision & A-beta Antibodies Uptake</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US5324571083 / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Sage & Biogen  : Phase 3 SHORELINE Update Further Supports Consistency of Zuranolone Profile and Durability of Effect</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / SAGE.O</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Ms. Tiffany Sun / Manish Jajoo / Mr. Thomas Deal</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Zuranolone's SHORELINE Data Shows Durability At 1 Year; Supports '22 NDA Filing</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">SAGE/BIIB Zuranolone 50mg SHORELINE OL MDD Data Help Set-Up for Real-World Use</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.OQ / US09062X1037 / US78667J1088</td><td class="leftalignment">Biogen Inc / Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gary Nachman / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Mgmt color on zuranolone data; depression is upside but focus remains on Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">SHORELINE Highlights Continuing Zuranolone Efficacy; 50 mg Dose Adds to Adverse Event Incidence; Focus on CORAL in Early 2022</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X103 / 78667J108 / 74006W108</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Sarah Schram / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SAGE - Open-Label SHORELINE Data Continue to Show Added Benefits of 50mg Dose; We Think the Overall Profile of the Drug Is Appealing</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BP4GNK9 / 2455965 / BYZR4X4</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc / Axsome Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Nov 30 2021 10:24PM</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">2303.TW / 2330.TW / 7974.T / AAP / ADS / AZO / CMRX / CRM / DBD / DIN / GME / GPC / IBM / INTC.O / MA / MSFT.O / U / UBIP.PA / V / AMZN.O / AAPL.O / ATVI.O / DNLI.O / NVDA.O / SQ / TTWO.O / SGMO.O / AMD.O / NTAP.O / FISV.O / NBIX.O / ARGX.O / SHOO.O / UTHR.O / GPN / 2454.TW / BMRN.O / MU.O / MRVL.O / HPE / AVGO.O / SWTX.O / ACET.O / RARE.O / ORLY.O / AXTI.O / BIIB.O / STX.O / SIMO.O / VMW / PCRX.O / ZNGA.O / EA.O / WDC.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / ARDX.O / SAGE.O / XENE.O / CDTX.O / WING.O / SHOP.K / PYPL.O / GBT.O / PSTG.K / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / CLSD.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / FENC.O / APLS.O / ZS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / BHVN.K / ALNA.O / DELL.K / ETTX.O / HARP.O / TPTX.O / SCPL.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BDTX.O / BCEL.O / ZNTL.O / FUSN.O / ITOS.O / TSHA.O / RCUS.K / TVTX.O / PRAX.O / EWTX.O / 23954D109 / 23284P103 / 28623U101 / AVTE / 68217N105 / IMPL.O / 88369M101 / GFS.O</td><td class="leftalignment">United Microelectronics Corp / Taiwan Semiconductor Manufacturing Co Ltd / Nintendo Co Ltd / Advance Auto Parts Inc / Alliance Data Systems Corp / Autozone Inc / Chimerix Inc / Salesforce.Com Inc / Diebold Nixdorf Inc / Dine Brands Global Inc / GameStop Corp / Genuine Parts Co / International Business Machines Corp / Intel Corp / Mastercard Inc / Microsoft Corp / Unity Software Inc / Ubisoft Entertainment SA / Visa Inc / Amazon.com Inc / Apple Inc / Activision Blizzard Inc / Denali Therapeutics Inc / NVIDIA Corp / Block Inc / Take-Two Interactive Software Inc / Sangamo Therapeutics Inc / Advanced Micro Devices Inc / NetApp Inc / Fiserv Inc / Neurocrine Biosciences Inc / argenx SE / Steven Madden Ltd / United Therapeutics Corp / Global Payments Inc / MediaTek Inc / Biomarin Pharmaceutical Inc / Micron Technology Inc / Marvell Technology Inc / Hewlett Packard Enterprise Co / Broadcom Inc / SpringWorks Therapeutics Inc / Adicet Bio Inc / Ultragenyx Pharmaceutical Inc / O'Reilly Automotive Inc / AXT Inc / Biogen Inc / Seagate Technology Holdings PLC / Silicon Motion Technology Corp / VMware Inc / Pacira Biosciences Inc / Zynga Inc / Electronic Arts Inc / Western Digital Corp / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Ardelyx Inc / SAGE Therapeutics Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Wingstop Inc / Shopify Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Pure Storage Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Zscaler Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Biohaven Pharmaceutical Holding Company Ltd / Allena Pharmaceuticals Inc / Dell Technologies Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Turning Point Therapeutics Inc / Sciplay Corp / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Black Diamond Therapeutics Inc / Atreca Inc / Zentalis Pharmaceuticals Inc / Fusion Pharmaceuticals Inc / Iteos Therapeutics Inc / Taysha Gene Therapies Inc / Arcus Biosciences Inc / Travere Therapeutics Inc / Praxis Precision Medicines Inc / Edgewise Therapeutics Inc / Day One Biopharmaceuticals Inc / Cyteir Therapeutics Inc / Elevation Oncology Inc / Aerovate Therapeutics Inc / Omega Therapeutics Inc / Impel Neuropharma Inc / Theseus Pharmaceuticals Inc / Globalfoundries Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / France / Ireland / Japan / Netherlands / Turkey / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FR0000121014 / GB0004544929 / GB0002875804 / US09061G1013 / US00971T1016 / US02553E1064 / US1912161007 / US22160K1051 / US3695501086 / US4523271090 / US5002551043 / US5801351017 / US7134481081 / US87612E1064 / US91324P1021 / US92343V1044 / US9311421039 / JP3726800000 / US20030N1019 / US02209S1033 / US09062X1037 / US0042251084 / US79466L3024 / US02043Q1076 / US2538681030 / US19239V3024 / US2090341072 / US00206R1023 / ACOR.OQ / US1696561059 / US8485741099 / US55616P1049 / US53261M1045 / US90384S3031 / US25470M1099 / US64110D1046 / US7181721090 / US95058W1009 / US03027X1000 / US8725901040 / KYG037AX1015 / US23283R1005 / US5253271028 / US0465131078 / US22822V1017 / US29444U7000 / US00653A1079 / US9741551033 / US12685J1051 / US61174X1090 / US05464T1043 / US90041L1052 / US00773U1088 / US16119P1084 / US36165L1089 / US78410G1040 / US91325V1089 / US02156K1034 / US87105L1044 / US6085501095 / US98980G1022 / US80706P1030 / US49271V1008 / US0197701065 / US0144421072 / US18915M1071 / US09203E1055 / CH0499880968 / KYG3902L1095 / US5502411037 / US25401T1088 / US35909D1090 / US1095041000 / KYG393871085 / KYG4701H1092 / US04302A1043 / US01675A1097</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Imperial Brands PLC / British American Tobacco PLC / Biomarin Pharmaceutical Inc / Akamai Technologies Inc / American Eagle Outfitters Inc / Coca-Cola Co / Costco Wholesale Corp / General Dynamics Corp / Illumina Inc / Kohls Corp / McDonald's Corp / PepsiCo Inc / Target Corp / UnitedHealth Group Inc / Verizon Communications Inc / Walmart Inc / Japan Tobacco Inc / Comcast Corp / Altria Group Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Salesforce.Com Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / AT&T Inc / Acorda Therapeutics Inc / Chipotle Mexican Grill Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Limelight Networks Inc / Ulta Beauty Inc / DISH Network Corp / NetApp Inc / Philip Morris International Inc / Wendys Co / American Tower Corp / T-Mobile US Inc / Ambarella Inc / CyrusOne Inc / Leidos Holdings Inc / Atara Biotherapeutics Inc / Crown Castle International Corp / Equinix Inc / Adaptimmune Therapeutics PLC / Wingstop Inc / Cable One Inc / Monster Beverage Corp / Axsome Therapeutics Inc / Turning Point Brands Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / SBA Communications Corp / Uniti Group Inc / Altice USA Inc / Switch Inc / Molecular Templates Inc / Zscaler Inc / Scholar Rock Holding Corp / Keurig Dr Pepper Inc / Allogene Therapeutics Inc / Alector Inc / Cloudflare Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / GDS Holdings Ltd / Lumen Technologies Inc / DigitalBridge Group Inc / Frontier Communications Parent Inc / Brilliant Earth Group Inc / Globalfoundries Inc / IHS Holding Ltd / Arteris Inc / Allbirds Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">IL0002810146 / IL0006290147 / US0091581068 / US0536111091 / US2788651006 / US3154051003 / US4282911084 / US5324571083 / US5949181045 / US64125C1099 / US6935061076 / US7496851038 / US8243481061 / CA0641491075 / US09062X1037 / NO0010208051 / US79466L3024 / US9604131022 / CA5503721063 / US7588491032 / US1508701034 / US3137472060 / CA14068G1046 / NL0009434992 / US61945C1036 / US71922G2093 / US11120U1051 / CA68827L1013 / BMG0750C1082 / US1638511089 / US45688C1071 / US0441861046 / GB00BF3ZNS54 / CA67077M1086 / US98980G1022 / IE00BZ12WP82 / US28618M1062 / US2605571031 / GB00BJT16S69 / US26614N1028 / JE00BMVMZ478 / US90364P1057 / US27923Q1094 / US04302A1043</td><td class="leftalignment">Icl Group Ltd / Teva Pharmaceutical Industries Ltd / Air Products and Chemicals Inc / Avery Dennison Corp / Ecolab Inc / Ferro Corp / Hexcel Corp / Eli Lilly and Co / Microsoft Corp / Neurocrine Biosciences Inc / PPG Industries Inc / RPM International Inc / Sherwin-Williams Co / Bank of Nova Scotia / Biogen Inc / Yara International ASA / Salesforce.Com Inc / Westlake Chemical Corp / Lundin Mining Corp / Regency Centers Corp / Celanese Corp / Federal Realty Investment Trust / Capstone Mining Corp / LyondellBasell Industries NV / Mosaic Co / PhosAgro PAO / Brixmor Property Group Inc / Osisko Gold Royalties Ltd / Axalta Coating Systems Ltd / Chemours Co / Ingevity Corp / Ashland Global Holdings Inc / Venator Materials PLC / Nutrien Ltd / Zscaler Inc / Linde PLC / Element Solutions Inc / Dow Inc / Tronox Holdings PLC / Dupont De Nemours Inc / Atotech Ltd / UiPath Inc / Ecovyst Inc / Arteris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Ireland / Israel / Netherlands / Norway / Russian Federation / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Wedbush Monthly Check-Up: December 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">CMRX / DNLI.O / SGMO.O / NBIX.O / ARGX.O / UTHR.O / BMRN.O / SWTX.O / ACET.O / RARE.O / BIIB.O / PCRX.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / ARDX.O / SAGE.O / XENE.O / CDTX.O / GBT.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / CLSD.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / FENC.O / APLS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / BHVN.K / ALNA.O / ETTX.O / HARP.O / TPTX.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BDTX.O / BCEL.O / ZNTL.O / FUSN.O / ITOS.O / TSHA.O / RCUS.K / TVTX.O / PRAX.O / EWTX.O / 23954D109 / 23284P103 / 28623U101 / AVTE / 68217N105 / IMPL.O / 88369M101</td><td class="leftalignment">Chimerix Inc / Denali Therapeutics Inc / Sangamo Therapeutics Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / Biomarin Pharmaceutical Inc / SpringWorks Therapeutics Inc / Adicet Bio Inc / Ultragenyx Pharmaceutical Inc / Biogen Inc / Pacira Biosciences Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Ardelyx Inc / SAGE Therapeutics Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Biohaven Pharmaceutical Holding Company Ltd / Allena Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Turning Point Therapeutics Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Black Diamond Therapeutics Inc / Atreca Inc / Zentalis Pharmaceuticals Inc / Fusion Pharmaceuticals Inc / Iteos Therapeutics Inc / Taysha Gene Therapies Inc / Arcus Biosciences Inc / Travere Therapeutics Inc / Praxis Precision Medicines Inc / Edgewise Therapeutics Inc / Day One Biopharmaceuticals Inc / Cyteir Therapeutics Inc / Elevation Oncology Inc / Aerovate Therapeutics Inc / Omega Therapeutics Inc / Impel Neuropharma Inc / Theseus Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Mr. Andreas Argyrides / Dennis Pak</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">0989529 / 2000019 / 2778844 / 2437071 / 2219224 / 2190750 / 2216850 / 2270726 / 2317087 / 2328915 / 2455965 / 2457864 / 2638625 / 2684703 / B067BM3 / 2857817 / B7TL820 / BDZCRX3 / BZ07BW4 / BYRY499 / BNGY4Q0 / BD9GVY0 / BZ1LFB2 / BZ00V34 / BJ2Z0H2 / BFZ1K46 / BLGJ610 / BKTNTR9 / BJVR9Y9 / BYY88Y7 / BDZ30Q0 / BMPRZV5 / BN7K304 / BNNTQY0 / BP7KZP7 / BMHRMK1 / BP81RH5</td><td class="leftalignment">AstraZeneca PLC / Amazon.com Inc / Merck & Co Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Chesapeake Utilities Corp / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / National Beverage Corp / Pfizer Inc / Molson Coors Beverage Co / Netflix Inc / Meta Platforms Inc / RingCentral Inc / Monster Beverage Corp / Kraft Heinz Co / Nextera Energy Partners LP / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Zscaler Inc / Pinterest Inc / Spotify Technology SA / Warner Music Group Corp / ViacomCBS Inc / iHeartMedia Inc / Alphabet Inc / Arvinas Inc / Kymera Therapeutics Inc / Academy Sports and Outdoors Inc / Oatly Group AB / Monte Rosa Therapeutics Inc / Vita Coco Company Inc / Allbirds Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / United Kingdom / Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Alzheimer’s Survey Supports A-beta Thesis: Slow Launch to Increase Over Time</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US5324571083 / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen's Biotech Thermometer</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US0465131078 / US00653A1079 / US05464T1043 / US00773U1088 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Live @ The PSC Healthcare Conference: A Discussion On Movement Disorders</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">64125C109 / 09062X103 / 881624209 / 00287Y109 / G50871105 / 78667J108 / 868459108 / 03168L105 / 74006W108</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Jazz Pharmaceuticals PLC / SAGE Therapeutics Inc / Supernus Pharmaceuticals Inc / Amneal Pharmaceuticals Inc / Praxis Precision Medicines Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Biogen sinks 14.7% from 2 week high</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Appeals Court Affirms That Tecfidera Patent Is Invalid; We Don't See a Meaningful Impact as Generic Launch Is Underway</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Nail In The Tecfidera Coffin Arrives - Appeal Denied, Aduhelm Remains The Key</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB: Gone for Good: Tec Appeal Loss Continues To Wash Out Stock, But Hard To Find Upside Catalysts As Potential Growth Drivers Further Dissolve</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Biopharma Adial reports in-line 3Q21 - reiterate Buy rating and $15 PT</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ADIL.OQ / ALKS.OQ / OPNT.OQ / EXAS.OQ / BIIB.OQ / EBS.N / MNOV.OQ / ACRX.OQ / TRVN.OQ / INDV.L / TTNP.OQ / ALT.OQ / ANEB.OQ</td><td class="leftalignment">Adial Pharmaceuticals Inc / Alkermes Plc / Opiant Pharmaceuticals Inc / Exact Sciences Corp / Biogen Inc / Emergent BioSolutions Inc / MediciNova Inc / AcelRx Pharmaceuticals Inc / Trevena Inc / Indivior PLC / Titan Pharmaceuticals Inc / Altimmune Inc / Anebulo Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Annexon’s Differentiated Platform Targets Complement Biology; Initiating With a Buy Rating and $40 PT</td><td class="leftalignment">English</td><td class="rightalignment">93</td><td class="leftalignment">ANNX.OQ / BIIB / 02043Q107 / 800677106 / 92915B106 / 24823R105 / 014442107 / N90064101</td><td class="leftalignment">Annexon Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sangamo Therapeutics Inc / Voyager Therapeutics Inc / Denali Therapeutics Inc / Alector Inc / Uniqure NV</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AIR.N / BA.N / CAS.TO / CP.TO / ELE.MC / IBE.MC / IP.N / NSC.N / RWEG.DE / CFP.TO / GILD.O / LPX.N / INCY.O / CNR.TO / HEI.N / UNH.N / CSX.N / UNP.N / EPC.N / CTAS.O / EXPE.O / NBIX.O / CHD.N / JHX.AX / DCO.N / VSEC.OQ / BIIB.O / ACAD.O / WEF.TO / TDG.N / MERC.O / SPR.N / SLRS.MC / IFP.TO / FB.O / RFP.N / CFF.TO / KPTI.O / GLPG.O / GBT.OQ / BKNG.O / NTGY.MC / LYFT.O / UBER.N / ETNB.O / SPRB.OQ / ABNB.OQ / WFG.N / DBM.TO / ANE.MC / NVEI.OQ</td><td class="leftalignment">AAR Corp / Boeing Co / Cascades Inc / Canadian Pacific Railway Ltd / Endesa SA / Iberdrola SA / International Paper Co / Norfolk Southern Corp / Rwe AG / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Incyte Corp / Canadian National Railway Co / HEICO Corp / UnitedHealth Group Inc / CSX Corp / Union Pacific Corp / Edgewell Personal Care Co / Cintas Corp / Expedia Group Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / James Hardie Industries PLC / Ducommun Inc / VSE Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / TransDigm Group Inc / Mercer International Inc / Spirit AeroSystems Holdings Inc / Solaria Energia y Medio Ambiente SA / Interfor Corp / Meta Platforms Inc / Resolute Forest Products Inc / Conifex Timber Inc / Karyopharm Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / Booking Holdings Inc / Naturgy Energy Group SA / Lyft Inc / Uber Technologies Inc / 89Bio Inc / Spruce Biosciences Inc / Airbnb Inc / West Fraser Timber Co Ltd / Doman Building Materials Group Ltd / Corporacion Acciona Energias Renovables SA / Nuvei Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Germany / Spain / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech Lit Bits: A Review of Interesting Literature and Science</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / BIIB.O / ACAD.O / KPTI.O / GLPG.O / GBT.OQ / ETNB.O / SPRB.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / 89Bio Inc / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">207940.KS: Samsung Biologics Co., Ltd. - A focused large-scale biologics specialist</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">207940.KS / 4901.T / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / ROG.S / DHR.N / 1177.HK / TEVA.TA / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / 005930.KS / 000100.KS / 008930.KS / SFZN.S / BIIB.OQ / 006280.KS / TEVA.N / EBS.N / MRNA.OQ / 068270.KS / 1099.HK / 032830.KS / 128940.KS / ABBV.N / CTLT.N / 196170.KQ / 028260.KS / 2269.HK / 091990.KQ / 302440.KS</td><td class="leftalignment">Samsung Biologics Co Ltd / Fujifilm Holdings Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Sino Biopharmaceutical Ltd / Teva Pharmaceutical Industries Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Samsung Electronics Co Ltd / Yuhan Corp / Hanmi Science Co Ltd / Siegfried Holding AG / Biogen Inc / Green Cross Corp / Teva Pharmaceutical Industries Ltd / Emergent BioSolutions Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / Samsung Life Insurance Co Ltd / Hanmi Pharm Co Ltd / Abbvie Inc / Catalent Inc / Alteogen Inc / Samsung C&T Corp / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Israel / Japan / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Medical Staffing & Clinical Labs Outperform; Explaining the Prescription Drug Provisions of BBBA</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">CAH.N / CI.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N / CLOV.OQ / OSCR.N</td><td class="leftalignment">Cardinal Health Inc / Cigna Corp / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp / Clover Health Investments Corp / Oscar Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="even"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Second Straight Week of Negative Biotech Fund Flows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/27/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward 575</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 11/19/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">Hong Kong / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALLO / AMGN / C.N / DE / ICE / INCY / NBIX / NKE / QCOM.O / RARE / SEIC / VCTR / GILD.O / TRIT / ALKS.O / SQ / ARNA.O / FDS.N / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / NDAQ / NKTR / LIFE.O / MSTR.O / PHAR.O / BIIB / MNKD.O / SPGI / ACAD.O / ALNY.O / COIN / MRNA.O / SRPT.O / TGTX.OQ / FATE.O / ARGX.BR / INO.O / GLPG.O / IONS.O / CLLS.O / APLS.O / CBOE.K / TPTX.O / NBSE.O / ONCT.O / OPT.O / FSTX.O / VIRX.O / GANX.O / 390320109 / ATXS.O</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / Citigroup Inc / Deere & Co / Intercontinental Exchange Inc / Incyte Corp / Neurocrine Biosciences Inc / Nike Inc / Qualcomm Inc / Ultragenyx Pharmaceutical Inc / SEI Investments Co / Victory Capital Holdings Inc / Gilead Sciences Inc / Triterras Inc / Alkermes Plc / Block Inc / Arena Pharmaceuticals Inc / Factset Research Systems Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nasdaq Inc / Nektar Therapeutics / aTyr Pharma Inc / Microstrategy Inc / Pharming Group NV / Biogen Inc / MannKind Corp / S&P Global Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Coinbase Global Inc / Moderna Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Fate Therapeutics Inc / argenx SE / Inovio Pharmaceuticals Inc / Galapagos NV / Ionis Pharmaceuticals Inc / Cellectis SA / Apellis Pharmaceuticals Inc / Cboe Global Markets Inc / Turning Point Therapeutics Inc / NeuBase Therapeutics Inc / Oncternal Therapeutics Inc / Opthea Ltd / F-Star Therapeutics Inc / Viracta Therapeutics Inc / Gain Therapeutics Inc / Great Elm Capital Corp / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Cayman Islands / France / Ireland / Netherlands / El Salvador / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Post-3Q21 Biotech Review</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ALLO / AMGN / INCY / NBIX / RARE / GILD.O / ALKS.O / ARNA.O / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / NKTR / LIFE.O / PHAR.O / BIIB / MNKD.O / ACAD.O / ALNY.O / MRNA.O / SRPT.O / TGTX.OQ / FATE.O / ARGX.BR / INO.O / GLPG.O / IONS.O / CLLS.O / APLS.O / TPTX.O / NBSE.O / ONCT.O / OPT.O / FSTX.O / VIRX.O / GANX.O / 390320109 / ATXS.O</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Ultragenyx Pharmaceutical Inc / Gilead Sciences Inc / Alkermes Plc / Arena Pharmaceuticals Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / aTyr Pharma Inc / Pharming Group NV / Biogen Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Fate Therapeutics Inc / argenx SE / Inovio Pharmaceuticals Inc / Galapagos NV / Ionis Pharmaceuticals Inc / Cellectis SA / Apellis Pharmaceuticals Inc / Turning Point Therapeutics Inc / NeuBase Therapeutics Inc / Oncternal Therapeutics Inc / Opthea Ltd / F-Star Therapeutics Inc / Viracta Therapeutics Inc / Gain Therapeutics Inc / Great Elm Capital Corp / Astria Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Eka Gigauri</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Biogen Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Will Biogen Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US0079031078 / US02553E1064 / US0326541051 / US5324571083 / US67066G1040 / CA9611485090 / CA0636711016 / CA0641491075 / CA7800871021 / US09062X1037 / CA8911605092 / CA1360691010 / US9285634021 / US2567461080 / CA45868C1095 / US00737L1035</td><td class="leftalignment">Advanced Micro Devices Inc / American Eagle Outfitters Inc / Analog Devices Inc / Eli Lilly and Co / NVIDIA Corp / George Weston Ltd / Bank of Montreal / Bank of Nova Scotia / Royal Bank of Canada / Biogen Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / VMware Inc / Dollar Tree Inc / Interfor Corp / Adtalem Global Education Inc</td><td class="leftalignment"></td><td class="leftalignment">United Arab Emirates / Argentina / Australia / Belgium / Brazil / Canada / Switzerland / China / Germany / Egypt / Spain / France / United Kingdom / Greece / Hong Kong / India / Iran, Islamic Republic of / Italy / Japan / Korea, Republic of / Kuwait / Mali / Malaysia / Nigeria / Netherlands / Norway / New Zealand / Philippines / Poland / Russian Federation / Saudi Arabia / Singapore / Slovakia / Sweden / Thailand / Turkey / Taiwan / United States / Vietnam / South Africa</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Addressing Recent Negative Aduhelm News; Reiterating Our OP Rating</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Ownership Timelines & Shareholder Analytics (November 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 11 23</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT.N / CSL.N / DOW.N / FCX.N / MSM.N / ROP.N / UNP.N / HON.N / VZ.N / AAPL.OQ / CTAS.OQ / MSFT.OQ / SNPS.OQ / EBAY.OQ / ISRG.OQ / NFLX.OQ / BIIB.OQ / CMG.N / NEE.N / LGIH.OQ / ANTM.N</td><td class="leftalignment">Abbott Laboratories / Carlisle Companies Inc / Dow Inc / Freeport-McMoRan Inc / MSC Industrial Direct Co Inc / Roper Technologies Inc / Union Pacific Corp / Honeywell International Inc / Verizon Communications Inc / Apple Inc / Cintas Corp / Microsoft Corp / Synopsys Inc / eBay Inc / Intuitive Surgical Inc / Netflix Inc / Biogen Inc / Chipotle Mexican Grill Inc / Nextera Energy Inc / LGI Homes Inc / Anthem Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Healthcare / Info. Tech./Peripheral / Info. Tech./Software / Lodging & Restaurants / Media / Metals & Minerals / Railroads / Retailing / Services / Telecommunications / Utilities / Wholesale</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Seasonal COVID-19 Wave Continues as Holidays Approach, Thankful for Broad Adult Booster Approval, Ramping Up Pediatric Shots</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">CTAD 2021 KOL Pulse Call Supports Our Positive View for Alzheimer’s</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X10 / 05464T10 / H0026310</td><td class="leftalignment">Biogen Inc / Axsome Therapeutics Inc / AC Immune SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Medical Staffing & Death Care Outperform; CDC Estimate of Health Insurance Coverage</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (22 Nov-): Sysmex, Terumo continue to rise, Eisai still falling holiday mode starts in Europe/US</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4543.T / 6869.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / CSL.AX / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Terumo Corp / Sysmex Corp / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / CSL Ltd / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品・医療機器セクター: 週間レビューと見通し（11月22日～）: シスメックスとテルモが続伸、エーザイは続落、感謝祭で欧米はそろそろ休暇モード入り</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / CSL.AX / 4516.T / 4506.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / CSL Ltd / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Investor Targeting - November 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 574</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACA / RAD / WMT / WSM / ONEM.O / GENI / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / MBRX.O / ENSG.O / 483548103 / ADUS.O / WWD.O / EVH / 100063846 / BABA.K / 720795103 / GRWG / PNTG.O / FVRR.K</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / Williams-Sonoma Inc / 1Life Healthcare Inc / Genius Sports Ltd / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Moleculin Biotech Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Woodward Inc / Evolent Health Inc / Truist Financial Corp / Alibaba Group Holding Ltd / Pieris Pharmaceuticals Inc / GrowGeneration Corp / Pennant Group Inc / Fiverr International Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Israel / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 12 to 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / US8336351056 / GB0000456144 / US0311621009 / US0341641035 / US0351282068 / US0383361039 / US0394831020 / US0530151036 / US1101221083 / US1564311082 / US1924461023 / US2017231034 / US2310211063 / US3755581036 / US38059T1060 / US4227041062 / US45337C1027 / US4891701009 / US5324571083 / US64125C1099 / US6516391066 / US6703461052 / US67066G1040 / US7170811035 / US75886F1075 / US7782961038 / US7802871084 / US8581191009 / US87612E1064 / US9024941034 / US92532F1003 / US9311421039 / CA13321L1085 / CA59162N1096 / CA5394811015 / CA4296951094 / CA9611485090 / CA85472N1096 / CA90457D1006 / CA4609191032 / CA5649051078 / CA6979001089 / CA78460T1057 / CA8787422044 / CA0679011084 / US9129091081 / CA3039011026 / CA1349211054 / CA8765111064 / US0017441017 / CA3359341052 / CA09950M3003 / CA00762V1094 / US2274831047 / US35671D8570 / AU000000FMG4 / US09062X1037 / BMG169621056 / US20451N1019 / CA98462Y1007 / CA56501R1064 / CA4969024047 / CA5503721063 / CA4436281022 / US1011211018 / CA6445351068 / CA95083R1001 / CA0906971035 / US8666741041 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA0966311064 / CA29258Y1034 / CA4369131079 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / BMG162521014 / US00507V1098 / GB00B2QPKJ12 / CA86828P1036 / US91912E1055 / US1921085049 / IE00B4BNMY34 / US58933Y1055 / CA07317Q1054 / CA00208D4084 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US74340W1036 / US95058W1009 / CA54928Q1081 / CA00829Q1019 / AU000000EVN4 / JE00B5TT1872 / US09609G1004 / US98138H1014 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA3807381049 / CA0805581091 / CA9323971023 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA6674951059 / CA04682R1073 / US16208T1025 / CA89531J1093 / GB00B11DNM70 / US29355A1079 / US8486371045 / US6974351057 / US08579W1036 / CA5054401073 / US23283R1005 / CA33812R1091 / US60468T1051 / CA46579R1047 / CA65340P1062 / US31189P1021 / US03674X1063 / US11120U1051 / CA92938W2022 / CA68827L1013 / CA30606C1086 / CA5503711080 / US29444U7000 / CA74273V1067 / CA82621K1021 / AU000000S320 / CA0115321089 / CA83179X1087 / CA83125J1049 / CA05329M1041 / US72703H1014 / CA8283631015 / CY0106002112 / CA19239C1068 / AU000000NST8 / CA17040T3001 / CA4991131083 / CA6882811046 / CA8910546032 / US5588681057 / CA31730E1016 / CA89621C1059 / US0441861046 / US15136A1025 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA75601Y1007 / CA9628791027 / CY0103562118 / CA7847301032 / CA15713J1049 / CA53680Q2071 / US68404V1008 / LU1701428291 / CA2960061091 / CA8585221051 / CA46136U1030 / US00191U1025 / US3843135084 / US76029N1063 / US08579X1019 / KYG370921069 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA7426943006 / CA33767E2024 / CA57776F4050 / US26614N1028 / CA5625684025 / CA48086P1009 / US2681501092 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / MHY0436Q1098 / CA4220961078 / CA3901437093 / CA36352H1001 / US6544051096 / US03940R1077 / CA70137W1086 / US44862P1093 / US05478C1053 / US7501021056 / CA33843T1084 / CA9004352071 / US3680361090 / CA64782A1075 / US87969B1017 / US03750L1098 / CA36261G1028 / CA65401N1078 / US11135E2037 / CA55292X1087 / AU0000143729 / US00848J1043 / US05356F1057 / CA53227W1059 / CA65532M6062 / CA00791P1071 / CA24874B1085 / GB00BL6K5J42 / CA66979W8429 / US45828L1089 / US0708301041 / US9264001028 / US98955K1043 / US89269P1030 / US9778521024 / US4718711033 / US1374041093 / 116833187</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Sociedad Quimica y Minera de Chile SA / Antofagasta PLC / Amgen Inc / Andersons Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Automatic Data Processing Inc / Bristol-Myers Squibb Co / Century Aluminum Co / Cognizant Technology Solutions Corp / Commercial Metals Co / Cummins Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Incyte Corp / Kennametal Inc / Eli Lilly and Co / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / NVIDIA Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Royal Gold Inc / Steel Dynamics Inc / Target Corp / Tyson Foods Inc / Vertex Pharmaceuticals Inc / Walmart Inc / Cameco Corp / Metro Inc / Loblaw Companies Ltd / High Liner Foods Inc / George Weston Ltd / Stantec Inc / Uni-Select Inc / Intertape Polymer Group Inc / Maple Leaf Foods Inc / Pan American Silver Corp / SNC-Lavalin Group Inc / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Fairfax Financial Holdings Ltd / Canadian Apartment Properties Real Estate Investment Trust / Taseko Mines Ltd / AMN Healthcare Services Inc / First Quantum Minerals Ltd / Boralex Inc / Aecon Group Inc / Cross Country Healthcare Inc / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Bunge Ltd / Compass Minerals International Inc / Yamana Gold Inc / Manulife Financial Corp / Kinross Gold Corp / Lundin Mining Corp / Hudbay Minerals Inc / Boston Properties Inc / New Gold Inc / Wesdome Gold Mines Ltd / Birchcliff Energy Ltd / Sun Communities Inc / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Home Capital Group Inc / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Brookfield Infrastructure Partners LP / Activision Blizzard Inc / Fresnillo PLC / Superior Plus Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Merck & Co Inc / Baytex Energy Corp / ARC Resources Ltd / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / Prologis Inc / Wendys Co / Lucara Diamond Corp / Africa Oil Corp / Evolution Mining Ltd / Centamin PLC / bluebird bio Inc / Workday Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Gold Standard Ventures Corp / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Athabasca Oil Corp / Chatham Lodging Trust / Trevali Mining Corp / Horizonte Minerals PLC / Enphase Energy Inc / Splunk Inc / Palo Alto Networks Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / CyrusOne Inc / Fission Uranium Corp / Mirati Therapeutics Inc / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Fate Therapeutics Inc / Antero Resources Corp / Brixmor Property Group Inc / WSP Global Inc / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Equinix Inc / Probe Metals Inc / Sienna Senior Living Inc / South32 Ltd / Alamos Gold Inc / SmartCentres Real Estate Investment Trust / Sleep Country Canada Holdings Inc / Automotive Properties Real Estate Investment Trust / Planet Fitness Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Cogeco Communications Inc / Northern Star Resources Ltd / Chorus Aviation Inc / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Madrigal Pharmaceuticals Inc / Filo Mining Corp / Trilogy Metals Inc / Ashland Global Holdings Inc / Centennial Resource Development Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Real Matters Inc / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / CES Energy Solutions Corp / Lithium Americas Corp / OptiNose Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / Invesque Inc / ASGN Inc / GrafTech International Ltd / Replimune Group Inc / Berry Corporation (Bry) / Galaxy Digital Holdings Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / FirstService Corp / Maverix Metals Inc / Dupont De Nemours Inc / Mandalay Resources Corp / Josemaria Resources Inc / Dynatrace Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Atlas Corp / Headwater Exploration Inc / Great Bear Resources Ltd / Galiano Gold Inc / 9 Meters Biopharma Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Azek Company Inc / Rackspace Technology Inc / Flagship Communities Real Estate Investment Trust / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Telos Corp / Apartment Income REIT Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Broadstone Net Lease Inc / MDA Ltd / Sunrise Energy Metals Ltd / Agiliti Inc / Aveanna Healthcare Holdings Inc / LifeWorks Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Endeavour Mining PLC / Nouveau Monde Graphite Inc / Integral Ad Science Holding Corp / Bath & Body Works Inc / Victoria's Secret & Co / Zevia PBC / Traeger Inc / Wolfspeed Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc / NextSource Materials Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Chile / Cayman Islands / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Nov. 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">ACA / AMGN / ATRC / CGEN / CSII / EPIX / GE / ICPT / INCY / MBIO / RAD / WMT / ONEM.O / RLMD / FMTX / BWAY.O / SSNC.O / CUE / NKTR / CCRN.O / ABMD.O / ICAD.O / AMED.O / EXAS.O / ANGN.O / PHAR.O / BIIB / 478160104 / 00846U101 / 868168105 / NUVA.O / GOOG.O / CMMB / FREQ / DXCM.O / LHCG.O / MBRX.O / CBAY / HUMA / PODD.O / 02043Q107 / TNDM.O / ENSG.O / 483548103 / MRNA.O / VERO / BLRX / ADUS.O / GLAXOSM.LG / AGIO / FATE.O / TRVN / MDWD.O / 02005N100 / RXDX.O / CASI.O / VBLT.O / EVH / CFMS.O / CRBP.O / 100063846 / NVTA.K / EDIT / MDGL / CRSP / VREX / URGN.O / PLXP.O / IOVA / KALA.O / MTEM.O / VERU.O / SVRA.O / 720795103 / FIXX.O / MIST.O / TMDX / IDYA.O / DMTK.O / PNTG.O / ETNB.O / GMDA / BCYC / ZNTL.O / NMTR.O / NNOX / CMPS.OQ / HGEN.O / PMVP / AYLA / PRTG.O / SNSE.O / IMCR.O / VIRX.O / NKTX.O / 03823M100 / GANX.O / US00449L1026 / RZLT.O / SERA.OQ / ATXS.O / MDNA.O / JSPR.O</td><td class="leftalignment">Arcosa Inc / Amgen Inc / AtriCure Inc / Compugen Ltd / Cardiovascular Systems Inc / ESSA Pharma Inc / General Electric Co / Intercept Pharmaceuticals Inc / Incyte Corp / Mustang Bio Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / Relmada Therapeutics Inc / Forma Therapeutics Holdings Inc / Brainsway Ltd / SS&C Technologies Holdings Inc / Cue Biopharma Inc / Nektar Therapeutics / Cross Country Healthcare Inc / ABIOMED Inc / ICAD Inc / Amedisys Inc / Exact Sciences Corp / Angion Biomedica Corp / Pharming Group NV / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / NuVasive Inc / Alphabet Inc / Chemomab Therapeutics Ltd / Frequency Therapeutics Inc / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / Cymabay Therapeutics Inc / Humacyte Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Venus Concept Inc / BioLine RX Ltd / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Trevena Inc / Mediwound Ltd / Ally Financial Inc / Prometheus Biosciences Inc / CASI Pharmaceuticals Inc / Vascular Biogenics Ltd / Evolent Health Inc / Conformis Inc / Corbus Pharmaceuticals Holdings Inc / Truist Financial Corp / Invitae Corp / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Varex Imaging Corp / Urogen Pharma Ltd / PLx Pharma Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Molecular Templates Inc / Veru Inc / Savara Inc / Pieris Pharmaceuticals Inc / Homology Medicines Inc / Milestone Pharmaceuticals Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / DermTech Inc / Pennant Group Inc / 89Bio Inc / Gamida Cell Ltd / Bicycle Therapeutics PLC / Zentalis Pharmaceuticals Inc / 9 Meters Biopharma Inc / Nano-X Imaging Ltd / Compass Pathways PLC / Humanigen Inc / PMV Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Portage Biotech Inc / Sensei Biotherapeutics Inc / Immunocore Holdings PLC / Viracta Therapeutics Inc / Nkarta Inc / Applied Minerals Inc / Gain Therapeutics Inc / Achilles Therapeutics PLC / Rezolute Inc / Sera Prognostics Inc / Astria Therapeutics Inc / Medicenna Therapeutics Corp / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Israel / Nigeria / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB: The Bad News Keeps Rolling In, As CHMP Ruling Likely Opens Door For Generic Tecfidera in Europe</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 11/12/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US8336351056 / US0311621009 / US0383361039 / US1101221083 / US1270971039 / US1924461023 / US25179M1036 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US5324571083 / US64125C1099 / US6745991058 / US7170811035 / US7237871071 / US75281A1097 / US75886F1075 / US7782961038 / AN8068571086 / US81211K1007 / US89531P1057 / US92532F1003 / CA9611485090 / US1667641005 / US5658491064 / US20825C1045 / US09062X1037 / US42809H1077 / US58933Y1055 / US09609G1004 / US98138H1014 / US34964C1062 / US6974351057 / US08579W1036 / US60468T1051 / US03674X1063 / US2057683029 / GB00BDSFG982 / US87484T1088 / US26614N1028 / US69047Q1022 / US05478C1053 / CA33843T1084 / US62955J1034 / US1651677353 / US45828L1089 / US1374041093</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / Coterra Energy Inc / Cognizant Technology Solutions Corp / Devon Energy Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Schlumberger NV / Sealed Air Corp / Trex Company Inc / Vertex Pharmaceuticals Inc / George Weston Ltd / Chevron Corp / Marathon Oil Corp / Conocophillips / Biogen Inc / Hess Corp / Merck & Co Inc / bluebird bio Inc / Workday Inc / Fortune Brands Home & Security Inc / Palo Alto Networks Inc / Berry Global Group Inc / Mirati Therapeutics Inc / Antero Resources Corp / Comstock Resources Inc / TechnipFMC PLC / Talos Energy Inc / Dupont De Nemours Inc / Ovintiv Inc / Azek Company Inc / Flagship Communities Real Estate Investment Trust / Nov Inc / Chesapeake Energy Corp / Integral Ad Science Holding Corp / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Chile / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ALB.N / CB.N / CCO.TO / CVS.N / ECL.N / EL.N / FGP.L / GM.N / GOG.L / IP.N / L.TO / LVMH.PA / MMC.N / NA / NXT.L / OREP.PA / RTO.L / SCHN.PA / T.TO / DRE.N / VOWG_p.DE / PG.N / AMZN.O / CFP.TO / GILD.O / LPX.N / AAL.L / DV.N / ENEI.MI / AMT.N / LONN.S / VZ.N / STZ.N / HP.N / ARE.N / WSM.N / PLD.N / WSP.TO / KRC.N / CTSH.O / ONT.L / NET.N / ALFA.ST / VSEC.OQ / CRC.N / NRZ.N / COA.L / SIVB.O / BLUE.O / CASY.O / ATDb.TO / BIIB.O / CSH_u.TO / EDR.N / DRX.L / CMG.N / MERC.O / SGRO.L / RENE.LS / KTOS.OQ / ABCA.L / NOG.A / NEE.N / OCDO.L / CIO.N / PKI.TO / IFP.TO / BKR.N / MTDR.N / XYL.N / EFN.TO / HTGC.N / FB.O / RFP.N / SRPT.O / PANW.N / NYCB.N / TSLA.N / ENTA.O / 46579R104 / XNCR.OQ / 922475108 / GOOGL.O / SHOP.N / TDOC.N / PYPL.OQ / UBSG.S / SPGI.N / VACN.S / NTLA.O / TWLO.N / ATKR.N / TTD.O / GDS.O / RCM.OQ / DHER.DE / NTGY.MC / ZM.O / CRWD.O / NOVA.N / GMAB.O / DDOG.O / AZEK.N / MGNI.OQ / PUBM.O / WFG.N / AG1G.DE / COUR.N / SQSP.N / FLYW.O / TTEF.PA / TRMR.OQ</td><td class="leftalignment">Albemarle Corp / Chubb Ltd / Cameco Corp / CVS Health Corp / Ecolab Inc / Estee Lauder Companies Inc / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / International Paper Co / Loblaw Companies Ltd / LVMH Moet Hennessy Louis Vuitton SE / Marsh & McLennan Companies Inc / National Bank of Canada / Next PLC / L'Oreal SA / Rentokil Initial PLC / Schneider Electric SE / Telus Corp / Duke Realty Corp / Volkswagen AG / Procter & Gamble Co / Amazon.com Inc / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Anglo American PLC / DoubleVerify Holdings Inc / Enel SpA / American Tower Corp / Lonza Group AG / Verizon Communications Inc / Constellation Brands Inc / Helmerich and Payne Inc / Alexandria Real Estate Equities Inc / Williams-Sonoma Inc / Prologis Inc / WSP Global Inc / Kilroy Realty Corp / Cognizant Technology Solutions Corp / Oxford Nanopore Technologies PLC / Cloudflare Inc / Alfa Laval AB / VSE Corp / California Resources Corp / New Residential Investment Corp / Coats Group PLC / SVB Financial Group / bluebird bio Inc / Caseys General Stores Inc / Alimentation Couche-Tard Inc / Biogen Inc / Chartwell Retirement Residences / Endeavor Group Holdings Inc / Drax Group PLC / Chipotle Mexican Grill Inc / Mercer International Inc / SEGRO PLC / Ren Redes Energeticas Nacionais SGPS SA / Kratos Defense and Security Solutions Inc / Abcam PLC / Northern Oil and Gas Inc / Nextera Energy Inc / Ocado Group PLC / City Office REIT Inc / Parkland Corp / Interfor Corp / Baker Hughes Co / Matador Resources Co / Xylem Inc / Element Fleet Management Corp / Hercules Capital Inc / Meta Platforms Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / New York Community Bancorp Inc / Tesla Inc / Enanta Pharmaceuticals Inc / Ivanhoe Mines Ltd / Xencor Inc / Veeva Systems Inc / Alphabet Inc / Shopify Inc / Teladoc Health Inc / PayPal Holdings Inc / UBS Group AG / S&P Global Inc / VAT Group AG / Intellia Therapeutics Inc / Twilio Inc / Atkore Inc / Trade Desk Inc / GDS Holdings Ltd / R1 RCM Inc / Delivery Hero SE / Naturgy Energy Group SA / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Sunnova Energy International Inc / Genmab A/S / Datadog Inc / Azek Company Inc / Magnite Inc / PubMatic Inc / West Fraser Timber Co Ltd / AUTO1 Group SE / Coursera Inc / Squarespace Inc / Flywire Corp / TotalEnergies SE / Tremor International Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Israel / Italy / Portugal / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare Reform: Impact of Build Back Better on global branded pharma</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">4502.T / 4503.T / BMY.N / JNJ.N / LLY.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / AMGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Herr. Christoph Gretler / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Tiago Fauth</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">A Swing and a Miss - Biotech Fund Flows Turn Negative</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ASND / US09062X1037 / US00847X1046 / US8162121045 / ZAE000185005</td><td class="leftalignment">Ascendis Pharma A/S / Biogen Inc / Agios Pharmaceuticals Inc / Selecta Biosciences Inc / Ascendis Health Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Updating Model To Incorporate Recent Alzheimer's Developments; Price Target To $277</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Bullish on BioPharma as We Emerge From COVID-19: Finding Alpha in the Sector That Saved the World</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Initiating at OP: ‘What’s Past Is Prologue’; We See Opportunity in Controversy</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Could the Adu Pt Death Have Been Prevented? We Obtained and Analyzed the Case Report</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Unprecedented Proteomics Ahead; Investor Day Takeaways; Buy, $44 PT</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">68071010 / 09062X103</td><td class="leftalignment">Olink Holding AB (publ) / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Sweden / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Sung Ji Nam</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CACI=US / HD=US / BLD=US / NVDA=US / PEB=US / H=US / MTN=US / LOW=US / MAR=US / TNL=US / VMC=US / HLT=US / MLM=US / CHH=US / CPRT=US / DRH=US / GFF=US / ABG=US / IBP=US / MHK=US / VRTX=US / MANT=US / BIIB=US / BECN=US / SHO=US / BAH=US / BLDR=US / GMS=US / KBR=US / HST=US / PAG=US / ICFI=US / AWI=US / OC=US / SAIC=US / WH=US / PSN=US / HGV=US / RLJ=US / VAC=US / RHP=US / ABBV=US / TILE=US / FOXF=US / LDOS=US / BVH=US / BWXT=US / PK=US / PLYA=US / FERG=US</td><td class="leftalignment">CACI International Inc / Home Depot Inc / TopBuild Corp / NVIDIA Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / Marriott International Inc / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Choice Hotels International Inc / Copart Inc / Diamondrock Hospitality Co / Griffon Corp / Asbury Automotive Group Inc / Installed Building Products Inc / Mohawk Industries Inc / Vertex Pharmaceuticals Inc / ManTech International Corp / Biogen Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / Builders FirstSource Inc / GMS Inc / KBR Inc / Host Hotels & Resorts Inc / Penske Automotive Group Inc / ICF International Inc / Armstrong World Industries Inc / Owens Corning / Science Applications International Corp / Wyndham Hotels & Resorts Inc / Parsons Corp / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Abbvie Inc / Interface Inc / Fox Factory Holding Corp / Leidos Holdings Inc / Bluegreen Vacations Holding Corp / BWX Technologies Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Ferguson PLC</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">CTAD 2021 Recap: BIIB Adu Tau Data Overshadowed by Negative CHMP Opinion, Tau and Novel Mechanism Data Still Mixed</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">09062X103 / 462222100 / IONS.OQ / 014442107</td><td class="leftalignment">Biogen Inc / Ionis Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Alector Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Sarah Schram / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Negative view by EU on aducanumab for Alzheimer's; still a long road ahead</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - アルツハイマー型認知症治療薬アデュカヌマブ、EUで否定的見解、まだ先は長い</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">BIIB - Embedded Expectations Analysis - 2021 11 17</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Limited stock reaction to EU negative trend for Aduhelm, focus remains on U.S. oppy; removing EU Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q take: multiple data readouts expected in 2022 and most remain optionality at this level</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ELDN / US09062X1037</td><td class="leftalignment">Eledon Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : Aduhelm Continues to Take on Water with Negative CHMP Trend Vote</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Ms. Tiffany Sun / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Aducanumab Receives Negative Trend Vote From The CHMP; No Change To Ests</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">EU Aduhelm Rejection Minimally Impactful to Our Model; Still, Not a Good Look</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Negative EU Update As Expected</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Europe Aduhelm oppy not in our numbers; it’s all about lecanemab (BAN2401)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB: Europe Rejects Adu, Effectively Wiping Away 40% Of Potential Future Adu Revenue; Lecanemab Now Increasingly Important To Salvage Alzheimer's Franchise</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">EMA's CHMP Says No Thanks to Aduhelm - Negative Vote From CHMP</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AAPL / CTAS / EA / GE / INTC.O / INTU / JACK / MSFT / NOW / ORCL / QCOM.O / SAP / SBUX / SONY / TTWO / AMZN.O / MSCI / ATVI.O / NVDA.O / ADBE.O / HEAR / AQUA / NFLX / FRSH.OQ / PCTY.O / BIIB / DPZ / GOOG.O / FREQ / 36467W109 / PCYO.O / ZNGA / ENPH.O / FB.O / WDAY / FDEV.L / WIX.O / ARMK / 82655M107 / 02005N100 / RMR.O / COUP.O / BL.O / VREX / OCSL / BILI.O / CBOE.K / CDAY.K / SNSE.O / VIRX.O / HUYA.K</td><td class="leftalignment">Apple Inc / Cintas Corp / Electronic Arts Inc / General Electric Co / Intel Corp / Intuit Inc / Jack in the Box Inc / Microsoft Corp / ServiceNow Inc / Oracle Corp / Qualcomm Inc / SAP SE / Starbucks Corp / Sony Group Corp / Take-Two Interactive Software Inc / Amazon.com Inc / MSCI Inc / Activision Blizzard Inc / NVIDIA Corp / Adobe Inc / Turtle Beach Corp / Evoqua Water Technologies Corp / Netflix Inc / Freshworks Inc / Paylocity Holding Corp / Biogen Inc / Domino's Pizza Inc / Alphabet Inc / Frequency Therapeutics Inc / GameStop Corp / Pure Cycle Corp / Zynga Inc / Enphase Energy Inc / Meta Platforms Inc / Workday Inc / Frontier Developments PLC / Wix.Com Ltd / Aramark / Sify Technologies Ltd / Ally Financial Inc / RMR Group Inc / Coupa Software Inc / Blackline Inc / Varex Imaging Corp / Oaktree Specialty Lending Corp / Bilibili Inc / Cboe Global Markets Inc / Ceridian HCM Holding Inc / Sensei Biotherapeutics Inc / Viracta Therapeutics Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">2434209 / 2936921 / 2126335 / 2000019 / 2778844 / 2270726 / 2317087 / 2455965 / 2684703 / 2829601 / 2822019 / B1HMF22 / 2857817 / B7TL820 / B65SQW4 / B7VD3F2 / BFDV8K0 / B87ZMX0 / BDZCRX3 / B424494 / BFLR866 / BQPVQZ6 / BYVY8G0 / BYZLV46 / BZBY005 / BD8DJ71 / BGCYWN8 / BFZ1K46 / BLGJ610 / BJJMGL2 / BFNR303 / BYQHPK7 / BZ1LFG7 / BYY88Y7 / BKX9VD3 / BDVLM39 / BF3N4P3 / BMPRZV5 / BGDQ8B3 / 021513106 / BMDJ397 / BMZ9Z11 / BNGJQZ8 / BP96C52</td><td class="leftalignment">Home Depot Inc / Walmart Inc / Bristol-Myers Squibb Co / Amazon.com Inc / Merck & Co Inc / Walt Disney Co / Entergy Corp / Biogen Inc / Pfizer Inc / Southern Co / Advance Auto Parts Inc / First Solar Inc / Netflix Inc / Meta Platforms Inc / Enphase Energy Inc / Duke Energy Corp / MacroGenics Inc / Palo Alto Networks Inc / RingCentral Inc / Splunk Inc / Twitter Inc / Horizon Therapeutics PLC / Alphabet Inc / InflaRx NV / Merus NV / Snap Inc / Xencor Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / Northwest Natural Holding Co / Zymeworks Inc / Roku Inc / Alphabet Inc / Arcutis Biotherapeutics Inc / argenx SE / Arena Pharmaceuticals Inc / Kymera Therapeutics Inc / Axonics Inc / Alto Ingredients Inc / Bolt Biotherapeutics Inc / Prometheus Biosciences Inc / Porch Group Inc / Surrozen Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from the 2021 CTAD Conference</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">09062X10 / H0026310 / 40422M10</td><td class="leftalignment">Biogen Inc / AC Immune SA / H Lundbeck A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Takeaways from CTAD and Related Observations</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB / 02005N100</td><td class="leftalignment">Biogen Inc / Ally Financial Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB: Call Me Retired: Scientific Voice Al Sandrock Steps Down, Leaving Big Shoes To Fill</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">End of Era: Widely Regarded Al Sandrock to Retire Year-End 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sarah Schram</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 5, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AFL.N / AIG.N / ALV.N / CB.N / CCI.N / CL.N / CP.TO / EDP.LS / EOG.N / F.N / FSR.N / GM.N / MSFT.O / NA / NSC.N / PFE.N / T.N / VC.N / PXD.N / GILD.O / TEN.N / WLL.N / AMGN.O / INCY.O / THC.N / FER.MC / CNR.TO / DUK.N / BWA.N / LEA.N / FE.N / DISH.O / CSX.N / UNP.N / NICE.O / DV.N / MRO.N / PCG.N / PAA.N / DVN.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / MTG.N / RDN.N / VZ.N / LNC.N / APH.N / RRC.N / EQT.N / V.N / OKE.N / AXL.N / AWK.N / IG.MI / EPAY.O / AJG.N / REGN.O / VRTX.O / SRG.MI / PRU.N / SM.N / TEL.N / GFI.N / COP.N / CPE.N / ST.N / SWN.N / SR.N / CRC.N / PEGA.OQ / PLUG.OQ / GPN.N / LIFE.O / CASY.O / ACGL.O / PAAS.O / EQIX.O / ATDb.TO / BIIB.O / DPM.TO / EDV.TO / TRN.MI / DLR.N / ACAD.O / 416515104 / FIS.N / CCOI.O / MA.N / EHTH.O / AON.N / CLR.N / DAN.N / NOG.A / EDPR.LS / PHR.N / PKI.TO / MSP.N / MTOR.N / MTDR.N / SRPT.O / PANW.N / FFHu.TO / FANG.O / ABBV.N / KPT.TO / TSLA.N / TMUS.N / PTCT.O / 81762P102 / ESNT.N / XNCR.OQ / ITCI.O / SAGE.OQ / HQY.OQ / NMIH.O / NEWR.N / GLPG.O / TDOC.N / PYPL.OQ / RGNX.O / SPGI.N / TTD.O / ADNT.N / AQN.N / UNIT.O / CDEV.O / ESTE.N / WOW.N / ATNX.O / SAIL.N / APTV.N / SMAR.N / VRCA.OQ / ITRM.O / OPRX.OQ / VNE.N / HCAT.OQ / GMAB.O / CRNC.OQ / PNTG.OQ / IGMS.O / OAS.OQ / NKLA.OQ / APA.OQ / FOUR.N / NRIX.OQ / RXT.OQ / GOCO.O / IBEX.O / PLTR.N / AEP.OQ / SPRB.OQ / BSY.O / GATO.N / GDRX.O / MCFE.OQ / RIDE.OQ / MAX.N / TLMD.OQ / LSPD.N / PUBM.O / TIXT.TO / AFRM.O / NUVB.N / CHK.OQ / OLO.N / PATH.N / PSFE.N / TSP.OQ / TFPM.TO / FLYW.O / BHG.N / XMTR.OQ / TASK.O / TRMR.OQ / EVCM.O / NABL.N / RYAN.N / TWKS.OQ / GTLB.OQ / ROCC.O</td><td class="leftalignment">Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / EDP Energias de Portugal SA / EOG Resources Inc / Ford Motor Co / Fisker Inc / General Motors Co / Microsoft Corp / National Bank of Canada / Norfolk Southern Corp / Pfizer Inc / AT&T Inc / Visteon Corp / Pioneer Natural Resources Co / Gilead Sciences Inc / Tenneco Inc / Whiting Petroleum Corp / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Ferrovial SA / Canadian National Railway Co / Duke Energy Corp / Borgwarner Inc / Lear Corp / FirstEnergy Corp / DISH Network Corp / CSX Corp / Union Pacific Corp / Nice Ltd / DoubleVerify Holdings Inc / Marathon Oil Corp / PG&E Corp / Plains All American Pipeline LP / Devon Energy Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / MGIC Investment Corp / Radian Group Inc / Verizon Communications Inc / Lincoln National Corp / Amphenol Corp / Range Resources Corp / EQT Corp / Visa Inc / ONEOK Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Italgas SpA / Bottomline Technologies Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Snam SpA / Prudential Financial Inc / SM Energy Co / TE Connectivity Ltd / Gold Fields Ltd / Conocophillips / Callon Petroleum Co / Sensata Technologies Holding PLC / Southwestern Energy Co / Spire Inc / California Resources Corp / Pegasystems Inc / Plug Power Inc / Global Payments Inc / aTyr Pharma Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Pan American Silver Corp / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Dundee Precious Metals Inc / Endeavour Mining PLC / Terna Rete Elettrica Nazionale SpA / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Mastercard Inc / eHealth Inc / Aon PLC / Continental Resources Inc / Dana Inc / Northern Oil and Gas Inc / EDP Renovaveis SA / Phreesia Inc / Parkland Corp / Datto Holding Corp / Meritor Inc / Matador Resources Co / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / Diamondback Energy Inc / Abbvie Inc / KP Tissue Inc / Tesla Inc / T-Mobile US Inc / PTC Therapeutics Inc / ServiceNow Inc / Essent Group Ltd / Xencor Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Healthequity Inc / NMI Holdings Inc / New Relic Inc / Galapagos NV / Teladoc Health Inc / PayPal Holdings Inc / Regenxbio Inc / S&P Global Inc / Trade Desk Inc / Adient PLC / Algonquin Power & Utilities Corp / Uniti Group Inc / Centennial Resource Development Inc / Earthstone Energy Inc / WideOpenWest Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Smartsheet Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Veoneer Inc / Health Catalyst Inc / Genmab A/S / Cerence Inc / Pennant Group Inc / IGM Biosciences Inc / Oasis Petroleum Inc / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Nurix Therapeutics Inc / Rackspace Technology Inc / Gohealth Inc / Ibex Ltd / Palantir Technologies Inc / American Electric Power Company Inc / Spruce Biosciences Inc / Bentley Systems Inc / Gatos Silver Inc / Goodrx Holdings Inc / Mcafee Corp / Lordstown Motors Corp / Mediaalpha Inc / Soc Telemed Inc / Lightspeed Commerce Inc / PubMatic Inc / Telus International Cda Inc / Affirm Holdings Inc / Nuvation Bio Inc / Chesapeake Energy Corp / Olo Inc / UiPath Inc / Paysafe Ltd / TuSimple Holdings Inc / Triple Flag Precious Metals Corp / Flywire Corp / Bright Health Group Inc / Xometry Inc / Taskus Inc / Tremor International Ltd / EverCommerce Inc / N-Able Inc / Ryan Specialty Group Holdings Inc / Thoughtworks Holding Inc / GitLab Inc / Ranger Oil Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Portugal / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Spiking European COVID Cases Could Negatively Impact NT Biotech Earnings and Clinical Trial Conduct</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NA / PFE.N / GILD.O / JAZZ.O / VRTX.O / BIIB.O / ACAD.O / SRPT.O / ABBV.N / PTCT.O / ITCI.O / SAGE.OQ / GLPG.O / IGMS.O / SPRB.OQ</td><td class="leftalignment">National Bank of Canada / Pfizer Inc / Gilead Sciences Inc / Jazz Pharmaceuticals PLC / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / PTC Therapeutics Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Galapagos NV / IGM Biosciences Inc / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Stephen Mallon / Leonid Timashev / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Post-Acute & Hospitals Outperform; Consumer Sentiment Entering Open Enrollment</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">CAH.N / CI.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N / CLOV.OQ / OSCR.N</td><td class="leftalignment">Cardinal Health Inc / Cigna Corp / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp / Clover Health Investments Corp / Oscar Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / BAYGN.DE</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 573</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101 / 603693102</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc / Mink Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">11/13/2021</td><td class="leftalignment">TheScreener</td><td class="leftalignment">BIOGEN sees an upgrade to Slightly Positive due to a better fundamental star rating</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AAPL / ACA / AMT / AXP / AZO / BJ / COST / CSII / CSL / DLTR / ECL / EEFT.O / EL / FOCS / GE / GS / INCY / INTC.O / JPM.N / KR / LOW / LRCX.O / MPAA / MS / MSFT / NET / NKE / O / ORLY / PZZA / RAD / ROK / RXN / SAGE / SAP / SFT / T / TH / TREE / TUP / URI / USM / V / WH / WMT / AMZN.O / GILD.O / EW / ONEM.O / ASTE.O / NVDA.O / ADBE.O / SQ / AKAM / CRVL.O / MPWR.O / XRAY.O / VECO.O / ISRG / ADI.O / VZ / NFLX / PLUG.O / FRPT / UTHR.O / EXTR.O / OSUR.O / AYI / MRVL.O / SSNC.O / AVGO.O / NDAQ / VRTS.OQ / POOL.OQ / CALM.OQ / CCRN.O / TEAM.O / SIVB.O / QDEL.O / NATI.O / AMED.O / PHAR.O / BIIB / 459200101 / 00846U101 / 868168105 / PEB.NZ / DPZ / GOOG.O / SPGI / 315616102 / QSR / DXCM.O / LHCG.O / IOSP.OQ / XPO / ATNI.O / EHTH / IPGP.O / LULU / MASI.O / 02043Q107 / ULTA / ENSG.O / 483548103 / DECK.N / ADUS.O / TSLA.O / NXPI.O / AMRS.O / HZNP.OQ / ENPH.O / FB.O / CG.O / WDAY / PANW.O / TBK.O / EVH / BWXT.K / 100063846 / TTD.O / ROKU.O / MDB.O / 720795103 / CBOE.K / ARVN / LOVE / CRWD.O / PNTG.O / TCOM.O / 975657107 / MYPS / 744285206 / ATXS.O</td><td class="leftalignment">Apple Inc / Arcosa Inc / American Tower Corp / American Express Co / Autozone Inc / BJ's Wholesale Club Holdings Inc / Costco Wholesale Corp / Cardiovascular Systems Inc / Carlisle Companies Inc / Dollar Tree Inc / Ecolab Inc / Euronet Worldwide Inc / Estee Lauder Companies Inc / Focus Financial Partners Inc / General Electric Co / Goldman Sachs Group Inc / Incyte Corp / Intel Corp / JPMorgan Chase & Co / Kroger Co / Lowe's Companies Inc / Lam Research Corp / Motorcar Parts of America Inc / Morgan Stanley / Microsoft Corp / Cloudflare Inc / Nike Inc / Realty Income Corp / O'Reilly Automotive Inc / Papa John's International Inc / Rite Aid Corp / Rockwell Automation Inc / Zurn Water Solutions Corp / SAGE Therapeutics Inc / SAP SE / Shift Technologies Inc / AT&T Inc / Target Hospitality Corp / Lendingtree Inc / Tupperware Brands Corp / United Rentals Inc / United States Cellular Corp / Visa Inc / Wyndham Hotels & Resorts Inc / Walmart Inc / Amazon.com Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Astec Industries Inc / NVIDIA Corp / Adobe Inc / Block Inc / Akamai Technologies Inc / CorVel Corp / Monolithic Power Systems Inc / DENTSPLY SIRONA Inc / Veeco Instruments Inc / Intuitive Surgical Inc / Analog Devices Inc / Verizon Communications Inc / Netflix Inc / Plug Power Inc / Freshpet Inc / United Therapeutics Corp / Extreme Networks Inc / OraSure Technologies Inc / Acuity Brands Inc / Marvell Technology Inc / SS&C Technologies Holdings Inc / Broadcom Inc / Nasdaq Inc / Virtus Investment Partners Inc / Pool Corp / Cal-Maine Foods Inc / Cross Country Healthcare Inc / Atlassian Corporation PLC / SVB Financial Group / Quidel Corp / National Instruments Corp / Amedisys Inc / Pharming Group NV / Biogen Inc / International Business Machines Corp / Agilent Technologies Inc / Superior Industries International Inc / Pacific Edge Ltd / Domino's Pizza Inc / Alphabet Inc / S&P Global Inc / F5 Inc / Restaurant Brands International Inc / Dexcom Inc / LHC Group Inc / Innospec Inc / XPO Logistics Inc / ATN International Inc / eHealth Inc / IPG Photonics Corp / Lululemon Athletica Inc / Masimo Corp / Alnylam Pharmaceuticals Inc / Ulta Beauty Inc / Ensign Group Inc / Kaman Corp / Deckers Outdoor Corp / Addus Homecare Corp / Tesla Inc / NXP Semiconductors NV / Amyris Inc / Horizon Therapeutics PLC / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Workday Inc / Palo Alto Networks Inc / Triumph Bancorp Inc / Evolent Health Inc / BWX Technologies Inc / Truist Financial Corp / Trade Desk Inc / Roku Inc / MongoDB Inc / Pieris Pharmaceuticals Inc / Cboe Global Markets Inc / Arvinas Inc / Lovesac Co / CrowdStrike Holdings Inc / Pennant Group Inc / Trip.com Group Ltd / Winston Pharmaceuticals Inc / Playstudios Inc / Proxim Wireless Corp / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / United Kingdom / Ireland / Netherlands / New Zealand / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for BIIB. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">The Feedback Loop: November Rain Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / INCY.O / BIIB.O / ITCI.O / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Biogen Inc / Intra-Cellular Therapies Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 11/5/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / BMY=US / HD=US / AMZN=US / T=US / AMT=US / PEB=US / H=US / LOW=US / ENR=US / VRM=US / EXPE=US / LEG=US / W=US / FLO=US / ARRY=US / BLL=US / CCK=US / DRH=US / EPC=US / SAFE=US / MAPS=US / MHK=US / HOOK=US / SFT=US / SNAP=US / TRIP=US / WIX=US / PSA=US / CGEN=US / BKNG=US / FB=US / KRT=US / MTCH=US / WRE=US / AUTL=US / OGN / PTON=US / STRO=US / BIIB=US / TPX=US / APP=US / SHO=US / HST=US / PGTI=US / PRPL=US / WH=US / UTZ=US / INSE / CLDT=US / NXPI=US / RLJ=US / FBHS=US / ANGI=US / RHP=US / GOOGL=US / 00770K202 / BABA=US / CMPR=US / RLMD=US / GDDY=US / SQ=US / PK=US / GDS=US / CVNA=US / IOVA=US / SFIX=US / ROOT=US / FTDR=US / SITC=US / LYFT=US / UBER=US / TCRR=US / XAIR=US / GMAB=US / NGMS=US / HYFM=US / PRVA=US / VMEO=US / MNTV=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Home Depot Inc / Amazon.com Inc / AT&T Inc / American Tower Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Lowe's Companies Inc / Energizer Holdings Inc / Vroom Inc / Expedia Group Inc / Leggett & Platt Inc / Wayfair Inc / Flowers Foods Inc / Array Technologies Inc / Ball Corp / Crown Holdings Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / Safehold Inc / WM Technology Inc / Mohawk Industries Inc / HOOKIPA Pharma Inc / Shift Technologies Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Public Storage / Compugen Ltd / Booking Holdings Inc / Meta Platforms Inc / Karat Packaging Inc / Match Group Inc / Washington Real Estate Investment Trust / Autolus Therapeutics PLC / Organon & Co / Peloton Interactive Inc / Sutro Biopharma Inc / Biogen Inc / Tempur Sealy International Inc / Applovin Corp / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / PGT Innovations Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / UTZ Brands Inc / Inspired Entertainment Inc / Chatham Lodging Trust / NXP Semiconductors NV / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Angi Inc / Ryman Hospitality Properties Inc / Alphabet Inc / Aemetis Inc / Alibaba Group Holding Ltd / Cimpress PLC / Relmada Therapeutics Inc / GoDaddy Inc / Block Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / Carvana Co / Iovance Biotherapeutics Inc / Stitch Fix Inc / Root Inc / Frontdoor Inc / Site Centers Corp / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Beyond Air Inc / Genmab A/S / NeoGames SA / Hydrofarm Holdings Group Inc / Privia Health Group Inc / Vimeo Inc / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ALTR.O / BB.N / BCE.TO / CCI.N / CRM.N / DFDS.CO / EDP.LS / MSFT.O / T.N / T.TO / AVB.N / DRE.N / EQR.N / FR.N / TCN.N / WY.N / CFP.TO / SJRb.TO / RCIb.TO / CHKP.O / INCY.O / CLS.N / QBRb.TO / DIS.N / CCA.TO / DT.N / EPR.N / ADBE.O / NICE.O / DV.N / EPC.N / SBAC.O / AMT.N / SIRI.O / CONE.O / VZ.N / AKAM.O / NNN.N / DSGX.O / EFX.N / V.N / CPT.N / ACN.N / ARE.N / EGP.N / PLD.N / ESS.N / UDR.N / SUI.N / KRC.N / MAA.N / OTEX.O / JKHY.O / VTR.N / NCR.N / NET.N / SSNC.O / CRC.N / LTC.N / ADC.N / O.N / PEGA.OQ / AMH.N / WPC.N / NTCT.OQ / FFIV.O / EQIX.O / BIIB.O / DLR.N / ELS.N / EDR.N / VIAC.O / WEF.TO / SRC.N / MPW.N / IHS.N / DRX.L / FIS.N / MA.N / PRTS.OQ / ATL.MI / TDC.N / NOG.A / SWI.N / CIO.N / PCH.O / CFX.TO / MSP.N / STAG.N / IFP.TO / ANGI.OQ / RFP.N / ADT.N / TMUS.N / DOC.N / 81762P102 / WIX.O / PTC.O / VRNS.O / KXS.TO / ZALG.DE / NEWR.N / 03835T200 / SHOP.N / PYPL.OQ / GBT.OQ / RPD.O / SQ.N / MP1.AX / SPGI.N / TWLO.N / GDS.O / INVH.N / UNIT.O / OKTA.OQ / WOW.N / CARG.O / SAIL.N / COLD.N / ILPT.O / WELL.N / DBX.O / GMDA.OQ / OPI.OQ / FSLY.N / FVRR.N / PING.N / TMV.DE / DDOG.O / PEAK.N / NLOK.O / ETNB.O / DHC.O / VVNT.N / EGLX.TO / FOUR.N / ZI.O / MGNI.OQ / JAMF.O / RIDE.OQ / MAX.N / ABNB.OQ / DASH.N / SKLZ.N / WFG.N / CLVT.N / BMBL.OQ / TIXT.TO / AFRM.O / OLO.N / COUR.N / PSFE.N / MAGT.TO / FLYW.O / DBRG.N / BHG.N / FA.OQ / XMTR.OQ / TRMR.OQ / EVCM.O / NABL.N / RYAN.N / PWSC.N / CWAN.N / ZD.OQ</td><td class="leftalignment">Altair Engineering Inc / BlackBerry Ltd / BCE Inc / Crown Castle International Corp / Salesforce.Com Inc / DFDS AS / EDP Energias de Portugal SA / Microsoft Corp / AT&T Inc / Telus Corp / Avalonbay Communities Inc / Duke Realty Corp / Equity Residential / First Industrial Realty Trust Inc / Tricon Residential Inc / Weyerhaeuser Co / Canfor Corp / Shaw Communications Inc / Rogers Communications Inc / Check Point Software Technologies Ltd / Incyte Corp / Celestica Inc / Quebecor Inc / Walt Disney Co / Cogeco Communications Inc / Dynatrace Inc / EPR Properties / Adobe Inc / Nice Ltd / DoubleVerify Holdings Inc / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Sirius XM Holdings Inc / CyrusOne Inc / Verizon Communications Inc / Akamai Technologies Inc / National Retail Properties Inc / Descartes Systems Group Inc / Equifax Inc / Visa Inc / Camden Property Trust / Accenture PLC / Alexandria Real Estate Equities Inc / Eastgroup Properties Inc / Prologis Inc / Essex Property Trust Inc / UDR Inc / Sun Communities Inc / Kilroy Realty Corp / Mid-America Apartment Communities Inc / Open Text Corp / Jack Henry & Associates Inc / Ventas Inc / NCR Corp / Cloudflare Inc / SS&C Technologies Holdings Inc / California Resources Corp / LTC Properties Inc / Agree Realty Corp / Realty Income Corp / Pegasystems Inc / American Homes 4 Rent / WP Carey Inc / Netscout Systems Inc / F5 Inc / Equinix Inc / Biogen Inc / Digital Realty Trust Inc / Equity LifeStyle Properties Inc / Endeavor Group Holdings Inc / ViacomCBS Inc / Western Forest Products Inc / Spirit Realty Capital Inc / Medical Properties Trust Inc / IHS Holding Ltd / Drax Group PLC / Fidelity National Information Services Inc / Mastercard Inc / Carparts.Com Inc / Atlantia SpA / Teradata Corp / Northern Oil and Gas Inc / SolarWinds Corp / City Office REIT Inc / Potlatchdeltic Corp / Canfor Pulp Products Inc / Datto Holding Corp / STAG Industrial Inc / Interfor Corp / Angi Inc / Resolute Forest Products Inc / ADT Inc / T-Mobile US Inc / Physicians Realty Trust / ServiceNow Inc / Wix.Com Ltd / PTC Inc / Varonis Systems Inc / Kinaxis Inc / Zalando SE / New Relic Inc / Aptose Biosciences Inc / Shopify Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Rapid7 Inc / Block Inc / Megaport Ltd / S&P Global Inc / Twilio Inc / GDS Holdings Ltd / Invitation Homes Inc / Uniti Group Inc / Okta Inc / WideOpenWest Inc / CarGurus Inc / SailPoint Technologies Holdings Inc / Americold Realty Trust / Industrial Logistics Properties Trust / Welltower Inc / Dropbox Inc / Gamida Cell Ltd / Office Properties Income Trust / Fastly Inc / Fiverr International Ltd / Ping Identity Holding Corp / TeamViewer AG / Datadog Inc / Healthpeak Properties Inc / NortonLifeLock Inc / 89Bio Inc / Diversified Healthcare Trust / Vivint Smart Home Inc / Enthusiast Gaming Holdings Inc / Shift4 Payments Inc / ZoomInfo Technologies Inc / Magnite Inc / Jamf Holding Corp / Lordstown Motors Corp / Mediaalpha Inc / Airbnb Inc / DoorDash Inc / Skillz Inc / West Fraser Timber Co Ltd / CLARIVATE PLC / Bumble Inc / Telus International Cda Inc / Affirm Holdings Inc / Olo Inc / Coursera Inc / Paysafe Ltd / Magnet Forensics Inc / Flywire Corp / DigitalBridge Group Inc / Bright Health Group Inc / First Advantage Corp / Xometry Inc / Tremor International Ltd / EverCommerce Inc / N-Able Inc / Ryan Specialty Group Holdings Inc / PowerSchool Holdings Inc / Clearwater Analytics Holdings Inc / Ziff Davis Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Italy / Mauritius / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Healthy Biotech Inflows Continue for a Third Straight Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Laying out the EMA timelines for aducanumab</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Nov. 11, 2021 / 5:10PM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">We Believe Adu CHMP Opinion Likely Tomorrow or December - Our Take on Potential Impact</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Some Pandemic-Related Disruptions, but Full Year Guidance Is Intact; Inaugural Investor Day On November 15; Maintain Buy and $44 PT Post-3Q21 Results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">68071010 / 09062X103 / 359664109</td><td class="leftalignment">Olink Holding AB (publ) / Biogen Inc / Fulgent Genetics Inc</td><td class="leftalignment"></td><td class="leftalignment">Sweden / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Sung Ji Nam</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MRK=US / BSX=US / LLY=US / BMY=US / OXY=US / AMD=US / RRC=US / IP=US / MDT=US / DVN=US / INCY=US / GILD=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / PLUG=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / IGT=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / ESS=US / CLI=US / DV=US / AVGO=US / BLL=US / BNL=US / ENV=US / ELY=US / CTRA=US / CNX=US / CCK=US / EQT=US / GPOR=US / DOC=US / HOOK=US / REGI=US / TRIP=US / TGI=US / CVX=US / CGEN=US / SGMS=US / BDN=US / OFC=US / CUZ=US / PRI=US / DCP=US / EGP=US / FR=US / JAZZ=US / KIM=US / NHI=US / PRA=US / DRE=US / NLS=US / COP=US / MRNS=US / PTON=US / MMP=US / BIIB=US / RNG=US / APTX=US / NUVA=US / EXR=US / WRK=US / CLR=US / PRPL=US / SEAS=US / TIL=US / NOG=US / RCUS=US / HTA=US / OLO=US / AR=US / OAS=US / HGV=US / ESTE=US / CUBE=US / MTDR=US / PDCE=US / FANG=US / MODN=US / CNCE=US / VNOM=US / CIVI=US / OSH=US / VCEL=US / GSBD=US / NSA=US / EVBG=US / CDEV=US / VRNA=US / SBOW=US / IOVA=US / CARG=US / SAIL=US / COLD=US / FSK=US / RPAY=US / GMAB=US / GOCO=US / PNTG=US / OVV=US / CRMD.US / AZYO=US / ABNB=US / DASH=US / SHLS=US / ROCC=US / DHT.UN=CA / REPX=US / MNTV=US / DNUT=US / PYCR=US / PKG=U / 00152K101</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Bristol-Myers Squibb Co / Occidental Petroleum Corp / Advanced Micro Devices Inc / Range Resources Corp / International Paper Co / Medtronic PLC / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Plug Power Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Essex Property Trust Inc / Veris Residential Inc / DoubleVerify Holdings Inc / Broadcom Inc / Ball Corp / Bunzl plc / Envestnet Inc / Callaway Golf Co / Coterra Energy Inc / CNX Resources Corp / Crown Holdings Inc / EQT Corp / Gulfport Energy Corp / Physicians Realty Trust / HOOKIPA Pharma Inc / Renewable Energy Group Inc / Tripadvisor Inc / Triumph Group Inc / Chevron Corp / Compugen Ltd / Scientific Games Corp / Brandywine Realty Trust / Corporate Office Properties Trust / Cousins Properties Inc / Primerica Inc / DCP Midstream LP / Eastgroup Properties Inc / First Industrial Realty Trust Inc / Jazz Pharmaceuticals PLC / Kimco Realty Corp / National Health Investors Inc / ProAssurance Corp / Duke Realty Corp / Nautilus Inc / Conocophillips / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / Magellan Midstream Partners LP / Biogen Inc / RingCentral Inc / Aptinyx Inc / NuVasive Inc / Extra Space Storage Inc / Westrock Co / Continental Resources Inc / Purple Innovation Inc / SeaWorld Entertainment Inc / Instil Bio Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Healthcare Trust Of America Inc / Olo Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Earthstone Energy Inc / CubeSmart / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Model N Inc / Concert Pharmaceuticals Inc / Viper Energy Partners LP / Civitas Resources Inc / Oak Street Health Inc / Vericel Corp / Goldman Sachs BDC Inc / National Storage Affiliates Trust / Everbridge Inc / Centennial Resource Development Inc / Verona Pharma PLC / SilverBow Resources Inc / Iovance Biotherapeutics Inc / CarGurus Inc / SailPoint Technologies Holdings Inc / Americold Realty Trust / FS KKR Capital Corp / Repay Holdings Corp / Genmab A/S / Gohealth Inc / Pennant Group Inc / Ovintiv Inc / CorMedix Inc / Aziyo Biologics Inc / Airbnb Inc / DoorDash Inc / Shoals Technologies Group Inc / Ranger Oil Corp / Dri Healthcare Trust / Riley Exploration Permian Inc / Momentive Global Inc / Krispy Kreme Inc / Paycor HCM Inc / Packaging Corp of America / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">CAS.TO / GE.N / IP.N / PNW.N / SO.N / WLL.N / TA.TO / ETR.N / THC.N / FER.MC / DUK.N / IMO.TO / DV.N / WM.N / PPL.N / JAZZ.O / DHI.N / EXC.N / RRC.N / RSG.N / EPAY.O / DK.N / OTEX.O / SWIR.O / WCN.N / LNG.A / PLUG.OQ / HOOK.O / PAAS.O / BIIB.O / MNKD.OQ / HUN.N / MWA.N / CQP.A / CIM.N / INO.OQ / EONGn.DE / CLW.N / NEE.N / HFC.N / RFP.N / ADT.N / GRT_u.TO / KPT.TO / DOOR.N / ITCI.O / WRK.N / PARR.N / OR.N / AQN.N / ESTE.N / CARG.O / AY.O / SAIL.N / OPRX.OQ / HCAT.OQ / PNTG.OQ / OAS.OQ / GFL.N / GOCO.O / PLTR.N / BSY.O / DASH.N / PUBM.O / CLVT.N / OLO.N / FLYW.O / NABL.N / AVTX.OQ / NVEI.OQ</td><td class="leftalignment">Cascades Inc / General Electric Co / International Paper Co / Pinnacle West Capital Corp / Southern Co / Whiting Petroleum Corp / TransAlta Corp / Entergy Corp / Tenet Healthcare Corp / Ferrovial SA / Duke Energy Corp / Imperial Oil Ltd / DoubleVerify Holdings Inc / Waste Management Inc / PPL Corp / Jazz Pharmaceuticals PLC / D R Horton Inc / Exelon Corp / Range Resources Corp / Republic Services Inc / Bottomline Technologies Inc / Delek US Holdings Inc / Open Text Corp / Sierra Wireless Inc / Waste Connections Inc / Cheniere Energy Inc / Plug Power Inc / HOOKIPA Pharma Inc / Pan American Silver Corp / Biogen Inc / MannKind Corp / Huntsman Corp / Mueller Water Products Inc / Cheniere Energy Partners LP / Chimera Investment Corp / Inovio Pharmaceuticals Inc / E.ON SE / Clearwater Paper Corp / Nextera Energy Inc / HollyFrontier Corp / Resolute Forest Products Inc / ADT Inc / Granite Real Estate Investment Trust / KP Tissue Inc / Masonite International Corp / Intra-Cellular Therapies Inc / Westrock Co / Par Pacific Holdings Inc / Osisko Gold Royalties Ltd / Algonquin Power & Utilities Corp / Earthstone Energy Inc / CarGurus Inc / Atlantica Sustainable Infrastructure PLC / SailPoint Technologies Holdings Inc / OPTIMIZERx Corp / Health Catalyst Inc / Pennant Group Inc / Oasis Petroleum Inc / GFL Environmental Inc / Gohealth Inc / Palantir Technologies Inc / Bentley Systems Inc / DoorDash Inc / PubMatic Inc / CLARIVATE PLC / Olo Inc / Flywire Corp / N-Able Inc / Avalo Therapeutics Inc / Nuvei Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Spain / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Come On In, The Water’s Fine!</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">375558103 / 031162100 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 90400D108 / 00461U105 / 00166B105 / 46565G104 / 49705R105 / 670703107</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Biogen Inc. (BIIB) - Competition from generics</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN / BMY / GILD / JNJ / LLY / MRK / PFE / ACRS / UTHR / ACRX / BIIB / ABBV / AERI / ALDX</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aclaris Therapeutics Inc / United Therapeutics Corp / AcelRx Pharmaceuticals Inc / Biogen Inc / Abbvie Inc / Aerie Pharmaceuticals Inc / Aldeyra Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">It's difficult to compare cognition off-treatment across trials despite sustained plaque reduction</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB=US / LLY=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">CTAD Data Lends Further Support, In Our View, For Finite Dosing Of Alzheimer's Antibodies</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">F1Q22 Results; AGTC-501 Strenghtens Its Profile in XLRP; Pediatric Data in ACHM by YE21</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03820J100 / BIIB / 68906L105</td><td class="leftalignment">Applied Genetic Technologies Corp / Biogen Inc / Otonomy Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Inflections Suggest Early Stages of Seasonal COVID-19 Wave; Growing Armamentarium to Blunt Future Spikes in Severe Disease</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AAPL / AMGN / BKI / BOLT / DNLI / EA / FISV / INTC.O / JKHY / JPM.N / MA / MRTX / MSFT / NOW / ORCL / PRTA / RNG / SAP / SONY / TH / TTWO / V / VGR / WMT / WSC / AMZN.O / EBAY.O / MWA / FIS / ATVI.O / NVDA.O / ADBE.O / HEAR / MPWR.O / AMD.O / NFLX / ADSK.O / FRPT / GPN / PYPL / MRVL.O / AVGO.O / HELE.OQ / FRSH.OQ / INTA.O / BIIB / GOOG.O / 36467W109 / CCOI / 771195104 / SWAV / AMRS.O / ZNGA / FB.O / WDAY / FDEV.L / WIX.O / 82655M107 / NVRO / VCEL.O / TTD.O / COUP.O / BL.O / TCMD / AVDL.O / ROKU.O / APLS.O / BILI.O / DOCU.O / ORIC.O / ZI.OQ / KDNY.O / PUBM.O / XM.O / HUYA.K / 010196103 / SOFI / EVCM.O / CGTX.OQ / ENVX.O / CWAN.N / JSPR.O</td><td class="leftalignment">Apple Inc / Amgen Inc / Black Knight Inc / Bolt Biotherapeutics Inc / Denali Therapeutics Inc / Electronic Arts Inc / Fiserv Inc / Intel Corp / Jack Henry & Associates Inc / JPMorgan Chase & Co / Mastercard Inc / Mirati Therapeutics Inc / Microsoft Corp / ServiceNow Inc / Oracle Corp / Prothena Corporation PLC / RingCentral Inc / SAP SE / Sony Group Corp / Target Hospitality Corp / Take-Two Interactive Software Inc / Visa Inc / Vector Group Ltd / Walmart Inc / Willscot Mobile Mini Holdings Corp / Amazon.com Inc / eBay Inc / Mueller Water Products Inc / Fidelity National Information Services Inc / Activision Blizzard Inc / NVIDIA Corp / Adobe Inc / Turtle Beach Corp / Monolithic Power Systems Inc / Advanced Micro Devices Inc / Netflix Inc / Autodesk Inc / Freshpet Inc / Global Payments Inc / PayPal Holdings Inc / Marvell Technology Inc / Broadcom Inc / Helen of Troy Ltd / Freshworks Inc / Intapp Inc / Biogen Inc / Alphabet Inc / GameStop Corp / Cogent Communications Holdings Inc / Roche Holding AG / Shockwave Medical Inc / Amyris Inc / Zynga Inc / Meta Platforms Inc / Workday Inc / Frontier Developments PLC / Wix.Com Ltd / Sify Technologies Ltd / Nevro Corp / Vericel Corp / Trade Desk Inc / Coupa Software Inc / Blackline Inc / Tactile Systems Technology Inc / Avadel Pharmaceuticals PLC / Roku Inc / Apellis Pharmaceuticals Inc / Bilibili Inc / DocuSign Inc / Oric Pharmaceuticals Inc / ZoomInfo Technologies Inc / Chinook Therapeutics Inc / PubMatic Inc / Qualtrics International Inc / HUYA Inc / Aksys Ltd / SoFi Technologies Inc / EverCommerce Inc / Cognition Therapeutics Inc / Enovix Corp / Clearwater Analytics Holdings Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Germany / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Takeaways from AD Panel</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">BOLT / DNLI / PRTA / BIIB / 771195104 / CGTX.OQ / JSPR.O</td><td class="leftalignment">Bolt Biotherapeutics Inc / Denali Therapeutics Inc / Prothena Corporation PLC / Biogen Inc / Roche Holding AG / Cognition Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ALB.N / BA.N / C.N / CNA.L / CP.TO / DD.N / GE.N / NSC.N / SAND.ST / SKFb.ST / WEIR.L / VOWG_p.DE / GILD.O / LPX.N / AAL.L / CNR.TO / DHR.N / LEA.N / WCC.N / ROP.N / CSX.N / TV.TO / UNP.N / WM.N / WHR.N / SHW.N / MTG.N / VLY.N / SNV.N / BC.N / STL.N / ALFA.ST / CPE.N / VSEC.OQ / WBS.N / FCF.N / HCC.N / ONC.TO / PFS.N / WSBC.O / BCRX.O / BIIB.O / RUS.TO / DCP.N / AINV.O / BECN.O / MAIN.N / ACAD.O / ISBC.O / CS.TO / 443628102 / MERC.O / EHTH.O / 3IN.L / DAIGn.DE / KTOS.OQ / GETP.PA / CLW.N / ENV.N / BHPB.L / TRGP.N / CFX.TO / NLSN.N / BKU.N / GLEN.L / FBHS.N / 505440107 / FANG.O / NYCB.N / MRON.L / KPT.TO / TPH.N / TSLA.N / PTC.O / KPTI.O / XNCR.OQ / IBP.N / ITCI.O / CIA.TO / AXTA.N / NEWR.N / SUM.N / PYPL.OQ / RACE.MI / EDIT.O / VACN.S / TTD.O / CDEV.O / RHIM.L / STLC.TO / APTV.N / GTES.N / VCTR.N / EPIRa.ST / RTLR.O / APRE.OQ / CRNC.OQ / BEAM.O / SLQT.N / MOCORP.HE / MCFE.OQ / 900435207 / WFG.N / RKT.L / SQSP.N / EVCM.O</td><td class="leftalignment">Albemarle Corp / Boeing Co / Citigroup Inc / Centrica PLC / Canadian Pacific Railway Ltd / Dupont De Nemours Inc / General Electric Co / Norfolk Southern Corp / Sandvik AB / AB Skf / Weir Group PLC / Volkswagen AG / Gilead Sciences Inc / Louisiana-Pacific Corp / Anglo American PLC / Canadian National Railway Co / Danaher Corp / Lear Corp / Wesco International Inc / Roper Technologies Inc / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Waste Management Inc / Whirlpool Corp / Sherwin-Williams Co / MGIC Investment Corp / Valley National Bancorp / Synovus Financial Corp / Brunswick Corp / Sterling Bancorp / Alfa Laval AB / Callon Petroleum Co / VSE Corp / Webster Financial Corp / First Commonwealth Financial Corp / Warrior Met Coal Inc / Oncolytics Biotech Inc / Provident Financial Services Inc / WesBanco Inc / BioCryst Pharmaceuticals Inc / Biogen Inc / Russel Metals Inc / DCP Midstream LP / Apollo Investment Corp / Beacon Roofing Supply Inc / Main Street Capital Corp / ACADIA Pharmaceuticals Inc / Investors Bancorp Inc / Capstone Mining Corp / Hudbay Minerals Inc / Mercer International Inc / eHealth Inc / 3I Infrastructure PLC / Daimler AG / Kratos Defense and Security Solutions Inc / Getlink SE / Clearwater Paper Corp / Envestnet Inc / BHP Group PLC / Targa Resources Corp / Canfor Pulp Products Inc / Nielsen Holdings PLC / BankUnited Inc / Glencore PLC / Fortune Brands Home & Security Inc / Labrador Iron Ore Royalty Corp / Diamondback Energy Inc / New York Community Bancorp Inc / Melrose Industries PLC / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / PTC Inc / Karyopharm Therapeutics Inc / Xencor Inc / Installed Building Products Inc / Intra-Cellular Therapies Inc / Champion Iron Ltd / Axalta Coating Systems Ltd / New Relic Inc / Summit Materials Inc / PayPal Holdings Inc / Ferrari NV / Editas Medicine Inc / VAT Group AG / Trade Desk Inc / Centennial Resource Development Inc / RHI Magnesita NV / Stelco Holdings Inc / Aptiv PLC / Gates Industrial Corporation PLC / Victory Capital Holdings Inc / Epiroc AB / Rattler Midstream LP / Aprea Therapeutics Inc / Cerence Inc / Beam Therapeutics Inc / SelectQuote Inc / Metso Outotec Corp / Mcafee Corp / Turquoise Hill Resources Ltd / West Fraser Timber Co Ltd / Reckitt Benckiser Group PLC / Squarespace Inc / EverCommerce Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Finland / France / United Kingdom / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABOS: Credit Suisse Healthcare Conference: Fireside Chat Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABOS.OQ / LLY.N / BIIB.OQ</td><td class="leftalignment">Acumen Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Adverse Events Monitor – 3Q21</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.O / BCRX.O / BIIB.O / PTC.O / KPTI.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / BioCryst Pharmaceuticals Inc / Biogen Inc / PTC Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">CTAD 2021 Preview: Amyloid/Tau Heavy but Novel Mechanisms, Measures, and Biomarkers Coming Through; Incremental FTD Updates</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">09062X103 / 462222100 / 014442107</td><td class="leftalignment">Biogen Inc / Ionis Pharmaceuticals Inc / Alector Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Sarah Schram</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Uncovered: New AERS Data Show Some Seizures, 1 Death In ARIA Patient, On Adu</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / PFE.N / GILD.O / JAZZ.O / VRTX.O / BLU.N / BIIB.O / PCRX.O / ABBV.N / ENTA.O / ITCI.O / XENE.O / GMDA.OQ / MTCR.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Jazz Pharmaceuticals PLC / Vertex Pharmaceuticals Inc / BELLUS Health Inc / Biogen Inc / Pacira Biosciences Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Xenon Pharmaceuticals Inc / Gamida Cell Ltd / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">4502.T / AAPL / AGCO / ATRC / C.N / COF / CRY / CSII / DE / DNLI / EVER / GECC / GS / ICPT / INTC.O / JACK / JPM.N / MS / MSFT / NET / NPO / PRTA / ROK / SRCL / TH / TREE / TRMB / WEN / AMZN.O / EW / QUOT / ADI.O / PLUG.O / ARRY.O / FCEL.O / TXN.O / SYNA / LFUS.O / AMSC.O / MRVL.O / AVGO.O / HELE.OQ / SIVB.O / MMSI.O / ITRI.O / BIIB / CARG / 493267108 / 316773100 / MAIN.N / ACAD.O / 315616102 / G02602103 / 029899101 / SPWR.O / INFI.O / CSIQ.O / FSLR.O / Z.O / 02043Q107 / STX.OQ / WPRT.O / TWIN.O / 771195104 / TSLA.O / SWAV / PCYO.O / NXPI.O / AMRS.O / FDUS / ANGI.O / ENPH.O / 576485205 / CNHI / CIEN.K / XENT / 174610105 / KEYS.K / ETSY.O / SEDG.O / RUN.O / IAC.O / WKHS.O / AQMS.O / SYRS / MDGL / SRRA / AQB / MDB.O / 83417M104 / KRTX / TARA.O / BXRX.O / DKNG / VLDR.O / VRDN.O / SHLS.O / APPH / DOCN / TSP.O / SOFI / ENVX.O / LILM.O / IL0011796880</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Apple Inc / AGCO Corp / AtriCure Inc / Citigroup Inc / Capital One Financial Corp / CryoLife Inc / Cardiovascular Systems Inc / Deere & Co / Denali Therapeutics Inc / EverQuote Inc / Great Elm Capital Corp / Goldman Sachs Group Inc / Intercept Pharmaceuticals Inc / Intel Corp / Jack in the Box Inc / JPMorgan Chase & Co / Morgan Stanley / Microsoft Corp / Cloudflare Inc / EnPro Industries Inc / Prothena Corporation PLC / Rockwell Automation Inc / Stericycle Inc / Target Hospitality Corp / Lendingtree Inc / Trimble Inc / Wendys Co / Amazon.com Inc / Edwards Lifesciences Corp / Quotient Technology Inc / Analog Devices Inc / Plug Power Inc / Array Technologies Inc / Fuelcell Energy Inc / Texas Instruments Inc / Synaptics Inc / Littelfuse Inc / American Superconductor Corp / Marvell Technology Inc / Broadcom Inc / Helen of Troy Ltd / SVB Financial Group / Merit Medical Systems Inc / Itron Inc / Biogen Inc / CarGurus Inc / KeyCorp / Fifth Third Bancorp / Main Street Capital Corp / ACADIA Pharmaceuticals Inc / F5 Inc / Amdocs Ltd / American States Water Co / SunPower Corp / Infinity Pharmaceuticals Inc / Canadian Solar Inc / First Solar Inc / Zillow Group Inc / Alnylam Pharmaceuticals Inc / Seagate Technology Holdings PLC / Westport Fuel Systems Inc / Twin Disc Inc / Roche Holding AG / Tesla Inc / Shockwave Medical Inc / Pure Cycle Corp / NXP Semiconductors NV / Amyris Inc / Fidus Investment Corp / Angi Inc / Enphase Energy Inc / Matador Resources Co / CNH Industrial NV / Ciena Corp / Intersect Ent Inc / Citizens Financial Group Inc / Keysight Technologies Inc / ETSY Inc / Solaredge Technologies Inc / Sunrun Inc / IAC/Interactivecorp / Workhorse Group Inc / Aqua Metals Inc / Syros Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Sierra Oncology Inc / AquaBounty Technologies Inc / MongoDB Inc / Solaredge Technologies Inc / Karuna Therapeutics Inc / Protara Therapeutics Inc / Baudax Bio Inc / DraftKings Inc / Velodyne Lidar Inc / Viridian Therapeutics Inc / Shoals Technologies Group Inc / AppHarvest Inc / DigitalOcean Holdings Inc / TuSimple Holdings Inc / SoFi Technologies Inc / Enovix Corp / Lilium NV / Valens Semiconductor Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Israel / Japan / Netherlands / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">3Q Update Highlights Key Opportunities</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">DNLI / 4502.T / BIIB</td><td class="leftalignment">Denali Therapeutics Inc / Takeda Pharmaceutical Co Ltd / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">FISV=US / BSX=US / PFE=US / OXY=US / GBT=US / IP=US / MDT=US / PD=US / AMZN=US / RUN=US / CMA=US / EOG=US / PB=US / DIOD=US / VRM=US / MUR=US / EWBC=US / UMPQ=US / EXPE=US / ATVI=US / VMC=US / UNM=US / CVS=US / CI=US / W=US / MLM=US / ARCC=US / PATH=US / COLL=US / MAIN=US / DOC=US / ORCC=US / PACW=US / REGN=US / SGMO=US / SNAP=US / TRGP=US / TRIP=US / VRTX=US / WAL=US / WIX=US / CVX=US / GPN=US / FNF=US / BKNG=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / CNM=US / FB=US / KIM=US / MKL=US / MTCH=US / SSB=US / RF=US / CATY=US / SBSI=US / BE=US / APPN=US / PNFP=US / BDSI=US / PTON=US / BIIB=US / TCBI=US / MOG.A=US / FNB=US / EXP=US / FHN=US / APP=US / AINV=US / XM=US / FIS=US / GPRE=US / CADE=US / WRK=US / PNNT=US / NOG=US / ATSG=US / IAC=US / HTA=US / OLO=US / OAS=US / BLND=US / ESTE=US / ANGI=US / ZNGA=US / PDCE=US / TILE=US / VOYA=US / CEQP=US / AERI=US / GOOGL=US / QTWO=US / TSLX=US / 70806A106 / BABA=US / CIVI=US / CMPR=US / RLMD=US / GDDY=US / GSBD=US / CHCT=US / LOB=US / PEN=US / SQ=US / ADVM=US / CDEV=US / ANAB=US / CVNA=US / SBOW=US / RDFN=US / SWCH=US / DCPH=US / MBIN=US / SFIX=US / HWC=US / OZK=US / FOCS=US / FTDR=US / FSK=US / LYFT=US / UBER=US / FERG=US / RPAY=US / AHCO=US / ONEM=US / DKNG=US / NCNO=US / PAYA=US / ABNB=US / RBLX=US / COUR=US / VMEO=US / MNTV=US / DNUT=US / PKG=U / 00152K101 / GTLB=US</td><td class="leftalignment">Fiserv Inc / Boston Scientific Corp / Pfizer Inc / Occidental Petroleum Corp / Global Blood Therapeutics Inc / International Paper Co / Medtronic PLC / PagerDuty Inc / Amazon.com Inc / Sunrun Inc / Comerica Inc / EOG Resources Inc / Prosperity Bancshares Inc / Diodes Inc / Vroom Inc / Murphy Oil Corp / East West Bancorp Inc / Umpqua Holdings Corp / Expedia Group Inc / Activision Blizzard Inc / Vulcan Materials Co / Unum Group / CVS Health Corp / Cigna Corp / Wayfair Inc / Martin Marietta Materials Inc / Ares Capital Corp / UiPath Inc / Collegium Pharmaceutical Inc / Main Street Capital Corp / Physicians Realty Trust / Owl Rock Capital Corp / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Snap Inc / Targa Resources Corp / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / Wix.Com Ltd / Chevron Corp / Global Payments Inc / Fidelity National Financial Inc / Booking Holdings Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Core & Main Inc / Meta Platforms Inc / Kimco Realty Corp / Markel Corp / Match Group Inc / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / Southside Bancshares Inc / Bloom Energy Corp / Appian Corp / Pinnacle Financial Partners Inc / BioDelivery Sciences International Inc / Peloton Interactive Inc / Biogen Inc / Texas Capital Bancshares Inc / Moog Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Applovin Corp / Apollo Investment Corp / Qualtrics International Inc / Fidelity National Information Services Inc / Green Plains Inc / Cadence Bank / Westrock Co / Pennantpark Investment Corp / Northern Oil and Gas Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Healthcare Trust Of America Inc / Olo Inc / Oasis Petroleum Inc / Blend Labs Inc / Earthstone Energy Inc / Angi Inc / Zynga Inc / PDC Energy Inc / Interface Inc / Voya Financial Inc / Crestwood Equity Partners LP / Aerie Pharmaceuticals Inc / Alphabet Inc / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Alibaba Group Holding Ltd / Civitas Resources Inc / Cimpress PLC / Relmada Therapeutics Inc / GoDaddy Inc / Goldman Sachs BDC Inc / Community Healthcare Trust Inc / Live Oak Bancshares Inc / Penumbra Inc / Block Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / AnaptysBio Inc / Carvana Co / SilverBow Resources Inc / Redfin Corp / Switch Inc / Deciphera Pharmaceuticals Inc / Merchants Bancorp / Stitch Fix Inc / Hancock Whitney Corp / Bank Ozk / Focus Financial Partners Inc / Frontdoor Inc / FS KKR Capital Corp / Lyft Inc / Uber Technologies Inc / Ferguson PLC / Repay Holdings Corp / Adapthealth Corp / 1Life Healthcare Inc / DraftKings Inc / nCino Inc / Paya Holdings Inc / Airbnb Inc / Roblox Corp / Coursera Inc / Vimeo Inc / Momentive Global Inc / Krispy Kreme Inc / Packaging Corp of America / AKA Brands Holding Corp / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Retail Pharmacies & Medical Staffing Outperform; How Filling the Medicaid Coverage Gap Would Affect Hospital Finances</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="even"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">3Q21 results and model update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SGMO=US / BIIB=US</td><td class="leftalignment">Sangamo Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">11/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 572</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / N90064101 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103 / 747324101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Uniqure NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc / Pyxis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Sarah Schram / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / CGC / CHTR / CRY / MSFT / RAD / T / VCTR / WMT / WW / GILD.O / CMCSA.O / ONEM.O / XRAY.O / VZ / DOX.O / REGN.O / VRTX.O / SSNC.O / CCRN.O / AMED.O / BIIB / 459200101 / 00846U101 / 868168105 / GOOG.O / LHCG.O / PODD.O / MASI.O / ENSG.O / 483548103 / MRNA.O / STX.OQ / 771195104 / ADUS.O / TMUS / EVH / 100063846 / 720795103 / PNTG.O / FCRD / KDNY.O / LTH.N</td><td class="leftalignment">Arcosa Inc / Canopy Growth Corp / Charter Communications Inc / CryoLife Inc / Microsoft Corp / Rite Aid Corp / AT&T Inc / Victory Capital Holdings Inc / Walmart Inc / WW International Inc / Gilead Sciences Inc / Comcast Corp / 1Life Healthcare Inc / DENTSPLY SIRONA Inc / Verizon Communications Inc / Amdocs Ltd / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / International Business Machines Corp / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Insulet Corp / Masimo Corp / Ensign Group Inc / Kaman Corp / Moderna Inc / Seagate Technology Holdings PLC / Roche Holding AG / Addus Homecare Corp / T-Mobile US Inc / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / First Eagle Alternative Capital BDC Inc / Chinook Therapeutics Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Ireland / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matt Nirenberg, CFA, CFA / Michael D. Wiederhorn</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Nov. 05, 2021</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">AAPL / ALLO / AMGN / ATRC / CRY / CSII / EXEL / GBT / ICPT / INCY / INSP / IRTC / NBIX / OM / RARE / SAGE / ASND.O / GILD.O / EW / IART.O / SGEN / UTHR.O / PCSA.O / BMRN.O / DRRX.O / REGN.O / VRTX.O / NKTR / CCRN.O / STAA.O / AMED.O / EXAS.O / BIIB / 478160104 / MNKD.O / CMMB / ALNY.O / DXCM.O / LHCG.O / INFI.O / PODD.O / TNDM.O / MRNA.O / 771195104 / ADUS.O / SWAV / SRPT.O / AGIO / FATE.O / AERI.O / 02005N100 / AGRX.O / RXDX.O / APTO.O / AUPH.O / CFMS.O / VKTX / IONS.O / 04280A100 / MDGL / VRAY / NTLA / CRSP / IOVA / ATNX.O / 720795103 / PRVB.O / ORTX.O / BNGO.O / ARVN / XFOR.O / TMDX / PSNL.O / BCYC / ORIC.O / HGEN.O / 03823M100 / CLNN.O / CGTX.OQ</td><td class="leftalignment">Apple Inc / Allogene Therapeutics Inc / Amgen Inc / AtriCure Inc / CryoLife Inc / Cardiovascular Systems Inc / Exelixis Inc / Global Blood Therapeutics Inc / Intercept Pharmaceuticals Inc / Incyte Corp / Inspire Medical Systems Inc / iRhythm Technologies Inc / Neurocrine Biosciences Inc / Outset Medical Inc / Ultragenyx Pharmaceutical Inc / SAGE Therapeutics Inc / Ascendis Pharma A/S / Gilead Sciences Inc / Edwards Lifesciences Corp / Integra Lifesciences Holdings Corp / Seagen Inc / United Therapeutics Corp / Processa Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / DURECT Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Cross Country Healthcare Inc / STAAR Surgical Co / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / MannKind Corp / Chemomab Therapeutics Ltd / Alnylam Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / Infinity Pharmaceuticals Inc / Insulet Corp / Tandem Diabetes Care Inc / Moderna Inc / Roche Holding AG / Addus Homecare Corp / Shockwave Medical Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Ally Financial Inc / Agile Therapeutics Inc / Prometheus Biosciences Inc / Aptose Biosciences Inc / Aurinia Pharmaceuticals Inc / Conformis Inc / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / ViewRay Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Orchard Therapeutics PLC / Bionano Genomics Inc / Arvinas Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Personalis Inc / Bicycle Therapeutics PLC / Oric Pharmaceuticals Inc / Humanigen Inc / Applied Minerals Inc / Clene Inc. / Cognition Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">11012210 / 71708110 / 00846U10 / 88162420 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 10/29/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Let the Good Times Roll - Another Week of Biotech Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended November 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">AAPL / AMGN / AOS / APP / APPS / CSWC / DISH / ECL / HRB / INCY / INSP / INTC.O / IRTC / IS / KLAC.O / MSFT / PNR / RNG / ROK / RSI / RXN / SAGE / T / U / WMT / WTS / MWA / ATVI.O / AKAM / VECO.O / IART.O / VZ / AQUA / GPN / REGN.O / VRTX.O / FRSH.OQ / AMED.O / EXAS.O / BIIB / 478160104 / DENN.O / LHCG.O / XPO / INFI.O / Z.O / 88162G103 / MRNA.O / ADUS.O / XYL / TMUS / AGRX.O / RXDX.O / SEDG.O / VRAY / TTD.O / UAA / EGHT.K / 83417M104 / FRG.O / DKNG / CGTX.OQ</td><td class="leftalignment">Apple Inc / Amgen Inc / A O Smith Corp / Applovin Corp / Digital Turbine Inc / Capital Southwest Corp / DISH Network Corp / Ecolab Inc / H & R Block Inc / Incyte Corp / Inspire Medical Systems Inc / Intel Corp / iRhythm Technologies Inc / Ironsource Ltd / KLA Corp / Microsoft Corp / Pentair PLC / RingCentral Inc / Rockwell Automation Inc / Rush Street Interactive Inc / Zurn Water Solutions Corp / SAGE Therapeutics Inc / AT&T Inc / Unity Software Inc / Walmart Inc / Watts Water Technologies Inc / Mueller Water Products Inc / Activision Blizzard Inc / Akamai Technologies Inc / Veeco Instruments Inc / Integra Lifesciences Holdings Corp / Verizon Communications Inc / Evoqua Water Technologies Corp / Global Payments Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Freshworks Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Denny's Corp / LHC Group Inc / XPO Logistics Inc / Infinity Pharmaceuticals Inc / Zillow Group Inc / Tetra Tech Inc / Moderna Inc / Addus Homecare Corp / Xylem Inc / T-Mobile US Inc / Agile Therapeutics Inc / Prometheus Biosciences Inc / Solaredge Technologies Inc / ViewRay Inc / Trade Desk Inc / Under Armour Inc / 8x8 Inc / Solaredge Technologies Inc / Franchise Group Inc / DraftKings Inc / Cognition Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Tip of the Iceberg; Initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">CGTX.OQ / BIIB</td><td class="leftalignment">Cognition Therapeutics Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">3Q Update Highlights Execution on All Fronts</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">SAGE / BIIB</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FISV=US / MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / KO=US / MCD=US / OXY=US / ADI=US / RRC=US / GBT=US / WEN=US / DVN=US / INCY=US / TXN=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / EXPE=US / LEG=US / SEIC=US / KFRC=US / AMK=US / BNL=US / CBRL=US / ENV=US / CTRA=US / CNX=US / DRI=US / EQT=US / EXEL=US / GPOR=US / HZO=US / MCHP=US / REGI=US / SBAC=US / SSNC=US / TRIP=US / WIX=US / CVX=US / PSA=US / SPG=US / CGEN=US / BKNG=US / ADC=US / CUZ=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / MGNI=US / OGN / JRVR=US / BIIB=US / TXRH=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / FIS=US / GPRE=US / AMRX=US / TAST=US / QSR=US / CLR=US / TIL=US / NOG=US / EPRT=US / JACK=US / RCUS=US / GNRC=US / AR=US / OAS=US / NXPI=US / LPLA=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / ABBV=US / NDLS=US / ANIP=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / BWXT=US / WING=US / MCFT=US / WLTW=US / GXO=US / CDEV=US / CRSP=US / TRVG=US / JELD=US / SBOW=US / IOVA=US / FOCS=US / HARP=US / TCRR=US / NXTC=US / GMAB=US / PNTG=US / OVV=US / ZI=US / VTRS=US / ABNB=US / CELU=US / ROCC=US / REPX=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Range Resources Corp / Global Blood Therapeutics Inc / Wendys Co / Devon Energy Corp / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Leggett & Platt Inc / SEI Investments Co / Kforce Inc / AssetMark Financial Holdings Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Envestnet Inc / Coterra Energy Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Gulfport Energy Corp / MarineMax Inc / Microchip Technology Inc / Renewable Energy Group Inc / SBA Communications Corp / SS&C Technologies Holdings Inc / Tripadvisor Inc / Wix.Com Ltd / Chevron Corp / Public Storage / Simon Property Group Inc / Compugen Ltd / Booking Holdings Inc / Agree Realty Corp / Cousins Properties Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Magnite Inc / Organon & Co / James River Group Holdings Ltd / Biogen Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / Generac Holdings Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / LPL Financial Holdings Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / ANI Pharmaceuticals Inc / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / BWX Technologies Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Willis Towers Watson PLC / GXO Logistics Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Trivago NV / JELD-WEN Holding Inc / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Focus Financial Partners Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / Pennant Group Inc / Ovintiv Inc / ZoomInfo Technologies Inc / Viatris Inc / Airbnb Inc / Celularity Inc / Ranger Oil Corp / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BXP-US -  Dividend Quality Analysis, for the period ended October 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BXP / MSFT.O / BIIB.O / MAR.O / PTC.O / GOOGL.O</td><td class="leftalignment">Boston Properties Inc / Microsoft Corp / Biogen Inc / Marriott International Inc / PTC Inc / Alphabet Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">A.N / AAP / AAPL / ACA / ACI / ACN / ADS / AGCO / AIG.N / AIT / AKR / ALLO / AMGN / AMH / AMT / AOS / APPS / ARCC / ASML.AS / ATRC / AXP / AZO / BBY / BCLI / BIO / BJ / BKH / BKI / BKNG / BSET / BYND / C.N / CAKE / CCI / DE / FISV / OM / ALSN / ASND.O / AMZN.O / ATVI.O / ASTE.O / CBRL.O / ADBE.O / ALKS.O / AKAM / AHH / AMBA / AMKR.O / CDK / AMD.O / ADI.O / AQUA / CAMT.O / ARNA.O / CRNT.O / BLDP.O / ADSK.O / ALPN / BRKS.O / CBSH.O / ALGN.O / AVID.O / BLK.N / ARLP.O / BMRN.O / AMSC.O / AYI / AGEN.O / AVGO.O / BLFS / AZPN.OQ / CALM.OQ / AMRN.OQ / CCRN.O / ASYS.O / ABMD.O / ALCO.O / AMWD.O / APOG.O / CAMP.O / AAON.O / BCRX.O / AMED.O / ANSS.O / BDSI.O / BIIB / CARG / 02553E106 / BLKB.O / BJRI / ANGO.O / ACAD.O / BIDU.O / ALNY.O / 029899101 / CDNS.O / CBAY / CCOI / 089302103 / ATNI.O / ALLT.O / AIMC / 02043Q107 / 016255101 / 124805102 / 29076N206 / ATEC.O / CDXC / BLRX / ADUS.O / BCPC.O / CAC.O / CDXS.O / AOSL.O / AMRS.O / 02364V107 / ANGI.O / CCXI / BCOV.O / BLMN.O / 98138H101 / ANIP.O / AGIO / BRX.N / AERI.O / ARMK / CARA.O / AGRX.O / ARDX.O / ARGX.BR / ALDX.O / AFMD.O / APTO.O / ADMA.OQ / AUPH.O / ATEN.K / ABEO.OQ / APPF.O / BLD.N / BWXT.K / AGFS / BLBD.O / AVXL.O / ADAP.O / BPMC.O / AQMS.O / AXSM.O / BABA.K / PHARN.PA / BL.O / ACIU.O / AVDL.O / AKTS.O / APPN.O / ATNX.O / ACER.O / APLS.O / CAAP / BLNK.O / BSIG.N / BTAI.O / BILI.O / AVT.O / CBOE.K / ANIX / BNGO.O / ARVN / BYSI.O / 861780104 / BCYC / ABST.TO / BEST.K / ATXS.O / 45254C200 / 766883102 / 07831X107</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Apple Inc / Arcosa Inc / Albertsons Companies Inc / Accenture PLC / Alliance Data Systems Corp / AGCO Corp / American International Group Inc / Applied Industrial Technologies Inc / Acadia Realty Trust / Allogene Therapeutics Inc / Amgen Inc / American Homes 4 Rent / American Tower Corp / A O Smith Corp / Digital Turbine Inc / Ares Capital Corp / ASML Holding NV / AtriCure Inc / American Express Co / Autozone Inc / Best Buy Co Inc / Brainstorm Cell Therapeutics Inc / Bio Rad Laboratories Inc / BJ's Wholesale Club Holdings Inc / Black Hills Corp / Black Knight Inc / Booking Holdings Inc / Bassett Furniture Industries Inc / Beyond Meat Inc / Citigroup Inc / Cheesecake Factory Inc / Crown Castle International Corp / Deere & Co / Fiserv Inc / Outset Medical Inc / Allison Transmission Holdings Inc / Ascendis Pharma A/S / Amazon.com Inc / Activision Blizzard Inc / Astec Industries Inc / Cracker Barrel Old Country Store Inc / Adobe Inc / Alkermes Plc / Akamai Technologies Inc / Armada Hoffler Properties Inc / Ambarella Inc / Amkor Technology Inc / CDK Global Inc / Advanced Micro Devices Inc / Analog Devices Inc / Evoqua Water Technologies Corp / Camtek Ltd / Arena Pharmaceuticals Inc / Ceragon Networks Ltd / Ballard Power Systems Inc / Autodesk Inc / Alpine Immune Sciences Inc / Azenta Inc / Commerce Bancshares Inc / Align Technology Inc / Avid Technology Inc / BlackRock Inc / Alliance Resource Partners LP / Biomarin Pharmaceutical Inc / American Superconductor Corp / Acuity Brands Inc / Agenus Inc / Broadcom Inc / BioLife Solutions Inc / Aspen Technology Inc / Cal-Maine Foods Inc / Amarin Corporation PLC / Cross Country Healthcare Inc / Amtech Systems Inc / ABIOMED Inc / Alico Inc / American Woodmark Corp / Apogee Enterprises Inc / CalAmp Corp / Aaon Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / ANSYS Inc / BioDelivery Sciences International Inc / Biogen Inc / CarGurus Inc / American Eagle Outfitters Inc / Blackbaud Inc / BJ's Restaurants Inc / AngioDynamics Inc / ACADIA Pharmaceuticals Inc / Baidu Inc / Alnylam Pharmaceuticals Inc / American States Water Co / Cadence Design Systems Inc / Cymabay Therapeutics Inc / Cogent Communications Holdings Inc / Big Lots Inc / ATN International Inc / Allot Ltd / Altra Industrial Motion Corp / Alnylam Pharmaceuticals Inc / Align Technology Inc / CBIZ Inc / eMagin Corp / Alphatec Holdings Inc / Chromadex Corp / BioLine RX Ltd / Addus Homecare Corp / Balchem Corp / Camden National Corp / Codexis Inc / Alpha and Omega Semiconductor Ltd / Amyris Inc / America First Multifamily Investors LP / Angi Inc / ChemoCentryx Inc / Brightcove Inc / Bloomin' Brands Inc / Workday Inc / ANI Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Brixmor Property Group Inc / Aerie Pharmaceuticals Inc / Aramark / Cara Therapeutics Inc / Agile Therapeutics Inc / Ardelyx Inc / argenx SE / Aldeyra Therapeutics Inc / Affimed NV / Aptose Biosciences Inc / ADMA Biologics Inc / Aurinia Pharmaceuticals Inc / A10 Networks Inc / Abeona Therapeutics Inc / Appfolio Inc / TopBuild Corp / BWX Technologies Inc / AgroFresh Solutions Inc / Blue Bird Corp / Anavex Life Sciences Corp / Adaptimmune Therapeutics PLC / Blueprint Medicines Corp / Aqua Metals Inc / Axsome Therapeutics Inc / Alibaba Group Holding Ltd / Pharnext SA / Blackline Inc / AC Immune SA / Avadel Pharmaceuticals PLC / Akoustis Technologies Inc / Appian Corp / Athenex Inc / Acer Therapeutics Inc / Apellis Pharmaceuticals Inc / Corporacion America Airports SA / Blink Charging Co / Brightsphere Investment Group Inc / BioXcel Therapeutics Inc / Bilibili Inc / Avnet Inc / Cboe Global Markets Inc / Anixa Biosciences Inc / Bionano Genomics Inc / Arvinas Inc / Beyondspring Inc / StoneCastle Financial Corp / Bicycle Therapeutics PLC / Absolute Software Corp / BEST Inc / Astria Therapeutics Inc / Immune Pharmaceuticals Inc / RINO International Corp / Bellatora Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">MacroRisk Analytics/EconomicInvestor</td><td class="leftalignment">The Economy Matters for BIIB</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Eisai color on Aduhelm and lecanemab on FY2Q21 earnings call</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Wedbush Monthly Check-Up: November 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DNLI.O / NBIX.O / ARGX.O / UTHR.O / BMRN.O / SWTX.O / RARE.O / BIIB.O / PCRX.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / ARDX.O / SAGE.O / XENE.O / CDTX.O / GBT.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / FENC.O / APLS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / BHVN.K / ALNA.O / ETTX.O / HARP.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BDTX.O / BCEL.O / ZNTL.O / FUSN.O / KDNY / TSHA.O / RCUS.K / PRAX.O / EWTX.O / 23954D109 / 23284P103 / 28623U101 / 1BCR8K47US / 68217N105 / IMPL.O</td><td class="leftalignment">Denali Therapeutics Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / Biomarin Pharmaceutical Inc / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Biogen Inc / Pacira Biosciences Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Ardelyx Inc / SAGE Therapeutics Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Biohaven Pharmaceutical Holding Company Ltd / Allena Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Black Diamond Therapeutics Inc / Atreca Inc / Zentalis Pharmaceuticals Inc / Fusion Pharmaceuticals Inc / Chinook Therapeutics Inc / Taysha Gene Therapies Inc / Arcus Biosciences Inc / Praxis Precision Medicines Inc / Edgewise Therapeutics Inc / Day One Biopharmaceuticals Inc / Cyteir Therapeutics Inc / Elevation Oncology Inc / Aerovate Therapeutics Inc / Omega Therapeutics Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Mr. Andreas Argyrides / Dennis Pak</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Upgrading to Outperform, $200 PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALNY.O / AMGN / EXEL / INCY / NBIX / ASND.O / GILD.O / SGEN / UTHR.O / BMRN.O / REGN.O / VRTX.O / BIIB / MRNA.O / SRPT.O / 04280A100</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Amgen Inc / Exelixis Inc / Incyte Corp / Neurocrine Biosciences Inc / Ascendis Pharma A/S / Gilead Sciences Inc / Seagen Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / Sarepta Therapeutics Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Leland Gershell, MD, Ph.D. / Trevor Allred</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - 2Q results: 1H results announced during the market on 1 Nov; full-year guidance raised</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / BMY.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Bristol-Myers Squibb Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - 2Q決算：11月1日場中に1H決算発表：通期予想を上方修正</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / BMY.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Bristol-Myers Squibb Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Death Care and Clinical Labs Outperform; Medicare Prices as Benchmarks for Commercial Insurance Payments</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="odd"><td class="leftalignment">10/31/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Peer Group Analytics - Q3 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">10/30/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Information Content of Earnings Releases 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/30/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Biogen, Inc.: Credit Rating - Unbiased Research Based on Superior Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/30/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">BIIB: Forensic Stock Earnings & Valuation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q3 2021: Biogen reports 26.6% sequential fall in Quarterly Net Profit</td><td class="leftalignment">English</td><td class="rightalignment">85</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACA / CHD / RAD / SONY / WMT / GILD.O / ONEM.O / AKAM / SSNC.O / AVGO.O / CCRN.O / AMED.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / LHCG.O / MASI.O / ENSG.O / 483548103 / ADUS.O / EVH / CFMS.O / 100063846 / 720795103 / CBOE.K / HEXO / PNTG.O</td><td class="leftalignment">Arcosa Inc / Church & Dwight Co Inc / Rite Aid Corp / Sony Group Corp / Walmart Inc / Gilead Sciences Inc / 1Life Healthcare Inc / Akamai Technologies Inc / SS&C Technologies Holdings Inc / Broadcom Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Masimo Corp / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Conformis Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Cboe Global Markets Inc / Hexo Corp / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 10/22/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">AFL.N / AIR.N / BA.N / ECL.N / FLS.N / MO.N / VC.N / AVB.N / AMZN.O / GILD.O / CMCSA.O / CHKP.O / RBA.N / HBAN.O / SU.TO / CLX.N / YUM.N / MRO.N / EMR.N / HSY.N / RMD.N / SIRI.O / VLY.N / SBUX.O / CYH.N / AMP.N / CINF.O / DVA.N / RRC.N / RSG.N / BC.N / MAA.N / AJG.N / PTEN.O / FTT.TO / MCO.N / SSNC.O / CPE.N / CFR.N / MEOH.O / WCN.N / CHE.N / VSEC.OQ / ADS.N / SGEN.OQ / SIGI.O / WSBC.O / COLB.O / ACGL.O / BIIB.O / TIH.TO / NVT.N / TXRH.O / ALNY.O / ARWR.O / TDG.N / ISBC.O / MA.N / HOG.N / MERC.O / AUY.N / KTOS.OQ / ENSG.O / SWI.N / AAV.TO / EGO.N / NLSN.N / ACHC.O / VCRA.N / PTCT.O / 922475108 / ARES.N / CFG.N / SHOP.N / FTV.N / KNSL.OQ / INVH.N / GRPG.I / ORSTED.CO / NEXA.TO / KDP.N / OAS.OQ / TFII.N / CARR.N / APA.OQ</td><td class="leftalignment">Aflac Inc / AAR Corp / Boeing Co / Ecolab Inc / Flowserve Corp / Altria Group Inc / Visteon Corp / Avalonbay Communities Inc / Amazon.com Inc / Gilead Sciences Inc / Comcast Corp / Check Point Software Technologies Ltd / Ritchie Bros Auctioneers Inc / Huntington Bancshares Inc / Suncor Energy Inc / Clorox Co / Yum! Brands Inc / Marathon Oil Corp / Emerson Electric Co / Hershey Co / Resmed Inc / Sirius XM Holdings Inc / Valley National Bancorp / Starbucks Corp / Community Health Systems Inc / Ameriprise Financial Inc / Cincinnati Financial Corp / DaVita Inc / Range Resources Corp / Republic Services Inc / Brunswick Corp / Mid-America Apartment Communities Inc / Arthur J Gallagher & Co / Patterson-UTI Energy Inc / Finning International Inc / Moody's Corp / SS&C Technologies Holdings Inc / Callon Petroleum Co / Cullen/Frost Bankers Inc / Methanex Corp / Waste Connections Inc / Chemed Corp / VSE Corp / Alliance Data Systems Corp / Seagen Inc / Selective Insurance Group Inc / WesBanco Inc / Columbia Banking System Inc / Arch Capital Group Ltd / Biogen Inc / Toromont Industries Ltd / nVent Electric PLC / Texas Roadhouse Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / TransDigm Group Inc / Investors Bancorp Inc / Mastercard Inc / Harley-Davidson Inc / Mercer International Inc / Yamana Gold Inc / Kratos Defense and Security Solutions Inc / Ensign Group Inc / SolarWinds Corp / Advantage Energy Ltd / Eldorado Gold Corp / Nielsen Holdings PLC / Acadia Healthcare Company Inc / Vocera Communications Inc / PTC Therapeutics Inc / Veeva Systems Inc / Ares Management Corp / Citizens Financial Group Inc / Shopify Inc / Fortive Corp / Kinsale Capital Group Inc / Invitation Homes Inc / Greencoat Renewables PLC / Orsted A/S / Nexa Resources SA / Keurig Dr Pepper Inc / Oasis Petroleum Inc / TFI International Inc / Carrier Global Corp / APA Corp (US)</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Ireland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Scenario Analysis Suggests Limited Downside Into 4Q Tecfidera IP Events, Though Full Clarity Unlikely</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Back on Track - Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BXP-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BXP / MSFT.O / BIIB.O / MAR.O / PTC.O / GOOGL.O</td><td class="leftalignment">Boston Properties Inc / Microsoft Corp / Biogen Inc / Marriott International Inc / PTC Inc / Alphabet Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">TENX-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">TENX.O / JNJ / PTN / NBY / BIIB.O / CYTK.O / ANIP.O / XNCR.O</td><td class="leftalignment">Tenax Therapeutics Inc / Johnson & Johnson / Palatin Technologies Inc / NovaBay Pharmaceuticals Inc / Biogen Inc / Cytokinetics Inc / ANI Pharmaceuticals Inc / Xencor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SYN-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SYN / ABT / MRK / PFE / AZN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Synthetic Biologics Inc / Abbott Laboratories / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BCLI-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BCLI.O / GILD.O / AGEN.O / SGEN.O / BIIB.O / CYTK.O / IDRA.O / BIEI.PK</td><td class="leftalignment">Brainstorm Cell Therapeutics Inc / Gilead Sciences Inc / Agenus Inc / Seagen Inc / Biogen Inc / Cytokinetics Inc / Idera Pharmaceuticals Inc / Premier Biomedical Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SPPI-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SPPI.O / ABT / BMY / JNJ / NVS / PFE / GSK / CRIS.O / SGEN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Spectrum Pharmaceuticals Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Curis Inc / Seagen Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US09062X1037 / US02043Q1076 / CA68620P1018 / US87918A1051 / CA1380351009 / US22663K1079 / US88688T1007 / CA39342L1085 / CA58507M1077 / CA22587M1068 / CA89788C1041 / US12482W1018 / CA16106R1091 / CA23126M1023 / US1266541028 / CA05156X8843 / CA4283043079 / CA00489Y6001</td><td class="leftalignment">Biogen Inc / Alnylam Pharmaceuticals Inc / OrganiGram Holdings Inc / Teladoc Health Inc / Canopy Growth Corp / Crinetics Pharmaceuticals Inc / Tilray Brands Inc / Green Thumb Industries Inc / Medmen Enterprises Inc / Cresco Labs Inc / Trulieve Cannabis Corp / cbdMD Inc / Charlotte's Web Holdings Inc / Curaleaf Holdings Inc / CV Sciences Inc / Aurora Cannabis Inc / Hexo Corp / Acreage Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">2H 2022 is now a key timeframe around how the Alzheimer's competitive and treatment landscape shapes up: Lowering PT</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037 / LLY</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Biogen down 7% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">4502.T / AAPL / CHD / CHRW / EA / FDX / GLW / IEX / INTC.O / KMX / MSFT / NCR / PNR / QCOM.O / RARE / RNG / RXN / SONY / T / TTWO / UPS / V / AMZN.O / MSCI / ATVI.O / NVDA.O / HEAR / MPWR.O / AMD.O / ADI.O / VZ / NFLX / SMTC.O / TXN.O / LFUS.O / CRUS.O / MRVL.O / AVGO.O / XLNX.OQ / BCRX.O / SWKS.O / ANGN.O / PHAR.O / BIIB / GOOG.O / SPGI / 36467W109 / 514766104 / NXPI.O / ZNGA / ENPH.O / FDEV.L / 82655M107 / 02005N100 / IONS.O / NTLA / OVID.O / BILI.O / ORTX.O / ZM.O / GMDA / RRTS.PK / 84764T304 / TSHA.O / XM.O / PHVS.O / HUYA.K / ATXS.O</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Apple Inc / Church & Dwight Co Inc / CH Robinson Worldwide Inc / Electronic Arts Inc / FedEx Corp / Corning Inc / IDEX Corp / Intel Corp / Carmax Inc / Microsoft Corp / NCR Corp / Pentair PLC / Qualcomm Inc / Ultragenyx Pharmaceutical Inc / RingCentral Inc / Zurn Water Solutions Corp / Sony Group Corp / AT&T Inc / Take-Two Interactive Software Inc / United Parcel Service Inc / Visa Inc / Amazon.com Inc / MSCI Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Monolithic Power Systems Inc / Advanced Micro Devices Inc / Analog Devices Inc / Verizon Communications Inc / Netflix Inc / Semtech Corp / Texas Instruments Inc / Littelfuse Inc / Cirrus Logic Inc / Marvell Technology Inc / Broadcom Inc / Xilinx Inc / BioCryst Pharmaceuticals Inc / Skyworks Solutions Inc / Angion Biomedica Corp / Pharming Group NV / Biogen Inc / Alphabet Inc / S&P Global Inc / GameStop Corp / Landec Corp / NXP Semiconductors NV / Zynga Inc / Enphase Energy Inc / Frontier Developments PLC / Sify Technologies Ltd / Ally Financial Inc / Ionis Pharmaceuticals Inc / Intellia Therapeutics Inc / Ovid Therapeutics Inc / Bilibili Inc / Orchard Therapeutics PLC / Zoom Video Communications Inc / Gamida Cell Ltd / Roadrunner Transportation Systems Inc / Speed Commerce Inc / Taysha Gene Therapies Inc / Qualtrics International Inc / Pharvaris NV / HUYA Inc / Astria Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Ireland / Israel / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AIN / LLY=US / PFE=US / TWTR=US / AMD=US / RRC=US / EFX=US / BXP=US / TXN=US / GILD=US / GPK=US / APA=US / MPWR=US / TRU=US / V=US / DIOD=US / XLNX=US / BRO=US / BYD=US / MAR=US / SPOT=US / ADS=US / TTWO=US / ATVI=US / ESS=US / MANH=US / AKR=US / EQR=US / AIR=US / ARCC=US / ATRO=US / CSGP=US / DCO=US / ABG=US / HAS=US / HEI=US / HXL=US / MAIN=US / HZO=US / MRCY=US / MCHP=US / ORCC=US / OI=US / PII=US / ST=US / SGMO=US / STRA=US / TGI=US / VSEC=US / BXS=US / HIW=US / PYPL=US / CNC=US / BDN=US / EGP=US / SPR=US / UDR=US / CATY=US / ECPG=US / PRAA=US / JRVR=US / BIIB=US / AINV=US / DLR=US / XM=US / SCPL=US / TDG=US / HST=US / MA=US / AWI=US / CADE=US / CLR=US / PNNT=US / KTOS=US / NMTR=US / APEI=US / RCUS=US / AAN=US / 45665G303 / OAS=US / NXPI=US / RLJ=US / FBHS=US / ZNGA=US / EA=US / MTDR=US / ENPH=US / MEIP=US / SSTK=US / IBTX=US / CEQP=US / GOOGL=US / TSLX=US / 70806A106 / AFMD=US / ON=US / AJRD=US / GSBD=US / BWXT=US / SQ=US / TENB=US / FSK=US / LHX=US / HYFM=US / RBLX=US / SSBK=US / PKG=U / ROIV=US</td><td class="leftalignment">Albany International Corp / Eli Lilly and Co / Pfizer Inc / Twitter Inc / Advanced Micro Devices Inc / Range Resources Corp / Equifax Inc / Boston Properties Inc / Texas Instruments Inc / Gilead Sciences Inc / Graphic Packaging Holding Co / APA Corp (US) / Monolithic Power Systems Inc / TransUnion / Visa Inc / Diodes Inc / Xilinx Inc / Brown & Brown Inc / Boyd Gaming Corp / Marriott International Inc / Spotify Technology SA / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Activision Blizzard Inc / Essex Property Trust Inc / Manhattan Associates Inc / Acadia Realty Trust / Equity Residential / AAR Corp / Ares Capital Corp / Astronics Corp / CoStar Group Inc / Ducommun Inc / Asbury Automotive Group Inc / Hasbro Inc / HEICO Corp / Hexcel Corp / Main Street Capital Corp / MarineMax Inc / Mercury Systems Inc / Microchip Technology Inc / Owl Rock Capital Corp / O-I Glass Inc / Polaris Inc / Sensata Technologies Holding PLC / Sangamo Therapeutics Inc / Strategic Education Inc / Triumph Group Inc / VSE Corp / Cadence Bank / Highwoods Properties Inc / PayPal Holdings Inc / Centene Corp / Brandywine Realty Trust / Eastgroup Properties Inc / Spirit AeroSystems Holdings Inc / UDR Inc / Cathay General Bancorp / Encore Capital Group Inc / PRA Group Inc / James River Group Holdings Ltd / Biogen Inc / Apollo Investment Corp / Digital Realty Trust Inc / Qualtrics International Inc / Sciplay Corp / TransDigm Group Inc / Host Hotels & Resorts Inc / Mastercard Inc / Armstrong World Industries Inc / Cadence Bank / Continental Resources Inc / Pennantpark Investment Corp / Kratos Defense and Security Solutions Inc / 9 Meters Biopharma Inc / American Public Education Inc / Arcus Biosciences Inc / Aaron's Company Inc / Infinity Pharmaceuticals Inc / Oasis Petroleum Inc / NXP Semiconductors NV / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Zynga Inc / Electronic Arts Inc / Matador Resources Co / Enphase Energy Inc / MEI Pharma Inc / Shutterstock Inc / Independent Bank Group Inc / Crestwood Equity Partners LP / Alphabet Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Affimed NV / ON Semiconductor Corp / Aerojet Rocketdyne Holdings Inc / Goldman Sachs BDC Inc / BWX Technologies Inc / Block Inc / Tenable Holdings Inc / FS KKR Capital Corp / L3harris Technologies Inc / Hydrofarm Holdings Group Inc / Roblox Corp / Southern States Bancshares Inc / Packaging Corp of America / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">2516152 / 2026242 / 2270726 / 2317087 / 2455965 / 2689560 / 2680905 / 2048804 / 2138158 / 7103065 / 2857817 / B3D7K31 / B03PGL4 / B7TL820 / B65SQW4 / BFLR866 / BFH3N85 / BVVN4Q8 / BJXBP41 / BD8DJ71 / BJ2Z0H2 / BLGJ610 / BKTNTR9 / BYY88Y7</td><td class="leftalignment">Eli Lilly and Co / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Biogen Inc / PG&E Corp / PPL Corp / Pinnacle West Capital Corp / Sempra Energy / Novartis AG / Netflix Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Enphase Energy Inc / Twitter Inc / Veeva Systems Inc / Eversource Energy / Alcon AG / Snap Inc / Pinterest Inc / Warner Music Group Corp / ViacomCBS Inc / Alphabet Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Amyloid Plot Thickens with Duel on Horizon</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB / 02005N100</td><td class="leftalignment">Biogen Inc / Ally Financial Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended September 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Alzheimer’s Updates from Lilly Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Alzheimer's color from LLY 3Q21 call and additional BIIB commentary</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / LLY.N / LLY=US / SGMO=US / BIIB=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Eli Lilly and Co / Sangamo Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Broad Domestic Declines Continue With No Signals of Seasonally Driven Wave, FDA Authorizes Moderna and JNJ Boosters</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">LLY plans head-to-head comparing donanemab to aducanumab; could take time in our view</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US / LLY.N / LLY=US / BIIB.OQ</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2026242 / 2270726 / 2542049 / 2317087 / 2100920 / 2455965 / 2684703 / 2799351 / 2503529 / 7103065 / 2857817 / B125XQ6 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / BVVN4Q8 / BQPVQZ6 / BD8DJ71 / BJFSR88 / BJ2Z0H2 / BJJMGL2 / BFXC911 / BKTNTR9 / BYY88Y7 / BFYVZ75 / BP96C52 / BMDTR28</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / FirstEnergy Corp / Biogen Inc / Pfizer Inc / Sinclair Broadcast Group Inc / World Wrestling Entertainment Inc / Novartis AG / Netflix Inc / Portland General Electric Co / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / Horizon Therapeutics PLC / Snap Inc / Uniqure NV / Pinterest Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Alphabet Inc / Seelos Therapeutics Inc / Surrozen Inc / First Watch Restaurant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CRTX: GAIN Trial for Atuzaginstat (COR388) Misses Primary Endpoints, Lower TP</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CRTX.OQ / 4523.T / LLY.N / BIIB.OQ</td><td class="leftalignment">Cortexyme Inc / Eisai Co Ltd / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Post 3Q Model Update; Lowering PT to $340</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">A Triple Threat, at Least; Initiating at Buy and $2 PT</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BIIB / 23282W605 / 09075V102 / 03843E104 / Y95308105</td><td class="leftalignment">Biogen Inc / Cytokinetics Inc / BioNTech SE / Aquestive Therapeutics Inc / WAVE Life Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Germany / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Raghuram Selvaraju, Ph.D. / Boobalan Pachaiyappan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Hospitals and Managed Care Outperform; Impact of Healthcare Proposals in Budget Reconciliation Bill</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="even"><td class="leftalignment">10/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 570</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Oct 22 2021 11:01AM</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACA / ATRC / BAX / BOLT / CSII / DNLI / OM / RAD / SAGE / WMT / GILD.O / EW / ONEM.O / VSTM / ISRG / UTHR.O / VRTX.O / SSNC.O / CCRN.O / LIFE.O / AMED.O / ANGN.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / MNKD.O / DXCM.O / LHCG.O / MBRX.O / HUMA / PODD.O / 02043Q107 / TNDM.O / ENSG.O / 483548103 / 771195104 / ADUS.O / SWAV / EVH / 100063846 / IONS.O / ADAP.O / WINT.O / EDIT / VRAY / AVDL.O / KALA.O / MTEM.O / 720795103 / ORTX.O / PDSB.O / PNTG.O / ABST.TO / IMCR.O / VIRX.O / JSPR.O</td><td class="leftalignment">Arcosa Inc / AtriCure Inc / Baxter International Inc / Bolt Biotherapeutics Inc / Cardiovascular Systems Inc / Denali Therapeutics Inc / Outset Medical Inc / Rite Aid Corp / SAGE Therapeutics Inc / Walmart Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / Verastem Inc / Intuitive Surgical Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Angion Biomedica Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / MannKind Corp / Dexcom Inc / LHC Group Inc / Moleculin Biotech Inc / Humacyte Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Ensign Group Inc / Kaman Corp / Roche Holding AG / Addus Homecare Corp / Shockwave Medical Inc / Evolent Health Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / Windtree Therapeutics Inc / Editas Medicine Inc / ViewRay Inc / Avadel Pharmaceuticals PLC / Kala Pharmaceuticals Inc / Molecular Templates Inc / Pieris Pharmaceuticals Inc / Orchard Therapeutics PLC / PDS Biotechnology Corp / Pennant Group Inc / Absolute Software Corp / Immunocore Holdings PLC / Viracta Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Navigating Project Optimus Recap: Shift to Earlier Dose-Randomization; Intelligent Trial Design Could Lessen Timeline Impacts</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109 / 87978U108 / 471871103</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc / Tempest Therapeutics Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 10/15/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAPL / ACA / AMT / APP / APPS / ASML.AS / BOLT / CCI / CHTR / CME / CSL / DFS / DISH / DLR / DNLI / EA / GGG / GLW / INTC.O / IS / MCD / MSFT / NET / NKE / NOW / ORCL / QCOM.O / QUIK / RAD / RNG / RXT / SAP / SONY / SPOT / T / TTWO / U / UPS / WMT / AMZN.O / GILD.O / CMCSA.O / NICE / CSCO.O / ATVI.O / ONEM.O / NVDA.O / EGAN / RDWR / HEAR / KLR / SQ / AKAM / CSGS.O / SBAC.O / MPWR.O / VG / AMD.O / ADI.O / EQIX / VZ / NFLX / CEVA / CRNT.O / LUMN / SMTC.O / NUAN.O / TXN.O / DOX.O / CRUS.O / MRVL.O / VRNT / SSNC.O / HPE / AVGO.O / GTT / XLNX.OQ / CCRN.O / TEAM.O / SIVB.O / AMED.O / SWKS.O / ANGN.O / BIIB / 459200101 / 00846U101 / 868168105 / GOOG.O / 315616102 / LHCG.O / 36467W109 / CCOI / LLNW.OQ / ENSG.O / 483548103 / 514766104 / 771195104 / ADUS.O / TSLA.O / NXPI.O / ZNGA / SPLK.O / FB.O / WDAY / TMUS / FDEV.L / WIX.O / FIVN.O / 563771203 / 82655M107 / CXDO / EVH / 100063846 / EDIT / BABA.K / TTD.O / OKTA.O / ATUS.K / KALA.O / ROKU.O / MDB.O / EGHT.K / 83417M104 / 720795103 / BILI.O / AVYA.K / PDSB.O / ZM.O / FSLY / DDOG.O / CMBM / PNTG.O / DKNG / FUBO / 84764T304 / TEUM.PK / ONDS.OQ / PUBM.O / DOCN / HUYA.K / MNDY.O / PRCH.O / JSPR.O</td><td class="leftalignment">Apple Inc / Arcosa Inc / American Tower Corp / Applovin Corp / Digital Turbine Inc / ASML Holding NV / Bolt Biotherapeutics Inc / Crown Castle International Corp / Charter Communications Inc / CME Group Inc / Carlisle Companies Inc / Discover Financial Services / DISH Network Corp / Digital Realty Trust Inc / Denali Therapeutics Inc / Electronic Arts Inc / Graco Inc / Corning Inc / Intel Corp / Ironsource Ltd / McDonald's Corp / Microsoft Corp / Cloudflare Inc / Nike Inc / ServiceNow Inc / Oracle Corp / Qualcomm Inc / QuickLogic Corp / Rite Aid Corp / RingCentral Inc / Rackspace Technology Inc / SAP SE / Sony Group Corp / Spotify Technology SA / AT&T Inc / Take-Two Interactive Software Inc / Unity Software Inc / United Parcel Service Inc / Walmart Inc / Amazon.com Inc / Gilead Sciences Inc / Comcast Corp / Nice Ltd / Cisco Systems Inc / Activision Blizzard Inc / 1Life Healthcare Inc / NVIDIA Corp / eGain Corp / Radware Ltd / Turtle Beach Corp / Kaleyra Inc / Block Inc / Akamai Technologies Inc / CSG Systems International Inc / SBA Communications Corp / Monolithic Power Systems Inc / Vonage Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Equinix Inc / Verizon Communications Inc / Netflix Inc / CEVA Inc / Ceragon Networks Ltd / Lumen Technologies Inc / Semtech Corp / Nuance Communications Inc / Texas Instruments Inc / Amdocs Ltd / Cirrus Logic Inc / Marvell Technology Inc / Verint Systems Inc / SS&C Technologies Holdings Inc / Hewlett Packard Enterprise Co / Broadcom Inc / GTT Communications Inc / Xilinx Inc / Cross Country Healthcare Inc / Atlassian Corporation PLC / SVB Financial Group / Amedisys Inc / Skyworks Solutions Inc / Angion Biomedica Corp / Biogen Inc / International Business Machines Corp / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / F5 Inc / LHC Group Inc / GameStop Corp / Cogent Communications Holdings Inc / Limelight Networks Inc / Ensign Group Inc / Kaman Corp / Landec Corp / Roche Holding AG / Addus Homecare Corp / Tesla Inc / NXP Semiconductors NV / Zynga Inc / Splunk Inc / Meta Platforms Inc / Workday Inc / T-Mobile US Inc / Frontier Developments PLC / Wix.Com Ltd / Five9 Inc / Mannatech Inc / Sify Technologies Ltd / Crexendo Inc / Evolent Health Inc / Truist Financial Corp / Editas Medicine Inc / Alibaba Group Holding Ltd / Trade Desk Inc / Okta Inc / Altice USA Inc / Kala Pharmaceuticals Inc / Roku Inc / MongoDB Inc / 8x8 Inc / Solaredge Technologies Inc / Pieris Pharmaceuticals Inc / Bilibili Inc / Avaya Holdings Corp / PDS Biotechnology Corp / Zoom Video Communications Inc / Fastly Inc / Datadog Inc / Cambium Networks Corp / Pennant Group Inc / DraftKings Inc / Fubotv Inc / Speed Commerce Inc / Pareteum Corp / Ondas Holdings Inc / PubMatic Inc / DigitalOcean Holdings Inc / HUYA Inc / Monday.Com Ltd / Porch Group Inc / Jasper Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / United Kingdom / India / Israel / Japan / Korea, Republic of / Luxembourg / Netherlands / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US09062X1037 / 83304A106 / 816212104 / 46116X101 / 04965G109 / 47074L105 / 59101E103 / 67181A107 / 48213Y107 / 49926T104</td><td class="leftalignment">Biogen Inc / Snap Inc / Selecta Biosciences Inc / Intra-Cellular Therapies Inc / Atreca Inc / Jamf Holding Corp / Metacrine Inc / Oak Street Health Inc / Jushi Holdings Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / SFT / US09062X1037 / QURE</td><td class="leftalignment">Pfizer Inc / Shift Technologies Inc / Biogen Inc / Uniqure NV</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Model</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Back to the Hurt Locker: Biotech Outflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 3Q21 Earnings (ANTM, BIIB, DGX, JNJ, UNH) — What Mattered for Credit</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ / ANTM.N / DGX.N / JNJ.N / UNH.N / BIIB.O</td><td class="leftalignment">Biogen Inc / Anthem Inc / Quest Diagnostics Inc / Johnson & Johnson / UnitedHealth Group Inc / Biogen Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Biogen Idec</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW / OPERATING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Kiwoom Securities</td><td class="leftalignment">kiwoom 미 국 주 식 가 이드 weekly (2021.10.14~10.21)-10/21/2021</td><td class="leftalignment">Korean</td><td class="rightalignment">32</td><td class="leftalignment">DRI / JBHT / UAL / GNRC / BIIB / DPZ / ULTA</td><td class="leftalignment">Darden Restaurants Inc / J B Hunt Transport Services Inc / United Airlines Holdings Inc / Generac Holdings Inc / Biogen Inc / Domino's Pizza Inc / Ulta Beauty Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">RESEARCH SUMMARY / MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Won Ju Lee / Seong Jin Ji</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Key Aduhelm catalysts coming as zura flies under the radar; PT down from $423 to $390, maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sumant Kulkarni</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AAPL / CCI / DISH / DNLI / EA / GGG / INTC.O / KR / LSTR / MSFT / QCOM.O / SEIC / SONY / T / TTWO / AMZN.O / FIS / ATVI.O / HEAR / MPWR.O / ADI.O / VZ / NFLX / SMTC.O / TXN.O / CRUS.O / AVGO.O / XLNX.OQ / SWKS.O / BIIB / 36467W109 / 514766104 / TSLA.O / NXPI.O / ZNGA / SPLK.O / TMUS / FDEV.L / 82655M107 / BILI.O / 84764T304 / ASAN.K / XM.O / HUYA.K / BASE.O</td><td class="leftalignment">Apple Inc / Crown Castle International Corp / DISH Network Corp / Denali Therapeutics Inc / Electronic Arts Inc / Graco Inc / Intel Corp / Kroger Co / Landstar System Inc / Microsoft Corp / Qualcomm Inc / SEI Investments Co / Sony Group Corp / AT&T Inc / Take-Two Interactive Software Inc / Amazon.com Inc / Fidelity National Information Services Inc / Activision Blizzard Inc / Turtle Beach Corp / Monolithic Power Systems Inc / Analog Devices Inc / Verizon Communications Inc / Netflix Inc / Semtech Corp / Texas Instruments Inc / Cirrus Logic Inc / Broadcom Inc / Xilinx Inc / Skyworks Solutions Inc / Biogen Inc / GameStop Corp / Landec Corp / Tesla Inc / NXP Semiconductors NV / Zynga Inc / Splunk Inc / T-Mobile US Inc / Frontier Developments PLC / Sify Technologies Ltd / Bilibili Inc / Speed Commerce Inc / Asana Inc / Qualtrics International Inc / HUYA Inc / Couchbase Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">US0028241000 / US00971T1016 / US0126531013 / US1264081035 / US1491231015 / US16411R2085 / US2310211063 / US2944291051 / US3614481030 / US5128071082 / US92343V1044 / CA13645T1003 / AU000000LYC6 / US20030N1019 / US60855R1005 / US2533931026 / US09062X1037 / US00206R1023 / US42330P1075 / US4103451021 / US55616P1049 / US25470M1099 / US88160R1014 / US9100471096 / US40412C1018 / US6936561009 / US7512121010 / US03027X1000 / US8725901040 / US0367521038 / US22822V1017 / US12685J1051 / US70450Y1038 / US40434L1052 / US16119P1084 / US90138F1021 / US45782B1044 / GB00BDSFG982 / US91325V1089 / US05722G1004 / US02156K1034 / US4990491049 / CA53680Q2071 / US05351X1019 / US68373M1071 / US53814L1089 / US90184D1000 / US4833791035 / US92537N1081 / US5533681012 / US82933R1005 / US13781Y1038 / 50066V107 / US8852601090</td><td class="leftalignment">Abbott Laboratories / Akamai Technologies Inc / Albemarle Corp / CSX Corp / Caterpillar Inc / Cheniere Energy Inc / Cummins Inc / Equifax Inc / GATX Corp / Lam Research Corp / Verizon Communications Inc / Canadian Pacific Railway Ltd / Lynas Rare Earths Ltd / Comcast Corp / Molina Healthcare Inc / DICK'S Sporting Goods Inc / Biogen Inc / AT&T Inc / Helix Energy Solutions Group Inc / HanesBrands Inc / Macy's Inc / DISH Network Corp / Tesla Inc / United Airlines Holdings Inc / HCA Healthcare Inc / PVH Corp / Ralph Lauren Corp / American Tower Corp / T-Mobile US Inc / Anthem Inc / Crown Castle International Corp / Cable One Inc / PayPal Holdings Inc / HP Inc / Charter Communications Inc / Twilio Inc / Inseego Corp / TechnipFMC PLC / Uniti Group Inc / Baker Hughes Co / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Lithium Americas Corp / Avaya Holdings Corp / Opera Ltd / Livent Corp / Twist Bioscience Corp / Kaleyra Inc / Vertiv Holdings Co / Mp Materials Corp / Singular Genomics Systems Inc / Cano Health Inc / KORE Group Holdings Inc / Thorne Healthtech Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Cayman Islands / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / BMY=US / TWTR=US / EFX=US / AMZN=US / T=US / BLD=US / KMI=US / CMA=US / PEB=US / SLG=US / BC=US / H=US / TRU=US / CONE=US / V=US / MTN=US / VZ=US / CCI=US / THC=US / MAR=US / UMPQ=US / LSTR=US / TNL=US / HLT=US / WTFC=US / AIR=US / ELY=US / FUN=US / CHH=US / DRH=US / EEFT=US / HAS=US / IBP=US / HZO=US / MAS=US / MAT=US / PII=US / SNAP=US / THO=US / WW=US / WGO=US / GOLF=US / PYPL=US / FMBI=US / FB=US / FR=US / NLS=US / NFLX=US / STRO=US / BIIB=US / EXP=US / BECN=US / SHO=US / DENN=US / XM=US / GMS=US / HST=US / MA=US / SIX=US / AWI=US / OC=US / WH=US / SEAS=US / CWH=US / JACK=US / HGV=US / RLJ=US / VAC=US / MTDR=US / SPLK=US / RHP=US / TILE=US / FOXF=US / FATE=US / MBUU=US / GOOGL=US / AFMD=US / ANTM=US / BVH=US / MCFT=US / SQ=US / CRSP=US / PK=US / 50189K103 / PLYA=US / FNKO=US / LAZY=US / HWC=US / ALLO=US / TCRR=US / FERG=US / XAIR=US / ONEW=US / SQSP=US / HLLY=US / PKG=U</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Twitter Inc / Equifax Inc / Amazon.com Inc / AT&T Inc / TopBuild Corp / Kinder Morgan Inc / Comerica Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Brunswick Corp / Hyatt Hotels Corp / TransUnion / CyrusOne Inc / Visa Inc / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Tenet Healthcare Corp / Marriott International Inc / Umpqua Holdings Corp / Landstar System Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wintrust Financial Corp / AAR Corp / Callaway Golf Co / Cedar Fair LP / Choice Hotels International Inc / Diamondrock Hospitality Co / Euronet Worldwide Inc / Hasbro Inc / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mattel Inc / Polaris Inc / Snap Inc / Thor Industries Inc / WW International Inc / Winnebago Industries Inc / Acushnet Holdings Corp / PayPal Holdings Inc / First Midwest Bancorp Inc / Meta Platforms Inc / First Industrial Realty Trust Inc / Nautilus Inc / Netflix Inc / Sutro Biopharma Inc / Biogen Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Denny's Corp / Qualtrics International Inc / GMS Inc / Host Hotels & Resorts Inc / Mastercard Inc / Six Flags Entertainment Corp / Armstrong World Industries Inc / Owens Corning / Wyndham Hotels & Resorts Inc / SeaWorld Entertainment Inc / Camping World Holdings Inc / Jack in the Box Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Matador Resources Co / Splunk Inc / Ryman Hospitality Properties Inc / Interface Inc / Fox Factory Holding Corp / Fate Therapeutics Inc / Malibu Boats Inc / Alphabet Inc / Affimed NV / Anthem Inc / Bluegreen Vacations Holding Corp / Mastercraft Boat Holdings Inc / Block Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / LCI Industries / Playa Hotels & Resorts NV / Funko Inc / Lazydays Holdings Inc / Hancock Whitney Corp / Allogene Therapeutics Inc / TCR2 Therapeutics Inc / Ferguson PLC / Beyond Air Inc / OneWater Marine Inc / Squarespace Inc / Holley Inc / Packaging Corp of America</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2434209 / 2936921 / 2516152 / 2000019 / 2536763 / 2002305 / 2050832 / 2219224 / 2280220 / 2317087 / 2328915 / 2100920 / 2415204 / 2455965 / 2515030 / 2825933 / 4595739 / 7103065 / 2857817 / B03PGL4 / 2949758 / B7TL820 / B4MG4Z6 / BNGY4Q0 / BJFSR88 / BR4T3B3 / BJ2Z0H2 / BMQ5T49 / BFZ1K46 / BLGJ610 / BJVR9Y9 / BYY88Y7 / BDZ30Q0 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Home Depot Inc / Walmart Inc / Eli Lilly and Co / Amazon.com Inc / Lowe's Companies Inc / Abbott Laboratories / Ameren Corp / CMS Energy Corp / DTE Energy Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Biogen Inc / Lithia Motors Inc / South Jersey Industries Inc / Genmab A/S / Novartis AG / Netflix Inc / NorthWestern Corp / Nexstar Media Group Inc / Meta Platforms Inc / AMC Networks Inc / Nextera Energy Partners LP / Uniqure NV / HubSpot Inc / Pinterest Inc / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Warner Music Group Corp / iHeartMedia Inc / Alphabet Inc / Arvinas Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Insights on Aduhelm Coverage, BAN2401 and Tofersen; Reit Buy and $452 PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MUTUAL FUNDS / TRUSTS RESEARCH</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BK.N / CP.TO / KBH.N / NTRS.O / PHM.N / TOL.N / CMA.N / THC.N / CNR.TO / REE.MC / CSX.N / LEN.N / EAT.N / VZ.N / STT.N / DHI.N / KMI.N / EFX.N / MTB.N / SAM.N / FTT.TO / RLI.N / TRU.N / HCSG.O / BPOP.O / BOKF.O / WTFC.O / TCBI.O / BIIB.O / TIH.TO / FHN.N / IAG.N / ATL.MI / EONGn.DE / FICO.N / BKR.N / SPLK.OQ / TPH.N / TSLA.N / TMHC.N / WIX.O / ITCI.O / CFG.N / ANTM.N / PYPL.OQ / TWLO.N / PARR.N / PINS.N / FVRR.N / DFH.OQ / FA.OQ / BASE.OQ</td><td class="leftalignment">Bank of New York Mellon Corp / Canadian Pacific Railway Ltd / KB Home / Northern Trust Corp / Pultegroup Inc / Toll Brothers Inc / Comerica Inc / Tenet Healthcare Corp / Canadian National Railway Co / Red Electrica Corporacion SA / CSX Corp / Lennar Corp / Brinker International Inc / Verizon Communications Inc / State Street Corp / D R Horton Inc / Kinder Morgan Inc / Equifax Inc / M&T Bank Corp / Boston Beer Company Inc / Finning International Inc / Rli Corp / TransUnion / Healthcare Services Group Inc / Popular Inc / BOK Financial Corp / Wintrust Financial Corp / Texas Capital Bancshares Inc / Biogen Inc / Toromont Industries Ltd / First Horizon Corp / IAMGOLD Corp / Atlantia SpA / E.ON SE / Fair Isaac Corp / Baker Hughes Co / Splunk Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Taylor Morrison Home Corp / Wix.Com Ltd / Intra-Cellular Therapies Inc / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / Twilio Inc / Par Pacific Holdings Inc / Pinterest Inc / Fiverr International Ltd / Dream Finders Homes Inc / First Advantage Corp / Couchbase Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Spain / Israel / Italy / Puerto Rico / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Auerbach Grayson & Co., Inc.</td><td class="leftalignment">AUERBACH GRAYSON: CEEMEA & LATAM Daily Morning Note 10-21-21:  (11 Bit Studios, Agora, Alpha Bank, Alumetal, Asbis, EYDAP (Athens Water Supply & Sewage Company SA), Bank Albilad, Pekao, CD Projekt, CEZ, Coop Pank, Credit Bank of Iraq, DEVELIA SA)</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">1140.SE / 11B.WA / AGOP.WA / AMT.WA / ASBP.WA / BROI.ISX / CDR.WA / CEZP.PR / CPA1T.TL / EYDr.AT / PEO.WA / CZ0005112300 / BRPETRACNPR6 / GRS282183003 / GRS359353000 / PLKETY000011 / PLAGORA00067 / GRS434003000 / HU0000073507 / SI0031100090 / PLPEKAO00016 / IS0000013464 / PLBSK0000017 / SA000A0KFKK0 / SA000A0D9HK3 / BRPETRACNOR9 / AE000A0M6531 / CY1000031710 / PS4002112937 / HRERNTRA0000 / BNOR@IQ / IMC@PW / GNB@PW / SADAFCO@AB / SNN@RO / BROI@IQ / 11B@PW / AML@PW / FTE@PW / BIIB@IQ / KOFOL@CP / CDR@PW / MONET@CP / MTNN@NL / DVL@PW / PLW@PW / CPA1T@ET / ULG@PW</td><td class="leftalignment">Bank Albilad Sjsc / 11 Bit Studios SA / Agora SA / Alumetal SA / ASBISc Enterprises PLC / Credit Bank of Iraq SA / CD Projekt SA / CEZ as / Coop Pank AS / Athens Water Supply and Sewerage Company SA / Bank Polska Kasa Opieki SA / CEZ as / Petroleo Brasileiro SA Petrobras / Jumbo SA / Athens Water Supply and Sewerage Company SA / Grupa Kety SA / Agora SA / Public Power Corporation SA / Magyar Telekom Tavkozlesi Nyrt / Intereuropa dd / Bank Polska Kasa Opieki SA / Icelandair Group hf / ING Bank Slaski SA / Sahara International Petrochemical Company SJSC / Bank Albilad Sjsc / Petroleo Brasileiro SA Petrobras / Emirates NBD Bank PJSC / ASBISc Enterprises PLC / Palestine Development and Investment Ltd / Ericsson Nikola Tesla dd / North Bank for Finance and Investment PJSC / IMC SA / Getin Noble Bank SA / Saudia Dairy and Foodstuff Company SJSC / Societatea Nationala Nuclearelectrica SA / Credit Bank of Iraq SA / 11 Bit Studios SA / Alumetal SA / Fabryki Mebli Forte SA / Iraqi Islamic Bank for Investment & Development / Kofola CeskoSlovensko as / CD Projekt SA / Moneta Money Bank as / MTN Nigeria Communications PLC / Develia SA / Playway SA / Coop Pank AS / Ultimate Games SA</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United Arab Emirates / Brazil / Botswana / Czech Republic / Estonia / Greece / Croatia / Hungary / Iraq / Iceland / Jamaica / Lithuania / Latvia / Namibia / Nigeria / Peru / Poland / Romania / Russian Federation / Saudi Arabia / Slovenia / Trinidad and Tobago / Tunisia / Turkey / Tanzania, United Republic of / Ukraine / Zimbabwe / Serbia & Montenegro - Discontinue with effect from December 11, 2006 / Palestine</td><td class="leftalignment">Advertising / Agriculture / Air Transportation / Apparel & Textiles / Banks / Beverages & Tobacco / Broadcasting & Cable / Chemicals / Communications / Electrical / Financial Services / Food / Household Products / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Manufacturing / Metals & Minerals / Office Equipment / Real Estate / Retailing / Technology / Transportation / Utilities / Wholesale</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Auerbach Grayson</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : 3Q Snapshot - Adu Goes Missing in 3Q As Near-Term Outlook Remains Challenged</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB 3Q21 Postview:  MS remains resilient for another quarter, but Aduhelm uptake remains disappointing</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Base Business Resilient While Remaining Patient for Alzheimer’s Franchise</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q Take: Access and doctor perception are key headwinds for Aduhelm uptake in next 12 months</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">3Q Beats While Aduhelm Underwhelms</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB / DNLI</td><td class="leftalignment">Biogen Inc / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Solid Q3 Despite Aduhelm's Slow Launch; '21 Guidance Increased</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third-Quarter Earnings; Beat and Raise Does Not Change Aduhelm Launch Lag and 2022 NCD Importance</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">3Q21 update - no surprises; all about draft NCD coverage in January and BAN2401 in 2022</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB 3Q21: They said what?! Highlights from conf call…and our impressions</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Andrew Galler / Dr. Tim M. Anderson, MD</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Nice Q321 Beat/Raise, But Aduhelm Stuck on the Launchpad</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Aduhelm 2022 #s need major revision</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">New Quarter, Same Concerns - Stuck on Repeat</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">3Q21: Adu Slowness May Finally Reset Expectations; Base Business Hanging On Despite Headwinds</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : First Look at 3Q Results; Where's Adu?</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Thomas Deal</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Laidlaw & Company</td><td class="leftalignment">Laidlaw: IONS: 3Q21 Spinraza sales still in decline but potential positive outcomes from two Phase IV studies could be helpful</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">IONS=US / BIIB=US</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yale I. Jen, PHD</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">3Q 2021 - Defiant Aduhelm Stance Heading Into Medicare Coverage Decision in 1/22. Interesting Nf-L Comments from SOD1 ALS Readout.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103 / 92915B106 / 24823R105</td><td class="leftalignment">Biogen Inc / Voyager Therapeutics Inc / Denali Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Sung Jun Hong</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on October 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BKR.N / ABT.N / ASML.AS / BP.L / CCI.N / IBM.N / PPG.N / SLB.N / CMA.N / HAL.N / XOM.N / VZ.N / KMI.N / EFX.N / MTB.N / AAPL.OQ / GGG.N / MSFT.OQ / NTRS.OQ / SBUX.OQ / DFS.N / BANR.OQ / GL.N / AMZN.OQ / BIIB.OQ / 0700.HK / MKTX.OQ / LVS.N / NDAQ.OQ / RDSa.L / KALU.OQ / 9999.HK / NEE.N / TSLA.OQ / CFG.N / ANTM.N / CSX.OQ / LYFT.OQ / PINS.N / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / 9618.HK / CVLG.OQ / ABNB.OQ</td><td class="leftalignment">Baker Hughes Co / Abbott Laboratories / ASML Holding NV / BP PLC / Crown Castle International Corp / International Business Machines Corp / PPG Industries Inc / Schlumberger NV / Comerica Inc / Halliburton Co / Exxon Mobil Corp / Verizon Communications Inc / Kinder Morgan Inc / Equifax Inc / M&T Bank Corp / Apple Inc / Graco Inc / Microsoft Corp / Northern Trust Corp / Starbucks Corp / Discover Financial Services / Banner Corp / Globe Life Inc / Amazon.com Inc / Biogen Inc / Tencent Holdings Ltd / Marketaxess Holdings Inc / Las Vegas Sands Corp / Nasdaq Inc / Royal Dutch Shell PLC / Kaiser Aluminum Corp / NetEase Inc / Nextera Energy Inc / Tesla Inc / Citizens Financial Group Inc / Anthem Inc / CSX Corp / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / JD.Com Inc / Covenant Logistics Group Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Netherlands / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Muted Beat and Raise Quarter</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - 3Q21; In a Surprise, Almost No Revs From Aduhelm; Topline Beat Driven By Continued Strength of MS Franchise</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Rev. And EPS Beats, '21 Guidance Increased, But Aduhelm As Low As Previewed</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">First Take: 3Q21 topline beat & FY2021 guidance raised; focus remains on Aduhelm coverage</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q pre-Call take: beat on top-line and bottom-line, but large miss on Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Overall Beat/Raise is Nice, But Aduhelm Launch Even Worse Than We Feared</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Brief of Biogen Inc conference call, Oct. 20, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Oct. 20, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Biogen Third-Quarter Quick Take: Aduhelm Launch Needs a Lifeline From CMS</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103 / 462222100 / IONS.OQ</td><td class="leftalignment">Biogen Inc / Ionis Pharmaceuticals Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2Q21 First Take: Adu Launch Still Getting Off The Ground; Guidance Upped On Solid MS Franchise Sales</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">3Q21 First Take: Beat/Raise But Aduhelm's Absence Unlikely to Quell Debate</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">SE0000108656 / US09061G1013 / US00971T1016 / US0311621009 / US1924461023 / US2786421030 / US30161Q1040 / US3755581036 / US4062161017 / US4282911084 / US4433201062 / US45253H1014 / US45337C1027 / US4567881085 / US4781601046 / US64125C1099 / US75886F1075 / US91307C1027 / US92343V1044 / US92532F1003 / CA1363751027 / US64110L1061 / US2948216088 / US20030N1019 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US00206R1023 / US3020811044 / US29089Q1058 / US92932M1018 / NL0000687663 / US87874R1005 / US53261M1045 / US03152W1099 / BMG3922B1072 / US90384S3031 / US25470M1099 / IE00B4BNMY34 / US46333X1081 / US9100471096 / US29414B1044 / NL0010273215 / US8725901040 / US09609G1004 / US8036071004 / US4576693075 / US6951271005 / US00912X3026 / US74587V1070 / US45845P1084 / US23283R1005 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / US0994061002 / US2681582019 / US31572Q8087 / CA89620X5064 / US29444U7000 / US09627Y1091 / US12685J1051 / US37890U1088 / US4622221004 / US07725L1026 / US16119P1084 / US36165L1089 / US2067871036 / US23355L1061 / IL0011407140 / US02156K1034 / US87105L1044 / US76243J1051 / US5011471027 / US77313F1066 / US89854H1023 / US09354A1007 / US05455M1009 / US29260V1052 / US0197701065 / US61775R1059 / US85205L1070 / US39813G1094 / US4432011082 / US65487U1088 / US07373B1098 / US20451W1018 / US69353Y1038 / US81181C1045 / US50107A1043 / KYG3902L1095 / US74767V1098 / US7761531083 / US15961R1059 / US25401T1088 / US30052F1003 / US88546E1055</td><td class="leftalignment">Telefonaktiebolaget LM Ericsson / Biomarin Pharmaceutical Inc / Akamai Technologies Inc / Amgen Inc / Cognizant Technology Solutions Corp / eBay Inc / Exelixis Inc / Gilead Sciences Inc / Halliburton Co / Hexcel Corp / Hub Group Inc / ImmunoGen Inc / Incyte Corp / Infosys Ltd / Johnson & Johnson / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Verizon Communications Inc / Vertex Pharmaceuticals Inc / Canadian National Railway Co / Netflix Inc / Telefonaktiebolaget LM Ericsson / Comcast Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / AT&T Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / AerCap Holdings NV / TechTarget Inc / Limelight Networks Inc / Amicus Therapeutics Inc / Genpact Ltd / Ulta Beauty Inc / DISH Network Corp / Accenture PLC / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / Epam Systems Inc / ASML Holding NV / T-Mobile US Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Air Lease Corp / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / CyrusOne Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Dynavax Technologies Corp / FibroGen Inc / Pfizer Inc / Equinix Inc / Blueprint Medicines Corp / Cable One Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Charter Communications Inc / GDS Holdings Ltd / Conduent Inc / DXC Technology Co / Urogen Pharma Ltd / Altice USA Inc / Switch Inc / Rhythm Pharmaceuticals Inc / Krystal Biotech Inc / Rocket Pharmaceuticals Inc / TTEC Holdings Inc / Blink Charging Co / AVROBIO Inc / Endava PLC / Allogene Therapeutics Inc / Morphic Holding Inc / SpringWorks Therapeutics Inc / Grid Dynamics Holdings Inc / Howmet Aerospace Inc / Nkarta Inc / Beam Global / Compass Pathways PLC / PMV Pharmaceuticals Inc / Seagen Inc / Kronos Bio Inc / GDS Holdings Ltd / Quantumscape Corp / Romeo Power Inc / ChargePoint Holdings Inc / DigitalBridge Group Inc / EVgo Inc / Thoughtworks Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United Kingdom / India / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BIIB / 478160104 / GOOG.O / 36467W109 / 02043Q107 / ULTA / 01877R108 / 771195104 / ZNGA / CG.O / MPLX.K / FDEV.L / 82655M107 / ADAP.O / WINT.O / BABA.K / HLNE.O / BILI.O / ORTX.O / GRWG / ZI.OQ / ASO.OQ / GCMG.O / IMCR.O / VIRX.O / HUYA.K / CWAN.N / APP / DOV / EA / FISV / MSFT / RXT / SAGE / SONY / SPOT / T / TTWO / V / WMT / AMZN.O / ATVI.O / ONEM.O / NVDA.O / VSTM / HEAR / ISRG / AMD.O / NFLX / SYF / AVGO.O</td><td class="leftalignment">Biogen Inc / Johnson & Johnson / Alphabet Inc / GameStop Corp / Alnylam Pharmaceuticals Inc / Ulta Beauty Inc / Alliance Resource Partners LP / Roche Holding AG / Zynga Inc / Carlyle Group Inc / MPLX LP / Frontier Developments PLC / Sify Technologies Ltd / Adaptimmune Therapeutics PLC / Windtree Therapeutics Inc / Alibaba Group Holding Ltd / Hamilton Lane Inc / Bilibili Inc / Orchard Therapeutics PLC / GrowGeneration Corp / ZoomInfo Technologies Inc / Academy Sports and Outdoors Inc / GCM Grosvenor Inc / Immunocore Holdings PLC / Viracta Therapeutics Inc / HUYA Inc / Clearwater Analytics Holdings Inc / Applovin Corp / Dover Corp / Electronic Arts Inc / Fiserv Inc / Microsoft Corp / Rackspace Technology Inc / SAGE Therapeutics Inc / Sony Group Corp / Spotify Technology SA / AT&T Inc / Take-Two Interactive Software Inc / Visa Inc / Walmart Inc / Amazon.com Inc / Activision Blizzard Inc / 1Life Healthcare Inc / NVIDIA Corp / Verastem Inc / Turtle Beach Corp / Intuitive Surgical Inc / Advanced Micro Devices Inc / Netflix Inc / Synchrony Financial / Broadcom Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / India / Japan / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Earnings Preview: Wishing For A Biotech Rally To End 2021</td><td class="leftalignment">English</td><td class="rightalignment">285</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Biogen Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: October 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / DD.N / DOW.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / PFE.N / PPG.N / SLB.N / T.N / WMB.N / SPG.N / PG.N / WY.N / NUE.N / ROK.N / UHS.N / ETN.N / DHR.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / BRO.N / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / AMZN.OQ / CHTR.OQ / MTCH.OQ / ALGN.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / VRSK.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / MPC.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / GOOGL.OQ / ANET.N / ANTM.N / TMUS.OQ / CSX.OQ / IQV.N / FB.PS / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Rockwell Automation Inc / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / Charter Communications Inc / Match Group Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Marathon Petroleum Corp / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Alphabet Inc / Arista Networks Inc / Anthem Inc / T-Mobile US Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for BIIB</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Delay in Filing but Now with a Clear Path Forward</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">78667J10 / 09062X10</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US64125C1099 / US09062X1037 / US0042251084 / US40637H1095 / US46116X1019 / CA68620P1018 / CA1380351009 / US88688T1007 / CA05156X8843 / CA4283043079</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / Intra-Cellular Therapies Inc / OrganiGram Holdings Inc / Canopy Growth Corp / Tilray Brands Inc / Aurora Cannabis Inc / Hexo Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">NDA Filing Update Outlines Path to Approval</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SAGE / BIIB</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Zuranolone Rolling NDA To Start Early 2022 With CORAL Topline Early 2022</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SAGE=US / BIIB=US</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AAPL / BBY / DCI / DNLI / EA / EVER / MSFT / NKE / NOW / SAGE / SONY / TTWO / U / ATVI.O / HEAR / NFLX / UTHR.O / HPE / DKS / AVGO.O / HIBB.O / SWKS.O / BIIB / OPEN.O / 344849104 / MNKD.O / 36467W109 / Z.O / SPSC.O / ZNGA / WDAY / FDEV.L / 82655M107 / QRVO.O / UAA / AKTS.O / CVNA / BILI.O / LOVE / ASO.OQ / HUYA.K / CWAN.N</td><td class="leftalignment">Apple Inc / Best Buy Co Inc / Donaldson Company Inc / Denali Therapeutics Inc / Electronic Arts Inc / EverQuote Inc / Microsoft Corp / Nike Inc / ServiceNow Inc / SAGE Therapeutics Inc / Sony Group Corp / Take-Two Interactive Software Inc / Unity Software Inc / Activision Blizzard Inc / Turtle Beach Corp / Netflix Inc / United Therapeutics Corp / Hewlett Packard Enterprise Co / DICK'S Sporting Goods Inc / Broadcom Inc / Hibbett Inc / Skyworks Solutions Inc / Biogen Inc / Opendoor Technologies Inc / Foot Locker Inc / MannKind Corp / GameStop Corp / Zillow Group Inc / SPS Commerce Inc / Zynga Inc / Workday Inc / Frontier Developments PLC / Sify Technologies Ltd / Qorvo Inc / Under Armour Inc / Akoustis Technologies Inc / Carvana Co / Bilibili Inc / Lovesac Co / Academy Sports and Outdoors Inc / HUYA Inc / Clearwater Analytics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, October 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US83175M2052 / US8636671013 / US98956P1021 / US09062X1037 / US6707041058 / ATEC.OQ / 008073108 / US3795772082 / 05463X106 / US20717E1010 / 632307104 / 825704109 / 54738L109 / THTX.N / 81255T108 / 72814P109 / 09075A108</td><td class="leftalignment">Smith & Nephew PLC / Stryker Corp / Zimmer Biomet Holdings Inc / Biogen Inc / NuVasive Inc / Alphatec Holdings Inc / AeroVironment Inc / Globus Medical Inc / AxoGen Inc / Conformis Inc / Natera Inc / SI-BONE Inc / Lovesac Co / Theratechnologies Inc / SeaSpine Holdings Corp / Plby Group Inc / Bioventus Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: October 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BK.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DD.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / OMC.N / PM.N / PPG.N / SLB.N / T.N / TRV.N / WMB.N / SPG.N / PG.N / WY.N / NUE.N / UHS.N / HAL.N / DHR.N / DOV.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / ARE.N / CVX.N / MCO.N / RF.N / INTC.OQ / AAPL.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / BRO.N / TROW.OQ / SIVB.OQ / SBUX.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / AMZN.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / GOOGL.OQ / ANET.N / SYF.N / ANTM.N / KHC.OQ / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Danaher Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Chevron Corp / Moody's Corp / Regions Financial Corp / Intel Corp / Apple Inc / Fiserv Inc / Hologic Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Anthem Inc / Kraft Heinz Co / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">BIIB 3Q21 preview: It's still all about managing Aduhelm, for now; maintain BUY, $423PT</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sumant Kulkarni</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Considerations Ahead of 3Q Results</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB / DNLI / SAGE</td><td class="leftalignment">Biogen Inc / Denali Therapeutics Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Surprising pivotal SOD1 setback; removing from model</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">3Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">US09062X1037 / US0311621009 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Biogen Inc / Amgen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Laidlaw & Company</td><td class="leftalignment">Laidlaw: IONS: Tofersen in SOD1-ALS VALOR trial failed to meet primary endpoint but substantial knowledge learned – reduce PT to $68</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">IONS=US / BIIB=US</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / PRICE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yale I. Jen, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AIN / CAG=US / KO=US / OXY=US / TWTR=US / IP=US / CL=US / PG=US / MDT=US / PLD=US / GPK=US / APA=US / CRM=US / ENR=US / SWN=US / ATVI=US / NWL=US / FLO=US / STZ=US / DV=US / AIR=US / ATRO=US / B=US / CTRA=US / CENT=US / CHD=US / COLL=US / CW=US / DCO=US / EPC=US / EQT=US / HAIN=US / HEI=US / HXL=US / TREE=US / MRCY=US / ROLL=US / SGMO=US / SMG=US / SHOP=US / SNAP=US / TGI=US / VSEC=US / POST=US / FB=US / SPR=US / MGPI=US / BDSI=US / MNST=US / NOMD=US / BIIB=US / MOG.A=US / APP=US / FRPT=US / THS=US / ESMT=US / TDG=US / ELF=US / CENTA=US / WRK=US / KTOS=US / AAN=US / UTZ=US / OLO=US / WWD=US / PCRX=US / ZNGA=US / EA=US / GOOGL=US / COUP=US / LOCO=US / HUBS=US / AJRD=US / BWXT=US / TTD=US / PETQ=US / CARG=US / MAXR=US / KDP=US / AXNX=US / LHX=US / BRBR=US / REYN=US / SPCE=US / NCNO=US / HYFM=US / 67421J108 / DNUT=US / EWCZ=US / PKG=U / 00152K101</td><td class="leftalignment">Albany International Corp / Conagra Brands Inc / Coca-Cola Co / Occidental Petroleum Corp / Twitter Inc / International Paper Co / Colgate-Palmolive Co / Procter & Gamble Co / Medtronic PLC / Prologis Inc / Graphic Packaging Holding Co / APA Corp (US) / Salesforce.Com Inc / Energizer Holdings Inc / Southwestern Energy Co / Activision Blizzard Inc / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / DoubleVerify Holdings Inc / AAR Corp / Astronics Corp / Barnes Group Inc / Coterra Energy Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Curtiss-Wright Corp / Ducommun Inc / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / HEICO Corp / Hexcel Corp / Lendingtree Inc / Mercury Systems Inc / RBC Bearings Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Shopify Inc / Snap Inc / Triumph Group Inc / VSE Corp / Post Holdings Inc / Meta Platforms Inc / Spirit AeroSystems Holdings Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Nomad Foods Ltd / Biogen Inc / Moog Inc / Applovin Corp / Freshpet Inc / TreeHouse Foods Inc / EngageSmart Inc / TransDigm Group Inc / elf Beauty Inc / Central Garden & Pet Co / Westrock Co / Kratos Defense and Security Solutions Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / Woodward Inc / Pacira Biosciences Inc / Zynga Inc / Electronic Arts Inc / Alphabet Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / HubSpot Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Trade Desk Inc / PetIQ Inc / CarGurus Inc / Maxar Technologies Inc / Keurig Dr Pepper Inc / Axonics Inc / L3harris Technologies Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / nCino Inc / Hydrofarm Holdings Group Inc / Oatly Group AB / Krispy Kreme Inc / European Wax Center Inc / Packaging Corp of America / AKA Brands Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Luxembourg / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">3Q21 Preview; Still Cautious Overall</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">00422510 / H0026310 / 64125C10 / 09062X10 / G0176710 / G5087110 / 05337M104 / 38942Q10 / 98420N10 / 30052C10 / 05464T10 / 01438T10 / G1119610 / 40422M10 / 98978L20 / 78667J10 / 46116X10 / 80405P10 / 75955J40 / 03836N10 / 56854Q20 / 36870G10 / 28658R10</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / AC Immune SA / Neurocrine Biosciences Inc / Biogen Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Avadel Pharmaceuticals PLC / Graybug Vision Inc / Xenon Pharmaceuticals Inc / Evolus Inc / Axsome Therapeutics Inc / Aldeyra Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / SAGE Therapeutics Inc / Intra-Cellular Therapies Inc / Satsuma Pharmaceuticals Inc / Relmada Therapeutics Inc / Aptinyx Inc / Marinus Pharmaceuticals Inc / Gemini Therapeutics Inc / Eliem Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Marc Goodman / Madhu Yennawar, Ph.D. / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AXP / 2000019 / 2050832 / 2219224 / 2190750 / 2270726 / 2542049 / 2317087 / 2342034 / 2455965 / 2613990 / 2632003 / 2680905 / 2684703 / 2048804 / 2799351 / 2825933 / 2857817 / B125XQ6 / B02R1L6 / B28TS42 / 2598246 / B0796X4 / B7TL820 / B7VD3F2 / BDZCRX3 / BFLR866 / BD8DJ71 / BJ5FZ74 / BR4T3B3 / BFZ1K46 / BMYML02 / BJFSR99 / BFXC911 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BF3W461 / BKS3RS7 / BQXZP64</td><td class="leftalignment">American Express Co / Amazon.com Inc / Ameren Corp / CMS Energy Corp / Chesapeake Utilities Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Fiserv Inc / Biogen Inc / Illumina Inc / New York Times Co / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Netflix Inc / Portland General Electric Co / ALLETE Inc / Ulta Beauty Inc / Neogenomics Inc / Dexcom Inc / Meta Platforms Inc / Duke Energy Corp / RingCentral Inc / Twitter Inc / Snap Inc / Adaptive Biotechnologies Corp / HubSpot Inc / Spotify Technology SA / DraftKings Inc / Revance Therapeutics Inc / Guardant Health Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Tandem Diabetes Care Inc / 10X Genomics Inc / Wayfair Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Master of the Mental Health Care Universe Poised to Shine; Initiating With a Buy and $40 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">140</td><td class="leftalignment">ATAI.OQ / BIIB / 64125C109 / 20451W101 / MNMD.OQ / FTRP.OQ</td><td class="leftalignment">ATAI Life Sciences NV / Biogen Inc / Neurocrine Biosciences Inc / Compass Pathways PLC / Mind Medicine (MindMed) Inc / Field Trip Health Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / BCE.TO / CB.N / CMS.N / ECL.N / EIX.N / EL.N / IBE.MC / KO.N / MAS.N / PNC.N / PNW.N / RIO.L / SO.N / T.N / T.TO / TOTF.PA / CMCSA.O / SJRb.TO / RCIb.TO / AMGN.O / AAL.L / DUK.N / QBRb.TO / UNH.N / CCA.TO / K.N / DISH.O / GS.N / CLX.N / VMC.N / PCG.N / EPC.N / ADCT.N / WHR.N / CONE.O / NG.L / VZ.N / EXEL.O / AKAM.O / XEL.N / STZ.N / LNC.N / V.N / NWN.N / UDR.N / DB1Gn.DE / AJG.N / BMRN.O / REGN.O / ENR.N / PRU.N / MHK.N / CEY.L / NCR.N / GFI.N / CNP.N / BLU.N / CPK.N / SKY.N / SGEN.OQ / GPN.N / LIFE.O / EQIX.O / BIIB.O / TFC.N / EDV.TO / BECN.O / DLR.N / 416515104 / GMS.N / BLDR.O / FIS.N / MA.N / OC.N / AON.N / ATL.MI / BGS.N / PPL.TO / HOCM.L / FRES.L / EDPR.LS / SPB.N / NEE.N / NXT.AX / PCRX.O / CTT.N / GLEN.L / TRL.TO / FBHS.N / POLYP.L / FFHu.TO / TMUS.N / UKWG.L / PRTA.O / BEP.N / DOOR.N / IBP.N / HUBS.N / NEWR.N / WBA.N / SUM.N / EVA.N / PYPL.OQ / SQ.N / SITE.N / IONS.O / JELD.N / ATNX.O / GMAB.O / AZEK.N / WTRG.N / FOUR.N / NRIX.OQ / DCT.O / LSPD.N / NAPA.N / OTLY.O / RYAN.N / CNM.N / TWKS.OQ / THRN.OQ</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / BCE Inc / Chubb Ltd / CMS Energy Corp / Ecolab Inc / Edison International / Estee Lauder Companies Inc / Iberdrola SA / Coca-Cola Co / Masco Corp / PNC Financial Services Group Inc / Pinnacle West Capital Corp / Rio Tinto PLC / Southern Co / AT&T Inc / Telus Corp / TotalEnergies SE / Comcast Corp / Shaw Communications Inc / Rogers Communications Inc / Amgen Inc / Anglo American PLC / Duke Energy Corp / Quebecor Inc / UnitedHealth Group Inc / Cogeco Communications Inc / Kellogg Co / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / Vulcan Materials Co / PG&E Corp / Edgewell Personal Care Co / ADC Therapeutics SA / Whirlpool Corp / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Akamai Technologies Inc / Xcel Energy Inc / Constellation Brands Inc / Lincoln National Corp / Visa Inc / Northwest Natural Holding Co / UDR Inc / Deutsche Boerse AG / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / Mohawk Industries Inc / Centamin PLC / NCR Corp / Gold Fields Ltd / CenterPoint Energy Inc / BELLUS Health Inc / Chesapeake Utilities Corp / Skyline Champion Corp / Seagen Inc / Global Payments Inc / aTyr Pharma Inc / Equinix Inc / Biogen Inc / Truist Financial Corp / Endeavour Mining PLC / Beacon Roofing Supply Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / GMS Inc / Builders FirstSource Inc / Fidelity National Information Services Inc / Mastercard Inc / Owens Corning / Aon PLC / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Hochschild Mining PLC / Fresnillo PLC / EDP Renovaveis SA / Spectrum Brands Holdings Inc / Nextera Energy Inc / NEXTDC Ltd / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Glencore PLC / Trilogy International Partners Inc / Fortune Brands Home & Security Inc / Polymetal International PLC / Fairfax Financial Holdings Ltd / T-Mobile US Inc / Greencoat UK Wind PLC / Prothena Corporation PLC / Brookfield Renewable Partners LP / Masonite International Corp / Installed Building Products Inc / HubSpot Inc / New Relic Inc / Walgreens Boots Alliance Inc / Summit Materials Inc / Enviva Inc / PayPal Holdings Inc / Block Inc / SiteOne Landscape Supply Inc / Ionis Pharmaceuticals Inc / JELD-WEN Holding Inc / Athenex Inc / Genmab A/S / Azek Company Inc / Essential Utilities Inc / Shift4 Payments Inc / Nurix Therapeutics Inc / Duck Creek Technologies Inc / Lightspeed Commerce Inc / Duckhorn Portfolio Inc / Oatly Group AB / Ryan Specialty Group Holdings Inc / Core & Main Inc / Thoughtworks Holding Inc / Thorne Healthtech Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / China / Germany / Denmark / Spain / United Kingdom / Ireland / Italy / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Negative VALOR Supports on Target SOD1 Activity; No Change to Outlook</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IONS.O / BIIB</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter / Zhiqi He, Ph.D., CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">VALOR Not the Answer ALS Patients Have Been Hoping For; Filing Potential Questionable With Current Data</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103 / 462222100</td><td class="leftalignment">Biogen Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: October 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAX.N / BK.N / BMY.N / BR.N / BSX.N / CB.N / CCI.N / CE.N / CL.N / CNC.N / COF.N / DD.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / NEM.N / NSC.N / OMC.N / PM.N / PNC.N / PPG.N / SLB.N / T.N / TEL.PS / TRV.N / PG.N / DGX.N / WY.N / NUE.N / UHS.N / HAL.N / ADML.L / DHR.N / GD.N / DOV.N / ROP.N / CAT.N / UNP.N / GS.N / RCL.N / MCD.N / YUM.N / VLO.N / SYK.N / GLW.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / GWW.N / VZ.N / STT.N / HCA.N / VFC.N / APH.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / CHD.N / TWTR.N / MTB.N / GPC.N / CVX.N / MCO.N / RF.N / INTC.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / BRO.N / TROW.OQ / SIVB.OQ / ZION.OQ / SBUX.OQ / ORLY.OQ / GILD.OQ / DFS.N / TSCO.OQ / POOL.OQ / AMZN.OQ / EBAY.OQ / CHTR.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / DLR.N / MKTX.OQ / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / NVR.N / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / LYB.N / MSI.N / KEY.TO / BKR.N / PSX.N / NOW.N / ABBV.N / GOOGL.OQ / SYF.N / CFG.N / ANTM.N / KHC.OQ / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Baxter International Inc / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Broadridge Financial Solutions Inc / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Celanese Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PNC Financial Services Group Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / PLDT Inc / Travelers Companies Inc / Procter & Gamble Co / Quest Diagnostics Inc / Weyerhaeuser Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Danaher Corp / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Goldman Sachs Group Inc / Royal Caribbean Cruises Ltd / McDonald's Corp / Yum! Brands Inc / Valero Energy Corp / Stryker Corp / Corning Inc / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / W W Grainger Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / VF Corp / Amphenol Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / Twitter Inc / M&T Bank Corp / Genuine Parts Co / Chevron Corp / Moody's Corp / Regions Financial Corp / Intel Corp / Apple Inc / Cerner Corp / Fiserv Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / O'Reilly Automotive Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Pool Corp / Amazon.com Inc / eBay Inc / Charter Communications Inc / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / NVR Inc / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Baker Hughes Co / Phillips 66 / ServiceNow Inc / Abbvie Inc / Alphabet Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Kraft Heinz Co / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Liberia / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Managed Care and Retail Pharmacy Outperform; Winter COVID-19 Scenarios</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB: VALOR was not the R&D win BIIB was hoping for...but some signs of efficacy</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">10/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">VALOR in Defeat? – Disappointing Outcome for ALS Patients, BIIB Presses On</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">46222210 / 09062X10</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Tofersen's VALOR Ph. III Fails But Has Intriguing Trends; No Change To Ests</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US09062X1037 / US4622221004</td><td class="leftalignment">Biogen Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Tofersen Misses in SOD1 ALS</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Complex Readout For Tofersen Affirms That Adu Will Likely Remain Near-Term Value Driver For Shares</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Tofersen Fails to Meet Primary Endpoint in SOD1-ALS; Biomarker Trends Don't Correlate to Functional Efficacy</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Tofersen primary endpoint not met; investor focus remains on depression data in 2H21</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Discretion is the Better Part of VALOR; Tofersen Stays Unmodeled</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Oct. 17, 2021 / 4:20PM ET</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 569</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Navigating Project Optimus: Panel Discussion on FDA Initiative on Finding the Optimal Dose, October 21, 11:00 a.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">03116210 / 110122108 / 09062X103 / 45337C102 / 00847G705 / 268158201 / 04651310 / 00887A105 / 67022C106 / 720795103 / 49372L100 / 05280R100 / 717224109 / N5749R100 / 16961L106 / 192010106 / 13089P101 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Biogen Inc / Incyte Corp / Agenus Inc / Dynavax Technologies Corp / Atara Biotherapeutics Inc / Aileron Therapeutics Inc / NuCana PLC / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / PhaseBio Pharmaceuticals Inc / Merus NV / Chinook Therapeutics Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Hunter Rogers / Mr. Tim F. Lugo / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 10/8/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third Quarter 2021 Biotechnology Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">09062X103 / 03116210 / 64125C109 / 110122108 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 462222100 / 19459J104 / G11196105 / 69366J200 / 09609G100 / 37890U108 / 81181C104 / 91864C107</td><td class="leftalignment">Biogen Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / bluebird bio Inc / Global Blood Therapeutics Inc / Seagen Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 15 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US00846U1016 / US0231351067 / US0320951017 / US2358511028 / US2371941053 / US28176E1082 / US4364401012 / US4523271090 / US4663671091 / US4781601046 / US5801351017 / US62855J1043 / US7140461093 / US8552441094 / US8835561023 / US92343V1044 / US9418481035 / US30063P1057 / US9884981013 / US1167941087 / US0003752047 / US09062X1037 / US25754A2015 / US00206R1023 / US1696561059 / US01748X1028 / CH0102993182 / US1920051067 / US69404D1081 / US95058W1009 / US30303M1027 / US8725901040 / US72919P2020 / US63009R1095 / US60468T1051 / US90184L1026 / US09062W2044 / IE00BLS09M33 / CA76131D1033 / US9314271084 / US8190471016 / US46185L1035 / US9741551033 / US6323071042 / NL0012169213 / US83304A1060 / US03236M2008 / US74766Q1013 / US57777K1060 / US05351X1019 / US09354A1007 / US40131M1099 / US90184D1000 / US05352A1007 / US71535D1063 / US00650F1093 / US24984K1051 / US88025U1097 / US30068X1037 / US92537N1081 / US4432011082 / US12233L1070 / US0843101017 / US07373B1098 / US74767V1098 / US81578P1066 / US65443P1021 / US7761531083 / US15961R1059 / US98985X1000 / US82933R1005 / US1920031010 / US02080L1026 / US28623U1016 / US30052F1003 / US75340L1044 / US81749D1072 / US00091E1091 / CH1125843347 / US23285D1090 / US81663L1017 / US26701L1008 / 50066V107</td><td class="leftalignment">Agilent Technologies Inc / Amazon.com Inc / Amphenol Corp / Danaher Corp / Darden Restaurants Inc / Edwards Lifesciences Corp / Hologic Inc / Illumina Inc / Jack in the Box Inc / Johnson & Johnson / McDonald's Corp / Myriad Genetics Inc / PerkinElmer Inc / Starbucks Corp / Thermo Fisher Scientific Inc / Verizon Communications Inc / Waters Corp / Exact Sciences Corp / Yum! Brands Inc / Bruker Corp / Abb Ltd / Biogen Inc / Domino's Pizza Inc / AT&T Inc / Chipotle Mexican Grill Inc / Allegiant Travel Co / TE Connectivity Ltd / Codexis Inc / Pacific Biosciences of California Inc / Wendys Co / Meta Platforms Inc / T-Mobile US Inc / Plug Power Inc / NanoString Technologies Inc / Mirati Therapeutics Inc / Twitter Inc / BioLife Solutions Inc / Pentair PLC / Restaurant Brands International Inc / Walgreens Boots Alliance Inc / Shake Shack Inc / Invitae Corp / Wingstop Inc / Natera Inc / Qiagen NV / Snap Inc / Amyris Inc / Quanterix Corp / MaxCyte Inc / Avaya Holdings Corp / Blink Charging Co / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Personalis Inc / Adaptive Biotechnologies Corp / DermTech Inc / 10X Genomics Inc / Exagen Inc / Vertiv Holdings Co / Howmet Aerospace Inc / Burning Rock Biotech Ltd / Berkeley Lights Inc / Beam Global / Quantumscape Corp / Seer Inc / 908 Devices Inc. / Romeo Power Inc / ChargePoint Holdings Inc / Zymergen Inc / Singular Genomics Systems Inc / Codex DNA Inc / Alpha Teknova Inc / Elevation Oncology Inc / EVgo Inc / Rapid Micro Biosystems Inc / Sera Prognostics Inc / Absci Corp / Sophia Genetics SA / Cytek Biosciences Inc / Sema4 Holdings Corp / Dutch Bros Inc / KORE Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0311621009 / US2666051048 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US88322Q1085 / IL0011313900</td><td class="leftalignment">Amgen Inc / DURECT Corp / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / TG Therapeutics Inc / Galmed Pharmaceuticals Ltd</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2026242 / 2437071 / 2280220 / 2270726 / 2317087 / 2576941 / 2455965 / 2471950 / 2623911 / 2632003 / 2048804 / 2730190 / 2825933 / 2931034 / 4595739 / B00FWN1 / B1F76F9 / B19FQ48 / 2713317 / B01SD70 / 2857817 / B3D7K31 / B7TL820 / BBFL7S1 / B8DPDT7 / BQPVQZ6 / BXDZ9Z0 / BZ1LFB2 / BD8DJ71 / BMQ5T49 / BFZ1K46 / BJJMGL2 / BKTNTR9 / BZ05388 / BDFZSP1 / BK6N347 / BFWK4R7 / BYYWPW6 / BWY52P3 / BYY88Y7 / BDZ30Q0 / BYTJZL1 / BNRQM83 / BJ62Z18</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Entergy Corp / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / New York Times Co / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / South Jersey Industries Inc / Vertex Pharmaceuticals Inc / Genmab A/S / Alnylam Pharmaceuticals Inc / Western Union Co / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Domino's Pizza Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Horizon Therapeutics PLC / Shopify Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Fox Corp / ViacomCBS Inc / Global Blood Therapeutics Inc / Okta Inc / Uber Technologies Inc / PagSeguro Digital Ltd / Beigene Ltd / Blueprint Medicines Corp / Alphabet Inc / Arvinas Inc / Zogenix Inc / Petco Health and Wellness Company Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / France / United Kingdom / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AFL.N / AIG.N / ANTO.L / BAC.N / C.N / CB.N / EOG.N / MMC.N / TRV.N / USB.N / WFC.N / WY.N / LPX.N / INCY.O / MET.N / UNH.N / MRO.N / UNM.N / MTG.N / RDN.N / CINF.O / LNC.N / FISV.O / V.N / AJG.N / PFG.N / PRU.N / MKL.N / BRO.N / RLI.N / PLUG.OQ / SIGI.O / ACGL.O / ICPT.O / BIIB.O / DPZ.N / 416515104 / MS.N / 025676206 / ADP.PA / 3IN.L / AON.N / ATL.MI / CLR.N / WRB.N / 759351604 / MTDR.N / SRPT.O / FFHu.TO / VOYA.N / PTCT.O / ESNT.N / NMIH.O / GLPG.O / IONS.O / KNSL.OQ / BHF.O / CDMO.OQ / EQH.N / GSHD.O / KRTX.OQ / IGMS.O / IGIC.OQ / NRIX.OQ / DCT.O / WFG.N / RYAN.N</td><td class="leftalignment">Aflac Inc / American International Group Inc / Antofagasta PLC / Bank of America Corp / Citigroup Inc / Chubb Ltd / EOG Resources Inc / Marsh & McLennan Companies Inc / Travelers Companies Inc / US Bancorp / Wells Fargo & Co / Weyerhaeuser Co / Louisiana-Pacific Corp / Incyte Corp / MetLife Inc / UnitedHealth Group Inc / Marathon Oil Corp / Unum Group / MGIC Investment Corp / Radian Group Inc / Cincinnati Financial Corp / Lincoln National Corp / Fiserv Inc / Visa Inc / Arthur J Gallagher & Co / Principal Financial Group Inc / Prudential Financial Inc / Markel Corp / Brown & Brown Inc / Rli Corp / Plug Power Inc / Selective Insurance Group Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / Biogen Inc / Domino's Pizza Inc / Hartford Financial Services Group Inc / Morgan Stanley / American Equity Investment Life Holding Co / Aeroports de Paris SA / 3I Infrastructure PLC / Aon PLC / Atlantia SpA / Continental Resources Inc / W R Berkley Corp / Reinsurance Group of America Inc / Matador Resources Co / Sarepta Therapeutics Inc / Fairfax Financial Holdings Ltd / Voya Financial Inc / PTC Therapeutics Inc / Essent Group Ltd / NMI Holdings Inc / Galapagos NV / Ionis Pharmaceuticals Inc / Kinsale Capital Group Inc / Brighthouse Financial Inc / Avid Bioservices Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Karuna Therapeutics Inc / IGM Biosciences Inc / International General Insurance Holdings Ltd / Nurix Therapeutics Inc / Duck Creek Technologies Inc / West Fraser Timber Co Ltd / Ryan Specialty Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / France / United Kingdom / Ireland / Italy / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Guggenheim Biotech 3Q 2021 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">4595739 / 2471950 / 2023607 / 2437071 / 2576941 / 2455965 / 2623911 / 2730190 / 2931034 / B00FWN1 / B19FQ48 / 2713317 / BBFL7S1 / B8DPDT7 / BQPVQZ6 / BZ1LFB2 / BZ05388 / BYYWPW6 / BWY52P3 / BYTJZL1 / BJ62Z18</td><td class="leftalignment">Genmab A/S / Incyte Corp / Amgen Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / Biogen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Global Blood Therapeutics Inc / Beigene Ltd / Blueprint Medicines Corp / Zogenix Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Guggenheim Biot Research / Mr. Charles Zhu, Ph.D., III / Debjit Chattopadhyay, Ph.D. / Michael W. Schmidt, Ph.D., PHD / Mr. Yatin Suneja / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next in Biotech: RNA-Targeting Small Molecule Drugs? Non-Canonical Roles of Estrogen Receptor (ER) as an RNA Binding Protein</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2576941 / 2455965 / 2684703 / 2931034 / BMQ5T49 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Exelixis Inc / Biogen Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Debjit Chattopadhyay, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3Q Large Cap Preview: New World Order is Navigating Consistent COVID-19 Trends to the Base Business</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US09062X1037 / US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003</td><td class="leftalignment">Biogen Inc / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAC.N / BK.N / BMY.N / BSX.N / C.N / CB.N / CCI.N / COF.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / NEM.N / NSC.N / OMC.N / PM.N / PNC.N / PPG.N / RHI.N / SLB.N / T.N / TRV.N / PG.N / NUE.N / UHS.N / HAL.N / DHR.N / UNH.N / DOV.N / ROP.N / CAT.N / UNP.N / GS.N / MCD.N / VLO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / STT.N / HCA.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / MCO.N / TDY.N / RF.N / INTC.OQ / AAPL.OQ / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / BRO.N / SIVB.OQ / ZION.OQ / SBUX.OQ / GILD.OQ / DFS.N / TSCO.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / TFC.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / MS.N / CMG.N / STX.AX / ADP.PA / CME.OQ / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / KEY.TO / NOW.N / SYF.N / ANTM.N / CSX.OQ / IQV.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bank of America Corp / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Boston Scientific Corp / Citigroup Inc / Chubb Ltd / Crown Castle International Corp / Capital One Financial Corp / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PNC Financial Services Group Inc / PPG Industries Inc / Robert Half International Inc / Schlumberger NV / AT&T Inc / Travelers Companies Inc / Procter & Gamble Co / Nucor Corp / Universal Health Services Inc / Halliburton Co / Danaher Corp / UnitedHealth Group Inc / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Goldman Sachs Group Inc / McDonald's Corp / Valero Energy Corp / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Moody's Corp / Teledyne Technologies Inc / Regions Financial Corp / Intel Corp / Apple Inc / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Brown & Brown Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Truist Financial Corp / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / CME Group Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / Keyera Corp / ServiceNow Inc / Synchrony Financial / Anthem Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">BIIB Q3:21 Preview: In-Line Rev And EPS, But Aduhelm Likely To Fall Well Short</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="even"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Here Comes The Sun: Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105 / 670703107</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc / Nuvalent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB/IONS: Tofersen Disclosure Plan Suggests Ph.III Data Likely Not A Zero, But Probably Mixed</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.OQ / IONS.OQ / BIIB.O / IONS.O</td><td class="leftalignment">Biogen Inc / Ionis Pharmaceuticals Inc / Biogen Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Luca Issi, PHD / Leonid Timashev / Lisa Walter / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">New Boss Same As The Old Boss: Former Commish Califf Floated For Top FDA Job - What It Would Mean For Biotech</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">INCY.O / ICPT.O / BIIB.O / SRPT.O / PTCT.O / IGMS.O</td><td class="leftalignment">Incyte Corp / Intercept Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Updating our Aduhelm estimates ahead of 3Q earnings - more cautious; lowering PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAC.N / BK.N / BMY.N / BSX.N / C.N / CB.N / CCI.N / CE.N / CNC.N / COF.N / DAL.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / JPM.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / NSC.N / OMC.N / PM.N / PNC.N / PPG.N / RHI.N / SLB.N / T.N / TEL.PS / TRV.N / USB.N / WFC.N / PG.N / DGX.N / NUE.N / UHS.N / HAL.N / ADML.L / DHR.N / UNH.N / GD.N / DOV.N / ROP.N / IPG.N / UNP.N / GS.N / MCD.N / VLO.N / UPS.N / WM.N / MMM.N / SHW.N / PKG.N / VZ.N / STT.N / HCA.N / WST.N / VFC.N / APH.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / TWTR.N / MTB.N / GPC.N / BLK.N / TDY.N / RF.N / INTC.OQ / FRC.N / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / BRO.N / SIVB.OQ / ZION.OQ / ORLY.OQ / DFS.N / TSCO.OQ / POOL.OQ / EBAY.OQ / ISRG.OQ / ALGN.OQ / FITB.OQ / NFLX.OQ / TXN.OQ / BIIB.OQ / TFC.N / DPZ.N / DLR.N / NDAQ.OQ / CDNS.OQ / MS.N / CMG.N / STX.AX / ADP.PA / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / KEY.TO / BKR.N / NOW.N / SYF.N / CFG.N / ANTM.N / WBA.OQ / CSX.OQ / IQV.N / FB.PS / UAL.OQ / TER.OQ / RTX.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bank of America Corp / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Boston Scientific Corp / Citigroup Inc / Chubb Ltd / Crown Castle International Corp / Celanese Corp / Centene Corp / Capital One Financial Corp / Delta Air Lines Inc / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Norfolk Southern Corp / Omnicom Group Inc / Philip Morris International Inc / PNC Financial Services Group Inc / PPG Industries Inc / Robert Half International Inc / Schlumberger NV / AT&T Inc / PLDT Inc / Travelers Companies Inc / US Bancorp / Wells Fargo & Co / Procter & Gamble Co / Quest Diagnostics Inc / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Danaher Corp / UnitedHealth Group Inc / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Interpublic Group of Companies Inc / Union Pacific Corp / Goldman Sachs Group Inc / McDonald's Corp / Valero Energy Corp / United Parcel Service Inc / Waste Management Inc / 3M Co / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / West Pharmaceutical Services Inc / VF Corp / Amphenol Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Twitter Inc / M&T Bank Corp / Genuine Parts Co / BlackRock Inc / Teledyne Technologies Inc / Regions Financial Corp / Intel Corp / First Republic Bank / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / SVB Financial Group / Zions Bancorporation NA / O'Reilly Automotive Inc / Discover Financial Services / Tractor Supply Co / Pool Corp / eBay Inc / Intuitive Surgical Inc / Align Technology Inc / Fifth Third Bancorp / Netflix Inc / Texas Instruments Inc / Biogen Inc / Truist Financial Corp / Domino's Pizza Inc / Digital Realty Trust Inc / Nasdaq Inc / Cadence Design Systems Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / Keyera Corp / Baker Hughes Co / ServiceNow Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Walgreens Boots Alliance Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Teradyne Inc / Raytheon Technologies Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Digging Deeper Into Recent Bullish Aduhelm Survey, Mixed Messages Abound</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 1, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Renewed Optimism With Broad Domestic Declines, Oral Antiviral Success, and Near-Term Vaccine Authorization for Children</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">DIS=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / BLD=US / DVN=US / KMI=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / SPOT=US / UMPQ=US / MRO=US / LEG=US / VMC=US / MLM=US / SWIM=US / CBRL=US / CSTR=US / CNX=US / DRI=US / EQT=US / GPOR=US / IBP=US / MHK=US / PACW=US / REGI=US / SGMO=US / CVX=US / SAGE=US / BXS=US / SNV=US / ZION=US / ABCB=US / FB=US / FBK=US / SSB=US / CATY=US / NFLX=US / COP=US / DIN=US / BIIB=US / TPX=US / FNB=US / EXP=US / BECN=US / PLAY=US / WMG=US / RNST=US / DENN=US / GMS=US / CMG=US / REX=US / GPRE=US / OC=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / JACK=US / AR=US / OAS=US / PCRX=US / ESTE=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / TILE=US / NDLS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / WING=US / CDEV=US / IRTC=US / LGF.B=US / PVAC=US / JELD=US / SBOW=US / ROKU=US / MBIN=US / GSHD=US / HWC=US / OZK=US / GMAB=US / OVV=US / AZEK=US / REPX=US / SNPO=US</td><td class="leftalignment">Walt Disney Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / TopBuild Corp / Devon Energy Corp / Kinder Morgan Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Spotify Technology SA / Umpqua Holdings Corp / Marathon Oil Corp / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Gulfport Energy Corp / Installed Building Products Inc / Mohawk Industries Inc / PacWest Bancorp / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Chevron Corp / SAGE Therapeutics Inc / Cadence Bank / Synovus Financial Corp / Zions Bancorporation NA / Ameris Bancorp / Meta Platforms Inc / FB Financial Corp / SouthState Corp / Cathay General Bancorp / Netflix Inc / Conocophillips / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Warner Music Group Corp / Renasant Corp / Denny's Corp / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Antero Resources Corp / Oasis Petroleum Inc / Pacira Biosciences Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Noodles & Co / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / Lions Gate Entertainment Corp / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Roku Inc / Merchants Bancorp / Goosehead Insurance Inc / Hancock Whitney Corp / Bank Ozk / Genmab A/S / Ovintiv Inc / Azek Company Inc / Riley Exploration Permian Inc / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">BIOTECH: Incrementally Positive On CORAL But Still A Nail Biter. Topline By YE21 + 50mg SHORELINE</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SAGE=US / BIIB=US</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Joon Lee, MD / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Les Sulewski</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Biogen climbs 17% in 2021, outperforming Medical/Biomedical sector</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AAPL / ACI / AGCO / ALLO / AMGN / ATRC / AXP / AZO / CSL / DE / DG / EA / EL / FDX / FOCS / FTR / ICE / INCY / LOW / NET / NKE / NOW / RSI / SBUX / SONY / TRMB / UPS / V / WH / AMZN.O / GXO / GNSS / GILD.O / EW / MSCI / CBOE / GENI / NVDA.O / ADBE.O / RMD / SQ / MPWR.O / VG / IART.O / ADI.O / NFLX / PLUG.O / ADSK.O / SGEN / UTHR.O / ARRY.O / FCEL.O / TXN.O / EXPD.O / BMRN.O / AMSC.O / REGN.O / VRTX.O / MRVL.O / AVGO.O / NDAQ / TEAM.O / ITRI.O / BIIB / DPZ / MNKD.O / SPGI / DXCM.O / SPWR.O / XPO / CSIQ.O / FSLR.O / LULU / ULTA / WPRT.O / TWIN.O / TSLA.O / PCYO.O / NXPI.O / AMRS.O / ENPH.O / FB.O / CG.O / WDAY / CNHI / FATE.O / XENT / QRVO.O / SEDG.O / RUN.O / WKHS.O / AQMS.O / FLGT.O / CRSP / AQB / ROKU.O / MDB.O / LOVE / TPTX.O / CRWD.O / DKNG / 02081G201 / VLDR.O / SHLS.O / APPH / NKTX.O / TSP.O / ENVX.O / LILM.O / MDNA.O</td><td class="leftalignment">Apple Inc / Albertsons Companies Inc / AGCO Corp / Allogene Therapeutics Inc / Amgen Inc / AtriCure Inc / American Express Co / Autozone Inc / Carlisle Companies Inc / Deere & Co / Dollar General Corp / Electronic Arts Inc / Estee Lauder Companies Inc / FedEx Corp / Focus Financial Partners Inc / Frontier Communications Parent Inc / Intercontinental Exchange Inc / Incyte Corp / Lowe's Companies Inc / Cloudflare Inc / Nike Inc / ServiceNow Inc / Rush Street Interactive Inc / Starbucks Corp / Sony Group Corp / Trimble Inc / United Parcel Service Inc / Visa Inc / Wyndham Hotels & Resorts Inc / Amazon.com Inc / GXO Logistics Inc / Genasys Inc / Gilead Sciences Inc / Edwards Lifesciences Corp / MSCI Inc / Cboe Global Markets Inc / Genius Sports Ltd / NVIDIA Corp / Adobe Inc / Resmed Inc / Block Inc / Monolithic Power Systems Inc / Vonage Holdings Corp / Integra Lifesciences Holdings Corp / Analog Devices Inc / Netflix Inc / Plug Power Inc / Autodesk Inc / Seagen Inc / United Therapeutics Corp / Array Technologies Inc / Fuelcell Energy Inc / Texas Instruments Inc / Expeditors International of Washington Inc / Biomarin Pharmaceutical Inc / American Superconductor Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Broadcom Inc / Nasdaq Inc / Atlassian Corporation PLC / Itron Inc / Biogen Inc / Domino's Pizza Inc / MannKind Corp / S&P Global Inc / Dexcom Inc / SunPower Corp / XPO Logistics Inc / Canadian Solar Inc / First Solar Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Westport Fuel Systems Inc / Twin Disc Inc / Tesla Inc / Pure Cycle Corp / NXP Semiconductors NV / Amyris Inc / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Workday Inc / CNH Industrial NV / Fate Therapeutics Inc / Intersect Ent Inc / Qorvo Inc / Solaredge Technologies Inc / Sunrun Inc / Workhorse Group Inc / Aqua Metals Inc / Fulgent Genetics Inc / CRISPR Therapeutics AG / AquaBounty Technologies Inc / Roku Inc / MongoDB Inc / Lovesac Co / Turning Point Therapeutics Inc / CrowdStrike Holdings Inc / DraftKings Inc / Alphatec Holdings Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / AppHarvest Inc / Nkarta Inc / TuSimple Holdings Inc / Enovix Corp / Lilium NV / Medicenna Therapeutics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Japan / Netherlands / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">T=US / CHTR=US / CRM=US / VZ=US / CMCSA=US / CI=US / DISH=US / ARCC=US / PATH=US / COLL=US / NOW=US / MAIN=US / ORCC=US / FORG=US / SAGE=US / APPN=US / AUTL=US / BDSI=US / BIIB=US / APTX=US / AINV=US / BAH=US / KBR=US / ICFI=US / PNNT=US / TIL=US / BLND=US / TMUS=US / LDOS=US / FATE=US / QTWO=US / TSLX=US / 70806A106 / COUP=US / RLMD=US / GSBD=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / OKTA=US / IOVA=US / SAIL=US / BTAI=US / ALLO=US / FSK=US / OSMT=US / NCNO=US</td><td class="leftalignment">AT&T Inc / Charter Communications Inc / Salesforce.Com Inc / Verizon Communications Inc / Comcast Corp / Cigna Corp / DISH Network Corp / Ares Capital Corp / UiPath Inc / Collegium Pharmaceutical Inc / ServiceNow Inc / Main Street Capital Corp / Owl Rock Capital Corp / ForgeRock Inc / SAGE Therapeutics Inc / Appian Corp / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Biogen Inc / Aptinyx Inc / Apollo Investment Corp / Booz Allen Hamilton Holding Corp / KBR Inc / ICF International Inc / Pennantpark Investment Corp / Instil Bio Inc / Blend Labs Inc / T-Mobile US Inc / Leidos Holdings Inc / Fate Therapeutics Inc / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Coupa Software Inc / Relmada Therapeutics Inc / Goldman Sachs BDC Inc / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Okta Inc / Iovance Biotherapeutics Inc / SailPoint Technologies Holdings Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / FS KKR Capital Corp / Osmotica Pharmaceuticals PLC / nCino Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Large Cap Medtech</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN / INCY / SYK / GILD.O / EW / RMD / SGEN / BMRN.O / REGN.O / VRTX.O / BIIB / XENT</td><td class="leftalignment">Amgen Inc / Incyte Corp / Stryker Corp / Gilead Sciences Inc / Edwards Lifesciences Corp / Resmed Inc / Seagen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Intersect Ent Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steven M. Lichtman / David Kuang</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037 / US24823R1059</td><td class="leftalignment">Biogen Inc / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2000019 / 2023607 / 2778844 / 2045623 / 2065159 / 2270726 / 2829515 / 2317087 / 2328915 / 2415204 / 2455965 / 2459020 / 2689560 / 2138158 / 2825933 / 2928683 / 2857817 / B7TL820 / B7VD3F2 / BBPK0J0 / B87ZMX0 / B95N910 / BDZCRX3 / BFZCHN7 / BYZLV46 / BXDZ9Z0 / BZ00V34 / BR4T3B3 / BLGJ610 / BDFZSP1 / BGSP7M9 / BFWK4R7 / BL95N25 / BD6D4Y5 / BWY52P3 / BYY88Y7 / BL71K91 / BN2R582 / BM8MM05 / BMDCDP2 / BKPGJQ1 / BLF0CW7 / BJLV8T9 / 120483382</td><td class="leftalignment">Visa Inc / Amazon.com Inc / Amgen Inc / Merck & Co Inc / ANSYS Inc / Autodesk Inc / Walt Disney Co / Edison International / Entergy Corp / Nextera Energy Inc / Hawaiian Electric Industries Inc / Biogen Inc / Intuit Inc / PG&E Corp / Sempra Energy / South Jersey Industries Inc / VF Corp / Netflix Inc / Meta Platforms Inc / Duke Energy Corp / Mirati Therapeutics Inc / Palo Alto Networks Inc / PTC Inc / RingCentral Inc / Wix.Com Ltd / InflaRx NV / Shopify Inc / Zscaler Inc / HubSpot Inc / Warner Music Group Corp / Okta Inc / Zoom Video Communications Inc / PagSeguro Digital Ltd / Phibro Animal Health Corp / Altair Engineering Inc / Blueprint Medicines Corp / Alphabet Inc / Revolution Medicines Inc / Relay Therapeutics Inc / Madison Square Garden Entertainment Corp / Bigcommerce Holdings Inc / Squarespace Inc / Repare Therapeutics Inc / Celldex Therapeutics Inc / Procept Biorobotics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALV.N / CAS.TO / CB.N / EL.N / ELE.MC / F.N / FSR.N / GM.N / IBE.MC / KBH.N / KO.N / MSFT.O / NA / PHM.N / RYN.N / T.N / TOL.N / VC.N / WY.N / CFP.TO / GILD.O / TEN.N / CMCSA.O / AMGN.O / INCY.O / FER.MC / BWA.N / LEA.N / K.N / DISH.O / LEN.N / CLX.N / EPC.N / AMT.N / SIRI.O / CONE.O / VZ.N / EXEL.O / DHI.N / ARNA.O / STZ.N / LNC.N / APH.N / FISV.O / CHTR.O / AXL.N / BC.N / AJG.N / REGN.O / ENR.N / VRTX.O / JHX.AX / PRU.N / NCR.N / TEL.N / SSNC.O / CHE.N / PII.N / ST.N / SWN.N / PLUG.OQ / GPN.N / AMED.O / BIIB.O / DPM.TO / DLR.N / 416515104 / LHCG.O / BKD.N / FIS.N / HOG.N / MERC.O / AON.N / BGS.N / DAN.N / NOG.A / CLW.N / ADUS.OQ / SPB.N / TXG.TO / PCH.O / CFX.TO / CTT.N / MTOR.N / RFP.N / SRPT.O / PANW.N / FFHu.TO / KPT.TO / TPH.N / TSLA.N / ENTA.O / TMUS.N / TMHC.N / PTCT.O / PRTA.O / 81762P102 / QTWO.N / 922475108 / RYAM.N / RGNX.O / SQ.N / MESO.O / RACE.MI / ADVM.OQ / ADNT.N / ESTE.N / WOW.N / ATUS.N / ORSTED.CO / APTV.N / VNE.N / FOCS.O / ZM.O / FSLY.N / CRWD.O / GMAB.O / DOCU.N / CRNC.OQ / PNTG.OQ / ETNB.O / AHCO.O / NKLA.OQ / FOUR.N / RXT.OQ / LUMN.N / RIDE.OQ / LSPD.N / DFH.OQ / AFRM.O / PSFE.N / TSP.OQ / OTLY.O / FLYW.O / TASK.O / RYAN.N / TWKS.OQ</td><td class="leftalignment">Autoliv Inc / Cascades Inc / Chubb Ltd / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / Fisker Inc / General Motors Co / Iberdrola SA / KB Home / Coca-Cola Co / Microsoft Corp / National Bank of Canada / Pultegroup Inc / Rayonier Inc / AT&T Inc / Toll Brothers Inc / Visteon Corp / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Ferrovial SA / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Lennar Corp / Clorox Co / Edgewell Personal Care Co / American Tower Corp / Sirius XM Holdings Inc / CyrusOne Inc / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Brunswick Corp / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / James Hardie Industries PLC / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / SS&C Technologies Holdings Inc / Chemed Corp / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Plug Power Inc / Global Payments Inc / Amedisys Inc / Biogen Inc / Dundee Precious Metals Inc / Digital Realty Trust Inc / Hartford Financial Services Group Inc / LHC Group Inc / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Harley-Davidson Inc / Mercer International Inc / Aon PLC / B&G Foods Inc / Dana Inc / Northern Oil and Gas Inc / Clearwater Paper Corp / Addus Homecare Corp / Spectrum Brands Holdings Inc / Torex Gold Resources Inc / Potlatchdeltic Corp / Canfor Pulp Products Inc / CatchMark Timber Trust Inc / Meritor Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / Taylor Morrison Home Corp / PTC Therapeutics Inc / Prothena Corporation PLC / ServiceNow Inc / Q2 Holdings Inc / Veeva Systems Inc / Rayonier Advanced Materials Inc / Regenxbio Inc / Block Inc / Mesoblast Ltd / Ferrari NV / Adverum Biotechnologies Inc / Adient PLC / Earthstone Energy Inc / WideOpenWest Inc / Altice USA Inc / Orsted A/S / Aptiv PLC / Veoneer Inc / Focus Financial Partners Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Genmab A/S / DocuSign Inc / Cerence Inc / Pennant Group Inc / 89Bio Inc / Adapthealth Corp / Nikola Corp / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Dream Finders Homes Inc / Affirm Holdings Inc / Paysafe Ltd / TuSimple Holdings Inc / Oatly Group AB / Flywire Corp / Taskus Inc / Ryan Specialty Group Holdings Inc / Thoughtworks Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Our Second Survey Suggests Physician View of Aduhelm Is Rapidly Declining; Commercial, Clinical, and Payer Issues All Likely to Blame</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Patent Patrol – Biotechnology: 3Q21</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">NA / GILD.O / INCY.O / VRTX.O / BIIB.O / SRPT.O / ENTA.O / PTCT.O / ETNB.O</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / 89Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Medical Staffing and Managed Care Outperform; Competition in Commercial Health Insurance Markets</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="even"><td class="leftalignment">10/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">No Stress with Broadening Neuro-Innovator Leading Pipeline with Emerging Oral Small Molecules, and TV Candidates in Near Term</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US24823R1059 / US09062X1037</td><td class="leftalignment">Denali Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="odd"><td class="leftalignment">10/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 568</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Oct 08 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ALLO / AMGN / ATRC / CSII / DNLI / INCY / INSP / IRTC / ROG / SAGE / CNSP.O / EW / FMTX / ARNA.O / UTHR.O / MRNS / NOVN.O / AMED.O / BIIB / 478160104 / CORT.O / MNKD.O / LHCG.O / 02043Q107 / ENSG.O / SWAV / MCRB / RDHL.O / MDWD.O / TBPH.O / RXDX.O / VCEL.O / IONS.O / PTGX.O / XFOR.O / TPTX.O / TMDX / BCYC / ORIC.O / PHGE.K / AMTI.O / TSHA.O / LABP.O / 03823M100 / US00449L1026</td><td class="leftalignment">Allogene Therapeutics Inc / Amgen Inc / AtriCure Inc / Cardiovascular Systems Inc / Denali Therapeutics Inc / Incyte Corp / Inspire Medical Systems Inc / iRhythm Technologies Inc / Rogers Corp / SAGE Therapeutics Inc / CNS Pharmaceuticals Inc / Edwards Lifesciences Corp / Forma Therapeutics Holdings Inc / Arena Pharmaceuticals Inc / United Therapeutics Corp / Marinus Pharmaceuticals Inc / Novan Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Corcept Therapeutics Inc / MannKind Corp / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Shockwave Medical Inc / Seres Therapeutics Inc / Redhill Biopharma Ltd / Mediwound Ltd / Theravance Biopharma Inc / Prometheus Biosciences Inc / Vericel Corp / Ionis Pharmaceuticals Inc / Protagonist Therapeutics Inc / X4 Pharmaceuticals Inc / Turning Point Therapeutics Inc / Transmedics Group Inc / Bicycle Therapeutics PLC / Oric Pharmaceuticals Inc / Biomx Inc / Applied Molecular Transport Inc. / Taysha Gene Therapies Inc / Landos Biopharma Inc / Applied Minerals Inc / Achilles Therapeutics PLC</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">October 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">166</td><td class="leftalignment">US09062X1037 / US0311621009 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Biogen Inc / Amgen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 10/1/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AXP.N / CAS.TO / CNA.L / COF.N / ELE.MC / F.N / GM.N / IBE.MC / PB.N / RWEG.DE / SGEF.PA / ZION.O / SSE.L / CMA.N / CFP.TO / FER.MC / AAL.L / HBAN.O / CAG.N / RKT.N / NG.L / VLY.N / SNV.N / PACW.O / EFX.N / ARE.N / RPM.N / VTR.N / STL.N / VRTX.O / FTT.TO / SM.N / COP.N / CFR.N / BLU.N / FRC.N / WBS.N / FCF.N / DFS.N / LTC.N / ADS.N / PFS.N / FFBC.O / SIVB.O / WSBC.O / HOOK.O / BOKF.O / COLB.O / WTFC.O / TCBI.O / BIIB.O / TIH.TO / FHN.N / ACAD.O / WEF.TO / WAL.N / MPW.N / DRX.L / ISBC.O / VMW.N / HOMB.O / FICO.N / BKU.N / GLEN.L / IFP.TO / SLM.OQ / ALLY.N / FANG.O / NYCB.N / BHLB.N / DOC.N / ONB.OQ / CFF.TO / SYF.N / TRUP.N / GWB.N / CTRE.O / ASB.N / AENA.MC / CADE.N / 05971J102 / WELL.N / PEAK.N / DHC.O / WFG.N / AVTX.OQ</td><td class="leftalignment">American Express Co / Cascades Inc / Centrica PLC / Capital One Financial Corp / Endesa SA / Ford Motor Co / General Motors Co / Iberdrola SA / Prosperity Bancshares Inc / Rwe AG / Vinci SA / Zions Bancorporation NA / SSE PLC / Comerica Inc / Canfor Corp / Ferrovial SA / Anglo American PLC / Huntington Bancshares Inc / Conagra Brands Inc / Rocket Companies Inc / National Grid PLC / Valley National Bancorp / Synovus Financial Corp / PacWest Bancorp / Equifax Inc / Alexandria Real Estate Equities Inc / RPM International Inc / Ventas Inc / Sterling Bancorp / Vertex Pharmaceuticals Inc / Finning International Inc / SM Energy Co / Conocophillips / Cullen/Frost Bankers Inc / BELLUS Health Inc / First Republic Bank / Webster Financial Corp / First Commonwealth Financial Corp / Discover Financial Services / LTC Properties Inc / Alliance Data Systems Corp / Provident Financial Services Inc / First Financial Bancorp / SVB Financial Group / WesBanco Inc / HOOKIPA Pharma Inc / BOK Financial Corp / Columbia Banking System Inc / Wintrust Financial Corp / Texas Capital Bancshares Inc / Biogen Inc / Toromont Industries Ltd / First Horizon Corp / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Western Alliance Bancorp / Medical Properties Trust Inc / Drax Group PLC / Investors Bancorp Inc / VMware Inc / Home BancShares Inc / Fair Isaac Corp / BankUnited Inc / Glencore PLC / Interfor Corp / SLM Corp / Ally Financial Inc / Diamondback Energy Inc / New York Community Bancorp Inc / Berkshire Hills Bancorp Inc / Physicians Realty Trust / Old National Bancorp / Conifex Timber Inc / Synchrony Financial / Trupanion Inc / Great Western Bancorp Inc / CareTrust REIT Inc / Associated Banc-Corp / Aena SME SA / Cadence Bank / Cadence Bank / Welltower Inc / Healthpeak Properties Inc / Diversified Healthcare Trust / West Fraser Timber Co Ltd / Avalo Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Chile / Germany / Spain / France / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Expect CMS To Reimburse Adu For Ph.III Population, Middle Ground Scenario, Leaving Uptake To Docs</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">VRTX.O / BLU.N / BIIB.O / ACAD.O / AVTX.OQ</td><td class="leftalignment">Vertex Pharmaceuticals Inc / BELLUS Health Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Avalo Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">When It Rains, It Pours: Another Week of Big Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Anti-Abeta mAbs Reinvigorated</td><td class="leftalignment">English</td><td class="rightalignment">87</td><td class="leftalignment">71708110 / 09062X10 / 478160104 / H0026310 / 61776010</td><td class="leftalignment">Pfizer Inc / Biogen Inc / Johnson & Johnson / AC Immune SA / MorphoSys AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Biotechnology Fourth-Quarter Catalyst Watch Call: Monday, October 11, at 12:00 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third-Quarter Grand Rounds: A Review of Financing, Regulatory, and Business Development Activity</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">09062X103 / 03116210 / 110122108 / 45337C102 / 31572Q80 / 76133010 / 00461U105 / G11196105 / 01671P100 / 501147102 / 77313F106 / 05464T104 / G10830100 / 16961L106 / 89422G107</td><td class="leftalignment">Biogen Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / FibroGen Inc / Revance Therapeutics Inc / Aclaris Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Allakos Inc / Krystal Biotech Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Beyondspring Inc / Chinook Therapeutics Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BOX.N / CF.N / DOW.N / EIX.N / ELE.MC / EOG.N / FLS.N / GE.N / GM.N / IBE.MC / ETN.N / DHR.N / WCC.N / DOV.N / IEX.N / ROP.N / K.N / CTXS.O / HON.N / MMM.N / EMR.N / VMC.N / PCG.N / GWW.N / NG.L / JCI.N / STZ.N / SRE.N / FDS.N / AME.N / GGG.N / PNR.N / TT.N / CRC.N / BIIB.O / NTR.N / NVT.N / MOS.N / MWA.N / ATL.MI / XYL.N / SRPT.O / FLOW.N / PTCT.O / ITCI.O / SAGE.OQ / SQ.N / IONS.O / FTV.N / ATKR.N / AQUA.N / GTES.N / KRTX.OQ / PING.N / EPAC.N / CARR.N / APA.OQ / PATH.N / 9VC.F</td><td class="leftalignment">Box Inc / CF Industries Holdings Inc / Dow Inc / Edison International / Endesa SA / EOG Resources Inc / Flowserve Corp / General Electric Co / General Motors Co / Iberdrola SA / Eaton Corporation PLC / Danaher Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / Kellogg Co / Citrix Systems Inc / Honeywell International Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / PG&E Corp / W W Grainger Inc / National Grid PLC / Johnson Controls International PLC / Constellation Brands Inc / Sempra Energy / Factset Research Systems Inc / AMETEK Inc / Graco Inc / Pentair PLC / Trane Technologies PLC / California Resources Corp / Biogen Inc / Nutrien Ltd / nVent Electric PLC / Mosaic Co / Mueller Water Products Inc / Atlantia SpA / Xylem Inc / Sarepta Therapeutics Inc / SPX FLOW Inc / PTC Therapeutics Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Block Inc / Ionis Pharmaceuticals Inc / Fortive Corp / Atkore Inc / Evoqua Water Technologies Corp / Gates Industrial Corporation PLC / Karuna Therapeutics Inc / Ping Identity Holding Corp / Enerpac Tool Group Corp / Carrier Global Corp / APA Corp (US) / UiPath Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Spain / United Kingdom / Ireland / Italy / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Initiating At Neutral: Current Asset Mix Gives Us Pause</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">68622V106 / 717081103 / 031162100 / 09062X103 / 881624209 / 75886F107 / 216648402 / 58933Y105 / 00287Y109 / G30401106 / G97822103 / 03168L105 / 071734107 / 30048L104 / 92556V106</td><td class="leftalignment">Organon & Co / Pfizer Inc / Amgen Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd / Regeneron Pharmaceuticals Inc / Cooper Companies Inc / Merck & Co Inc / Abbvie Inc / Endo International PLC / Perrigo Company PLC / Amneal Pharmaceuticals Inc / Bausch Health Companies Inc / Evofem Biosciences Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">10/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Undeniably High Risk, But We Like The Set-Up Into Phase III Data For ALS</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">IONS.O / BIIB.O</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Luca Issi, PHD / Lisa Walter / Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">10/06/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Transforming Novel Drug Discovery With Vyant; Initiate Buy With $5 PT</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">92942V109 / BIIB / 189464100 / 74587V107</td><td class="leftalignment">Vyant Bio Inc / Biogen Inc / Clovis Oncology Inc / Puma Biotechnology Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Edward P. White, II</td></tr>
<tr class="even"><td class="leftalignment">10/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CNA.L / RWEG.DE / SSE.L / PEP.N / AVB.N / EQR.N / PXD.N / GILD.O / WLL.N / INCY.O / MET.N / AAL.L / DRI.N / EAT.N / MCD.N / YUM.N / UNM.N / AEM.N / SBUX.O / CPT.N / NBIX.O / ESS.N / SUI.N / MAA.N / VRTX.O / FCF.N / AMH.N / BCRX.O / ICPT.O / BIIB.O / DPZ.N / ELS.N / TXRH.O / ACAD.O / LHCG.O / DRX.L / CMG.N / GETP.PA / 759351604 / JACK.OQ / VALE.N / BHPB.L / GLEN.L / WEN.O / SRPT.O / ENTA.O / PTCT.O / 46579R104 / KPTI.O / ITCI.O / HQY.OQ / QSR.N / S32.AX / GBT.OQ / INVH.N / KL.N / GSHD.O / CRNC.OQ / CHK.OQ / WING.N</td><td class="leftalignment">Centrica PLC / Rwe AG / SSE PLC / PepsiCo Inc / Avalonbay Communities Inc / Equity Residential / Pioneer Natural Resources Co / Gilead Sciences Inc / Whiting Petroleum Corp / Incyte Corp / MetLife Inc / Anglo American PLC / Darden Restaurants Inc / Brinker International Inc / McDonald's Corp / Yum! Brands Inc / Unum Group / Agnico Eagle Mines Ltd / Starbucks Corp / Camden Property Trust / Neurocrine Biosciences Inc / Essex Property Trust Inc / Sun Communities Inc / Mid-America Apartment Communities Inc / Vertex Pharmaceuticals Inc / First Commonwealth Financial Corp / American Homes 4 Rent / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Domino's Pizza Inc / Equity LifeStyle Properties Inc / Texas Roadhouse Inc / ACADIA Pharmaceuticals Inc / LHC Group Inc / Drax Group PLC / Chipotle Mexican Grill Inc / Getlink SE / Reinsurance Group of America Inc / Jack in the Box Inc / Vale SA / BHP Group PLC / Glencore PLC / Wendys Co / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Ivanhoe Mines Ltd / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Healthequity Inc / Restaurant Brands International Inc / South32 Ltd / Global Blood Therapeutics Inc / Invitation Homes Inc / Kirkland Lake Gold Ltd / Goosehead Insurance Inc / Cerence Inc / Chesapeake Energy Corp / Wingstop Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Germany / France / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">3Q21 Earnings Preview On Select Biotechs</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / AXP.N / CAH.N / CCK.N / CE.N / COF.N / EIX.N / GPS.N / HLT.N / MAN.N / MO.N / NOC.N / PFE.N / PHM.N / PM.N / SC.N / TMX.N / U.N / USB.N / VNT.N / ZEN.N / PXD.N / DELL.N / NUE.N / X.N / JBL.N / DIS.N / GD.N / AIZ.N / CR.N / AFG.N / R.N / SPOT.N / RCL.N / PRI.N / LH.N / EMR.N / PCG.N / TGT.N / AVY.N / RKT.N / SNV.N / ACN.N / H.N / DNB.N / GPC.N / HRL.N / SAM.N / CVX.N / MHK.N / L.N / GME.N / GPK.N / OSK.N / INTC.OQ / ORI.N / ADPT.OQ / CSL.N / FAF.N / RJF.N / TTC.N / TYL.N / FL.N / QCOM.OQ / ORLY.OQ / GILD.OQ / BRKS.OQ / STLD.OQ / MRCY.OQ / UMPQ.OQ / PLUG.OQ / HAIN.OQ / PNFP.OQ / WYNN.OQ / PA1436583006 / CRI.N / BIIB.OQ / OPEN.OQ / BRKR.OQ / EXP.N / OSH.N / LVS.N / THG.N / BRKb.N / OC.N / FRPT.OQ / CFX.N / MRNA.OQ / CME.OQ / CLH.N / AI.N / AVGO.OQ / NXPI.OQ / CZR.OQ / TRGP.N / SABR.OQ / Z.OQ / ALSN.N / FB.OQ / WEX.N / RNG.N / ALLE.N / ARMK.N / NCLH.N / SNOW.N / FIVN.OQ / ANET.N / SYF.N / CTLT.N / AXTA.N / LBRDK.O / QRVO.OQ / TDOC.N / RUN.OQ / PEN.N / USFD.N / TWLO.N / VVV.N / TTD.OQ / COUP.OQ / OKTA.OQ / CVNA.N / ROKU.OQ / MDB.OQ / PFG.OQ / CDAY.N / PLAN.N / STNE.OQ / CPRI.N / NFE.OQ / BYND.OQ / UBER.N / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / DKNG.OQ / APA.OQ / VRM.OQ / LMND.N / NCNO.OQ / JAMF.OQ / DCT.OQ / PLTR.N / SHC.OQ / DASH.N / CERT.OQ / SKLZ.N / DRVN.OQ / SGFY.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / American Express Co / Cardinal Health Inc / Crown Holdings Inc / Celanese Corp / Capital One Financial Corp / Edison International / Gap Inc / Hilton Worldwide Holdings Inc / ManpowerGroup Inc / Altria Group Inc / Northrop Grumman Corp / Pfizer Inc / Pultegroup Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / Terminix Global Holdings Inc / Unity Software Inc / US Bancorp / Vontier Corp / Zendesk Inc / Pioneer Natural Resources Co / Dell Technologies Inc / Nucor Corp / United States Steel Corp / Jabil Inc / Walt Disney Co / General Dynamics Corp / Assurant Inc / Crane Co / American Financial Group Inc / Ryder System Inc / Spotify Technology SA / Royal Caribbean Cruises Ltd / Primerica Inc / Laboratory Corporation of America Holdings / Emerson Electric Co / PG&E Corp / Target Corp / Avery Dennison Corp / Rocket Companies Inc / Synovus Financial Corp / Accenture PLC / Hyatt Hotels Corp / Dun & Bradstreet Holdings Inc / Genuine Parts Co / Hormel Foods Corp / Boston Beer Company Inc / Chevron Corp / Mohawk Industries Inc / Loews Corp / GameStop Corp / Graphic Packaging Holding Co / Oshkosh Corp / Intel Corp / Old Republic International Corp / Adaptive Biotechnologies Corp / Carlisle Companies Inc / First American Financial Corp / Raymond James Financial Inc / Toro Co / Tyler Technologies Inc / Foot Locker Inc / Qualcomm Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Azenta Inc / Steel Dynamics Inc / Mercury Systems Inc / Umpqua Holdings Corp / Plug Power Inc / Hain Celestial Group Inc / Pinnacle Financial Partners Inc / Wynn Resorts Ltd / Carnival Corp / Carter's Inc / Biogen Inc / Opendoor Technologies Inc / Bruker Corp / Eagle Materials Inc / Oak Street Health Inc / Las Vegas Sands Corp / Hanover Insurance Group Inc / Berkshire Hathaway Inc / Owens Corning / Freshpet Inc / Colfax Corp / Moderna Inc / CME Group Inc / Clean Harbors Inc / C3.ai Inc / Broadcom Inc / NXP Semiconductors NV / Caesars Entertainment Inc / Targa Resources Corp / Sabre Corp / Zillow Group Inc / Allison Transmission Holdings Inc / Meta Platforms Inc / WEX Inc / RingCentral Inc / Allegion PLC / Aramark / Norwegian Cruise Line Holdings Ltd / Snowflake Inc. / Five9 Inc / Arista Networks Inc / Synchrony Financial / Catalent Inc / Axalta Coating Systems Ltd / Liberty Broadband Corp / Qorvo Inc / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / US Foods Holding Corp / Twilio Inc / Valvoline Inc / Trade Desk Inc / Coupa Software Inc / Okta Inc / Carvana Co / Roku Inc / MongoDB Inc / Principal Financial Group Inc / Ceridian HCM Holding Inc / Anaplan Inc / StoneCo Ltd / Capri Holdings Ltd / New Fortress Energy Inc / Beyond Meat Inc / Uber Technologies Inc / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / DraftKings Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / nCino Inc / Jamf Holding Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / DoorDash Inc / Certara Inc / Skillz Inc / Driven Brands Holdings Inc / Signify Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Ireland / Liberia / Luxembourg / Netherlands / Panama / United States / Virgin Islands, British</td><td class="leftalignment">Aerospace / Agriculture / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AAPL / ACI / AMGN / BJ / BYND / COST / DG / DLTR / EA / EL / ELF / INCY / INSP / KR / MSFT / QCOM.O / ROG / SAGE / SONY / TSCO / TTWO / WMT / WSM / CNSP.O / ATVI.O / NVDA.O / HEAR / NFLX / ARNA.O / FRPT / UTZ / NOVN.O / TEAM.O / NDSN.O / BIIB / 478160104 / MAIN.N / 36467W109 / 02043Q107 / ULTA / MCRB / ZNGA / RDHL.O / FDEV.L / 82655M107 / TBPH.O / RXDX.O / IONS.O / PTGX.O / BILI.O / XFOR.O / ZM.O / PHGE.K / AMTI.O / ASAN.K / LABP.O / HUYA.K / 03823M100 / OTLY / MNDY.O / KLTR.O</td><td class="leftalignment">Apple Inc / Albertsons Companies Inc / Amgen Inc / BJ's Wholesale Club Holdings Inc / Beyond Meat Inc / Costco Wholesale Corp / Dollar General Corp / Dollar Tree Inc / Electronic Arts Inc / Estee Lauder Companies Inc / elf Beauty Inc / Incyte Corp / Inspire Medical Systems Inc / Kroger Co / Microsoft Corp / Qualcomm Inc / Rogers Corp / SAGE Therapeutics Inc / Sony Group Corp / Tractor Supply Co / Take-Two Interactive Software Inc / Walmart Inc / Williams-Sonoma Inc / CNS Pharmaceuticals Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Netflix Inc / Arena Pharmaceuticals Inc / Freshpet Inc / UTZ Brands Inc / Novan Inc / Atlassian Corporation PLC / Nordson Corp / Biogen Inc / Johnson & Johnson / Main Street Capital Corp / GameStop Corp / Alnylam Pharmaceuticals Inc / Ulta Beauty Inc / Seres Therapeutics Inc / Zynga Inc / Redhill Biopharma Ltd / Frontier Developments PLC / Sify Technologies Ltd / Theravance Biopharma Inc / Prometheus Biosciences Inc / Ionis Pharmaceuticals Inc / Protagonist Therapeutics Inc / Bilibili Inc / X4 Pharmaceuticals Inc / Zoom Video Communications Inc / Biomx Inc / Applied Molecular Transport Inc. / Asana Inc / Landos Biopharma Inc / HUYA Inc / Applied Minerals Inc / Oatly Group AB / Monday.Com Ltd / Kaltura Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Israel / Japan / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Oct 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEO / ANF / CAL / CRI / DDS / FL / GPS / HBI / KSS / MSFT.O / NKE / PVH / RL / SKX / VFC / WWW / AMZN.O / EBAY.O / AAPL.O / JWN / CYBR.O / COLM.O / TJX.N / ROST.O / NBIX.O / PLCE.O / SHOO.O / URBN.O / DKS / REAL.O / RARE.O / PEGA.O / OSTK.O / BIIB.O / ZUMZ.O / LULU.O / FTNT.O / EXPR.K / ADSGn.DE / GRPN.O / PANW.K / VRNS.O / DECK.K / BURL.K / ETSY.O / SHOP.K / CLSD.O / UAA / ANAB.O / SFIX.O / APLS.O / SAIL.K / ZS.O / DOCU.O / SRRK.O / TENB.O / BHVN.K / PINS.K / FTCH.K / RVLV.K / TVTX.O / TLS.O / POSH.O / INZY.O / TDUP / BBWI.K / IMPL.O / MTTR.O</td><td class="leftalignment">American Eagle Outfitters Inc / Abercrombie & Fitch Co / Caleres Inc / Carter's Inc / Dillard's Inc / Foot Locker Inc / Gap Inc / HanesBrands Inc / Kohls Corp / Microsoft Corp / Nike Inc / PVH Corp / Ralph Lauren Corp / Skechers USA Inc / VF Corp / Wolverine World Wide Inc / Amazon.com Inc / eBay Inc / Apple Inc / Nordstrom Inc / Cyberark Software Ltd / Columbia Sportswear Co / TJX Companies Inc / Ross Stores Inc / Neurocrine Biosciences Inc / Children's Place Inc / Steven Madden Ltd / Urban Outfitters Inc / DICK'S Sporting Goods Inc / RealReal Inc / Ultragenyx Pharmaceutical Inc / Pegasystems Inc / Overstock.com Inc / Biogen Inc / Zumiez Inc / Lululemon Athletica Inc / Fortinet Inc / Express Inc / Adidas AG / Groupon Inc / Palo Alto Networks Inc / Varonis Systems Inc / Deckers Outdoor Corp / Burlington Stores Inc / ETSY Inc / Shopify Inc / Clearside Biomedical Inc / Under Armour Inc / AnaptysBio Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / SailPoint Technologies Holdings Inc / Zscaler Inc / DocuSign Inc / Scholar Rock Holding Corp / Tenable Holdings Inc / Biohaven Pharmaceutical Holding Company Ltd / Pinterest Inc / Farfetch Ltd / Revolve Group Inc / Travere Therapeutics Inc / Telos Corp / Poshmark Inc / Inozyme Pharma Inc / ThredUp Inc / Bath & Body Works Inc / Impel Neuropharma Inc / Matterport Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Israel / United States / Virgin Islands, British / Vietnam</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / MCD=US / WEN=US / MDT=US / PATH=US / CBRL=US / DRI=US / MHK=US / REGI=US / SAGE=US / OPT=US / CGEN=US / KRT=US / APPN=US / DIN=US / OGN / BIIB=US / NUVA=US / PLAY=US / DENN=US / CMG=US / REX=US / GPRE=US / AWI=US / AMRX=US / TAST=US / QSR=US / JACK=US / PCRX=US / ESTE=US / TILE=US / NDLS=US / FEYE=US / ARCB=US / 00770K202 / LOCO=US / SHAK=US / WING=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / McDonald's Corp / Wendys Co / Medtronic PLC / UiPath Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Mohawk Industries Inc / Renewable Energy Group Inc / SAGE Therapeutics Inc / Opthea Ltd / Compugen Ltd / Karat Packaging Inc / Appian Corp / Dine Brands Global Inc / Organon & Co / Biogen Inc / NuVasive Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Armstrong World Industries Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / Pacira Biosciences Inc / Earthstone Energy Inc / Interface Inc / Noodles & Co / Mandiant Inc / ArcBest Corp / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">3Q21 Commercial Biotech Preview: Will We See Tricks or Treats in 3Q21 Earnings?</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">BIIB.O / BHVN.K / NBIX.O / RARE.O / APLS.O / TVTX.O / IMPL.O</td><td class="leftalignment">Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Neurocrine Biosciences Inc / Ultragenyx Pharmaceutical Inc / Apellis Pharmaceuticals Inc / Travere Therapeutics Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">What Can We Learn From NfL as a Biomarker in Neuro Trials?―Implications for Biogen's Upcoming Phase 3 ALS Trial Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Preview of 4Q21 Tofersen SOD1 ALS Readout</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">IONS.O / CNSP.O / BIIB</td><td class="leftalignment">Ionis Pharmaceuticals Inc / CNS Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter / Zhiqi He, Ph.D., CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ECNP Presentations Highlight Consistent Zuranolone Profile, Market Opportunity Uncertain; Maintain Market Perform for Sage</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103 / 78667J108 / BIIB.OQ / 74006W108</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / Biogen Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: October 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIG.N / AIRP.PA / ALB.N / AN.N / AXP.N / BA.N / BAC.N / BMY.N / CB.N / CCI.N / CI.N / CL.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / JPM.N / KO.N / LLY.N / MMC.N / NEM.N / OXY.N / PFE.N / PHM.N / PPCJ.J / RHI.N / SC.N / T.N / TMO.N / WFC.N / WMT.N / ACI.N / AA.N / PG.N / HUM.N / NUE.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / DT.N / IPG.N / UNP.N / SPOT.N / GS.N / CLX.N / MCD.N / HD.N / LOW.N / MRO.N / UPS.N / MMM.N / XOM.N / DVN.N / NKE.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / PWR.N / V.N / ACN.N / WSM.N / JLL.N / HAE.N / SAM.N / CRL.N / CVX.N / COP.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / AGL.N / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / RGEN.OQ / SIVB.OQ / ZION.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / LNG.A / MRCY.OQ / NVDA.OQ / PACW.OQ / ISRG.OQ / ILMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / BIIB.OQ / TPX.N / TFC.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / CMG.N / FIS.N / STX.AX / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / PAG.N / TDC.N / TNDM.OQ / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / NLSN.N / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / ZNGA.OQ / EPAM.N / PSX.N / WDC.OQ / NOW.N / SRPT.OQ / PANW.N / FANG.OQ / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / OLLI.OQ / NVCR.OQ / PSTG.N / TMUS.OQ / IONS.OQ / TWLO.N / COUP.OQ / LW.N / ATUS.N / IOVA.OQ / ROKU.OQ / CBRE.N / FB.PS / STNE.OQ / CTRA.N / TER.OQ / NWL.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / LFG.AX / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">American International Group Inc / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / AutoNation Inc / American Express Co / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Marsh & McLennan Companies Inc / Newmont Corporation / Occidental Petroleum Corp / Pfizer Inc / Pultegroup Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Alcoa Corp / Procter & Gamble Co / Humana Inc / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / Dynatrace Inc / Interpublic Group of Companies Inc / Union Pacific Corp / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / 3M Co / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / Quanta Services Inc / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / agilon health Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Repligen Corp / SVB Financial Group / Zions Bancorporation NA / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / PacWest Bancorp / Intuitive Surgical Inc / Illumina Inc / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Biogen Inc / Tempur Sealy International Inc / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Penske Automotive Group Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Nielsen Holdings PLC / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Zynga Inc / Epam Systems Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Diamondback Energy Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Ollie's Bargain Outlet Holdings Inc / Novocure Ltd / Pure Storage Inc / T-Mobile US Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Altice USA Inc / Iovance Biotherapeutics Inc / Roku Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Coterra Energy Inc / Teradyne Inc / Newell Brands Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Liberty Financial Group Ltd / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Good for BIIB - add'l zuranolone data presented by SAGE</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US / SAGE.OQ / SAGE=US</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: General Outsourcing and Death Care Outperform; Future of Healthcare Labor Markets?</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 10.3.21</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 01988P10 / 00282410 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 44485910 / 45253H10 / 07181310 / 10113710 / 04635310 / 43644010 / 64125C10 / 37555810 / 15678210 / 03116210 / 75886F10 / 46120E60 / 11679410 / M2572210 / 45232710 / 02343610 / 09062X10 / 01625510 / 30063P10 / 478160104 / 640268108 / 075887109 / 00422510 / 02043Q10 / 67070410 / 40637H10 / 207410101 / 205306103 / 45784P10 / 25213110 / 50187A10 / 58502B10 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 02311120 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 05463X10 / 45780L10 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 03675210 / 75046920 / 00287Y10 / 40412C10 / G5960L10 / 46222210 / 18946410 / 04004760 / 21232630 / 04280A10 / 05337M104 / 23283X20 / 40131M10 / 604749101 / 63230710 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 67181A10 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 58949210 / 09627Y10 / 68071010 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 04685N10 / 13089P10 / 34633R10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 45332Y10 / 80405P10 / N4482110 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / 16961L10 / 65443P10 / 82939910 / 87410C10 / 19240Q20 / 00288U10 / 36870G10 / 64128810 / 00404A10 / N6960510 / 28036F10 / 51506910 / N5749R10 / 24343R10 / 75629V10 / 26622P10 / 52634L10 / 23003110 / 49705R10 / 38246G10 / 85209E10 / 25056L10 / 09770210 / 82835W10 / N5151710 / 78349D10 / 68386J20 / 30315R10 / 37230320 / 14203810 / 75382E10 / 29251M10 / 81064810 / G637AM10 / 15117B20 / 00038020 / 82489T10 / 00653Q10 / 12552310 / 04683R10 / 01626L10 / 20752310 / 28623U10 / 28658R10 / 38870X10 / 95075A10 / 15673T10 / 60853G10 / 87427V10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Abbott Laboratories / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / ImmunoGen Inc / Baxter International Inc / Boston Scientific Corp / AstraZeneca PLC / Hologic Inc / Neurocrine Biosciences Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Bruker Corp / Compugen Ltd / Illumina Inc / Amedisys Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Becton Dickinson and Co / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / NuVasive Inc / Halozyme Therapeutics Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / LHC Group Inc / MEDNAX Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Amarin Corporation PLC / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / AxoGen Inc / Inogen Inc / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Anthem Inc / Radius Health Inc / Abbvie Inc / HCA Healthcare Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Arrowhead Pharmaceuticals Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Mirum Pharmaceuticals Inc / Natera Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Olink Holding AB (publ) / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Inari Medical Inc / Satsuma Pharmaceuticals Inc / InflaRx NV / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / Chinook Therapeutics Inc / 908 Devices Inc. / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Cogent Biosciences Inc / Abcellera Biologics Inc / Gemini Therapeutics Inc / Neuropace Inc / Acadia Healthcare Company Inc / Pharvaris NV / Edgewise Therapeutics Inc / Landos Biopharma Inc / Merus NV / Decibel Therapeutics Inc / Recursion Pharmaceuticals Inc / Doximity Inc / LENSAR Inc / Cullinan Oncology Inc / Kinnate Biopharma Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Design Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / LAVA Therapeutics NV / Rxsight Inc / Opthea Ltd / F-Star Therapeutics Inc / Genmab A/S / Caribou Biosciences Inc / Rapt Therapeutics Inc / Enanta Pharmaceuticals Inc / scPharmaceuticals Inc / Myovant Sciences Ltd / Celldex Therapeutics Inc / Abcam PLC / Shockwave Medical Inc / Adapthealth Corp / Cigna Corp / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc / Connect Biopharma Holdings Ltd / Elevation Oncology Inc / Eliem Therapeutics Inc / Graphite Bio Inc / Werewolf Therapeutics Inc / Century Therapeutics Inc / Molecular Partners AG / Talkspace Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ACA / RAD / WMT / WW / ONEM.O / REGN.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / ANGO.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / WW International Inc / 1Life Healthcare Inc / Regeneron Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / AngioDynamics Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 567</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">The Cowen Edge - October 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">FR0000121014 / DE0007164600 / US00846U1016 / US0116591092 / US0530151036 / US1264081035 / US22160K1051 / US22284P1057 / US2358511028 / US3021301094 / US3377381088 / US3647601083 / US4433201062 / US4456581077 / US5002551043 / US5150981018 / US5949181045 / US6245801062 / US6556641008 / US6558441084 / US6795801009 / US68389X1054 / US7043261079 / US8030542042 / US8308791024 / US8356993076 / US8447411088 / US87612E1064 / US8835561023 / US9029251066 / US9078181081 / US9139031002 / US9311421039 / US9418481035 / US9507551086 / CA1363751027 / JP3435000009 / CA13645T1003 / US37940X1028 / US4771431016 / US4198791018 / US1167941087 / US09062X1037 / US0042251084 / US02043Q1076 / US12541W2098 / US31620M1062 / ACOR.OQ / US78709Y1055 / PAP310761054 / US75025X1000 / US79546E1047 / US01748X1028 / US2473617023 / US55616P1049 / US90384S3031 / US9100471096 / US92335C1062 / US40412C1018 / US9837931008 / US98138H1014 / US04649U1025 / US63009R1095 / US8485771021 / US21240E1055 / CH0210483332 / US02376R1023 / US70438V1061 / US70432V1026 / US03937C1053 / US0465131078 / CA0089118776 / US00653A1079 / US05464T1043 / US00773U1088 / US26856L1035 / CA87241L1094 / US23753F1075 / CA1350861060 / US80689H1023 / US4990491049 / US8760301072 / US15677J1088 / US5904791358 / KY30744W1070 / US0197701065 / VGG1890L1076 / US0144421072 / US76156B1070 / US88339P1012 / US88025U1097 / US09203E1055 / CH0499880968 / US0843101017 / US81578P1066 / US65443P1021 / US73739W1045 / US55406W1036 / US35909R1086 / US82933R1005 / US89142B1070 / US70435P1021 / US0708301041 / US81663L1017</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / SAP SE / Agilent Technologies Inc / Alaska Air Group Inc / Automatic Data Processing Inc / CSX Corp / Costco Wholesale Corp / Covenant Logistics Group Inc / Danaher Corp / Expeditors International of Washington Inc / Fiserv Inc / Gap Inc / Hub Group Inc / J B Hunt Transport Services Inc / Kohls Corp / Landstar System Inc / Microsoft Corp / Movado Group Inc / Nordstrom Inc / Norfolk Southern Corp / Old Dominion Freight Line Inc / Oracle Corp / Paychex Inc / SAP SE / SkyWest Inc / Sony Group Corp / Southwest Airlines Co / Target Corp / Thermo Fisher Scientific Inc / USA Truck Inc / Union Pacific Corp / Universal Health Services Inc / Walmart Inc / Waters Corp / Werner Enterprises Inc / Canadian National Railway Co / Sony Group Corp / Canadian Pacific Railway Ltd / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Bruker Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / CH Robinson Worldwide Inc / Fidelity National Information Services Inc / Acorda Therapeutics Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Sally Beauty Holdings Inc / Allegiant Travel Co / Delta Air Lines Inc / Macy's Inc / Ulta Beauty Inc / United Airlines Holdings Inc / Vera Bradley Inc / HCA Healthcare Inc / XPO Logistics Inc / Workday Inc / Asure Software Inc / NanoString Technologies Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / American Airlines Group Inc / Paylocity Holding Corp / Paycom Software Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / elf Beauty Inc / TFI International Inc / Daseke Inc / Canada Goose Holdings Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Tapestry Inc / Ceridian HCM Holding Inc / Mesa Air Group Inc / Farfetch Ltd / Allogene Therapeutics Inc / Capri Holdings Ltd / Alector Inc / Revolve Group Inc / RealReal Inc / 10X Genomics Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / Berkeley Lights Inc / Seer Inc / 908 Devices Inc. / Poshmark Inc / MYT Netherlands Parent BV / Frontier Group Holdings Inc / Singular Genomics Systems Inc / Torrid Holdings Inc / Paycor HCM Inc / Bath & Body Works Inc / Sema4 Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Japan / Mexico / Netherlands / Panama / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary --Oct .01, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACA / BAX / CSII / GBT / INCY / OM / PRTA / RAD / WMT / EW / ONEM.O / XRAY.O / UTHR.O / ALGN.O / REGN.O / SSNC.O / CCRN.O / AMED.O / BIIB / 478160104 / 00846U101 / 868168105 / GOOG.O / MNKD.O / ANGO.O / LHCG.O / 02043Q107 / ENSG.O / 483548103 / MRNA.O / BBI.O / 771195104 / ADUS.O / GLAXOSM.LG / SWAV / SPRO.O / TRVN / 02005N100 / VBIV.O / AUPH.O / 189464100 / EVH / 100063846 / EDIT / VRAY / FLGT.O / GTHX / ATNX.O / NCNA.O / APLS.O / 720795103 / ARVN / DMAC.O / TMDX / PNTG.O / ZNTL.O / ABST.TO / 03823M100 / CLNN.O</td><td class="leftalignment">Arcosa Inc / Baxter International Inc / Cardiovascular Systems Inc / Global Blood Therapeutics Inc / Incyte Corp / Outset Medical Inc / Prothena Corporation PLC / Rite Aid Corp / Walmart Inc / Edwards Lifesciences Corp / 1Life Healthcare Inc / DENTSPLY SIRONA Inc / United Therapeutics Corp / Align Technology Inc / Regeneron Pharmaceuticals Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / MannKind Corp / AngioDynamics Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Brickell Biotech Inc / Roche Holding AG / Addus Homecare Corp / Glaxo Smithkline Consumer Nigeria PLC / Shockwave Medical Inc / Spero Therapeutics Inc / Trevena Inc / Ally Financial Inc / VBI Vaccines Inc / Aurinia Pharmaceuticals Inc / Clovis Oncology Inc / Evolent Health Inc / Truist Financial Corp / Editas Medicine Inc / ViewRay Inc / Fulgent Genetics Inc / G1 Therapeutics Inc / Athenex Inc / NuCana PLC / Apellis Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Arvinas Inc / DiaMedica Therapeutics Inc / Transmedics Group Inc / Pennant Group Inc / Zentalis Pharmaceuticals Inc / Absolute Software Corp / Applied Minerals Inc / Clene Inc.</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / RAD / WMT / ONEM.O / SSNC.O / CCRN.O / AMED.O / BIIB / 00846U101 / 868168105 / GOOG.O / LHCG.O / ENSG.O / 483548103 / ADUS.O / EVH / 100063846 / 720795103 / PNTG.O</td><td class="leftalignment">Arcosa Inc / Rite Aid Corp / Walmart Inc / 1Life Healthcare Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alphabet Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Addus Homecare Corp / Evolent Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matt Nirenberg, CFA, CFA / Michael D. Wiederhorn</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">COVID/scope Realtime Update: MRK Data Brightens Light At End Of COVID Tunnel - Implications For Our Space</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / GILD.O / INCY.O / BIIB.O / ENTA.O / PTCT.O / ITCI.O</td><td class="leftalignment">Merck & Co Inc / Gilead Sciences Inc / Incyte Corp / Biogen Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 9/24/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Oct 01 2021 6:32AM</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">KMX / DNLI.O / NBIX.O / ARGX.O / UTHR.O / BMRN.O / SWTX.O / RARE.O / ICPT.O / BIIB.O / COGT.O / LXRX.O / OMER.O / PCRX.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / ARDX.O / SAGE.O / XENE.O / CDTX.O / GBT.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / OBSV.O / FENC.O / APLS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / BHVN.K / ALNA.O / ETTX.O / HARP.O / TPTX.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BDTX.O / BCEL.O / ZNTL.O / FUSN.O / KDNY / TSHA.O / RCUS.K / KNTE.O / PRAX.O / EWTX.O / 23954D109 / 23284P103 / 28623U101 / 1BCR8K47US / 68217N105 / IMPL.O</td><td class="leftalignment">Carmax Inc / Denali Therapeutics Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / Biomarin Pharmaceutical Inc / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Cogent Biosciences Inc / Lexicon Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Ardelyx Inc / SAGE Therapeutics Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Biohaven Pharmaceutical Holding Company Ltd / Allena Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Turning Point Therapeutics Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Black Diamond Therapeutics Inc / Atreca Inc / Zentalis Pharmaceuticals Inc / Fusion Pharmaceuticals Inc / Chinook Therapeutics Inc / Taysha Gene Therapies Inc / Arcus Biosciences Inc / Kinnate Biopharma Inc / Praxis Precision Medicines Inc / Edgewise Therapeutics Inc / Day One Biopharmaceuticals Inc / Cyteir Therapeutics Inc / Elevation Oncology Inc / Aerovate Therapeutics Inc / Omega Therapeutics Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">VSAT / FR0000120271 / GB0007980591 / US00846U1016 / US0556221044 / US1271903049 / US22160K1051 / US2358511028 / US30231G1022 / US3647601083 / US45253H1014 / US4698141078 / US87612E1064 / US8835561023 / US9311421039 / US9418481035 / US1667641005 / US89151E1091 / US5645631046 / US1167941087 / US09062X1037 / US0042251084 / US02043Q1076 / GB00B03MLX29 / RDSa.AS / ACOR.OQ / US48242W1062 / US79546E1047 / US90384S3031 / US58933Y1055 / US92335C1062 / US0995021062 / LU0914713705 / US69327R1014 / US38046C1099 / US63009R1095 / US8086251076 / US5253271028 / US4277461020 / US0465131078 / CA89620X5064 / US9314271084 / US00653A1079 / US30050B1017 / US05464T1043 / US00773U1088 / US26856L1035 / US45782B1044 / US74967X1037 / CA1350861060 / US05351X1019 / US68373M1071 / US0197701065 / US0144421072 / US70202L1026 / US88025U1097 / US4833791035 / US09203E1055 / US92537N1081 / CH0499880968 / US0843101017 / US75943R1023 / US81578P1066 / US65443P1021 / US55406W1036 / US82933R1005 / US89142B1070 / US92747V1061 / US00032Q1040</td><td class="leftalignment">ViaSat Inc / TotalEnergies SE / BP PLC / Agilent Technologies Inc / BP PLC / CACI International Inc / Costco Wholesale Corp / Danaher Corp / Exxon Mobil Corp / Gap Inc / ImmunoGen Inc / Jacobs Engineering Group Inc / Target Corp / Thermo Fisher Scientific Inc / Walmart Inc / Waters Corp / Chevron Corp / TotalEnergies SE / ManTech International Corp / Bruker Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Royal Dutch Shell PLC / Acorda Therapeutics Inc / KBR Inc / Sally Beauty Holdings Inc / Ulta Beauty Inc / Merck & Co Inc / Vera Bradley Inc / Booz Allen Hamilton Holding Corp / Intelsat SA / PDC Energy Inc / Gogo Inc / NanoString Technologies Inc / Science Applications International Corp / Leidos Holdings Inc / Heron Therapeutics Inc / Atara Biotherapeutics Inc / Pfizer Inc / Walgreens Boots Alliance Inc / Adaptimmune Therapeutics PLC / Evolent Health Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / elf Beauty Inc / Inseego Corp / RH / Canada Goose Holdings Inc / Avaya Holdings Corp / Opera Ltd / Allogene Therapeutics Inc / Alector Inc / Parsons Corp / 10X Genomics Inc / Kaleyra Inc / Black Diamond Therapeutics Inc / Vertiv Holdings Co / ADC Therapeutics SA / Berkeley Lights Inc / Relay Therapeutics Inc / Seer Inc / 908 Devices Inc. / MYT Netherlands Parent BV / Singular Genomics Systems Inc / Torrid Holdings Inc / Vintage Wine Estates Inc / Aadi Bioscience Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Wedbush Monthly Check-Up: October 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">DNLI.O / NBIX.O / ARGX.O / UTHR.O / BMRN.O / SWTX.O / RARE.O / ICPT.O / BIIB.O / LXRX.O / OMER.O / PCRX.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / ARDX.O / SAGE.O / XENE.O / CDTX.O / GBT.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / OBSV.O / FENC.O / APLS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / BHVN.K / ALNA.O / ETTX.O / HARP.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BDTX.O / BCEL.O / ZNTL.O / FUSN.O / KDNY / TSHA.O / RCUS.K / PRAX.O / EWTX.O / 23954D109 / 23284P103 / 28623U101 / 1BCR8K47US / 68217N105 / IMPL.O</td><td class="leftalignment">Denali Therapeutics Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / Biomarin Pharmaceutical Inc / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Lexicon Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Ardelyx Inc / SAGE Therapeutics Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Biohaven Pharmaceutical Holding Company Ltd / Allena Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Black Diamond Therapeutics Inc / Atreca Inc / Zentalis Pharmaceuticals Inc / Fusion Pharmaceuticals Inc / Chinook Therapeutics Inc / Taysha Gene Therapies Inc / Arcus Biosciences Inc / Praxis Precision Medicines Inc / Edgewise Therapeutics Inc / Day One Biopharmaceuticals Inc / Cyteir Therapeutics Inc / Elevation Oncology Inc / Aerovate Therapeutics Inc / Omega Therapeutics Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Mr. Andreas Argyrides / Dennis Pak</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Biotechnology Monthly: An interesting year for neuro stocks is poised to get even more interesting</td><td class="leftalignment">English</td><td class="rightalignment">175</td><td class="leftalignment">US09062X1037 / ACAD.N / 78667J108 / G11196105 / 46116X101 / 22053A107 / 20451W101 / 23256X100 / G3855L106</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / SAGE Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Intra-Cellular Therapies Inc / Cortexyme Inc / Compass Pathways PLC / Cybin Inc / GH Research PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / China / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Canaccord Genui Research / Sumant Kulkarni / Michelle Gilson / Ms. Arlinda A. Lee, PHD / Mr. Edward H. Nash / Mr. John L. Newman, Ph.D., CFA, PHD / Benedict Shim</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - October 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CCO.TO / DGE.L / NA / PD.N / SGEF.PA / STO.AX / AMZN.O / CNQ.TO / GILD.O / AMGN.O / AAL.L / ADCT.N / KGC.N / EXEL.O / ALA.TO / ARNA.O / RRC.N / KMX.N / ADSK.O / EPD.N / BMRN.O / REGN.O / VRTX.O / MCO.N / CEY.L / COP.N / SWN.N / CRC.N / LNG.A / SGEN.OQ / IMGN.O / RGLD.O / CASY.O / ATDb.TO / BIIB.O / FM.TO / NST.AX / 878742204 / EDV.TO / NTR.N / MOS.N / NESTE.HE / RDSb.L / DRX.L / SES.TO / CS.TO / 443628102 / HOCM.L / SLR.AX / OSK.TO / INO.OQ / ARX.TO / VALE.N / CVE.TO / BHPB.L / NEE.N / TOU.TO / GLEN.L / XYL.N / TVE.TO / FB.O / PANW.N / ENTA.O / PTCT.O / PRTA.O / AGIO.O / 46579R104 / GOOGL.O / CIA.TO / S32.AX / MESO.O / SPGI.N / AZRE.N / AKERBP.OL / PBYI.OQ / AQN.N / SNAP.N / SSRM.O / KL.N / ATNX.O / ZS.OQ / VRCA.OQ / PINS.N / ZM.O / CRWD.O / GMAB.O / ADT1.L / MGNI.OQ / NRIX.OQ / MTCR.O / NUVB.N / PATH.N / TSP.OQ / ANE.MC</td><td class="leftalignment">Cameco Corp / Diageo PLC / National Bank of Canada / PagerDuty Inc / Vinci SA / Santos Ltd / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Anglo American PLC / ADC Therapeutics SA / Kinross Gold Corp / Exelixis Inc / AltaGas Ltd / Arena Pharmaceuticals Inc / Range Resources Corp / Carmax Inc / Autodesk Inc / Enterprise Products Partners LP / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Moody's Corp / Centamin PLC / Conocophillips / Southwestern Energy Co / California Resources Corp / Cheniere Energy Inc / Seagen Inc / ImmunoGen Inc / Royal Gold Inc / Caseys General Stores Inc / Alimentation Couche-Tard Inc / Biogen Inc / First Quantum Minerals Ltd / Northern Star Resources Ltd / Teck Resources Ltd / Endeavour Mining PLC / Nutrien Ltd / Mosaic Co / Neste Oyj / Royal Dutch Shell PLC / Drax Group PLC / Secure Energy Services Inc / Capstone Mining Corp / Hudbay Minerals Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Osisko Mining Inc / Inovio Pharmaceuticals Inc / ARC Resources Ltd / Vale SA / Cenovus Energy Inc / BHP Group PLC / Nextera Energy Inc / Tourmaline Oil Corp / Glencore PLC / Xylem Inc / Tamarack Valley Energy Ltd / Meta Platforms Inc / Palo Alto Networks Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Ivanhoe Mines Ltd / Alphabet Inc / Champion Iron Ltd / South32 Ltd / Mesoblast Ltd / S&P Global Inc / Azure Power Global Ltd / Aker BP ASA / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Snap Inc / SSR Mining Inc / Kirkland Lake Gold Ltd / Athenex Inc / Zscaler Inc / Verrica Pharmaceuticals Inc / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Adriatic Metals PLC / Magnite Inc / Nurix Therapeutics Inc / Metacrine Inc / Nuvation Bio Inc / UiPath Inc / TuSimple Holdings Inc / Corporacion Acciona Energias Renovables SA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Denmark / Spain / Finland / France / United Kingdom / Ireland / Mauritius / Norway / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech Lit Bits: A Review of Interesting Literature and Science</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / VRTX.O / BIIB.O / INO.OQ / ENTA.O / PTCT.O / VRCA.OQ / MTCR.O</td><td class="leftalignment">Gilead Sciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Inovio Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Verrica Pharmaceuticals Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">4Q21 Biopharma Catalyst Calendar</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CBIO.OQ / 031162100 / 64125C109 / 766559603 / 09062X103 / 09061G101 / 75886F107 / AADI / 02043Q107 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 00287Y109 / 29251M106 / 023111206 / 45773H201 / 03835T200 / 189464100 / 78667J108 / 03209R103 / 16383L106 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 00771V108 / 01345P106 / 52187K101 / G11196105 / 462260100 / 558868105 / 98401F105 / 23284F105 / 29014R103 / 039697107 / H17182108 / 67576A100 / 761330109 / 41358P106 / 483347100 / 37890U108 / 269796108 / 088786108 / G46188101 / 29668H708 / 68906L105 / 04016X101 / 62921N105 / 87184Q107 / 481116101 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 64049K104 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 729139105 / 00972D105 / 760273102 / 282559103 / 02155H200 / 03969T109 / 24344T101 / 604749101 / 92243A200 / 00166B105 / 576810105 / 45790W108 / 04335A105 / 23257D103 / 4525EP101 / 46565G104 / 501575104 / 14147L108 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 83422E105 / 50107A104 / 01626L105 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 03890D108 / 55028X109 / 03835L207 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 38406L103 / 81728A108 / 92941V209 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 09077A106 / 75082Q105 / 15673T100 / 670703107 / 87990A106 / 87978U108</td><td class="leftalignment">Catalyst Biosciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Aadi Bioscience Inc / Alnylam Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Amarin Corporation PLC / Inovio Pharmaceuticals Inc / Aptose Biosciences Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Aerie Pharmaceuticals Inc / Albireo Pharma Inc / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / Xencor Inc / CytomX Therapeutics Inc / Eloxx Pharmaceuticals Inc / Ardelyx Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / Eagle Pharmaceuticals Inc / Bicycle Therapeutics PLC / Horizon Therapeutics PLC / ESSA Pharma Inc / Otonomy Inc / argenx SE / NGM Biopharmaceuticals Inc / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Neoleukin Therapeutics Inc / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / 89Bio Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / Vaxart Inc / ALX Oncology Holdings Inc / Matinas BioPharma Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Immunic Inc / Iteos Therapeutics Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Solid Biosciences Inc / Kronos Bio Inc / Aligos Therapeutics Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Aravive Inc / Lumos Pharma Inc / Aptevo Therapeutics Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Gracell Biotechnologies Inc / Sensei Biotherapeutics Inc / Vyne Therapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Biomea Fusion Inc / Rain Therapeutics Inc / Century Therapeutics Inc / Nuvalent Inc / Tenaya Therapeutics Inc / Tempest Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen's Biotech Thermometer</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US0465131078 / US00653A1079 / US05464T1043 / US00773U1088 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Reversal of Fortune - Biotech Fund Flows Turn Negative</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Biogen slumps 18% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / AMGN=US / CMA=US / PEB=US / AKAM=US / H=US / MTN=US / CHKP=US / PB=US / VRM=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / TNL=US / HLT=US / WTFC=US / BL=US / CHH=US / CSTR=US / DRH=US / ABG=US / OI=US / PACW=US / SFT=US / WAL=US / HTH=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / UCBI=US / PNFP=US / SBCF=US / BIIB=US / TCBI=US / FNB=US / FHN=US / SHO=US / RNST=US / SIBN=US / HST=US / CADE=US / WH=US / HTA=US / HGV=US / SBRA=US / RLJ=US / VAC=US / PANW=US / RHP=US / ABBV=US / IBTX=US / LOB=US / ACBI=US / ZS=US / EDIT=US / PK=US / PLYA=US / CVNA=US / NCNA=US / MBIN=US / HWC=US / OZK=US / AMTB=US / CRWD=US / FERG=US / ARQT=US / ABNB=US / SSBK=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Comerica Inc / Pebblebrook Hotel Trust / Akamai Technologies Inc / Hyatt Hotels Corp / Vail Resorts Inc / Check Point Software Technologies Ltd / Prosperity Bancshares Inc / Vroom Inc / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wintrust Financial Corp / Blackline Inc / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Asbury Automotive Group Inc / O-I Glass Inc / PacWest Bancorp / Shift Technologies Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / United Community Banks Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Renasant Corp / SI-BONE Inc / Host Hotels & Resorts Inc / Cadence Bank / Wyndham Hotels & Resorts Inc / Healthcare Trust Of America Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Palo Alto Networks Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / Editas Medicine Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / NuCana PLC / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Amerant Bancorp Inc / CrowdStrike Holdings Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Airbnb Inc / Southern States Bancshares Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Biogen Inc. SEPTEMPBER 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Pulling The Curtains Back On A Highly Active Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">G46188101 / 09062X103 / 03168L105 / 04016X101</td><td class="leftalignment">Horizon Therapeutics PLC / Biogen Inc / Amneal Pharmaceuticals Inc / argenx SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRNA.OQ / AMGN.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / BMRN.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / ALNY.OQ / SRPT.OQ / ABBV.N / MRTX.OQ / FATE.OQ / NVTA.N / NTRA.OQ / NTLA.OQ / 6160.HK / BBIO.OQ / 22UAy.DE</td><td class="leftalignment">Moderna Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Biomarin Pharmaceutical Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Invitae Corp / Natera Inc / Intellia Therapeutics Inc / Beigene Ltd / BridgeBio Pharma Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="even"><td class="leftalignment">09/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">The Feedback Loop: 'In It for the Long Fall' Edition</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">NBIX.O / VRTX.O / BIIB.O / SRPT.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">NVDA=US / PEB=US / MPWR=US / CONE=US / MTN=US / DIOD=US / TNL=US / BKI=US / CHH=US / DRH=US / EQT=US / MRCY=US / THO=US / NFLX=US / BIIB=US / KTOS=US / WH=US / HGV=US / RLJ=US / VAC=US / BVH=US / GDDY=US / ON=US / AJRD=US / BWXT=US / WVE=US / EVBG=US / PVAC=US / PLYA=US / LHX=US</td><td class="leftalignment">NVIDIA Corp / Pebblebrook Hotel Trust / Monolithic Power Systems Inc / CyrusOne Inc / Vail Resorts Inc / Diodes Inc / Travel + Leisure Co / Black Knight Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / EQT Corp / Mercury Systems Inc / Thor Industries Inc / Netflix Inc / Biogen Inc / Kratos Defense and Security Solutions Inc / Wyndham Hotels & Resorts Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Bluegreen Vacations Holding Corp / GoDaddy Inc / ON Semiconductor Corp / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / WAVE Life Sciences Ltd / Everbridge Inc / Ranger Oil Corp / Playa Hotels & Resorts NV / L3harris Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ANTO.L / BAER.S / BARC.L / BHP.AX / CSGN.S / IBE.MC / KBH.N / NCM.AX / PHM.N / RIO.AX / RIO.L / SOGN.PA / TA.TO / AAL.L / ENB.TO / TV.TO / SBM.AX / BOL.ST / OI.N / MTG.N / RDN.N / DHI.N / FDS.N / CEY.L / ENAG.MC / APF.L / BLU.N / HCC.N / WSBC.O / ACGL.O / BIIB.O / IGO.AX / FMG.AX / FM.TO / RMS.AX / NST.AX / 878742204 / RRL.AX / WSA.AX / 35671D857 / MS.N / CS.TO / 443628102 / 3IN.L / 550372106 / NCU.TO / HOCM.L / SLR.AX / DAN.N / FRES.L / OZL.AX / SFR.AX / OGC.TO / VALE.N / BHPB.L / SLS.TO / GOR.AX / CAML.L / GLEN.L / POLYP.L / EVN.AX / 505440107 / TPH.N / TMHC.N / RNW.TO / 46579R104 / ESNT.N / CIA.TO / NMIH.O / S32.AX / AENA.MC / WVE.OQ / TRHC.OQ / UBSG.S / NEXA.TO / ITRM.O / NTGY.MC / ADT1.L / SBSW.N / 900435207 / DFH.OQ / AFRM.O</td><td class="leftalignment">Antofagasta PLC / Julius Baer Gruppe AG / Barclays PLC / BHP Group Ltd / Credit Suisse Group AG / Iberdrola SA / KB Home / Newcrest Mining Ltd / Pultegroup Inc / Rio Tinto Ltd / Rio Tinto PLC / Societe Generale SA / TransAlta Corp / Anglo American PLC / Enbridge Inc / Trevali Mining Corp / St Barbara Ltd / Boliden AB / O-I Glass Inc / MGIC Investment Corp / Radian Group Inc / D R Horton Inc / Factset Research Systems Inc / Centamin PLC / Enagas SA / Anglo Pacific Group PLC / BELLUS Health Inc / Warrior Met Coal Inc / WesBanco Inc / Arch Capital Group Ltd / Biogen Inc / IGO Ltd / Fortescue Metals Group Ltd / First Quantum Minerals Ltd / Ramelius Resources Ltd / Northern Star Resources Ltd / Teck Resources Ltd / Regis Resources Ltd / Western Areas Ltd / Freeport-McMoRan Inc / Morgan Stanley / Capstone Mining Corp / Hudbay Minerals Inc / 3I Infrastructure PLC / Lundin Mining Corp / Nevada Copper Corp / Hochschild Mining PLC / Silver Lake Resources Ltd / Dana Inc / Fresnillo PLC / OZ Minerals Ltd / Sandfire Resources Ltd / OceanaGold Corp / Vale SA / BHP Group PLC / Solaris Resources Inc / Gold Road Resources Ltd / Central Asia Metals PLC / Glencore PLC / Polymetal International PLC / Evolution Mining Ltd / Labrador Iron Ore Royalty Corp / Tri Pointe Homes Inc (Delaware) / Taylor Morrison Home Corp / TransAlta Renewables Inc / Ivanhoe Mines Ltd / Essent Group Ltd / Champion Iron Ltd / NMI Holdings Inc / South32 Ltd / Aena SME SA / WAVE Life Sciences Ltd / Tabula Rasa HealthCare Inc / UBS Group AG / Nexa Resources SA / Iterum Therapeutics PLC / Naturgy Energy Group SA / Adriatic Metals PLC / Sibanye Stillwater Ltd / Turquoise Hill Resources Ltd / Dream Finders Homes Inc / Affirm Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / China / Spain / France / United Kingdom / Ireland / Luxembourg / Singapore / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Revising Our Alzheimer's Ests. To Better Reflect Balance of Adu Challenges and Lecanemab Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Updates from IPMDS Conference; Poised for Progress</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">64125C10 / 09062X10 / 00422510 / G5087110 / 00287Y10 / G1119610 / 78667J10</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Jazz Pharmaceuticals PLC / Abbvie Inc / Biohaven Pharmaceutical Holding Company Ltd / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Rolling BLA filing for BAN2401 initiated; Phase 3 data in 2022 should be investor focus</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AAPL / BYND / DAL / EA / INTC.O / MSFT / QCOM.O / SONY / TTWO / AMZN.O / ATVI.O / NVDA.O / HEAR / MPWR.O / AMD.O / NFLX / MRVL.O / AVGO.O / BIIB / 871829107 / BIDU.O / 36467W109 / 771195104 / TSLA.O / ZNGA / FDEV.L / 82655M107 / ETSY.O / FLGT.O / 05464C101 / BILI.O / HUYA.K / BLDE.OQ / HON.O / CLNN.O / LILM.O</td><td class="leftalignment">Apple Inc / Beyond Meat Inc / Delta Air Lines Inc / Electronic Arts Inc / Intel Corp / Microsoft Corp / Qualcomm Inc / Sony Group Corp / Take-Two Interactive Software Inc / Amazon.com Inc / Activision Blizzard Inc / NVIDIA Corp / Turtle Beach Corp / Monolithic Power Systems Inc / Advanced Micro Devices Inc / Netflix Inc / Marvell Technology Inc / Broadcom Inc / Biogen Inc / Sysco Corp / Baidu Inc / GameStop Corp / Roche Holding AG / Tesla Inc / Zynga Inc / Frontier Developments PLC / Sify Technologies Ltd / ETSY Inc / Fulgent Genetics Inc / Axon Enterprise Inc / Bilibili Inc / HUYA Inc / Blade Air Mobility Inc / Honeywell International Inc / Clene Inc. / Lilium NV</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / India / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3956</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch Fourth Quarter 2021</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">00444P108 / 654405109 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 16961L106 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Acer Therapeutics Inc / 9 Meters Biopharma Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Charge Up with Clene—Initiate Outperform, $20 PT</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">CLNN.O / BIIB / 771195104</td><td class="leftalignment">Clene Inc. / Biogen Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Leland Gershell, MD, Ph.D. / Trevor Allred</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Boosters Approved for High Risk and Elderly, Cases in South and West Decline, 5- to 11-Year-Old Data Positive</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / John Boyle / Lachlan Hanbury-Brown / Sami Corwin, PHD / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Lecanemab BLA Filing Process Finally Beginning</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator: Advancing Targeted Neurology With Genetic Insights Into Neuroinflammation</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 014442107 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Alector Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Psych Hospitals and Medical Staffing Outperform; What Happened to Aduhelm?</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">CAH.N / CNC.N / CVS.N / MCK.N / DGX.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / LH.N / HCA.N / ABC.N / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / MOH.N / BIIB.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N</td><td class="leftalignment">Cardinal Health Inc / Centene Corp / CVS Health Corp / Mckesson Corp / Quest Diagnostics Inc / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / HCA Healthcare Inc / Amerisourcebergen Corp / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Molina Healthcare Inc / Biogen Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="odd"><td class="leftalignment">09/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / COST.O / CVS / DG / DRI / HUM / KR / RAD / UNH / WMT / ACI.N / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / BJRI.OQ / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ / ONEM.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / Costco Wholesale Corp / CVS Health Corp / Dollar General Corp / Darden Restaurants Inc / Humana Inc / Kroger Co / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Albertsons Companies Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / BJ's Restaurants Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / 1Life Healthcare Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 566</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ESMO Recap: Enchanting Data From Enhertu, CD73 Excitement, Ensuing KRAS Battle, and Emerging New Targets</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">110122108 / G10830100 / 03116210 / 09062X103 / 640268108 / 30161Q104 / 45337C102 / 45253H101 / 00847G705 / 803607100 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 462222100 / 19459J104 / G11196105 / 00887A105 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 720795103 / 49372L100 / 05280R100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 37890U108 / 03836N103 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / 73730P108 / 81181C104 / 877619106 / 00507W206 / 92840H202 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Bristol-Myers Squibb Co / Beyondspring Inc / Amgen Inc / Biogen Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Global Blood Therapeutics Inc / Aptinyx Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Poseida Therapeutics Inc / Seagen Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Tim F. Lugo / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Sept. 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / SGE.L / UNH / WMT / GILD.O / AMGN.O / NOVN.S / HCA.N / CYH.N / DRRX.O / RIGL.O / SSNC.O / ISR / SRDX.O / INCY.OQ / EPIX.OQ / SGMO.OQ / CCRN.O / ICAD.O / LIFE.O / MMSI.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / CORT.O / CRTX.O / ATRC.OQ / LHCG.O / CYCC.OQ / INFI.OQ / LMAT.O / 02043Q107 / ENSG.OQ / TNDM.O / SLP.OQ / 483548103 / SPRO.OQ / MRNA.O / TMDX.OQ / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / SRPT.O / MRTX.OQ / AERI.O / TRVN.O / GOOGL.O / ALDX.OQ / 02005N100 / AGRX.OQ / CASI.OQ / MRNS.O / INO.O / VBLT.O / NVRO.N / EVH.N / TDOC.N / CFMS.O / VYGR.OQ / 100063846 / IONS.OQ / SSKN.OQ / SYRS.OQ / SLNO.OQ / PLXP.O / VERU.OQ / ACHV.O / MTEM.O / SVRA.O / ATNX.O / NCNA.O / SYBX.O / DNLI.OQ / CUE.OQ / 720795103 / PRVB.OQ / ORTX.OQ / SWAV.O / XFOR.OQ / PDSB.OQ / BWAY.TA / ORGO.O / ONCT.OQ / BCYC.O / A71.F / XAIR.OQ / PSNL.O / NBSE.O / DMTK.O / FREQ.OQ / PNTG.OQ / BXRX.OQ / ONEM.OQ / ORIC.OQ / ZNTL.OQ / US97382D3035 / AYLA.O / HGEN.O / US74275C2052 / ABST.TO / PRTG.OQ / REGW.M3 / 03823M100 / RZLT.O / HUMA.OQ / ATXS.OQ / CRXT.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / DURECT Corp / Rigel Pharmaceuticals Inc / SS&C Technologies Holdings Inc / IsoRay Inc / Surmodics Inc / Incyte Corp / ESSA Pharma Inc / Sangamo Therapeutics Inc / Cross Country Healthcare Inc / ICAD Inc / aTyr Pharma Inc / Merit Medical Systems Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Corcept Therapeutics Inc / Cortexyme Inc / AtriCure Inc / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / LeMaitre Vascular Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Simulations Plus Inc / Kaman Corp / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Sarepta Therapeutics Inc / Mirati Therapeutics Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Alphabet Inc / Aldeyra Therapeutics Inc / Ally Financial Inc / Agile Therapeutics Inc / CASI Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Evolent Health Inc / Teladoc Health Inc / Conformis Inc / Voyager Therapeutics Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / Syros Pharmaceuticals Inc / Soleno Therapeutics Inc / PLx Pharma Inc / Veru Inc / Achieve Life Sciences Inc / Molecular Templates Inc / Savara Inc / Athenex Inc / NuCana PLC / Synlogic Inc / Denali Therapeutics Inc / Cue Biopharma Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / X4 Pharmaceuticals Inc / PDS Biotechnology Corp / Brainsway Ltd / Organogenesis Holdings Inc / Oncternal Therapeutics Inc / Bicycle Therapeutics PLC / Ascendis Pharma A/S / Beyond Air Inc / Personalis Inc / NeuBase Therapeutics Inc / DermTech Inc / Frequency Therapeutics Inc / Pennant Group Inc / Baudax Bio Inc / 1Life Healthcare Inc / Oric Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Windtree Therapeutics Inc / Ayala Pharmaceuticals Inc / Humanigen Inc / Processa Pharmaceuticals Inc / Absolute Software Corp / Portage Biotech Inc / Regency World Consulting Ltd / Applied Minerals Inc / Rezolute Inc / Humacyte Inc / Astria Therapeutics Inc / Clarus Therapeutics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / India / Ireland / Israel / Nigeria / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ / ONEM.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / 1Life Healthcare Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matt Nirenberg, CFA, CFA / Michael D. Wiederhorn</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 9/17/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Aduhelm Approval Likely To Return Biogen To Growth</td><td class="leftalignment">English</td><td class="rightalignment">94</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">FY21 Results; Upcoming Catalysts and Pipeline Progress Set Stage for Continued Value Creation</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03820J100 / BIIB / 68906L105</td><td class="leftalignment">Applied Genetic Technologies Corp / Biogen Inc / Otonomy Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">They May Be Small, But Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US45337C1027 / US64125C1099 / US09062X1037 / US0042251084 / US78667J1088 / US05464T1043 / US0327973006 / US03753U1060 / US03836N1037</td><td class="leftalignment">Incyte Corp / Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / SAGE Therapeutics Inc / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Apellis Pharmaceuticals Inc / Aptinyx Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">09/23/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Biogen's Neurodegenerative Pipeline at a Glance―Key Takeaways from R&D Day</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">BIIB / PRTA.OQ / 24823R105 / H00263105</td><td class="leftalignment">Biogen Inc / Prothena Corporation PLC / Denali Therapeutics Inc / AC Immune SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Complementary Pathology-Relevant Mechanisms for Complement-Mediated Diseases Yields Broad Pipeline; Initiating Coverage with OW and $40 PT</td><td class="leftalignment">English</td><td class="rightalignment">86</td><td class="leftalignment">ANNX / US64125C1099 / US09062X1037 / US0042251084 / US78667J1088 / US05464T1043 / US0327973006 / US03753U1060 / US03836N1037</td><td class="leftalignment">Annexon Inc / Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / SAGE Therapeutics Inc / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Apellis Pharmaceuticals Inc / Aptinyx Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Pete Stavropoulos / Charles C. Duncan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Sep 22 2021 6:51AM</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AAP / AZO / GPC / KMX / LEN / SFT / AMZN.O / DNLI.O / EXPE.O / BLUE.O / ORLY.O / EWBC.O / BIIB.O / COIN.O / PCRX.O / SAGE.O / CVNA.K / ALPN.O / BKNG.O / US82837P4081 / VRM.O / ABNB.O</td><td class="leftalignment">Advance Auto Parts Inc / Autozone Inc / Genuine Parts Co / Carmax Inc / Lennar Corp / Shift Technologies Inc / Amazon.com Inc / Denali Therapeutics Inc / Expedia Group Inc / bluebird bio Inc / O'Reilly Automotive Inc / East West Bancorp Inc / Biogen Inc / Coinbase Global Inc / Pacira Biosciences Inc / SAGE Therapeutics Inc / Carvana Co / Alpine Immune Sciences Inc / Booking Holdings Inc / Silvergate Capital Corp / Vroom Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">FR0000120271 / NL0000226223 / DE0006231004 / US00724F1012 / US0079031078 / US0378331005 / US0382221051 / US1727551004 / US31428X1063 / US45337C1027 / US4581401001 / US4663671091 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5370081045 / US55306N1046 / US5719032022 / US5951121038 / US67066G1040 / US7392761034 / US7475251036 / US8610121027 / US8807701029 / US9282981086 / US9581021055 / US89151E1091 / US83088M1027 / US21036P1084 / US09062X1037 / US1572101053 / US6098391054 / US82706C1080 / US4485791028 / US30212P3038 / US8969452015 / NL0010273215 / US09609G1004 / US98138H1014 / US55405Y1001 / KYG037AX1015 / US74736K1016 / KYG4740B1059 / US89686D1054 / US43300A2033 / VGG273581030 / US09857L1089 / US11135F1012 / US2575541055 / US90353T1007 / US89677Q1076 / US0090661010 / US5738741041 / IE00BKVD2N49</td><td class="leftalignment">TotalEnergies SE / STMicroelectronics NV / Infineon Technologies AG / Adobe Inc / Advanced Micro Devices Inc / Apple Inc / Applied Materials Inc / Cirrus Logic Inc / FedEx Corp / Incyte Corp / Intel Corp / Jack in the Box Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Littelfuse Inc / MKS Instruments Inc / Marriott International Inc / Micron Technology Inc / NVIDIA Corp / Power Integrations Inc / Qualcomm Inc / STMicroelectronics NV / Teradyne Inc / Vishay Intertechnology Inc / Western Digital Corp / TotalEnergies SE / Skyworks Solutions Inc / Constellation Brands Inc / Biogen Inc / CEVA Inc / Monolithic Power Systems Inc / Silicon Motion Technology Corp / Hyatt Hotels Corp / Expedia Group Inc / Tripadvisor Inc / ASML Holding NV / bluebird bio Inc / Workday Inc / MACOM Technology Solutions Holdings Inc / Ambarella Inc / Qorvo Inc / Ichor Holdings Ltd / Trivago NV / Hilton Worldwide Holdings Inc / Despegar.com Corp / Booking Holdings Inc / Broadcom Inc / Domo Inc / Uber Technologies Inc / Trip.com Group Ltd / Airbnb Inc / Marvell Technology Inc / Seagate Technology Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / France / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AZO / BAC.N / BMI / FDX / INTC.O / JPM / KR / MCD / MSFT.O / PNC.N / PNR / SGE.L / URI / USB / WFC.N / WMT / YUM / ACI.N / MWA / WTS.N / ADBE.O / HEAR.O / UPS.N / SBUX.O / AOS.N / ATVI.OQ / POOL.OQ / TTWO.OQ / MGRC.O / ORLY.O / NFLX.O / BIIB.O / 36467W109 / 88162G103 / GNRC.K / GBDC.OQ / XYL / ZNGA.O / EA.O / FDEV.L / AERI.O / TRVN.O / 82655M107 / CASI.OQ / CFMS.O / PLXP.O / WDAY.O / DNLI.OQ / WSC.OQ / BILI.O / PDSB.OQ / UBER.K / NBSE.O / HUYA.K</td><td class="leftalignment">Autozone Inc / Bank of America Corp / Badger Meter Inc / FedEx Corp / Intel Corp / JPMorgan Chase & Co / Kroger Co / McDonald's Corp / Microsoft Corp / PNC Financial Services Group Inc / Pentair PLC / Sage Group PLC / United Rentals Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Yum! Brands Inc / Albertsons Companies Inc / Mueller Water Products Inc / Watts Water Technologies Inc / Adobe Inc / Turtle Beach Corp / United Parcel Service Inc / Starbucks Corp / A O Smith Corp / Activision Blizzard Inc / Pool Corp / Take-Two Interactive Software Inc / McGrath RentCorp / O'Reilly Automotive Inc / Netflix Inc / Biogen Inc / GameStop Corp / Tetra Tech Inc / Generac Holdings Inc / Golub Capital Bdc Inc / Xylem Inc / Zynga Inc / Electronic Arts Inc / Frontier Developments PLC / Aerie Pharmaceuticals Inc / Trevena Inc / Sify Technologies Ltd / CASI Pharmaceuticals Inc / Conformis Inc / PLx Pharma Inc / Workday Inc / Denali Therapeutics Inc / Willscot Mobile Mini Holdings Corp / Bilibili Inc / PDS Biotechnology Corp / Uber Technologies Inc / NeuBase Therapeutics Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BSX=US / LLY=US / AMZN=US / BLD=US / INCY=US / PB=US / EWBC=US / UMPQ=US / VMC=US / MGM=US / RCL=US / MLM=US / CBRL=US / CCL=US / EXEL=US / IBP=US / PACW=US / TRIP=US / WAL=US / BXS=US / FMBI=US / SNV=US / SSB=US / WRE=US / CATY=US / BDSI=US / BCO=US / STRO=US / BIIB=US / TCBI=US / FNB=US / FHN=US / KAR=US / PLAY=US / BLDR=US / NCLH=US / FOXF=US / VCEL=US / PEN=US / SFIX=US / COLD=US / HWC=US / OZK=US / UBER=US / XAIR=US / GMAB=US / DKNG=US</td><td class="leftalignment">Boston Scientific Corp / Eli Lilly and Co / Amazon.com Inc / TopBuild Corp / Incyte Corp / Prosperity Bancshares Inc / East West Bancorp Inc / Umpqua Holdings Corp / Vulcan Materials Co / MGM Resorts International / Royal Caribbean Cruises Ltd / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / Carnival Corp / Exelixis Inc / Installed Building Products Inc / PacWest Bancorp / Tripadvisor Inc / Western Alliance Bancorp / Cadence Bank / First Midwest Bancorp Inc / Synovus Financial Corp / SouthState Corp / Washington Real Estate Investment Trust / Cathay General Bancorp / BioDelivery Sciences International Inc / Brinks Co / Sutro Biopharma Inc / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / KAR Auction Services Inc / Dave & Buster's Entertainment Inc / Builders FirstSource Inc / Norwegian Cruise Line Holdings Ltd / Fox Factory Holding Corp / Vericel Corp / Penumbra Inc / Stitch Fix Inc / Americold Realty Trust / Hancock Whitney Corp / Bank Ozk / Uber Technologies Inc / Beyond Air Inc / Genmab A/S / DraftKings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Denmark / Liberia / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">R&D Day Highlights Key Pipeline Opportunities</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BIIB.O / SGE.L / DNLI.OQ</td><td class="leftalignment">Biogen Inc / Sage Group PLC / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2126335 / 2000019 / 2008154 / 2065955 / 2270726 / 2829515 / 2317087 / 2455965 / 2459020 / 2630085 / 2048804 / 2440637 / 7123870 / B1Y9TB3 / 2857817 / B02R1L6 / B4Y1MH7 / B03PGL4 / B7577T2 / BFLR866 / BVVN4Q8 / BJLKVS6 / BMYML02 / BLGJ610 / BFMXGR0 / BZ1LFG7 / BYY88Y7 / BZ0P3Z5 / BF3N4P3 / BN7K304 / BNG3RZ7 / BMFPJK6 / BMBP1Q0</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / Amazon.com Inc / Adobe Inc / Autozone Inc / Walt Disney Co / Edison International / Entergy Corp / Biogen Inc / Intuit Inc / Neogen Corp / Pinnacle West Capital Corp / CenterPoint Energy Inc / Nestle SA / Danone SA / Netflix Inc / ALLETE Inc / KAR Auction Services Inc / NorthWestern Corp / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / Phathom Pharmaceuticals Inc / DraftKings Inc / Warner Music Group Corp / Evergy Inc / Roku Inc / Alphabet Inc / Tegna Inc / Arena Pharmaceuticals Inc / Academy Sports and Outdoors Inc / Leslie's Inc / ACV Auctions Inc / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EOG.N / USB.N / ADML.L / REE.MC / LEN.N / ARNA.O / FTT.TO / COP.N / SGEN.OQ / BIIB.O / TIH.TO / 878742204 / RENE.LS / BIP.N / VALE.N / GLEN.L / DLGD.L / BEP.N / BBU.N / ROOT.TO / ORSTED.CO / OVV.N / RXT.OQ</td><td class="leftalignment">EOG Resources Inc / US Bancorp / Admiral Group PLC / Red Electrica Corporacion SA / Lennar Corp / Arena Pharmaceuticals Inc / Finning International Inc / Conocophillips / Seagen Inc / Biogen Inc / Toromont Industries Ltd / Teck Resources Ltd / Ren Redes Energeticas Nacionais SGPS SA / Brookfield Infrastructure Partners LP / Vale SA / Glencore PLC / Direct Line Insurance Group PLC / Brookfield Renewable Partners LP / Brookfield Business Partners LP / Roots Corp / Orsted A/S / Ovintiv Inc / Rackspace Technology Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Chile / Denmark / Spain / United Kingdom / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">R&D Day Production Value on Point but Data Cards Need to Be Flipped to Turn This Story Away From Aduhelm NCD</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103 / 64125C109 / 78667J108 / 462222100 / 74006W108</td><td class="leftalignment">Biogen Inc / Neurocrine Biosciences Inc / SAGE Therapeutics Inc / Ionis Pharmaceuticals Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Investor R&D Day Supports Our Positive Thesis, Although No New Data</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Highlights from R&D Investor Event; ALS and Depression Data Coming Later This Year</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Investor Day Takeaways, Read Throughs</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O / SAGE.O / DNLI.O</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB's R&D Day – Summarized Here</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">R&D Day Highlights Opportunities In BIIB's Neuroscience-Focused Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">R&D Day Highlights Broad Development Portfolio; But No New Data</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Takeaways from R&D Day; EMBARK data in AD could give color on potential finite regimen</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">R&D Day Takeaways: Showcasing The Forest, Though The Trees Still Matter</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Sep. 21, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">FDX / KKR / MSFT.O / GILD.O / AMGN.O / AAPL.O / NVDA.O / HEAR.O / UPS.N / EXPD.O / RIGL.O / ATVI.OQ / TTWO.OQ / SGMO.OQ / NFLX.O / BIIB.O / CRTX.O / 36467W109 / XPO / 02043Q107 / MRNA.O / GLAXOSM.LG / TSLA.O / ZNGA.O / EA.O / CG.O / MRTX.OQ / FDEV.L / 82655M107 / G29183103 / 02005N100 / MRNS.O / VYGR.OQ / IONS.OQ / SYRS.OQ / APL.PS / SLNO.OQ / VERU.OQ / MTEM.O / ATNX.O / SYBX.O / DNLI.OQ / BILI.O / ORTX.OQ / ORGO.O / BCYC.O / PRTG.OQ / REGW.M3 / HUYA.K / 03823M100 / TBLA.OQ</td><td class="leftalignment">FedEx Corp / KKR & Co Inc / Microsoft Corp / Gilead Sciences Inc / Amgen Inc / Apple Inc / NVIDIA Corp / Turtle Beach Corp / United Parcel Service Inc / Expeditors International of Washington Inc / Rigel Pharmaceuticals Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / Sangamo Therapeutics Inc / Netflix Inc / Biogen Inc / Cortexyme Inc / GameStop Corp / XPO Logistics Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / Zynga Inc / Electronic Arts Inc / Carlyle Group Inc / Mirati Therapeutics Inc / Frontier Developments PLC / Sify Technologies Ltd / Eaton Corporation PLC / Ally Financial Inc / Marinus Pharmaceuticals Inc / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Syros Pharmaceuticals Inc / Apollo Global Capital Inc / Soleno Therapeutics Inc / Veru Inc / Molecular Templates Inc / Athenex Inc / Synlogic Inc / Denali Therapeutics Inc / Bilibili Inc / Orchard Therapeutics PLC / Organogenesis Holdings Inc / Bicycle Therapeutics PLC / Portage Biotech Inc / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc / Taboola.com Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Ireland / Israel / Nigeria / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ANA.MC / CB.N / CCI.N / CI.N / CNA.L / DD.N / ECL.N / EL.N / GM.N / KO.N / PNC.N / PPG.N / SLB.N / TOTF.PA / USB.N / VC.N / HUM.N / AMGN.O / WCC.N / MCD.N / VLO.N / GIS.N / AMT.N / CONE.O / SHW.N / HCA.N / MDRX.O / ARNA.O / AMP.N / SRE.N / EXC.N / FISV.O / PLD.N / AME.N / REGN.O / VRNT.O / COP.N / BKH.N / DFS.N / SEM.N / GPN.N / MNST.O / JCOM.O / EQIX.O / BIIB.O / TFC.N / DLR.N / GMS.N / BAM.N / ARWR.O / 025676206 / ISBC.O / SLRS.MC / ENSG.O / DAN.N / BIP.N / JACK.OQ / MSCI.N / ADUS.OQ / NXT.AX / BKU.N / PCRX.O / MTOR.N / STAG.N / MTDR.N / MDLZ.OQ / APAM.N / BEP.N / DOOR.N / ESNT.N / IBP.N / VRNS.O / QTWO.N / NMIH.O / AXTA.N / RPD.O / MIME.OQ / MP1.AX / SPGI.N / ATKR.N / KNSL.OQ / BBU.N / UN01.DE / GDS.O / GREG.MC / RCM.OQ / ORSTED.CO / AQUA.N / APTV.N / CDMO.OQ / EAF.N / VRCA.OQ / FOCS.O / HCAT.OQ / APRE.OQ / CARR.N / OTIS.N / ANE.MC</td><td class="leftalignment">Acciona SA / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Centrica PLC / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / PNC Financial Services Group Inc / PPG Industries Inc / Schlumberger NV / TotalEnergies SE / US Bancorp / Visteon Corp / Humana Inc / Amgen Inc / Wesco International Inc / McDonald's Corp / Valero Energy Corp / General Mills Inc / American Tower Corp / CyrusOne Inc / Sherwin-Williams Co / HCA Healthcare Inc / Allscripts Healthcare Solutions Inc / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Sempra Energy / Exelon Corp / Fiserv Inc / Prologis Inc / AMETEK Inc / Regeneron Pharmaceuticals Inc / Verint Systems Inc / Conocophillips / Black Hills Corp / Discover Financial Services / Select Medical Holdings Corp / Global Payments Inc / Monster Beverage Corp / Ziff Davis Inc / Equinix Inc / Biogen Inc / Truist Financial Corp / Digital Realty Trust Inc / GMS Inc / Brookfield Asset Management Inc / Arrowhead Pharmaceuticals Inc / American Equity Investment Life Holding Co / Investors Bancorp Inc / Solaria Energia y Medio Ambiente SA / Ensign Group Inc / Dana Inc / Brookfield Infrastructure Partners LP / Jack in the Box Inc / MSCI Inc / Addus Homecare Corp / NEXTDC Ltd / BankUnited Inc / Pacira Biosciences Inc / Meritor Inc / STAG Industrial Inc / Matador Resources Co / Mondelez International Inc / Artisan Partners Asset Management Inc / Brookfield Renewable Partners LP / Masonite International Corp / Essent Group Ltd / Installed Building Products Inc / Varonis Systems Inc / Q2 Holdings Inc / NMI Holdings Inc / Axalta Coating Systems Ltd / Rapid7 Inc / Mimecast Ltd / Megaport Ltd / S&P Global Inc / Atkore Inc / Kinsale Capital Group Inc / Brookfield Business Partners LP / Uniper SE / GDS Holdings Ltd / Grenergy Renovables SA / R1 RCM Inc / Orsted A/S / Evoqua Water Technologies Corp / Aptiv PLC / Avid Bioservices Inc / GrafTech International Ltd / Verrica Pharmaceuticals Inc / Focus Financial Partners Inc / Health Catalyst Inc / Aprea Therapeutics Inc / Carrier Global Corp / Otis Worldwide Corp / Corporacion Acciona Energias Renovables SA</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / United Kingdom / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">393</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Scaling from Basecamp to Summit; Initiate at OP</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">DNLI.OQ / RIGL.O / SGMO.OQ / BIIB.O / CRTX.O / GLAXOSM.LG / 02005N100 / VYGR.OQ / IONS.OQ / ORTX.OQ / BCYC.O</td><td class="leftalignment">Denali Therapeutics Inc / Rigel Pharmaceuticals Inc / Sangamo Therapeutics Inc / Biogen Inc / Cortexyme Inc / Glaxo Smithkline Consumer Nigeria PLC / Ally Financial Inc / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Orchard Therapeutics PLC / Bicycle Therapeutics PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Nigeria / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Multiple New Presentations Aim to Re-Ground Street Beyond Adu Towards Multimodal R&D Capabilities</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Sep 20 2021 6:28AM</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2330.TW / CCS / DHI / IBM / INTC.O / KBH / LEN / MSFT.O / QCOM.O / TPH / AAPL.O / NVDA.O / AMD.O / NTAP.O / 2454.TW / MU.O / MRVL.O / HPE / AVGO.O / SWKS.O / BIIB.O / BLDR.O / STX.O / SIMO.O / VMW / WDC.O / TMHC.K / MGNX.O / AGTC.O / DOOR.K / XENE.O / QRVO.O / CDTX.O / PSTG.K / CLSD.O / ALBO.O / ANAB.O / REPL.O / DELL.K / TPTX.O / KRTX.O / AZEK.K / VRDN</td><td class="leftalignment">Taiwan Semiconductor Manufacturing Co Ltd / Century Communities Inc / D R Horton Inc / International Business Machines Corp / Intel Corp / KB Home / Lennar Corp / Microsoft Corp / Qualcomm Inc / Tri Pointe Homes Inc (Delaware) / Apple Inc / NVIDIA Corp / Advanced Micro Devices Inc / NetApp Inc / MediaTek Inc / Micron Technology Inc / Marvell Technology Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Skyworks Solutions Inc / Biogen Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Silicon Motion Technology Corp / VMware Inc / Western Digital Corp / Taylor Morrison Home Corp / MacroGenics Inc / Applied Genetic Technologies Corp / Masonite International Corp / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Pure Storage Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Replimune Group Inc / Dell Technologies Inc / Turning Point Therapeutics Inc / Karuna Therapeutics Inc / Azek Company Inc / Viridian Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Ireland / Turkey / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Aduhelm Sentiment/Uptake Metrics May Have Found a Bottom, Maybe Even Rebounding</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Auerbach Grayson & Co., Inc.</td><td class="leftalignment">AUERBACH GRAYSON: CEEMEA & LATAM Daily Morning Note 09-20-21:  (Aegean Airlines, AL-Mamoura, Alpha Bank, America Movil, Amica, AmRest, Archicom, Asiacell Communications, Atal, Baghdad Hotel, Budimex, CCC, CI Capital Holding, Cyfrowy Polsat, DEVELIA SA)</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">AMXL@MM / PLBUDMX00013 / PLKETY000011 / TRASISEW91Q3 / PLAMICA00010 / GRS434003000 / EGS65851C015 / ZW0009011272 / PLCCC0000016 / SKA@PW / EAT@PW / PLPGNIG00014 / EGS37091C013 / GRS495003006 / QA0007227737 / PLCFRPT00013 / ATT@PW / PLENEA000013 / GPW@PW / IQ000A0Q20W1 / EGS30901C010 / TTP710771044 / PLLWBGD00024 / 6873659 / TASC@IQ / EKHO@EY / SMRI@IQ / HBAG@IQ / BIIB@IQ / DVL@PW / ARH@PW / 1AT@PW / SPMD@EY / CICH@EY / WLT@PW</td><td class="leftalignment">America Movil SAB de CV / Budimex SA / Grupa Kety SA / Turkiye Sise ve Cam Fabrikalari AS / Amica SA / Public Power Corporation SA / Sixth of October Development and Investment Co SAE / Hippo Valley Estates Ltd / CCC SA / Fabryka Farb i Lakierow Sniezka SA / Amrest Holdings SE / Polskie Gornictwo Naftowe i Gazownictwo SA / Eastern Company SAE / Aegean Airlines SA / Ooredoo QPSC / Cyfrowy Polsat SA / Grupa Azoty SA / Enea SA / Gielda Papierow Wartosciowych w Warszawie SA / Mosul Bank for Development and Investment / Juhayna Food Industries SAE / Massy Holdings Ltd / Lubelski Wegiel Bogdanka SA / Tanzania Cigarette Company Ltd / Asiacell Communications PJSC / Egypt Kuwait Holding Co SAE / Al Mamoura Company for Real Estate Investment / Baghdad Hotel / Iraqi Islamic Bank for Investment & Development / Develia SA / Archicom SA / Atal SA / Speed Medical SAE / CI Capital Holding Company SAE / Wielton SA</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United Arab Emirates / Brazil / Czech Republic / Egypt / Greece / Croatia / Hungary / Iraq / Iceland / Jamaica / Mexico / Namibia / Nigeria / Peru / Poland / Qatar / Russian Federation / Trinidad and Tobago / Turkey / Tanzania, United Republic of / Ukraine / Zimbabwe / Palestine</td><td class="leftalignment">Advertising / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Banks / Beverages & Tobacco / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Electrical / Electronics / Engineering & Construction / Fertilizers / Financial Services / Food / Household Products / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Publishing / Real Estate / Retailing / Telecommunications / Transportation / Utilities / Wholesale</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Auerbach Grayson</td></tr>
<tr class="odd"><td class="leftalignment">09/18/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.O / AGTC.O / XENE.O / CDTX.O / CLSD.O / ALBO.O / ANAB.O / TPTX.O / KRTX.O / VRDN</td><td class="leftalignment">Biogen Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Turning Point Therapeutics Inc / Karuna Therapeutics Inc / Viridian Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD / Mr. Andreas Argyrides</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ / ONEM.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / 1Life Healthcare Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 565</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Sept. 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / UNH / WMT / AMGN.O / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / SSNC.O / UTHR.OQ / CCRN.O / LIFE.O / AMED.O / BIIB.O / 00846U101 / 868168105 / NUVA.O / MNKD.O / ATRC.OQ / DXCM.O / LHCG.O / ENSG.OQ / 483548103 / MD.N / CSII.O / ADUS.O / USPH.N / MDXG.O / PRTA.OQ / AERI.O / GOOGL.O / 02005N100 / EVH.N / TDOC.N / MCRB.OQ / ZBH.N / APLS.OQ / 100063846 / EDIT.OQ / IRTC.OQ / ACIU.O / ATNX.O / 720795103 / ORTX.OQ / SWAV.O / ISEE.O / ORGO.O / PNTG.OQ / ONEM.OQ / 14888D208 / RZLT.O</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Amgen Inc / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / United Therapeutics Corp / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / NuVasive Inc / MannKind Corp / AtriCure Inc / Dexcom Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / MiMedx Group Inc / Prothena Corporation PLC / Aerie Pharmaceuticals Inc / Alphabet Inc / Ally Financial Inc / Evolent Health Inc / Teladoc Health Inc / Seres Therapeutics Inc / Zimmer Biomet Holdings Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Editas Medicine Inc / iRhythm Technologies Inc / AC Immune SA / Athenex Inc / Pieris Pharmaceuticals Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / Iveric Bio Inc / Organogenesis Holdings Inc / Pennant Group Inc / 1Life Healthcare Inc / Catalyst Biosciences Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ / ONEM.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / 1Life Healthcare Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 9/10/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AHT.L / BMY.N / CSL.AX / ELE.MC / HSX.L / IBE.MC / JD.L / JNJ.N / KOMN.S / KSP.I / PRTP.PA / SAN.MC / SAPJ.J / STM.PA / AZN.L / AAL.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / BAMI.MI / NOVN.S / FMEG.DE / ENEI.MI / MRCG.DE / BBVA.MC / BANB.S / GSK.L / ITX.MC / FLS.CO / PFIZ.NS / REGN.OQ / GILD.OQ / MAERSKB.CO / IFCN.S / BIIB.OQ / LXSG.DE / DRX.L / ISP.MI / ALM.MC / FXPO.L / SOON.S / GRLS.MC / SABE.MC / BAYGN.DE / 0486.HK / PHNX.L / OCDO.L / CABK.MC / CDR.WA / ABBV.N / OCI.AS / ELIOR.PA / SKIN.S / G24N.DE / LANDI.S / KAPQ.L / MOVE.S / GMAB.CO / JETJ.L / PPGN.S</td><td class="leftalignment">Ashtead Group PLC / Bristol-Myers Squibb Co / CSL Ltd / Endesa SA / Hiscox Ltd / Iberdrola SA / JD Sports Fashion PLC / Johnson & Johnson / Komax Holding AG / Kingspan Group PLC / Kering SA / Banco Santander SA / Sappi Ltd / STMicroelectronics NV / AstraZeneca PLC / Anglo American PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Banco BPM SpA / Novartis AG / Fresenius Medical Care AG & Co KGaA / Enel SpA / Merck KGaA / Banco Bilbao Vizcaya Argentaria SA / Bachem Holding AG / GlaxoSmithKline PLC / Industria de Diseno Textil SA / FLSmidth & Co A/S / Pfizer Ltd / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / AP Moeller - Maersk A/S / Inficon Holding AG / Biogen Inc / Lanxess AG / Drax Group PLC / Intesa Sanpaolo SpA / Almirall SA / Ferrexpo PLC / Sonova Holding AG / Grifols SA / Banco de Sabadell SA / Bayer AG / OK Rusal MKPAO / Phoenix Group Holdings PLC / Ocado Group PLC / Caixabank SA / CD Projekt SA / Abbvie Inc / OCI NV / Elior Group SA / Cassiopea SpA / Scout24 SE / Landis+Gyr Group AG / NAK Kazatomprom AO / Medacta Group SA / Genmab A/S / Just Eat Takeaway.com NV / PolyPeptide Group AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Austria / Belgium / Bermuda / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / India / Ireland / Italy / Kazakhstan / Netherlands / Norway / Poland / Russian Federation / Sweden / Turkey / United States / South Africa</td><td class="leftalignment">Apparel & Textiles / Banks / Biotechnology / Building & Building Materials / Chemicals / Consumer / Electronics / Energy / Financial Services / Food / Healthcare / Industrial Materials / Info. Tech./Computers / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Retailing / Semiconductors / Shipping & Shipbuilding / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Samuel Burgess</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Auerbach Grayson & Co., Inc.</td><td class="leftalignment">AUERBACH GRAYSON: CEEMEA & LATAM Daily Morning Note 09-17-21:  (Alpha Bank, Amica, AmRest, Archicom, Atal, Baghdad Passengers Transport, Budimex, Capricorn Investment Group, CCC, Cyfrowy Polsat, DEVELIA SA, Enea, Sniezka, GPW, Grupa Azoty, Grupa Kety)</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">1AT.WA / AMCP.WA / ARHP.WA / ATTP.WA / BDXP.WA / CPS.WA / EATP.WA / ENAE.WA / GPW.WA / KTY.WA / SBPT.ISX / GRS282183003 / PLBUDMX00013 / PLKETY000011 / PLAMICA00010 / GRS419003009 / PLCCC0000016 / SKA@PW / EAT@PW / PLPGNIG00014 / PLCFRPT00013 / ATT@PW / PLENEA000013 / GPW@PW / PLLWBGD00024 / 6873659 / SBPT@IQ / BIIB@IQ / CGP@NW / DVL@PW / ARH@PW / 1AT@PW / WLT@PW</td><td class="leftalignment">Atal SA / Amica SA / Archicom SA / Grupa Azoty SA / Budimex SA / Cyfrowy Polsat SA / Amrest Holdings SE / Enea SA / Gielda Papierow Wartosciowych w Warszawie SA / Grupa Kety SA / Baghdad Iraq for Public Transport and Real Estate Investments / Jumbo SA / Budimex SA / Grupa Kety SA / Amica SA / Greek Organisation of Football Prognostics SA / CCC SA / Fabryka Farb i Lakierow Sniezka SA / Amrest Holdings SE / Polskie Gornictwo Naftowe i Gazownictwo SA / Cyfrowy Polsat SA / Grupa Azoty SA / Enea SA / Gielda Papierow Wartosciowych w Warszawie SA / Lubelski Wegiel Bogdanka SA / Tanzania Cigarette Company Ltd / Baghdad Iraq for Public Transport and Real Estate Investments / Iraqi Islamic Bank for Investment & Development / Capricorn Group Ltd / Develia SA / Archicom SA / Atal SA / Wielton SA</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">Botswana / Czech Republic / Egypt / Greece / Croatia / Iraq / Jamaica / Namibia / Peru / Poland / Russian Federation / Slovenia / Trinidad and Tobago / Turkey / Tanzania, United Republic of / Ukraine / Uganda / Zimbabwe / Serbia & Montenegro - Discontinue with effect from December 11, 2006</td><td class="leftalignment">Advertising / Air Transportation / Apparel & Textiles / Appliances / Banks / Beverages & Tobacco / Broadcasting & Cable / Building & Building Materials / Chemicals / Electrical / Electronics / Engineering & Construction / Fertilizers / Financial Services / Food / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Metals & Minerals / Publishing / Real Estate / Retailing / Transportation / Utilities / Wholesale</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Auerbach Grayson</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Another Week of Moderate Biotech Outflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ALB.N / ANA.MC / CCK.N / ECL.N / ELE.MC / FMC.N / NTRS.O / PNC.N / PPG.N / SRCL.O / CNQ.TO / GILD.O / WLK.N / DRI.N / OLN.N / SHW.N / AMP.N / AJG.N / VRTX.O / SRG.MI / GPK.N / JCOM.O / BIIB.O / 878742204 / IVZ.N / FHI.N / MTDR.N / SMSS.L / BERY.N / APAM.N / AXTA.N / TDOC.N / VNTR.N / VCTR.N / EAF.N / FVRR.N / IBEX.O / PTVE.O / ANE.MC / CNM.N</td><td class="leftalignment">Albemarle Corp / Acciona SA / Crown Holdings Inc / Ecolab Inc / Endesa SA / FMC Corp / Northern Trust Corp / PNC Financial Services Group Inc / PPG Industries Inc / Stericycle Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Westlake Chemical Corp / Darden Restaurants Inc / Olin Corp / Sherwin-Williams Co / Ameriprise Financial Inc / Arthur J Gallagher & Co / Vertex Pharmaceuticals Inc / Snam SpA / Graphic Packaging Holding Co / Ziff Davis Inc / Biogen Inc / Teck Resources Ltd / Invesco Ltd / Federated Hermes Inc / Matador Resources Co / Smart Metering Systems PLC / Berry Global Group Inc / Artisan Partners Asset Management Inc / Axalta Coating Systems Ltd / Teladoc Health Inc / Venator Materials PLC / Victory Capital Holdings Inc / GrafTech International Ltd / Fiverr International Ltd / Ibex Ltd / Pactiv Evergreen Inc / Corporacion Acciona Energias Renovables SA / Core & Main Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Spain / United Kingdom / Israel / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ESMO Abstract Highlights and Virtual Conference Itinerary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">00887A105 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Aileron Therapeutics Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Tim F. Lugo / Mr. Raju Prasad, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 09 14</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">ATVI.OQ / EPAM.N / DIS.N / IT.N / HOLX.OQ / IIVI.OQ / INCY.OQ / PENN.OQ / EBAY.OQ / NVDA.OQ / GPN.N / BIIB.OQ / HES.N / LYB.N / ASGN.N / FOXA.OQ / AAL.OQ / KEYS.N / KHC.OQ / BHC.N / UBER.N</td><td class="leftalignment">Activision Blizzard Inc / Epam Systems Inc / Walt Disney Co / Gartner Inc / Hologic Inc / II-VI Inc / Incyte Corp / Penn National Gaming Inc / eBay Inc / NVIDIA Corp / Global Payments Inc / Biogen Inc / Hess Corp / LyondellBasell Industries NV / ASGN Inc / Fox Corp / American Airlines Group Inc / Keysight Technologies Inc / Kraft Heinz Co / Bausch Health Companies Inc / Uber Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Netherlands / United States</td><td class="leftalignment">Air Transportation / Biotechnology / Broadcasting & Cable / Chemicals / Electronics / Food / Healthcare / Info. Tech./Software / Leisure & Entertainment / Media / Pharmaceuticals / Retailing / Semiconductors / Services / Technology / Oil & Gas</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GILD.O / BIIB.O</td><td class="leftalignment">Gilead Sciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Nat gas is exploding; looking at implications</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">US1258961002 / US15189T1079 / GB0009895292 / US0188021085 / US0236081024 / US0255371017 / US2091151041 / US2333311072 / US25746U1097 / US2810201077 / US30161N1019 / US3379321074 / US65473P1057 / US6708371033 / US69331C1080 / US7234841010 / US7445731067 / US8168511090 / US98389B1008 / CA3495531079 / US09062X1037 / US6293775085 / US7365088472 / US25470M1099 / US0304201033 / CH0102993182 / US65339F1012 / US26441C2044 / US65341B1061 / US30040W1080 / US92939U1060 / US05351W1036 / US30034W1062 / US92336X1090 / US18539C1053 / US0090661010</td><td class="leftalignment">CMS Energy Corp / CenterPoint Energy Inc / AstraZeneca PLC / Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Consolidated Edison Inc / DTE Energy Co / Dominion Energy Inc / Edison International / Exelon Corp / FirstEnergy Corp / NiSource Inc / OGE Energy Corp / PG&E Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Sempra Energy / Xcel Energy Inc / Fortis Inc / Biogen Inc / NRG Energy Inc / Portland General Electric Co / DISH Network Corp / American Water Works Company Inc / TE Connectivity Ltd / Nextera Energy Inc / Duke Energy Corp / Nextera Energy Partners LP / Eversource Energy / WEC Energy Group Inc / Avangrid Inc / Evergy Inc / Veoneer Inc / Clearway Energy Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Steve Fleishman / Alex Kania / Mr. David Paz / Keith Stanley / Michael Sullivan / David Peters / Connor McMahon</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALB.N / BSX / DE / DRI / INTC.O / JCI / MDT / MSFT.O / NEP / NPO / 4716.T / HEAR.O / INTU.O / ATVI.OQ / AMSC.OQ / TTWO.OQ / PLUG.OQ / LIFE.O / TRMB.O / ITRI.O / NFLX.O / BIIB.O / NUVA.O / DXCM.O / 36467W109 / TSLA.O / AMRC.K / AMRS.OQ / CODI.K / AMD.OQ / ZNGA.O / EA.O / ENPH.O / PANW.K / PRTA.OQ / HASI.N / FDEV.L / PTC.O / 82655M107 / 02005N100 / ZBH.N / SEDG.O / RUN.O / IAC.O / IRTC.OQ / ACIU.O / APTV.K / BILI.O / CWENa.K / ZM.OQ / AVNT.K / RWRh.V / HUYA.K</td><td class="leftalignment">Albemarle Corp / Boston Scientific Corp / Deere & Co / Darden Restaurants Inc / Intel Corp / Johnson Controls International PLC / Medtronic PLC / Microsoft Corp / Nextera Energy Partners LP / EnPro Industries Inc / Oracle Corp Japan / Turtle Beach Corp / Intuit Inc / Activision Blizzard Inc / American Superconductor Corp / Take-Two Interactive Software Inc / Plug Power Inc / aTyr Pharma Inc / Trimble Inc / Itron Inc / Netflix Inc / Biogen Inc / NuVasive Inc / Dexcom Inc / GameStop Corp / Tesla Inc / Ameresco Inc / Amyris Inc / Compass Diversified Holdings / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / Palo Alto Networks Inc / Prothena Corporation PLC / Hannon Armstrong Sustainable Infrastructure Capital Inc / Frontier Developments PLC / PTC Inc / Sify Technologies Ltd / Ally Financial Inc / Zimmer Biomet Holdings Inc / Solaredge Technologies Inc / Sunrun Inc / IAC/Interactivecorp / iRhythm Technologies Inc / AC Immune SA / Aptiv PLC / Bilibili Inc / Clearway Energy Inc / Zoom Video Communications Inc / Avient Corp / Strathmore Plus Energy Corp / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Cayman Islands / United Kingdom / India / Ireland / Japan / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Labor Day Holiday Clouds Preliminary Domestic Declines, Focus on Imminent Pfizer Adolescent Vaccine Data and Booster Debate</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US healthcare reform back in focus: Build Back Better includes direct negotiation</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / CSL.AX / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Emerging Mosaic Portrays a Favorable Vision</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PRTA.OQ / BIIB.O / 02005N100 / ACIU.O</td><td class="leftalignment">Prothena Corporation PLC / Biogen Inc / Ally Financial Inc / AC Immune SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 03, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Sep 13 2021 6:38AM</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">2303.TW / 2330.TW / CCS / CMA / DBD / DHI / ERICb.ST / IBM / INTC.O / KBH / KEY / LEN / MSFT.O / QCOM.O / TOL / TPH / AAPL.O / NVDA.O / NOKIA.HE / AMD.O / NTAP.O / 2454.TW / MU.O / MRVL.O / HPE / AVGO.O / SWKS.O / BIIB.O / 62886E108 / BLDR.O / STX.O / SIMO.O / VMW / WDC.O / TMHC.K / EPZM.O / MGNX.O / FATE.O / KPTI.O / DOOR.K / XENE.O / QRVO.O / CDTX.O / WING.O / PSTG.K / CLSD.O / ALBO.O / GTHX.O / YMAB.O / ORTX.O / DELL.K / TPTX.O / KRTX.O / TCRR.O / ZNTL.O / AZEK.K / VRDN / 68217N105</td><td class="leftalignment">United Microelectronics Corp / Taiwan Semiconductor Manufacturing Co Ltd / Century Communities Inc / Comerica Inc / Diebold Nixdorf Inc / D R Horton Inc / Telefonaktiebolaget LM Ericsson / International Business Machines Corp / Intel Corp / KB Home / KeyCorp / Lennar Corp / Microsoft Corp / Qualcomm Inc / Toll Brothers Inc / Tri Pointe Homes Inc (Delaware) / Apple Inc / NVIDIA Corp / Nokia Oyj / Advanced Micro Devices Inc / NetApp Inc / MediaTek Inc / Micron Technology Inc / Marvell Technology Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Skyworks Solutions Inc / Biogen Inc / NCR Corp / Builders FirstSource Inc / Seagate Technology Holdings PLC / Silicon Motion Technology Corp / VMware Inc / Western Digital Corp / Taylor Morrison Home Corp / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Masonite International Corp / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Wingstop Inc / Pure Storage Inc / Clearside Biomedical Inc / Albireo Pharma Inc / G1 Therapeutics Inc / Y-mAbs Therapeutics Inc / Orchard Therapeutics PLC / Dell Technologies Inc / Turning Point Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / Zentalis Pharmaceuticals Inc / Azek Company Inc / Viridian Therapeutics Inc / Omega Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Finland / United Kingdom / Ireland / Sweden / Turkey / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BIIB.O / MGNX.O / KPTI.O / XENE.O / CDTX.O / CLSD.O / ALBO.O / ORTX.O / KRTX.O / TCRR.O / VRDN</td><td class="leftalignment">Biogen Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / Orchard Therapeutics PLC / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / Viridian Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD / Mr. Andreas Argyrides</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (13 September-): Terumo and Sysmex extend gains; Shionogi, some others in favor</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4507.T / 6869.T / 4502.T / 4503.T / 4519.T / 4523.T / 4528.T / 4543.T / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 4541.T / NVAX.OQ / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Shionogi & Co Ltd / Sysmex Corp / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Nichi-Iko Pharmaceutical Co Ltd / Novavax Inc / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（9月13日～）: テルモとシスメックスは続伸、医薬品は塩野義などの個別銘柄が選好物色された</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / NVAX.OQ / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Novavax Inc / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ACA / ALB.N / AMN / CHE / CI / CNC / CVS / HUM / KR / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / LOVE.OQ / PNTG.OQ / ONEM.OQ</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Kroger Co / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Lovesac Co / Pennant Group Inc / 1Life Healthcare Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 564</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Sept. 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / HUM / IVC / MDT / RAD / UNH / WMT / GILD.O / RMD.N / HCA.N / CYH.N / EW.N / SSNC.O / UTHR.OQ / BMRN.OQ / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / MNKD.O / LHCG.O / CYCC.OQ / ENSG.OQ / 483548103 / MRNA.O / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / GBT.OQ / APLS.OQ / 100063846 / EDIT.OQ / TCMD.OQ / IRTC.OQ / SLNO.OQ / FIXX.OQ / 720795103 / SWAV.O / PNTG.OQ / ONEM.OQ / HGEN.O</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Invacare Corp / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / MannKind Corp / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Global Blood Therapeutics Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Editas Medicine Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Soleno Therapeutics Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Shockwave Medical Inc / Pennant Group Inc / 1Life Healthcare Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ / ONEM.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / 1Life Healthcare Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matt Nirenberg, CFA, CFA / Michael D. Wiederhorn</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 9/3/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2113393 / 2206657 / 2208073 / 2270726 / 2542049 / 2317087 / 2328915 / 2342034 / 2455965 / 2638625 / 2645409 / 2138158 / 2503529 / 2712013 / 2969637 / 2857817 / B3D7K31 / B3P93Y7 / B6197Q2 / B03PGL4 / B44C366 / B7TL820 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYNZGK1 / BJLT387 / BZ00V34 / BFZ1K46 / BKTNTR9 / BL95N25 / BZ0P3Z5 / BN7K304 / BFY7DC4 / BMVBZF5</td><td class="leftalignment">Boston Beer Company Inc / Coca-Cola Co / Copart Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / Fiserv Inc / Biogen Inc / National Beverage Corp / NiSource Inc / Sempra Energy / World Wrestling Entertainment Inc / Global Payments Inc / DICK'S Sporting Goods Inc / Netflix Inc / Discovery Inc / Anheuser Busch Inbev SA / Generac Holdings Inc / NorthWestern Corp / Heska Corp / Meta Platforms Inc / Duke Energy Corp / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Block Inc / Avantor Inc / Zscaler Inc / Spotify Technology SA / ViacomCBS Inc / Phibro Animal Health Corp / Tegna Inc / Academy Sports and Outdoors Inc / Altimmune Inc / Immuneering Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Aduhelm Launch Experiencing Early Challenges, But BIIB Confident in Long-Term Outlook</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Small, Hopefully Brief Pause in the Action; Modest Biotech Outflows This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">our raw notes from mgmt comments just now</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB: &quot;Here For The Long Run&quot;: Mgmt Acknowledges Bleak NT Picture For Adu, Though Believe Most Investors Already Waiting For '22</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Sep. 09, 2021 / 9:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">KOL Call Takeaways: IBD Still a Big Market for JAKs, 2L+ Was Always the Spot</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">71708110 / 09062X10 / 478160104 / 640268108 / 58933Y10 / 00287Y10 / 38341P10 / 4525EP10 / 74366E10 / G8807B10 / 00461U10 / 51506910</td><td class="leftalignment">Pfizer Inc / Biogen Inc / Johnson & Johnson / Nektar Therapeutics / Merck & Co Inc / Abbvie Inc / Gossamer Bio Inc / Immunic Inc / Protagonist Therapeutics Inc / Theravance Biopharma Inc / Aclaris Therapeutics Inc / Landos Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Hong Kong / Israel / Japan / Luxembourg / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Mr. Thomas J. Smith / Anna Baran, CFA / Na Sun / Mike Kratky, CFA / Nat Charoensook, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">BIIB - Embedded Expectations Analysis - 2021 09 07</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Auerbach Grayson & Co., Inc.</td><td class="leftalignment">AUERBACH GRAYSON: CEEMEA & LATAM Daily Morning Note 09-08-21:  (AC, Arabian Food Industries, BAT Zimbabwe, CCC, CEZ, Commercial International Bank, Cyfrowy Polsat, Dom Development, El Sewedy Electric, Etisalat, Eurobank, Gek Terna)</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">CCCP.WA / CEZP.PR / COMI.CA / CPS.WA / DOMP.WA / HRMr.AT / SWDY.CA / CZ0005112300 / ASURB@MM / GRS204003008 / GRS298343005 / PLRELPL00014 / PLKGHM000017 / PLPKN0000018 / GRS419003009 / GRS434003000 / HU0000061726 / EGS60121C018 / EGS65851C015 / EGS48031C016 / PLINTCS00010 / ZW0009011710 / PLCCC0000016 / PLDMDVL00012 / TRETAVH00018 / EGS3G0Z1C014 / GRS145003000 / US46630Q2021 / PLCFRPT00013 / MARK@QD / PLTAURN00011 / IQ000A0Q20S9 / 6873659 / BIIB@IQ / WPL@PW / DOMT@EY / MONET@CP / ACG@PW / LKD@PW / SPMD@EY / WARBABAN@KK</td><td class="leftalignment">CCC SA / CEZ as / Commercial International Bank Egypt SAE / Cyfrowy Polsat SA / Dom Development SA / GEK TERNA Holdings Real Estate Construction SA / El Sewedy Electric Co SAE / CEZ as / Grupo Aeroportuario del Sureste SAB de CV / Gr Sarantis SA / Hellenic Petroleum SA / Relpol SA / KGHM Polska Miedz SA / Polski Koncern Naftowy Orlen SA / Greek Organisation of Football Prognostics SA / Public Power Corporation SA / OTP Bank Nyrt / Commercial International Bank Egypt SAE / Sixth of October Development and Investment Co SAE / Telecom Egypt Co SAE / Inter Cars SA / British American Tobacco Zimbabwe (Holdings) Ltd / CCC SA / Dom Development SA / TAV Havalimanlari Holding AS / El Sewedy Electric Co SAE / GEK TERNA Holdings Real Estate Construction SA / Bank VTB PAO / Cyfrowy Polsat SA / Masraf Al Rayan QPSC / Tauron Polska Energia SA / Iraqi Middle East Investment Bank Private / Tanzania Cigarette Company Ltd / Iraqi Islamic Bank for Investment & Development / Wirtualna Polska Holding SA / Arabian Food Industries Company SAE / Moneta Money Bank as / AC SA / Lokum Deweloper SA / Speed Medical SAE / Warba Bank KSCP</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United Arab Emirates / Botswana / Czech Republic / Egypt / Greece / Croatia / Hungary / Iraq / Jamaica / Kuwait / Mexico / Namibia / Nigeria / Peru / Poland / Qatar / Russian Federation / Slovenia / Turkey / Tanzania, United Republic of / Ukraine / Uganda / Zimbabwe / Serbia & Montenegro - Discontinue with effect from December 11, 2006 / Palestine</td><td class="leftalignment">Advertising / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Broadcasting & Cable / Building & Building Materials / Communications / Electrical / Engineering & Construction / Financial Services / Food / Household Products / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Manufacturing / Media / Metals & Minerals / Publishing / Real Estate / Tire & Rubber / Transportation / Utilities / Wholesale / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Auerbach Grayson</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">The Weekly Mark - Looking at new hydrogen-capable gas plants</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">US1258961002 / US15189T1079 / GB0009895292 / US0188021085 / US0236081024 / US0255371017 / US2091151041 / US2333311072 / US25746U1097 / US2810201077 / US30161N1019 / US3379321074 / US65473P1057 / US6708371033 / US69331C1080 / US7234841010 / US7445731067 / US8168511090 / US98389B1008 / CA3495531079 / US09062X1037 / US6293775085 / US7365088472 / US25470M1099 / US0304201033 / CH0102993182 / US65339F1012 / US26441C2044 / US65341B1061 / US30040W1080 / US92939U1060 / US05351W1036 / US30034W1062 / US92336X1090 / US18539C1053 / US0090661010</td><td class="leftalignment">CMS Energy Corp / CenterPoint Energy Inc / AstraZeneca PLC / Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Consolidated Edison Inc / DTE Energy Co / Dominion Energy Inc / Edison International / Exelon Corp / FirstEnergy Corp / NiSource Inc / OGE Energy Corp / PG&E Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Sempra Energy / Xcel Energy Inc / Fortis Inc / Biogen Inc / NRG Energy Inc / Portland General Electric Co / DISH Network Corp / American Water Works Company Inc / TE Connectivity Ltd / Nextera Energy Inc / Duke Energy Corp / Nextera Energy Partners LP / Eversource Energy / WEC Energy Group Inc / Avangrid Inc / Evergy Inc / Veoneer Inc / Clearway Energy Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Steve Fleishman / Alex Kania / Mr. David Paz / Keith Stanley / Michael Sullivan / David Peters / Connor McMahon</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 27, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000120578 / GB0009895292 / FR0000054470 / GB0009252882 / DE0006969603 / US09061G1013 / CH0012032048 / CH0012005267 / US0116591092 / US0311621009 / US0463531089 / US1101221083 / US1311931042 / US14149Y1082 / US1985161066 / US2435371073 / US2855121099 / US3377381088 / US3755581036 / US37733W1053 / US45337C1027 / US5324571083 / US58155Q1031 / US6541061031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US7782961038 / US8305661055 / US8308791024 / US8447411088 / US8725401090 / US8740541094 / US9182041080 / US03073E1055 / US3448491049 / US37940X1028 / US4771431016 / US4198791018 / US80105N1054 / US2533931026 / US09062X1037 / US9043111072 / US31620M1062 / US1314761032 / US4103451021 / PAP310761054 / US29089Q1058 / US01748X1028 / US2473617023 / US5500211090 / US00507V1098 / DE000A0DJ6J9 / US58933Y1055 / US9100471096 / DE000A1EWWW0 / US6936561009 / US7512121010 / JE00B783TY65 / US98986T1088 / US00287Y1091 / US85916J4094 / US41068X1000 / US8485771021 / US21240E1055 / US1220171060 / US02376R1023 / DK0060534915 / CA0089118776 / US83417M1045 / US00653A1079 / VGG312491084 / US5904791358 / US98585X1046 / US89377M1099 / US26142R1041 / US02875D1090 / US04271T1007 / US82489W1071 / US30320C1036 / US1241551027 / US30260D1037 / US68622V1061</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Ubisoft Entertainment SA / GlaxoSmithKline PLC / Puma SE / Biomarin Pharmaceutical Inc / Roche Holding AG / Novartis AG / Alaska Air Group Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Callaway Golf Co / Cardinal Health Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Electronic Arts Inc / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Eli Lilly and Co / Mckesson Corp / Nike Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Ross Stores Inc / Skechers USA Inc / SkyWest Inc / Southwest Airlines Co / TJX Companies Inc / Take-Two Interactive Software Inc / VF Corp / Amerisourcebergen Corp / Foot Locker Inc / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / DICK'S Sporting Goods Inc / Biogen Inc / Under Armour Inc / Fidelity National Information Services Inc / Calumet Specialty Products Partners LP / HanesBrands Inc / Copa Holdings SA / Emergent BioSolutions Inc / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Activision Blizzard Inc / SMA Solar Technology AG / Merck & Co Inc / United Airlines Holdings Inc / Adidas AG / PVH Corp / Ralph Lauren Corp / Aptiv PLC / Zynga Inc / Abbvie Inc / Stereotaxis Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / American Airlines Group Inc / Novo Nordisk A/S / Air Canada / Solaredge Technologies Inc / Adaptimmune Therapeutics PLC / Establishment Labs Holdings Inc / Mesa Air Group Inc / Yeti Holdings Inc / Transmedics Group Inc / DraftKings Inc / American Outdoor Brands Inc / Array Technologies Inc / Shoals Technologies Group Inc / FTC Solar Inc / Butterfly Network Inc / Figs Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Panama / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BSX / DE / FDS / GS / LL / MCO / MDT / MSFT.O / QCOM.O / SYK / TPR / HEAR.O / EW.N / ALGN.O / URBN.O / ABMD.OQ / ATVI.OQ / IART.OQ / TTWO.OQ / BMRN.OQ / SWKS.OQ / NFLX.O / BIIB.O / DXCM.O / 36467W109 / MRNA.O / CSII.O / AGCO.K / ZNGA.O / EA.O / CG.O / FDEV.L / 82655M107 / SPGI.K / IRTC.OQ / APL.PS / FIXX.OQ / BILI.O / FOCS.OQ / CPRI.N / SWAV.O / HUYA.K</td><td class="leftalignment">Boston Scientific Corp / Deere & Co / Factset Research Systems Inc / Goldman Sachs Group Inc / LL Flooring Holdings Inc / Moody's Corp / Medtronic PLC / Microsoft Corp / Qualcomm Inc / Stryker Corp / Tapestry Inc / Turtle Beach Corp / Edwards Lifesciences Corp / Align Technology Inc / Urban Outfitters Inc / ABIOMED Inc / Activision Blizzard Inc / Integra Lifesciences Holdings Corp / Take-Two Interactive Software Inc / Biomarin Pharmaceutical Inc / Skyworks Solutions Inc / Netflix Inc / Biogen Inc / Dexcom Inc / GameStop Corp / Moderna Inc / Cardiovascular Systems Inc / AGCO Corp / Zynga Inc / Electronic Arts Inc / Carlyle Group Inc / Frontier Developments PLC / Sify Technologies Ltd / S&P Global Inc / iRhythm Technologies Inc / Apollo Global Capital Inc / Homology Medicines Inc / Bilibili Inc / Focus Financial Partners Inc / Capri Holdings Ltd / Shockwave Medical Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Ireland / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AC.TO / AEP.N / AES.N / ALV.N / CCK.N / CF.N / CI.N / CP.TO / DCC.L / DFDS.CO / ECM.L / EIX.N / F.N / FLS.N / FMC.N / FSR.N / GM.N / MAS.N / PD.N / PHM.N / PPG.N / RWEG.DE / SCHN.PA / SO.N / T.N / TOL.N / VC.N / WEIR.L / CONG.DE / CFP.TO / GILD.O / LPX.N / TEN.N / CMCSA.O / AMGN.O / INCY.O / ETR.N / THC.N / CNR.TO / BWA.N / LEA.N / WLK.N / WCC.N / DOV.N / IEX.N / ROP.N / DISH.O / ITP.TO / UNP.N / SIEGn.DE / DV.N / MMM.N / VMC.N / ADCT.N / MGA.N / CONE.O / OLN.N / SHW.N / VZ.N / JCI.N / XEL.N / ARNA.O / APH.N / FISV.O / ADSK.O / V.N / AXL.N / IG.MI / RSG.N / NBIX.O / NWN.N / BC.N / FTS.TO / BMRN.O / REGN.O / VRTX.O / EMA.TO / NCR.N / TEL.N / GPK.N / ALFA.ST / CNP.N / WCN.N / BLU.N / CPK.N / GGG.N / PNR.N / PII.N / ST.N / SKY.N / PLUG.OQ / SGEN.OQ / GPN.N / COA.L / SGSN.S / CCLb.TO / BCRX.O / AMED.O / ICPT.O / EQIX.O / SCHN.S / BIIB.O / NTR.N / NVT.N / MOS.N / BECN.O / DLR.N / ACAD.O / GMS.N / BUCN.S / BLDR.O / LHCG.O / SJW.N / FIS.N / MA.N / MWA.N / HOG.N / H.TO / DAIGn.DE / GETP.PA / DAN.N / TXG.TO / NEE.N / CJT.TO / MTOR.N / XYL.N / EFN.TO / SRPT.O / BERY.N / TPH.N / TSLA.N / ENTA.O / TMUS.N / PTCT.O / DOOR.N / IBP.N / ITCI.O / VRNS.O / 922475108 / SAGE.OQ / AXTA.N / GLPG.O / GBT.OQ / SITE.N / MESO.O / RACE.MI / SCWX.O / ATKR.N / AZRE.N / BBU.N / NTNX.O / ADNT.N / AQN.N / OKTA.OQ / WOW.N / VNTR.N / RHIM.L / ORSTED.CO / AQUA.N / APTV.N / GTES.N / ZS.OQ / SMAR.N / DBX.O / EAF.N / ITRM.O / VNE.N / PRVB.O / ZM.O / MORF.OQ / CRWD.O / DOCU.N / APRE.OQ / CRNC.OQ / EPAC.N / WTRG.N / TFII.N / GFL.N / CARR.N / NKLA.OQ / FOUR.N / MOCORP.HE / ASAN.N / MTCR.O / RIDE.OQ / LSPD.N / DFH.OQ / WFG.N / AFRM.O / PATH.N / TSP.OQ / 9VC.F / PWSC.N / BASE.OQ</td><td class="leftalignment">Air Canada / American Electric Power Company Inc / AES Corp / Autoliv Inc / Crown Holdings Inc / CF Industries Holdings Inc / Cigna Corp / Canadian Pacific Railway Ltd / DCC PLC / DFDS AS / Electrocomponents PLC / Edison International / Ford Motor Co / Flowserve Corp / FMC Corp / Fisker Inc / General Motors Co / Masco Corp / PagerDuty Inc / Pultegroup Inc / PPG Industries Inc / Rwe AG / Schneider Electric SE / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / Weir Group PLC / Continental AG / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Entergy Corp / Tenet Healthcare Corp / Canadian National Railway Co / Borgwarner Inc / Lear Corp / Westlake Chemical Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / DISH Network Corp / Intertape Polymer Group Inc / Union Pacific Corp / Siemens AG / DoubleVerify Holdings Inc / 3M Co / Vulcan Materials Co / ADC Therapeutics SA / Magna International Inc / CyrusOne Inc / Olin Corp / Sherwin-Williams Co / Verizon Communications Inc / Johnson Controls International PLC / Xcel Energy Inc / Arena Pharmaceuticals Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Italgas SpA / Republic Services Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Brunswick Corp / Fortis Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Emera Inc / NCR Corp / TE Connectivity Ltd / Graphic Packaging Holding Co / Alfa Laval AB / CenterPoint Energy Inc / Waste Connections Inc / BELLUS Health Inc / Chesapeake Utilities Corp / Graco Inc / Pentair PLC / Polaris Inc / Sensata Technologies Holding PLC / Skyline Champion Corp / Plug Power Inc / Seagen Inc / Global Payments Inc / Coats Group PLC / SGS SA / CCL Industries Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / Equinix Inc / Schindler Holding AG / Biogen Inc / Nutrien Ltd / nVent Electric PLC / Mosaic Co / Beacon Roofing Supply Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / GMS Inc / Bucher Industries AG / Builders FirstSource Inc / LHC Group Inc / SJW Group / Fidelity National Information Services Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Hydro One Ltd / Daimler AG / Getlink SE / Dana Inc / Torex Gold Resources Inc / Nextera Energy Inc / Cargojet Inc / Meritor Inc / Xylem Inc / Element Fleet Management Corp / Sarepta Therapeutics Inc / Berry Global Group Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Masonite International Corp / Installed Building Products Inc / Intra-Cellular Therapies Inc / Varonis Systems Inc / Veeva Systems Inc / SAGE Therapeutics Inc / Axalta Coating Systems Ltd / Galapagos NV / Global Blood Therapeutics Inc / SiteOne Landscape Supply Inc / Mesoblast Ltd / Ferrari NV / SecureWorks Corp / Atkore Inc / Azure Power Global Ltd / Brookfield Business Partners LP / Nutanix Inc / Adient PLC / Algonquin Power & Utilities Corp / Okta Inc / WideOpenWest Inc / Venator Materials PLC / RHI Magnesita NV / Orsted A/S / Evoqua Water Technologies Corp / Aptiv PLC / Gates Industrial Corporation PLC / Zscaler Inc / Smartsheet Inc / Dropbox Inc / GrafTech International Ltd / Iterum Therapeutics PLC / Veoneer Inc / Provention Bio Inc / Zoom Video Communications Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / DocuSign Inc / Aprea Therapeutics Inc / Cerence Inc / Enerpac Tool Group Corp / Essential Utilities Inc / TFI International Inc / GFL Environmental Inc / Carrier Global Corp / Nikola Corp / Shift4 Payments Inc / Metso Outotec Corp / Asana Inc / Metacrine Inc / Lordstown Motors Corp / Lightspeed Commerce Inc / Dream Finders Homes Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / UiPath Inc / TuSimple Holdings Inc / ATAI Life Sciences NV / PowerSchool Holdings Inc / Couchbase Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Finland / France / United Kingdom / Ireland / Italy / Mauritius / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / INCY.O / VRTX.O / BLU.N / BCRX.O / ICPT.O / BIIB.O / SRPT.O / ENTA.O / PTCT.O / SAGE.OQ / GLPG.O / GBT.OQ / ITRM.O / PRVB.O / MORF.OQ / APRE.OQ / MTCR.O / 9VC.F</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / BELLUS Health Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / SAGE Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / Iterum Therapeutics PLC / Provention Bio Inc / Morphic Holding Inc / Aprea Therapeutics Inc / Metacrine Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">The Utility Trader - A September to remember, we hope</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">US1258961002 / US15189T1079 / GB0009895292 / US0188021085 / US0236081024 / US0255371017 / US2091151041 / US2333311072 / US25746U1097 / US2810201077 / US30161N1019 / US3379321074 / US65473P1057 / US6708371033 / US69331C1080 / US7234841010 / US7445731067 / US8168511090 / US98389B1008 / CA3495531079 / US09062X1037 / US6293775085 / US7365088472 / US25470M1099 / US0304201033 / CH0102993182 / US65339F1012 / US26441C2044 / US65341B1061 / US30040W1080 / US92939U1060 / US05351W1036 / US30034W1062 / US92336X1090 / US18539C1053 / US0090661010</td><td class="leftalignment">CMS Energy Corp / CenterPoint Energy Inc / AstraZeneca PLC / Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Consolidated Edison Inc / DTE Energy Co / Dominion Energy Inc / Edison International / Exelon Corp / FirstEnergy Corp / NiSource Inc / OGE Energy Corp / PG&E Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Sempra Energy / Xcel Energy Inc / Fortis Inc / Biogen Inc / NRG Energy Inc / Portland General Electric Co / DISH Network Corp / American Water Works Company Inc / TE Connectivity Ltd / Nextera Energy Inc / Duke Energy Corp / Nextera Energy Partners LP / Eversource Energy / WEC Energy Group Inc / Avangrid Inc / Evergy Inc / Veoneer Inc / Clearway Energy Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Steve Fleishman / Alex Kania / Mr. David Paz / Keith Stanley / Michael Sullivan / David Peters / Connor McMahon</td></tr>
<tr class="even"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">TNGX - The Next Innovative Player in "La Cumparsita" of Synthetic Lethality; Initiating Coverage of Tango Therapeutics with a BUY Rating and $16 PT</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BP2P6L0 / 0989529 / 0925288 / 2126335 / 2369174 / 2455965 / 2684703 / 7103065 / BCBVTX1 / BBPK0J0 / BK0VHF6 / BYYWPW6 / BL71K91 / BN2RM92 / BLF0CW7</td><td class="leftalignment">Tango Therapeutics Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Novartis AG / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / IDEAYA Biosciences Inc / Beigene Ltd / Revolution Medicines Inc / Rain Therapeutics Inc / Repare Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Women in Biotech Progress - Yet Challenges Remain</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.O / MRNA.O</td><td class="leftalignment">Biogen Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Maldives / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 563</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Sept. 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / SYK / UNH / WMT / NOVN.S / HCA.N / CYH.N / COO.N / EW.N / SSNC.O / BCRX.OQ / ISRG.OQ / CCRN.O / ICAD.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / ATRC.OQ / LHCG.O / ENSG.OQ / 483548103 / TMDX.OQ / BBI.O / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GOOGL.O / AGRX.OQ / VBLT.O / EVH.N / TDOC.N / ZBH.N / CFMS.O / APLS.OQ / 100063846 / IONS.OQ / FLGT.OQ / ATXI.OQ / VERU.OQ / 720795103 / VCNX.OQ / MITO.OQ / SWAV.O / BWAY.TA / TPTX.O / BCYC.O / PNTG.OQ / ONEM.OQ / 14888D208 / REGW.M3</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Cooper Companies Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / BioCryst Pharmaceuticals Inc / Intuitive Surgical Inc / Cross Country Healthcare Inc / ICAD Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AtriCure Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / Brickell Biotech Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Agile Therapeutics Inc / Vascular Biogenics Ltd / Evolent Health Inc / Teladoc Health Inc / Zimmer Biomet Holdings Inc / Conformis Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / Fulgent Genetics Inc / Avenue Therapeutics Inc / Veru Inc / Pieris Pharmaceuticals Inc / Vaccinex Inc / Stealth BioTherapeutics Corp / Shockwave Medical Inc / Brainsway Ltd / Turning Point Therapeutics Inc / Bicycle Therapeutics PLC / Pennant Group Inc / 1Life Healthcare Inc / Catalyst Biosciences Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - September 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">FR0000120271 / NL0000226223 / DE0006231004 / GB0007980591 / US00971T1016 / US0126531013 / US0378331005 / US0382221051 / US0556221044 / US1727551004 / US2480191012 / US30231G1022 / US3695501086 / US5951121038 / US7392761034 / US7475251036 / US8168501018 / US8610121027 / US8807701029 / US8832031012 / US91347P1057 / US92343V1044 / US9581021055 / US1667641005 / US89151E1091 / US87157D1090 / AU000000LYC6 / US83088M1027 / US92343X1000 / US20030N1019 / US09062X1037 / US1572101053 / US0042251084 / US02043Q1076 / GB00B03MLX29 / US2538681030 / US19239V3024 / RDSa.AS / US2090341072 / US00206R1023 / ACOR.OQ / US82706C1080 / US8485741099 / US53261M1045 / US25470M1099 / US03027X1000 / NL0010273215 / US8725901040 / US23283R1005 / US5253271028 / US0465131078 / US22822V1017 / US74736K1016 / US29444U7000 / US00653A1079 / US12685J1051 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / US78410G1040 / US91325V1089 / US02156K1034 / US87105L1044 / CA53680Q2071 / US05351X1019 / US11135F1012 / US92336X1090 / US0197701065 / US53814L1089 / US0144421072 / US09203E1055 / US92537N1081 / CH0499880968 / KYG3902L1095 / US5533681012 / US5502411037 / US25401T1088 / US35909D1090 / US86738J1060</td><td class="leftalignment">TotalEnergies SE / STMicroelectronics NV / Infineon Technologies AG / BP PLC / Akamai Technologies Inc / Albemarle Corp / Apple Inc / Applied Materials Inc / BP PLC / Cirrus Logic Inc / Deluxe Corp / Exxon Mobil Corp / General Dynamics Corp / Micron Technology Inc / Power Integrations Inc / Qualcomm Inc / Semtech Corp / STMicroelectronics NV / Teradyne Inc / Textron Inc / Universal Display Corp / Verizon Communications Inc / Western Digital Corp / Chevron Corp / TotalEnergies SE / Synaptics Inc / Lynas Rare Earths Ltd / Skyworks Solutions Inc / Verint Systems Inc / Comcast Corp / Biogen Inc / CEVA Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Royal Dutch Shell PLC / Consolidated Communications Holdings Inc / AT&T Inc / Acorda Therapeutics Inc / Silicon Motion Technology Corp / Spirit AeroSystems Holdings Inc / Limelight Networks Inc / DISH Network Corp / American Tower Corp / ASML Holding NV / T-Mobile US Inc / CyrusOne Inc / Leidos Holdings Inc / Atara Biotherapeutics Inc / Crown Castle International Corp / Qorvo Inc / Equinix Inc / Adaptimmune Therapeutics PLC / Cable One Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / SBA Communications Corp / Uniti Group Inc / Altice USA Inc / Switch Inc / Lithium Americas Corp / Avaya Holdings Corp / Broadcom Inc / Veoneer Inc / Allogene Therapeutics Inc / Livent Corp / Alector Inc / Black Diamond Therapeutics Inc / Vertiv Holdings Co / ADC Therapeutics SA / GDS Holdings Ltd / Mp Materials Corp / Lumen Technologies Inc / DigitalBridge Group Inc / Frontier Communications Parent Inc / Sunlight Financial Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 8/27/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Inflows Keep on Rollin'</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / DCI / HRL / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ / ONEM.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Donaldson Company Inc / Hormel Foods Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / 1Life Healthcare Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ / ONEM.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / 1Life Healthcare Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Matt Nirenberg, CFA, CFA / Michael D. Wiederhorn</td></tr>
<tr class="even"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, BIIB</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 01 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0126531013 / US1264081035 / US2480191012 / US6558441084 / US9078181081 / CA1363751027 / CA13645T1003 / AU000000LYC6 / US92343X1000 / US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / KYG037AX1015 / US0465131078 / US00653A1079 / US05464T1043 / US00773U1088 / GB00BDSFG982 / US05351X1019 / US0197701065 / US0144421072 / US22788C1053 / US09203E1055 / US92537N1081 / CH0499880968 / US5533681012 / US70435P1021</td><td class="leftalignment">Albemarle Corp / CSX Corp / Deluxe Corp / Norfolk Southern Corp / Union Pacific Corp / Canadian National Railway Co / Canadian Pacific Railway Ltd / Lynas Rare Earths Ltd / Verint Systems Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Ambarella Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / TechnipFMC PLC / Avaya Holdings Corp / Allogene Therapeutics Inc / Alector Inc / CrowdStrike Holdings Inc / Black Diamond Therapeutics Inc / Vertiv Holdings Co / ADC Therapeutics SA / Mp Materials Corp / Paycor HCM Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Sep 01 2021 6:53AM</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">2303.TW / 2330.TW / 7974.T / DBD / DIN / FITB.O / GME / IBM / INTC.O / IS / MSFT.O / QCOM.O / U / UBIP.PA / WSM / AMZN.O / AAPL.O / ATVI.O / HBAN.O / DNLI.O / NVDA.O / TTWO.O / AMD.O / NTAP.O / TPX / NBIX.O / ARGX.O / UTHR.O / 2454.TW / BMRN.O / MU.O / CAKE.O / MRVL.O / HPE / AVGO.O / SWTX.O / RARE.O / ICPT.O / SWKS.O / AXTI.O / BIIB.O / SBNY.O / STX.O / SIMO.O / LXRX.O / OMER.O / TSLA.O / 37045V100 / PCRX.O / ZNGA.O / EA.O / WEN.O / WDC.O / EPZM.O / ORCL.K / MGNX.O / FATE.O / WIX.O / KPTI.O / XNCR.O / GOOGL.O / ARDX.O / SAGE.O / XENE.O / QRVO.O / CUBI.K / CDTX.O / PYPL.O / GBT.O / PSTG.K / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / OBSV.O / FENC.O / SNBR.O / APLS.O / SAIL.K / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / BHVN.K / ALNA.O / DELL.K / ETTX.O / HARP.O / PRPL.O / ISEE.O / SCPL.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / US82837P4081 / CSPR.K / BDTX.O / BCEL.O / ZNTL.O / VRM.O / FUSN.O / TSHA.O / RCUS.K / PRAX.O / EWTX.O / 23954D109 / 23284P103 / 28623U101 / 1BCR8K47US / 68217N105 / IMPL.O</td><td class="leftalignment">United Microelectronics Corp / Taiwan Semiconductor Manufacturing Co Ltd / Nintendo Co Ltd / Diebold Nixdorf Inc / Dine Brands Global Inc / Fifth Third Bancorp / GameStop Corp / International Business Machines Corp / Intel Corp / Ironsource Ltd / Microsoft Corp / Qualcomm Inc / Unity Software Inc / Ubisoft Entertainment SA / Williams-Sonoma Inc / Amazon.com Inc / Apple Inc / Activision Blizzard Inc / Huntington Bancshares Inc / Denali Therapeutics Inc / NVIDIA Corp / Take-Two Interactive Software Inc / Advanced Micro Devices Inc / NetApp Inc / Tempur Sealy International Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / MediaTek Inc / Biomarin Pharmaceutical Inc / Micron Technology Inc / Cheesecake Factory Inc / Marvell Technology Inc / Hewlett Packard Enterprise Co / Broadcom Inc / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Skyworks Solutions Inc / AXT Inc / Biogen Inc / Signature Bank / Seagate Technology Holdings PLC / Silicon Motion Technology Corp / Lexicon Pharmaceuticals Inc / Omeros Corp / Tesla Inc / General Motors Co / Pacira Biosciences Inc / Zynga Inc / Electronic Arts Inc / Wendys Co / Western Digital Corp / Epizyme Inc / Oracle Corp / MacroGenics Inc / Fate Therapeutics Inc / Wix.Com Ltd / Karyopharm Therapeutics Inc / Xencor Inc / Alphabet Inc / Ardelyx Inc / SAGE Therapeutics Inc / Xenon Pharmaceuticals Inc / Qorvo Inc / Customers Bancorp Inc / Cidara Therapeutics Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Pure Storage Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Sleep Number Corp / Apellis Pharmaceuticals Inc / SailPoint Technologies Holdings Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Biohaven Pharmaceutical Holding Company Ltd / Allena Pharmaceuticals Inc / Dell Technologies Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Purple Innovation Inc / Iveric Bio Inc / Sciplay Corp / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Silvergate Capital Corp / Casper Sleep Inc / Black Diamond Therapeutics Inc / Atreca Inc / Zentalis Pharmaceuticals Inc / Vroom Inc / Fusion Pharmaceuticals Inc / Taysha Gene Therapies Inc / Arcus Biosciences Inc / Praxis Precision Medicines Inc / Edgewise Therapeutics Inc / Day One Biopharmaceuticals Inc / Cyteir Therapeutics Inc / Elevation Oncology Inc / Aerovate Therapeutics Inc / Omega Therapeutics Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / Ireland / Israel / Japan / Netherlands / Turkey / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Wedbush Monthly Check-Up: September 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">DNLI.O / NBIX.O / ARGX.O / UTHR.O / BMRN.O / SWTX.O / RARE.O / ICPT.O / BIIB.O / LXRX.O / OMER.O / PCRX.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / ARDX.O / SAGE.O / XENE.O / CDTX.O / GBT.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / OBSV.O / FENC.O / APLS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / BHVN.K / ALNA.O / ETTX.O / HARP.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BDTX.O / BCEL.O / ZNTL.O / FUSN.O / TSHA.O / RCUS.K / PRAX.O / EWTX.O / 23954D109 / 23284P103 / 28623U101 / 1BCR8K47US / 68217N105 / IMPL.O</td><td class="leftalignment">Denali Therapeutics Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / Biomarin Pharmaceutical Inc / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Lexicon Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Ardelyx Inc / SAGE Therapeutics Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Biohaven Pharmaceutical Holding Company Ltd / Allena Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Black Diamond Therapeutics Inc / Atreca Inc / Zentalis Pharmaceuticals Inc / Fusion Pharmaceuticals Inc / Taysha Gene Therapies Inc / Arcus Biosciences Inc / Praxis Precision Medicines Inc / Edgewise Therapeutics Inc / Day One Biopharmaceuticals Inc / Cyteir Therapeutics Inc / Elevation Oncology Inc / Aerovate Therapeutics Inc / Omega Therapeutics Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Mr. Andreas Argyrides / Dennis Pak</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - September 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMO.TO / CAS.TO / CM.TO / CP.TO / IBE.MC / NA / RWEG.DE / STO.AX / T.TO / TD.TO / TRI.N / CNQ.TO / GILD.O / AAL.L / ENB.TO / TRP.TO / SU.TO / DVN.N / MGA.N / NG.L / ALA.TO / SRE.N / RRC.N / EPD.N / WSP.TO / FTS.TO / VRTX.O / FTT.TO / COP.N / APF.L / MEOH.O / WCN.N / DOL.TO / CRC.N / HCC.N / LNG.A / CCLb.TO / ATDb.TO / BIIB.O / FMG.AX / TIH.TO / MFI.TO / 878742204 / NTR.N / ACAD.O / NESTE.HE / WSA.AX / RDSb.L / BAM.N / DRX.L / SES.TO / CSU.TO / PPL.TO / GETP.PA / EDPR.LS / ARX.TO / CLW.N / IFC.TO / AAV.TO / CVE.TO / BHPB.L / MNR.N / NEE.N / MEG.TO / TOU.TO / GLEN.L / TVE.TO / EFN.TO / RFP.N / KPT.TO / ENTA.O / PTCT.O / QSR.N / AZRE.N / AKERBP.OL / AQN.N / WPM.N / ORSTED.CO / GMDA.OQ / CRWD.O / FCR_u.TO / GFL.N / AKES.OL / MTCR.O / WFG.N / GIP.V / EVGN.V</td><td class="leftalignment">Bank of Montreal / Cascades Inc / Canadian Imperial Bank of Commerce / Canadian Pacific Railway Ltd / Iberdrola SA / National Bank of Canada / Rwe AG / Santos Ltd / Telus Corp / Toronto-Dominion Bank / Thomson Reuters Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Anglo American PLC / Enbridge Inc / TC Energy Corp / Suncor Energy Inc / Devon Energy Corp / Magna International Inc / National Grid PLC / AltaGas Ltd / Sempra Energy / Range Resources Corp / Enterprise Products Partners LP / WSP Global Inc / Fortis Inc / Vertex Pharmaceuticals Inc / Finning International Inc / Conocophillips / Anglo Pacific Group PLC / Methanex Corp / Waste Connections Inc / Dollarama Inc / California Resources Corp / Warrior Met Coal Inc / Cheniere Energy Inc / CCL Industries Inc / Alimentation Couche-Tard Inc / Biogen Inc / Fortescue Metals Group Ltd / Toromont Industries Ltd / Maple Leaf Foods Inc / Teck Resources Ltd / Nutrien Ltd / ACADIA Pharmaceuticals Inc / Neste Oyj / Western Areas Ltd / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Drax Group PLC / Secure Energy Services Inc / Constellation Software Inc / Pembina Pipeline Corp / Getlink SE / EDP Renovaveis SA / ARC Resources Ltd / Clearwater Paper Corp / Intact Financial Corp / Advantage Energy Ltd / Cenovus Energy Inc / BHP Group PLC / Monmouth Real Estate Investment Corp / Nextera Energy Inc / MEG Energy Corp / Tourmaline Oil Corp / Glencore PLC / Tamarack Valley Energy Ltd / Element Fleet Management Corp / Resolute Forest Products Inc / KP Tissue Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Restaurant Brands International Inc / Azure Power Global Ltd / Aker BP ASA / Algonquin Power & Utilities Corp / Wheaton Precious Metals Corp / Orsted A/S / Gamida Cell Ltd / CrowdStrike Holdings Inc / First Capital Real Estate Investment Trust / GFL Environmental Inc / Aker Solutions ASA / Metacrine Inc / West Fraser Timber Co Ltd / Green Impact Partners Inc / EverGen Infrastructure Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Mauritius / Norway / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech Lit Bits: A Review of Interesting Literature and Science</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / VRTX.O / BIIB.O / ACAD.O / ENTA.O / PTCT.O / GMDA.OQ / MTCR.O</td><td class="leftalignment">Gilead Sciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Gamida Cell Ltd / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen's Biotech Thermometer</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US0465131078 / US00653A1079 / US05464T1043 / US00773U1088 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / China / Germany / Denmark / United Kingdom / Ireland / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Biogen (BIIB: $338.91) lifts 2%, beating 84% of stocks</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">QCOM.O / SYK / NOVN.S / AVGO.O / CRUS.OQ / BCRX.OQ / SWKS.OQ / NDSN.O / SYNA.O / BIIB.O / 478160104 / 691497309 / 00826A109 / 771195104 / AGRX.OQ / QRVO.O / ZBH.N / CFMS.O / APLS.OQ / IONS.OQ / FLGT.OQ / AKTS.OQ / VERU.OQ / MITO.OQ / ZM.OQ / RXT.O / 14888D208 / REGW.M3</td><td class="leftalignment">Qualcomm Inc / Stryker Corp / Novartis AG / Broadcom Inc / Cirrus Logic Inc / BioCryst Pharmaceuticals Inc / Skyworks Solutions Inc / Nordson Corp / Synaptics Inc / Biogen Inc / Johnson & Johnson / Oxford Industries Inc / Affymax Inc / Roche Holding AG / Agile Therapeutics Inc / Qorvo Inc / Zimmer Biomet Holdings Inc / Conformis Inc / Apellis Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Fulgent Genetics Inc / Akoustis Technologies Inc / Veru Inc / Stealth BioTherapeutics Corp / Zoom Video Communications Inc / Rackspace Technology Inc / Catalyst Biosciences Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / India / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Watershed Moment Approaching for Complement Therapeutics?</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">NOVN.S / BCRX.OQ / BIIB.O / 478160104 / 771195104 / APLS.OQ / IONS.OQ / MITO.OQ / 14888D208 / REGW.M3</td><td class="leftalignment">Novartis AG / BioCryst Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Roche Holding AG / Apellis Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / Stealth BioTherapeutics Corp / Catalyst Biosciences Inc / Regency World Consulting Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Justin A. Kim / Mr. Hartaj K. Singh</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Preliminary Signs of Domestic Inflection, Awaiting Return to School Impact, Fall Seasonality, and Booster Rollout</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 20, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Innovative Platforms Could Offer an Advantage in the ADC Market; Initiate Buy with $28 PT</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">ADCT.N / 59045L106 / BIIB / 45253H101 / 84763A108 / 189464100 / 74587V107 / MRSN.OQ / 09203E105 / H0036K147 / CGEM.OQ</td><td class="leftalignment">ADC Therapeutics SA / Mersana Therapeutics Inc / Biogen Inc / ImmunoGen Inc / Spectrum Pharmaceuticals Inc / Clovis Oncology Inc / Puma Biotechnology Inc / Mersana Therapeutics Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / Cullinan Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Edward P. White, II</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Auerbach Grayson & Co., Inc.</td><td class="leftalignment">AUERBACH GRAYSON: CEEMEA & LATAM Daily Morning Note 08-30-21:  (Al-Ahlyia, Alinma Bank, Allegro.eu, Ariston, CD Projekt, Cleopatra Hospital, Commercial International Bank, Dar Al-Salam for Insurance, Gruma, Grupa Azoty, Lotos, I&M Bank)</td><td class="leftalignment">English</td><td class="rightalignment">73</td><td class="leftalignment">AL0.F / ARIS.ZI / ATTP.WA / CDR.WA / CLHO.CA / COMI.CA / GRUMAB.MX / LTSP.WA / GRUMAB@MM / PLKGHM000017 / PLPKN0000018 / SI0031102153 / SI0031101346 / EGS60121C018 / EGS65851C015 / ZW0009011041 / PLLOTOS00025 / SA0007879543 / US46630Q2021 / ATT@PW / IQ000A0M7TE8 / IQ000A0M9C48 / PLJSW0000015 / TOL@TZ / 6873659 / OVO@PW / PKP@PW / LVC@PW / NEMAKA@MM / BIIB@IQ / ALINMA@AB / CDR@PW / CLHO@EY / M@RO / PLW@PW / SPMD@EY / NCBA@KN / RBW@PW / ALE@PW / IMH@KN / ORIGO@IR / MFPC@EY / IS0000000479</td><td class="leftalignment">Allegro.eu SA / Ariston Holdings Ltd / Grupa Azoty SA / CD Projekt SA / Cleopatra Hospital SAE / Commercial International Bank Egypt SAE / Gruma SAB de CV / Grupa Lotos SA / Gruma SAB de CV / KGHM Polska Miedz SA / Polski Koncern Naftowy Orlen SA / Petrol dd Ljubljana / Luka Koper dd / Commercial International Bank Egypt SAE / Sixth of October Development and Investment Co SAE / Ariston Holdings Ltd / Grupa Lotos SA / Saudi Telecom Company SJSC / Bank VTB PAO / Grupa Azoty SA / Al Ahlyia for Agricultural Production / Dar Al Salam for Insurance Co / Jastrzebska Spolka Weglowa SA / Tol Gases Ltd / Tanzania Cigarette Company Ltd / Ovostar Union NV / PKP Cargo SA / Livechat Software SA / Nemak SAB de CV / Iraqi Islamic Bank for Investment & Development / Alinma Bank SJSC / CD Projekt SA / Cleopatra Hospital SAE / Med Life SA / Playway SA / Speed Medical SAE / NCBA Group PLC / Rainbow Tours SA / Allegro.eu SA / I&M Holdings PLC / Origo hf / Misr Fertilizers Production Co SAE / Sildarvinnslan hf</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">Brazil / Czech Republic / Egypt / Greece / Croatia / Hungary / Iraq / Iceland / Jamaica / Kenya / Mexico / Namibia / Nigeria / Peru / Poland / Romania / Russian Federation / Saudi Arabia / Slovenia / Tanzania, United Republic of / Ukraine / Uganda / Zimbabwe / Palestine</td><td class="leftalignment">Agriculture / Automotive / Banks / Beverages & Tobacco / Building & Building Materials / Chemicals / Communications / Engineering & Construction / Fertilizers / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Insurance / Metals & Minerals / Railroads / Real Estate / Retailing / Tire & Rubber / Transportation / Wholesale</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Auerbach Grayson</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Biogen Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / INTC.O / QCOM.O / RAD / UNH / WMT / NVDA.O / MPWR.O / HCA.N / CYH.N / SMTC.O / SSNC.O / AVGO.O / CRUS.OQ / XLNX.OQ / SWKS.OQ / CCRN.O / TXN.OQ / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / 514766104 / MD.N / ADUS.O / USPH.N / NXPI.O / AMD.OQ / ADI.OQ / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ / 84764T304</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Intel Corp / Qualcomm Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / NVIDIA Corp / Monolithic Power Systems Inc / HCA Healthcare Inc / Community Health Systems Inc / Semtech Corp / SS&C Technologies Holdings Inc / Broadcom Inc / Cirrus Logic Inc / Xilinx Inc / Skyworks Solutions Inc / Cross Country Healthcare Inc / Texas Instruments Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Landec Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / NXP Semiconductors NV / Advanced Micro Devices Inc / Analog Devices Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc / Speed Commerce Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 562</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101 / 45114M109</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc / Icosavax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 8/20/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN.K / IMPL.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Will Biogen Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Inflows Come Roaring Back</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Achieves 100% enrollment Phase 3 addiction trial - Adial Pharma - Raising PT to $15 from $5 - reiterate Buy rating</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ADIL.OQ / ALKS.OQ / EXAS.OQ / BIIB.OQ / EBS.N / MNOV.OQ / ACRX.OQ / TRVN.OQ / INDV.L / TTNP.OQ / ALT.OQ / ANEB.OQ / 120551486</td><td class="leftalignment">Adial Pharmaceuticals Inc / Alkermes Plc / Exact Sciences Corp / Biogen Inc / Emergent BioSolutions Inc / MediciNova Inc / AcelRx Pharmaceuticals Inc / Trevena Inc / Indivior PLC / Titan Pharmaceuticals Inc / Altimmune Inc / Anebulo Pharmaceuticals Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">CAR-Treg Trailblazer: STEADFAST Program Could Open Platform to Multiple Blockbuster Autoimmune Disease Indications</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">800677106 / BIIB</td><td class="leftalignment">Sangamo Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">2Q21 Results; Broad Progress Across Internal and External Pipeline; Fabry Program Moves Into Third Cohort</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">800677106 / BIIB</td><td class="leftalignment">Sangamo Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Patrick R. Trucchio, CFA</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BOX.N / TOL.N / ADML.L / ADSK.O / WSM.N / BIIB.O / DRX.L / SPLK.OQ / DLGD.L / CARG.O / ESTC.N / SLQT.N / ACC-ME.OL</td><td class="leftalignment">Box Inc / Toll Brothers Inc / Admiral Group PLC / Autodesk Inc / Williams-Sonoma Inc / Biogen Inc / Drax Group PLC / Splunk Inc / Direct Line Insurance Group PLC / CarGurus Inc / Elastic NV / SelectQuote Inc / Aker Carbon Capture ASA</td><td class="leftalignment"></td><td class="leftalignment">China / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">NOVN / PRGO / TEVA / ARDS / BIIB / TXMD / HRTX</td><td class="leftalignment">Novan Inc / Perrigo Company PLC / Teva Pharmaceutical Industries Ltd / Aridis Pharmaceuticals Inc / Biogen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Latest Monthly Aduhelm Pulse Survey Points to Moderating Sentiment</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Ownership Timelines & Shareholder Analytics (August 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 13, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Biogen in top 10% performers of NASDAQ market in past quarter; Institutional Ownership down 3%</td><td class="leftalignment">English</td><td class="rightalignment">85</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / NKE / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 344849104 / 868168105 / LHCG.O / LULU.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / UAA / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Nike Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Foot Locker Inc / Superior Industries International Inc / LHC Group Inc / Lululemon Athletica Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Under Armour Inc / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 561</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--August 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">4502.T / ACA / AMN / BSX / CHE / CI / CNC / CRY.N / CVS / HUM / IVC / MDT / RAD / ROG / SYK / UNH / WMT / GILD.O / AMGN.O / NOVN.S / HCA.N / CYH.N / EW.N / SSNC.O / ISR / SRDX.O / NOVN.OQ / EPIX.OQ / ICPT.OQ / ISRG.OQ / CCRN.O / ICAD.O / AMED.O / EXAS.O / BIIB.O / 478160104 / 00846U101 / 868168105 / ANGO.OQ / MBRX.OQ / ATRC.OQ / LHCG.O / BLRX.TA / ENSG.OQ / 483548103 / MRNA.O / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / MDXG.O / AXGN.O / FATE.OQ / GOOGL.O / CBAY.OQ / MRNS.O / VBLT.O / CATB.OQ / EVH.N / TDOC.N / ZBH.N / SPNE.O / 100063846 / SSKN.OQ / VREX.OQ / 45780L104 / IPIX.PK / MBIO.OQ / CUE.OQ / 720795103 / MOTS.O / ORTX.OQ / SWAV.O / BWAY.TA / FREQ.OQ / PNTG.OQ / APRE.O / VERO.O / ETNB.O / AYLA.O / FMTX.O / NNOX.O / 03823M100 / N69603145</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Humana Inc / Invacare Corp / Medtronic PLC / Rite Aid Corp / Rogers Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / IsoRay Inc / Surmodics Inc / Novan Inc / ESSA Pharma Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / Cross Country Healthcare Inc / ICAD Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AngioDynamics Inc / Moleculin Biotech Inc / AtriCure Inc / LHC Group Inc / BioLine RX Ltd / Ensign Group Inc / Kaman Corp / Moderna Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / MiMedx Group Inc / AxoGen Inc / Fate Therapeutics Inc / Alphabet Inc / Cymabay Therapeutics Inc / Marinus Pharmaceuticals Inc / Vascular Biogenics Ltd / Astria Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Zimmer Biomet Holdings Inc / SeaSpine Holdings Corp / Truist Financial Corp / STRATA Skin Sciences Inc / Varex Imaging Corp / Inogen Inc / Innovation Pharmaceuticals Inc / Mustang Bio Inc / Cue Biopharma Inc / Pieris Pharmaceuticals Inc / Motus GI Holdings Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / Brainsway Ltd / Frequency Therapeutics Inc / Pennant Group Inc / Aprea Therapeutics Inc / Venus Concept Inc / 89Bio Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Nano-X Imaging Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Israel / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 8/13/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Another Week, Another Outflow - Fund Flow Stays Negative This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">INTC.O / IVC / MSFT.O / QCOM.O / ROG / SYK / AMGN.O / NVDA.O / HEAR.O / MPWR.O / SMTC.O / AVGO.O / CSCO.OQ / CRUS.OQ / ATVI.OQ / NOVN.OQ / XLNX.OQ / TTWO.OQ / ADS.N / SWKS.OQ / TXN.OQ / EXAS.O / NFLX.O / BIIB.O / 478160104 / 00846U101 / 36467W109 / BLRX.TA / 514766104 / MRNA.O / 771195104 / NXPI.O / AMD.OQ / ZNGA.O / EA.O / ADI.OQ / FDEV.L / 82655M107 / CBAY.OQ / ZBH.N / 45780L104 / IPIX.PK / BILI.O / APRE.O / DKNG.O / 84764T304 / HUYA.K / 03823M100</td><td class="leftalignment">Intel Corp / Invacare Corp / Microsoft Corp / Qualcomm Inc / Rogers Corp / Stryker Corp / Amgen Inc / NVIDIA Corp / Turtle Beach Corp / Monolithic Power Systems Inc / Semtech Corp / Broadcom Inc / Cisco Systems Inc / Cirrus Logic Inc / Activision Blizzard Inc / Novan Inc / Xilinx Inc / Take-Two Interactive Software Inc / Alliance Data Systems Corp / Skyworks Solutions Inc / Texas Instruments Inc / Exact Sciences Corp / Netflix Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / GameStop Corp / BioLine RX Ltd / Landec Corp / Moderna Inc / Roche Holding AG / NXP Semiconductors NV / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Frontier Developments PLC / Sify Technologies Ltd / Cymabay Therapeutics Inc / Zimmer Biomet Holdings Inc / Inogen Inc / Innovation Pharmaceuticals Inc / Bilibili Inc / Aprea Therapeutics Inc / DraftKings Inc / Speed Commerce Inc / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / India / Israel / Japan / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Women Leaders in Biotechnology Inspire from Kendall Square</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BIIB.O / MRNA.O</td><td class="leftalignment">Biogen Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">08/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">9960.HK: Kindstar Globalgene Technology Inc - A comprehensive one-stop, esoteric-testing top player in the making</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">9960.HK / ROG.S / BIIB.OQ / 002030.SZ / 300244.SZ / NEO.OQ</td><td class="leftalignment">Kindstar Globalgene Technology Inc / Roche Holding AG / Biogen Inc / Daan Gene Co Ltd / Dian Diagnostics Group Co Ltd / Neogenomics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INTERNAL REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Delta Continues to Drive Domestic and Global Growth; Early Signs From Back to School in Low Vaccination Areas Concerning</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 6, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / BBI.O / MD.N / ADUS.O / USPH.N / GOOGL.O / CASI.OQ / EVH.N / TDOC.N / 100063846 / 720795103 / PDSB.OQ / 21833P103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Brickell Biotech Inc / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / CASI Pharmaceuticals Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / PDS Biotechnology Corp / Corbus Pharmaceuticals Holdings Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 560</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--August 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / HUM / KR / MDT / RAD / UNH / WMT / ACI.N / GILD.O / AMGN.O / NOVN.S / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / SSNC.O / ICPT.OQ / UTHR.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / VRTX.OQ / CCRN.O / LIFE.O / AMED.O / EXAS.O / BIIB.O / 478160104 / 00846U101 / 868168105 / MBRX.OQ / MNKD.O / ATRC.OQ / LHCG.O / CYCC.OQ / B8FGn.DE / ALCLS.PA / 02043Q107 / ENSG.OQ / 483548103 / TMDX.OQ / BBI.O / MD.N / 771195104 / ADUS.O / SVA.O / USPH.N / GLAXOSM.LG / ENTA.O / PRTA.OQ / MRTX.OQ / FATE.OQ / TRVN.O / GOOGL.O / MDWD.O / 02005N100 / CASI.OQ / XENT.OQ / CLRB.OQ / MRNS.O / INO.O / VCEL.O / EVH.N / TDOC.N / GKOS.K / MMD.WA / APLS.OQ / 100063846 / IONS.OQ / FLGT.OQ / MDGL.O / SRRA.O / PLXP.O / IOVA.OQ / ALPN.O / VERU.OQ / ACHV.O / MTEM.O / SVRA.O / SYBX.O / FIXX.OQ / 720795103 / ALLO.OQ / MRKR.OQ / SWAV.O / PDSB.OQ / 21833P103 / BWAY.TA / TPTX.O / ORGO.O / IDYA.OQ / ONCT.OQ / BCYC.O / XAIR.OQ / PNTG.OQ / RLMD.OQ / ORIC.OQ / HGEN.O / NNOX.O</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Kroger Co / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Albertsons Companies Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / SS&C Technologies Holdings Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Moleculin Biotech Inc / MannKind Corp / AtriCure Inc / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Biofrontera AG / Cellectis SA / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / Brickell Biotech Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / Sinovac Biotech Ltd / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Enanta Pharmaceuticals Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Fate Therapeutics Inc / Trevena Inc / Alphabet Inc / Mediwound Ltd / Ally Financial Inc / CASI Pharmaceuticals Inc / Intersect Ent Inc / Cellectar Biosciences Inc / Marinus Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Vericel Corp / Evolent Health Inc / Teladoc Health Inc / Glaukos Corp / Milestone Medical Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Ionis Pharmaceuticals Inc / Fulgent Genetics Inc / Madrigal Pharmaceuticals Inc / Sierra Oncology Inc / PLx Pharma Inc / Iovance Biotherapeutics Inc / Alpine Immune Sciences Inc / Veru Inc / Achieve Life Sciences Inc / Molecular Templates Inc / Savara Inc / Synlogic Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / Shockwave Medical Inc / PDS Biotechnology Corp / Corbus Pharmaceuticals Holdings Inc / Brainsway Ltd / Turning Point Therapeutics Inc / Organogenesis Holdings Inc / IDEAYA Biosciences Inc / Oncternal Therapeutics Inc / Bicycle Therapeutics PLC / Beyond Air Inc / Pennant Group Inc / Relmada Therapeutics Inc / Oric Pharmaceuticals Inc / Humanigen Inc / Nano-X Imaging Ltd</td><td class="leftalignment"></td><td class="leftalignment">Antigua and Barbuda / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Japan / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 8/6/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Summer May Be Ending, but Things Are Heating Up for Innate Immunity Drug Development: Featuring Top 10 Hot Targets in Neuro/Immunology</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">0925288 / 2126335 / 2516152 / 2778844 / 2369174 / 2455965 / 7103065 / BGCYWN8 / BMPRZV5 / BJLV8T9</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Novartis AG / Xencor Inc / Kymera Therapeutics Inc / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yatin Suneja / Debjit Chattopadhyay, Ph.D. / Mr. Etzer Darout / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Brief (We Hope) Pause in the Action – Fund Flow Turns Negative This Week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Biotechnology Sector - Dejavu? Will we see a strong 1H22 following weak 2H21 just like we had a strong 1H21 after weak 2H20?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BGNE.OQ / 1177.HK / SGEN.OQ / BIIB.OQ / 600276.SS / 0656.HK / ZLAB.OQ / 1877.HK</td><td class="leftalignment">Beigene Ltd / Sino Biopharmaceutical Ltd / Seagen Inc / Biogen Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Fosun International Ltd / Zai Lab Ltd / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Hong Kong / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Adverse Events Monitor - 2Q21</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">GILD.O / INCY.O / BCRX.O / ICPT.O / BIIB.O / KPTI.O / ITCI.O / SAGE.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - August 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALB.N / CC.N / CCK.N / CE.N / CF.N / DD.N / DOW.N / EMN.N / FMC.N / IP.N / PPG.N / RIO.L / SEE.N / WY.N / CFP.TO / GILD.O / TA.TO / INCY.O / WLK.N / PAA.N / OLN.N / SHW.N / OI.N / BLL.N / EFX.N / OKE.N / RPM.N / SLGN.O / WSP.TO / VRTX.O / GPK.N / BCRX.O / ICPT.O / PAAS.O / STN.TO / BIIB.O / SNC.TO / NTR.N / HUN.N / WEF.TO / MPW.N / 443628102 / EONGn.DE / LYB.N / PCH.O / CFX.TO / NGL.N / IFP.TO / RFP.N / SRPT.O / BERY.N / ORCC.N / ENTA.O / PTCT.O / DOOR.N / RNW.TO / TSLX.N / SAGE.OQ / AXTA.N / CTRE.O / GLPG.O / GBT.OQ / UN01.DE / VNTR.N / EAF.N / VRCA.OQ / ITRM.O / PRVB.O / CTVA.N / MORF.OQ / APRE.OQ / PNTG.OQ / NLOK.O / BEAM.O / APA.OQ / JAMF.O / MTCR.O / PTVE.O / BSY.O / PUBM.O / WFG.N / OSO.N / FLYW.O / TASK.O / 9VC.F</td><td class="leftalignment">Albemarle Corp / Chemours Co / Crown Holdings Inc / Celanese Corp / CF Industries Holdings Inc / Dupont De Nemours Inc / Dow Inc / Eastman Chemical Co / FMC Corp / International Paper Co / PPG Industries Inc / Rio Tinto PLC / Sealed Air Corp / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / TransAlta Corp / Incyte Corp / Westlake Chemical Corp / Plains All American Pipeline LP / Olin Corp / Sherwin-Williams Co / O-I Glass Inc / Ball Corp / Equifax Inc / ONEOK Inc / RPM International Inc / Silgan Holdings Inc / WSP Global Inc / Vertex Pharmaceuticals Inc / Graphic Packaging Holding Co / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Pan American Silver Corp / Stantec Inc / Biogen Inc / SNC-Lavalin Group Inc / Nutrien Ltd / Huntsman Corp / Western Forest Products Inc / Medical Properties Trust Inc / Hudbay Minerals Inc / E.ON SE / LyondellBasell Industries NV / Potlatchdeltic Corp / Canfor Pulp Products Inc / NGL Energy Partners LP / Interfor Corp / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Berry Global Group Inc / Owl Rock Capital Corp / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Masonite International Corp / TransAlta Renewables Inc / Sixth Street Specialty Lending Inc / SAGE Therapeutics Inc / Axalta Coating Systems Ltd / CareTrust REIT Inc / Galapagos NV / Global Blood Therapeutics Inc / Uniper SE / Venator Materials PLC / GrafTech International Ltd / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / Provention Bio Inc / Corteva Inc / Morphic Holding Inc / Aprea Therapeutics Inc / Pennant Group Inc / NortonLifeLock Inc / Beam Therapeutics Inc / APA Corp (US) / Jamf Holding Corp / Metacrine Inc / Pactiv Evergreen Inc / Bentley Systems Inc / PubMatic Inc / West Fraser Timber Co Ltd / Olo Inc / Flywire Corp / Taskus Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Germany / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Simoa is Continuing to Build Momentum in Neurodegenerative Disease Therapy Development; Model Update Post-2Q21; Buy and $92 PT</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">74766Q101 / 09062X103</td><td class="leftalignment">Quanterix Corp / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Sung Ji Nam</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / INCY.O / VRTX.O / BCRX.O / ICPT.O / BIIB.O / SRPT.O / ENTA.O / PTCT.O / SAGE.OQ / GLPG.O / GBT.OQ / ITRM.O / PRVB.O / MORF.OQ / APRE.OQ / MTCR.O / 9VC.F</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / SAGE Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / Iterum Therapeutics PLC / Provention Bio Inc / Morphic Holding Inc / Aprea Therapeutics Inc / Metacrine Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ERAS (BUY) - ERASe CAncer with a Deep RAS/MAPK-Focused Pipeline - Initiating Coverage with a BUY Rating and $25 PT</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">BNLYBF3 / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / 2713317 / BBFL7S1 / BBPK0J0 / BD9GVY0 / BDHF4K6 / BZ1LFB2 / BZ8FPH3 / BWY52P3 / BL71K91 / BDZ30Q0 / BN2R582 / BMPRZV5 / BMDJ397 / BN2RM92 / BP7KZP7</td><td class="leftalignment">Erasca Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / ACADIA Pharmaceuticals Inc / bluebird bio Inc / Mirati Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / Editas Medicine Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Relay Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharma Food for Thought : US healthcare in FY22 Budget Resolution bill & latest touted FDA Commissioner candidate tough views on pricing</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / UCB.BR / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Aug 09 2021 6:48AM</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">2330.TW / ADS / CCL / IBM / INTC.O / MA / MSFT.O / RCL / V / AAPL.O / NVDA.O / SQ / SGMO.O / AMD.O / NTAP.O / FISV.O / NBIX.O / GPN / 2454.TW / MU.O / MRVL.O / HPE / AVGO.O / SWKS.O / BIIB.O / IMPL / STX.O / SIMO.O / VMW / GRPN.O / WDC.O / QRVO.O / PYPL.O / PSTG.K / CTMX.O / EIGR.O / CVNA.K / PLYM.K / MRSN.O / NCLH.K / REPL.O / DELL.K / IMUX.O / VRM.O / RCUS.K</td><td class="leftalignment">Taiwan Semiconductor Manufacturing Co Ltd / Alliance Data Systems Corp / Carnival Corp / International Business Machines Corp / Intel Corp / Mastercard Inc / Microsoft Corp / Royal Caribbean Cruises Ltd / Visa Inc / Apple Inc / NVIDIA Corp / Block Inc / Sangamo Therapeutics Inc / Advanced Micro Devices Inc / NetApp Inc / Fiserv Inc / Neurocrine Biosciences Inc / Global Payments Inc / MediaTek Inc / Micron Technology Inc / Marvell Technology Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Skyworks Solutions Inc / Biogen Inc / Impel Neuropharma Inc / Seagate Technology Holdings PLC / Silicon Motion Technology Corp / VMware Inc / Groupon Inc / Western Digital Corp / Qorvo Inc / PayPal Holdings Inc / Pure Storage Inc / CytomX Therapeutics Inc / Eiger BioPharmaceuticals Inc / Carvana Co / Plymouth Industrial REIT Inc / Mersana Therapeutics Inc / Norwegian Cruise Line Holdings Ltd / Replimune Group Inc / Dell Technologies Inc / Immunic Inc / Vroom Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Ireland / Liberia / Panama / Turkey / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 7/30/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX.O / BIIB.O / BHVN</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ESALY-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ESALY.PK / BIIB.O / EPZM.O / RDHL.O / ABBV.K</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc / Epizyme Inc / Redhill Biopharma Ltd / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BXP-US -  Dividend Quality Analysis, for the period ended July 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BXP / MSFT.O / BIIB.O / MAR.O / PTC.O / GOOGL.O</td><td class="leftalignment">Boston Properties Inc / Microsoft Corp / Biogen Inc / Marriott International Inc / PTC Inc / Alphabet Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended August 02,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / MCO / MDT / RAD / SRCL.O / UNH / WMT / WCC / HEAR.O / HCA.N / CYH.N / SSNC.O / ICPT.OQ / EXEL.OQ / NKTR.O / CCRN.O / AMED.O / GPRO.O / BIIB.O / 00846U101 / 868168105 / NDAQ.O / LHCG.O / ICE.N / CME.O / 02043Q107 / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / SPB.N / FDUS.O / GOOGL.O / XENT.OQ / EVH.N / TDOC.N / GKOS.K / 100063846 / RMR.OQ / SPGI.K / WPRT.TO / MDGL.O / WEED.TO / VICp.V / 720795103 / CBOE.Z / PNTG.OQ / 100004825 / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Moody's Corp / Medtronic PLC / Rite Aid Corp / Stericycle Inc / UnitedHealth Group Inc / Walmart Inc / Wesco International Inc / Turtle Beach Corp / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Intercept Pharmaceuticals Inc / Exelixis Inc / Nektar Therapeutics / Cross Country Healthcare Inc / Amedisys Inc / GoPro Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Nasdaq Inc / LHC Group Inc / Intercontinental Exchange Inc / CME Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Spectrum Brands Holdings Inc / Fidus Investment Corp / Alphabet Inc / Intersect Ent Inc / Evolent Health Inc / Teladoc Health Inc / Glaukos Corp / Truist Financial Corp / RMR Group Inc / S&P Global Inc / Westport Fuel Systems Inc / Madrigal Pharmaceuticals Inc / Canopy Growth Corp / Victory Capital Corp / Pieris Pharmaceuticals Inc / Cboe Global Markets Inc / Pennant Group Inc / Enterprise Financial Services Corp / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for BIIB. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--August 06, 2021</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BSX / CI / CVS / GE / MDT / SGE.L / SYK / AMGN.O / AAPL.O / NOVN.S / RMD.N / INSP.N / EW.N / INCY.OQ / NBIX.OQ / UTHR.OQ / EXEL.OQ / VRTX.OQ / NKTR.O / CCRN.O / ICAD.O / STAA.O / AMED.O / BIIB.O / ALNY.OQ / MNKD.O / ACAD.O / ATRC.OQ / DXCM.O / LHCG.O / PODD.O / 02043Q107 / TNDM.O / SPRO.OQ / MRNA.O / TMDX.OQ / 771195104 / CSII.O / ADUS.O / FATE.OQ / AERI.O / CNCE.OQ / FLXN.OQ / ALDX.OQ / MDWD.O / XENT.OQ / VBIV.O / MRNS.O / APS.TO / OTIC.O / NVRO.N / VCEL.O / VRAY.OQ / MCRB.OQ / CERC.OQ / GKOS.K / ZBH.N / CFMS.O / GBT.OQ / APLS.OQ / EDIT.OQ / NTLA.O / SYRS.OQ / TCMD.OQ / IRTC.OQ / VREX.OQ / URGN.O / IOVA.OQ / KALA.O / ATNX.O / FENC.O / NCNA.O / 720795103 / PRVB.OQ / BNGO.OQ / ARVN.OQ / ALLO.OQ / ORTX.OQ / CRSP.BN / SWAV.O / XFOR.OQ / ISEE.O / KRTX.OQ / PSNL.O / DMTK.O / BXRX.OQ / HGEN.O / REGW.M3 / 03823M100 / N69603145</td><td class="leftalignment">Boston Scientific Corp / Cigna Corp / CVS Health Corp / General Electric Co / Medtronic PLC / Sage Group PLC / Stryker Corp / Amgen Inc / Apple Inc / Novartis AG / Resmed Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / Incyte Corp / Neurocrine Biosciences Inc / United Therapeutics Corp / Exelixis Inc / Vertex Pharmaceuticals Inc / Nektar Therapeutics / Cross Country Healthcare Inc / ICAD Inc / STAAR Surgical Co / Amedisys Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Tandem Diabetes Care Inc / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Concert Pharmaceuticals Inc / Pacira Biosciences Inc / Aldeyra Therapeutics Inc / Mediwound Ltd / Intersect Ent Inc / VBI Vaccines Inc / Marinus Pharmaceuticals Inc / Aptose Biosciences Inc / Otonomy Inc / Nevro Corp / Vericel Corp / ViewRay Inc / Seres Therapeutics Inc / Avalo Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / Global Blood Therapeutics Inc / Apellis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Varex Imaging Corp / Urogen Pharma Ltd / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Athenex Inc / Fennec Pharmaceuticals Inc / NuCana PLC / Pieris Pharmaceuticals Inc / Provention Bio Inc / Bionano Genomics Inc / Arvinas Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / CRISPR Therapeutics AG / Shockwave Medical Inc / X4 Pharmaceuticals Inc / Iveric Bio Inc / Karuna Therapeutics Inc / Personalis Inc / DermTech Inc / Baudax Bio Inc / Humanigen Inc / Regency World Consulting Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / India / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 559</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from the AAIC 2021 Conference</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">09062X10 / 00422510 / H0026310</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / AC Immune SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Glitter in the Sky, Glitter in my Eyes - 6th Straight Week of Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Aug 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">US0126531013 / US0323325045 / US09058V1035 / US0997241064 / US2855121099 / US4663671091 / US5012421013 / US58155Q1031 / US5951121038 / US6701002056 / US8636671013 / US9427491025 / US9581021055 / CA8265161064 / LU0156801721 / US88031M1099 / US64111Q1040 / US09062X1037 / US1281261099 / US0042251084 / US6247581084 / PAP310761054 / US8485741099 / US87874R1005 / US64110D1046 / CH0048265513 / US3390411052 / US56585A1025 / US75972A3014 / US8036071004 / US69327R1014 / US88338N1072 / IE00B4Q5ZN47 / US8684591089 / US63009R1095 / US00771V1089 / DK0060534915 / US67011P1003 / US69888T2078 / US68906L1052 / IE00BQPVQZ61 / US4435731009 / US0994061002 / US2681582019 / US74736K1016 / US30050B1017 / US20717E1010 / US74624M1027 / US4622221004 / US34959J1088 / US26856L1035 / US45782B1044 / US23355L1061 / US1468691027 / US3621LQ1099 / US24665A1034 / US8753722037 / US76674Q1076 / US05351X1019 / US09857L1089 / US15677J1088 / US0937121079 / US04206A1016 / US0197701065 / US35137L1052 / US46583P1021 / US90353T1007 / US76156B1070 / US71535D1063 / US00650F1093 / US24984K1051 / US88025U1097 / CA74319B5027 / US92537N1081 / US57667L1070 / US9663875089 / US30233G2093 / US72815L1070 / US03743Q1085 / US35909R1086 / US83089J1088 / IE00BKVD2N49</td><td class="leftalignment">Albemarle Corp / Amtech Systems Inc / BioCryst Pharmaceuticals Inc / Borgwarner Inc / Electronic Arts Inc / Jack in the Box Inc / Kulicke and Soffa Industries Inc / Mckesson Corp / Micron Technology Inc / Novo Nordisk A/S / Stryker Corp / Watts Water Technologies Inc / Western Digital Corp / Sierra Wireless Inc / Tenaris SA / Tenaris SA / NETGEAR Inc / Biogen Inc / CalAmp Corp / ACADIA Pharmaceuticals Inc / Mueller Water Products Inc / Copa Holdings SA / Spirit AeroSystems Holdings Inc / TechTarget Inc / NetApp Inc / Transocean Ltd / Fleetcor Technologies Inc / Marathon Petroleum Corp / Renewable Energy Group Inc / Sarepta Therapeutics Inc / PDC Energy Inc / TherapeuticsMD Inc / Jazz Pharmaceuticals PLC / Supernus Pharmaceuticals Inc / NanoString Technologies Inc / Aerie Pharmaceuticals Inc / Novo Nordisk A/S / NOW Inc / Par Pacific Holdings Inc / Otonomy Inc / Horizon Therapeutics PLC / HubSpot Inc / Boot Barn Holdings Inc / Dynavax Technologies Corp / Qorvo Inc / Evolent Health Inc / Conformis Inc / Pure Storage Inc / Ionis Pharmaceuticals Inc / Fortive Corp / elf Beauty Inc / Inseego Corp / DXC Technology Co / Carvana Co / G1 Therapeutics Inc / Delek US Holdings Inc / Tandem Diabetes Care Inc / Rimini Street Inc / Avaya Holdings Corp / Booking Holdings Inc / Ceridian HCM Holding Inc / Bloom Energy Corp / Arlo Technologies Inc / Allogene Therapeutics Inc / Fox Corp / Iveric Bio Inc / Uber Technologies Inc / Revolve Group Inc / Personalis Inc / Adaptive Biotechnologies Corp / DermTech Inc / 10X Genomics Inc / Profound Medical Corp / Vertiv Holdings Co / Match Group Inc / Whiting Petroleum Corp / EyePoint Pharmaceuticals Inc / Playtika Holding Corp / APA Corp (US) / Frontier Group Holdings Inc / Skywater Technology Inc / Seagate Technology Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / Ireland / Luxembourg / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / T=US / DVN=US / CMA=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / H=US / V=US / MTN=US / CRK=US / WLL=US / PB=US / MGY=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / MRO=US / TNL=US / KFRC=US / VMC=US / MGM=US / HLT=US / UNM=US / CVS=US / RCL=US / UNH=US / MAC=US / WTFC=US / AIZ=US / AMED=US / AMN=US / APH=US / FUN=US / CENT=US / KIDS=US / CHH=US / CSTR=US / CW=US / DRH=US / EEFT=US / MPLX=US / DOC=US / ASGN=US / OKE=US / PACW=US / RHI=US / SGMO=US / SMG=US / TGI=US / WAL=US / HTH=US / BXS=US / CCRN=US / FNF=US / BKNG=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / DCP=US / FRT=US / FBK=US / JAZZ=US / MTCH=US / ASB=US / SSB=US / SPR=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / EVOP=US / UCBI=US / VICI=US / ECPG=US / MGP=US / PNFP=US / SBCF=US / BDSI=US / JRVR=US / RPD=US / BIIB=US / FLT=US / TCBI=US / FNB=US / FHN=US / KAR=US / BDC=US / SHO=US / RNST=US / LHCG=US / CHNG=US / HST=US / MA=US / GPRE=US / ELF=US / WU=US / TEL=US / CADE=US / WH=US / IAC=US / PSN=US / JACK=US / SWI=US / VRSK=US / OAS=US / HGV=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ANGI=US / EA=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / HUBS=US / VCEL=US / NVRO=US / UPLD=US / GDDY=US / ETSY=US / LOB=US / EVRI=US / ACBI=US / EDIT=US / 82982L103 / VVV=US / PK=US / PVAC=US / TVTY=US / 50189K103 / PLYA=US / SBOW=US / PETQ=US / ROKU=US / MBIN=US / MAXR=US / EOLS=US / HWC=US / OZK=US / FTDR=US / ALLO=US / AMTB=US / UBER=US / RTLR=US / IMVT=US / 100017125</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / AT&T Inc / Devon Energy Corp / Comerica Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Comstock Resources Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Marathon Oil Corp / Travel + Leisure Co / Kforce Inc / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Unum Group / CVS Health Corp / Royal Caribbean Cruises Ltd / UnitedHealth Group Inc / Macerich Co / Wintrust Financial Corp / Assurant Inc / Amedisys Inc / AMN Healthcare Services Inc / Amphenol Corp / Cedar Fair LP / Central Garden & Pet Co / OrthoPediatrics Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Euronet Worldwide Inc / MPLX LP / Physicians Realty Trust / ASGN Inc / ONEOK Inc / PacWest Bancorp / Robert Half International Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Triumph Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Cross Country Healthcare Inc / Fidelity National Financial Inc / Booking Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / DCP Midstream LP / Federal Realty Investment Trust / FB Financial Corp / Jazz Pharmaceuticals PLC / Match Group Inc / Associated Banc-Corp / SouthState Corp / Spirit AeroSystems Holdings Inc / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / EVO Payments Inc / United Community Banks Inc / VICI Properties Inc / Encore Capital Group Inc / MGM Growth Properties LLC / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / James River Group Holdings Ltd / Rapid7 Inc / Biogen Inc / Fleetcor Technologies Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / KAR Auction Services Inc / Belden Inc / Sunstone Hotel Investors Inc / Renasant Corp / LHC Group Inc / Change Healthcare Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / elf Beauty Inc / Western Union Co / TE Connectivity Ltd / Cadence Bank / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Parsons Corp / Jack in the Box Inc / SolarWinds Corp / Verisk Analytics Inc / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Electronic Arts Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / HubSpot Inc / Vericel Corp / Nevro Corp / Upland Software Inc / GoDaddy Inc / ETSY Inc / Live Oak Bancshares Inc / Everi Holdings Inc / Atlantic Capital Bancshares Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / Valvoline Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / Tivity Health Inc / LCI Industries / Playa Hotels & Resorts NV / SilverBow Resources Inc / PetIQ Inc / Roku Inc / Merchants Bancorp / Maxar Technologies Inc / Evolus Inc / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Amerant Bancorp Inc / Uber Technologies Inc / Rattler Midstream LP / Immunovant Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / France / Ireland / Liberia / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">V / 2367026 / 2000019 / 2486813 / 2026242 / 2045623 / 2942605 / 2111955 / 2270726 / 2317087 / 2670519 / 2328915 / 2342034 / 2100920 / 2455965 / 2632003 / 2645409 / 2689560 / 2707677 / 2440637 / 2799351 / 2829601 / 5531000 / B1F76F9 / 2769796 / 2713317 / 2857817 / B0T7YX2 / B02R1L6 / B2R3PV1 / B3D7K31 / B4Y1MH7 / 2390817 / B44C366 / 2949758 / B7TL820 / B7254K9 / BCZS820 / BJ0KXV4 / BDZCRX3 / B8DPDT7 / BFZCHN7 / BYRY499 / BYY8XK8 / BYVY8G0 / BS7K7C9 / BFZNYB7 / BJ5FZ74 / BR4T3B3 / BGCYWN8 / BZ8FPH3 / BMYML02 / BLGJ610 / BJJMGL2 / BKTNTR9 / BK6N347 / BYWMQJ2 / BYQHPK7 / BDH65C8 / BZ1LFG7 / BGT3960 / BKS3RS7 / BNG3RZ7 / BD72R64 / 021513106 / BNTB3N8 / BMHR7K6 / BKPGJQ1</td><td class="leftalignment">Visa Inc / General Mills Inc / Amazon.com Inc / Kellogg Co / American Electric Power Company Inc / ANSYS Inc / Avista Corp / Borgwarner Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / Biogen Inc / New York Times Co / NiSource Inc / PG&E Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / Southern Co / MorphoSys AG / Western Union Co / Fidelity National Information Services Inc / ACADIA Pharmaceuticals Inc / Netflix Inc / Live Nation Entertainment Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / KAR Auction Services Inc / Gray Television Inc / Heska Corp / Nexstar Media Group Inc / Meta Platforms Inc / AxoGen Inc / Fate Therapeutics Inc / ONE Gas Inc / RingCentral Inc / Sarepta Therapeutics Inc / Wix.Com Ltd / Kraft Heinz Co / WEC Energy Group Inc / Alphabet Inc / Nevro Corp / Allogene Therapeutics Inc / Adaptive Biotechnologies Corp / HubSpot Inc / Xencor Inc / Editas Medicine Inc / DraftKings Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Uber Technologies Inc / Alteryx Inc / Zymeworks Inc / PetIQ Inc / Roku Inc / Orchard Therapeutics PLC / 10X Genomics Inc / Leslie's Inc / Liberty Media Corp / Alto Ingredients Inc / Vizio Holding Corp / Impel Neuropharma Inc / Squarespace Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Progress Across Diversified Neurodegeneration-Focused Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">H00263105 / BIIB / PRTA.OQ</td><td class="leftalignment">AC Immune SA / Biogen Inc / Prothena Corporation PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">See Risk in Tofersen SOD-1 ALS Phase III Data; More Constructive on PSCK9 and Vopanorsen</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">IONS.OQ / NOVN.S / BIIB.O / 771195104 / BCYC.O</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Novartis AG / Biogen Inc / Roche Holding AG / Bicycle Therapeutics PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter / Zhiqi He, Ph.D., CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">2Q21 Model Update - Additional Plans for the TV Platform. Other Clinical Programs Moving Forward.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">24823R105 / 09062X103 / 014442107</td><td class="leftalignment">Denali Therapeutics Inc / Biogen Inc / Alector Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Ms. Kaveri Pohlman</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Solid Clinical Progress In Q2 Tees Up Multiple Key Data Readouts In H2</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US4622221004 / US09062X1037</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D. / Gabriel Schneider, M.D. / Eve Reilly, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Second-Quarter Earnings; VALOR SOD1-ALS Tofersen Study Readout by Fall to Kick Off Plans for 12 Medicines by 2026</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">462222100 / 09062X103</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Post 2Q Model Update; Lowering PT to $442</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">OIG reviewing FDA's accelerated approval pathway of drugs including Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Tidbits on BAN2401 updates from partner Eisai</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">AME / CMI / CRM.N / GE / KKR / MDT / MSFT.O / NCR / NICE.TA / SCM.N / SGE.L / T.N / URI / AMZN.O / AMGN.O / AAPL.O / FIS / NVDA.O / DTE.N / HEAR.O / NOVN.S / VECO.O / INSP.N / CSCO.OQ / ATVI.OQ / INCY.OQ / NBIX.OQ / TTWO.OQ / AKAM.OQ / MGRC.O / NFLX.O / BIIB.O / 92343V104 / AYX / ALNY.OQ / DENN.O / 36467W109 / SPWR.O / ADUS.O / ANGI.O / ZNGA.O / EA.O / RNG.N / FDEV.L / GOOGL.O / 82655M107 / PAYC.K / SABR.O / MRNS.O / NEWR.K / ZBH.N / GBT.OQ / ZG.OQ / IAC.O / BABA.K / APL.PS / UAA / VREX.OQ / HLNE.OQ / WSC.OQ / EGHT.K / BILI.O / XFOR.OQ / ZM.OQ / FSLY.K / VG.O / HUYA.K / 390320109</td><td class="leftalignment">AMETEK Inc / Cummins Inc / Salesforce.Com Inc / General Electric Co / KKR & Co Inc / Medtronic PLC / Microsoft Corp / NCR Corp / Nice Ltd / Stellus Capital Investment Corp / Sage Group PLC / AT&T Inc / United Rentals Inc / Amazon.com Inc / Amgen Inc / Apple Inc / Fidelity National Information Services Inc / NVIDIA Corp / DTE Energy Co / Turtle Beach Corp / Novartis AG / Veeco Instruments Inc / Inspire Medical Systems Inc / Cisco Systems Inc / Activision Blizzard Inc / Incyte Corp / Neurocrine Biosciences Inc / Take-Two Interactive Software Inc / Akamai Technologies Inc / McGrath RentCorp / Netflix Inc / Biogen Inc / Verizon Communications Inc / Alteryx Inc / Alnylam Pharmaceuticals Inc / Denny's Corp / GameStop Corp / SunPower Corp / Addus Homecare Corp / Angi Inc / Zynga Inc / Electronic Arts Inc / RingCentral Inc / Frontier Developments PLC / Alphabet Inc / Sify Technologies Ltd / Paycom Software Inc / Sabre Corp / Marinus Pharmaceuticals Inc / New Relic Inc / Zimmer Biomet Holdings Inc / Global Blood Therapeutics Inc / Zillow Group Inc / IAC/Interactivecorp / Alibaba Group Holding Ltd / Apollo Global Capital Inc / Under Armour Inc / Varex Imaging Corp / Hamilton Lane Inc / Willscot Mobile Mini Holdings Corp / 8x8 Inc / Bilibili Inc / X4 Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / Vonage Holdings Corp / HUYA Inc / Great Elm Capital Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / India / Ireland / Israel / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">DNB / WMB=US / CACI=US / LLY=US / LSI=US / AMGN=US / OXY=US / GBT=US / AMZN=US / BLD=US / DVN=US / INCY=US / PEB=US / AKAM=US / H=US / V=US / CRK=US / PXD=US / PAA=US / IGT=US / MAR=US / LEG=US / ATVI=US / KFRC=US / HLT=US / BKI=US / CVS=US / AIZ=US / BNL=US / CSGP=US / DVA=US / AJG=US / MRCY=US / MCHP=US / OKE=US / SAGE=US / PSA=US / BXS=US / MANT=US / MTCH=US / SRC=US / COP=US / MRNS=US / BIIB=US / RNG=US / CZR=US / KAR=US / SHO=US / BAH=US / DENN=US / SPWR=US / FIS=US / HST=US / MA=US / GPRE=US / ICFI=US / SAIC=US / CADE=US / CLR=US / LUMN=US / PAGP=US / IAA=US / KTOS=US / CWH=US / PSN=US / HTA=US / TREX=US / OAS=US / NXPI=US / GDOT=US / PCRX=US / RLJ=US / VAC=US / RHP=US / FANG=US / NDLS=US / LDOS=US / NMIH=US / VNOM=US / BABA=US / NEWR=US / WBA=US / WK=US / DEA=US / NSA=US / CHCT=US / ZBH=US / SQ=US / MIME=US / WLTW=US / 82982L103 / CDEV=US / PVAC=US / 50189K103 / AYX=US / SWCH=US / LYFT=US / LHX=US / OPCH=US / ZI=US / COUR-US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Williams Companies Inc / CACI International Inc / Eli Lilly and Co / Life Storage Inc / Amgen Inc / Occidental Petroleum Corp / Global Blood Therapeutics Inc / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Incyte Corp / Pebblebrook Hotel Trust / Akamai Technologies Inc / Hyatt Hotels Corp / Visa Inc / Comstock Resources Inc / Pioneer Natural Resources Co / Plains All American Pipeline LP / International Game Technology PLC / Marriott International Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Hilton Worldwide Holdings Inc / Black Knight Inc / CVS Health Corp / Assurant Inc / Bunzl plc / CoStar Group Inc / DaVita Inc / Arthur J Gallagher & Co / Mercury Systems Inc / Microchip Technology Inc / ONEOK Inc / SAGE Therapeutics Inc / Public Storage / Cadence Bank / ManTech International Corp / Match Group Inc / Spirit Realty Capital Inc / Conocophillips / Marinus Pharmaceuticals Inc / Biogen Inc / RingCentral Inc / Caesars Entertainment Inc / KAR Auction Services Inc / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / Denny's Corp / SunPower Corp / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / ICF International Inc / Science Applications International Corp / Cadence Bank / Continental Resources Inc / Lumen Technologies Inc / Plains GP Holdings LP / IAA Inc / Kratos Defense and Security Solutions Inc / Camping World Holdings Inc / Parsons Corp / Healthcare Trust Of America Inc / Trex Company Inc / Oasis Petroleum Inc / NXP Semiconductors NV / Green Dot Corp / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Noodles & Co / Leidos Holdings Inc / NMI Holdings Inc / Viper Energy Partners LP / Alibaba Group Holding Ltd / New Relic Inc / Walgreens Boots Alliance Inc / Workiva Inc / Easterly Government Properties Inc / National Storage Affiliates Trust / Community Healthcare Trust Inc / Zimmer Biomet Holdings Inc / Block Inc / Mimecast Ltd / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / LCI Industries / Alteryx Inc / Switch Inc / Lyft Inc / L3harris Technologies Inc / Option Care Health Inc / ZoomInfo Technologies Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">2Q Update Highlights Continued Progress</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SGE.L / BIIB.O</td><td class="leftalignment">Sage Group PLC / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / ALL.N / AXP.N / CAH.N / CE.N / CF.N / COF.N / ED.N / EIX.N / F.N / GPS.N / HLT.N / KEY.N / MAN.N / MO.N / NOC.N / PHM.N / PM.N / RYN.N / SC.N / TMX.N / U.N / ZEN.N / NUE.N / BKI.N / LPX.N / MET.N / JBL.N / DIS.N / TFX.N / GD.N / DE.N / AFG.N / R.N / SPOT.N / AMG.N / EVR.N / GS.N / PRI.N / LOW.N / GLW.N / LH.N / JWN.N / FNF.N / PCG.N / TGT.N / RKT.N / HCA.N / KMI.N / UGI.N / DNB.N / GPC.N / SAM.N / STL.N / MHK.N / GME.N / OSK.N / INTC.OQ / ADPT.OQ / AMAT.OQ / CSCO.OQ / FISV.OQ / PBCT.OQ / TEAM.OQ / RJF.N / RGEN.OQ / SF.N / ZION.OQ / QCOM.OQ / CREE.OQ / DFS.N / POOL.OQ / TPR.N / PCTY.OQ / STLD.OQ / EEFT.OQ / MRCY.OQ / UMPQ.OQ / CSGP.OQ / EWBC.OQ / MKSI.OQ / PLUG.OQ / MRVL.OQ / GPN.N / BIIB.OQ / FNB.N / EXP.N / OSH.N / MKTX.OQ / LVS.N / THG.N / BRKb.N / OC.N / FRPT.OQ / IVZ.N / ACM.N / PODD.OQ / MASI.OQ / ES.N / DECK.N / AI.N / AVGO.OQ / TREX.N / NEE.N / TSLA.OQ / TRGP.N / MSP.N / LKQ.OQ / BFAM.N / CDW.OQ / RNG.N / MAR.OQ / NCLH.N / SNOW.N / FIVN.OQ / PAYC.N / SYF.N / CTLT.N / AXTA.N / LBRDK.O / QRVO.OQ / TDOC.N / ZBH.N / RUN.OQ / PEN.N / TWLO.N / TTD.OQ / COUP.OQ / OKTA.OQ / CVNA.N / JHG.N / PFG.OQ / ZS.OQ / SMAR.N / DOCU.OQ / CDAY.N / AVLR.N / ELAN.N / ESTC.N / PLAN.N / STNE.OQ / NFE.OQ / UBER.N / FSLY.N / GO.OQ / DDOG.OQ / AZEK.N / APA.OQ / VRM.OQ / LMND.N / NCNO.OQ / DCT.OQ / PLTR.N / SHC.OQ / CERT.OQ / CLVT.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / Allstate Corp / American Express Co / Cardinal Health Inc / Celanese Corp / CF Industries Holdings Inc / Capital One Financial Corp / Consolidated Edison Inc / Edison International / Ford Motor Co / Gap Inc / Hilton Worldwide Holdings Inc / KeyCorp / ManpowerGroup Inc / Altria Group Inc / Northrop Grumman Corp / Pultegroup Inc / Philip Morris International Inc / Rayonier Inc / Santander Consumer USA Holdings Inc / Terminix Global Holdings Inc / Unity Software Inc / Zendesk Inc / Nucor Corp / Black Knight Inc / Louisiana-Pacific Corp / MetLife Inc / Jabil Inc / Walt Disney Co / Teleflex Inc / General Dynamics Corp / Deere & Co / American Financial Group Inc / Ryder System Inc / Spotify Technology SA / Affiliated Managers Group Inc / Evercore Inc / Goldman Sachs Group Inc / Primerica Inc / Lowe's Companies Inc / Corning Inc / Laboratory Corporation of America Holdings / Nordstrom Inc / Fidelity National Financial Inc / PG&E Corp / Target Corp / Rocket Companies Inc / HCA Healthcare Inc / Kinder Morgan Inc / UGI Corp / Dun & Bradstreet Holdings Inc / Genuine Parts Co / Boston Beer Company Inc / Sterling Bancorp / Mohawk Industries Inc / GameStop Corp / Oshkosh Corp / Intel Corp / Adaptive Biotechnologies Corp / Applied Materials Inc / Cisco Systems Inc / Fiserv Inc / People's United Financial Inc / Atlassian Corporation PLC / Raymond James Financial Inc / Repligen Corp / Stifel Financial Corp / Zions Bancorporation NA / Qualcomm Inc / Wolfspeed Inc / Discover Financial Services / Pool Corp / Tapestry Inc / Paylocity Holding Corp / Steel Dynamics Inc / Euronet Worldwide Inc / Mercury Systems Inc / Umpqua Holdings Corp / CoStar Group Inc / East West Bancorp Inc / MKS Instruments Inc / Plug Power Inc / Marvell Technology Inc / Global Payments Inc / Biogen Inc / FNB Corp / Eagle Materials Inc / Oak Street Health Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Hanover Insurance Group Inc / Berkshire Hathaway Inc / Owens Corning / Freshpet Inc / Invesco Ltd / AECOM / Insulet Corp / Masimo Corp / Eversource Energy / Deckers Outdoor Corp / C3.ai Inc / Broadcom Inc / Trex Company Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Datto Holding Corp / LKQ Corp / Bright Horizons Family Solutions Inc / CDW Corp / RingCentral Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Snowflake Inc. / Five9 Inc / Paycom Software Inc / Synchrony Financial / Catalent Inc / Axalta Coating Systems Ltd / Liberty Broadband Corp / Qorvo Inc / Teladoc Health Inc / Zimmer Biomet Holdings Inc / Sunrun Inc / Penumbra Inc / Twilio Inc / Trade Desk Inc / Coupa Software Inc / Okta Inc / Carvana Co / Janus Henderson Group PLC / Principal Financial Group Inc / Zscaler Inc / Smartsheet Inc / DocuSign Inc / Ceridian HCM Holding Inc / Avalara Inc / Elanco Animal Health Inc / Elastic NV / Anaplan Inc / StoneCo Ltd / New Fortress Energy Inc / Uber Technologies Inc / Fastly Inc / Grocery Outlet Holding Corp / Datadog Inc / Azek Company Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / nCino Inc / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / Certara Inc / CLARIVATE PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Cayman Islands / United Kingdom / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment">Aerospace / Agriculture / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Defense / Education / Electrical / Electronics / Engineering & Construction / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Takeaways on LLY's Donanemab on 2Q21 EPS call and read to BIIB's Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB=US / LLY=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Delta Continues to Drive Domestic and Global Growth; Vaccines Continue to Show Efficacy Despite Breakthrough Infections</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Wedbush Monthly Check-Up: August 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">DNLI.O / NBIX.O / ARGX.O / UTHR.O / BMRN.O / SWTX.O / RARE.O / ICPT.O / BIIB.O / ACOR.O / LXRX.O / IDRA.O / OMER.O / PCRX.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / SAGE.O / PRTK.O / XENE.O / CDTX.O / ABUS.O / GBT.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / SYRS.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / OBSV.O / FENC.O / APLS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / ALNA.O / ETTX.O / HARP.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BCEL.O / FUSN.O / RCUS.K / PRAX.O</td><td class="leftalignment">Denali Therapeutics Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / Biomarin Pharmaceutical Inc / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Acorda Therapeutics Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / SAGE Therapeutics Inc / Paratek Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Arbutus Biopharma Corp / Global Blood Therapeutics Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Syros Pharmaceuticals Inc / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Allena Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Atreca Inc / Fusion Pharmaceuticals Inc / Arcus Biosciences Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Mr. Andreas Argyrides</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Perception is Reality – Spate of FDA Surprises Eroding Physician Confidence</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">0989529 / 717081103 / 375558103 / 532457108 / 09062X103 / 09061G101 / 45337C102 / 00287Y109 / 039697107 / 00972D105</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Gilead Sciences Inc / Eli Lilly and Co / Biogen Inc / Biomarin Pharmaceutical Inc / Incyte Corp / Abbvie Inc / Ardelyx Inc / Akebia Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Yasmeen Rahimi, Ph.D. / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/31/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Biogen Inc. (BIIB) - Multiple Sclerosis sales decline</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Peer Group Analytics - Q2 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Biogen tumbles 30.3% from 7 week high</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / DAN / HUM / RAD / UNH / WMT / GWW.N / HCA.N / CYH.N / CHTR.O / CHD.N / ARCC.O / SSNC.O / B.N / VRTX.OQ / CCRN.O / MMSI.O / AMED.O / BIIB.O / 00846U101 / 868168105 / TXRH.O / LHCG.O / 20564W105 / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / ARES.K / EVH.N / TDOC.N / 100063846 / 720795103 / HEXO.TO / TLRY.O / CBOE.Z / CRSP.BN / PNTG.OQ / AVNT.K</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Dana Inc / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / W W Grainger Inc / HCA Healthcare Inc / Community Health Systems Inc / Charter Communications Inc / Church & Dwight Co Inc / Ares Capital Corp / SS&C Technologies Holdings Inc / Barnes Group Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Merit Medical Systems Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Texas Roadhouse Inc / LHC Group Inc / Comscore Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Ares Management Corp / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Hexo Corp / Tilray Brands Inc / Cboe Global Markets Inc / CRISPR Therapeutics AG / Pennant Group Inc / Avient Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 558</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CRY.N / CVS / HAE / HUM / MDT / RAD / SYK / UNH / WMT / GILD.O / TFX.N / ANIK.O / NOVN.S / RMD.N / XRAY.O / HCA.N / CYH.N / COO.N / INSP.N / CERS.O / EW.N / ALGN.O / OSUR.O / DRRX.O / SSNC.O / ISR / SRDX.O / ABMD.OQ / ICUI.OQ / INCY.OQ / IART.OQ / NBIX.OQ / ICPT.OQ / BMRN.OQ / ISRG.OQ / BLUE.OQ / CCRN.O / STAA.O / IDXX.O / INMD.O / MMSI.O / AMED.O / CGEN.O / EXAS.O / BIIB.O / 025816109 / 478160104 / 00846U101 / 881624209 / 868168105 / ANGO.OQ / NUVA.O / ACAD.O / GLPG.AS / ATRC.OQ / DXCM.O / LHCG.O / B8FGn.DE / INFI.OQ / LMAT.O / ALCLS.PA / ARAY.O / PODD.O / MASI.O / 02043Q107 / ENSG.OQ / KIDS.O / 483548103 / MRNA.O / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / GMED.K / PRTA.OQ / AXGN.O / AGIO.OQ / AERI.O / GOOGL.O / MDWD.O / 02005N100 / AGRX.OQ / XENT.OQ / VKTX.O / NVRO.N / SIEN.O / VCEL.O / VRAY.OQ / EVH.N / TDOC.N / CERC.OQ / GKOS.K / ZBH.N / CFMS.O / SPNE.O / NVCR.OQ / 100063846 / SSKN.OQ / SENS.A / TCMD.OQ / IRTC.OQ / SRTS.O / MDGL.O / VREX.OQ / 45780L104 / SLNO.OQ / PLXP.O / KALA.O / 720795103 / SWAV.O / KRTX.OQ / XAIR.OQ / PNTG.OQ / RLMD.OQ / VERO.O / NNOX.O / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Haemonetics Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Teleflex Inc / Anika Therapeutics Inc / Novartis AG / Resmed Inc / DENTSPLY SIRONA Inc / HCA Healthcare Inc / Community Health Systems Inc / Cooper Companies Inc / Inspire Medical Systems Inc / Cerus Corp / Edwards Lifesciences Corp / Align Technology Inc / OraSure Technologies Inc / DURECT Corp / SS&C Technologies Holdings Inc / IsoRay Inc / Surmodics Inc / ABIOMED Inc / ICU Medical Inc / Incyte Corp / Integra Lifesciences Holdings Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Intuitive Surgical Inc / bluebird bio Inc / Cross Country Healthcare Inc / STAAR Surgical Co / IDEXX Laboratories Inc / Inmode Ltd / Merit Medical Systems Inc / Amedisys Inc / Compugen Ltd / Exact Sciences Corp / Biogen Inc / American Express Co / Johnson & Johnson / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Superior Industries International Inc / AngioDynamics Inc / NuVasive Inc / ACADIA Pharmaceuticals Inc / Galapagos NV / AtriCure Inc / Dexcom Inc / LHC Group Inc / Biofrontera AG / Infinity Pharmaceuticals Inc / LeMaitre Vascular Inc / Cellectis SA / Accuray Inc / Insulet Corp / Masimo Corp / Alnylam Pharmaceuticals Inc / Ensign Group Inc / OrthoPediatrics Corp / Kaman Corp / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Globus Medical Inc / Prothena Corporation PLC / AxoGen Inc / Agios Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Alphabet Inc / Mediwound Ltd / Ally Financial Inc / Agile Therapeutics Inc / Intersect Ent Inc / Viking Therapeutics Inc / Nevro Corp / Sientra Inc / Vericel Corp / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Avalo Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / SeaSpine Holdings Corp / Novocure Ltd / Truist Financial Corp / STRATA Skin Sciences Inc / Senseonics Holdings Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Sensus Healthcare Inc / Madrigal Pharmaceuticals Inc / Varex Imaging Corp / Inogen Inc / Soleno Therapeutics Inc / PLx Pharma Inc / Kala Pharmaceuticals Inc / Pieris Pharmaceuticals Inc / Shockwave Medical Inc / Karuna Therapeutics Inc / Beyond Air Inc / Pennant Group Inc / Relmada Therapeutics Inc / Venus Concept Inc / Nano-X Imaging Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / SSNC.O / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / SS&C Technologies Holdings Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">IN 2 HOURS: Join Our Healthcare Small/Mid Cap 2Q21 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 7/23/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Second CMS Public Hearing Sees Industry Weigh In on Aduhelm NCD; Takeaways From AAIC Important for Clinical Guidelines</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BXP-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BXP / MSFT.O / BIIB.O / MAR.O / PTC.O / GOOGL.O</td><td class="leftalignment">Boston Properties Inc / Microsoft Corp / Biogen Inc / Marriott International Inc / PTC Inc / Alphabet Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Trend is Your Friend – Fifth Straight Week of Biotech Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US64125C1099 / US09062X1037 / US0042251084 / US02043Q1076 / US40637H1095 / US8036071004 / US88322Q1085 / US74587V1070 / US45845P1084 / US69366J2006 / CA05156V1022 / US46116X1019 / US37890U1088 / US03753U1060</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / Aurinia Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Global Blood Therapeutics Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q2 2021: Biogen reports 9.3% sequential rise in Quarterly Net Profit</td><td class="leftalignment">English</td><td class="rightalignment">85</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Model Update Pre-Q2 Results</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IONS.OQ / BIIB.O / BCYC.O</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Biogen Inc / Bicycle Therapeutics PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter / Zhiqi He, Ph.D., CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Disrupting Drug Delivery to the Eye; Initiating at Buy and $10 PT</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">CLSD.OQ / REGN.OQ / BIIB / 00771V108 / 67576A100 / 483119103 / 19249H103 / 98419J206 / 67577C105 / 69012T107</td><td class="leftalignment">Clearside Biomedical Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Aerie Pharmaceuticals Inc / Ocular Therapeutix Inc / Kala Pharmaceuticals Inc / Coherus BioSciences Inc / XOMA Corp / Ocugen Inc / Outlook Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Yi Chen, Ph.D. CFA / Raghuram Selvaraju, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Biogen tumbles 28.7% from 7 week high</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Small/Mid Cap 2Q Preview Call on 7/30 @ 10 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ALB.N / DD.N / FMC.N / GE.N / MO.N / MSFT.O / PHM.N / RWEG.DE / GILD.O / INCY.O / UHS.N / AAL.L / CLS.N / WM.N / MMM.N / SIRI.O / SBUX.O / ARNA.O / AMP.N / RRC.N / FISV.O / V.N / RPM.N / NBIX.O / CHD.N / SUI.N / VRTX.O / CHE.N / PNR.N / BRO.N / PII.N / ST.N / TRU.N / ICPT.O / BIIB.O / FM.TO / 878742204 / ACAD.O / DRX.L / CVLT.O / IVZ.N / MSCI.N / AAV.TO / PCH.O / MTDR.N / SMSS.L / SRPT.O / AXTA.N / FSV.O / TDOC.N / GBT.OQ / EHC.N / NWL.O / CTVA.N / NLOK.O / OTIS.N / SKLZ.N / ATC.N / DSEY.O</td><td class="leftalignment">Albemarle Corp / Dupont De Nemours Inc / FMC Corp / General Electric Co / Altria Group Inc / Microsoft Corp / Pultegroup Inc / Rwe AG / Gilead Sciences Inc / Incyte Corp / Universal Health Services Inc / Anglo American PLC / Celestica Inc / Waste Management Inc / 3M Co / Sirius XM Holdings Inc / Starbucks Corp / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Range Resources Corp / Fiserv Inc / Visa Inc / RPM International Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Sun Communities Inc / Vertex Pharmaceuticals Inc / Chemed Corp / Pentair PLC / Brown & Brown Inc / Polaris Inc / Sensata Technologies Holding PLC / TransUnion / Intercept Pharmaceuticals Inc / Biogen Inc / First Quantum Minerals Ltd / Teck Resources Ltd / ACADIA Pharmaceuticals Inc / Drax Group PLC / Commvault Systems Inc / Invesco Ltd / MSCI Inc / Advantage Energy Ltd / Potlatchdeltic Corp / Matador Resources Co / Smart Metering Systems PLC / Sarepta Therapeutics Inc / Axalta Coating Systems Ltd / FirstService Corp / Teladoc Health Inc / Global Blood Therapeutics Inc / Encompass Health Corp / Newell Brands Inc / Corteva Inc / NortonLifeLock Inc / Otis Worldwide Corp / Skillz Inc / Atotech Ltd / Diversey Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Imagine™: Game Changers: Disruptive Forces in Biotech</td><td class="leftalignment">English</td><td class="rightalignment">59</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / David Szeto / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US00846U1016 / US1101221083 / US42222N1037 / US09062X1037 / US8162121045 / US7310941080 / US03753U1060</td><td class="leftalignment">Agilent Technologies Inc / Bristol-Myers Squibb Co / HealthStream Inc / Biogen Inc / Selecta Biosciences Inc / PolarityTE Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">EU Pharmaceuticals: Alzheimer's expert call: key takes (ROG/MOR) - Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ROG.S / LLY.N / MORG.DE / BIIB.OQ</td><td class="leftalignment">Roche Holding AG / Eli Lilly and Co / MorphoSys AG / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma / Manos Mastorakis</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">REGN.O / BIIB.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AIN / MRK=US / LLY=US / PFE=US / BMY=US / HD=US / INTC=US / MCD=US / AMD=US / RRC=US / WEN=US / PD=US / AMZN=US / DT=US / BLD=US / TEVA=US / NVDA=US / PEB=US / LOW=US / CHKP=US / HSII=US / CHRS=US / BRO=US / SPOT=US / LEG=US / VMC=US / HLT=US / MLM=US / KFY=US / SWIM=US / BNL=US / CBRL=US / DRI=US / ENDP=US / AJG=US / GFF=US / HAS=US / HXL=US / IBP=US / TREE=US / NOW=US / MAS=US / MEDP=US / MHK=US / TEAM=US / NTST=US / PRGO=US / REGI=US / ROLL=US / SNOW=US / BXS=US / CFB=US / LCI=US / ADC=US / BDN=US / FB=US / SSB=US / CATY=US / GBCI=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / PRPL=US / LUMN=US / APEI=US / TIL=US / EPRT=US / JACK=US / ZTS=US / TREX=US / AR=US / RLJ=US / FBHS=US / SPLK=US / ABBV=US / TILE=US / NDLS=US / QURE=US / 00770K202 / LOCO=US / NEWR=US / SHAK=US / WING=US / ACBI=US / WLTW=US / 82982L103 / PVAC=US / ANAB=US / JELD=US / AYX=US / IOVA=US / ARVN=US / ESTC=US / FERG=US / DDOG=US / AZEK=US / BALY=US / DBRG=US</td><td class="leftalignment">Albany International Corp / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Intel Corp / McDonald's Corp / Advanced Micro Devices Inc / Range Resources Corp / Wendys Co / PagerDuty Inc / Amazon.com Inc / Dynatrace Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / Pebblebrook Hotel Trust / Lowe's Companies Inc / Check Point Software Technologies Ltd / Heidrick & Struggles International Inc / Coherus BioSciences Inc / Brown & Brown Inc / Spotify Technology SA / Leggett & Platt Inc / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Korn Ferry / Latham Group Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Endo International PLC / Arthur J Gallagher & Co / Griffon Corp / Hasbro Inc / Hexcel Corp / Installed Building Products Inc / Lendingtree Inc / ServiceNow Inc / Masco Corp / Medpace Holdings Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / Perrigo Company PLC / Renewable Energy Group Inc / RBC Bearings Inc / Snowflake Inc. / Cadence Bank / Crossfirst Bankshares Inc / Lannett Company Inc / Agree Realty Corp / Brandywine Realty Trust / Meta Platforms Inc / SouthState Corp / Cathay General Bancorp / Glacier Bancorp Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lumen Technologies Inc / American Public Education Inc / Instil Bio Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Zoetis Inc / Trex Company Inc / Antero Resources Corp / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Splunk Inc / Abbvie Inc / Interface Inc / Noodles & Co / Uniqure NV / Aemetis Inc / El Pollo Loco Holdings Inc / New Relic Inc / Shake Shack Inc / Wingstop Inc / Atlantic Capital Bancshares Inc / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Alteryx Inc / Iovance Biotherapeutics Inc / Arvinas Inc / Elastic NV / Ferguson PLC / Datadog Inc / Azek Company Inc / Bally's Corp / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, July 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US09062X1037 / 125919308 / 918284100 / TSLA.OQ / 78667J108 / SESN.OQ / 67577R102 / 186760104</td><td class="leftalignment">Biogen Inc / CPI Aerostructures Inc / VSE Corp / Tesla Inc / SAGE Therapeutics Inc / Sesen Bio Inc / Ocuphire Pharma Inc / Clever Leaves Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Colombia / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Aduhelm next steps key as dust spreads not settles; raising PT from $359 to $423, maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">US09062X1037 / 78667J108</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sumant Kulkarni</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Misunderstood WATERFALL not yet under the bridge as we await CORAL; adjusting PT from $119 to $96, reiterate BUY</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">78667J108 / US09062X1037</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sumant Kulkarni</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">BIIB 2Q Takes: entry point beginning to look more interesting to us, although ADUHELM public headwinds keep us cautious</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">AAIC Data Shows CSF Tau Reductions With BIIB080; PET and Cognitive Data Required to Support Intracellular Knockdown Theory</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">09062X103 / 462222100</td><td class="leftalignment">Biogen Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Encouraging results from Phase 1b anti-tau ASO in patients with mild Alzheimer's disease</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Positive Update From BII080/IONIS-MAPT Rx Good Read-Through To ARVN's Tau Degrader In 2022</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ARVN=US / BIIB=US</td><td class="leftalignment">Arvinas Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Expert Call Invite: Alzheimer's double-header: TODAY 15:00 UK (ROG/MOR) reminder*</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ROG.S / LLY.N / MORG.DE / BIIB.OQ</td><td class="leftalignment">Roche Holding AG / Eli Lilly and Co / MorphoSys AG / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AXP.N / BAC.N / BK.N / BOX.N / C.N / CAS.TO / CCI.N / CL.N / CNA.L / COF.N / DFDS.CO / EIX.N / EL.N / F.N / FITB.O / GM.N / IP.N / JPM.N / KEY.N / KMB.N / KO.N / MO.N / NA / NEM.N / NTRS.O / PEG.N / PNC.N / RYN.N / SO.N / T.N / USB.N / WFC.N / SSE.L / PEP.N / BFb.N / PG.N / CFP.TO / GILD.O / FNV.N / CPB.N / CMCSA.O / CHKP.O / INCY.O / FER.MC / DIS.N / ROP.N / K.N / DT.N / DISH.O / GS.N / CLX.N / MCD.N / CAG.N / YUM.N / HON.N / DV.N / GIS.N / HSY.N / EPC.N / VZ.N / STT.N / SBUX.O / XEL.N / STZ.N / FISV.O / V.N / CHTR.O / NBIX.O / CHD.N / NWN.N / MTB.N / SAM.N / BMRN.O / REGN.O / ENR.N / NCR.N / RF.N / CPK.N / HL.N / TYL.N / NRZ.N / GPN.N / MNST.O / FFBC.O / RGLD.O / PCTY.O / BIIB.O / TFC.N / DPM.TO / DPZ.N / DLR.N / TXRH.O / VIAC.O / IAG.N / WEF.TO / DISCA.O / SJW.N / MS.N / CMG.N / FIS.N / MA.N / MERC.O / BGS.N / GETP.PA / CLW.N / FICO.N / EGO.N / SPB.N / NEE.N / TWO.N / MDLZ.OQ / ALLY.N / KPT.TO / PRMW.N / TMUS.N / COTY.N / FOXA.OQ / PTCT.O / BEP.N / 81762P102 / PTC.O / ITCI.O / 922475108 / PAYC.N / NEP.N / CFG.N / QSR.N / CRBP.OQ / GLPG.O / PYPL.OQ / GDS.O / LGFB.N / VST.N / WPM.N / WOW.N / ATUS.N / ORSTED.CO / COLD.N / VNE.N / KDP.N / NWL.O / KRTX.OQ / GMAB.O / NLOK.O / WTRG.N / REYN.O / FOUR.N / RXT.OQ / LUMN.N / LSPD.N / WFG.N / NAPA.N / WING.N / DBM.TO / OTLY.O / XMTR.OQ / 9VC.F / EVCM.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American Express Co / Bank of America Corp / Bank of New York Mellon Corp / Box Inc / Citigroup Inc / Cascades Inc / Crown Castle International Corp / Colgate-Palmolive Co / Centrica PLC / Capital One Financial Corp / DFDS AS / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Fifth Third Bancorp / General Motors Co / International Paper Co / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / National Bank of Canada / Newmont Corporation / Northern Trust Corp / Public Service Enterprise Group Inc / PNC Financial Services Group Inc / Rayonier Inc / Southern Co / AT&T Inc / US Bancorp / Wells Fargo & Co / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Comcast Corp / Check Point Software Technologies Ltd / Incyte Corp / Ferrovial SA / Walt Disney Co / Roper Technologies Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Conagra Brands Inc / Yum! Brands Inc / Honeywell International Inc / DoubleVerify Holdings Inc / General Mills Inc / Hershey Co / Edgewell Personal Care Co / Verizon Communications Inc / State Street Corp / Starbucks Corp / Xcel Energy Inc / Constellation Brands Inc / Fiserv Inc / Visa Inc / Charter Communications Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / M&T Bank Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / NCR Corp / Regions Financial Corp / Chesapeake Utilities Corp / Hecla Mining Co / Tyler Technologies Inc / New Residential Investment Corp / Global Payments Inc / Monster Beverage Corp / First Financial Bancorp / Royal Gold Inc / Paylocity Holding Corp / Biogen Inc / Truist Financial Corp / Dundee Precious Metals Inc / Domino's Pizza Inc / Digital Realty Trust Inc / Texas Roadhouse Inc / ViacomCBS Inc / IAMGOLD Corp / Western Forest Products Inc / Discovery Inc / SJW Group / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Mastercard Inc / Mercer International Inc / B&G Foods Inc / Getlink SE / Clearwater Paper Corp / Fair Isaac Corp / Eldorado Gold Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Two Harbors Investment Corp / Mondelez International Inc / Ally Financial Inc / KP Tissue Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Fox Corp / PTC Therapeutics Inc / Brookfield Renewable Partners LP / ServiceNow Inc / PTC Inc / Intra-Cellular Therapies Inc / Veeva Systems Inc / Paycom Software Inc / Nextera Energy Partners LP / Citizens Financial Group Inc / Restaurant Brands International Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / GDS Holdings Ltd / Lions Gate Entertainment Corp / Vistra Corp / Wheaton Precious Metals Corp / WideOpenWest Inc / Altice USA Inc / Orsted A/S / Americold Realty Trust / Veoneer Inc / Keurig Dr Pepper Inc / Newell Brands Inc / Karuna Therapeutics Inc / Genmab A/S / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / Duckhorn Portfolio Inc / Wingstop Inc / Doman Building Materials Group Ltd / Oatly Group AB / Xometry Inc / ATAI Life Sciences NV / EverCommerce Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Denmark / Spain / France / United Kingdom / Israel / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Patent Patrol – Biotechnology: 2Q21</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">NA / GILD.O / INCY.O / NBIX.O / BIIB.O / PTCT.O / ITCI.O / CRBP.OQ / GLPG.O / KRTX.OQ / 9VC.F</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biogen Inc / PTC Therapeutics Inc / Intra-Cellular Therapies Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Karuna Therapeutics Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Event Analysis (2): Development status and event outlook for Alzheimer's disease drug development programs</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">4519.T / 4523.T / LLY.N / ROG.S / BIIB.OQ</td><td class="leftalignment">Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Eli Lilly and Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABOS: A Differentiated A  Approach; Initiate with an Outperform Rating, $26 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">ABOS.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / NOVN.S / AMGN.OQ / BIIB.OQ / PRTA.OQ / ACIU.OQ</td><td class="leftalignment">Acumen Pharmaceuticals Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Amgen Inc / Biogen Inc / Prothena Corporation PLC / AC Immune SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Mark Connolly / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: イベントアナリシス②：アルツハイマー病治療薬の開発状況とイベント予測</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4519.T / 4523.T / LLY.N / ROG.S / BIIB.OQ</td><td class="leftalignment">Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Eli Lilly and Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/25/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">DNL310 Update: GAG Data Terrific, Safety Data Reassuring, Lysosomal Function Data In Progress, Nf-L Data Hypothesis Generating.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">24823R105 / 09062X103 / 014442107</td><td class="leftalignment">Denali Therapeutics Inc / Biogen Inc / Alector Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Ms. Kaveri Pohlman</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACA / AMN / AZO / CHE / CI / CNC / CVS / GLW / HUM / NEP / RAD / ROP / UNH / WMT / HCA.N / CYH.N / CCRN.O / ORLY.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / AIMC.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Autozone Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Corning Inc / Humana Inc / Nextera Energy Partners LP / Rite Aid Corp / Roper Technologies Inc / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / Cross Country Healthcare Inc / O'Reilly Automotive Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Altra Industrial Motion Corp / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Model Update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 557</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Model Adjustments Following 10-Q Filing; Tecfidera EU Legal Events From Second Half Onward</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CRY.N / CVS / HAE / HUM / MDT / RAD / SYK / UNH / WMT / AMZN.O / AMGN.O / TFX.N / ANIK.O / RMD.N / XRAY.O / HCA.N / CYH.N / COO.N / INSP.N / CERS.O / EW.N / ALGN.O / OSUR.O / ISR / SRDX.O / ABMD.OQ / ICUI.OQ / INCY.OQ / IART.OQ / ISRG.OQ / CCRN.O / STAA.O / IDXX.O / INMD.O / MMSI.O / AMED.O / BIIB.O / 025816109 / 478160104 / 00846U101 / 868168105 / ANGO.OQ / NUVA.O / 749685103 / ATRC.OQ / DXCM.O / LHCG.O / B8FGn.DE / LMAT.O / ARAY.O / PODD.O / MASI.O / ENSG.OQ / KIDS.O / 483548103 / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / SRPT.O / GMED.K / AXGN.O / GOOGL.O / MDWD.O / AGRX.OQ / XENT.OQ / NVRO.N / SIEN.O / VCEL.O / VRAY.OQ / EVH.N / TDOC.N / MCRB.OQ / GKOS.K / ZBH.N / CFMS.O / SPNE.O / 100063846 / SSKN.OQ / SENS.A / SYRS.OQ / TCMD.OQ / FLGT.OQ / IRTC.OQ / SRTS.O / VREX.OQ / 45780L104 / URGN.O / PLXP.O / 720795103 / ARVN.OQ / SWAV.O / XAIR.OQ / PNTG.OQ / VERO.O / ONEM.OQ / NNOX.O</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Haemonetics Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Amazon.com Inc / Amgen Inc / Teleflex Inc / Anika Therapeutics Inc / Resmed Inc / DENTSPLY SIRONA Inc / HCA Healthcare Inc / Community Health Systems Inc / Cooper Companies Inc / Inspire Medical Systems Inc / Cerus Corp / Edwards Lifesciences Corp / Align Technology Inc / OraSure Technologies Inc / IsoRay Inc / Surmodics Inc / ABIOMED Inc / ICU Medical Inc / Incyte Corp / Integra Lifesciences Holdings Corp / Intuitive Surgical Inc / Cross Country Healthcare Inc / STAAR Surgical Co / IDEXX Laboratories Inc / Inmode Ltd / Merit Medical Systems Inc / Amedisys Inc / Biogen Inc / American Express Co / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AngioDynamics Inc / NuVasive Inc / RPM International Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Biofrontera AG / LeMaitre Vascular Inc / Accuray Inc / Insulet Corp / Masimo Corp / Ensign Group Inc / OrthoPediatrics Corp / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Sarepta Therapeutics Inc / Globus Medical Inc / AxoGen Inc / Alphabet Inc / Mediwound Ltd / Agile Therapeutics Inc / Intersect Ent Inc / Nevro Corp / Sientra Inc / Vericel Corp / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Seres Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / SeaSpine Holdings Corp / Truist Financial Corp / STRATA Skin Sciences Inc / Senseonics Holdings Inc / Syros Pharmaceuticals Inc / Tactile Systems Technology Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Sensus Healthcare Inc / Varex Imaging Corp / Inogen Inc / Urogen Pharma Ltd / PLx Pharma Inc / Pieris Pharmaceuticals Inc / Arvinas Inc / Shockwave Medical Inc / Beyond Air Inc / Pennant Group Inc / Venus Concept Inc / 1Life Healthcare Inc / Nano-X Imaging Ltd</td><td class="leftalignment"></td><td class="leftalignment">Germany / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">STARTING IN 1 HOUR: Join Our KOL Call to Discuss New Drugs to Treat Alzheimer's and How They Will Be Reimbursed</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 7/16/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AIG.N / AXP / AZO / CCI.N / CMG / COF / CRM.N / CSL / DFS / GGG / HD / INTC.O / MSFT.O / NKE / ORA / QCOM.O / SNA / T.N / AMZN.O / AAPL.O / NVDA.O / DISH.O / HEAR.O / LSTR.O / AVGO.O / ATVI.OQ / XLNX.OQ / TTWO.OQ / SWKS.OQ / TXN.OQ / SIVB.O / NFLX.O / BIIB.O / 92343V104 / 20030N101 / DPZ / 36467W109 / NXPI.O / AMD.OQ / ZNGA.O / EA.O / ADI.OQ / TWTR.K / FDEV.L / GOOGL.O / 82655M107 / XENT.OQ / MCRB.OQ / TMUS.OQ / TTD.OQ / SNAP.K / STM.BN / BILI.O / ARVN.OQ / GRWG.O / HUYA.K</td><td class="leftalignment">American International Group Inc / American Express Co / Autozone Inc / Crown Castle International Corp / Chipotle Mexican Grill Inc / Capital One Financial Corp / Salesforce.Com Inc / Carlisle Companies Inc / Discover Financial Services / Graco Inc / Home Depot Inc / Intel Corp / Microsoft Corp / Nike Inc / Ormat Technologies Inc / Qualcomm Inc / Snap-On Inc / AT&T Inc / Amazon.com Inc / Apple Inc / NVIDIA Corp / DISH Network Corp / Turtle Beach Corp / Landstar System Inc / Broadcom Inc / Activision Blizzard Inc / Xilinx Inc / Take-Two Interactive Software Inc / Skyworks Solutions Inc / Texas Instruments Inc / SVB Financial Group / Netflix Inc / Biogen Inc / Verizon Communications Inc / Comcast Corp / Domino's Pizza Inc / GameStop Corp / NXP Semiconductors NV / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Twitter Inc / Frontier Developments PLC / Alphabet Inc / Sify Technologies Ltd / Intersect Ent Inc / Seres Therapeutics Inc / T-Mobile US Inc / Trade Desk Inc / Snap Inc / STMicroelectronics NV / Bilibili Inc / Arvinas Inc / GrowGeneration Corp / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / India / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 23 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">NL0000226223 / DE0006231004 / CH0012221716 / US0028241000 / US00971T1016 / US0116591092 / US0378331005 / US0382221051 / US1005571070 / US1727551004 / US17275R1023 / US22284P1057 / US2358511028 / US28176E1082 / US4581401001 / US48203R1041 / US5951121038 / US6549022043 / US7392761034 / US7475251036 / US8168501018 / US8305661055 / US8447411088 / US8610121027 / US8793601050 / US8807701029 / US9021041085 / US91347P1057 / US9581021055 / US87157D1090 / AU000000LYC6 / US83088M1027 / US2948216088 / US21036P1084 / US0003752047 / US09062X1037 / US1572101053 / US82706C1080 / US1717793095 / US7181721090 / US78454L1008 / US03027X1000 / NL0010273215 / US69327R1014 / US64051T1007 / US5764852050 / US90184L1026 / US02376R1023 / US90137F1030 / US22822V1017 / US74736K1016 / US00773U1088 / US87266J1043 / US15136A1025 / US36165L1089 / GB00BDSFG982 / US83304A1060 / US05351X1019 / US11135F1012 / CA39342L1085 / US85205L1070 / US69047Q1022 / US92537N1081 / US7602731025 / US13123X5086 / US5533681012 / CA1867601041 / US67080N1019</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Abb Ltd / Abbott Laboratories / Akamai Technologies Inc / Alaska Air Group Inc / Apple Inc / Applied Materials Inc / Boston Beer Company Inc / Cirrus Logic Inc / Cisco Systems Inc / Covenant Logistics Group Inc / Danaher Corp / Edwards Lifesciences Corp / Intel Corp / Juniper Networks Inc / Micron Technology Inc / Nokia Oyj / Power Integrations Inc / Qualcomm Inc / Semtech Corp / Skechers USA Inc / Southwest Airlines Co / STMicroelectronics NV / Teledyne Technologies Inc / Teradyne Inc / II-VI Inc / Universal Display Corp / Western Digital Corp / Synaptics Inc / Lynas Rare Earths Ltd / Skyworks Solutions Inc / Telefonaktiebolaget LM Ericsson / Constellation Brands Inc / Abb Ltd / Biogen Inc / CEVA Inc / Silicon Motion Technology Corp / Ciena Corp / Philip Morris International Inc / SM Energy Co / American Tower Corp / ASML Holding NV / PDC Energy Inc / NeoPhotonics Corp / Matador Resources Co / Twitter Inc / American Airlines Group Inc / 22nd Century Group Inc / Crown Castle International Corp / Qorvo Inc / Adverum Biotechnologies Inc / TPI Composites Inc / Centennial Resource Development Inc / GDS Holdings Ltd / TechnipFMC PLC / Snap Inc / Avaya Holdings Corp / Broadcom Inc / Green Thumb Industries Inc / SpringWorks Therapeutics Inc / Ovintiv Inc / Vertiv Holdings Co / Repare Therapeutics Inc / Callon Petroleum Co / Mp Materials Corp / Clever Leaves Holdings Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Germany / Finland / United Kingdom / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CACI=US / INTC=US / TWTR=US / ICLR=US / AMD=US / RRC=US / EFX=US / AMZN=US / T=US / GL=US / NVDA=US / DGX=US / TRU=US / CCI=US / VRM=US / EWBC=US / EXPE=US / LSTR=US / MANH=US / CVS=US / W=US / RCL=US / UNH=US / AVGO=US / CCL=US / SAFE=US / HZO=US / RHI=US / SNAP=US / TRIP=US / WIX=US / MANT=US / BKNG=US / FAF=US / FB=US / MTCH=US / GBCI=US / AUTL=US / BCO=US / PTON=US / BIIB=US / APP=US / BECN=US / BAH=US / KBR=US / ICFI=US / OC=US / SAIC=US / EIG=US / TIL=US / PSN=US / INSE / ANGI=US / EA=US / NCLH=US / LDOS=US / GOOGL=US / BABA=US / CMPR=US / ANTM=US / GDDY=US / LOB=US / ADVM=US / CVNA=US / IOVA=US / SFIX=US / FTDR=US / ARVN=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / BIGC=US / VMEO=US / MNTV=US</td><td class="leftalignment">CACI International Inc / Intel Corp / Twitter Inc / ICON PLC / Advanced Micro Devices Inc / Range Resources Corp / Equifax Inc / Amazon.com Inc / AT&T Inc / Globe Life Inc / NVIDIA Corp / Quest Diagnostics Inc / TransUnion / Crown Castle International Corp / Vroom Inc / East West Bancorp Inc / Expedia Group Inc / Landstar System Inc / Manhattan Associates Inc / CVS Health Corp / Wayfair Inc / Royal Caribbean Cruises Ltd / UnitedHealth Group Inc / Broadcom Inc / Carnival Corp / Safehold Inc / MarineMax Inc / Robert Half International Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / ManTech International Corp / Booking Holdings Inc / First American Financial Corp / Meta Platforms Inc / Match Group Inc / Glacier Bancorp Inc / Autolus Therapeutics PLC / Brinks Co / Peloton Interactive Inc / Biogen Inc / Applovin Corp / Beacon Roofing Supply Inc / Booz Allen Hamilton Holding Corp / KBR Inc / ICF International Inc / Owens Corning / Science Applications International Corp / Employers Holdings Inc / Instil Bio Inc / Parsons Corp / Inspired Entertainment Inc / Angi Inc / Electronic Arts Inc / Norwegian Cruise Line Holdings Ltd / Leidos Holdings Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / Anthem Inc / GoDaddy Inc / Live Oak Bancshares Inc / Adverum Biotechnologies Inc / Carvana Co / Iovance Biotherapeutics Inc / Stitch Fix Inc / Frontdoor Inc / Arvinas Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Bigcommerce Holdings Inc / Vimeo Inc / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Ireland / Israel / Liberia / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">2000019 / 2002305 / 2026242 / 2113393 / 2270726 / 2829515 / 2317087 / 2328915 / 2342034 / 2100920 / 2367480 / 2455965 / 2689560 / 2684703 / 2440637 / 2138158 / 2829601 / 2900335 / 2769796 / 2857817 / B3D7K31 / B7TL820 / BFLR866 / BYVY8G0 / BP4GNK9 / BD8DJ71 / BP7RS48 / BR4T3B3 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BZ1LFG7 / BDZ30Q0 / BMPRZV5 / BD5GSZ4 / BP7KZP7</td><td class="leftalignment">Amazon.com Inc / Abbott Laboratories / American Electric Power Company Inc / Boston Beer Company Inc / Walt Disney Co / Edison International / Entergy Corp / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / Genuine Parts Co / Biogen Inc / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Sempra Energy / Southern Co / Tractor Supply Co / Fidelity National Information Services Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / Twitter Inc / Alphabet Inc / SAGE Therapeutics Inc / Snap Inc / Intersect Ent Inc / HubSpot Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / Vistra Corp / ViacomCBS Inc / Roku Inc / Arvinas Inc / Kymera Therapeutics Inc / Infrastructure and Energy Alternatives Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Biogen's AD Pipeline beyond Aducanumab―Our Thoughts</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">R&D Day Projects a Bright Future for AGTC’s Leading Programs and Beyond; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">03820J100 / BIIB / 68906L105</td><td class="leftalignment">Applied Genetic Technologies Corp / Biogen Inc / Otonomy Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BB.N / COF.N / FITB.O / IP.N / MMC.N / PD.TO / RWEG.DE / SGEF.PA / T.N / CFP.TO / LPX.N / FN.TO / POW.TO / CHKP.O / AMGN.O / THC.N / FER.MC / CLS.N / DHR.N / DT.N / DISH.O / UNP.N / DV.N / MRO.N / WHR.N / JAZZ.O / GIBa.TO / VLY.N / EXEL.O / DHI.N / DSGX.O / RRC.N / FDS.N / EFX.N / EQT.N / CHTR.O / DNB.N / OTEX.O / BMRN.O / STL.N / REGN.O / SWIR.O / JHX.AX / AIF.TO / MCO.N / CIX.TO / GGG.N / RLI.N / SWN.N / WBS.N / DFS.N / TRU.N / SGEN.OQ / X.TO / SIVB.O / BPOP.O / BIIB.O / HCG.TO / DPZ.N / IGM.TO / WEF.TO / DISCA.O / BAM.N / 35671D857 / CSU.TO / MERC.O / EXPN.L / CLR.N / CBRO.L / WRB.N / SII.TO / MSCI.N / IFC.TO / FICO.N / VRSK.O / FSZ.TO / CHW.TO / NLSN.N / IFP.TO / MTDR.N / SLM.OQ / EFN.TO / RFP.N / ADT.N / FANG.O / TPH.N / TMUS.N / PTCT.O / ISV.TO / EQB.TO / KXS.TO / ASB.N / SHOP.N / OMF.N / UBSG.S / MTRO.L / SPGI.N / ADVM.OQ / BBU.N / ECN.TO / ENGH.TO / ONEX.TO / CADE.N / FOOD.TO / APTV.N / 05971J102 / VNE.N / GMAB.O / 260557103 / PAGPA.L / AD_u.TO / NVEIu.TO / LSPD.N / WFG.N / TIXT.TO / MAGT.TO / DBM.TO</td><td class="leftalignment">BlackBerry Ltd / Capital One Financial Corp / Fifth Third Bancorp / International Paper Co / Marsh & McLennan Companies Inc / Precision Drilling Corp / Rwe AG / Vinci SA / AT&T Inc / Canfor Corp / Louisiana-Pacific Corp / First National Financial Corp / Power Corporation of Canada / Check Point Software Technologies Ltd / Amgen Inc / Tenet Healthcare Corp / Ferrovial SA / Celestica Inc / Danaher Corp / Dynatrace Inc / DISH Network Corp / Union Pacific Corp / DoubleVerify Holdings Inc / Marathon Oil Corp / Whirlpool Corp / Jazz Pharmaceuticals PLC / CGI Inc / Valley National Bancorp / Exelixis Inc / D R Horton Inc / Descartes Systems Group Inc / Range Resources Corp / Factset Research Systems Inc / Equifax Inc / EQT Corp / Charter Communications Inc / Dun & Bradstreet Holdings Inc / Open Text Corp / Biomarin Pharmaceutical Inc / Sterling Bancorp / Regeneron Pharmaceuticals Inc / Sierra Wireless Inc / James Hardie Industries PLC / Altus Group Ltd / Moody's Corp / CI Financial Corp / Graco Inc / Rli Corp / Southwestern Energy Co / Webster Financial Corp / Discover Financial Services / TransUnion / Seagen Inc / TMX Group Ltd / SVB Financial Group / Popular Inc / Biogen Inc / Home Capital Group Inc / Domino's Pizza Inc / IGM Financial Inc / Western Forest Products Inc / Discovery Inc / Brookfield Asset Management Inc / Freeport-McMoRan Inc / Constellation Software Inc / Mercer International Inc / Experian PLC / Continental Resources Inc / Close Brothers Group PLC / W R Berkley Corp / Sprott Inc / MSCI Inc / Intact Financial Corp / Fair Isaac Corp / Verisk Analytics Inc / Fiera Capital Corp / Chesswood Group Ltd / Nielsen Holdings PLC / Interfor Corp / Matador Resources Co / SLM Corp / Element Fleet Management Corp / Resolute Forest Products Inc / ADT Inc / Diamondback Energy Inc / Tri Pointe Homes Inc (Delaware) / T-Mobile US Inc / PTC Therapeutics Inc / Information Services Corp / Equitable Group Inc / Kinaxis Inc / Associated Banc-Corp / Shopify Inc / OneMain Holdings Inc / UBS Group AG / Metro Bank PLC / S&P Global Inc / Adverum Biotechnologies Inc / Brookfield Business Partners LP / ECN Capital Corp / Enghouse Systems Ltd / Onex Corp / Cadence Bank / Goodfood Market Corp / Aptiv PLC / Cadence Bank / Veoneer Inc / Genmab A/S / Dow Inc / Paragon Banking Group PLC / Alaris Equity Partners Income Trust / Nuvei Corp / Lightspeed Commerce Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Magnet Forensics Inc / Doman Building Materials Group Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Puerto Rico / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB 2Q21 Postview:  Adu, adu, and more adu…</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Base Business Remains Resilient; Stay Tuned for Adu Launch</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 2Q21 Earnings (ABT, BIIB, DGX) — What Mattered for Credit</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.O / DGX.N</td><td class="leftalignment">Biogen Inc / Quest Diagnostics Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 Above Expectations As Aduhelm's Launch Begins</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : 2Q Snapshot - Quarterly Performance Muted by Aduhelm Noise</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037 / US0367521038</td><td class="leftalignment">Biogen Inc / Anthem Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Mo’ Money, Mo’ Problems? Big Time Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">2Q Delivers in the Face of Adversity</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">2Q21 EPS: Lots of Bullish details on Aduhelm is the focus</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Aduhelm Waiting for NCD Determination; Prelim Public CMS Hearing Focused on Optimizing Access and Against CED</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on July 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">TWTR.N / ABT.N / ALK.N / BP.L / CE.N / COF.N / DOW.N / FCX.N / IBM.N / LUV.N / MMC.N / NEM.N / SLB.N / T.N / DGX.N / NUE.N / HAL.N / DHR.N / FE.N / UNP.N / XOM.N / DHI.N / SNA.N / GPC.N / AAPL.OQ / MSFT.OQ / SIVB.OQ / SBUX.OQ / POOL.OQ / AMZN.OQ / VRSN.OQ / FITB.OQ / BIIB.OQ / 0700.HK / DPZ.N / RDSa.L / CROX.OQ / 9999.HK / WRB.N / BKR.N / GTLS.N / ALLE.N / AAL.OQ / SNAP.N / LYFT.OQ / PINS.N / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / 9618.HK / AEP.OQ / ABNB.OQ</td><td class="leftalignment">Twitter Inc / Abbott Laboratories / Alaska Air Group Inc / BP PLC / Celanese Corp / Capital One Financial Corp / Dow Inc / Freeport-McMoRan Inc / International Business Machines Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Newmont Corporation / Schlumberger NV / AT&T Inc / Quest Diagnostics Inc / Nucor Corp / Halliburton Co / Danaher Corp / FirstEnergy Corp / Union Pacific Corp / Exxon Mobil Corp / D R Horton Inc / Snap-On Inc / Genuine Parts Co / Apple Inc / Microsoft Corp / SVB Financial Group / Starbucks Corp / Pool Corp / Amazon.com Inc / Verisign Inc / Fifth Third Bancorp / Biogen Inc / Tencent Holdings Ltd / Domino's Pizza Inc / Royal Dutch Shell PLC / Crocs Inc / NetEase Inc / W R Berkley Corp / Baker Hughes Co / Chart Industries Inc / Allegion PLC / American Airlines Group Inc / Snap Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / JD.Com Inc / American Electric Power Company Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SAGE - Read-Through From BIIB Call; SKYLARK Data Likely To Be Pushed To 2022</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / BP4GNK9 / 2455965</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB 2Q21: They said what? Highlights from conf call…and our impressions</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Controversy Sells - Or So We'll Soon Find Out</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2Q21: Base Biz Performing Well, Though Clarity On Adu Outlook Slow To Materialize</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">2Q 2021 Refreshingly Unapologetic Aducanumab Update. Two Additional Catalysts Expected by YE21</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103 / 92915B106 / 24823R105</td><td class="leftalignment">Biogen Inc / Voyager Therapeutics Inc / Denali Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Ms. Kaveri Pohlman</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Love the Beat/Raise; Aduhelm Uptake Remains Central Issue</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : First Look at 2Q Results</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN (BUY) - New PFE Deal Positions ARV-471 as Potl. Best-in-Class ER Degrader, Removes Downside Scenario and Further Validates TPD Category</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BDZ30Q0 / PFE.N / 2369174 / 2455965 / 2684703 / BMPRZV5 / BP7KZP7</td><td class="leftalignment">Arvinas Inc / Pfizer Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Kymera Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Expert Call Invite: Alzheimer's double-header: Mon 26 July 15:00 UK (ROG/MOR) reminder*</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ROG.S / LLY.N / MORG.DE / BIIB.OQ</td><td class="leftalignment">Roche Holding AG / Eli Lilly and Co / MorphoSys AG / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - 2Q21; A Solid Quarter Overall, Focus Remains on Aducanumab Launch and Payer Dynamics</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Positive Comments on BIIB earnings call regarding Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">BIIB Reports Q2 Top- And Bottom- Line Beat, 2021 Revenue Guidance Bumped Up</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Another Solid Quarter, but All Eyes on Adu</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">First Take: 2Q21 top and bottom-line beat; focus remains on Aduhelm coverage</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Biogen Second-Quarter Quick Take: 35% of Aduhelm Sites Reportedly on Board, Legacy Product Sales Flat Quarter-Over-Quarter</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">09062X103 / 462222100 / IONS.OQ</td><td class="leftalignment">Biogen Inc / Ionis Pharmaceuticals Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q221 First Take: Strong Beat/Raise;  All Eyes on Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Brief of Biogen Inc conference call, Jul. 22, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Jul. 22, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2Q21 First Take: Strong Quarter As Expected; Aduhelm Defense on Display</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">2Q21 First Take: Aduhelm Arrives As BIIB Reports Beat</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: July 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / EOG.N / FCX.N / GE.N / GM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for BIIB</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Strengthening Foothold in Population-Scale Proteomics; Buy and $44 PT</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">68071010 / 09062X103</td><td class="leftalignment">Olink Holding AB (publ) / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Sweden / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Sung Ji Nam</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Friday 7/23 @ 11 AM ET: Join Our KOL Call to Discuss New Drugs to Treat Alzheimer's and How They Will Be Reimbursed</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, BIIB</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Mr. Jasper Hellweg</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Monthly Institutional Prescription Sales -- June 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / BIIB.O</td><td class="leftalignment">Biogen Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : Survey Says: Aduhelm Utilization Remains Difficult to Predict as Controversy Swirls</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : Post Approval Aduhelm Physician Survey</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">FR0000054470 / US09061G1013 / US8816242098 / US00971T1016 / US02553E1064 / US0311621009 / US0366421065 / US09058V1035 / US30161Q1040 / US3755581036 / US4062161017 / US45337C1027 / US64125C1099 / US66987V1098 / US75886F1075 / US8305661055 / US91307C1027 / US92532F1003 / CA1363751027 / US64110L1061 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US1696561059 / US29089Q1058 / US2521311074 / US45784P1012 / US53261M1045 / US03152W1099 / US0231112063 / US7181721090 / US46333X1081 / US9100471096 / US4464131063 / NL0010273215 / US5017971046 / US8036071004 / US4576693075 / US88338N1072 / IE00B4Q5ZN47 / US6951271005 / US74587V1070 / US8684591089 / US45845P1084 / US23283R1005 / US29428V1044 / US69366J2006 / US29664W1053 / US00771V1089 / US4277461020 / US5034596040 / US90400D1081 / US7613301099 / IE00BJ3V9050 / KYG8807B1068 / US78667J1088 / IE00BQPVQZ61 / US19249H1032 / US2681582019 / US31572Q8087 / CA89620X5064 / US29444U7000 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / US87184Q1076 / US36165L1089 / NL0012169213 / IL0011407140 / VGG111961055 / US04016X1019 / US87105L1044 / US8753722037 / US76243J1051 / US68404V1008 / US05455M1009 / CA0717341071 / KY30744W1070 / US8740602052 / US61775R1059 / US85205L1070 / US65487U1088 / US69353Y1038 / US81181C1045 / US55406W1036 / US92941V2097 / US25401T1088 / US35909D1090</td><td class="leftalignment">Ubisoft Entertainment SA / Biomarin Pharmaceutical Inc / Teva Pharmaceutical Industries Ltd / Akamai Technologies Inc / American Eagle Outfitters Inc / Amgen Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Exelixis Inc / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Neurocrine Biosciences Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Skechers USA Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Canadian National Railway Co / Netflix Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Chipotle Mexican Grill Inc / Emergent BioSolutions Inc / Dexcom Inc / Insulet Corp / Limelight Networks Inc / Amicus Therapeutics Inc / Amarin Corporation PLC / Philip Morris International Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / Huntington Ingalls Industries Inc / ASML Holding NV / Bath & Body Works Inc / Sarepta Therapeutics Inc / Insmed Inc / TherapeuticsMD Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Puma Biotechnology Inc / Supernus Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / CyrusOne Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Revance Therapeutics Inc / Endo International PLC / Theravance Biopharma Inc / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Coherus BioSciences Inc / Dynavax Technologies Corp / FibroGen Inc / Pfizer Inc / Equinix Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Syros Pharmaceuticals Inc / GDS Holdings Ltd / Qiagen NV / Urogen Pharma Ltd / Biohaven Pharmaceutical Holding Company Ltd / argenx SE / Switch Inc / Tandem Diabetes Care Inc / Rhythm Pharmaceuticals Inc / OptiNose Inc / AVROBIO Inc / Bausch Health Companies Inc / Farfetch Ltd / Takeda Pharmaceutical Co Ltd / Morphic Holding Inc / SpringWorks Therapeutics Inc / Nkarta Inc / PMV Pharmaceuticals Inc / Seagen Inc / MYT Netherlands Parent BV / Vyne Therapeutics Inc / DigitalBridge Group Inc / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Japan / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Second Quarter 2021 Biotechnology Earnings Preview: Sector Trading in Line as Earnings Kicks Off and New Products Approved</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">G11196105 / 09061G101 / 03116210 / 64125C109 / 110122108 / 09062X103 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 803607100 / 26979610 / 00847L10 / 268158201 / 31572Q80 / 76133010 / 462222100 / 19459J104 / 69366J200 / 09609G100 / 37890U108 / 517125100 / 74006W108</td><td class="leftalignment">Biohaven Pharmaceutical Holding Company Ltd / Biomarin Pharmaceutical Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / PTC Therapeutics Inc / bluebird bio Inc / Global Blood Therapeutics Inc / Larimar Therapeutics Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 Earnings Preview: Hoping That Solid Financials Are What The Doctor Ordered</td><td class="leftalignment">English</td><td class="rightalignment">238</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DD.N / DOW.N / FCX.N / GE.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / PM.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / MTB.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ANTM.N / ZBH.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Freeport-McMoRan Inc / General Electric Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Philip Morris International Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Anthem Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Deutsche Bank</td><td class="leftalignment">Expert Call Invite: Alzheimer's double-header: Mon 26 July 15:00 UK/10:00 ET (ROG/MOR)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ROG.S / LLY.N / MORG.DE / BIIB.OQ</td><td class="leftalignment">Roche Holding AG / Eli Lilly and Co / MorphoSys AG / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">ACCOUNTING / COMPLIANCE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Emmanuel D. Papadakis, PHD / Mr. Rajan Sharma</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Delta, Now Dominant in the U.S., Is Driving Domestic and Global Growth; Regions With Low Vaccination Rates at Greatest Risk</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">2Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">09062X103 / 031162100 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Biogen Inc / Amgen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">EDP.LS / EOG.N / NA / OXB.L / RIO.L / SGEF.PA / ZION.O / GILD.O / AMGN.O / INCY.O / UNH.N / EVTG.DE / SGMO.O / VZ.N / EXEL.O / ARNA.O / AMP.N / DPH.L / NBIX.O / WSP.TO / BMRN.O / REGN.O / ABC.N / VRTX.O / ENAG.MC / BLU.N / HCC.N / AMH.N / SGEN.OQ / IMGN.O / HOOK.O / BLUE.O / BCRX.O / ICPT.O / STN.TO / BIIB.O / IGO.AX / FMG.AX / SNC.TO / FM.TO / 878742204 / SPI.L / ACAD.O / ALNY.O / 35671D857 / ARWR.O / CS.TO / 443628102 / AUY.N / 550372106 / IVZ.N / CVSG.L / INO.OQ / OZL.AX / TCN.TO / SLS.TO / FHI.N / SRPT.O / CLINC.L / 505440107 / APAM.N / ENTA.O / PTCT.O / PRTA.O / AGIO.O / 46579R104 / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / CIA.TO / ARES.N / SAGE.OQ / MOLN.S / 03835T200 / AENA.MC / CRBP.OQ / GLPG.O / GBT.OQ / RPD.O / RGNX.O / WVE.OQ / MESO.O / RMR.OQ / IONS.O / EDIT.O / ADVM.OQ / NTLA.O / CRSP.OQ / CTEC.L / PBYI.OQ / INVH.N / OVID.O / ATNX.O / VCTR.N / BSIG.N / ITRM.O / PRVB.O / MGTX.O / GMDA.OQ / HNSA.ST / NBSE.OQ / ZM.O / FIXX.O / KRTX.OQ / MORF.OQ / NOVA.N / GMAB.O / APRE.OQ / IGMS.O / ETNB.O / BEAM.O / APA.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GATO.N / GDRX.O / ALOO.O / 900435207 / NUVB.N / BHG.N / 9VC.F</td><td class="leftalignment">EDP Energias de Portugal SA / EOG Resources Inc / National Bank of Canada / Oxford BioMedica PLC / Rio Tinto PLC / Vinci SA / Zions Bancorporation NA / Gilead Sciences Inc / Amgen Inc / Incyte Corp / UnitedHealth Group Inc / Evotec SE / Sangamo Therapeutics Inc / Verizon Communications Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Ameriprise Financial Inc / Dechra Pharmaceuticals PLC / Neurocrine Biosciences Inc / WSP Global Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Amerisourcebergen Corp / Vertex Pharmaceuticals Inc / Enagas SA / BELLUS Health Inc / Warrior Met Coal Inc / American Homes 4 Rent / Seagen Inc / ImmunoGen Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Stantec Inc / Biogen Inc / IGO Ltd / Fortescue Metals Group Ltd / SNC-Lavalin Group Inc / First Quantum Minerals Ltd / Teck Resources Ltd / Spire Healthcare Group PLC / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Arrowhead Pharmaceuticals Inc / Capstone Mining Corp / Hudbay Minerals Inc / Yamana Gold Inc / Lundin Mining Corp / Invesco Ltd / CVS Group PLC / Inovio Pharmaceuticals Inc / OZ Minerals Ltd / Tricon Residential Inc / Solaris Resources Inc / Federated Hermes Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Labrador Iron Ore Royalty Corp / Artisan Partners Asset Management Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Ivanhoe Mines Ltd / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Champion Iron Ltd / Ares Management Corp / SAGE Therapeutics Inc / Molecular Partners AG / Aptose Biosciences Inc / Aena SME SA / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Rapid7 Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / RMR Group Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / ConvaTec Group PLC / Puma Biotechnology Inc / Invitation Homes Inc / Ovid Therapeutics Inc / Athenex Inc / Victory Capital Holdings Inc / Brightsphere Investment Group Inc / Iterum Therapeutics PLC / Provention Bio Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Hansa Biopharma AB / NeuBase Therapeutics Inc / Zoom Video Communications Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Sunnova Energy International Inc / Genmab A/S / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Beam Therapeutics Inc / APA Corp (US) / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Gatos Silver Inc / Goodrx Holdings Inc / Allogene Therapeutics Inc / Turquoise Hill Resources Ltd / Nuvation Bio Inc / Bright Health Group Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / Portugal / Singapore / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2021 RBC Biotech Halftime Report: Negativity May Create Long-Term Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">105</td><td class="leftalignment">NA / OXB.L / GILD.O / AMGN.O / INCY.O / EVTG.DE / SGMO.O / EXEL.O / ARNA.O / DPH.L / NBIX.O / BMRN.O / REGN.O / ABC.N / VRTX.O / BLU.N / SGEN.OQ / IMGN.O / HOOK.O / BLUE.O / BCRX.O / ICPT.O / BIIB.O / SPI.L / ACAD.O / ALNY.O / ARWR.O / CVSG.L / INO.OQ / SRPT.O / CLINC.L / ENTA.O / PTCT.O / PRTA.O / AGIO.O / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / SAGE.OQ / MOLN.S / 03835T200 / CRBP.OQ / GLPG.O / GBT.OQ / RGNX.O / WVE.OQ / MESO.O / IONS.O / EDIT.O / ADVM.OQ / NTLA.O / CRSP.OQ / CTEC.L / PBYI.OQ / OVID.O / ATNX.O / ITRM.O / PRVB.O / MGTX.O / GMDA.OQ / HNSA.ST / NBSE.OQ / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / IGMS.O / ETNB.O / BEAM.O / NRIX.OQ / SPRB.OQ / MTCR.O / ALOO.O / NUVB.N / 9VC.F</td><td class="leftalignment">National Bank of Canada / Oxford BioMedica PLC / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Evotec SE / Sangamo Therapeutics Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Amerisourcebergen Corp / Vertex Pharmaceuticals Inc / BELLUS Health Inc / Seagen Inc / ImmunoGen Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Spire Healthcare Group PLC / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / CVS Group PLC / Inovio Pharmaceuticals Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / SAGE Therapeutics Inc / Molecular Partners AG / Aptose Biosciences Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / ConvaTec Group PLC / Puma Biotechnology Inc / Ovid Therapeutics Inc / Athenex Inc / Iterum Therapeutics PLC / Provention Bio Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Hansa Biopharma AB / NeuBase Therapeutics Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Beam Therapeutics Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Allogene Therapeutics Inc / Nuvation Bio Inc / ATAI Life Sciences NV</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Jack Reynolds-Clark / Yinglu Zhang / Jackie Yan / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Mr. Charles Weston / Stephen Mallon / Leonid Timashev / David Szeto / Lisa Walter</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 2Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Future Forecasts: July 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DOW.N / FCX.N / GE.N / IBM.N / JNJ.N / KMB.N / KO.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / OMC.N / PFE.N / PM.N / PPG.N / SLB.N / SO.N / TMO.N / TRV.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / HAL.N / ETN.N / DHR.N / DOV.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / TWTR.N / MTB.N / CVX.N / MCO.N / RF.N / HAYS.L / INTC.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / KEY.TO / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / SYF.N / CFG.N / ANTM.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / UAL.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dow Inc / Freeport-McMoRan Inc / General Electric Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Pfizer Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Halliburton Co / Eaton Corporation PLC / Danaher Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Twitter Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Regions Financial Corp / Hays PLC / Intel Corp / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Keyera Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 09, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Key Takeaways From Day 2 of the 2021 William Blair Biotech Focus Conference</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">110122108 / 268158201 / 03116210 / 64125C109 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Bristol-Myers Squibb Co / Dynavax Technologies Corp / Amgen Inc / Neurocrine Biosciences Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ALB.N / AMT / BE / BSX / CAT / CI / CLH / CMG / CMI / COST.O / CRM.N / DAN / DE / DG / DHI / ECL.N / EL.N / ENS / FDX / GE / GS / INTC.O / JCI / JPM / KKR / KR / LRCX.O / MA / MDT / MS / MSFT.O / NEP / NICE.TA / NOW / O / ORA / ROP / RSG / T.N / UNH / URI / WM / ZEN / 4716.T / AMZN.O / AAPL.O / FIS / BWA.N / NVDA.O / ADBE.O / DTE.N / SAPG.DE / SQ / NOVN.S / RMD.N / TREE.O / SBUX.O / INSP.N / ADSK.O / V.N / EW.N / DLTR.O / CHD.N / IO.N / CSGP.O / FCEL.O / ALGN.O / CREE.O / NET.N / AVGO.O / CSCO.OQ / ATVI.OQ / XLNX.OQ / AMSC.OQ / INCY.OQ / AKAM.OQ / PLUG.OQ / ISRG.OQ / SWKS.OQ / SIVB.O / TRMB.O / ITRI.O / PCTY.O / ANSS.O / LPSN.O / NFLX.O / BIIB.O / 92343V104 / DPZ / SPWR.O / CSIQ.O / FSLR.O / IPGP.O / VMW / TWIN.O / CSII.O / AGCO.K / GLAXOSM.LG / TSLA.O / AMRC.K / AMRS.OQ / QSR.TO / ENPH.O / FB.O / HASI.N / GOOGL.O / FIVN.O / PAYC.K / HUBS.K / SHOP.K / SEDG.O / RUN.O / TMUS.OQ / WKHS.O / WCN.TO / AQMS.O / 34959J108 / FLGT.OQ / COUP.O / WPRT.TO / TWLO.K / UAA / WDAY.O / APTV.K / AVYA.K / DOCU.O / CWENa.K / SWAV.O / ZM.OQ / UBER.K / BILL.K / AVNT.K / RWRh.V / 03823M100 / 30260D103 / 744285206</td><td class="leftalignment">Albemarle Corp / American Tower Corp / Bloom Energy Corp / Boston Scientific Corp / Caterpillar Inc / Cigna Corp / Clean Harbors Inc / Chipotle Mexican Grill Inc / Cummins Inc / Costco Wholesale Corp / Salesforce.Com Inc / Dana Inc / Deere & Co / Dollar General Corp / D R Horton Inc / Ecolab Inc / Estee Lauder Companies Inc / EnerSys / FedEx Corp / General Electric Co / Goldman Sachs Group Inc / Intel Corp / Johnson Controls International PLC / JPMorgan Chase & Co / KKR & Co Inc / Kroger Co / Lam Research Corp / Mastercard Inc / Medtronic PLC / Morgan Stanley / Microsoft Corp / Nextera Energy Partners LP / Nice Ltd / ServiceNow Inc / Realty Income Corp / Ormat Technologies Inc / Roper Technologies Inc / Republic Services Inc / AT&T Inc / UnitedHealth Group Inc / United Rentals Inc / Waste Management Inc / Zendesk Inc / Oracle Corp Japan / Amazon.com Inc / Apple Inc / Fidelity National Information Services Inc / Borgwarner Inc / NVIDIA Corp / Adobe Inc / DTE Energy Co / SAP SE / Block Inc / Novartis AG / Resmed Inc / Lendingtree Inc / Starbucks Corp / Inspire Medical Systems Inc / Autodesk Inc / Visa Inc / Edwards Lifesciences Corp / Dollar Tree Inc / Church & Dwight Co Inc / ION Geophysical Corp / CoStar Group Inc / Fuelcell Energy Inc / Align Technology Inc / Wolfspeed Inc / Cloudflare Inc / Broadcom Inc / Cisco Systems Inc / Activision Blizzard Inc / Xilinx Inc / American Superconductor Corp / Incyte Corp / Akamai Technologies Inc / Plug Power Inc / Intuitive Surgical Inc / Skyworks Solutions Inc / SVB Financial Group / Trimble Inc / Itron Inc / Paylocity Holding Corp / ANSYS Inc / LivePerson Inc / Netflix Inc / Biogen Inc / Verizon Communications Inc / Domino's Pizza Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / IPG Photonics Corp / VMware Inc / Twin Disc Inc / Cardiovascular Systems Inc / AGCO Corp / Glaxo Smithkline Consumer Nigeria PLC / Tesla Inc / Ameresco Inc / Amyris Inc / Restaurant Brands International Inc / Enphase Energy Inc / Meta Platforms Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Alphabet Inc / Five9 Inc / Paycom Software Inc / HubSpot Inc / Shopify Inc / Solaredge Technologies Inc / Sunrun Inc / T-Mobile US Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / Fortive Corp / Fulgent Genetics Inc / Coupa Software Inc / Westport Fuel Systems Inc / Twilio Inc / Under Armour Inc / Workday Inc / Aptiv PLC / Avaya Holdings Corp / DocuSign Inc / Clearway Energy Inc / Shockwave Medical Inc / Zoom Video Communications Inc / Uber Technologies Inc / Bill.com Holdings Inc / Avient Corp / Strathmore Plus Energy Corp / Applied Minerals Inc / Figs Inc / Proxim Wireless Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Hong Kong / Ireland / Israel / Japan / Nigeria / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2Q21 Preview; Still Cautious Overall but See Opportunities</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">00422510 / H0026310 / 64125C10 / 09062X10 / G0176710 / G5087110 / 05337M104 / 38942Q10 / 98420N10 / 30052C10 / 05464T10 / 01438T10 / G1119610 / 40422M10 / 98978L20 / 78667J10 / 46116X10 / 80405P10 / 75955J40 / 03836N10 / 56854Q20 / 36870G10</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / AC Immune SA / Neurocrine Biosciences Inc / Biogen Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Avadel Pharmaceuticals PLC / Graybug Vision Inc / Xenon Pharmaceuticals Inc / Evolus Inc / Axsome Therapeutics Inc / Aldeyra Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / SAGE Therapeutics Inc / Intra-Cellular Therapies Inc / Satsuma Pharmaceuticals Inc / Relmada Therapeutics Inc / Aptinyx Inc / Marinus Pharmaceuticals Inc / Gemini Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GLUE (BUY) - Molecular Glue - Differentiated Approach to Targeted Protein Degradation - Initiating Coverage with a BUY Rating and $30 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BP7KZP7 / 5671735 / 0989529 / 0925288 / 2126335 / 2023607 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / BBFL7S1 / BDHF4K6 / BZ8FPH3 / BWY52P3 / BDZ30Q0 / BN2R582 / BDD1B07 / BMPRZV5 / BMDJ397 / BN2RM92</td><td class="leftalignment">Monte Rosa Therapeutics Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amgen Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / bluebird bio Inc / CRISPR Therapeutics AG / Editas Medicine Inc / Blueprint Medicines Corp / Arvinas Inc / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAX.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / CNC.N / COF.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / IBM.N / JNJ.N / KMB.N / KO.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / OMC.N / PFE.N / PM.N / PPG.N / SLB.N / SO.N / TEL.PS / TMO.N / TRV.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / NUE.N / UHS.N / HAL.N / ADML.L / ETN.N / DHR.N / FE.N / GD.N / DOV.N / ROP.N / CAT.N / IPG.N / UNP.N / MCD.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / WHR.N / LIN.N / SHW.N / PKG.N / GWW.N / VZ.N / STT.N / HCA.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / CHD.N / TWTR.N / MTB.N / CVX.N / MCO.N / RF.N / HAYS.L / INTC.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / ZION.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / POOL.OQ / AMZN.OQ / TTWO.OQ / VRSN.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ISRG.OQ / EQIX.OQ / ALGN.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / LVS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / ES.N / NVR.N / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / KEY.TO / BKR.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / SYF.N / CFG.N / ANTM.N / PYPL.OQ / CSX.OQ / IQV.N / XEL.OQ / WELL.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Pfizer Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / FirstEnergy Corp / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Interpublic Group of Companies Inc / Union Pacific Corp / McDonald's Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Whirlpool Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / W W Grainger Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / Twitter Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Regions Financial Corp / Hays PLC / Intel Corp / Apple Inc / Cerner Corp / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Pool Corp / Amazon.com Inc / Take-Two Interactive Software Inc / Verisign Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Intuitive Surgical Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / NVR Inc / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Keyera Corp / Baker Hughes Co / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / CSX Corp / IQVIA Holdings Inc / Xcel Energy Inc / Welltower Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CS Hospital Volume Tracker: July Survey: June Inpatient Volumes Up 0.1% Y/Y, Outpatient Up 2.8%</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">THC.N / UHS.N / HCA.N / CYH.N / BIIB.OQ</td><td class="leftalignment">Tenet Healthcare Corp / Universal Health Services Inc / HCA Healthcare Inc / Community Health Systems Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. A.J. Rice / Alexander Khan</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (19 July-): Eisai shares caught in controversy over Alzheimer's drug</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4507.T / 4523.T / 4502.T / 4503.T / 4519.T / 4528.T / 4543.T / 4516.T / HUM.N / 4506.T / 4536.T / UNH.N / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / SRPT.OQ / 4587.T / 4887.T</td><td class="leftalignment">Shionogi & Co Ltd / Eisai Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / Humana Inc / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / UnitedHealth Group Inc / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（7月19日～）: アルツハイマー病治療薬という十字架を背負ったエーザイ</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4507.T / 4523.T / 4502.T / 4503.T / 4519.T / 4528.T / 4543.T / 4516.T / HUM.N / 4506.T / 4536.T / UNH.N / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / SRPT.OQ / 4587.T / 4887.T</td><td class="leftalignment">Shionogi & Co Ltd / Eisai Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / Humana Inc / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / UnitedHealth Group Inc / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Headlines Notwithstanding, Docs Continue to Project Robust Aduhelm Uptake</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Considerations Ahead of 2Q Results</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1266501006 / US1567821046 / US3755581036 / US4448591028 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US15135B1017 / US0367521038 / US1255231003</td><td class="leftalignment">Amgen Inc / CVS Health Corp / Cerner Corp / Gilead Sciences Inc / Humana Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Centene Corp / Anthem Inc / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Small/Mid Cap 2Q Preview Call on 7/30 @ 10 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">4502.T / ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / KR / MDT / RAD / SGE.L / UNH / WMT / ACI.N / GILD.O / AMGN.O / NOVN.S / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / NBIX.OQ / ICPT.OQ / EXEL.OQ / VRTX.OQ / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / ALNY.OQ / MBRX.OQ / ACAD.O / ATRC.OQ / LHCG.O / 02043Q107 / ENSG.OQ / SLP.OQ / 483548103 / TMDX.OQ / MD.N / 771195104 / ADUS.O / USPH.N / ENTA.O / PRTA.OQ / MRTX.OQ / FATE.OQ / MGNX.O / GOOGL.O / 02005N100 / CBAY.OQ / VKTX.O / EVH.N / TDOC.N / GKOS.K / 100063846 / IONS.OQ / EDIT.OQ / NTLA.O / IRTC.OQ / MDGL.O / PLXP.O / VERU.OQ / MTEM.O / 720795103 / ARVN.OQ / ALLO.OQ / CRSP.BN / BCYC.O / PNTG.OQ / REGW.M3</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Kroger Co / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Albertsons Companies Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / Exelixis Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alnylam Pharmaceuticals Inc / Moleculin Biotech Inc / ACADIA Pharmaceuticals Inc / AtriCure Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Simulations Plus Inc / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / US Physical Therapy Inc / Enanta Pharmaceuticals Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Fate Therapeutics Inc / MacroGenics Inc / Alphabet Inc / Ally Financial Inc / Cymabay Therapeutics Inc / Viking Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Glaukos Corp / Truist Financial Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / iRhythm Technologies Inc / Madrigal Pharmaceuticals Inc / PLx Pharma Inc / Veru Inc / Molecular Templates Inc / Pieris Pharmaceuticals Inc / Arvinas Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Bicycle Therapeutics PLC / Pennant Group Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Uncertainties Remain After All The Changes In Strategic Plan, Partnerships, And Management; Transferring Coverage with Neutral</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">92915B106 / 09062X103 / G72800108 / 24823R105 / N90064101</td><td class="leftalignment">Voyager Therapeutics Inc / Biogen Inc / Prothena Corporation PLC / Denali Therapeutics Inc / Uniqure NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yun Zhong, PHD / Xu Zou</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 7/9/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">STARTING IN 1 HOUR (11 AM ET): Cantor Healthcare Large Cap 2Q2021 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biopharma / IQVIA Script Trends for the Week Ended July 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 556</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 49705R105 / 30315R107 / 45175G108 / 91864C107 / 92539P101</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / Kinnate Biopharma Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">4502.T / AMT / AXP / BAC.N / CCI.N / CLH / COF / COST.O / CRM.N / DFS / DLR / GLW / GS / INTC.O / JEF / JPM / MA / MCD / MDT / MS / MSFT.O / NICE.TA / NOW / PNC.N / QCOM.O / QUIK.O / ROP / RSG / SBH.N / SGE.L / T.N / UNH / USB / WM / WMT / 4716.T / AMZN.O / AAPL.O / DISH.O / HEAR.O / INTU.O / UPS.N / SBAC.O / OUT / RDWR.O / SBUX.O / INSP.N / CRNT.O / HRB.N / SYF / CTAS.O / V.N / PZZA.O / CHTR.O / NUAN.O / DOX.O / NET.N / HPE / GTT / CSCO.OQ / ATVI.OQ / CSGS.OQ / TTWO.OQ / UTHR.OQ / AKAM.OQ / EXEL.OQ / MRVL.OQ / ADS.N / VRNT.OQ / EGAN.O / EQIX.O / NFLX.O / BIIB.O / CEVA.O / 364760108 / 92343V104 / 20030N101 / 459200101 / ALNY.OQ / 0700.HK / OLED.O / 153527106 / 36467W109 / CCOI.O / CME.O / LLNW.OQ / LULU.O / 02043Q107 / SLP.OQ / STX.OQ / AGCO.K / SPB.N / TSLA.O / ZNGA.O / EA.O / FB.O / WDC.O / RNG.N / FATE.OQ / FDEV.L / AUP.TO / GOOGL.O / FIVN.O / 563771203 / 82655M107 / ALLE.K / SNOW.K / QRVO.O / APPS.O / VRAY.OQ / MCRB.OQ / SHOP.K / PYPL.O / SPXC.K / TMUS.OQ / WCN.TO / SPGI.K / TTD.OQ / TWLO.K / ATUS.K / ROKU.O / EGHT.K / 83417M104 / BILI.O / AVYA.K / ALLO.OQ / CRSP.BN / PDSB.OQ / TH.OQ / ZM.OQ / UBER.K / BCYC.O / CMBM.OQ / FSLY.K / VG.O / ORIC.OQ / DKNG.O / AVNT.K / CXDO.O / RXT.O / TEUM.PK / ONDS.OQ / REGW.M3 / HUYA.K</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / American Tower Corp / American Express Co / Bank of America Corp / Crown Castle International Corp / Clean Harbors Inc / Capital One Financial Corp / Costco Wholesale Corp / Salesforce.Com Inc / Discover Financial Services / Digital Realty Trust Inc / Corning Inc / Goldman Sachs Group Inc / Intel Corp / Jefferies Financial Group Inc / JPMorgan Chase & Co / Mastercard Inc / McDonald's Corp / Medtronic PLC / Morgan Stanley / Microsoft Corp / Nice Ltd / ServiceNow Inc / PNC Financial Services Group Inc / Qualcomm Inc / QuickLogic Corp / Roper Technologies Inc / Republic Services Inc / Sally Beauty Holdings Inc / Sage Group PLC / AT&T Inc / UnitedHealth Group Inc / US Bancorp / Waste Management Inc / Walmart Inc / Oracle Corp Japan / Amazon.com Inc / Apple Inc / DISH Network Corp / Turtle Beach Corp / Intuit Inc / United Parcel Service Inc / SBA Communications Corp / OUTFRONT Media Inc / Radware Ltd / Starbucks Corp / Inspire Medical Systems Inc / Ceragon Networks Ltd / H & R Block Inc / Synchrony Financial / Cintas Corp / Visa Inc / Papa John's International Inc / Charter Communications Inc / Nuance Communications Inc / Amdocs Ltd / Cloudflare Inc / Hewlett Packard Enterprise Co / GTT Communications Inc / Cisco Systems Inc / Activision Blizzard Inc / CSG Systems International Inc / Take-Two Interactive Software Inc / United Therapeutics Corp / Akamai Technologies Inc / Exelixis Inc / Marvell Technology Inc / Alliance Data Systems Corp / Verint Systems Inc / eGain Corp / Equinix Inc / Netflix Inc / Biogen Inc / CEVA Inc / Gap Inc / Verizon Communications Inc / Comcast Corp / International Business Machines Corp / Alnylam Pharmaceuticals Inc / Tencent Holdings Ltd / Universal Display Corp / Central Garden & Pet Co / GameStop Corp / Cogent Communications Holdings Inc / CME Group Inc / Limelight Networks Inc / Lululemon Athletica Inc / Alnylam Pharmaceuticals Inc / Simulations Plus Inc / Seagate Technology Holdings PLC / AGCO Corp / Spectrum Brands Holdings Inc / Tesla Inc / Zynga Inc / Electronic Arts Inc / Meta Platforms Inc / Western Digital Corp / RingCentral Inc / Fate Therapeutics Inc / Frontier Developments PLC / Aurinia Pharmaceuticals Inc / Alphabet Inc / Five9 Inc / Mannatech Inc / Sify Technologies Ltd / Allegion PLC / Snowflake Inc. / Qorvo Inc / Digital Turbine Inc / ViewRay Inc / Seres Therapeutics Inc / Shopify Inc / PayPal Holdings Inc / SPX Corp / T-Mobile US Inc / Waste Connections Inc / S&P Global Inc / Trade Desk Inc / Twilio Inc / Altice USA Inc / Roku Inc / 8x8 Inc / Solaredge Technologies Inc / Bilibili Inc / Avaya Holdings Corp / Allogene Therapeutics Inc / CRISPR Therapeutics AG / PDS Biotechnology Corp / Target Hospitality Corp / Zoom Video Communications Inc / Uber Technologies Inc / Bicycle Therapeutics PLC / Cambium Networks Corp / Fastly Inc / Vonage Holdings Corp / Oric Pharmaceuticals Inc / DraftKings Inc / Avient Corp / Crexendo Inc / Rackspace Technology Inc / Pareteum Corp / Ondas Holdings Inc / Regency World Consulting Ltd / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / India / Ireland / Israel / Japan / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US / HD=US / AMZN=US / T=US / TEVA=US / LOW=US / IGT=US / VRM=US / BYD=US / EXPE=US / LEG=US / MGM=US / PENN=US / W=US / UNH=US / MAS=US / MHK=US / MCRI=US / SNAP=US / TRIP=US / WAL=US / WIX=US / SGMS=US / BKNG=US / FB=US / ATRS=US / RRR=US / PTON=US / BIIB=US / TPX=US / EXP=US / CZR=US / APP=US / BECN=US / BLDR=US / GMS=US / SCPL=US / CHNG=US / PGTI=US / AWI=US / OC=US / PRPL=US / TREX=US / FBHS=US / ANGI=US / TILE=US / GOOGL=US / COUP=US / BABA=US / CMPR=US / GDDY=US / GDS=US / JELD=US / CVNA=US / SFIX=US / FTDR=US / LYFT=US / UBER=US / FERG=US / DKNG=US / AZEK=US / BALY=US / VMEO=US / DBRG=US</td><td class="leftalignment">Pfizer Inc / Home Depot Inc / Amazon.com Inc / AT&T Inc / Teva Pharmaceutical Industries Ltd / Lowe's Companies Inc / International Game Technology PLC / Vroom Inc / Boyd Gaming Corp / Expedia Group Inc / Leggett & Platt Inc / MGM Resorts International / Penn National Gaming Inc / Wayfair Inc / UnitedHealth Group Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Snap Inc / Tripadvisor Inc / Western Alliance Bancorp / Wix.Com Ltd / Scientific Games Corp / Booking Holdings Inc / Meta Platforms Inc / Antares Pharma Inc / Red Rock Resorts Inc / Peloton Interactive Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Applovin Corp / Beacon Roofing Supply Inc / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Change Healthcare Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Purple Innovation Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Angi Inc / Interface Inc / Alphabet Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / GDS Holdings Ltd / JELD-WEN Holding Inc / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Lyft Inc / Uber Technologies Inc / Ferguson PLC / DraftKings Inc / Azek Company Inc / Bally's Corp / Vimeo Inc / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">0989529 / 2000019 / 2219224 / 2280220 / 2829515 / 2328915 / 2455965 / 2459020 / 2707677 / 2138158 / 2829601 / 2712013 / B17HG57 / 2769796 / 2857817 / 2390817 / B7TL820 / B7VD3F2 / BFLR866 / BFZCHN7 / BVVN4Q8 / BYVY8G0 / BYNZGK1 / BD8DJ71 / BJ5FZ74 / BFZ1K46 / BLGJ610 / BYXJQG9 / BKTNTR9 / BJVR9Y9 / BG0Q4Y1 / BNTB3N8 / BKPGJQ1</td><td class="leftalignment">AstraZeneca PLC / Amazon.com Inc / CMS Energy Corp / DTE Energy Co / Edison International / Nextera Energy Inc / Biogen Inc / Intuit Inc / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / Global Payments Inc / Cardiovascular Systems Inc / Fidelity National Information Services Inc / Netflix Inc / Gray Television Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Wix.Com Ltd / Eversource Energy / Alphabet Inc / Block Inc / Snap Inc / Adaptive Biotechnologies Corp / Spotify Technology SA / Warner Music Group Corp / Spire Inc / ViacomCBS Inc / iHeartMedia Inc / Exicure Inc / Vizio Holding Corp / Squarespace Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BK.N / CCK.N / FOUG.PA / SEE.N / USB.N / FER.MC / UNH.N / OI.N / BLL.N / STZ.N / EXPE.O / SLGN.O / BC.N / VTR.N / SAM.N / GPK.N / MKL.N / PII.N / MTCH.OQ / PBCT.O / BIIB.O / TFC.N / MS.N / ADP.PA / HOG.N / HOMB.O / SPLK.OQ / BERY.N / WIX.O / COUP.N / HQY.OQ / ZG.O / CVNA.N / RDFN.O / 00183L102 / CARG.O / BKNG.O / WELL.N / LYFT.O / UBER.N / FVRR.N / PTVE.O / ABNB.OQ / DASH.N / BMBL.OQ / SQSP.N</td><td class="leftalignment">Bank of New York Mellon Corp / Crown Holdings Inc / Eiffage SA / Sealed Air Corp / US Bancorp / Ferrovial SA / UnitedHealth Group Inc / O-I Glass Inc / Ball Corp / Constellation Brands Inc / Expedia Group Inc / Silgan Holdings Inc / Brunswick Corp / Ventas Inc / Boston Beer Company Inc / Graphic Packaging Holding Co / Markel Corp / Polaris Inc / Match Group Inc / People's United Financial Inc / Biogen Inc / Truist Financial Corp / Morgan Stanley / Aeroports de Paris SA / Harley-Davidson Inc / Home BancShares Inc / Splunk Inc / Berry Global Group Inc / Wix.Com Ltd / Coupa Software Inc / Healthequity Inc / Zillow Group Inc / Carvana Co / Redfin Corp / Angi Inc / CarGurus Inc / Booking Holdings Inc / Welltower Inc / Lyft Inc / Uber Technologies Inc / Fiverr International Ltd / Pactiv Evergreen Inc / Airbnb Inc / DoorDash Inc / Bumble Inc / Squarespace Inc</td><td class="leftalignment"></td><td class="leftalignment">Spain / France / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Takeaways from Discussion with Management</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SGE.L / BIIB.O / ALNY.OQ</td><td class="leftalignment">Sage Group PLC / Biogen Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">2Q21 Large Cap Earnings Preview: We Expect Fewer Surprises and a Recovery in Earnings from COVID</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US75886F1075 / US3755581036 / US45337C1027 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Cleveland and Sinai and ICER, Oh My!</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Tidbits on commercial uptake</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Don’t Look Now, But Last Week Saw Biggest Biotech Inflows of the Year</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 83422E105 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Solid Biosciences Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB — Readthrough from UnitedHealth Earnings Call: UNH Mgmt Is NOT Guiding for a Very Rapid Decision on Aduhelm Reimbursement</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Commercial plans not likely to reimburse until NCD – near-term focus on MACs</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BAC.N / C.N / CRM.N / CVS / DG / INTC.O / KR / MSFT.O / SGE.L / T.N / USB / WFC.N / WMT / ACI.N / 4716.T / AMZN.O / AMGN.O / DISH.O / SAPG.DE / HEAR.O / INTU.O / NOVN.S / GWW.N / SBUX.O / ATVI.OQ / SNPS.OQ / NBIX.OQ / TTWO.OQ / ICPT.OQ / EXEL.OQ / PRGS.O / NFLX.O / BIIB.O / 459200101 / ACAD.O / CDNS.O / 36467W109 / VMW / TMDX.OQ / 771195104 / ZNGA.O / EA.O / ENTA.O / MRTX.OQ / FDEV.L / GOOGL.O / 82655M107 / CBAY.OQ / VKTX.O / EDIT.OQ / NTLA.O / BABA.K / MDGL.O / OTEX.TO / PLXP.O / BILI.O / CRSP.BN / HUYA.K</td><td class="leftalignment">Bank of America Corp / Citigroup Inc / Salesforce.Com Inc / CVS Health Corp / Dollar General Corp / Intel Corp / Kroger Co / Microsoft Corp / Sage Group PLC / AT&T Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Oracle Corp Japan / Amazon.com Inc / Amgen Inc / DISH Network Corp / SAP SE / Turtle Beach Corp / Intuit Inc / Novartis AG / W W Grainger Inc / Starbucks Corp / Activision Blizzard Inc / Synopsys Inc / Neurocrine Biosciences Inc / Take-Two Interactive Software Inc / Intercept Pharmaceuticals Inc / Exelixis Inc / Progress Software Corp / Netflix Inc / Biogen Inc / International Business Machines Corp / ACADIA Pharmaceuticals Inc / Cadence Design Systems Inc / GameStop Corp / VMware Inc / Transmedics Group Inc / Roche Holding AG / Zynga Inc / Electronic Arts Inc / Enanta Pharmaceuticals Inc / Mirati Therapeutics Inc / Frontier Developments PLC / Alphabet Inc / Sify Technologies Ltd / Cymabay Therapeutics Inc / Viking Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Alibaba Group Holding Ltd / Madrigal Pharmaceuticals Inc / Open Text Corp / PLx Pharma Inc / Bilibili Inc / CRISPR Therapeutics AG / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United Kingdom / India / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LSI=US / HD=US / T=US / RUN=US / PEB=US / PLUG=US / H=US / MTN=US / LOW=US / MAR=US / TNL=US / HLT=US / CHH=US / DRH=US / TRIP=US / PSA=US / BIIB=US / EXR=US / SHO=US / DLR=US / SPWR=US / HST=US / WH=US / HGV=US / RLJ=US / VAC=US / CUBE=US / EA=US / ENPH=US / RHP=US / WBA=US / SEDG=US / NSA=US / PK=US / 50189K103 / PLYA=US / ARVN=US / FERG=US</td><td class="leftalignment">Life Storage Inc / Home Depot Inc / AT&T Inc / Sunrun Inc / Pebblebrook Hotel Trust / Plug Power Inc / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Tripadvisor Inc / Public Storage / Biogen Inc / Extra Space Storage Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / SunPower Corp / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / CubeSmart / Electronic Arts Inc / Enphase Energy Inc / Ryman Hospitality Properties Inc / Walgreens Boots Alliance Inc / Solaredge Technologies Inc / National Storage Affiliates Trust / Park Hotels & Resorts Inc / LCI Industries / Playa Hotels & Resorts NV / Arvinas Inc / Ferguson PLC</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 0989529 / 2516152 / 2000019 / 2026242 / 2219224 / 2206657 / 2270726 / 2542049 / 2829515 / 2328915 / 2100920 / 2366799 / 2455965 / 2707677 / 2138158 / 2829601 / 2712013 / B121557 / 2769796 / 2857817 / B3D7K31 / B4N0JJ6 / B7TL820 / B783TY6 / B7VD3F2 / BYVY8G0 / BP4GNK9 / BXDZ9Z0 / BYNZGK1 / BD8DJ71 / BZ1HM42 / BFZ1K46 / BLGJ610 / BYXJQG9 / BKTNTR9 / BZ1LFG7 / BKS3RS7 / BKPGJQ1 / BJ62Z18</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / CMS Energy Corp / Coca-Cola Co / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / FirstEnergy Corp / Gentex Corp / Biogen Inc / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / Global Payments Inc / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Discovery Inc / Visteon Corp / Meta Platforms Inc / Aptiv PLC / Duke Energy Corp / Alphabet Inc / SAGE Therapeutics Inc / Shopify Inc / Block Inc / Snap Inc / Adyen NV / Spotify Technology SA / Warner Music Group Corp / Spire Inc / ViacomCBS Inc / Roku Inc / 10X Genomics Inc / Squarespace Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Exploring the Link Between R&D Productivity and Valuation</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">SGE.L / AMGN.O / NBIX.OQ / ICPT.OQ / EXEL.OQ / BIIB.O / ACAD.O / ENTA.O / MRTX.OQ / CBAY.OQ / VKTX.O / EDIT.OQ / NTLA.O / MDGL.O / CRSP.BN</td><td class="leftalignment">Sage Group PLC / Amgen Inc / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / Exelixis Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Mirati Therapeutics Inc / Cymabay Therapeutics Inc / Viking Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Woodcock has a quality reputation; IG/Gov’t investigations likely won’t have Adu impact</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Clarification from BIIB and LLY on Comments Made by Our Expert with Regard to the NCD Process and CED Studies</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / LLY.N / 2516152 / 2455965</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">7/16 @ 11am ET: Cantor Healthcare Large Cap 2Q21 Preview Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">The Feedback Loop: Earnings and COVID Rebounds Edition</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / NBIX.O / VRTX.O / BIIB.O</td><td class="leftalignment">Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 2681511 / 2486813 / 2219224 / 2216850 / 2208073 / 2280220 / 2270726 / 2829515 / 2328915 / 2455965 / 2707677 / 2138158 / 2829601 / 2503529 / B121557 / 2857817 / B3D7K31 / B7TL820 / B7VD3F2 / BBGVT40 / BYVY8G0 / BYVYD43 / BXDZ9Z0 / BJF8Q81 / BYZR4X4 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BDT5KT5 / BYTJZL1 / BYXR425 / BMC8SQ7 / BKPGJQ1</td><td class="leftalignment">American Express Co / PepsiCo Inc / Kellogg Co / CMS Energy Corp / Consolidated Edison Inc / Copart Inc / DTE Energy Co / Walt Disney Co / Edison International / Nextera Energy Inc / Biogen Inc / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / World Wrestling Entertainment Inc / Mastercard Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / Duke Energy Corp / News Corp / Alphabet Inc / Performance Food Group Co / Shopify Inc / IAA Inc / Axsome Therapeutics Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Inspire Medical Systems Inc / Zogenix Inc / RH / BTRS Holdings Inc / Squarespace Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Healthcare : Key Takeaways from Our First Expert call on President Biden's Healthcare Executive Orders</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston / Mr. A.J. Rice / Herr. Christoph Gretler / Mr. Matt S. Miksic / Vik Chopra / Alexander Khan</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB — Highlights from Our Payer Call: Expert KOL Outlined Two Possible NCD Scenarios for Adu; Either Way, BIIB Benefits</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Expert Call Starts In 30mins to Understand the NCD Process That Was Just Triggered by the CMS</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB - Mid-stage Orelabrutinib BTKi Asset In-license Reinforces Commitment to Oral MS Space, but Perhaps Waning Enthusiasm for '091</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - BREAKING - Expert Call Today at 11AM ET to Understand the Implications of the NCD That Was Just Triggered by the CMS</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">DAN / INTC.O / MSFT.O / GILD.O / AAPL.O / BWA.N / HEAR.O / NOVN.S / ATVI.OQ / FLEX.OQ / TTWO.OQ / NFLX.O / BIIB.O / 36467W109 / 02043Q107 / SLP.OQ / TMDX.OQ / 771195104 / TSLA.O / ZNGA.O / EA.O / ENTA.O / PRTA.OQ / FDEV.L / MGNX.O / 82655M107 / 02005N100 / WKHS.O / WPRT.TO / VERU.OQ / APTV.K / BILI.O / ARVN.OQ / 02081G201 / HUYA.K</td><td class="leftalignment">Dana Inc / Intel Corp / Microsoft Corp / Gilead Sciences Inc / Apple Inc / Borgwarner Inc / Turtle Beach Corp / Novartis AG / Activision Blizzard Inc / Flex Ltd / Take-Two Interactive Software Inc / Netflix Inc / Biogen Inc / GameStop Corp / Alnylam Pharmaceuticals Inc / Simulations Plus Inc / Transmedics Group Inc / Roche Holding AG / Tesla Inc / Zynga Inc / Electronic Arts Inc / Enanta Pharmaceuticals Inc / Prothena Corporation PLC / Frontier Developments PLC / MacroGenics Inc / Sify Technologies Ltd / Ally Financial Inc / Workhorse Group Inc / Westport Fuel Systems Inc / Veru Inc / Aptiv PLC / Bilibili Inc / Arvinas Inc / Alphatec Holdings Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / United Kingdom / India / Ireland / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / INTC=US / MCD=US / OXY=US / ADI=US / AMD=US / RRC=US / WEN=US / AMZN=US / BLD=US / DVN=US / TXN=US / TEVA=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / PB=US / DIOD=US / MGY=US / SWN=US / XLNX=US / MUR=US / CHRS=US / BRO=US / UMPQ=US / MRO=US / LEG=US / TTMI=US / VMC=US / MLM=US / APH=US / SWIM=US / ARW=US / AVGO=US / AVT=US / CBRL=US / CERN=US / CNX=US / DRI=US / EQT=US / GFF=US / IBP=US / MAN=US / MAS=US / MCHP=US / MHK=US / PACW=US / REGI=US / ST=US / WAL=US / CVX=US / BXS=US / SNV=US / FB=US / CATY=US / COP=US / DIN=US / BIIB=US / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BDC=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / TEL=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / JACK=US / TREX=US / AR=US / OAS=US / NXPI=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / TILE=US / NDLS=US / GOOGL=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / WING=US / WLTW=US / EDIT=US / 82982L103 / CDEV=US / PVAC=US / JELD=US / SBOW=US / MPWR-US / HWC=US / OZK=US / RTLR=US / FERG=US / GMAB=US / OVV=US / AZEK=US / VTRS=US / VMEO=US / REPX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / Intel Corp / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Advanced Micro Devices Inc / Range Resources Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Xilinx Inc / Murphy Oil Corp / Coherus BioSciences Inc / Brown & Brown Inc / Umpqua Holdings Corp / Marathon Oil Corp / Leggett & Platt Inc / TTM Technologies Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Amphenol Corp / Latham Group Inc / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Cerner Corp / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Microchip Technology Inc / Mohawk Industries Inc / PacWest Bancorp / Renewable Energy Group Inc / Sensata Technologies Holding PLC / Western Alliance Bancorp / Chevron Corp / Cadence Bank / Synovus Financial Corp / Meta Platforms Inc / Cathay General Bancorp / Conocophillips / Dine Brands Global Inc / Biogen Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / TE Connectivity Ltd / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Noodles & Co / Alphabet Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / Willis Towers Watson PLC / Editas Medicine Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Monolithic Power Systems Inc / Hancock Whitney Corp / Bank Ozk / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Azek Company Inc / Viatris Inc / Vimeo Inc / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2026242 / 2219224 / 2270726 / 2542049 / 2829515 / 2100920 / 2455965 / 2684703 / 2048804 / 2707677 / 2138158 / 2825933 / 2829601 / 2503529 / 7103065 / B121557 / 2857817 / B125XQ6 / B02R1L6 / B7TL820 / BFLR866 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BD8DJ71 / BNFWR44 / BFZ1K46 / BKTNTR9 / BRJ3GY4 / BJ9N563 / BNKGXX2</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Edison International / FirstEnergy Corp / Biogen Inc / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Mastercard Inc / Netflix Inc / Portland General Electric Co / ALLETE Inc / Meta Platforms Inc / Twitter Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Snap Inc / Worldline SA / Spotify Technology SA / ViacomCBS Inc / Xenon Pharmaceuticals Inc / Sunnova Energy International Inc / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ATAI: A Diversified Platform Approach to NeuroPsych Drug Development; Initiate with an Outperform Rating</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">ATAI.OQ / 4503.T / BMY.N / JNJ.N / AZN.L / NOVN.S / 4768.T / NBIX.OQ / BIIB.OQ / JAZZ.OQ / ABBV.N / SAGE.OQ</td><td class="leftalignment">ATAI Life Sciences NV / Astellas Pharma Inc / Bristol-Myers Squibb Co / Johnson & Johnson / AstraZeneca PLC / Novartis AG / Otsuka Corp / Neurocrine Biosciences Inc / Biogen Inc / Jazz Pharmaceuticals PLC / Abbvie Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Mark Connolly / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Auerbach Grayson & Co., Inc.</td><td class="leftalignment">AUERBACH GRAYSON: CEEMEA & LATAM Daily Morning Note 07-13-21:  (Aksigorta, Alpha Bank, Arcelik, Aselsan, Budimex, CCC, Clico Investment Fund, Commercial International Bank, Vesta, Econet Wireless Zimbabwe, Egyptian Resorts, GB Auto, Grupa Azoty, Lotos)</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">AKGRT.IS / ARCLK.IS / ASELS.IS / ATTP.WA / AUTO.CA / CIF.TTB / COMI.CA / EGTS.CA / VESTA.MX / PLBUDMX00013 / PLKGHM000017 / TRAARCLK91H5 / TRAASELS91H2 / TRASISEW91Q3 / TRATHYAO91M5 / TRAKCHOL91Q8 / GRS419003009 / TRAAKGRT91O5 / GRS434003000 / SI0031101346 / EGS60121C018 / PLCCC0000016 / LAMDA@GA / PLLOTOS00025 / EGS70431C019 / ATT@PW / MARK@QD / QA000A0KD6L1 / EGS673T1C012 / PLJSW0000015 / EXTRA@AB / NIC@UG / STX@PW / VESTA*@MM / BIIB@IQ / SLV@PW / CIF@TP / XTB@PW / TEN@PW / RECV3@BZ</td><td class="leftalignment">AK Sigorta AS / Arcelik AS / Aselsan Elektronik Sanayi ve Ticaret AS / Grupa Azoty SA / GB Auto SAE / CLICO Investment Fund / Commercial International Bank Egypt SAE / Egyptian Resorts Co SAE / Corporacion Inmobiliaria Vesta SAB de CV / Budimex SA / KGHM Polska Miedz SA / Arcelik AS / Aselsan Elektronik Sanayi ve Ticaret AS / Turkiye Sise ve Cam Fabrikalari AS / Turk Hava Yollari AO / Koc Holding AS / Greek Organisation of Football Prognostics SA / AK Sigorta AS / Public Power Corporation SA / Luka Koper dd / Commercial International Bank Egypt SAE / CCC SA / Lamda Development SA / Grupa Lotos SA / Egyptian Resorts Co SAE / Grupa Azoty SA / Masraf Al Rayan QPSC / Qatar Gas Transport Nakilat Co Ltd QPSC / GB Auto SAE / Jastrzebska Spolka Weglowa SA / United Electronics Company JSC / NIC Holdings Ltd / Stalexport Autostrady SA / Corporacion Inmobiliaria Vesta SAB de CV / Iraqi Islamic Bank for Investment & Development / Selvita SA / CLICO Investment Fund / Xtb SA / Ten Square Games SA / PetroReconcavo SA</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">Brazil / Egypt / Greece / Croatia / Iraq / Jamaica / Mexico / Namibia / Nigeria / Poland / Qatar / Russian Federation / Saudi Arabia / Slovenia / Trinidad and Tobago / Turkey / Tanzania, United Republic of / Ukraine / Uganda / Zimbabwe / Serbia & Montenegro - Discontinue with effect from December 11, 2006 / Palestine</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Biotechnology / Building & Building Materials / Communications / Conglomerates / Defense / Electrical / Electronics / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Household Products / Info. Tech./Computers / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Office Equipment / Real Estate / Retailing / Telecommunications / Transportation / Utilities / Wholesale</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Auerbach Grayson</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">PRX004 Sale Intensifies Focus on Neuroscience</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PRTA.OQ / BIIB.O / 02043Q107 / 771195104 / 02005N100</td><td class="leftalignment">Prothena Corporation PLC / Biogen Inc / Alnylam Pharmaceuticals Inc / Roche Holding AG / Ally Financial Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities BIIB Nightcap</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - CMS Is Initiating an NCD for Aduhelm; While Expected, This Is Faster Than Our Previous Estimates</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">NCD Analysis begins - start of relief for BIIB, in our view.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">EMA approval likely, according to KOL</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Purchase by Novo Nordisk of PRX004 Assets for ATTR Amyloidosis</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">G72800108 / 09062X103</td><td class="leftalignment">Prothena Corporation PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Robert C. Hazlett</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 02, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Jul 12 2021 6:46AM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2303.TW / 2330.TW / 7974.T / IBM / INTC.O / MSFT.O / TPH / UBIP.PA / AMZN.O / AAPL.O / ATVI.O / NVDA.O / TTWO.O / AMD.O / NTAP.O / NBIX.O / 2454.TW / MU.O / MRVL.O / HPE / AVGO.O / RARE.O / SWKS.O / BIIB.O / STX.O / SIMO.O / VMW / ZNGA.O / EA.O / WDC.O / LGIH.O / GOOGL.O / QRVO.O / PSTG.K / APLS.O / DELL.K</td><td class="leftalignment">United Microelectronics Corp / Taiwan Semiconductor Manufacturing Co Ltd / Nintendo Co Ltd / International Business Machines Corp / Intel Corp / Microsoft Corp / Tri Pointe Homes Inc (Delaware) / Ubisoft Entertainment SA / Amazon.com Inc / Apple Inc / Activision Blizzard Inc / NVIDIA Corp / Take-Two Interactive Software Inc / Advanced Micro Devices Inc / NetApp Inc / Neurocrine Biosciences Inc / MediaTek Inc / Micron Technology Inc / Marvell Technology Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Ultragenyx Pharmaceutical Inc / Skyworks Solutions Inc / Biogen Inc / Seagate Technology Holdings PLC / Silicon Motion Technology Corp / VMware Inc / Zynga Inc / Electronic Arts Inc / Western Digital Corp / LGI Homes Inc / Alphabet Inc / Qorvo Inc / Pure Storage Inc / Apellis Pharmaceuticals Inc / Dell Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / France / Ireland / Japan / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CONE=US / VRM=US / SWIM=US / COLL=US / CPRT=US / EQIX=US / SMG=US / BDSI=US / NOMD=US / BIIB=US / XM=US / AWI=US / IAA=US / EVBG=US / CVNA=US / SPCE=US / DBRG=US / CNVY</td><td class="leftalignment">CyrusOne Inc / Vroom Inc / Latham Group Inc / Collegium Pharmaceutical Inc / Copart Inc / Equinix Inc / Scotts Miracle-Gro Co / BioDelivery Sciences International Inc / Nomad Foods Ltd / Biogen Inc / Qualtrics International Inc / Armstrong World Industries Inc / IAA Inc / Everbridge Inc / Carvana Co / Virgin Galactic Holdings Inc / DigitalBridge Group Inc / Convey Health Solutions Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">2Q21 Commercial Biotech Preview: Time To Shine?</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">BIIB.O / NBIX.O / RARE.O / APLS.O</td><td class="leftalignment">Biogen Inc / Neurocrine Biosciences Inc / Ultragenyx Pharmaceutical Inc / Apellis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 2000019 / 2026242 / 2270726 / 2328915 / 2455965 / 2459202 / 2689560 / 2707677 / 2730190 / 2440637 / 2138158 / 2829601 / 2900335 / 2980906 / 2783815 / B00FWN1 / B121557 / 2857817 / 2983563 / B7TL820 / B7VD3F2 / BYVY8G0 / BYW36M8 / BK7Y2V9 / BD8DJ71 / BLGJ610 / BJJMGL2 / BKTNTR9 / BFWK4R7 / BNKGXX2</td><td class="leftalignment">American Express Co / Amazon.com Inc / American Electric Power Company Inc / Walt Disney Co / Nextera Energy Inc / Biogen Inc / IDEXX Laboratories Inc / PG&E Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sempra Energy / Southern Co / Tractor Supply Co / Foot Locker Inc / Zimmer Biomet Holdings Inc / Alnylam Pharmaceuticals Inc / Mastercard Inc / Netflix Inc / Carmax Inc / Meta Platforms Inc / Duke Energy Corp / Alphabet Inc / PayPal Holdings Inc / Akero Therapeutics Inc / Snap Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / PagSeguro Digital Ltd / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AXP.N / CCI.N / CI.N / COF.N / CVS.N / EDP.LS / EIX.N / ELE.MC / IBE.MC / IP.N / MRK.N / NA / PB.N / PFE.N / REP.MC / SO.N / T.N / ZION.O / PEP.N / CMA.N / WY.N / HUM.N / CFP.TO / GILD.O / CMCSA.O / AMGN.O / INCY.O / DUK.N / HBAN.O / UNH.N / NICE.O / CAG.N / PCG.N / CONE.O / VZ.N / VLY.N / SNV.N / PACW.O / FISV.O / V.N / AWK.N / NBIX.O / NWN.N / STL.N / VRTX.O / NCR.N / CPE.N / CFR.N / BLU.N / CPK.N / FRC.N / WBS.N / FCF.N / DFS.N / ADS.N / SGEN.OQ / GPN.N / PFS.N / FFBC.O / PBCT.O / SIVB.O / WSBC.O / HOOK.O / CASY.O / BOKF.O / BCRX.O / COLB.O / WTFC.O / ICPT.O / EQIX.O / TCBI.O / ATDb.TO / BIIB.O / SJ.TO / MTL.TO / FHN.N / DPZ.N / DLR.N / ACAD.O / WEF.TO / WAL.N / DISCA.O / SJW.N / BKD.N / CMG.N / FIS.N / ISBC.O / MA.N / GALP.LS / INO.OQ / HOMB.O / AND.TO / INPP.L / NEE.N / NXT.AX / PCH.O / CJT.TO / CFX.TO / BKU.N / PCRX.O / IFP.TO / WTE.TO / SLM.OQ / RFP.N / SRPT.O / ALLY.N / NYCB.N / ENTA.O / TMUS.N / PTCT.O / BEP.N / ONB.OQ / KPTI.O / XNCR.OQ / ITCI.O / FLXN.O / AGRX.O / SYF.N / GWB.N / ANTM.N / ASB.N / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / PYPL.OQ / GBT.OQ / MP1.AX / PVAC.O / CADE.N / OVID.O / ATNX.O / 05971J102 / ITRM.O / NTGY.MC / PRVB.O / GMDA.OQ / LSPD.TO / NBSE.OQ / KRTX.OQ / MORF.OQ / APRE.OQ / IGMS.O / ETNB.O / WTRG.N / TFII.N / FOUR.N / DCT.O / SPRB.OQ / MTCR.O / WFG.N / TASK.O</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American Express Co / Crown Castle International Corp / Cigna Corp / Capital One Financial Corp / CVS Health Corp / EDP Energias de Portugal SA / Edison International / Endesa SA / Iberdrola SA / International Paper Co / Merck & Co Inc / National Bank of Canada / Prosperity Bancshares Inc / Pfizer Inc / Repsol SA / Southern Co / AT&T Inc / Zions Bancorporation NA / PepsiCo Inc / Comerica Inc / Weyerhaeuser Co / Humana Inc / Canfor Corp / Gilead Sciences Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Huntington Bancshares Inc / UnitedHealth Group Inc / Nice Ltd / Conagra Brands Inc / PG&E Corp / CyrusOne Inc / Verizon Communications Inc / Valley National Bancorp / Synovus Financial Corp / PacWest Bancorp / Fiserv Inc / Visa Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Sterling Bancorp / Vertex Pharmaceuticals Inc / NCR Corp / Callon Petroleum Co / Cullen/Frost Bankers Inc / BELLUS Health Inc / Chesapeake Utilities Corp / First Republic Bank / Webster Financial Corp / First Commonwealth Financial Corp / Discover Financial Services / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / First Financial Bancorp / People's United Financial Inc / SVB Financial Group / WesBanco Inc / HOOKIPA Pharma Inc / Caseys General Stores Inc / BOK Financial Corp / BioCryst Pharmaceuticals Inc / Columbia Banking System Inc / Wintrust Financial Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Texas Capital Bancshares Inc / Alimentation Couche-Tard Inc / Biogen Inc / Stella-Jones Inc / Mullen Group Ltd / First Horizon Corp / Domino's Pizza Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Western Alliance Bancorp / Discovery Inc / SJW Group / Brookdale Senior Living Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Investors Bancorp Inc / Mastercard Inc / Galp Energia SGPS SA / Inovio Pharmaceuticals Inc / Home BancShares Inc / Andlauer Healthcare Group Inc / International Public Partnerships Ltd / Nextera Energy Inc / NEXTDC Ltd / Potlatchdeltic Corp / Cargojet Inc / Canfor Pulp Products Inc / BankUnited Inc / Pacira Biosciences Inc / Interfor Corp / Westshore Terminals Investment Corp / SLM Corp / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Ally Financial Inc / New York Community Bancorp Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Brookfield Renewable Partners LP / Old National Bancorp / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Pacira Biosciences Inc / Agile Therapeutics Inc / Synchrony Financial / Great Western Bancorp Inc / Anthem Inc / Associated Banc-Corp / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / Global Blood Therapeutics Inc / Megaport Ltd / Ranger Oil Corp / Cadence Bank / Ovid Therapeutics Inc / Athenex Inc / Cadence Bank / Iterum Therapeutics PLC / Naturgy Energy Group SA / Provention Bio Inc / Gamida Cell Ltd / Lightspeed Commerce Inc / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Essential Utilities Inc / TFI International Inc / Shift4 Payments Inc / Duck Creek Technologies Inc / Spruce Biosciences Inc / Metacrine Inc / West Fraser Timber Co Ltd / Taskus Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Spain / Ireland / Israel / Portugal / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Managed Care: CMS Opens National Coverage Determination Analysis for Alzheimer's Drug Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CI.N / CNC.N / CVS.N / HUM.N / UNH.N / MORR.AT / BIIB.OQ / ANTM.N</td><td class="leftalignment">Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / UnitedHealth Group Inc / Motor Oil Hellas Corinth Refineries SA / Biogen Inc / Anthem Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Greece / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. A.J. Rice / Alexander Khan</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare policy: new and updated democrat proposals: Biden drug proposals via EO; Pelosi & Wyden seek legislative approach</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/11/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Top of the Market's Mind</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">09062X103 / 526057104 / 297178105 / 59522J103 / 252131107 / 30212P30</td><td class="leftalignment">Biogen Inc / Lennar Corp / Essex Property Trust Inc / Mid-America Apartment Communities Inc / Dexcom Inc / Expedia Group Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Julian Emanuel / Michael Chu</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ACA / AMN / C.N / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / FISV.O / VRTX.OQ / CCRN.O / AMED.O / MSTR.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ICE.N / CME.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / TSLA.O / GOOGL.O / 64829B100 / EVH.N / TDOC.N / 100063846 / MTEM.O / 720795103 / FOCS.OQ / CBOE.Z / PNTG.OQ / HGEN.O</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Citigroup Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / Fiserv Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Amedisys Inc / Microstrategy Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Intercontinental Exchange Inc / CME Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Tesla Inc / Alphabet Inc / New Relic Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Molecular Templates Inc / Pieris Pharmaceuticals Inc / Focus Financial Partners Inc / Cboe Global Markets Inc / Pennant Group Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Our Take on the Woodcock Letter: Not Likely to Impact Aduhelm Approval, but Unwanted Attention Is Not Good</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FDA investigation not surprising, but unlikely to influence uptake of drug, in our view</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NA / GILD.O / INCY.O / NBIX.O / VRTX.O / BLU.N / HOOK.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / INO.OQ / SRPT.O / ENTA.O / PTCT.O / KPTI.O / XNCR.OQ / ITCI.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / OVID.O / ITRM.O / PRVB.O / GMDA.OQ / NBSE.OQ / KRTX.OQ / MORF.OQ / APRE.OQ / IGMS.O / ETNB.O / SPRB.OQ / MTCR.O</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Ovid Therapeutics Inc / Iterum Therapeutics PLC / Provention Bio Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Spruce Biosciences Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / UNH / WMT / AMGN.O / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / ICPT.OQ / ISRG.OQ / CCRN.O / STAA.O / INMD.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / ATRC.OQ / DXCM.O / LHCG.O / 02043Q107 / ENSG.OQ / TNDM.O / KIDS.O / 483548103 / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / MRTX.OQ / GOOGL.O / NVRO.N / EVH.N / TDOC.N / 100063846 / SENS.A / MDGL.O / ATNX.O / TXMD.O / 720795103 / PRVB.OQ / SWAV.O / A71.F / PNTG.OQ / HGEN.O / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Amgen Inc / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / Cross Country Healthcare Inc / STAAR Surgical Co / Inmode Ltd / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / OrthoPediatrics Corp / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Mirati Therapeutics Inc / Alphabet Inc / Nevro Corp / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Senseonics Holdings Inc / Madrigal Pharmaceuticals Inc / Athenex Inc / TherapeuticsMD Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Shockwave Medical Inc / Ascendis Pharma A/S / Pennant Group Inc / Humanigen Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 555</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB, LLY, ROG: Including Alzheimer's revenues for the first time EVER!</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">09062X103 / 532457108 / ROG.S / 7110388</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Roche Holding AG / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Services Weekly</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / ENSG.OQ / 483548103 / MD.N / ADUS.O / USPH.N / GOOGL.O / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Alphabet Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Michael D. Wiederhorn / Matt Nirenberg, CFA, CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 7/2/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Big Wheel Keep On Turnin': Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended June 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">7/16 @ 11am ET: Cantor Healthcare Large Cap 2Q21 Preview Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Updated Aduhelm Label Clarifies Use in MCI or Mild Patients; Reimbursement Still the Major Pushback on Initial Launch</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Aduhelm Prescribing Information Updated To Emphasize Mild Patients</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">New Aduhelm Label Shouldn’t Impact Sales</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Updated Label for Aduhelm Is Limited to Disease Stages Studied in Clinical Trials; Is In Line With How We Think Docs Will Use It</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Updated Aduhelm label reflects the patient population studied in clinical trials</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BAC.N / BK.N / C.N / CCO.TO / CF.N / DFDS.CO / FITB.O / IBE.MC / JPM.N / KBH.N / KEY.N / NTRS.O / PHM.N / PNC.N / SGEF.PA / TOL.N / USB.N / WFC.N / GILD.O / INCY.O / AAL.L / LEN.N / GS.N / KGC.N / VLY.N / STT.N / DHI.N / FDS.N / EFX.N / NBIX.O / MTB.N / DNB.N / VRTX.O / MCO.N / SM.N / RF.N / TRU.N / RGLD.O / BPOP.O / BCRX.O / ICPT.O / BIIB.O / GOLD.N / FM.TO / TFC.N / NST.AX / 878742204 / EDV.TO / TRN.MI / NTR.N / MOS.N / ACAD.O / LHCG.O / MS.N / CS.TO / 443628102 / ATL.MI / GETP.PA / SLR.AX / OSK.TO / EONGn.DE / VALE.N / MSCI.N / FICO.N / VRSK.O / BHPB.L / NLSN.N / GLEN.L / SMSS.L / SRPT.O / TPH.N / ENTA.O / TMHC.N / PTCT.O / 46579R104 / KPTI.O / ITCI.O / CIA.TO / CFG.N / S32.AX / 78667J108 / GLPG.O / GBT.OQ / SPGI.N / OR.N / CDEV.O / WPM.N / SSRM.O / KL.N / ORSTED.CO / NTGY.MC / PRVB.O / GMDA.OQ / ADT1.L / SBSW.N / SPRB.OQ / DFH.OQ</td><td class="leftalignment">Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Cameco Corp / CF Industries Holdings Inc / DFDS AS / Fifth Third Bancorp / Iberdrola SA / JPMorgan Chase & Co / KB Home / KeyCorp / Northern Trust Corp / Pultegroup Inc / PNC Financial Services Group Inc / Vinci SA / Toll Brothers Inc / US Bancorp / Wells Fargo & Co / Gilead Sciences Inc / Incyte Corp / Anglo American PLC / Lennar Corp / Goldman Sachs Group Inc / Kinross Gold Corp / Valley National Bancorp / State Street Corp / D R Horton Inc / Factset Research Systems Inc / Equifax Inc / Neurocrine Biosciences Inc / M&T Bank Corp / Dun & Bradstreet Holdings Inc / Vertex Pharmaceuticals Inc / Moody's Corp / SM Energy Co / Regions Financial Corp / TransUnion / Royal Gold Inc / Popular Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Barrick Gold Corp / First Quantum Minerals Ltd / Truist Financial Corp / Northern Star Resources Ltd / Teck Resources Ltd / Endeavour Mining PLC / Terna Rete Elettrica Nazionale SpA / Nutrien Ltd / Mosaic Co / ACADIA Pharmaceuticals Inc / LHC Group Inc / Morgan Stanley / Capstone Mining Corp / Hudbay Minerals Inc / Atlantia SpA / Getlink SE / Silver Lake Resources Ltd / Osisko Mining Inc / E.ON SE / Vale SA / MSCI Inc / Fair Isaac Corp / Verisk Analytics Inc / BHP Group PLC / Nielsen Holdings PLC / Glencore PLC / Smart Metering Systems PLC / Sarepta Therapeutics Inc / Tri Pointe Homes Inc (Delaware) / Enanta Pharmaceuticals Inc / Taylor Morrison Home Corp / PTC Therapeutics Inc / Ivanhoe Mines Ltd / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Champion Iron Ltd / Citizens Financial Group Inc / South32 Ltd / SAGE Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / S&P Global Inc / Osisko Gold Royalties Ltd / Centennial Resource Development Inc / Wheaton Precious Metals Corp / SSR Mining Inc / Kirkland Lake Gold Ltd / Orsted A/S / Naturgy Energy Group SA / Provention Bio Inc / Gamida Cell Ltd / Adriatic Metals PLC / Sibanye Stillwater Ltd / Spruce Biosciences Inc / Dream Finders Homes Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Brazil / Canada / Germany / Denmark / Spain / France / United Kingdom / Israel / Italy / Puerto Rico / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">2Q21 Earnings Preview On Select Biotechs</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GBT.OQ / PRVB.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Global Blood Therapeutics Inc / Provention Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech Lit Bits: A Review of Interesting Literature and Science</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / INCY.O / BIIB.O / 78667J108 / GLPG.O / GMDA.OQ / SPRB.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Biogen Inc / SAGE Therapeutics Inc / Galapagos NV / Gamida Cell Ltd / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Spread of Delta Variant Reverses Downward Trends in Regions With Low Vaccination, Global Spread Driving Broad Growth</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Programming Life: Supplemental Slide Deck</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">7333378 / 09062X103 / 235851102 / 14880610 / 90184D100 / 084310101 / 98985X100</td><td class="leftalignment">Lonza Group AG / Biogen Inc / Danaher Corp / Catalent Inc / Twist Bioscience Corp / Berkeley Lights Inc / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Matt Larew / Max Smock</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Monthly IQVIA Tracker: Japan focus</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / BMY.N / 4516.T / 4506.T / ROG.S / 4151.T / BIIB.OQ / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Biogen Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">33</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / BMY.N / 4516.T / 4506.T / ROG.S / 4151.T / BIIB.OQ / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Biogen Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: BIIB - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">BIIB</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 25, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Guggenheim Biotech 2Q 2021 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4595739 / 2471950 / 2023607 / 2437071 / 2576941 / 2369174 / 2455965 / 2623911 / 2730190 / 2931034 / 5531000 / B00FWN1 / B19FQ48 / 2713317 / BCBVTX1 / BBFL7S1 / BFDV8K0 / B8DPDT7 / BZ1LFB2 / B0SDJB4 / BG31GH0 / BZ05388 / BYYWPW6 / BWY52P3 / BYTJZL1</td><td class="leftalignment">Genmab A/S / Incyte Corp / Amgen Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / MorphoSys AG / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / MacroGenics Inc / Sarepta Therapeutics Inc / Deciphera Pharmaceuticals Inc / Zealand Pharma A/S / Y-mAbs Therapeutics Inc / Global Blood Therapeutics Inc / Beigene Ltd / Blueprint Medicines Corp / Zogenix Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Guggenheim Biot Research / Mr. Eddie Hickman, Ph.D. / Debjit Chattopadhyay, Ph.D. / Mr. Etzer Darout / Michael W. Schmidt, Ph.D., PHD / Mr. Yatin Suneja / Mr. Charles Zhu, Ph.D., III / Paul Jeng, Ph.D. / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from the SVB Leerink CNS Forum</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">64125C10 / 09062X10 / 00422510 / G0176710 / G5087110 / 98420N10 / 05464T10 / H0026310 / G1119610 / 40422M10 / 98978L20 / 78667J10 / 46116X10 / 80405P10 / 75955J40 / 03836N10 / 56854Q20</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Xenon Pharmaceuticals Inc / Axsome Therapeutics Inc / AC Immune SA / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / SAGE Therapeutics Inc / Intra-Cellular Therapies Inc / Satsuma Pharmaceuticals Inc / Relmada Therapeutics Inc / Aptinyx Inc / Marinus Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / LLY=US / OXY=US / RRC=US / T=US / DVN=US / TXN=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / VZ=US / XOM=US / CRK=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / BYD=US / MRO=US / MGM=US / MANH=US / PENN=US / W=US / STZ=US / AMED=US / ENV=US / COLL=US / CNX=US / DRH=US / EQT=US / HZO=US / MCRI=US / ASGN=US / PLAN=US / PCTY=US / REGN=US / SGMO=US / TRIP=US / VRTX=US / WAL=US / WIX=US / CVX=US / CGEN=US / SGMS=US / SIVB=US / FRT=US / COP=US / MGNI=US / BDSI=US / PTON=US / BIIB=US / CZR=US / TXRH=US / SHO=US / XM=US / BLDR=US / SCPL=US / HST=US / CLR=US / PRPL=US / NOG=US / JACK=US / AR=US / OAS=US / RLJ=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / GTT=US / GOOGL=US / VNOM=US / HUBS=US / VCEL=US / UPLD=US / PRAH=US / WBA=US / SHAK=US / BWXT=US / WING=US / NVCR=US / TTD=US / CDEV=US / PK=US / PVAC=US / SBOW=US / IOVA=US / BTAI=US / UBER=US / CRWD=US / OVV=US / SPCE=US / ZI=US / TSHA / 96758W101 / BALY=US / REPX=US / 100017125</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Occidental Petroleum Corp / Range Resources Corp / AT&T Inc / Devon Energy Corp / Texas Instruments Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Boyd Gaming Corp / Marathon Oil Corp / MGM Resorts International / Manhattan Associates Inc / Penn National Gaming Inc / Wayfair Inc / Constellation Brands Inc / Amedisys Inc / Envestnet Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Diamondrock Hospitality Co / EQT Corp / MarineMax Inc / Monarch Casino & Resort Inc / ASGN Inc / Anaplan Inc / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / Wix.Com Ltd / Chevron Corp / Compugen Ltd / Scientific Games Corp / SVB Financial Group / Federal Realty Investment Trust / Conocophillips / Magnite Inc / BioDelivery Sciences International Inc / Peloton Interactive Inc / Biogen Inc / Caesars Entertainment Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Qualtrics International Inc / Builders FirstSource Inc / Sciplay Corp / Host Hotels & Resorts Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Antero Resources Corp / Oasis Petroleum Inc / RLJ Lodging Trust / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / GTT Communications Inc / Alphabet Inc / Viper Energy Partners LP / HubSpot Inc / Vericel Corp / Upland Software Inc / Prahova Estival 2002 SA / Walgreens Boots Alliance Inc / Shake Shack Inc / BWX Technologies Inc / Wingstop Inc / Novocure Ltd / Trade Desk Inc / Centennial Resource Development Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / SilverBow Resources Inc / Iovance Biotherapeutics Inc / BioXcel Therapeutics Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Ovintiv Inc / Virgin Galactic Holdings Inc / ZoomInfo Technologies Inc / Taysha Gene Therapies Inc / WideOpenWest Inc / Bally's Corp / Riley Exploration Permian Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Israel / Romania / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Deep Dive Discussion of Synthetic Biology; July 7, 11:00 a.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">09062X103 / 235851102 / 14880610 / 90184D100 / 084310101 / 98985X100</td><td class="leftalignment">Biogen Inc / Danaher Corp / Catalent Inc / Twist Bioscience Corp / Berkeley Lights Inc / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Matt Larew / Max Smock</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Washington, D.C. Day Commentary Attempts to Navigate Aduhelm Reimbursement and Pricing; Tidbits From FDA Approval Docs Mixed</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 554</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / John Boyle / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers / Lachlan Hanbury-Brown</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--July 02 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">BSX / MDT / SGE.L / GILD.O / EXEL.OQ / ISRG.OQ / VRTX.OQ / LIFE.O / AMED.O / BIIB.O / 478160104 / ALNY.OQ / ACAD.O / ATRC.OQ / DXCM.O / LHCG.O / 02043Q107 / SPRO.OQ / MRNA.O / 771195104 / CSII.O / GLAXOSM.LG / FATE.OQ / MDWD.O / 02005N100 / INO.O / NVRO.N / VCEL.O / MCRB.OQ / NVCR.OQ / APLS.OQ / NVTA.K / NTLA.O / IRTC.OQ / IOVA.OQ / ACHV.O / BNGO.OQ / ORTX.OQ / CRSP.BN / SWAV.O / IDYA.OQ / KRTX.OQ / REGW.M3 / 03823M100 / N69603145</td><td class="leftalignment">Boston Scientific Corp / Medtronic PLC / Sage Group PLC / Gilead Sciences Inc / Exelixis Inc / Intuitive Surgical Inc / Vertex Pharmaceuticals Inc / aTyr Pharma Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Alnylam Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Spero Therapeutics Inc / Moderna Inc / Roche Holding AG / Cardiovascular Systems Inc / Glaxo Smithkline Consumer Nigeria PLC / Fate Therapeutics Inc / Mediwound Ltd / Ally Financial Inc / Inovio Pharmaceuticals Inc / Nevro Corp / Vericel Corp / Seres Therapeutics Inc / Novocure Ltd / Apellis Pharmaceuticals Inc / Invitae Corp / Intellia Therapeutics Inc / iRhythm Technologies Inc / Iovance Biotherapeutics Inc / Achieve Life Sciences Inc / Bionano Genomics Inc / Orchard Therapeutics PLC / CRISPR Therapeutics AG / Shockwave Medical Inc / IDEAYA Biosciences Inc / Karuna Therapeutics Inc / Regency World Consulting Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Israel / Nigeria / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US0028241000 / US00846U1016 / US00971T1016 / US1011371077 / US1264081035 / US17275R1023 / US1924221039 / US2358511028 / US3695501086 / US4364401012 / US4523271090 / US48203R1041 / US5719032022 / US62855J1043 / US6558441084 / US7140461093 / US8832031012 / US8835561023 / US9078181081 / US92343V1044 / US9418481035 / CA1363751027 / CA0977512007 / US30063P1057 / CA13645T1003 / US20030N1019 / US1167941087 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US19239V3024 / US2090341072 / US00206R1023 / US31620M1062 / ACOR.OQ / US1717793095 / US53261M1045 / US25470M1099 / US4485791028 / US1920051067 / US69404D1081 / US29082A1079 / US03027X1000 / US8725901040 / US64051T1007 / US23283R1005 / US63009R1095 / US03823U1025 / US09062W2044 / US0404131064 / US0465131078 / US22822V1017 / US29444U7000 / US46185L1035 / US00653A1079 / US12685J1051 / US6323071042 / US70450Y1038 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / US43300A2033 / US78410G1040 / NL0012169213 / US91325V1089 / US03236M2008 / US02156K1034 / US87105L1044 / US74766Q1013 / US40131M1099 / US0197701065 / US90184D1000 / US0144421072 / US05352A1007 / US71535D1063 / US00650F1093 / US24984K1051 / US88025U1097 / US30068X1037 / US09203E1055 / CH0499880968 / US12233L1070 / US0843101017 / US12769G1004 / CA67079A1021 / KYG3902L1095 / US05875B1061 / US81578P1066 / US65443P1021 / US5502411037 / US98985X1000 / BMG6964L1072 / US82933R1005 / US25401T1088</td><td class="leftalignment">Abbott Laboratories / Agilent Technologies Inc / Akamai Technologies Inc / Boston Scientific Corp / CSX Corp / Cisco Systems Inc / Cognex Corp / Danaher Corp / General Dynamics Corp / Hologic Inc / Illumina Inc / Juniper Networks Inc / Marriott International Inc / Myriad Genetics Inc / Norfolk Southern Corp / PerkinElmer Inc / Textron Inc / Thermo Fisher Scientific Inc / Union Pacific Corp / Verizon Communications Inc / Waters Corp / Canadian National Railway Co / Bombardier Inc / Exact Sciences Corp / Canadian Pacific Railway Ltd / Comcast Corp / Bruker Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / AT&T Inc / Fidelity National Information Services Inc / Acorda Therapeutics Inc / Ciena Corp / Limelight Networks Inc / DISH Network Corp / Hyatt Hotels Corp / Codexis Inc / Pacific Biosciences of California Inc / Embraer SA / American Tower Corp / T-Mobile US Inc / NeoPhotonics Corp / CyrusOne Inc / NanoString Technologies Inc / Applied Optoelectronics Inc / BioLife Solutions Inc / Arista Networks Inc / Atara Biotherapeutics Inc / Crown Castle International Corp / Equinix Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Cable One Inc / Natera Inc / PayPal Holdings Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / Hilton Worldwide Holdings Inc / SBA Communications Corp / Qiagen NV / Uniti Group Inc / Amyris Inc / Altice USA Inc / Switch Inc / Quanterix Corp / Guardant Health Inc / Allogene Therapeutics Inc / Twist Bioscience Corp / Alector Inc / Avantor Inc / Personalis Inc / Adaptive Biotechnologies Corp / DermTech Inc / 10X Genomics Inc / Exagen Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / Burning Rock Biotech Ltd / Berkeley Lights Inc / Caesars Entertainment Inc / Nuvei Corp / GDS Holdings Ltd / Bally's Corp / Seer Inc / 908 Devices Inc. / Lumen Technologies Inc / Zymergen Inc / Paysafe Ltd / Singular Genomics Systems Inc / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Cayman Islands / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 6/25/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY=US / ICLR=US / AMZN=US / HSII=US / VRM=US / EXPE=US / KFRC=US / MGM=US / W=US / KFY=US / AMN=US / MAN=US / HZO=US / ASGN=US / RHI=US / SNAP=US / TRIP=US / WAL=US / WIX=US / WGO=US / CCRN=US / BKNG=US / SIVB=US / FB=US / FRT=US / MGNI=US / PTON=US / BIIB=US / CZR=US / APP=US / NSP=US / MA=US / ANGI=US / GOOGL=US / BABA=US / CMPR=US / PRAH=US / WBA=US / GDDY=US / BWXT=US / MCFT=US / NVCR=US / CVNA=US / SFIX=US / FTDR=US / LYFT=US / UBER=US / OPCH=US / VMEO=US / 100017125</td><td class="leftalignment">Eli Lilly and Co / ICON PLC / Amazon.com Inc / Heidrick & Struggles International Inc / Vroom Inc / Expedia Group Inc / Kforce Inc / MGM Resorts International / Wayfair Inc / Korn Ferry / AMN Healthcare Services Inc / ManpowerGroup Inc / MarineMax Inc / ASGN Inc / Robert Half International Inc / Snap Inc / Tripadvisor Inc / Western Alliance Bancorp / Wix.Com Ltd / Winnebago Industries Inc / Cross Country Healthcare Inc / Booking Holdings Inc / SVB Financial Group / Meta Platforms Inc / Federal Realty Investment Trust / Magnite Inc / Peloton Interactive Inc / Biogen Inc / Caesars Entertainment Inc / Applovin Corp / Insperity Inc / Mastercard Inc / Angi Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / Prahova Estival 2002 SA / Walgreens Boots Alliance Inc / GoDaddy Inc / BWX Technologies Inc / Mastercraft Boat Holdings Inc / Novocure Ltd / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Lyft Inc / Uber Technologies Inc / Option Care Health Inc / Vimeo Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / Romania / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">2021 DC Day Review: Expect Incremental Policy Reform, Strong Support for Value-Based Care, Tech-Enabled Novel Delivery Models</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 09060J106 / 252131107 / 42222N103 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 90184D100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 88025U109 / 30068X103 / 15912K100 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107 / 98985X100</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Mr. Raju Prasad, PHD / John C. Kreger, III / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / Brian D. Weinstein, CFA / Mr. Tim F. Lugo / Mr. Matt Larew / Matt Phipps, PHD / Mr. Myles R. R. Minter</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Donanemab: not first, but perhaps better AND cheaper; raising est’s and PT to $262</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">LLY=US / BIIB=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Don’t Call it a Comeback; Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Lots to Write Home About – 2H21 Shaping Up as a Catalyst Rich Period</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">CBIO.OQ / 031162100 / 64125C109 / 766559603 / 09062X103 / 881624209 / 92532F100 / 09061G101 / 75886F107 / 30161Q104 / 02043Q107 / 036642106 / 09058V103 / 40637H109 / 45253H101 / 45665G303 / 68375N103 / 00287Y109 / 29251M106 / 23282W605 / G30401106 / 023111206 / G50871105 / 45773H201 / 189464100 / 78667J108 / 03209R103 / 16383L106 / 90400D108 / 31189P102 / 00461U105 / 45845P108 / 04280A100 / 09627Y109 / 00771V108 / 01345P106 / 52187K101 / G11196105 / 81750R102 / 462260100 / 558868105 / 805111101 / 98401F105 / 23284F105 / 03168L105 / 29014R103 / 039697107 / 140755109 / H17182108 / 67576A100 / 761330109 / 41358P106 / 483347100 / 37890U108 / 269796108 / 87166L100 / 088786108 / 29668H708 / 68906L105 / 04016X101 / 62921N105 / 87184Q107 / 481116101 / 03836N103 / 869367102 / BY2Z0H7 / 69242L106 / 44975P103 / 60770K107 / 65343E108 / 05337M104 / 04522R101 / 492327101 / 359616109 / 729139105 / 00972D105 / 760273102 / 282559103 / 02083G100 / 02155H200 / 03969T109 / 24344T101 / 604749101 / 92243A200 / 74366E102 / 00166B105 / 576810105 / 45790W108 / 04335A105 / 23257D103 / 4525EP101 / 46565G104 / 75382E109 / 501575104 / 14147L108 / 53272L103 / 67080M103 / 73730P108 / 26818M108 / 81181C104 / 019818103 / 50107A104 / 74006W108 / 38942Q103 / 68236R103 / M47364100 / 00773J103 / G59665102 / 03890D108 / 55028X109 / 14888D208 / 19240Q201 / 98872L102 / 49705R105 / 38406L103 / 81728A108 / 57055L107 / 45256X103 / 207523101 / 00449L102 / 09077A106 / 75082Q105</td><td class="leftalignment">Catalyst Biosciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Exelixis Inc / Alnylam Pharmaceuticals Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Halozyme Therapeutics Inc / ImmunoGen Inc / Infinity Pharmaceuticals Inc / OPKO Health Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Endo International PLC / Amarin Corporation PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Amphastar Pharmaceuticals Inc / ChemoCentryx Inc / Ultragenyx Pharmaceutical Inc / Fate Therapeutics Inc / Aclaris Therapeutics Inc / Intercept Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Blueprint Medicines Corp / Aerie Pharmaceuticals Inc / Albireo Pharma Inc / Leap Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / Savara Inc / Xencor Inc / CytomX Therapeutics Inc / Amneal Pharmaceuticals Inc / Eloxx Pharmaceuticals Inc / Ardelyx Inc / Cara Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Revance Therapeutics Inc / Harpoon Therapeutics Inc / Kaleido Biosciences Inc / Global Blood Therapeutics Inc / Eagle Pharmaceuticals Inc / Synlogic Inc / Bicycle Therapeutics PLC / ESSA Pharma Inc / Otonomy Inc / argenx SE / NGM Biopharmaceuticals Inc / Syros Pharmaceuticals Inc / Jounce Therapeutics Inc / Aptinyx Inc / Sutro Biopharma Inc / PureTech Health PLC / Oyster Point Pharma Inc / I-Mab / Moderna Inc / NextCure Inc / Avadel Pharmaceuticals PLC / Aslan Pharmaceuticals Ltd / Keros Therapeutics Inc / Fulcrum Therapeutics Inc / Pliant Therapeutics Inc / Akebia Therapeutics Inc / Repare Therapeutics Inc / 89Bio Inc / Alpine Immune Sciences Inc / Altimmune Inc / Arcturus Therapeutics Holdings Inc / Deciphera Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / Vaxart Inc / Protagonist Therapeutics Inc / ALX Oncology Holdings Inc / Matinas BioPharma Holdings Inc / Inozyme Pharma Inc / Arvinas Inc / Cymabay Therapeutics Inc / Immunic Inc / Iteos Therapeutics Inc / Rapt Therapeutics Inc / Kymera Therapeutics Inc / Cardiff Oncology Inc / Liminal BioSciences Inc / Nurix Therapeutics Inc / Poseida Therapeutics Inc / Dyne Therapeutics Inc / Seagen Inc / Allovir Inc / Kronos Bio Inc / Praxis Precision Medicines Inc / Graybug Vision Inc / Oncorus Inc / Gamida Cell Ltd / Aeglea Bio Therapeutics Inc / MeiraGTx Holdings PLC / Aravive Inc / Lumos Pharma Inc / Catalyst Biosciences Inc / Cogent Biosciences Inc / Yumanity Therapeutics Inc / Kinnate Biopharma Inc / Gracell Biotechnologies Inc / Sensei Biotherapeutics Inc / Marker Therapeutics Inc / Immunitybio Inc / Connect Biopharma Holdings Ltd / Achilles Therapeutics PLC / Biomea Fusion Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">David A. Amsellem / Joseph Catanzaro, PhD / Yasmeen Rahimi, Ph.D. / Mr. Christopher J. Raymond / Edward A. Tenthoff</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BAC.N / C.N / COF / DE / GS / JEF / JPM / MCO / MDT / MS / MSFT.O / PNC.N / QCOM.O / SGE.L / T.N / USB / WFC.N / DOX.O / NET.N / AKAM.OQ / ISRG.OQ / BLUE.OQ / TXN.OQ / SEIC.O / SIVB.O / EQIX.O / BIIB.O / 478160104 / 493267108 / 316773100 / G02602103 / 029899101 / AGCO.K / CDXS.O / AMRS.OQ / CG.O / RNG.N / FATE.OQ / 174610105 / ETSY.O / SPGI.K / AQB.O / FTCH.N / CRSP.BN / UBER.K / FVRR.K / FSLY.K / DKNG.O</td><td class="leftalignment">Bank of America Corp / Citigroup Inc / Capital One Financial Corp / Deere & Co / Goldman Sachs Group Inc / Jefferies Financial Group Inc / JPMorgan Chase & Co / Moody's Corp / Medtronic PLC / Morgan Stanley / Microsoft Corp / PNC Financial Services Group Inc / Qualcomm Inc / Sage Group PLC / AT&T Inc / US Bancorp / Wells Fargo & Co / Amdocs Ltd / Cloudflare Inc / Akamai Technologies Inc / Intuitive Surgical Inc / bluebird bio Inc / Texas Instruments Inc / SEI Investments Co / SVB Financial Group / Equinix Inc / Biogen Inc / Johnson & Johnson / KeyCorp / Fifth Third Bancorp / Amdocs Ltd / American States Water Co / AGCO Corp / Codexis Inc / Amyris Inc / Carlyle Group Inc / RingCentral Inc / Fate Therapeutics Inc / Citizens Financial Group Inc / ETSY Inc / S&P Global Inc / AquaBounty Technologies Inc / Farfetch Ltd / CRISPR Therapeutics AG / Uber Technologies Inc / Fiverr International Ltd / Fastly Inc / DraftKings Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 01 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DE0006231004 / US00846U1016 / US00971T1016 / US2254471012 / US2358511028 / US4062161017 / US4364401012 / US4523271090 / US5951121038 / US62855J1043 / US6821891057 / US7140461093 / AN8068571086 / US8610121027 / US8835561023 / US9021041085 / US91913Y1001 / US92343V1044 / US9418481035 / US30063P1057 / US64110L1061 / US20030N1019 / LU0156801721 / US1167941087 / US21036P1084 / US88031M1099 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US19239V3024 / US2090341072 / US00206R1023 / ACOR.OQ / US1314761032 / US53261M1045 / US25470M1099 / US1920051067 / US69404D1081 / US4361061082 / US56585A1025 / US03027X1000 / US7185461040 / US69318G1067 / US8725901040 / IE00B4Q5ZN47 / US55405Y1001 / US23283R1005 / US63009R1095 / US09062W2044 / US69888T2078 / US0465131078 / US22822V1017 / US74736K1016 / US29444U7000 / US46185L1035 / US00653A1079 / US12685J1051 / US6323071042 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / GB00BDSFG982 / US78410G1040 / NL0012169213 / US91325V1089 / US03236M2008 / US05722G1004 / US24665A1034 / US02156K1034 / US87105L1044 / US74766Q1013 / US03753U1060 / US40131M1099 / US0197701065 / US90184D1000 / US0144421072 / US55087P1049 / US90353T1007 / US05352A1007 / US71535D1063 / US00650F1093 / US24984K1051 / US88025U1097 / US30068X1037 / US09203E1055 / CH0499880968 / US15872M1045 / US12233L1070 / US0843101017 / KYG3902L1095 / US81578P1066 / US65443P1021 / US62955J1034 / US5502411037 / US98985X1000 / US82933R1005 / US25401T1088</td><td class="leftalignment">Infineon Technologies AG / Agilent Technologies Inc / Akamai Technologies Inc / Wolfspeed Inc / Danaher Corp / Halliburton Co / Hologic Inc / Illumina Inc / Micron Technology Inc / Myriad Genetics Inc / ON Semiconductor Corp / PerkinElmer Inc / Schlumberger NV / STMicroelectronics NV / Thermo Fisher Scientific Inc / II-VI Inc / Valero Energy Corp / Verizon Communications Inc / Waters Corp / Exact Sciences Corp / Netflix Inc / Comcast Corp / Tenaris SA / Bruker Corp / Constellation Brands Inc / Tenaris SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / AT&T Inc / Acorda Therapeutics Inc / Calumet Specialty Products Partners LP / Limelight Networks Inc / DISH Network Corp / Codexis Inc / Pacific Biosciences of California Inc / HollyFrontier Corp / Marathon Petroleum Corp / American Tower Corp / Phillips 66 / PBF Energy Inc / T-Mobile US Inc / Jazz Pharmaceuticals PLC / MACOM Technology Solutions Holdings Inc / CyrusOne Inc / NanoString Technologies Inc / BioLife Solutions Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Crown Castle International Corp / Qorvo Inc / Equinix Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Cable One Inc / Natera Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / TechnipFMC PLC / SBA Communications Corp / Qiagen NV / Uniti Group Inc / Amyris Inc / Baker Hughes Co / Delek US Holdings Inc / Altice USA Inc / Switch Inc / Quanterix Corp / Apellis Pharmaceuticals Inc / Guardant Health Inc / Allogene Therapeutics Inc / Twist Bioscience Corp / Alector Inc / Lyft Inc / Uber Technologies Inc / Avantor Inc / Personalis Inc / Adaptive Biotechnologies Corp / DermTech Inc / 10X Genomics Inc / Exagen Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / ChampionX Corp / Burning Rock Biotech Ltd / Berkeley Lights Inc / GDS Holdings Ltd / Seer Inc / 908 Devices Inc. / Nov Inc / Lumen Technologies Inc / Zymergen Inc / Singular Genomics Systems Inc / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Luxembourg / Netherlands / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Jul 01 2021 6:52AM</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">2330.TW / 7974.T / DBD / GME / INTC.O / MSFT.O / UBIP.PA / AMZN.O / AAPL.O / ATVI.O / DNLI.O / NVDA.O / BBBY.O / TTWO.O / AMD.O / NTAP.O / NBIX.O / ARGX.O / UTHR.O / BMRN.O / MU.O / MRVL.O / AVGO.O / SWTX.O / RARE.O / ICPT.O / BIIB.O / STX.O / SIMO.O / ACOR.O / LXRX.O / IDRA.O / OMER.O / TSLA.O / PCRX.O / EA.O / WDC.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / GOOGL.O / SAGE.O / PRTK.O / XENE.O / CDTX.O / ABUS.O / GBT.O / PSTG.K / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / SYRS.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / OBSV.O / FENC.O / APLS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / ALNA.O / ETTX.O / HARP.O / SCPL.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BEAM.O / BCEL.O / FUSN.O / RCUS.K / PRAX.O</td><td class="leftalignment">Taiwan Semiconductor Manufacturing Co Ltd / Nintendo Co Ltd / Diebold Nixdorf Inc / GameStop Corp / Intel Corp / Microsoft Corp / Ubisoft Entertainment SA / Amazon.com Inc / Apple Inc / Activision Blizzard Inc / Denali Therapeutics Inc / NVIDIA Corp / Bed Bath & Beyond Inc / Take-Two Interactive Software Inc / Advanced Micro Devices Inc / NetApp Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Micron Technology Inc / Marvell Technology Inc / Broadcom Inc / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Seagate Technology Holdings PLC / Silicon Motion Technology Corp / Acorda Therapeutics Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Omeros Corp / Tesla Inc / Pacira Biosciences Inc / Electronic Arts Inc / Western Digital Corp / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Alphabet Inc / SAGE Therapeutics Inc / Paratek Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Arbutus Biopharma Corp / Global Blood Therapeutics Inc / Pure Storage Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Syros Pharmaceuticals Inc / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Allena Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Sciplay Corp / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Beam Therapeutics Inc / Atreca Inc / Fusion Pharmaceuticals Inc / Arcus Biosciences Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / Ireland / Japan / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRK=US / BMY=US / OXY=US / RRC=US / GBT=US / DVN=US / TXN=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / H=US / MTN=US / XOM=US / CRK=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / MUR=US / MAR=US / MRO=US / TNL=US / HLT=US / W=US / STZ=US / AMED=US / CHH=US / CNX=US / DRH=US / EQT=US / MHK=US / RARE=US / TRIP=US / VRTX=US / CVX=US / SAGE=US / CGEN=US / VNO=US / COP=US / MRNS=US / PTON=US / BIIB=US / APTX=US / SHO=US / HST=US / CPRX=US / CLR=US / WH=US / NOG=US / RCUS=US / AR=US / OAS=US / HGV=US / NXPI=US / RLJ=US / ESTE=US / VAC=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / CNCE=US / VNOM=US / RLMD=US / VKTX=US / ARGX=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CDEV=US / CRSP=US / PK=US / PVAC=US / ANAB=US / PLYA=US / VRNA=US / SBOW=US / ARVN=US / OVV=US / CRMD.US / TSHA / 96758W101</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Occidental Petroleum Corp / Range Resources Corp / Global Blood Therapeutics Inc / Devon Energy Corp / Texas Instruments Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Hyatt Hotels Corp / Vail Resorts Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marriott International Inc / Marathon Oil Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wayfair Inc / Constellation Brands Inc / Amedisys Inc / Choice Hotels International Inc / CNX Resources Corp / Diamondrock Hospitality Co / EQT Corp / Mohawk Industries Inc / Ultragenyx Pharmaceutical Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Chevron Corp / SAGE Therapeutics Inc / Compugen Ltd / Vornado Realty Trust / Conocophillips / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / Biogen Inc / Aptinyx Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Catalyst Pharmaceuticals Inc / Continental Resources Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / Arcus Biosciences Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Concert Pharmaceuticals Inc / Viper Energy Partners LP / Relmada Therapeutics Inc / Viking Therapeutics Inc / argenx SE / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Ranger Oil Corp / AnaptysBio Inc / Playa Hotels & Resorts NV / Verona Pharma PLC / SilverBow Resources Inc / Arvinas Inc / Ovintiv Inc / CorMedix Inc / Taysha Gene Therapies Inc / WideOpenWest Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Wedbush Monthly Check-Up: July 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">DNLI.O / NBIX.O / ARGX.O / UTHR.O / BMRN.O / SWTX.O / RARE.O / ICPT.O / BIIB.O / ACOR.O / LXRX.O / IDRA.O / OMER.O / PCRX.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / SAGE.O / PRTK.O / XENE.O / CDTX.O / ABUS.O / GBT.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / SYRS.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / OBSV.O / FENC.O / APLS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / ALNA.O / ETTX.O / HARP.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BCEL.O / FUSN.O / RCUS.K / PRAX.O</td><td class="leftalignment">Denali Therapeutics Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / Biomarin Pharmaceutical Inc / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Acorda Therapeutics Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / SAGE Therapeutics Inc / Paratek Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Arbutus Biopharma Corp / Global Blood Therapeutics Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Syros Pharmaceuticals Inc / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Allena Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Atreca Inc / Fusion Pharmaceuticals Inc / Arcus Biosciences Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Kenneth Shields / Mr. Andreas Argyrides</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Deep Genomics, Inc.: Our Q&A With Management</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 92247510 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 90184D100 / 77313F106 / 03836N103 / 717224109 / 88025U109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 000380204 / 89422G107 / 56600D107 / 65443P102 / 30315R107 / 45175G108 / 91864C107 / 98985X100</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Veeva Systems Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Twist Bioscience Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / 10X Genomics Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / 908 Devices Inc. / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen's Biotech Thermometer</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US0465131078 / US00653A1079 / US05464T1043 / US00773U1088 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">WATERFALL Delivers on Key Predictor</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">SGE.L / BIIB.O</td><td class="leftalignment">Sage Group PLC / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">HHS's Advisory Council on Alzheimer's meeting on Aduhelm coming up</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Biogen in top 4% performers of NASDAQ-100 Index in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">84</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Biogen jumps 25% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Biogen Inc. JUNE 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Jun. 29, 2021 / 1:50PM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Initiating coverage of biopharmaceutical addiction treatment maker ADIL with a Buy rating and $5 PT</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ADIL.OQ / ALKS.OQ / EXAS.OQ / BIIB.OQ / EBS.N / MNOV.OQ / ACRX.OQ / TRVN.OQ / INDV.L / TTNP.OQ / ALT.OQ / ANEB.OQ / 120551486</td><td class="leftalignment">Adial Pharmaceuticals Inc / Alkermes Plc / Exact Sciences Corp / Biogen Inc / Emergent BioSolutions Inc / MediciNova Inc / AcelRx Pharmaceuticals Inc / Trevena Inc / Indivior PLC / Titan Pharmaceuticals Inc / Altimmune Inc / Anebulo Pharmaceuticals Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Overblown Competitive Concerns Create Attractive Entry Point for Mega-Cap Leader; Initiate at Buy and $703 PT</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">REGN.OQ / BIIB / 92532F100 / 02043Q107 / NTLA.OQ / ALT.OQ / 75382E109</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Biogen Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Intellia Therapeutics Inc / Altimmune Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AIN / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / LOW=US / LEG=US / LSTR=US / VMC=US / HUM=US / MLM=US / AMED=US / SWIM=US / CBRL=US / DRI=US / EXEL=US / GFF=US / HXL=US / IBP=US / MAS=US / MHK=US / REGI=US / VRTX=US / SPR=US / DIN=US / OGN / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / LHCG=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / SAIA=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / EHC=US / JACK=US / TREX=US / WWD=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / ARCB=US / 00770K202 / LOCO=US / SHAK=US / RLMD=US / ETSY=US / WING=US / EDIT=US / NTLA=US / 82982L103 / CRSP=US / JELD=US / FERG=US / PNTG=US / ARQT=US / AZEK=US / AVAH=US</td><td class="leftalignment">Albany International Corp / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Lowe's Companies Inc / Leggett & Platt Inc / Landstar System Inc / Vulcan Materials Co / Humana Inc / Martin Marietta Materials Inc / Amedisys Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Exelixis Inc / Griffon Corp / Hexcel Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Vertex Pharmaceuticals Inc / Spirit AeroSystems Holdings Inc / Dine Brands Global Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / LHC Group Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / Jack in the Box Inc / Trex Company Inc / Woodward Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / ArcBest Corp / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Relmada Therapeutics Inc / ETSY Inc / Wingstop Inc / Editas Medicine Inc / Intellia Therapeutics Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / JELD-WEN Holding Inc / Ferguson PLC / Pennant Group Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2113393 / 2280220 / 2270726 / 2576941 / 2670519 / 2100920 / 2369174 / 2455965 / 2471950 / 2689560 / 2672689 / 2684703 / 2707677 / 2138158 / 2825933 / 2829601 / 7103065 / 2857817 / B125XQ6 / B3D7K31 / B7TL820 / B4MG4Z6 / B7VD3F2 / BCZS820 / BDZCRX3 / BYVY8G0 / BYW36M8 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BHC8X90 / BD8DJ71 / BMQ5T49 / BWFKZT2 / BJJMGL2 / BKTNTR9 / BGSP7M9</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Boston Beer Company Inc / DTE Energy Co / Walt Disney Co / Exelixis Inc / Exelon Corp / FirstEnergy Corp / Gilead Sciences Inc / Biogen Inc / Incyte Corp / PG&E Corp / Patterson Companies Inc / Pfizer Inc / Public Service Enterprise Group Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / Novartis AG / Netflix Inc / Portland General Electric Co / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Fate Therapeutics Inc / RingCentral Inc / Alphabet Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Novo Nordisk A/S / Snap Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">KOL color on Aduhelm payer agreements; it'll be covered but may take 6 mos for investors to believe</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Programming Life: Understanding the Transformative Potential of Synthetic Biology</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">7333378 / 09062X103 / 235851102 / 14880610 / 90184D100 / 084310101 / 98985X100</td><td class="leftalignment">Lonza Group AG / Biogen Inc / Danaher Corp / Catalent Inc / Twist Bioscience Corp / Berkeley Lights Inc / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Matt Larew / Max Smock / Mr. Myles R. R. Minter / Mr. Raju Prasad, PHD / Mr. Bhavan S. Suri / Mr. Kamil Mielczarek / Mr. Dylan Becker / Sami Corwin, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Our Proprietary Physician Survey Suggests High Awareness for Amyloid-Beta Therapies; KOLs Have a Positive View on LLY's Donanemab</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Biogen sinks 13% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">HHS advisory council mtg on adu - Jul 19</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 18, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Final Reminder: Virtual Washington, D.C. Day - This Wednesday, June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Model Tweaks As Input On Aduhelm and WATERFALL Continues To Shape Views</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ALB.N / BE / BSX / C.N / CAT / CLH / CMI / DAN / DE / ENS / GLW / JCI / MDT / NEP / ORA / QCOM.O / RSG / WM / BWA.N / GIS.N / FISV.O / IO.N / FCEL.O / BLK.N / CREE.O / NET.N / ATVI.OQ / AMSC.OQ / TTWO.OQ / PLUG.OQ / ISRG.OQ / MRVL.OQ / TRMB.O / ITRI.O / MSTR.O / BIIB.O / ATRC.OQ / ICE.N / SPWR.O / CSIQ.O / FSLR.O / CME.O / TWIN.O / 771195104 / CSII.O / AGCO.K / TSLA.O / AMRC.K / AMRS.OQ / EA.O / ENPH.O / GMED.K / HASI.N / GOOGL.O / NVRO.N / 64829B100 / SHOP.K / SEDG.O / RUN.O / 40434L105 / WKHS.O / WCN.TO / AQMS.O / SPGI.K / TTD.OQ / IRTC.OQ / COUP.O / WPRT.TO / SNAP.K / ROKU.O / MDB.O / APTV.K / FOCS.OQ / CBOE.Z / CWENa.K / SWAV.O / PRPL.O / UBER.K / CRWD.O / AVNT.K / 02081G201 / RWRh.V / 03823M100</td><td class="leftalignment">Albemarle Corp / Bloom Energy Corp / Boston Scientific Corp / Citigroup Inc / Caterpillar Inc / Clean Harbors Inc / Cummins Inc / Dana Inc / Deere & Co / EnerSys / Corning Inc / Johnson Controls International PLC / Medtronic PLC / Nextera Energy Partners LP / Ormat Technologies Inc / Qualcomm Inc / Republic Services Inc / Waste Management Inc / Borgwarner Inc / General Mills Inc / Fiserv Inc / ION Geophysical Corp / Fuelcell Energy Inc / BlackRock Inc / Wolfspeed Inc / Cloudflare Inc / Activision Blizzard Inc / American Superconductor Corp / Take-Two Interactive Software Inc / Plug Power Inc / Intuitive Surgical Inc / Marvell Technology Inc / Trimble Inc / Itron Inc / Microstrategy Inc / Biogen Inc / AtriCure Inc / Intercontinental Exchange Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / CME Group Inc / Twin Disc Inc / Roche Holding AG / Cardiovascular Systems Inc / AGCO Corp / Tesla Inc / Ameresco Inc / Amyris Inc / Electronic Arts Inc / Enphase Energy Inc / Globus Medical Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Alphabet Inc / Nevro Corp / New Relic Inc / Shopify Inc / Solaredge Technologies Inc / Sunrun Inc / HP Inc / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / S&P Global Inc / Trade Desk Inc / iRhythm Technologies Inc / Coupa Software Inc / Westport Fuel Systems Inc / Snap Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Focus Financial Partners Inc / Cboe Global Markets Inc / Clearway Energy Inc / Shockwave Medical Inc / Purple Innovation Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Avient Corp / Alphatec Holdings Inc / Strathmore Plus Energy Corp / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AIN / FISV=US / PEP=US / CAG=US / KO=US / CL=US / PG=US / EBAY=US / RUN=US / CRM=US / V=US / ENR=US / PB=US / VMC=US / PENN=US / NWL=US / MLM=US / FLO=US / STZ=US / AIR=US / ATRO=US / B=US / CHD=US / COLL=US / CW=US / DCO=US / EPC=US / HAIN=US / HEI=US / HXL=US / REGN=US / REGI=US / ROLL=US / SGMO=US / SMG=US / TGI=US / VSEC=US / POST=US / GPN=US / PYPL=US / SPR=US / EVOP=US / MGPI=US / BDSI=US / MNST=US / JRVR=US / NOMD=US / BIIB=US / FLT=US / MOG.A=US / EXP=US / FRPT=US / THS=US / GMS=US / REX=US / FIS=US / TDG=US / MA=US / GPRE=US / ELF=US / CENTA=US / UTZ=US / WWD=US / QTWO=US / 00770K202 / NVRO=US / SQ=US / NTLA=US / PETQ=US / CARG=US / SMAR=US / KDP=US / OSMT=US / LSPD=US / RPAY=US / BRBR=US / REYN=US / SPCE=US / NCNO=US / PAYA=US / HYFM=US / 67421J108</td><td class="leftalignment">Albany International Corp / Fiserv Inc / PepsiCo Inc / Conagra Brands Inc / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / eBay Inc / Sunrun Inc / Salesforce.Com Inc / Visa Inc / Energizer Holdings Inc / Prosperity Bancshares Inc / Vulcan Materials Co / Penn National Gaming Inc / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Constellation Brands Inc / AAR Corp / Astronics Corp / Barnes Group Inc / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Curtiss-Wright Corp / Ducommun Inc / Edgewell Personal Care Co / Hain Celestial Group Inc / HEICO Corp / Hexcel Corp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / RBC Bearings Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Triumph Group Inc / VSE Corp / Post Holdings Inc / Global Payments Inc / PayPal Holdings Inc / Spirit AeroSystems Holdings Inc / EVO Payments Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / James River Group Holdings Ltd / Nomad Foods Ltd / Biogen Inc / Fleetcor Technologies Inc / Moog Inc / Eagle Materials Inc / Freshpet Inc / TreeHouse Foods Inc / GMS Inc / REX American Resources Corp / Fidelity National Information Services Inc / TransDigm Group Inc / Mastercard Inc / Green Plains Inc / elf Beauty Inc / Central Garden & Pet Co / UTZ Brands Inc / Woodward Inc / Q2 Holdings Inc / Aemetis Inc / Nevro Corp / Block Inc / Intellia Therapeutics Inc / PetIQ Inc / CarGurus Inc / Smartsheet Inc / Keurig Dr Pepper Inc / Osmotica Pharmaceuticals PLC / Lightspeed Commerce Inc / Repay Holdings Corp / Bellring Brands Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / nCino Inc / Paya Holdings Inc / Hydrofarm Holdings Group Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Luxembourg / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Next-Gen Lipid Nanoparticle Drug Delivery Under the Microscope; Discussion With Dan Siegwart, Ph.D., June 29, 12:00 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 88025U109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 000380204 / 89422G107 / 56600D107 / 65443P102 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / 10X Genomics Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / 908 Devices Inc. / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Raju Prasad, PHD / Mr. Myles R. R. Minter / Mr. Matt Larew / Sami Corwin, PHD / Max Smock</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2126335 / 2516152 / 2000019 / 2973821 / 2065159 / 2437071 / 2280220 / 2270726 / 2829515 / 2455965 / 2459020 / 2048804 / 2705198 / 2707677 / 2730190 / 2138158 / 2829601 / 2895163 / B00FWN1 / B125XQ6 / 2983563 / B6197Q2 / B87ZMX0 / B95N910 / B424494 / BFZCHN7 / BYVY8G0 / BS7K7C9 / BF4VBS8 / BXDZ9Z0 / BK0VHF6 / BD8DJ71 / BLGJ610 / BGSP7M9 / BZ1LFG7 / BMDCDP2 / BMC8SQ7 / BNTB3N8 / BN2RM92 / BLF0CW7</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Alliant Energy Corp / Autodesk Inc / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Edison International / Biogen Inc / Intuit Inc / Pinnacle West Capital Corp / Progress Software Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / United Natural Foods Inc / Alnylam Pharmaceuticals Inc / Portland General Electric Co / Carmax Inc / Generac Holdings Inc / Palo Alto Networks Inc / PTC Inc / Splunk Inc / Wix.Com Ltd / Alphabet Inc / Nevro Corp / BioXcel Therapeutics Inc / Shopify Inc / IDEAYA Biosciences Inc / Snap Inc / Warner Music Group Corp / Zoom Video Communications Inc / Roku Inc / Bigcommerce Holdings Inc / BTRS Holdings Inc / Vizio Holding Corp / Rain Therapeutics Inc / Repare Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / CCI.N / EDP.LS / EIX.N / ELE.MC / IBE.MC / IP.N / MRK.N / PD.N / PFE.N / PNN.L / RWEG.DE / SO.N / T.N / SSE.L / DRE.N / TRI.N / GILD.O / CMCSA.O / AMGN.O / INCY.O / DUK.N / REE.MC / GIS.N / JAZZ.O / CONE.O / NG.L / VZ.N / EXEL.O / KMX.N / AWK.N / NWN.N / BMRN.O / REGN.O / ENAG.MC / ENDP.O / CPK.N / PEGA.OQ / SEM.N / CASY.O / EQIX.O / ATDb.TO / BIIB.O / DLR.N / WEF.TO / ALNY.O / DISCA.O / SJW.N / DRX.L / TEVA.N / SLRS.MC / EONGn.DE / BHPB.L / NEE.N / CIO.N / SPLK.OQ / ABBV.N / TMUS.N / PRTA.O / BEP.N / ESNT.N / NEP.N / DEA.N / 78667J108 / EDIT.O / NTLA.O / TWLO.N / UN01.DE / NTNX.O / CRSP.OQ / GREG.MC / VST.N / ORSTED.CO / EHC.N / SMAR.N / DBX.O / CWEN.N / OSMT.O / 269796108 / ZM.O / FSLY.N / GMAB.O / DOCU.N / WTRG.N / BEAM.O / IGIC.OQ</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Crown Castle International Corp / EDP Energias de Portugal SA / Edison International / Endesa SA / Iberdrola SA / International Paper Co / Merck & Co Inc / PagerDuty Inc / Pfizer Inc / Pennon Group PLC / Rwe AG / Southern Co / AT&T Inc / SSE PLC / Duke Realty Corp / Thomson Reuters Corp / Gilead Sciences Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Red Electrica Corporacion SA / General Mills Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Carmax Inc / American Water Works Company Inc / Northwest Natural Holding Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Enagas SA / Endo International PLC / Chesapeake Utilities Corp / Pegasystems Inc / Select Medical Holdings Corp / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Digital Realty Trust Inc / Western Forest Products Inc / Alnylam Pharmaceuticals Inc / Discovery Inc / SJW Group / Drax Group PLC / Teva Pharmaceutical Industries Ltd / Solaria Energia y Medio Ambiente SA / E.ON SE / BHP Group PLC / Nextera Energy Inc / City Office REIT Inc / Splunk Inc / Abbvie Inc / T-Mobile US Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Essent Group Ltd / Nextera Energy Partners LP / Easterly Government Properties Inc / SAGE Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Twilio Inc / Uniper SE / Nutanix Inc / CRISPR Therapeutics AG / Grenergy Renovables SA / Vistra Corp / Orsted A/S / Encompass Health Corp / Smartsheet Inc / Dropbox Inc / Clearway Energy Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / Genmab A/S / DocuSign Inc / Essential Utilities Inc / Beam Therapeutics Inc / International General Insurance Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">The Feedback Loop: Digesting Biotech in June Edition</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / INCY.O / BIIB.O / 78667J108</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (28 June-): Short-term lull for Eisai; value back in play this week?</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（6月28日～）: エーザイ小休止、今週はバリュー系回帰か</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Neuroscience Shines by the Lake</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BIIB.O / 771195104 / 03823M100</td><td class="leftalignment">Biogen Inc / Roche Holding AG / Applied Minerals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Govt Aduhelm approval/pricing pushback – not a shocker; we await CMS coverage details</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 553</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - We Briefly Caught Up With Mgmt; Adu's Life Cycle Mgmt Is In The Works, A SubQ Formulation Is In The Clinic; New Patients Are Starting On Adu</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CRY.N / CVS / GE / HUM / JPM / MDT / RAD / SGE.L / UNH / WMT / AMZN.O / GILD.O / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / ISR / IART.OQ / BMRN.OQ / AMRN.OQ / ISRG.OQ / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / ATRC.OQ / LHCG.O / B8FGn.DE / ARAY.O / 02043Q107 / ENSG.OQ / 483548103 / TMDX.OQ / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / PRTA.OQ / GOOGL.O / 02005N100 / XENT.OQ / NVRO.N / VRAY.OQ / EVH.N / TDOC.N / MCRB.OQ / 100063846 / SSKN.OQ / SYRS.OQ / TCMD.OQ / IRTC.OQ / VREX.OQ / SRRA.O / ALPN.O / ACHV.O / 720795103 / SWAV.O / 21833P103 / XAIR.OQ / PNTG.OQ / VERO.O / NNOX.O / 03823M100 / 29271J109</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / General Electric Co / Humana Inc / JPMorgan Chase & Co / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Amazon.com Inc / Gilead Sciences Inc / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / IsoRay Inc / Integra Lifesciences Holdings Corp / Biomarin Pharmaceutical Inc / Amarin Corporation PLC / Intuitive Surgical Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / AtriCure Inc / LHC Group Inc / Biofrontera AG / Accuray Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Prothena Corporation PLC / Alphabet Inc / Ally Financial Inc / Intersect Ent Inc / Nevro Corp / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Seres Therapeutics Inc / Truist Financial Corp / STRATA Skin Sciences Inc / Syros Pharmaceuticals Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Varex Imaging Corp / Sierra Oncology Inc / Alpine Immune Sciences Inc / Achieve Life Sciences Inc / Pieris Pharmaceuticals Inc / Shockwave Medical Inc / Corbus Pharmaceuticals Holdings Inc / Beyond Air Inc / Pennant Group Inc / Venus Concept Inc / Nano-X Imaging Ltd / Applied Minerals Inc / Thermic Science International Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / United Kingdom / Ireland / Israel / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 6/18/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BSX=US / LLY=US / ADI=US / MDT=US / PD=US / AMZN=US / EBAY=US / INCY=US / CMA=US / BC=US / IART=US / PB=US / VRM=US / EWBC=US / TRMK=US / SPOT=US / UMPQ=US / EXPE=US / W=US / WTFC=US / ARCC=US / BNL=US / CCL=US / CSTR=US / DRI=US / AJG=US / MAIN=US / ORCC=US / PACW=US / SNAP=US / TRIP=US / WAL=US / WIX=US / HTH=US / BXS=US / BKNG=US / CFR=US / FMBI=US / SNV=US / SIVB=US / ABCB=US / BOKF=US / FB=US / FBK=US / MKL=US / ASB=US / SSB=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / UCBI=US / PNFP=US / SBCF=US / PTON=US / JRVR=US / BIIB=US / TCBI=US / FNB=US / FHN=US / APP=US / AINV=US / TXRH=US / RNST=US / MA=US / CADE=US / TAST=US / PNNT=US / NMTR=US / UTZ=US / KNSL=US / OAS=US / RLJ=US / ANGI=US / IBTX=US / GOOGL=US / TSLX=US / BABA=US / CMPR=US / UPLD=US / GDDY=US / GSBD=US / LOB=US / ACBI=US / TTD=US / CVNA=US / MBIN=US / 100088732 / SFIX=US / HWC=US / OZK=US / FTDR=US / EB=US / FSK=US / LYFT=US / UBER=US / ABNB=US / VMEO=US</td><td class="leftalignment">Boston Scientific Corp / Eli Lilly and Co / Analog Devices Inc / Medtronic PLC / PagerDuty Inc / Amazon.com Inc / eBay Inc / Incyte Corp / Comerica Inc / Brunswick Corp / Integra Lifesciences Holdings Corp / Prosperity Bancshares Inc / Vroom Inc / East West Bancorp Inc / Trustmark Corp / Spotify Technology SA / Umpqua Holdings Corp / Expedia Group Inc / Wayfair Inc / Wintrust Financial Corp / Ares Capital Corp / Bunzl plc / Carnival Corp / CapStar Financial Holdings Inc / Darden Restaurants Inc / Arthur J Gallagher & Co / Main Street Capital Corp / Owl Rock Capital Corp / PacWest Bancorp / Snap Inc / Tripadvisor Inc / Western Alliance Bancorp / Wix.Com Ltd / Hilltop Holdings Inc / Cadence Bank / Booking Holdings Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / Meta Platforms Inc / FB Financial Corp / Markel Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / United Community Banks Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Peloton Interactive Inc / James River Group Holdings Ltd / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / Applovin Corp / Apollo Investment Corp / Texas Roadhouse Inc / Renasant Corp / Mastercard Inc / Cadence Bank / Carrols Restaurant Group Inc / Pennantpark Investment Corp / 9 Meters Biopharma Inc / UTZ Brands Inc / Kinsale Capital Group Inc / Oasis Petroleum Inc / RLJ Lodging Trust / Angi Inc / Independent Bank Group Inc / Alphabet Inc / Sixth Street Specialty Lending Inc / Alibaba Group Holding Ltd / Cimpress PLC / Upland Software Inc / GoDaddy Inc / Goldman Sachs BDC Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Trade Desk Inc / Carvana Co / Merchants Bancorp / First Horizon Corp / Stitch Fix Inc / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Eventbrite Inc / FS KKR Capital Corp / Lyft Inc / Uber Technologies Inc / Airbnb Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AXP / 0989529 / 0925288 / 2516152 / 2000019 / 2640147 / 2219224 / 2280220 / 2270726 / 2455965 / 2471950 / 2705198 / 2829601 / 7103065 / 2857817 / B3D7K31 / B7TL820 / B85KFY9 / BFDV8K0 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BZ1HM42 / BJJMGL2 / BKTNTR9 / BZ1LFG7 / BYSGPK2 / BMDCDP2 / BJNQGL0 / BYXB1Y8 / BN7K304 / BJ9N563</td><td class="leftalignment">American Express Co / AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Amazon.com Inc / Nike Inc / CMS Energy Corp / DTE Energy Co / Walt Disney Co / Biogen Inc / Incyte Corp / Progress Software Corp / Southern Co / Novartis AG / Netflix Inc / Discovery Inc / Meta Platforms Inc / Five Below Inc / MacroGenics Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Adyen NV / Fox Corp / ViacomCBS Inc / Roku Inc / ViewRay Inc / Bigcommerce Holdings Inc / Rite Aid Corp / Sunrun Inc / Academy Sports and Outdoors Inc / Sunnova Energy International Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Anti A-Beta Regulatory Activity & Milestone Wins Reinforce Thesis for Multiple Assets: M&A Potential Now Considered - Target to $65</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">G72800108 / 09062X103</td><td class="leftalignment">Prothena Corporation PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Robert C. Hazlett</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Six In a Row - Biotech Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">IART.OQ / BIIB.O / 02043Q107 / 771195104 / PRTA.OQ / 02005N100 / VRAY.OQ</td><td class="leftalignment">Integra Lifesciences Holdings Corp / Biogen Inc / Alnylam Pharmaceuticals Inc / Roche Holding AG / Prothena Corporation PLC / Ally Financial Inc / ViewRay Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">LLY - LLY, BIIB, ROG: Donanemab a market leading product because of its differentiation? Coming early</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">09062X103 / 532457108 / ROG.S / 7110388</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Roche Holding AG / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">One thing seems clear: the FDA’s precedent post-Aduhelm  on Alzheimer's is seeing reduction in amyloid beta</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">ACHM Program Takes Big Step Forward with Important Data and Learnings; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">03820J100 / BIIB</td><td class="leftalignment">Applied Genetic Technologies Corp / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">PRX005 Opt-in Further Validates Platform</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PRTA.OQ / BIIB.O / 02043Q107 / 771195104 / 02005N100</td><td class="leftalignment">Prothena Corporation PLC / Biogen Inc / Alnylam Pharmaceuticals Inc / Roche Holding AG / Ally Financial Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Alzheimer’s Space Heating Up Faster than Expected</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X10 / 53245710</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Focus on reimbursement; multiple players are expected, we model competition</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US / LLY=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB: Everyone Joining The AD Rush, As LLY Announces Plans To File Donanemab - Though Not Surprising, And Not A Sure Thing</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">FDA Opens the Flood Gates in Alzheimer's, Grants BTD to BIIB/Eisai's BAN2401 and LLY's Donanemab; LLY to File for Accelerated Approval by YE21</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / LLY.N / 2516152 / 2455965</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">DIS=US / ADI=US / AMZN=US / TXN=US / GILD=US / PEB=US / H=US / MTN=US / MAR=US / EXPE=US / TNL=US / HLT=US / AKR=US / ELY=US / CHH=US / DRH=US / EQIX=US / INFO=US / TRIP=US / WGO=US / GOLF=US / BKNG=US / BIIB=US / SHO=US / GMS=US / HST=US / WH=US / RCUS=US / HGV=US / RLJ=US / VAC=US / EA=US / RHP=US / 00770K202 / TRVG=US / PK=US / PLYA=US / TSHA / ABNB=US</td><td class="leftalignment">Walt Disney Co / Analog Devices Inc / Amazon.com Inc / Texas Instruments Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Marriott International Inc / Expedia Group Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Callaway Golf Co / Choice Hotels International Inc / Diamondrock Hospitality Co / Equinix Inc / IHS Markit Ltd / Tripadvisor Inc / Winnebago Industries Inc / Acushnet Holdings Corp / Booking Holdings Inc / Biogen Inc / Sunstone Hotel Investors Inc / GMS Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Electronic Arts Inc / Ryman Hospitality Properties Inc / Aemetis Inc / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Taysha Gene Therapies Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch Third Quarter 2021</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">54142F102 / 73730P108 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 00847G705 / 803607100 / 26979610 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 04651310 / 462222100 / 01345P106 / 00887A105 / 69366J200 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 92686J106 / 37890U108 / 77313F106 / 717224109 / 05464T104 / 48576A100 / G10830100 / 81181C104 / 517125100 / 74006W108 / 92840H202 / 03890D108 / 192010106 / 13089P101 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">LogicBio Therapeutics Inc / Poseida Therapeutics Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Albireo Pharma Inc / Aileron Therapeutics Inc / PTC Therapeutics Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Viking Therapeutics Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / PhaseBio Pharmaceuticals Inc / Axsome Therapeutics Inc / Karuna Therapeutics Inc / Beyondspring Inc / Seagen Inc / Larimar Therapeutics Inc / Praxis Precision Medicines Inc / VistaGen Therapeutics Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB - Tidbits From Company's PR This Morning Reinforces That Adu Access Is Likely To Be Anything But Typical</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="even"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Aduhelm updates on pricing impact to payers and patients</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PLUG=US / CHKP=US / W=US / KFY=US / ELY=US / SGMO=US / GOLF=US / SPG=US / NET=US / CNC=US / KIM=US / RPD=US / BIIB=US / CMG=US / SPLK=US / PANW=US / FEYE=US / QURE=US / VRNS=US / ZS=US / OKTA=US / DCPH=US / SAIL=US / BTAI=US / TENB=US / CRWD=US / KNBE=US / DBRG=US</td><td class="leftalignment">Plug Power Inc / Check Point Software Technologies Ltd / Wayfair Inc / Korn Ferry / Callaway Golf Co / Sangamo Therapeutics Inc / Acushnet Holdings Corp / Simon Property Group Inc / Cloudflare Inc / Centene Corp / Kimco Realty Corp / Rapid7 Inc / Biogen Inc / Chipotle Mexican Grill Inc / Splunk Inc / Palo Alto Networks Inc / Mandiant Inc / Uniqure NV / Varonis Systems Inc / Zscaler Inc / Okta Inc / Deciphera Pharmaceuticals Inc / SailPoint Technologies Holdings Inc / BioXcel Therapeutics Inc / Tenable Holdings Inc / CrowdStrike Holdings Inc / Knowbe4 Inc / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB - FDA Defends Adu Approval In Just-Posted Documents - Though Not Surprising, Could Provide Physicians Incremental Cover to Prescribe</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Hem B BLA delayed; now expected in early 2022</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">QURE=US / BIIB=US</td><td class="leftalignment">Uniqure NV / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First-Dose Vaccinations Settle in at 500K Per Day, Domestic COVID-19 Metrics Continue to Improve Despite Spread of Variants</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AXP.N / BAC.N / BK.N / C.N / COF.N / ELE.MC / FITB.O / HSX.L / IBE.MC / JPM.N / KEY.N / NEX.L / NTRS.O / PNC.N / USB.N / WFC.N / HBAN.O / WLK.N / DRI.N / GS.N / KGC.N / STT.N / MTB.N / RF.N / DFS.N / SEM.N / BIIB.O / TFC.N / EDV.TO / CG.TO / IAG.N / MS.N / LRE.L / MA.N / 550372106 / BEZG.L / OSK.TO / EGO.N / SBB.TO / AR.TO / TXG.TO / SIL.TO / SLS.TO / MOZ.TO / ALLY.N / SMLP.N / 505440107 / BTG.N / CFG.N / SSRM.O / EHC.N / EQX.TO / ILPT.O</td><td class="leftalignment">American Express Co / Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Capital One Financial Corp / Endesa SA / Fifth Third Bancorp / Hiscox Ltd / Iberdrola SA / JPMorgan Chase & Co / KeyCorp / National Express Group PLC / Northern Trust Corp / PNC Financial Services Group Inc / US Bancorp / Wells Fargo & Co / Huntington Bancshares Inc / Westlake Chemical Corp / Darden Restaurants Inc / Goldman Sachs Group Inc / Kinross Gold Corp / State Street Corp / M&T Bank Corp / Regions Financial Corp / Discover Financial Services / Select Medical Holdings Corp / Biogen Inc / Truist Financial Corp / Endeavour Mining PLC / Centerra Gold Inc / IAMGOLD Corp / Morgan Stanley / Lancashire Holdings Ltd / Mastercard Inc / Lundin Mining Corp / Beazley PLC / Osisko Mining Inc / Eldorado Gold Corp / Sabina Gold & Silver Corp / Argonaut Gold Inc / Torex Gold Resources Inc / Silvercrest Metals Inc / Solaris Resources Inc / Marathon Gold Corp / Ally Financial Inc / Summit Midstream Partners LP / Labrador Iron Ore Royalty Corp / B2Gold Corp / Citizens Financial Group Inc / SSR Mining Inc / Encompass Health Corp / Equinox Gold Corp / Industrial Logistics Properties Trust</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Spain / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">MEDCAC Member Suggests NT Adu Access Is Likely, Though Commercial Story Still Far From Written</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Reminder: Virtual Washington, D.C. Day - June 30, 2021; Updated Full Agenda</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 11, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ACA / ALB.N / BE / BSX / CAT / CLH / CMI / DAN / DE / EAT / ENS / JCI / LL / MDT / MSFT.O / NEP / ORA / RBC / RSG / SGE.L / SWI / TUP / W / WM / AMZN.O / AAPL.O / BWA.N / ASTE.O / NVDA.O / ADBE.O / CRVL.O / MPWR.O / EW.N / IO.N / FCEL.O / OSUR.O / CREE.O / CRUS.OQ / AMSC.OQ / VRTS.OQ / POOL.OQ / CALM.OQ / UTHR.OQ / PLUG.OQ / MRVL.OQ / PDFS.OQ / IDCC.O / TRMB.O / QDEL.O / ITRI.O / NATI.O / BIIB.O / BJRI.OQ / 146229109 / ATRC.OQ / SPWR.O / ATNI.OQ / XPO / EHTH.O / CSIQ.O / FSLR.O / ARAY.O / LULU.O / ENSG.OQ / FRPT.O / TWIN.O / CSII.O / AGCO.K / GNRC.K / TSLA.O / AMRC.K / AMRS.OQ / ZNGA.O / ENPH.O / FB.O / CG.O / FIVE.OQ / GMED.K / HASI.N / FATE.OQ / GOOGL.O / ARES.K / VCEL.O / TBK.O / VRAY.OQ / PYPL.O / UQ1.F / SEDG.O / RUN.O / APLS.OQ / MIME.OQ / WKHS.O / WCN.TO / AQMS.O / WPRT.TO / GOOS.TO / CVNA.N / ROKU.O / MDB.O / APTV.K / LOVE.OQ / FOCS.OQ / FTCH.N / CWENa.K / SWAV.O / PRPL.O / UBER.K / PTON.OQ / PING.K / FVRR.K / QMCO.O / BILL.K / AVNT.K / 02081G201 / GRWG.O / RWRh.V / 390320109 / 29271J109</td><td class="leftalignment">Arcosa Inc / Albemarle Corp / Bloom Energy Corp / Boston Scientific Corp / Caterpillar Inc / Clean Harbors Inc / Cummins Inc / Dana Inc / Deere & Co / Brinker International Inc / EnerSys / Johnson Controls International PLC / LL Flooring Holdings Inc / Medtronic PLC / Microsoft Corp / Nextera Energy Partners LP / Ormat Technologies Inc / Regal Rexnord Corp / Republic Services Inc / Sage Group PLC / SolarWinds Corp / Tupperware Brands Corp / Wayfair Inc / Waste Management Inc / Amazon.com Inc / Apple Inc / Borgwarner Inc / Astec Industries Inc / NVIDIA Corp / Adobe Inc / CorVel Corp / Monolithic Power Systems Inc / Edwards Lifesciences Corp / ION Geophysical Corp / Fuelcell Energy Inc / OraSure Technologies Inc / Wolfspeed Inc / Cirrus Logic Inc / American Superconductor Corp / Virtus Investment Partners Inc / Pool Corp / Cal-Maine Foods Inc / United Therapeutics Corp / Plug Power Inc / Marvell Technology Inc / PDF Solutions Inc / InterDigital Inc / Trimble Inc / Quidel Corp / Itron Inc / National Instruments Corp / Biogen Inc / BJ's Restaurants Inc / Carter's Inc / AtriCure Inc / SunPower Corp / ATN International Inc / XPO Logistics Inc / eHealth Inc / Canadian Solar Inc / First Solar Inc / Accuray Inc / Lululemon Athletica Inc / Ensign Group Inc / Freshpet Inc / Twin Disc Inc / Cardiovascular Systems Inc / AGCO Corp / Generac Holdings Inc / Tesla Inc / Ameresco Inc / Amyris Inc / Zynga Inc / Enphase Energy Inc / Meta Platforms Inc / Carlyle Group Inc / Five Below Inc / Globus Medical Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Fate Therapeutics Inc / Alphabet Inc / Ares Management Corp / Vericel Corp / Triumph Bancorp Inc / ViewRay Inc / PayPal Holdings Inc / Uniqure NV / Solaredge Technologies Inc / Sunrun Inc / Apellis Pharmaceuticals Inc / Mimecast Ltd / Workhorse Group Inc / Waste Connections Inc / Aqua Metals Inc / Westport Fuel Systems Inc / Canada Goose Holdings Inc / Carvana Co / Roku Inc / MongoDB Inc / Aptiv PLC / Lovesac Co / Focus Financial Partners Inc / Farfetch Ltd / Clearway Energy Inc / Shockwave Medical Inc / Purple Innovation Inc / Uber Technologies Inc / Peloton Interactive Inc / Ping Identity Holding Corp / Fiverr International Ltd / Quantum Corp / Bill.com Holdings Inc / Avient Corp / Alphatec Holdings Inc / GrowGeneration Corp / Strathmore Plus Energy Corp / Great Elm Capital Corp / Thermic Science International Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">FISV=US / LSI=US / OXY=US / RRC=US / DVN=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / EWBC=US / UMPQ=US / MRO=US / MANH=US / COLL=US / CNX=US / EQT=US / PACW=US / SHOP=US / WAL=US / FOUR=US / CVX=US / PSA=US / GPN=US / PYPL=US / NHI=US / CATY=US / GBCI=US / COP=US / BDSI=US / BIIB=US / EXR=US / FIS=US / CLR=US / NOG=US / CLNY=US / AR=US / OAS=US / SBRA=US / ESTE=US / CUBE=US / ZNGA=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / VNOM=US / NSA=US / SQ=US / EVBG=US / CDEV=US / PVAC=US / SBOW=US / LSPD=US / RTLR=US / RPAY=US / OVV=US / BIGC=US / DASH=US / COUR-US</td><td class="leftalignment">Fiserv Inc / Life Storage Inc / Occidental Petroleum Corp / Range Resources Corp / Devon Energy Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / East West Bancorp Inc / Umpqua Holdings Corp / Marathon Oil Corp / Manhattan Associates Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / EQT Corp / PacWest Bancorp / Shopify Inc / Western Alliance Bancorp / Shift4 Payments Inc / Chevron Corp / Public Storage / Global Payments Inc / PayPal Holdings Inc / National Health Investors Inc / Cathay General Bancorp / Glacier Bancorp Inc / Conocophillips / BioDelivery Sciences International Inc / Biogen Inc / Extra Space Storage Inc / Fidelity National Information Services Inc / Continental Resources Inc / Northern Oil and Gas Inc / DigitalBridge Group Inc / Antero Resources Corp / Oasis Petroleum Inc / Sabra Health Care REIT Inc / Earthstone Energy Inc / CubeSmart / Zynga Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Viper Energy Partners LP / National Storage Affiliates Trust / Block Inc / Everbridge Inc / Centennial Resource Development Inc / Ranger Oil Corp / SilverBow Resources Inc / Lightspeed Commerce Inc / Rattler Midstream LP / Repay Holdings Corp / Ovintiv Inc / Bigcommerce Holdings Inc / DoorDash Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">388</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (21 June-): Expecting good returns from pharma stocks' defensive qualities</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4503.T / 4507.T / 4502.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / SAGE.OQ / 4887.T</td><td class="leftalignment">Astellas Pharma Inc / Shionogi & Co Ltd / Takeda Pharmaceutical Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / SAGE Therapeutics Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（6月21日～）: 医薬品のディフェンシブ性に期待</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4503.T / 4507.T / 4502.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / SAGE.OQ / 4887.T</td><td class="leftalignment">Astellas Pharma Inc / Shionogi & Co Ltd / Takeda Pharmaceutical Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / SAGE Therapeutics Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Auerbach Grayson & Co., Inc.</td><td class="leftalignment">AUERBACH GRAYSON: CEEMEA & LATAM Daily Morning Note 06-21-21:  (ADIB Egypt, Bahrain Telecommunications, BRADESCO, Bank Millennium, Bank Muscat, Budimex, CBZ Holdings, CD Projekt, Cemex, Eletrobras, Cleopatra Hospital, Dar Es Salaam Stock Exchange, EIPICO)</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BBDC4.SA / BDXP.WA / CDR.WA / CEMEXCPO.MX / CLHO.CA / DSE.TZ / ELET6.SA / MILP.WA / PHAR.CA / ELET3@BZ / CEMEXCPO@MM / PLBUDMX00013 / PLMSTWS00019 / PLPKN0000018 / TRATOASO91H3 / BRBBDCACNOR1 / EGS38081C013 / HU0000067624 / EGS65591C017 / EGS60241C014 / PLLOTOS00025 / PLBIG0000016 / SI0031104290 / PLERBUD00012 / EGS655L1C012 / BH0060713458 / OM0000002796 / SA000A0HNF36 / EGS673T1C012 / RSKOBBE33594 / TTP501551035 / PLPGER000028 / TNB@PS / ADIB@EY / EMFD@EY / BIIB@IQ / WPL@PW / CDR@PW / CLHO@EY / MTIE@EY / DSE@TZ / NLBR@SV / VGO@PW / IS0000000503 / NWG@PW / ISPH@EY / TBS@BU</td><td class="leftalignment">Banco Bradesco SA / Budimex SA / CD Projekt SA / Cemex SAB de CV / Cleopatra Hospital SAE / Dar es Salaam Stock Exchange PLC / Centrais Eletricas Brasileiras SA / Bank Millennium SA / Egyptian International Pharmaceutical Industries Company SAE / Centrais Eletricas Brasileiras SA / Cemex SAB de CV / Budimex SA / Mostostal Warszawa SA / Polski Koncern Naftowy Orlen SA / Tofas Turk Otomobil Fabrikasi AS / Banco Bradesco SA / Egyptian International Pharmaceutical Industries Company SAE / Richter Gedeon Vegyeszeti Gyar Nyrt / Heliopolis Company for Housing and Development SAE / Export Development Bank of Egypt SAE / Grupa Lotos SA / Bank Millennium SA / Telekom Slovenije dd / Erbud SA / Palm Hills Developments / Bahrain Telecommunications Company BSC / Bank Muscat SAOG / Yanbu National Petrochemicals Company SJSC / GB Auto SAE / Komercijalna Banka AD Skopje / Guardian Holdings Ltd / PGE Polska Grupa Energetyczna SA / National Bank / Abu Dhabi Islamic Bank Egypt SAE / Emaar Misr for Development SAE / Iraqi Islamic Bank for Investment & Development / Wirtualna Polska Holding SA / CD Projekt SA / Cleopatra Hospital SAE / MM Group for Industry and International Trade SAE / Dar es Salaam Stock Exchange PLC / Nova Ljubljanska Banka dd Ljubljana / Vigo System SA / Skeljungur Ltd / Newag SA / Ibnsina Pharma Co SAE / Telelink Business Services Group AD</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United Arab Emirates / Bahrain / Brazil / Bulgaria / Egypt / Ghana / Croatia / Hungary / Iraq / Iceland / Jamaica / Mexico / Namibia / Nigeria / Oman / Poland / Russian Federation / Saudi Arabia / Slovenia / Trinidad and Tobago / Turkey / Tanzania, United Republic of / Ukraine / Zimbabwe / Serbia & Montenegro - Discontinue with effect from December 11, 2006 / Palestine</td><td class="leftalignment">Appliances / Automotive / Banks / Building & Building Materials / Chemicals / Communications / Electrical / Electronics / Engineering & Construction / Fertilizers / Financial Services / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Insurance / Manufacturing / Pharmaceuticals / Real Estate / Technology / Tire & Rubber / Transportation / Utilities / Wholesale / Internet</td><td class="leftalignment">Africa / Europe / Latin America / Middle East / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Auerbach Grayson</td></tr>
<tr class="odd"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">MDD Patients Find Rapid Relief in WATERFALL</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">SGE.L / BIIB.O</td><td class="leftalignment">Sage Group PLC / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FDA KOL thinks zuranolone will be approved; gives color on other psych drug controversies</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 552</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / HCA.N / CYH.N / CCRN.O / AMED.O / BIIB.O / 00846U101 / 868168105 / LHCG.O / 02043Q107 / ENSG.OQ / 483548103 / MD.N / 771195104 / ADUS.O / USPH.N / PRTA.OQ / GOOGL.O / 02005N100 / EVH.N / TDOC.N / 100063846 / 720795103 / PNTG.OQ</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / HCA Healthcare Inc / Community Health Systems Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / US Physical Therapy Inc / Prothena Corporation PLC / Alphabet Inc / Ally Financial Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / Pieris Pharmaceuticals Inc / Pennant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--June 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / SGE.L / UNH / WMT / RMD.N / HCA.N / CYH.N / EW.N / UTHR.OQ / BLUE.OQ / VRTX.OQ / CCRN.O / ICAD.O / AMED.O / BIIB.O / 00846U101 / 868168105 / MNKD.O / ATRC.OQ / LHCG.O / 02043Q107 / ENSG.OQ / 483548103 / TMDX.OQ / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / PRTA.OQ / AGIO.OQ / GOOGL.O / 02005N100 / APS.TO / VBLT.O / EVH.N / TDOC.N / GBT.OQ / 100063846 / SRRA.O / MBIO.OQ / 720795103 / CRSP.BN / SWAV.O / XFOR.OQ / PDSB.OQ / A71.F / XAIR.OQ / PNTG.OQ / FMTX.O</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / United Therapeutics Corp / bluebird bio Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / ICAD Inc / Amedisys Inc / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / MannKind Corp / AtriCure Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / Alphabet Inc / Ally Financial Inc / Aptose Biosciences Inc / Vascular Biogenics Ltd / Evolent Health Inc / Teladoc Health Inc / Global Blood Therapeutics Inc / Truist Financial Corp / Sierra Oncology Inc / Mustang Bio Inc / Pieris Pharmaceuticals Inc / CRISPR Therapeutics AG / Shockwave Medical Inc / X4 Pharmaceuticals Inc / PDS Biotechnology Corp / Ascendis Pharma A/S / Beyond Air Inc / Pennant Group Inc / Forma Therapeutics Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 6/11/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMT / CAT / CCI.N / CMI / CRM.N / DE / KR / LNN / MSFT.O / NICE.TA / T.N / AMZN.O / DISH.O / ADBE.O / KLR / HEAR.O / RDWR.O / VMI / CHTR.O / DOX.O / NET.N / ATVI.OQ / TTWO.OQ / UTHR.OQ / AKAM.OQ / VRNT.OQ / TRMB.O / EQIX.O / NFLX.O / BIIB.O / 92343V104 / 20030N101 / MNKD.O / 36467W109 / VMW / 02043Q107 / 771195104 / AGCO.K / NXPI.O / ZNGA.O / EA.O / FB.O / PRTA.OQ / RNG.N / GOOGL.O / 563771203 / 82655M107 / N20944109 / 02005N100 / TMUS.OQ / TWLO.K / ROKU.O / EGHT.K / BILI.O / CBOE.Z / ZM.OQ / XAIR.OQ / FSLY.K / VG.O / ONDS.OQ / HUYA.K</td><td class="leftalignment">American Tower Corp / Caterpillar Inc / Crown Castle International Corp / Cummins Inc / Salesforce.Com Inc / Deere & Co / Kroger Co / Lindsay Corp / Microsoft Corp / Nice Ltd / AT&T Inc / Amazon.com Inc / DISH Network Corp / Adobe Inc / Kaleyra Inc / Turtle Beach Corp / Radware Ltd / Valmont Industries Inc / Charter Communications Inc / Amdocs Ltd / Cloudflare Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / United Therapeutics Corp / Akamai Technologies Inc / Verint Systems Inc / Trimble Inc / Equinix Inc / Netflix Inc / Biogen Inc / Verizon Communications Inc / Comcast Corp / MannKind Corp / GameStop Corp / VMware Inc / Alnylam Pharmaceuticals Inc / Roche Holding AG / AGCO Corp / NXP Semiconductors NV / Zynga Inc / Electronic Arts Inc / Meta Platforms Inc / Prothena Corporation PLC / RingCentral Inc / Alphabet Inc / Mannatech Inc / Sify Technologies Ltd / CNH Industrial NV / Ally Financial Inc / T-Mobile US Inc / Twilio Inc / Roku Inc / 8x8 Inc / Bilibili Inc / Cboe Global Markets Inc / Zoom Video Communications Inc / Beyond Air Inc / Fastly Inc / Vonage Holdings Corp / Ondas Holdings Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / India / Ireland / Israel / Netherlands / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Upgrade to OW; Neurologist Survey, Reimbursement Checks Too Bullish to Ignore</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">A Reminder that Epitope Matters</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PRTA.OQ / BIIB.O / 02043Q107 / 771195104 / 02005N100</td><td class="leftalignment">Prothena Corporation PLC / Biogen Inc / Alnylam Pharmaceuticals Inc / Roche Holding AG / Ally Financial Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Let It Go, Let It Go - Biotech Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 00461U105 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Aclaris Therapeutics Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037 / US15135B1017</td><td class="leftalignment">Biogen Inc / Centene Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Tau mAbs and Tao - Although the Way Forward May Not be Intuitive, Not All Candidates are Created Equal</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PRTA.OQ / US09062X1037</td><td class="leftalignment">Prothena Corporation PLC / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">OXY=US / BXP=US / BLD=US / DVN=US / RUN=US / AMT=US / PEB=US / CPE=US / EOG=US / BC=US / H=US / CONE=US / MTN=US / MUR=US / MAR=US / MRO=US / TNL=US / VMC=US / HLT=US / MLM=US / CHH=US / DRH=US / IBP=US / HZO=US / PDM=US / PII=US / REGN=US / TRIP=US / WGO=US / CNC=US / VNO=US / COP=US / BIIB=US / SHO=US / BLDR=US / SPWR=US / HST=US / XPO=US / WH=US / HGV=US / RLJ=US / VAC=US / MTDR=US / ENPH=US / PDCE=US / RHP=US / FATE=US / MBUU=US / 00770K202 / SEDG=US / MCFT=US / ZS=US / AXSM=US / WLTW=US / CDEV=US / PK=US / PLYA=US / LYFT=US / UBER=US / ONEW=US</td><td class="leftalignment">Occidental Petroleum Corp / Boston Properties Inc / TopBuild Corp / Devon Energy Corp / Sunrun Inc / American Tower Corp / Pebblebrook Hotel Trust / Callon Petroleum Co / EOG Resources Inc / Brunswick Corp / Hyatt Hotels Corp / CyrusOne Inc / Vail Resorts Inc / Murphy Oil Corp / Marriott International Inc / Marathon Oil Corp / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Installed Building Products Inc / MarineMax Inc / Piedmont Office Realty Trust Inc / Polaris Inc / Regeneron Pharmaceuticals Inc / Tripadvisor Inc / Winnebago Industries Inc / Centene Corp / Vornado Realty Trust / Conocophillips / Biogen Inc / Sunstone Hotel Investors Inc / Builders FirstSource Inc / SunPower Corp / Host Hotels & Resorts Inc / XPO Logistics Inc / Wyndham Hotels & Resorts Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Matador Resources Co / Enphase Energy Inc / PDC Energy Inc / Ryman Hospitality Properties Inc / Fate Therapeutics Inc / Malibu Boats Inc / Aemetis Inc / Solaredge Technologies Inc / Mastercraft Boat Holdings Inc / Zscaler Inc / Axsome Therapeutics Inc / Willis Towers Watson PLC / Centennial Resource Development Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Lyft Inc / Uber Technologies Inc / OneWater Marine Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 2434209 / 2516152 / 2280220 / 2270726 / 2670519 / 2328915 / 2369174 / 2455965 / 2689560 / 2829601 / B1F76F9 / B02R1L6 / B03PGL4 / 2949758 / B7TL820 / B783TY6 / B7VD3F2 / BFDV8K0 / BFLR866 / BYVY8G0 / BXDZ9Z0 / BF5L3T2 / BD9GVY0 / BJFSR88 / BWY52P3 / BN4RD42 / BFY7DC4 / BN4NJG4 / BMF1LH5</td><td class="leftalignment">American Express Co / Home Depot Inc / Eli Lilly and Co / DTE Energy Co / Walt Disney Co / Exelon Corp / Nextera Energy Inc / Gilead Sciences Inc / Biogen Inc / PG&E Corp / Southern Co / Western Union Co / ALLETE Inc / NorthWestern Corp / Nexstar Media Group Inc / Meta Platforms Inc / Aptiv PLC / Duke Energy Corp / MacroGenics Inc / Twitter Inc / Alphabet Inc / Shopify Inc / Elanco Animal Health Inc / Zai Lab Ltd / Uniqure NV / Blueprint Medicines Corp / CureVac NV / Altimmune Inc / Freeline Therapeutics Holdings PLC / Honest Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Highlights from Our Payer Call; Expect Swift Adu Uptake as We See a Few Ways for Medicare to Limit Coverage (Incl PET/CSF) to Eligible Patients</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">With Gosuranemab, the Fate of N-terminal Tau Antibodies Could Be Sealed</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB / PRTA.OQ / H00263105</td><td class="leftalignment">Biogen Inc / Prothena Corporation PLC / AC Immune SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4519.T: Chugai Pharmaceutical - ASCO seminar for institutional investors gives good impression of new antibody engineering technology</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4519.T / 4523.T / ROG.S / BIIB.OQ</td><td class="leftalignment">Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4519.T: 中外製薬 - 機関投資家向け「ASCO勉強会」を開催、抗体改変技術の高さを実感</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">4519.T / 4523.T / ROG.S / BIIB.OQ</td><td class="leftalignment">Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Anti-tau antibody miss; lots of high risk/reward assets in pipeline</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Another Tau Disappointment with Gosuranemab</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Sometimes it doesn’t take two to tango: gosuranemab (anti-tau) misses primary endpoint in Ph 2 TANGO study for Alzheimer’s</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Payer Call Starts In 30 Mins - Diving Into the Complex Payer Dynamic for Biogen’s Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="odd"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">DG / HON / HUM / MSFT.O / SGE.L / ACI.N / 4716.T / AMZN.O / NVDA.O / SAPG.DE / HEAR.O / HRB.N / DLTR.O / KLIC.OQ / ATVI.OQ / TTWO.OQ / NFLX.O / BIIB.O / 36467W109 / SLRC.O / SUNS.O / AMD.OQ / ZNGA.O / EA.O / ARMK.K / GOOGL.O / 82655M107 / VBLT.O / BABA.K / MBIO.OQ / BILI.O / HUYA.K</td><td class="leftalignment">Dollar General Corp / Honeywell International Inc / Humana Inc / Microsoft Corp / Sage Group PLC / Albertsons Companies Inc / Oracle Corp Japan / Amazon.com Inc / NVIDIA Corp / SAP SE / Turtle Beach Corp / H & R Block Inc / Dollar Tree Inc / Kulicke and Soffa Industries Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / Netflix Inc / Biogen Inc / GameStop Corp / SLR Investment Corp / SLR Senior Investment Corp / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Aramark / Alphabet Inc / Sify Technologies Ltd / Vascular Biogenics Ltd / Alibaba Group Holding Ltd / Mustang Bio Inc / Bilibili Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">HD=US / OXY=US / APA=US / CPE=US / EOG=US / LOW=US / MGY=US / VRM=US / MUR=US / MRO=US / TTWO=US / LEG=US / HUM=US / UNH=US / MHK=US / SAGE=US / WRE=US / BIIB=US / TPX=US / CHNG=US / PRPL=US / OAS=US / ESTE=US / FBHS=US / FATE=US / RLMD=US / ETSY=US / ZS=US / AXSM=US / PVAC=US / CVNA=US / SYNH=US / MAXR=US / OVV=US / SPCE=US / DKNG=US / RBLX=US / REPX=US</td><td class="leftalignment">Home Depot Inc / Occidental Petroleum Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Lowe's Companies Inc / Magnolia Oil & Gas Corp / Vroom Inc / Murphy Oil Corp / Marathon Oil Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / Humana Inc / UnitedHealth Group Inc / Mohawk Industries Inc / SAGE Therapeutics Inc / Washington Real Estate Investment Trust / Biogen Inc / Tempur Sealy International Inc / Change Healthcare Inc / Purple Innovation Inc / Oasis Petroleum Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Fate Therapeutics Inc / Relmada Therapeutics Inc / ETSY Inc / Zscaler Inc / Axsome Therapeutics Inc / Ranger Oil Corp / Carvana Co / Syneos Health Inc / Maxar Technologies Inc / Ovintiv Inc / Virgin Galactic Holdings Inc / DraftKings Inc / Roblox Corp / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037 / US69366J2006 / US62818Q1040</td><td class="leftalignment">Biogen Inc / PTC Therapeutics Inc / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AXP / 2000019 / 2008154 / 2942605 / 2216850 / 2280220 / 2270726 / 2542049 / 2670519 / 2328915 / 2455965 / 2138158 / 2829601 / 2769796 / 2857817 / B02R1L6 / B03PGL4 / B3SWPT2 / B7TL820 / BNGY4Q0 / BYVY8G0 / BP4GNK9 / BXDZ9Z0 / BJLFHW7 / BYZR4X4 / BMYML02 / BFMXGR0 / BKF9DQ8 / BP8GHT2</td><td class="leftalignment">American Express Co / Amazon.com Inc / Adobe Inc / Avista Corp / Consolidated Edison Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Exelon Corp / Nextera Energy Inc / Biogen Inc / Sempra Energy / Southern Co / Fidelity National Information Services Inc / Netflix Inc / ALLETE Inc / NorthWestern Corp / Ameresco Inc / Meta Platforms Inc / Nextera Energy Partners LP / Alphabet Inc / SAGE Therapeutics Inc / Shopify Inc / Chewy Inc / Axsome Therapeutics Inc / DraftKings Inc / Evergy Inc / Phreesia Inc / Vascular Biogenics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Substantial upside potential for Eisai, ¥1tn gap in increase in market cap compared with Biogen</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.OQ / 4523.T</td><td class="leftalignment">Biogen Inc / Eisai Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - バイオジェンとの時価総額上昇の差1兆円、エーザイの上昇余地が大きそう</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">4523.T / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Zuranolone Needed More Robust Effect Size To Shift Benefit/Risk Balance In Its Favor. Reit HOLD</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">SAGE=US / BIIB=US / RLMD=US / AXSM=US</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc / Relmada Therapeutics Inc / Axsome Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MUTUAL FUNDS / TRUSTS RESEARCH</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037 / US6700024010</td><td class="leftalignment">Biogen Inc / Novavax Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Go with the Flow; WATERFALL Shows Rapid Onset</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">SGE.L / BIIB.O</td><td class="leftalignment">Sage Group PLC / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Positive primary endpoint but mixed: Ph 3 data in WATERFALL study for Major Depressive Disorder; but does it really matter for BIIB shares anyway?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">WATERFALL Highlights GABAA PAM as Valid Mechanism for MDD, but PRAX-114 Could Improve Risk/Benefit Profile</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">74006W108 / 09062X103 / 78667J108</td><td class="leftalignment">Praxis Precision Medicines Inc / Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Going Over The WATERFALL Results - We Still Think There's A Path Forward</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BIIB.O / SAGE.O / PRAX.O</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Sage & Biogen : Time to Start Chasing Waterfalls?... Zuranolone Hits in Ph3, But Debate Likely to Continue</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / SAGE.O</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">WATERFALL Positive but Maybe Not an MDD Commercial Game Changer; Is It Worth It in Light of Aduhelm Approval?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">09062X103 / 78667J108 / 05464T104 / 74006W108</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / Axsome Therapeutics Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Zuranolone's WATERFALL Study Meets Primary Endpoint, FDA Filing To Be Discussed</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Why zuranolone data is GOOD for BIIB - remember, it's NOT in numbers</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - INVITE - Diving into the Complex Payer Dynamic for Biogen’s Aduhelm; KOL Call Tomorrow At 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">SAGE/BIIB: WATERFALL Crosses Finish Line, Though Close Result May Color NT Perception and Raise Questions On Commercial Oppty</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O / 78667J108 / SAGE.OQ</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">GSK Licensing Deal Hugely Validating for EOS-448 and TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">11012210 / 45337C10 / 71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / M2572210 / 09062X10 / 478160104 / 640268108 / 771195104 / 58933Y10 / 92337C10 / 04651310 / 75046920 / 00287Y10 / 98401F10 / ITOS.OQ / 58949210 / 09627Y10 / 07725L10 / G3910J11 / 81181C10 / K3967W10 / 46565G10 / 61776010 / 03969F10 / F5548N10 / 48111610</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Compugen Ltd / Biogen Inc / Johnson & Johnson / Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / Verastem Inc / Atara Biotherapeutics Inc / Radius Health Inc / Abbvie Inc / Xencor Inc / Iteos Therapeutics Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Beigene Ltd / GlaxoSmithKline PLC / Seagen Inc / Genmab A/S / Iteos Therapeutics Inc / MorphoSys AG / Arcus Biosciences Inc / Sanofi SA / Jounce Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Jeffrey La Rosa / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">When A WATERFALL Beats A MOUNTAIN</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.O / SAGE.O</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Zuranolone Hits HAMD Marginally On Day15 But Misses On Key Day42. AEs Higher On Zuranolone</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SAGE=US / BIIB=US / RLMD=US / AXSM=US</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc / Relmada Therapeutics Inc / Axsome Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 15 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US02553E1064 / US1005571070 / US16411R2085 / US22160K1051 / US2829141009 / US3647601083 / US4385161066 / US5002551043 / US55306N1046 / US6556641008 / US7782961038 / US8725401090 / US87612E1064 / US9311421039 / US21036P1084 / US09062X1037 / US55616P1049 / US90384S3031 / US30212P3038 / US5017971046 / US76680R2067 / US0994061002 / US29444U7000 / US90138F1021 / US26856L1035 / US87968A1043 / US23355L1061 / US65342K1051 / US8760301072 / US05351X1019 / US09857L1089 / KY30744W1070 / US39874R1014 / US4833791035 / US92537N1081 / CA36118A1003 / US56854Q2003 / US0090661010 / US55406W1036</td><td class="leftalignment">American Eagle Outfitters Inc / Boston Beer Company Inc / Cheniere Energy Inc / Costco Wholesale Corp / 8x8 Inc / Gap Inc / Honeywell International Inc / Kohls Corp / MKS Instruments Inc / Nordstrom Inc / Ross Stores Inc / TJX Companies Inc / Target Corp / Walmart Inc / Constellation Brands Inc / Biogen Inc / Macy's Inc / Ulta Beauty Inc / Expedia Group Inc / Bath & Body Works Inc / RingCentral Inc / Boot Barn Holdings Inc / Equinix Inc / Twilio Inc / elf Beauty Inc / Tellurian Inc / DXC Technology Co / NextDecade Corp / Tapestry Inc / Avaya Holdings Corp / Booking Holdings Inc / Farfetch Ltd / Grocery Outlet Holding Corp / Kaleyra Inc / Vertiv Holdings Co / Fusion Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Airbnb Inc / MYT Netherlands Parent BV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / MCD=US / OXY=US / RRC=US / WEN=US / DVN=US / INCY=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / PB=US / IGT=US / MGY=US / SWN=US / MUR=US / EWBC=US / BRO=US / BYD=US / UMPQ=US / MRO=US / EXPE=US / MGM=US / PENN=US / CBRL=US / CNX=US / DRI=US / EQIX=US / EQT=US / AJG=US / MCRI=US / PACW=US / REGI=US / TRIP=US / WAL=US / CVX=US / SGMS=US / BXS=US / BKNG=US / SNV=US / FBK=US / MKL=US / PRA=US / CATY=US / COP=US / DIN=US / PNFP=US / RRR=US / JRVR=US / BIIB=US / TCBI=US / FNB=US / CZR=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / GPRE=US / TAST=US / QSR=US / CLR=US / NMTR=US / NOG=US / JACK=US / KNSL=US / AR=US / ESTE=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / ABBV=US / NDLS=US / FATE=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / DEA=US / WING=US / ARGX=US / WLTW=US / CDEV=US / TRVG=US / PVAC=US / SBOW=US / HWC=US / OZK=US / RTLR=US / AHCO=US / OVV=US / ARQT=US / DKNG=US / ZI=US / BALY=US / ABNB=US / VMEO=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Devon Energy Corp / Incyte Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / East West Bancorp Inc / Brown & Brown Inc / Boyd Gaming Corp / Umpqua Holdings Corp / Marathon Oil Corp / Expedia Group Inc / MGM Resorts International / Penn National Gaming Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / Equinix Inc / EQT Corp / Arthur J Gallagher & Co / Monarch Casino & Resort Inc / PacWest Bancorp / Renewable Energy Group Inc / Tripadvisor Inc / Western Alliance Bancorp / Chevron Corp / Scientific Games Corp / Cadence Bank / Booking Holdings Inc / Synovus Financial Corp / FB Financial Corp / Markel Corp / ProAssurance Corp / Cathay General Bancorp / Conocophillips / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Red Rock Resorts Inc / James River Group Holdings Ltd / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / Caesars Entertainment Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / 9 Meters Biopharma Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Kinsale Capital Group Inc / Antero Resources Corp / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Easterly Government Properties Inc / Wingstop Inc / argenx SE / Willis Towers Watson PLC / Centennial Resource Development Inc / Trivago NV / Ranger Oil Corp / SilverBow Resources Inc / Hancock Whitney Corp / Bank Ozk / Rattler Midstream LP / Adapthealth Corp / Ovintiv Inc / Arcutis Biotherapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Bally's Corp / Airbnb Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HUM: MRA and Aduhelm Questions Remain, as HUM Discusses LT Strategy; Investor Day Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">HUM.N / CRM.N / IBM.N / MSFT.OQ / BIIB.OQ</td><td class="leftalignment">Humana Inc / Salesforce.Com Inc / International Business Machines Corp / Microsoft Corp / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. A.J. Rice / Alexander Khan / Robert Moon</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Phase III STAR Study Of BIIB111 In Choroideremia Fails, No Change To Estimates</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">No gold star for the BIIB111 STAR study — removing estimates</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">BIIB111 Missed in Choroideremia; No Change to Model</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Phase 3 choroideremia missed on primary endpoint, small opp'y; awaiting depression data</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Questions Remain But Downside Risk Should Be Limited. Initiating at Buy with a $110 PT.</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">803607100 / 09062X103 / 883556102 / 81621210</td><td class="leftalignment">Sarepta Therapeutics Inc / Biogen Inc / Thermo Fisher Scientific Inc / Selecta Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yun Zhong, PHD / Xu Zou</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Even Conservative Forecasts Suggest Strong Upside; Initiating at Buy with a $11 PT</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">03820J10 / 09062X103</td><td class="leftalignment">Applied Genetic Technologies Corp / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yun Zhong, PHD / Xu Zou</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 04, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / PFE=US / HD=US / GBT=US / BLD=US / INCY=US / LOW=US / ADS=US / LEG=US / VMC=US / MLM=US / SWIM=US / COLL=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / VRTX=US / WAL=US / AUTL=US / BDSI=US / OGN / BIIB=US / TPX=US / EXP=US / BECN=US / BLDR=US / GMS=US / PGTI=US / GPRE=US / AWI=US / OC=US / PRPL=US / APEI=US / ZTS=US / TREX=US / FBHS=US / MEIP=US / ABBV=US / TILE=US / PTCT=US / 00770K202 / 82982L103 / CRSP=US / JELD=US / FOCS=US / AXNX=US / FERG=US / ZI=US / AZEK=US / 67421J108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Home Depot Inc / Global Blood Therapeutics Inc / TopBuild Corp / Incyte Corp / Lowe's Companies Inc / Alliance Data Systems Corp / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Collegium Pharmaceutical Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Builders FirstSource Inc / GMS Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Purple Innovation Inc / American Public Education Inc / Zoetis Inc / Trex Company Inc / Fortune Brands Home & Security Inc / MEI Pharma Inc / Abbvie Inc / Interface Inc / PTC Therapeutics Inc / Aemetis Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / JELD-WEN Holding Inc / Focus Financial Partners Inc / Axonics Inc / Ferguson PLC / ZoomInfo Technologies Inc / Azek Company Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">To RSV or Not to RSV? Prevention Could Generate $10bn in Vaccine Sales 2030</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">G3910J11 / F5548N10 / 71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / 60770K10</td><td class="leftalignment">GlaxoSmithKline PLC / Sanofi SA / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">2000019 / 2050832 / 2045623 / 2065159 / 2216850 / 2270726 / 2542049 / 2670519 / 2328915 / 2342034 / 2455965 / 2613990 / 2471950 / 2707677 / 2799351 / 2829601 / 2931034 / B1F76F9 / B121557 / 2857817 / B02R1L6 / 2983563 / B3D7K31 / 2598246 / B7TL820 / BCBVTX1 / BBFL7S1 / B95N910 / BYVY8G0 / BP4GNK9 / BXDZ9Z0 / BDHF4K6 / BZ1LFB2 / BNFWR44 / BJ5FZ74 / BFMXGR0 / BJJMGL2 / BFXC911 / BKTNTR9 / BZ05388 / BYYWPW6 / BYY88Y7 / BKX9VD3 / BN4RD42 / BNTB3N8 / BJ9N563 / BNNTQY0</td><td class="leftalignment">Amazon.com Inc / Ameren Corp / ANSYS Inc / Autodesk Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Exelon Corp / Nextera Energy Inc / Fiserv Inc / Biogen Inc / Illumina Inc / Incyte Corp / Public Service Enterprise Group Inc / Sinclair Broadcast Group Inc / Southern Co / Vertex Pharmaceuticals Inc / Western Union Co / Mastercard Inc / Netflix Inc / ALLETE Inc / Carmax Inc / Discovery Inc / Neogenomics Inc / Meta Platforms Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / PTC Inc / Alphabet Inc / SAGE Therapeutics Inc / Shopify Inc / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / Worldline SA / Adaptive Biotechnologies Corp / Evergy Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Global Blood Therapeutics Inc / Beigene Ltd / Alphabet Inc / Arcutis Biotherapeutics Inc / CureVac NV / Vizio Holding Corp / Sunnova Energy International Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Our Payer Feedback Suggests Limited Ways to Stop Adu; PET/CSF Will Be Reimbursed, But Not Clear Who Pays and How Quickly</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Services Weekly Check-up: Post-Acute Care & Medical Staffing Outperform; Where is the Medical Cost Trend Headed in 2022?</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">CAH.N / CI.N / CNC.N / CVS.N / MCK.N / HUM.N / RAD.N / THC.N / UHS.N / SCI.N / UNH.N / HCA.N / CYH.N / ABC.N / MORR.AT / AMN.N / HCSG.OQ / AMED.OQ / CSV.N / SRCL.OQ / SEM.N / CCRN.OQ / BIIB.OQ / LHCG.OQ / MD.N / ADUS.OQ / ACHC.OQ / STON.N / ANTM.N / WBA.OQ / TDOC.N / EHC.N / AVAH.N</td><td class="leftalignment">Cardinal Health Inc / Cigna Corp / Centene Corp / CVS Health Corp / Mckesson Corp / Humana Inc / Rite Aid Corp / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / HCA Healthcare Inc / Community Health Systems Inc / Amerisourcebergen Corp / Motor Oil Hellas Corinth Refineries SA / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Carriage Services Inc / Stericycle Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / Biogen Inc / LHC Group Inc / MEDNAX Inc / Addus Homecare Corp / Acadia Healthcare Company Inc / Stonemor Inc / Anthem Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / Encompass Health Corp / Aveanna Healthcare Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Greece / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. A.J. Rice / Alexander Khan / Robert Moon</td></tr>
<tr class="even"><td class="leftalignment">06/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Updating model for higher Aduhelm pricing, EU approval could add ~$227/sh; PT goes to $647 from $458</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Reminder: Virtual Washington, D.C. Day - June 30, 2021; Full Agenda Now Available</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / UNH / WMT / AMGN.O / NOVN.S / RMD.N / HCA.N / CYH.N / INSP.N / EW.N / BCRX.OQ / ICPT.OQ / UTHR.OQ / BLUE.OQ / CCRN.O / ICAD.O / AMED.O / CGEN.O / BIIB.O / 00846U101 / 868168105 / MNKD.O / ATRC.OQ / LHCG.O / ENSG.OQ / 483548103 / TMDX.OQ / MD.N / 771195104 / ADUS.O / USPH.N / PRTA.OQ / FATE.OQ / GOOGL.O / MDWD.O / CASI.OQ / CLRB.OQ / VCEL.O / EVH.N / TDOC.N / APLS.OQ / 100063846 / IOVA.OQ / ALPN.O / VERU.OQ / KALA.O / ATNX.O / 720795103 / PDSB.OQ / ONCT.OQ / NBSE.O / PNTG.OQ / ETNB.O / REGW.M3 / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Amgen Inc / Novartis AG / Resmed Inc / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / bluebird bio Inc / Cross Country Healthcare Inc / ICAD Inc / Amedisys Inc / Compugen Ltd / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / MannKind Corp / AtriCure Inc / LHC Group Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / US Physical Therapy Inc / Prothena Corporation PLC / Fate Therapeutics Inc / Alphabet Inc / Mediwound Ltd / CASI Pharmaceuticals Inc / Cellectar Biosciences Inc / Vericel Corp / Evolent Health Inc / Teladoc Health Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / Iovance Biotherapeutics Inc / Alpine Immune Sciences Inc / Veru Inc / Kala Pharmaceuticals Inc / Athenex Inc / Pieris Pharmaceuticals Inc / PDS Biotechnology Corp / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / Pennant Group Inc / 89Bio Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 551</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : Alzheimer's Takes the aduHELM of the Biogen Growth Story...Rebuilding our Model Post Approval</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Encouraging new interim data for risdiplam from RAINBOWFISH in presymptomatic SMA</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PTCT=US / BIIB=US</td><td class="leftalignment">PTC Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Weekly Neurology Prescription Sales Tracker -- Week Ending 6/4/21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CCI.N / CNA.L / DFDS.CO / KBH.N / MAS.N / PHM.N / RWEG.DE / TOL.N / VOLVb.ST / AVB.N / DRE.N / FR.N / CMCSA.O / AMGN.O / AAL.L / DISH.O / EPR.N / LEN.N / AMT.N / CONE.O / RDN.N / DHI.N / FISV.O / V.N / CPT.N / CHTR.O / ARE.N / EGP.N / PLD.N / ESS.N / UDR.N / SUI.N / KRC.N / MAA.N / VTR.N / VRTX.O / CEY.L / ENAG.MC / APF.L / PNR.N / LTC.N / PEGA.OQ / AMH.N / GPN.N / JCOM.O / EQIX.O / BIIB.O / DLR.N / ELS.N / MPW.N / DISCA.O / FIS.N / ARWR.O / MA.N / 3IN.L / DAIGn.DE / HOCM.L / VALE.N / BHPB.L / CIO.N / GLEN.L / STAG.N / POLYP.L / TPH.N / TMHC.N / PRTA.O / DOC.N / CTLT.N / CTRE.O / 03835T200 / DEA.N / GBT.OQ / SQ.N / TWLO.N / UNIT.O / ORSTED.CO / COLD.N / ILPT.O / SMAR.N / DBX.O / OPI.OQ / ZM.O / FSLY.N / DOCU.N / PEAK.N / ETNB.O / DHC.O / SBSW.N / IGIC.OQ / WMG.OQ / FOUR.N / DCT.O / DFH.OQ / COUR.N</td><td class="leftalignment">Crown Castle International Corp / Centrica PLC / DFDS AS / KB Home / Masco Corp / Pultegroup Inc / Rwe AG / Toll Brothers Inc / Volvo AB / Avalonbay Communities Inc / Duke Realty Corp / First Industrial Realty Trust Inc / Comcast Corp / Amgen Inc / Anglo American PLC / DISH Network Corp / EPR Properties / Lennar Corp / American Tower Corp / CyrusOne Inc / Radian Group Inc / D R Horton Inc / Fiserv Inc / Visa Inc / Camden Property Trust / Charter Communications Inc / Alexandria Real Estate Equities Inc / Eastgroup Properties Inc / Prologis Inc / Essex Property Trust Inc / UDR Inc / Sun Communities Inc / Kilroy Realty Corp / Mid-America Apartment Communities Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Centamin PLC / Enagas SA / Anglo Pacific Group PLC / Pentair PLC / LTC Properties Inc / Pegasystems Inc / American Homes 4 Rent / Global Payments Inc / Ziff Davis Inc / Equinix Inc / Biogen Inc / Digital Realty Trust Inc / Equity LifeStyle Properties Inc / Medical Properties Trust Inc / Discovery Inc / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Mastercard Inc / 3I Infrastructure PLC / Daimler AG / Hochschild Mining PLC / Vale SA / BHP Group PLC / City Office REIT Inc / Glencore PLC / STAG Industrial Inc / Polymetal International PLC / Tri Pointe Homes Inc (Delaware) / Taylor Morrison Home Corp / Prothena Corporation PLC / Physicians Realty Trust / Catalent Inc / CareTrust REIT Inc / Aptose Biosciences Inc / Easterly Government Properties Inc / Global Blood Therapeutics Inc / Block Inc / Twilio Inc / Uniti Group Inc / Orsted A/S / Americold Realty Trust / Industrial Logistics Properties Trust / Smartsheet Inc / Dropbox Inc / Office Properties Income Trust / Zoom Video Communications Inc / Fastly Inc / DocuSign Inc / Healthpeak Properties Inc / 89Bio Inc / Diversified Healthcare Trust / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Warner Music Group Corp / Shift4 Payments Inc / Duck Creek Technologies Inc / Dream Finders Homes Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Germany / Denmark / Spain / United Kingdom / Ireland / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - Outperformに引き上げ：アルツハイマー型認知症治療薬Aduhelm承認、投資評価と目標株価引き上げ</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4523.T / 4519.T / CI.N / CVS.N / ROG.S / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Chugai Pharmaceutical Co Ltd / Cigna Corp / CVS Health Corp / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Upgrading to Outperform: Raise TP, upgrade on approval of Aduhelm for Alzheimer's disease</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4523.T / 4519.T / LLY.N / ROG.S / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Chugai Pharmaceutical Co Ltd / Eli Lilly and Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Will Biogen Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Short Interest Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AMGN.O / BIIB.O</td><td class="leftalignment">Amgen Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Outflows Lessen, but Continue to Drag On</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended June 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2026242 / 2219224 / 2216850 / 2280220 / 2670519 / 2328915 / 2342034 / 2455965 / 2707677 / 2138158 / 2829601 / 2895163 / 2503529 / B121557 / 2857817 / B02R1L6 / B3D7K31 / B7TL820 / BFLR866 / BFZCHN7 / BXDZ9Z0 / BD8DJ71 / BNFWR44 / BJ2Z0H2 / BFZ1K46 / BFMXGR0 / BDH65C8 / BYY88Y7 / BYXR425 / BKPGJQ1</td><td class="leftalignment">American Electric Power Company Inc / CMS Energy Corp / Consolidated Edison Inc / DTE Energy Co / Exelon Corp / Nextera Energy Inc / Fiserv Inc / Biogen Inc / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / United Natural Foods Inc / World Wrestling Entertainment Inc / Mastercard Inc / Netflix Inc / ALLETE Inc / Discovery Inc / Meta Platforms Inc / Twitter Inc / Wix.Com Ltd / Shopify Inc / Snap Inc / Worldline SA / Pinterest Inc / Spotify Technology SA / Evergy Inc / PetIQ Inc / Alphabet Inc / RH / Squarespace Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Samsung Biologics (207940.KS, Not Covered) - 2021 Asia Healthcare Corporate Day takeaways</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">207940.KS / LLY.N / GSK.L / BIIB.OQ / MRNA.OQ</td><td class="leftalignment">Samsung Biologics Co Ltd / Eli Lilly and Co / GlaxoSmithKline PLC / Biogen Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Managed Care: Leading MA Actuaries Discuss New Alzheimer's Drug; Offer Thoughts on 2022 MA Bid Process</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">CI.N / CNC.N / CVS.N / HUM.N / UNH.N / MORR.AT / BIIB.OQ / ANTM.N</td><td class="leftalignment">Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / UnitedHealth Group Inc / Motor Oil Hellas Corinth Refineries SA / Biogen Inc / Anthem Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Greece / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. A.J. Rice / Alexander Khan / Robert Moon</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Aduhelm Gives Biogen Its Groove Back</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - We Briefly Caught Up With Mgmt - Payer Dynamics Are Complex, But Verifying Amyloid Pathology (And Paying For It) Creates A Hurdle</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ASML.AS / AZO / HELE.O / INTC.O / LOW / MSFT.O / NVDA.O / SAPG.DE / HEAR.O / MPWR.O / AVGO.O / ATVI.OQ / TTWO.OQ / MRVL.OQ / ICAD.O / NFLX.O / BIIB.O / 459200101 / 36467W109 / TMDX.OQ / AMD.OQ / ZNGA.O / EA.O / 82655M107 / BILI.O / LOVE.OQ / FOCS.OQ / PDSB.OQ / PRPL.O / GRWG.O / HUYA.K</td><td class="leftalignment">ASML Holding NV / Autozone Inc / Helen of Troy Ltd / Intel Corp / Lowe's Companies Inc / Microsoft Corp / NVIDIA Corp / SAP SE / Turtle Beach Corp / Monolithic Power Systems Inc / Broadcom Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / Marvell Technology Inc / ICAD Inc / Netflix Inc / Biogen Inc / International Business Machines Corp / GameStop Corp / Transmedics Group Inc / Advanced Micro Devices Inc / Zynga Inc / Electronic Arts Inc / Sify Technologies Ltd / Bilibili Inc / Lovesac Co / Focus Financial Partners Inc / PDS Biotechnology Corp / Purple Innovation Inc / GrowGeneration Corp / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Germany / India / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">FR0000120073 / US0079031078 / US0091581068 / US02553E1064 / US0382221051 / US1264081035 / US1270971039 / US25179M1036 / US4581401001 / US5128071082 / US55306N1046 / US5951121038 / US6541061031 / US6558441084 / US67066G1040 / US6745991058 / US7237871071 / US75281A1097 / US8807701029 / US9078181081 / US9581021055 / CA1363751027 / US3448491049 / CA13645T1003 / US83088M1027 / US09062X1037 / US90385V1070 / US42809H1077 / US82706C1080 / US16115Q3083 / US64110D1046 / US2120151012 / US26884L1098 / US78454L1008 / NL0010273215 / US69327R1014 / US25278X1090 / US03674X1063 / US90184L1026 / US70432V1026 / US74736K1016 / US02079K1079 / US74624M1027 / US15136A1025 / KYG4740B1059 / US23355L1061 / US05351X1019 / US29260V1052 / US68373M1071 / KY30744W1070 / US89377M1099 / US69047Q1022 / US92537N1081 / US13123X5086 / US9663875089 / US55406W1036 / US03743Q1085 / US90364P1057 / US5738741041 / US30320C1036 / IE00BKVD2N49</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Advanced Micro Devices Inc / Air Products and Chemicals Inc / American Eagle Outfitters Inc / Applied Materials Inc / CSX Corp / Coterra Energy Inc / Devon Energy Corp / Intel Corp / Lam Research Corp / MKS Instruments Inc / Micron Technology Inc / Nike Inc / Norfolk Southern Corp / NVIDIA Corp / Occidental Petroleum Corp / Pioneer Natural Resources Co / Range Resources Corp / Teradyne Inc / Union Pacific Corp / Western Digital Corp / Canadian National Railway Co / Foot Locker Inc / Canadian Pacific Railway Ltd / Skyworks Solutions Inc / Biogen Inc / Ultra Clean Holdings Inc / Hess Corp / Silicon Motion Technology Corp / Chart Industries Inc / NetApp Inc / Continental Resources Inc / EQT Corp / SM Energy Co / ASML Holding NV / PDC Energy Inc / Diamondback Energy Inc / Antero Resources Corp / Twitter Inc / Paycom Software Inc / Qorvo Inc / Alphabet Inc / Pure Storage Inc / Centennial Resource Development Inc / Ichor Holdings Ltd / DXC Technology Co / Avaya Holdings Corp / Endava PLC / Opera Ltd / Farfetch Ltd / Transmedics Group Inc / Ovintiv Inc / Vertiv Holdings Co / Callon Petroleum Co / Whiting Petroleum Corp / MYT Netherlands Parent BV / APA Corp (US) / UiPath Inc / Marvell Technology Inc / FTC Solar Inc / Seagate Technology Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">V / 0989529 / 0925288 / 2126335 / 2000019 / 2023607 / 2778844 / 2973821 / 2026242 / 2219224 / 2270726 / 2829515 / 2317087 / 2342034 / 2455965 / 2471950 / 2689560 / 2680905 / 2684703 / 2705198 / 2707677 / 2829601 / 4595739 / 7103065 / B02R1L6 / B7TL820 / BBFL7S1 / B7VD3F2 / BFLR866 / BYVY8G0 / BYZLV46 / BXDZ9Z0 / BNFWR44 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BN7K304 / BMHR7K6</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Edison International / Entergy Corp / Fiserv Inc / Biogen Inc / Incyte Corp / PG&E Corp / PPL Corp / Pfizer Inc / Progress Software Corp / Public Service Enterprise Group Inc / Southern Co / Genmab A/S / Novartis AG / ALLETE Inc / Meta Platforms Inc / bluebird bio Inc / Duke Energy Corp / Twitter Inc / Alphabet Inc / InflaRx NV / Shopify Inc / Worldline SA / Evergy Inc / ViacomCBS Inc / Roku Inc / Academy Sports and Outdoors Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">The Pubmed Times―Interplay of Astrocytic APOE4 and Microglial TREM2 in Tau-Mediated Neurodegeneration</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB / 24823R105 / 014442107</td><td class="leftalignment">Biogen Inc / Denali Therapeutics Inc / Alector Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Cayman Islands / Germany / Denmark / France / United Kingdom / Greece / Ireland / Israel / Italy / Netherlands / Norway / Singapore / Sweden / Taiwan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Holds online briefing on approval of Aduhelm for Alzheimer's; may not fully penetrate clinical setting until 2022 or thereafter</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / CI.N / CVS.N / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Cigna Corp / CVS Health Corp / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - アルツハイマー型認知症治療薬ADUHELM承認についてオンライン説明会開催、治療現場への本格浸透は2022年以降となろう</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / CI.N / CVS.N / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Cigna Corp / CVS Health Corp / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Launch Plans Debunk Misleading Aduhelm Myths</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Medicare Likely to Cover Aducanumab, NCD Possible; Ups Chance Of Part B Demos</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Eric Assaraf / Rick Weissenstein / Mr. Phil M. Nadeau, Ph.D., PHD</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - With Aduhelm Approved Broadly for Alzheimer's, BIIB Looks Poised to Make Billions; Investor Focus Shifting to Launch/Payer Dynamics; PT to $455</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US1101221083 / US1266501006 / US4448591028 / US75886F1075 / US09062X1037 / US0042251084 / US15135B1017 / US42226A1079 / US0367521038 / US05464T1043 / US0327973006 / US24823R1059 / US1255231003</td><td class="leftalignment">Bristol-Myers Squibb Co / CVS Health Corp / Humana Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Centene Corp / Healthequity Inc / Anthem Inc / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Denali Therapeutics Inc / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Aduhelm Ready to Launch</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">If You Build It, Will They Come? We're Still Skeptical</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">More Commercial Questions Than Answers After Aduhelm Investor Call</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Biogen Discusses Plans For Aduhelm's Launch</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Impossible to Deny the Market Opportunity for Aduhelm; Upgrading Rating to Outperform</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Jun. 08, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pricing $56K/yr but gross margins and GTN are key questions</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">DRI / INTC.O / QCOM.O / AAPL.O / RMD.N / INSP.N / LSCC.O / SMTC.O / AYI / AVGO.O / MRVL.OQ / BLUE.OQ / TEAM.O / CGEN.O / BIIB.O / AMD.OQ / PRTA.OQ / GOOGL.O / CLRB.OQ / COUP.O / TWLO.K / CVNA.N / VERU.OQ / ROKU.O / ONCT.OQ / LMND.K / REGW.M3 / 03823M100</td><td class="leftalignment">Darden Restaurants Inc / Intel Corp / Qualcomm Inc / Apple Inc / Resmed Inc / Inspire Medical Systems Inc / Lattice Semiconductor Corp / Semtech Corp / Acuity Brands Inc / Broadcom Inc / Marvell Technology Inc / bluebird bio Inc / Atlassian Corporation PLC / Compugen Ltd / Biogen Inc / Advanced Micro Devices Inc / Prothena Corporation PLC / Alphabet Inc / Cellectar Biosciences Inc / Coupa Software Inc / Twilio Inc / Carvana Co / Veru Inc / Roku Inc / Oncternal Therapeutics Inc / Lemonade Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / INCY=US / TEVA=US / MTN=US / LOW=US / PB=US / CHRS=US / LEG=US / VMC=US / MLM=US / AIR=US / SWIM=US / CBRL=US / CSTR=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / PACW=US / REGN=US / REGI=US / FOUR=US / CGEN=US / FMBI=US / SNV=US / SIVB=US / ABCB=US / FBK=US / SSB=US / RF=US / FFIN=US / GBCI=US / DIN=US / PNFP=US / SBCF=US / BIIB=US / TPX=US / EXP=US / BDC=US / BECN=US / PLAY=US / RNST=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / IBTX=US / NDLS=US / FATE=US / 00770K202 / COUP=US / LOCO=US / HQY=US / SHAK=US / WING=US / ARGX=US / ACBI=US / SQ=US / 82982L103 / TVTY=US / JELD=US / SFIX=US / HWC=US / BTAI=US / LSPD=US / FERG=US / OPCH=US / ARQT=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Vail Resorts Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / AAR Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Shift4 Payments Inc / Compugen Ltd / First Midwest Bancorp Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / SouthState Corp / Regions Financial Corp / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Wingstop Inc / argenx SE / Atlantic Capital Bancshares Inc / Block Inc / SiteOne Landscape Supply Inc / Tivity Health Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Hancock Whitney Corp / BioXcel Therapeutics Inc / Lightspeed Commerce Inc / Ferguson PLC / Option Care Health Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Adult Vaccinations Near 65% as Record Lows Extend Across Key COVID-19 Metrics Domestically; Broad Global Declines Continue</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2973821 / 2065159 / 2216850 / 2270726 / 2542049 / 2829515 / 2576941 / 2328915 / 2455965 / 2457864 / 2689560 / 2684703 / 2048804 / 2705198 / 2707677 / 2730190 / 2138158 / 2829601 / 7103065 / B02R1L6 / B7TL820 / BBFL7S1 / BBGVT40 / BYVY8G0 / BP4GNK9 / BYNZGK1 / BJ2Z0H2 / BMQ5T49 / BFMXGR0 / BFNR303 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BDVLM39 / BP8XZL1 / BMG5660</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Alliant Energy Corp / Autodesk Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Exelixis Inc / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Progress Software Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / Novartis AG / ALLETE Inc / Meta Platforms Inc / bluebird bio Inc / News Corp / Alphabet Inc / SAGE Therapeutics Inc / Block Inc / Pinterest Inc / Zentalis Pharmaceuticals Inc / Evergy Inc / Northwest Natural Holding Co / ViacomCBS Inc / Roku Inc / Alphabet Inc / argenx SE / Healthequity Inc / Joann Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">All's Well That Ends Well for Aducanumab; PT to $452</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB / PRTA.OQ / 24823R105 / 014442107 / H00263105</td><td class="leftalignment">Biogen Inc / Prothena Corporation PLC / Denali Therapeutics Inc / Alector Inc / AC Immune SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Aduhelm Approval Shines A Light On OPCH's Attractive Model And Strong Positioning</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">OPCH=US / BIIB=US</td><td class="leftalignment">Option Care Health Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David S. MacDonald / Tom Buckley</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALB.N / BATS.L / CCK.N / CNA.L / CWK.L / DFDS.CO / DGE.L / EL.N / IBE.MC / KMB.N / KO.N / L.TO / MRK.N / RENA.PA / PEP.N / VOWG_p.DE / BFb.N / PG.N / CONG.DE / WY.N / CFP.TO / CPB.N / LPX.N / ENB.TO / CSX.N / UNP.N / CLX.N / CAG.N / GIS.N / EPC.N / OI.N / BLL.N / SGMO.O / MDRX.O / STZ.N / ADSK.O / SLGN.O / ALU.AX / TYL.N / HOOK.O / ICPT.O / ATDb.TO / EMPA.TO / BIIB.O / RUS.TO / SAP.TO / MFI.TO / 02209S103 / NESN.S / ACAD.O / WEF.TO / SJW.N / BVIC.L / ATL.MI / DAIGn.DE / GETP.PA / PCH.O / CFX.TO / IFP.TO / RFP.N / SRPT.O / MDLZ.OQ / BERY.N / PRTA.O / KPTI.O / XNCR.OQ / ITCI.O / COUP.N / FLXN.O / HQY.OQ / GWB.N / AXTA.N / FEVR.L / CTRE.O / WBA.N / 78667J108 / SGRY.O / IONS.O / RACE.MI / IMB.L / TRHC.OQ / ATZ.TO / ADNT.N / STLC.TO / EAF.N / ITRM.O / PRVB.O / LSPD.TO / 269796108 / MNRL.N / KRTX.OQ / SLQT.N / ALOO.O / WFG.N / NAPA.N / TSP.OQ</td><td class="leftalignment">Albemarle Corp / British American Tobacco PLC / Crown Holdings Inc / Centrica PLC / Cranswick PLC / DFDS AS / Diageo PLC / Estee Lauder Companies Inc / Iberdrola SA / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / Merck & Co Inc / Renault SA / PepsiCo Inc / Volkswagen AG / Brown-Forman Corp / Procter & Gamble Co / Continental AG / Weyerhaeuser Co / Canfor Corp / Campbell Soup Co / Louisiana-Pacific Corp / Enbridge Inc / CSX Corp / Union Pacific Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / O-I Glass Inc / Ball Corp / Sangamo Therapeutics Inc / Allscripts Healthcare Solutions Inc / Constellation Brands Inc / Autodesk Inc / Silgan Holdings Inc / Altium Ltd / Tyler Technologies Inc / HOOKIPA Pharma Inc / Intercept Pharmaceuticals Inc / Alimentation Couche-Tard Inc / Empire Company Ltd / Biogen Inc / Russel Metals Inc / Saputo Inc / Maple Leaf Foods Inc / Altria Group Inc / Nestle SA / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / SJW Group / Britvic PLC / Atlantia SpA / Daimler AG / Getlink SE / Potlatchdeltic Corp / Canfor Pulp Products Inc / Interfor Corp / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Mondelez International Inc / Berry Global Group Inc / Prothena Corporation PLC / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Coupa Software Inc / Pacira Biosciences Inc / Healthequity Inc / Great Western Bancorp Inc / Axalta Coating Systems Ltd / Fevertree Drinks PLC / CareTrust REIT Inc / Walgreens Boots Alliance Inc / SAGE Therapeutics Inc / Surgery Partners Inc / Ionis Pharmaceuticals Inc / Ferrari NV / Imperial Brands PLC / Tabula Rasa HealthCare Inc / Aritzia Inc / Adient PLC / Stelco Holdings Inc / GrafTech International Ltd / Iterum Therapeutics PLC / Provention Bio Inc / Lightspeed Commerce Inc / Eagle Pharmaceuticals Inc / Brigham Minerals Inc / Karuna Therapeutics Inc / SelectQuote Inc / Allogene Therapeutics Inc / West Fraser Timber Co Ltd / Duckhorn Portfolio Inc / TuSimple Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Italy / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">'Wild West' - KOL Call Reflects Hope But Also Perplexity on Adu Use; Tgt To $400 On Broad Approval</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Thoughts On The Most Meaningful Aducanumab Approval Reverberations In The Sector</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ICPT.O / BIIB.O / ACAD.O / SRPT.O / PRTA.O / ITCI.O / 78667J108 / IONS.O / ITRM.O / PRVB.O</td><td class="leftalignment">Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Prothena Corporation PLC / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Ionis Pharmaceuticals Inc / Iterum Therapeutics PLC / Provention Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Kennen MacKay, PHD / David Szeto / Leonid Timashev / Stephen Mallon / Yinglu Zhang / Lisa Walter</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: Read across for Roche, Lonza & Grifols on aducanumab approval in Alzheimer's disease</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GRLS.MC / LONN.S / ROG.S / 4502.T / 4519.T / 4523.T / CSL.AX / BIIB.OQ</td><td class="leftalignment">Grifols SA / Lonza Group AG / Roche Holding AG / Takeda Pharmaceutical Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / CSL Ltd / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Spain / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Jiangsu Hengrui Medicine Co. Ltd: Read through of FDA approval of aducanumab to China AD market and Hengrui. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">600276.SS / BIIB.OQ</td><td class="leftalignment">Jiangsu Hengrui Pharmaceuticals Co Ltd / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Accelerated US approval of Alzheimer's drug Aduhelm (aducanumab)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - 米国でアルツハイマー型認知症治療薬ADUHELM（アデュカヌマブ）迅速承認を取得</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from the Aducanumab KOL Pulse Call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Biogen : Catalyst Comes in BIIB's Favor; Now What?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">FIXED INCOME - CORPORATES</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: BIIB's Broad Aduhelm Label a Positive Surprise for BIIB, and a Potentially Positive Development for LLY and Other Biotechs; PT Raised to $246/shr</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.OQ / 2516152 / 2455965</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Disease-Modifying Therapy for Alz’s – End of the Beginning, with Several Cov’g Programs Gaining Traction</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / DNLI.O / BIIB.O / ACAD.O / PRTA.O / AVXL.O / AXSM.O / SAVA.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Denali Therapeutics Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Prothena Corporation PLC / Anavex Life Sciences Corp / Axsome Therapeutics Inc / Cassava Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Alz Dis Approval Puts New Captain at the Helm, but Platform Could Deliver Improved Drug for the Future World; Raise PT</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PRTA.OQ / US09062X1037</td><td class="leftalignment">Prothena Corporation PLC / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : Biogen Gets 'er Dunn...Adu Approved for Alzheimer's in Landmark FDA Decision</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 28, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB, LLY, ROG: Aducanumab approved, BROAD ramifications – see our category forecasts here</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">09062X103 / 532457108 / ROG.S / 7110388</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Roche Holding AG / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">NKE / BIIB.O / LULU.O / UAA</td><td class="leftalignment">Nike Inc / Biogen Inc / Lululemon Athletica Inc / Under Armour Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">7 points on aducanumab approval</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Register: Virtual Washington, D.C. Day - June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">AduCANumab: FDA Grants Accelerated Approval. A Required Triplet of PET Scans Seems Not Too Bad. Price of $56k May Lead to Negotiations.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103 / 92915B106 / 24823R105</td><td class="leftalignment">Biogen Inc / Voyager Therapeutics Inc / Denali Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Ms. Kaveri Pohlman</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">No more waiting for adu as FDA approves product; reiterate BUY as BIIB can play more offense now</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sumant Kulkarni</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Introducing Aduhelm</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Upgrade: Aduhelm Approval Likely To Return Biogen To Growth</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Adu Priced At $56K/Year Vs. Our $50K Est; BIIB Est 1-2MM Addressable Patients With Amyloid Pathology, Implying A $50-100B TAM</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB: Daring Price Point for Adu Could Multiply Opportunity, but May Very Well Come Back to Bite BIIB - And Biopharma</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Too Late For Sanctimony; Aduhelm Commecial Story Now Comes Into Focus</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">FDA Finds a Way; Accelerated Approval of Aducanumab With Broad Label Boosts Biogen’s Outlook</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Big News with Adu Approval</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB: FDA Threads Needle, Approving Adu On Conditional Basis But With Broad, Favorable Label, Major Win For BIIB</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Best-Case Scenario Label For Aduhelm, Broad Label, No Requirement For A New MRI and No REMS</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">So, This Is Actually Happening... Aduhelm (Aducanumab) Approved</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">BIIB - for the win - aducanumab is here</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Aduhelm label does not have language restricting to a subpopulation</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Aducanumab (now Aduhelm) Approved Under Accelerated Pathway for Treatment of Alzheimer's Disease</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Adu approved as we expected; awaiting label</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Glued to Our Screens Today: Our Latest Views on Time-of-Day of an Aduhelm Announcement, Scenarios</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">FISV=US / MRK=US / LLY=US / PEP=US / AMGN=US / CAG=US / KO=US / CL=US / PG=US / T=US / INCY=US / GILD=US / ENR=US / MANH=US / NWL=US / FLO=US / STZ=US / PATH=US / ENV=US / CENT=US / CHD=US / COLL=US / EPC=US / HAIN=US / REGN=US / SMG=US / FOUR=US / POST=US / GPN=US / SNV=US / AUTL=US / MGNI=US / MGPI=US / BDSI=US / MNST=US / NOMD=US / BIIB=US / FRPT=US / DENN=US / THS=US / FIS=US / ELF=US / TIL=US / AAN=US / UTZ=US / OLO=US / MEIP=US / ABBV=US / FATE=US / COUP=US / SQ=US / NTLA=US / IOVA=US / PETQ=US / EQH=US / KDP=US / BTAI=US / HARP=US / LSPD=US / RPAY=US / BRBR=US / GMAB=US / REYN=US / ZI=US / BIGC=US / HYFM=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Conagra Brands Inc / Coca-Cola Co / Colgate-Palmolive Co / Procter & Gamble Co / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Energizer Holdings Inc / Manhattan Associates Inc / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / UiPath Inc / Envestnet Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Edgewell Personal Care Co / Hain Celestial Group Inc / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Shift4 Payments Inc / Post Holdings Inc / Global Payments Inc / Synovus Financial Corp / Autolus Therapeutics PLC / Magnite Inc / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Nomad Foods Ltd / Biogen Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Fidelity National Information Services Inc / elf Beauty Inc / Instil Bio Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / Coupa Software Inc / Block Inc / Intellia Therapeutics Inc / Iovance Biotherapeutics Inc / PetIQ Inc / Equitable Holdings Inc / Keurig Dr Pepper Inc / BioXcel Therapeutics Inc / Harpoon Therapeutics Inc / Lightspeed Commerce Inc / Repay Holdings Corp / Bellring Brands Inc / Genmab A/S / Reynolds Consumer Products Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Luxembourg / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2000019 / 2023607 / 2778844 / 2216850 / 2280220 / 2317087 / 2576941 / 2328915 / 2455965 / 2457864 / 2471950 / 2689560 / 2048804 / 2707677 / 2829601 / 2712013 / B1HMF22 / B03L311 / 2857817 / B125XQ6 / B1GKCH1 / B02R1L6 / B3D7K31 / B1XGNW4 / B0796X4 / B7TL820 / BCZS820 / BFDV8K0 / BBPK0J0 / B95N910 / BDZCRX3 / B424494 / B59DK93 / BFZCHN7 / BTN1Y11 / B6XZN93 / BXDZ9Z0 / BFZNYB7 / BD9GVY0 / BZBY005 / BFXCLC6 / BZ1LFB2 / BD8DJ71 / BQT3XY6 / BJLKVS6 / BYQNYR5 / BR4T3B3 / BMQ5T49 / BKVDFF7 / BLGJ610 / BFMXGR0 / BGSP7M9 / BYYWPW6 / BZ1LFG7 / BWY52P3 / BYY88Y7 / BL71K91 / BWY4XV3 / BN2R582 / BMDCDP2 / BGJRH57 / BYP0CD9 / BMDJ085 / BMDJ397 / BLP5YB5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Consolidated Edison Inc / DTE Energy Co / Entergy Corp / Exelixis Inc / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / Incyte Corp / PG&E Corp / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Southern Co / Global Payments Inc / First Solar Inc / Ormat Technologies Inc / Netflix Inc / Portland General Electric Co / Canadian Solar Inc / ALLETE Inc / Discovery Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / Fate Therapeutics Inc / MacroGenics Inc / Mirati Therapeutics Inc / PTC Inc / RingCentral Inc / Splunk Inc / SunPower Corp / Wix.Com Ltd / Medtronic PLC / Brookfield Renewable Partners LP / Shopify Inc / Allogene Therapeutics Inc / Zai Lab Ltd / Merus NV / Elastic NV / Deciphera Pharmaceuticals Inc / Snap Inc / Cyberark Software Ltd / Phathom Pharmaceuticals Inc / Senseonics Holdings Inc / HubSpot Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Warner Music Group Corp / Evergy Inc / Zoom Video Communications Inc / Beigene Ltd / Roku Inc / Blueprint Medicines Corp / Alphabet Inc / Revolution Medicines Inc / Adaptimmune Therapeutics PLC / Relay Therapeutics Inc / Bigcommerce Holdings Inc / Clearway Energy Inc / Avangrid Inc / Shoals Technologies Group Inc / Bolt Biotherapeutics Inc / Atlantica Sustainable Infrastructure PLC</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Senolytics Platform Offers Novel Targets Within Retinopathies; Initiating With Buy Rating and $12 PT</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">UBX.OQ / BIIB / 75886F107 / 00771V108 / 67576A100 / RZLT.OQ / 00810B105 / 67577C105 / CGEM.OQ</td><td class="leftalignment">UNITY Biotechnology Inc / Biogen Inc / Regeneron Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Ocular Therapeutix Inc / Rezolute Inc / Aadi Bioscience Inc / Ocugen Inc / Cullinan Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">China / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew S. Fein / Matthew Caufield / Andres Y. Maldonado, PhD / Ananda Ghosh, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Managed Care: Further Perspective on Biogen's Alzheimer's Drug and Its Potential Impact on MCOs</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB.OQ / CI.N / CNC.N / CVS.N / HUM.N / UNH.N / MORR.AT / ANTM.N</td><td class="leftalignment">Biogen Inc / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / UnitedHealth Group Inc / Motor Oil Hellas Corinth Refineries SA / Anthem Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Greece / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. A.J. Rice / Alexander Khan / Robert Moon</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Managed Care: FDA Approves Biogen Alzheimer's Drug; No Change to MCO Estimates</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / HUM.N</td><td class="leftalignment">Biogen Inc / Humana Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. A.J. Rice / Alexander Khan / Robert Moon</td></tr>
<tr class="odd"><td class="leftalignment">06/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - The AGS Recommends Against Adu Approval, But We Don't Think The FDA Is Going To Change Its Decision</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 550</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">FR0000120073 / DE0006231004 / US0079031078 / US0091581068 / US0530151036 / US0970231058 / US1005571070 / US1264081035 / US1727551004 / US1924461023 / US22284P1057 / US2310211063 / US2371941053 / US2545431015 / US3021301094 / US3377381088 / US4433201062 / US4456581077 / US4567881085 / US4581401001 / US4663671091 / US5150981018 / US5324571083 / US5801351017 / US6558441084 / US67066G1040 / US6795801009 / US7043261079 / US8552441094 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / US37940X1028 / US9884981013 / US21036P1084 / US09062X1037 / US1572101053 / US25754A2015 / US0042251084 / US02043Q1076 / US60871R2094 / US12541W2098 / US31620M1062 / US1696561059 / US78709Y1055 / US75025X1000 / US16115Q3083 / US3020811044 / US92932M1018 / US87874R1005 / BMG3922B1072 / IE00B4BNMY34 / US58933Y1055 / US95058W1009 / US29414B1044 / US9837931008 / US98978V1035 / US72919P2020 / KYG037AX1015 / US70438V1061 / US70432V1026 / US03937C1053 / US98936J1016 / LU0974299876 / US0465131078 / US64829B1008 / CA76131D1033 / US8190471016 / US00653A1079 / US9741551033 / US70450Y1038 / US05464T1043 / US8522341036 / US00773U1088 / US90138F1021 / US2067871036 / CA87241L1094 / CA35805P1071 / US23753F1075 / US23355L1061 / US80689H1023 / US03782L1017 / US4990491049 / US89854H1023 / US15677J1088 / US46571Y1073 / US2575541055 / US0937121079 / US29260V1052 / US28414H1032 / US0197701065 / IE00BZ12WP82 / US0144421072 / US09203E1055 / US39813G1094 / CH0499880968 / US90364P1057 / US92719V1008</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Infineon Technologies AG / Advanced Micro Devices Inc / Air Products and Chemicals Inc / Automatic Data Processing Inc / Boeing Co / Boston Beer Company Inc / CSX Corp / Cirrus Logic Inc / Cognizant Technology Solutions Corp / Covenant Logistics Group Inc / Cummins Inc / Darden Restaurants Inc / Diodes Inc / Expeditors International of Washington Inc / Fiserv Inc / Hub Group Inc / J B Hunt Transport Services Inc / Infosys Ltd / Intel Corp / Jack in the Box Inc / Landstar System Inc / Eli Lilly and Co / McDonald's Corp / Norfolk Southern Corp / NVIDIA Corp / Old Dominion Freight Line Inc / Paychex Inc / Starbucks Corp / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Global Payments Inc / Yum! Brands Inc / Constellation Brands Inc / Biogen Inc / CEVA Inc / Domino's Pizza Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Molson Coors Beverage Co / CH Robinson Worldwide Inc / Fidelity National Information Services Inc / Chipotle Mexican Grill Inc / Saia Inc / Radiant Logistics Inc / Chart Industries Inc / Exlservice Holdings Inc / WNS (Holdings) Ltd / TechTarget Inc / Genpact Ltd / Accenture PLC / Merck & Co Inc / Wendys Co / Epam Systems Inc / XPO Logistics Inc / Zoetis Inc / Plug Power Inc / Ambarella Inc / Paylocity Holding Corp / Paycom Software Inc / ArcBest Corp / Zendesk Inc / Globant SA / Atara Biotherapeutics Inc / New Relic Inc / Restaurant Brands International Inc / Shake Shack Inc / Adaptimmune Therapeutics PLC / Wingstop Inc / PayPal Holdings Inc / Axsome Therapeutics Inc / Block Inc / Adverum Biotechnologies Inc / Twilio Inc / Conduent Inc / TFI International Inc / Freshii Inc / Daseke Inc / DXC Technology Co / Schneider National Inc / Appian Corp / Knight-Swift Transportation Holdings Inc / TTEC Holdings Inc / Ceridian HCM Holding Inc / I3 Verticals Inc / Domo Inc / Bloom Energy Corp / Endava PLC / Elanco Animal Health Inc / Allogene Therapeutics Inc / Linde PLC / Alector Inc / Black Diamond Therapeutics Inc / Grid Dynamics Holdings Inc / ADC Therapeutics SA / UiPath Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Germany / France / United Kingdom / India / Ireland / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">If BIIB gets approval, BTAI could be hot</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB.OQ / BTAI=US / BIIB=US</td><td class="leftalignment">Biogen Inc / BioXcel Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACA / AMN / CHE / CI / CNC / CVS / HUM / RAD / UNH / WMT / GILD.O / AMGN.O / HCA.N / CYH.N / COO.N / ICPT.OQ / UTHR.OQ / VRTX.OQ / CCRN.O / LIFE.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / DXCM.O / LHCG.O / ALCLS.PA / 02043Q107 / ENSG.OQ / TNDM.O / 483548103 / MRNA.O / TMDX.OQ / MD.N / 771195104 / ADUS.O / USPH.N / PRTA.OQ / TRVN.O / GOOGL.O / INO.O / VBLT.O / CATB.OQ / EVH.N / TDOC.N / 100063846 / IRTC.OQ / ATXI.OQ / 720795103 / ALLO.OQ / 21833P103 / BWAY.TA / ONCT.OQ / PSNL.O / NBSE.O / BXRX.OQ / ETNB.O / ORIC.OQ / HGEN.O / REGW.M3 / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Rite Aid Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / HCA Healthcare Inc / Community Health Systems Inc / Cooper Companies Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / Dexcom Inc / LHC Group Inc / Cellectis SA / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Kaman Corp / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Addus Homecare Corp / US Physical Therapy Inc / Prothena Corporation PLC / Trevena Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Astria Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Truist Financial Corp / iRhythm Technologies Inc / Avenue Therapeutics Inc / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Brainsway Ltd / Oncternal Therapeutics Inc / Personalis Inc / NeuBase Therapeutics Inc / Baudax Bio Inc / 89Bio Inc / Oric Pharmaceuticals Inc / Humanigen Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 5/28/21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Hope in Novel Mechanisms for ALS</td><td class="leftalignment">English</td><td class="rightalignment">59</td><td class="leftalignment">09062X10 / G1119610</td><td class="leftalignment">Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Yumanity’s Three-Prong Drug Discovery Engine―A Force to Reckon With; Initiate with Buy and $39 PT</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">YMTX.OQ / BIIB / PRTA.OQ / 24823R105 / H00263105</td><td class="leftalignment">Yumanity Therapeutics Inc / Biogen Inc / Prothena Corporation PLC / Denali Therapeutics Inc / AC Immune SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Hone, Seek, Target and Destroy Disease-Causing Proteins Using TORPEDO; Initiate With Buy and $63 PT</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">CCCC.OQ / BIIB / 92532F100 / 09627Y109 / 04335A105 / KYMR.OQ</td><td class="leftalignment">C4 Therapeutics Inc / Biogen Inc / Vertex Pharmaceuticals Inc / Blueprint Medicines Corp / Arvinas Inc / Kymera Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Andres Y. Maldonado, PhD / Matthew Caufield / Ananda Ghosh, PhD</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / ANA.MC / BP.L / CAS.TO / CMS.N / CNA.L / ED.N / EDP.LS / ENI.MI / HTG.L / IBE.MC / NA / NVA.TO / PD.N / PD.TO / PEG.N / PMO.L / RYN.N / SGEF.PA / SO.N / TOTF.PA / SSE.L / ACI.N / AMZN.O / WY.N / PXD.N / CNQ.TO / GILD.O / WLL.N / TA.TO / INCY.O / ETR.N / CLS.N / FE.N / TRP.TO / IMO.TO / SU.TO / BTE.TO / VLO.N / MRO.N / PCG.N / DVN.N / XEL.N / STZ.N / RRC.N / EQT.N / EXPE.O / DG.N / NBIX.O / NWN.N / POU.TO / PVH.N / ESI.TO / VRTX.O / CVX.N / SRG.MI / SM.N / PSI.TO / COP.N / CNP.N / CPE.N / ENDP.O / BLU.N / BKH.N / CPK.N / PNR.N / SWN.N / SR.N / CRC.N / HOOK.O / ORLY.O / BCRX.O / ICPT.O / BIIB.O / CFW.TO / TXRH.O / ACAD.O / NESTE.HE / SJW.N / DRX.L / SES.TO / BLX.TO / TEVA.N / GALP.LS / BIR.TO / PRTS.OQ / CLR.N / PPL.TO / LULU.O / RENE.LS / INO.OQ / INE.TO / BIP.N / NOG.A / ARX.TO / PHR.N / CLW.N / CPG.TO / AAV.TO / CVE.TO / CEU.TO / ATH.TO / MEG.TO / VET.TO / WCP.TO / B44XTX8 / TOU.TO / PCH.O / ERF.TO / FRU.TO / PEY.TO / PKI.TO / NPI.TO / KEY.TO / CTT.N / GEI.TO / MTDR.N / TVE.TO / RFP.N / SRPT.O / FIVE.OQ / FANG.O / ABBV.N / KPT.TO / KEL.TO / PRMW.N / ENTA.O / PTCT.O / BEP.N / KPTI.O / XNCR.OQ / ITCI.O / PSK.TO / BMEB.L / LXE.V / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / ZG.O / TWM.TO / SCWX.O / PARR.N / AZRE.N / AQN.N / PVAC.O / GREG.MC / CDEV.O / CVNA.N / ESTE.N / VST.N / OVID.O / RDFN.O / CARG.O / AY.O / SDRY.L / BKNG.O / AMRX.N / ITRM.O / PRVB.O / FLMN.OQ / CWEN.N / ESLX.PA / GMDA.OQ / PIPE.V / LYFT.O / NBSE.OQ / UBER.N / MNRL.N / KRTX.OQ / MORF.OQ / CRWD.O / APRE.OQ / IGMS.O / ETNB.O / OAS.OQ / OVV.N / WTRG.N / LUNE.ST / APA.OQ / ASAN.N / SPRB.OQ / MTCR.O / SUMO.O / TPZ.TO / VTRS.OQ / ABNB.OQ / DASH.N / CHK.OQ / TSP.OQ / 120385055 / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Acciona SA / BP PLC / Cascades Inc / CMS Energy Corp / Centrica PLC / Consolidated Edison Inc / EDP Energias de Portugal SA / Eni SpA / Hunting PLC / Iberdrola SA / National Bank of Canada / Nuvista Energy Ltd / PagerDuty Inc / Precision Drilling Corp / Public Service Enterprise Group Inc / Harbour Energy PLC / Rayonier Inc / Vinci SA / Southern Co / TotalEnergies SE / SSE PLC / Albertsons Companies Inc / Amazon.com Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Whiting Petroleum Corp / TransAlta Corp / Incyte Corp / Entergy Corp / Celestica Inc / FirstEnergy Corp / TC Energy Corp / Imperial Oil Ltd / Suncor Energy Inc / Baytex Energy Corp / Valero Energy Corp / Marathon Oil Corp / PG&E Corp / Devon Energy Corp / Xcel Energy Inc / Constellation Brands Inc / Range Resources Corp / EQT Corp / Expedia Group Inc / Dollar General Corp / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Paramount Resources Ltd / PVH Corp / Ensign Energy Services Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Snam SpA / SM Energy Co / Pason Systems Inc / Conocophillips / CenterPoint Energy Inc / Callon Petroleum Co / Endo International PLC / BELLUS Health Inc / Black Hills Corp / Chesapeake Utilities Corp / Pentair PLC / Southwestern Energy Co / Spire Inc / California Resources Corp / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Calfrac Well Services Ltd / Texas Roadhouse Inc / ACADIA Pharmaceuticals Inc / Neste Oyj / SJW Group / Drax Group PLC / Secure Energy Services Inc / Boralex Inc / Teva Pharmaceutical Industries Ltd / Galp Energia SGPS SA / Birchcliff Energy Ltd / Carparts.Com Inc / Continental Resources Inc / Pembina Pipeline Corp / Lululemon Athletica Inc / Ren Redes Energeticas Nacionais SGPS SA / Inovio Pharmaceuticals Inc / Innergex Renewable Energy Inc / Brookfield Infrastructure Partners LP / Northern Oil and Gas Inc / ARC Resources Ltd / Phreesia Inc / Clearwater Paper Corp / Crescent Point Energy Corp / Advantage Energy Ltd / Cenovus Energy Inc / CES Energy Solutions Corp / Athabasca Oil Corp / MEG Energy Corp / Vermilion Energy Inc / Whitecap Resources Inc / Pandora A/S / Tourmaline Oil Corp / Potlatchdeltic Corp / Enerplus Corp / Freehold Royalties Ltd / Peyto Exploration & Development Corp / Parkland Corp / Northland Power Inc / Keyera Corp / CatchMark Timber Trust Inc / Gibson Energy Inc / Matador Resources Co / Tamarack Valley Energy Ltd / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Five Below Inc / Diamondback Energy Inc / Abbvie Inc / KP Tissue Inc / Kelt Exploration Ltd / Primo Water Corp / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Brookfield Renewable Partners LP / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Prairiesky Royalty Ltd / B&M European Value Retail SA / Leucrotta Exploration Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Zillow Group Inc / Tidewater Midstream and Infrastructure Ltd / SecureWorks Corp / Par Pacific Holdings Inc / Azure Power Global Ltd / Algonquin Power & Utilities Corp / Ranger Oil Corp / Grenergy Renovables SA / Centennial Resource Development Inc / Carvana Co / Earthstone Energy Inc / Vistra Corp / Ovid Therapeutics Inc / Redfin Corp / CarGurus Inc / Atlantica Sustainable Infrastructure PLC / Superdry PLC / Booking Holdings Inc / Amneal Pharmaceuticals Inc / Iterum Therapeutics PLC / Provention Bio Inc / Falcon Minerals Corp / Clearway Energy Inc / EssilorLuxottica SA / Gamida Cell Ltd / Pipestone Energy Corp / Lyft Inc / NeuBase Therapeutics Inc / Uber Technologies Inc / Brigham Minerals Inc / Karuna Therapeutics Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Oasis Petroleum Inc / Ovintiv Inc / Essential Utilities Inc / Lundin Energy AB / APA Corp (US) / Asana Inc / Spruce Biosciences Inc / Metacrine Inc / Sumo Logic Inc / Topaz Energy Corp / Viatris Inc / Airbnb Inc / DoorDash Inc / Chesapeake Energy Corp / TuSimple Holdings Inc / Parkland Corp / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Mauritius / Portugal / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NA / GILD.O / INCY.O / NBIX.O / VRTX.O / BLU.N / HOOK.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / INO.OQ / SRPT.O / ENTA.O / PTCT.O / KPTI.O / XNCR.OQ / ITCI.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / OVID.O / ITRM.O / PRVB.O / GMDA.OQ / NBSE.OQ / KRTX.OQ / MORF.OQ / APRE.OQ / IGMS.O / ETNB.O / SPRB.OQ / MTCR.O</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Ovid Therapeutics Inc / Iterum Therapeutics PLC / Provention Bio Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Spruce Biosciences Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Three in a Row: The Bleeding Continues</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 09058V103 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Jun. 02, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AXP / COF / DFS / INTC.O / MS / MSFT.O / NPO / QCOM.O / T.N / 4716.T / GILD.O / AMGN.O / FIS / NVDA.O / SPOT.N / SQ / HEAR.O / LSCC.O / SMTC.O / FISV.O / GPN / AVGO.O / JKHY.OQ / ATVI.OQ / TTWO.OQ / UTHR.OQ / MRVL.OQ / VRTX.OQ / LIFE.O / BIIB.O / 92343V104 / 78442P106 / 36467W109 / 02043Q107 / MRNA.O / ZNGA.O / EA.O / AMBA.O / 82655M107 / G29183103 / INO.O / APPS.O / 63938C108 / CATB.OQ / PYPL.O / TMUS.OQ / TTD.OQ / IRTC.OQ / BILI.O / 21833P103 / ZM.OQ / ONCT.OQ / NBSE.O / SONM.O / REGW.M3 / HUYA.K / 03823M100</td><td class="leftalignment">American Express Co / Capital One Financial Corp / Discover Financial Services / Intel Corp / Morgan Stanley / Microsoft Corp / EnPro Industries Inc / Qualcomm Inc / AT&T Inc / Oracle Corp Japan / Gilead Sciences Inc / Amgen Inc / Fidelity National Information Services Inc / NVIDIA Corp / Spotify Technology SA / Block Inc / Turtle Beach Corp / Lattice Semiconductor Corp / Semtech Corp / Fiserv Inc / Global Payments Inc / Broadcom Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Take-Two Interactive Software Inc / United Therapeutics Corp / Marvell Technology Inc / Vertex Pharmaceuticals Inc / aTyr Pharma Inc / Biogen Inc / Verizon Communications Inc / SLM Corp / GameStop Corp / Alnylam Pharmaceuticals Inc / Moderna Inc / Zynga Inc / Electronic Arts Inc / Ambarella Inc / Sify Technologies Ltd / Eaton Corporation PLC / Inovio Pharmaceuticals Inc / Digital Turbine Inc / Navient Corp / Astria Therapeutics Inc / PayPal Holdings Inc / T-Mobile US Inc / Trade Desk Inc / iRhythm Technologies Inc / Bilibili Inc / Corbus Pharmaceuticals Holdings Inc / Zoom Video Communications Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / Sonim Technologies Inc / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / India / Ireland / Israel / Japan / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: May 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CAH.N / CC.N / CL.N / COF.N / CRM.N / ECL.N / EIX.N / EOG.N / F.N / FCX.N / FDX.N / GE.N / GPS.N / IBM.N / JNJ.N / JPM.N / KMB.N / LLY.N / LMT.N / MRK.N / SC.N / T.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / AAL.L / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / HD.N / LOW.N / MRO.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / NKE.N / LIN.N / OLN.N / IT.N / TGT.N / AVY.N / RKT.N / BLL.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / VFC.N / NRG.N / PWR.N / NEU.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / HAE.N / PVH.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / INTC.OQ / CTSH.OQ / ABMD.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / JKHY.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / SIVB.OQ / QDEL.OQ / QCOM.OQ / INTU.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / STLD.OQ / AMZN.OQ / LNG.A / MRCY.OQ / NVDA.OQ / SBAC.OQ / BMRN.OQ / PACW.OQ / TREE.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / TXN.OQ / CMCSA.OQ / BIIB.OQ / TPX.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / WAL.N / MS.N / FIS.N / STX.AX / RPRX.OQ / HES.N / MA.N / AWI.N / FSLR.OQ / CNK.N / IVZ.N / CLR.N / TDC.N / ES.N / MRNA.OQ / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / NEE.N / TSLA.OQ / LPLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / LDOS.N / RNG.N / COMM.OQ / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / TDOC.N / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / SQ.N / IONS.OQ / IAC.OQ / TTD.OQ / COUP.OQ / UAA.N / AYX.N / DXC.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / QRTEA.OQ / FB.PS / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / LMND.N / AMWL.N / VTRS.OQ / HON.OQ</td><td class="leftalignment">Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Cardinal Health Inc / Chemours Co / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / Ecolab Inc / Edison International / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Linde PLC / Olin Corp / Gartner Inc / Target Corp / Avery Dennison Corp / Rocket Companies Inc / Ball Corp / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / VF Corp / NRG Energy Inc / Quanta Services Inc / NewMarket Corp / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Haemonetics Corp / PVH Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Cognizant Technology Solutions Corp / ABIOMED Inc / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Jack Henry & Associates Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Quidel Corp / Qualcomm Inc / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / SBA Communications Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Lendingtree Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Western Alliance Bancorp / Morgan Stanley / Fidelity National Information Services Inc / Strike Energy Ltd / Royalty Pharma PLC / Hess Corp / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Cinemark Holdings Inc / Invesco Ltd / Continental Resources Inc / Teradata Corp / Eversource Energy / Moderna Inc / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / LPL Financial Holdings Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / Leidos Holdings Inc / RingCentral Inc / CommScope Holding Company Inc / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / Block Inc / Ionis Pharmaceuticals Inc / IAC/Interactivecorp / Trade Desk Inc / Coupa Software Inc / Under Armour Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Lemonade Inc / American Well Corp / Viatris Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / United Kingdom / Ireland / Luxembourg / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Post-1Q21 Biotech Review</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / AMGN.O / UTHR.OQ / VRTX.OQ / LIFE.O / BIIB.O / 02043Q107 / MRNA.O / INO.O / CATB.OQ / ONCT.OQ / NBSE.O / REGW.M3 / 03823M100</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / aTyr Pharma Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Astria Therapeutics Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Israel / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Why the Aducanumab FDA Decision Might be Positive.</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">09062X103 / 92915B106 / 24823R105 / 45782T10</td><td class="leftalignment">Biogen Inc / Voyager Therapeutics Inc / Denali Therapeutics Inc / INmune Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Ms. Kaveri Pohlman</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Highlights From William Blair’s 41st Annual Growth Stock Conference</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">462222100 / 09062X103 / 69366J200</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Biogen Inc / PTC Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 21, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - June 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0116591092 / US0970231058 / US5002551043 / US5324571083 / US6556641008 / US8308791024 / US8447411088 / US4771431016 / US4198791018 / US09062X1037 / US0042251084 / US02043Q1076 / PAP310761054 / US01748X1028 / US2473617023 / US5500211090 / US58933Y1055 / US9100471096 / US98419M1009 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US0465131078 / CA0089118776 / US00653A1079 / US05464T1043 / US00773U1088 / US5904791358 / US28414H1032 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Alaska Air Group Inc / Boeing Co / Kohls Corp / Eli Lilly and Co / Nordstrom Inc / SkyWest Inc / Southwest Airlines Co / JetBlue Airways Corp / Hawaiian Holdings Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Merck & Co Inc / United Airlines Holdings Inc / Xylem Inc / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Jun 01 2021 6:51AM</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">2330.TW / 7974.T / GME / IBM / INTC.O / UBIP.PA / W / WSM / AMZN.O / AAPL.O / ATVI.O / DNLI.O / NVDA.O / HEAR.O / TTWO.O / AMD.O / NTAP.O / NBIX.O / ARGX.O / UTHR.O / 2454.TW / BMRN.O / MU.O / MRVL.O / HPE / AVGO.O / LOGI.O / SWTX.O / RARE.O / ICPT.O / OSTK.O / SWKS.O / BIIB.O / SIMO.O / ACOR.O / LXRX.O / IDRA.O / OMER.O / PCRX.O / ZNGA.O / EA.O / WDC.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / SAGE.O / PRTK.O / XENE.O / QRVO.O / CDTX.O / ABUS.O / GBT.O / PSTG.K / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / SYRS.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / OBSV.O / FENC.O / APLS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / ALNA.O / DELL.K / ETTX.O / HARP.O / SCPL.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BCEL.O / FUSN.O / RCUS.K / PRAX.O</td><td class="leftalignment">Taiwan Semiconductor Manufacturing Co Ltd / Nintendo Co Ltd / GameStop Corp / International Business Machines Corp / Intel Corp / Ubisoft Entertainment SA / Wayfair Inc / Williams-Sonoma Inc / Amazon.com Inc / Apple Inc / Activision Blizzard Inc / Denali Therapeutics Inc / NVIDIA Corp / Turtle Beach Corp / Take-Two Interactive Software Inc / Advanced Micro Devices Inc / NetApp Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / MediaTek Inc / Biomarin Pharmaceutical Inc / Micron Technology Inc / Marvell Technology Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Logitech International SA / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Overstock.com Inc / Skyworks Solutions Inc / Biogen Inc / Silicon Motion Technology Corp / Acorda Therapeutics Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Zynga Inc / Electronic Arts Inc / Western Digital Corp / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / SAGE Therapeutics Inc / Paratek Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Arbutus Biopharma Corp / Global Blood Therapeutics Inc / Pure Storage Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Syros Pharmaceuticals Inc / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Allena Pharmaceuticals Inc / Dell Technologies Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Sciplay Corp / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Atreca Inc / Fusion Pharmaceuticals Inc / Arcus Biosciences Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / France / Japan / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN=US / OXY=US / RRC=US / GBT=US / DVN=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / H=US / MTN=US / XOM=US / CRK=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / MAR=US / MRO=US / TTWO=US / TNL=US / ATVI=US / HLT=US / CHH=US / COLL=US / CNX=US / DRH=US / EQT=US / DOC=US / RARE=US / VRTX=US / CVX=US / SAGE=US / KRT=US / NHI=US / OHI=US / COP=US / BDSI=US / MRNS=US / BIIB=US / APTX=US / SHO=US / MPW=US / HST=US / CPRX=US / CLR=US / WH=US / NOG=US / HTA=US / AR=US / OAS=US / HGV=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ZNGA=US / BCEI=US / EA=US / MTDR=US / PDCE=US / RHP=US / FANG=US / VEEV=US / CNCE=US / VNOM=US / RLMD=US / VKTX=US / CHCT=US / ARGX=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CDEV=US / CRSP=US / PK=US / PVAC=US / ANAB=US / PLYA=US / VRNA=US / SBOW=US / ARVN=US / RTLR=US / OVV=US / CRMD.US / ABNB=US / RBLX=US / REPX=US</td><td class="leftalignment">Amgen Inc / Occidental Petroleum Corp / Range Resources Corp / Global Blood Therapeutics Inc / Devon Energy Corp / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Hyatt Hotels Corp / Vail Resorts Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marriott International Inc / Marathon Oil Corp / Take-Two Interactive Software Inc / Travel + Leisure Co / Activision Blizzard Inc / Hilton Worldwide Holdings Inc / Choice Hotels International Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Diamondrock Hospitality Co / EQT Corp / Physicians Realty Trust / Ultragenyx Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Chevron Corp / SAGE Therapeutics Inc / Karat Packaging Inc / National Health Investors Inc / Omega Healthcare Investors Inc / Conocophillips / BioDelivery Sciences International Inc / Marinus Pharmaceuticals Inc / Biogen Inc / Aptinyx Inc / Sunstone Hotel Investors Inc / Medical Properties Trust Inc / Host Hotels & Resorts Inc / Catalyst Pharmaceuticals Inc / Continental Resources Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / Healthcare Trust Of America Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Zynga Inc / Civitas Resources Inc / Electronic Arts Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Veeva Systems Inc / Concert Pharmaceuticals Inc / Viper Energy Partners LP / Relmada Therapeutics Inc / Viking Therapeutics Inc / Community Healthcare Trust Inc / argenx SE / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Ranger Oil Corp / AnaptysBio Inc / Playa Hotels & Resorts NV / Verona Pharma PLC / SilverBow Resources Inc / Arvinas Inc / Rattler Midstream LP / Ovintiv Inc / CorMedix Inc / Airbnb Inc / Roblox Corp / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Wedbush Monthly Check-Up: June 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">DNLI.O / NBIX.O / ARGX.O / UTHR.O / BMRN.O / SWTX.O / RARE.O / ICPT.O / BIIB.O / ACOR.O / LXRX.O / IDRA.O / OMER.O / PCRX.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / SAGE.O / PRTK.O / XENE.O / CDTX.O / ABUS.O / GBT.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / SYRS.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / OBSV.O / FENC.O / APLS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / ALNA.O / ETTX.O / HARP.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BCEL.O / FUSN.O / RCUS.K / PRAX.O</td><td class="leftalignment">Denali Therapeutics Inc / Neurocrine Biosciences Inc / argenx SE / United Therapeutics Corp / Biomarin Pharmaceutical Inc / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Acorda Therapeutics Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / SAGE Therapeutics Inc / Paratek Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Arbutus Biopharma Corp / Global Blood Therapeutics Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Syros Pharmaceuticals Inc / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Allena Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Atreca Inc / Fusion Pharmaceuticals Inc / Arcus Biosciences Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Kenneth Shields / Shveta Dighe / Mr. Andreas Argyrides</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 5/21/21</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / AKER.OL / BMO.TO / CAS.TO / CL.N / CM.TO / CRM.N / EDP.LS / EIX.N / EL.N / ELE.MC / IBE.MC / IP.N / KMB.N / KO.N / MRK.N / NA.TO / PD.N / PEG.N / PFE.N / RYN.N / SO.N / STO.AX / T.N / T.TO / TD.TO / PEP.N / DRE.N / FR.N / TRI.N / BFb.N / PG.N / WY.N / CFP.TO / CNQ.TO / GILD.O / CPB.N / LPX.N / CMCSA.O / AMGN.O / INCY.O / AAL.L / DUK.N / TRP.TO / K.N / DT.N / ADBE.O / SU.TO / CLX.N / CAG.N / DV.N / GIS.N / EPC.N / MGA.N / AMT.N / JAZZ.O / CONE.O / VZ.N / HCA.N / STZ.N / EXC.N / FISV.O / EQT.N / ADSK.O / EPD.N / AWK.N / EGP.N / PLD.N / NBIX.O / CHD.N / NWN.N / WSP.TO / SAM.N / ENR.N / VRTX.O / JHX.AX / CEY.L / NCR.N / VRNT.O / COP.N / CNP.N / WCN.N / CPK.N / DOL.TO / TYL.N / CRC.N / LNG.A / NTCT.OQ / GPN.N / MNST.O / EFX.TO / CCLb.TO / CASY.O / PCTY.O / ICPT.O / EQIX.O / ATDb.TO / BIIB.O / TIH.TO / 02209S103 / NTR.N / DLR.N / SCL.TO / ACAD.O / 427866108 / WEF.TO / RDSb.L / BAM.N / SJW.N / DRX.L / FIS.N / CSU.TO / MERC.O / 3IN.L / BGS.N / PPL.TO / HOCM.L / ARX.TO / UTL.N / CLW.N / VALE.N / IFC.TO / CVE.TO / ADN.TO / SPB.N / NEE.N / TOU.TO / NXT.AX / PCH.O / CFX.TO / FRU.TO / SXY.AX / CTT.N / STAG.N / IFP.TO / PXT.TO / POLYP.L / EFN.TO / SPLK.OQ / RFP.N / SRPT.O / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / PRMW.N / TMUS.N / COTY.N / PRTA.O / BEP.N / 81762P102 / CFF.TO / COUP.N / VRNS.O / QTWO.N / RYAM.N / HUBS.N / QSR.N / CAR.AX / 78667J108 / EVA.N / GLPG.O / WRK.N / IONS.O / NTNX.O / GDS.O / AQN.N / OKTA.OQ / WPM.N / ZS.OQ / SMAR.N / VRCA.OQ / ITRM.O / NTGY.MC / KDP.N / ESTC.N / NWL.O / ZM.O / MORF.OQ / CRWD.O / PING.N / FCR_u.TO / REYN.O / GFL.N / FOUR.N / ZI.O / AKES.OL / PLTR.N / ASAN.N / WFG.N / AFRM.O / TEEC.L / NAPA.N / PATH.N / AVAH.OQ / GIP.V / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aker ASA / Bank of Montreal / Cascades Inc / Colgate-Palmolive Co / Canadian Imperial Bank of Commerce / Salesforce.Com Inc / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Endesa SA / Iberdrola SA / International Paper Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Rayonier Inc / Southern Co / Santos Ltd / AT&T Inc / Telus Corp / Toronto-Dominion Bank / PepsiCo Inc / Duke Realty Corp / First Industrial Realty Trust Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Campbell Soup Co / Louisiana-Pacific Corp / Comcast Corp / Amgen Inc / Incyte Corp / Anglo American PLC / Duke Energy Corp / TC Energy Corp / Kellogg Co / Dynatrace Inc / Adobe Inc / Suncor Energy Inc / Clorox Co / Conagra Brands Inc / DoubleVerify Holdings Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / HCA Healthcare Inc / Constellation Brands Inc / Exelon Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Enterprise Products Partners LP / American Water Works Company Inc / Eastgroup Properties Inc / Prologis Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / WSP Global Inc / Boston Beer Company Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / James Hardie Industries PLC / Centamin PLC / NCR Corp / Verint Systems Inc / Conocophillips / CenterPoint Energy Inc / Waste Connections Inc / Chesapeake Utilities Corp / Dollarama Inc / Tyler Technologies Inc / California Resources Corp / Cheniere Energy Inc / Netscout Systems Inc / Global Payments Inc / Monster Beverage Corp / Enerflex Ltd / CCL Industries Inc / Caseys General Stores Inc / Paylocity Holding Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Toromont Industries Ltd / Altria Group Inc / Nutrien Ltd / Digital Realty Trust Inc / Shawcor Ltd / ACADIA Pharmaceuticals Inc / Hershey Co / Western Forest Products Inc / Royal Dutch Shell PLC / Brookfield Asset Management Inc / SJW Group / Drax Group PLC / Fidelity National Information Services Inc / Constellation Software Inc / Mercer International Inc / 3I Infrastructure PLC / B&G Foods Inc / Pembina Pipeline Corp / Hochschild Mining PLC / ARC Resources Ltd / Unitil Corp / Clearwater Paper Corp / Vale SA / Intact Financial Corp / Cenovus Energy Inc / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Tourmaline Oil Corp / NEXTDC Ltd / Potlatchdeltic Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / Senex Energy Ltd / CatchMark Timber Trust Inc / STAG Industrial Inc / Interfor Corp / Parex Resources Inc / Polymetal International PLC / Element Fleet Management Corp / Splunk Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Conifex Timber Inc / Coupa Software Inc / Varonis Systems Inc / Q2 Holdings Inc / Rayonier Advanced Materials Inc / HubSpot Inc / Restaurant Brands International Inc / Carsales.Com Ltd / SAGE Therapeutics Inc / Enviva Inc / Galapagos NV / Westrock Co / Ionis Pharmaceuticals Inc / Nutanix Inc / GDS Holdings Ltd / Algonquin Power & Utilities Corp / Okta Inc / Wheaton Precious Metals Corp / Zscaler Inc / Smartsheet Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / First Capital Real Estate Investment Trust / Reynolds Consumer Products Inc / GFL Environmental Inc / Shift4 Payments Inc / ZoomInfo Technologies Inc / Aker Solutions ASA / Palantir Technologies Inc / Asana Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Duckhorn Portfolio Inc / UiPath Inc / Aveanna Healthcare Holdings Inc / Green Impact Partners Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Cayman Islands / Spain / United Kingdom / Ireland / Netherlands / Norway / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: The 3 Pushes And 3 Pulls We See Influencing M&A Activity In The Sector; Expect 2H21 Uptick</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / BIIB.O / ACAD.O / GLPG.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Galapagos NV</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Stephen Mallon / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">T-5; Steering Through Adu’s Potential Ripples and Waves – Projecting Second-Order Sector Read-Throughs</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / ICPT.O / ACAD.O / SRPT.O / PRTA.O / 78667J108 / IONS.O / ITRM.O</td><td class="leftalignment">Biogen Inc / Intercept Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Prothena Corporation PLC / SAGE Therapeutics Inc / Ionis Pharmaceuticals Inc / Iterum Therapeutics PLC</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen's Biotech Thermometer</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US0465131078 / US00653A1079 / US05464T1043 / US00773U1088 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Model Update</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Biogen (BIIB: $267.48) decreases, trailing 62% of stocks</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 549</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MDT=US / AMZN=US / CRM=US / VRM=US / BRO=US / BYD=US / SPOT=US / EXPE=US / MGM=US / PENN=US / W=US / AIR=US / ATRO=US / B=US / CW=US / DCO=US / HEI=US / HXL=US / MRCY=US / MCRI=US / PLAN=US / ROLL=US / SNAP=US / THO=US / TRIP=US / TGI=US / VSEC=US / WIX=US / WGO=US / BKNG=US / FB=US / KRT=US / PRA=US / SPR=US / AUTL=US / UCBI=US / PTON=US / BIIB=US / TPX=US / MOG.A=US / CZR=US / APP=US / TDG=US / RPRX=US / GPRE=US / ELF=US / TIL=US / CWH=US / CLNY=US / WWD=US / ANGI=US / SSTK=US / GOOGL=US / BABA=US / CMPR=US / GDDY=US / TRVG=US / LGF.B=US / CVNA=US / YEXT=US / IOVA=US / SFIX=US / LAZY=US / FTDR=US / SVMK=US / FSK=US / LYFT=US / UBER=US / PLMR=US / FSKR=US / BALY=US / ABNB=US / PRVA=US / VMEO=US</td><td class="leftalignment">Medtronic PLC / Amazon.com Inc / Salesforce.Com Inc / Vroom Inc / Brown & Brown Inc / Boyd Gaming Corp / Spotify Technology SA / Expedia Group Inc / MGM Resorts International / Penn National Gaming Inc / Wayfair Inc / AAR Corp / Astronics Corp / Barnes Group Inc / Curtiss-Wright Corp / Ducommun Inc / HEICO Corp / Hexcel Corp / Mercury Systems Inc / Monarch Casino & Resort Inc / Anaplan Inc / RBC Bearings Inc / Snap Inc / Thor Industries Inc / Tripadvisor Inc / Triumph Group Inc / VSE Corp / Wix.Com Ltd / Winnebago Industries Inc / Booking Holdings Inc / Meta Platforms Inc / Karat Packaging Inc / ProAssurance Corp / Spirit AeroSystems Holdings Inc / Autolus Therapeutics PLC / United Community Banks Inc / Peloton Interactive Inc / Biogen Inc / Tempur Sealy International Inc / Moog Inc / Caesars Entertainment Inc / Applovin Corp / TransDigm Group Inc / Royalty Pharma PLC / Green Plains Inc / elf Beauty Inc / Instil Bio Inc / Camping World Holdings Inc / DigitalBridge Group Inc / Woodward Inc / Angi Inc / Shutterstock Inc / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / Trivago NV / Lions Gate Entertainment Corp / Carvana Co / Yext Inc / Iovance Biotherapeutics Inc / Stitch Fix Inc / Lazydays Holdings Inc / Frontdoor Inc / Momentive Global Inc / FS KKR Capital Corp / Lyft Inc / Uber Technologies Inc / Palomar Holdings Inc / FS KKR Capital Corp / Bally's Corp / Airbnb Inc / Privia Health Group Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AES.N / ALTR.O / BBY.N / CCK.N / CM.TO / COST.O / CRM.N / DGE.L / EDP.LS / FGP.L / GPS.N / KGF.L / PD.N / SMWH.L / TD.TO / ACI.N / PG.N / WLL.N / HNKG_p.DE / THC.N / FER.MC / LEA.N / K.N / CLX.N / EAT.N / HD.N / EPC.N / CARLb.CO / HCA.N / STZ.N / DSGX.O / AZO.N / ADSK.O / DLTR.O / DG.N / GPC.N / ENR.N / GPK.N / CPE.N / TSCO.O / CRC.N / ORLY.O / BIIB.O / NESN.S / TXRH.O / 427866108 / SJW.N / PRTS.OQ / AEO.N / VMW.N / EDPR.LS / ABI.BR / SPB.N / CHNG.O / B44XTX8 / PCH.O / XYL.N / BOSSn.DE / MDLZ.OQ / PRMW.N / VOYA.N / BURL.N / BMEB.L / HQY.OQ / OLLI.OQ / GBT.OQ / RUN.O / AZRE.N / LGFB.N / ORSTED.CO / AQUA.N / SAIL.N / SDRY.L / ITRM.O / PRVB.O / ESLX.PA / ZM.O / PEAK.N / AZEK.N / WFG.N / 120681711</td><td class="leftalignment">AES Corp / Altair Engineering Inc / Best Buy Co Inc / Crown Holdings Inc / Canadian Imperial Bank of Commerce / Costco Wholesale Corp / Salesforce.Com Inc / Diageo PLC / EDP Energias de Portugal SA / FirstGroup PLC / Gap Inc / Kingfisher PLC / PagerDuty Inc / WH Smith PLC / Toronto-Dominion Bank / Albertsons Companies Inc / Procter & Gamble Co / Whiting Petroleum Corp / Henkel AG & Co KGaA / Tenet Healthcare Corp / Ferrovial SA / Lear Corp / Kellogg Co / Clorox Co / Brinker International Inc / Home Depot Inc / Edgewell Personal Care Co / Carlsberg A/S / HCA Healthcare Inc / Constellation Brands Inc / Descartes Systems Group Inc / Autozone Inc / Autodesk Inc / Dollar Tree Inc / Dollar General Corp / Genuine Parts Co / Energizer Holdings Inc / Graphic Packaging Holding Co / Callon Petroleum Co / Tractor Supply Co / California Resources Corp / O'Reilly Automotive Inc / Biogen Inc / Nestle SA / Texas Roadhouse Inc / Hershey Co / SJW Group / Carparts.Com Inc / American Eagle Outfitters Inc / VMware Inc / EDP Renovaveis SA / Anheuser Busch Inbev SA / Spectrum Brands Holdings Inc / Change Healthcare Inc / Pandora A/S / Potlatchdeltic Corp / Xylem Inc / Hugo Boss AG / Mondelez International Inc / Primo Water Corp / Voya Financial Inc / Burlington Stores Inc / B&M European Value Retail SA / Healthequity Inc / Ollie's Bargain Outlet Holdings Inc / Global Blood Therapeutics Inc / Sunrun Inc / Azure Power Global Ltd / Lions Gate Entertainment Corp / Orsted A/S / Evoqua Water Technologies Corp / SailPoint Technologies Holdings Inc / Superdry PLC / Iterum Therapeutics PLC / Provention Bio Inc / EssilorLuxottica SA / Zoom Video Communications Inc / Healthpeak Properties Inc / Azek Company Inc / West Fraser Timber Co Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Luxembourg / Mauritius / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Label debate; restrictions expected on who can get adu initially but KOLs suggest big oppy</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">T-7 Days; Suspense Builds as Palpable Adu Countdown Begins - Our Latest Thoughts/Feedback</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AMGN=US / DIS=US / MCD=US / AGL=US / AMZN=US / T=US / GILD=US / NVDA=US / PEB=US / H=US / MTN=US / VRM=US / SCOR=US / EWBC=US / BRO=US / MAR=US / UMPQ=US / TNL=US / HLT=US / WTFC=US / CHH=US / CW=US / DRH=US / DCO=US / AJG=US / MCRI=US / PACW=US / HOOK=US / REGN=US / WAL=US / HTH=US / SNOW=US / CGEN=US / BXS=US / FNF=US / CFB=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / WRE=US / CATY=US / GBCI=US / REG=US / NFLX=US / ECPG=US / PNFP=US / SBCF=US / PRAA=US / STRO=US / BIIB=US / FNB=US / FHN=US / SHO=US / RNST=US / REX=US / HST=US / ELF=US / CADE=US / TAST=US / QSR=US / NMTR=US / WH=US / RCUS=US / HGV=US / NLSN=US / PCRX=US / RLJ=US / VAC=US / MEIP=US / RHP=US / ABBV=US / IBTX=US / FATE=US / NMIH=US / EVH=US / ACBI=US / PK=US / LGF.B=US / PLYA=US / OKTA=US / CVNA=US / ROKU=US / HWC=US / BTAI=US / OZK=US / ALLO=US / HARP=US / PLMR=US / HCAT=US / AVAH=US</td><td class="leftalignment">Amgen Inc / Walt Disney Co / McDonald's Corp / agilon health Inc / Amazon.com Inc / AT&T Inc / Gilead Sciences Inc / NVIDIA Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Vroom Inc / Comscore Inc / East West Bancorp Inc / Brown & Brown Inc / Marriott International Inc / Umpqua Holdings Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Wintrust Financial Corp / Choice Hotels International Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Ducommun Inc / Arthur J Gallagher & Co / Monarch Casino & Resort Inc / PacWest Bancorp / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Snowflake Inc. / Compugen Ltd / Cadence Bank / Fidelity National Financial Inc / Crossfirst Bankshares Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Washington Real Estate Investment Trust / Cathay General Bancorp / Glacier Bancorp Inc / Regency Centers Corp / Netflix Inc / Encore Capital Group Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / PRA Group Inc / Sutro Biopharma Inc / Biogen Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Renasant Corp / REX American Resources Corp / Host Hotels & Resorts Inc / elf Beauty Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Hilton Grand Vacations Inc / Nielsen Holdings PLC / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / MEI Pharma Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Fate Therapeutics Inc / NMI Holdings Inc / Evolent Health Inc / Atlantic Capital Bancshares Inc / Park Hotels & Resorts Inc / Lions Gate Entertainment Corp / Playa Hotels & Resorts NV / Okta Inc / Carvana Co / Roku Inc / Hancock Whitney Corp / BioXcel Therapeutics Inc / Bank Ozk / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Palomar Holdings Inc / Health Catalyst Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Save the Date - Washington, D.C. Day - June 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">85891210 / 42190610 / 76115210 / 80640710 / 03116210 / 7333378 / 64125C109 / 002824100 / 110122108 / 09062X103 / 50540R409 / 74834L100 / 159864107 / 09061G101 / 703395103 / 640268108 / 075887109 / 20530610 / 30063P105 / 216648402 / 28176E108 / 30161Q104 / 45337C102 / 23918K108 / 038336103 / 852312305 / 023436108 / 589584101 / 955306105 / 50187A107 / 436440101 / 003654100 / 016255101 / 09060J106 / 252131107 / 42222N103 / 45168D104 / 45253H101 / 640491106 / 74838J101 / 759916109 / 90337L108 / 45784P101 / 58502B106 / 141619106 / 64049M20 / 40412C101 / 00847G705 / 92857F107 / 00404A109 / 88033G407 / 803607100 / G4705A100 / 74051N10 / 98978V10 / 92337F10 / 26979610 / 45780L10 / 14862Q100 / 006739106 / 00430H102 / 00847L10 / 045396108 / 14880610 / 82621J10 / 268158201 / 31572Q80 / 76133010 / G5960L103 / 78667J108 / 30050B10 / 98978L204 / 37732210 / 15117K103 / 87918A10 / 46185L10 / 04651310 / 00461U105 / 462222100 / 19459J104 / 24906P109 / 70975L107 / 64157F103 / 87357P100 / 58506Q109 / 01345P106 / 88870R102 / N72482123 / 690469101 / G11196105 / 00887A105 / 69366J200 / 46266C105 / 816212104 / 09609G100 / 450056106 / 67022C106 / 29261A100 / 87166B102 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / 28414H103 / H17182108 / 873379101 / 501147102 / 37890U108 / 40131M109 / 22304C100 / 05352A100 / 00650F109 / 77313F106 / 03836N103 / 717224109 / 83192H106 / 88025U109 / 30068X103 / 15912K100 / 29415F104 / 07373V105 / 68404L201 / 42225T107 / 05464T104 / 922107107 / 55234L105 / 71944F106 / 68269G107 / 74019P108 / 37148K100 / 64131A105 / 48576A100 / N5749R100 / 084310101 / 005111109 / 00437E102 / G10830100 / 24984K105 / 73730P108 / 81181C104 / 04537Y109 / 517125100 / 877619106 / 74006W108 / 67181A107 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 270087109 / 192010106 / 13089P101 / 151205200 / 09075X108 / 68401U204 / 04683R106 / 78472F101 / 000380204 / 89422G107 / 56600D107 / 15687V109 / 65443P102 / 54948U105 / 82671G100 / 45784A104 / 30315R107 / 01625V104 / 45175G108 / 00857U107 / 74276R102 / 91864C107</td><td class="leftalignment">Stericycle Inc / Healthcare Services Group Inc / Resmed Inc / Henry Schein Inc / Amgen Inc / Lonza Group AG / Neurocrine Biosciences Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Biogen Inc / Laboratory Corporation of America Holdings / Quest Diagnostics Inc / Charles River Laboratories International Inc / Biomarin Pharmaceutical Inc / Patterson Companies Inc / Nektar Therapeutics / Becton Dickinson and Co / Computer Programs and Systems Inc / Exact Sciences Corp / Cooper Companies Inc / Edwards Lifesciences Corp / Exelixis Inc / Incyte Corp / DaVita Inc / Aptargroup Inc / STAAR Surgical Co / Amedisys Inc / Meridian Bioscience Inc / West Pharmaceutical Services Inc / LHC Group Inc / Hologic Inc / ABIOMED Inc / Align Technology Inc / BioDelivery Sciences International Inc / Dexcom Inc / HealthStream Inc / IDEXX Laboratories Inc / ImmunoGen Inc / Neogen Corp / Quidel Corp / Repligen Corp / US Physical Therapy Inc / Insulet Corp / MEDNAX Inc / Cardiovascular Systems Inc / Neogenomics Inc / HCA Healthcare Inc / Agenus Inc / Vocera Communications Inc / Acadia Healthcare Company Inc / Tenet Healthcare Corp / Sarepta Therapeutics Inc / ICON PLC / Premier Inc / Zoetis Inc / Veracyte Inc / Eagle Pharmaceuticals Inc / Inogen Inc / Castlight Health Inc / Addus Homecare Corp / Accelerate Diagnostics Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Catalent Inc / Sientra Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / Medtronic PLC / SAGE Therapeutics Inc / Evolent Health Inc / Zogenix Inc / Glaukos Corp / Cellectis SA / Teladoc Health Inc / Invitae Corp / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Penumbra Inc / Nevro Corp / Tactile Systems Technology Inc / Medpace Holdings Inc / Albireo Pharma Inc / Tivity Health Inc / Qiagen NV / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / IQVIA Holdings Inc / Selecta Biosciences Inc / bluebird bio Inc / iRhythm Technologies Inc / NuCana PLC / Encompass Health Corp / Syneos Health Inc / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Elanco Animal Health Inc / CRISPR Therapeutics AG / Tabula Rasa HealthCare Inc / Krystal Biotech Inc / Global Blood Therapeutics Inc / Guardant Health Inc / Covetrus Inc / Avantor Inc / Adaptive Biotechnologies Corp / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / SmileDirectClub Inc / 10X Genomics Inc / Exagen Inc / Change Healthcare Inc / Envista Holdings Corp / Beam Therapeutics Inc / Option Care Health Inc / Health Catalyst Inc / Axsome Therapeutics Inc / Vapotherm Inc / Lyra Therapeutics Inc / Phreesia Inc / 1Life Healthcare Inc / Precision BioSciences Inc / Generation Bio Co / Neuronetics Inc / Karuna Therapeutics Inc / Merus NV / Berkeley Lights Inc / Acutus Medical Inc / Accolade Inc / Beyondspring Inc / DermTech Inc / Poseida Therapeutics Inc / Seagen Inc / Aspira Women's Health Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Oak Street Health Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Eargo Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Biodesix Inc / OPTIMIZERx Corp / Atea Pharmaceuticals Inc / Soc Telemed Inc / Abcam PLC / Travere Therapeutics Inc / Maravai LifeSciences Holdings Inc / Certara Inc / 908 Devices Inc. / Lucira Health Inc / Signify Health Inc / InnovAge Holding Corp / F-Star Therapeutics Inc / Alignment Healthcare Inc / Ikena Oncology Inc / agilon health Inc / Privia Health Group Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ryan S. Daniels, CFA / Brian D. Weinstein, CFA / Andy T. Hsieh, PHD / Ms. Margaret Kaczor / John C. Kreger, III / Mr. Matt Larew / Mr. Tim F. Lugo / Mr. Myles R. R. Minter / Matt Phipps, PHD / Mr. Raju Prasad, PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Navigating risk/reward into Aducanumab/Tecfidera; lots of unknown moving parts</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Biogen dips 1.4% in past quarter; Institutional Ownership up 3%</td><td class="leftalignment">English</td><td class="rightalignment">77</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / LSI=US / PFE=US / AMGN=US / BMY=US / MCD=US / WEN=US / INCY=US / CHKP=US / IART=US / MAC=US / BMRN=US / BNL=US / CBRL=US / CRL=US / DRI=US / EXEL=US / NOW=US / REGI=US / STOR=US / PSA=US / NET=US / OFC=US / SRC=US / NTRA=US / DIN=US / RPD=US / BIIB=US / EXR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / CMG=US / REX=US / GPRE=US / EHTH=US / OC=US / TAST=US / QSR=US / JACK=US / NEO=US / CUBE=US / PANW=US / ABBV=US / NDLS=US / FEYE=US / VRNS=US / 00770K202 / LOCO=US / SHAK=US / NSA=US / WING=US / LOB=US / ZS=US / LGF.B=US / OKTA=US / YEXT=US / SAIL=US / TENB=US / CRWD=US / ARQT=US / 96758W101 / VTRS=US / ABNB=US / HYFM=US / HIMS=US / KNBE=US</td><td class="leftalignment">Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / McDonald's Corp / Wendys Co / Incyte Corp / Check Point Software Technologies Ltd / Integra Lifesciences Holdings Corp / Macerich Co / Biomarin Pharmaceutical Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Charles River Laboratories International Inc / Darden Restaurants Inc / Exelixis Inc / ServiceNow Inc / Renewable Energy Group Inc / STORE Capital Corp / Public Storage / Cloudflare Inc / Corporate Office Properties Trust / Spirit Realty Capital Inc / Natera Inc / Dine Brands Global Inc / Rapid7 Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / eHealth Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / Neogenomics Inc / CubeSmart / Palo Alto Networks Inc / Abbvie Inc / Noodles & Co / Mandiant Inc / Varonis Systems Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / National Storage Affiliates Trust / Wingstop Inc / Live Oak Bancshares Inc / Zscaler Inc / Lions Gate Entertainment Corp / Okta Inc / Yext Inc / SailPoint Technologies Holdings Inc / Tenable Holdings Inc / CrowdStrike Holdings Inc / Arcutis Biotherapeutics Inc / WideOpenWest Inc / Viatris Inc / Airbnb Inc / Hydrofarm Holdings Group Inc / Hims & Hers Health Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Initiating Coverage of Werewolf Therapeutics; Cancer’s Worst Nightmare</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">HOWL.OQ / BIIB / 75886F107 / 00847G705 / M25722105 / ALPN.OQ / 23284F105 / 98985W102 / 41358P106 / 869367102 / 64049K104 / ALXO.OQ / ITOS.OQ / 449585108 / 58490H107</td><td class="leftalignment">Werewolf Therapeutics Inc / Biogen Inc / Regeneron Pharmaceuticals Inc / Agenus Inc / Compugen Ltd / Alpine Immune Sciences Inc / CytomX Therapeutics Inc / Zymeworks Inc / Harpoon Therapeutics Inc / Sutro Biopharma Inc / Neoleukin Therapeutics Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / IGM Biosciences Inc / Medicenna Therapeutics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Michael G. G. King, Jr., Jr</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">F.N / FER.MC / EXEL.O / ICPT.O / BIIB.O / DRX.L / EHTH.O / MTDR.N / 78667J108 / CDEV.O / NTGY.MC / XERS.O / 260557103 / ETNB.O / SBSW.N / MTCR.O / MAGT.TO</td><td class="leftalignment">Ford Motor Co / Ferrovial SA / Exelixis Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Drax Group PLC / eHealth Inc / Matador Resources Co / SAGE Therapeutics Inc / Centennial Resource Development Inc / Naturgy Energy Group SA / Xeris Biopharma Holdings Inc / Dow Inc / 89Bio Inc / Sibanye Stillwater Ltd / Metacrine Inc / Magnet Forensics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Spain / United Kingdom / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Record Lows Across Key COVID-19 Metrics as Vaccinations Near 50% in United States; Situation in India Continues to Improve</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108 / 91864C107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc / Vaccitech PLC</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Buyside Survey Highlights Underappreciated Setups, Mixed Scenarios Into Adu PDUFA and WATERFALL</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Buyside Survey Reflects Investor Caution on Zuranolone Durability but Confidence in Safety</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">78667J108 / BIIB.O</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Tecfidera KOL takeaways and replay info; key sensitivities on Tecfidera and aducanumab</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 14, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Takeaways from Expert call on Tecfidera appeal</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">VTRS=US / BIIB=US</td><td class="leftalignment">Viatris Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / PFE=US / INTC=US / ADI=US / AMD=US / AMZN=US / TXN=US / NVDA=US / H=US / CRM=US / IART=US / DIOD=US / XLNX=US / TTMI=US / EQR=US / FLO=US / ARCC=US / PATH=US / APH=US / ARW=US / AVGO=US / AVT=US / COLL=US / DRH=US / MAIN=US / MCHP=US / ORCC=US / ROLL=US / ST=US / BDSI=US / BIIB=US / BDC=US / AINV=US / SHO=US / BAH=US / REX=US / HST=US / TEL=US / PNNT=US / AGS=US / NXPI=US / PCRX=US / RHP=US / AERI=US / GOOGL=US / TSLX=US / 70806A106 / WK=US / ON=US / GSBD=US / LOB=US / NTLA=US / PK=US / PLYA=US / MPWR-US / SMAR=US / FSK=US / SPCE=US / FSKR=US / VTRS=US / PRVA=US / AVAH=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Amazon.com Inc / Texas Instruments Inc / NVIDIA Corp / Hyatt Hotels Corp / Salesforce.Com Inc / Integra Lifesciences Holdings Corp / Diodes Inc / Xilinx Inc / TTM Technologies Inc / Equity Residential / Flowers Foods Inc / Ares Capital Corp / UiPath Inc / Amphenol Corp / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Collegium Pharmaceutical Inc / Diamondrock Hospitality Co / Main Street Capital Corp / Microchip Technology Inc / Owl Rock Capital Corp / RBC Bearings Inc / Sensata Technologies Holding PLC / BioDelivery Sciences International Inc / Biogen Inc / Belden Inc / Apollo Investment Corp / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / REX American Resources Corp / Host Hotels & Resorts Inc / TE Connectivity Ltd / Pennantpark Investment Corp / PlayAGS Inc / NXP Semiconductors NV / Pacira Biosciences Inc / Ryman Hospitality Properties Inc / Aerie Pharmaceuticals Inc / Alphabet Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Workiva Inc / ON Semiconductor Corp / Goldman Sachs BDC Inc / Live Oak Bancshares Inc / Intellia Therapeutics Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Monolithic Power Systems Inc / Smartsheet Inc / FS KKR Capital Corp / Virgin Galactic Holdings Inc / FS KKR Capital Corp / Viatris Inc / Privia Health Group Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Biogen Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">05/23/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Catalysts in 2021 and beyond for our biotechnology coverage: May 2021 edition</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">NBIX.OQ / US09062X1037 / ACAD.N / 78667J108 / G11196105 / 98986X109 / 46116X101 / 92915B106 / 918385105 / 09075P105 / 22053A107 / 20451W101 / 23256X100</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / SAGE Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Zynerba Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Voyager Therapeutics Inc / vTv Therapeutics Inc / BioXcel Therapeutics Inc / Cortexyme Inc / Compass Pathways PLC / Cybin Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Sumant Kulkarni</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : Updated Credit Views from the "USD HG Coverage and Rating Report"</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABC.N / AMGN.O / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CI.N / JNJ.N / LLY.N / MCK.N / MRK.N / DGX.N / HUM.N / GILD.O / UNH.N / LH.N / BIIB.O / ZTS.N / PRGO.N / ANTM.N / VTRS.O</td><td class="leftalignment">Amerisourcebergen Corp / Amgen Inc / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Johnson & Johnson / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Quest Diagnostics Inc / Humana Inc / Gilead Sciences Inc / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / Biogen Inc / Zoetis Inc / Perrigo Company PLC / Anthem Inc / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CRY.N / CVS / HUM / MDT / RAD / SGE.L / UNH / WMT / GILD.O / AMGN.O / NOVN.S / HCA.N / CYH.N / EW.N / INCY.OQ / IART.OQ / EXEL.OQ / ISRG.OQ / CCRN.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / ATRC.OQ / LHCG.O / 02043Q107 / ENSG.OQ / 483548103 / TMDX.OQ / MD.N / CSII.O / ADUS.O / USPH.N / MRTX.OQ / GOOGL.O / XENT.OQ / CLRB.OQ / MRNS.O / CATB.OQ / EVH.N / TDOC.N / GBT.OQ / MMD.WA / APLS.OQ / 100063846 / IRTC.OQ / SRRA.O / PLXP.O / IOVA.OQ / ALPN.O / MBIO.OQ / NCNA.O / CUE.OQ / 720795103 / SURF.O / VCNX.OQ / MOTS.O / ALLO.OQ / ORTX.OQ / SWAV.O / PDSB.OQ / BWAY.TA / PNTG.OQ / IGMS.O / VERO.O / ORIC.OQ / AYLA.O / FMTX.O / REGW.M3</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CryoLife Inc / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Incyte Corp / Integra Lifesciences Holdings Corp / Exelixis Inc / Intuitive Surgical Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / AtriCure Inc / LHC Group Inc / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Transmedics Group Inc / MEDNAX Inc / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Mirati Therapeutics Inc / Alphabet Inc / Intersect Ent Inc / Cellectar Biosciences Inc / Marinus Pharmaceuticals Inc / Astria Therapeutics Inc / Evolent Health Inc / Teladoc Health Inc / Global Blood Therapeutics Inc / Milestone Medical Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / iRhythm Technologies Inc / Sierra Oncology Inc / PLx Pharma Inc / Iovance Biotherapeutics Inc / Alpine Immune Sciences Inc / Mustang Bio Inc / NuCana PLC / Cue Biopharma Inc / Pieris Pharmaceuticals Inc / Surface Oncology Inc / Vaccinex Inc / Motus GI Holdings Inc / Allogene Therapeutics Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / PDS Biotechnology Corp / Brainsway Ltd / Pennant Group Inc / IGM Biosciences Inc / Venus Concept Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 548</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 5/14/21</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">2434209 / 2936921 / 2496113 / 2973821 / 2050832 / 2942605 / 2219224 / 2190750 / 2208073 / 2280220 / 2270726 / 2317087 / 2455965 / 2459020 / 2600088 / 2630513 / 2657802 / 2048804 / 2730190 / 2746711 / 2829601 / B1F76F9 / 2857817 / B02R1L6 / B3D7K31 / 2598246 / B03PGL4 / B7TL820 / B4V9661 / BJ0KXV4 / B87ZMX0 / BFH3N85 / BP4GNK9 / BZ1HM42 / BJ5FZ74 / BJ2Z0H2 / BFZ1K46 / BMYML02 / BFMXGR0 / BYXJQG9 / BFXC911 / BKTNTR9 / BFWK4R7 / BGKG6M3 / BNRQM83 / BMDJ085</td><td class="leftalignment">Home Depot Inc / Walmart Inc / Kohls Corp / Alliant Energy Corp / Ameren Corp / Avista Corp / CMS Energy Corp / Chesapeake Utilities Corp / Copart Inc / DTE Energy Co / Walt Disney Co / Entergy Corp / Biogen Inc / Intuit Inc / Monro Inc / New Jersey Resources Corp / OGE Energy Corp / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Southern Co / Western Union Co / Netflix Inc / ALLETE Inc / Discovery Inc / Neogenomics Inc / NorthWestern Corp / Meta Platforms Inc / Ralph Lauren Corp / ONE Gas Inc / Palo Alto Networks Inc / Veeva Systems Inc / SAGE Therapeutics Inc / Adyen NV / Adaptive Biotechnologies Corp / Pinterest Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / Spire Inc / Guardant Health Inc / ViacomCBS Inc / PagSeguro Digital Ltd / StoneCo Ltd / Petco Health and Wellness Company Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Luxembourg / Mexico / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Ownership Timelines & Shareholder Analytics (May 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Watch for BIIB-092 and Semorinemab Data to Validate Anti-Tau</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">BIIB.OQ / 09062X10 / H0026310</td><td class="leftalignment">Biogen Inc / Biogen Inc / AC Immune SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">All Good Things Must Come to an End - Biotech Outflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / G11196105 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Biohaven Pharmaceutical Holding Company Ltd / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">HELE.O / MSFT.O / QUIK.O / AMZN.O / AAPL.O / NVDA.O / HEAR.O / NOVN.S / ATVI.OQ / TTWO.OQ / ADS.N / BIIB.O / AYX / BIDU.O / 36467W109 / ZNGA.O / EA.O / 82655M107 / CATB.OQ / GBT.OQ / BABA.K / IOVA.OQ / BILI.O / IQ.O / TPVG.K / TCOM.O / AYLA.O / HUYA.K</td><td class="leftalignment">Helen of Troy Ltd / Microsoft Corp / QuickLogic Corp / Amazon.com Inc / Apple Inc / NVIDIA Corp / Turtle Beach Corp / Novartis AG / Activision Blizzard Inc / Take-Two Interactive Software Inc / Alliance Data Systems Corp / Biogen Inc / Alteryx Inc / Baidu Inc / GameStop Corp / Zynga Inc / Electronic Arts Inc / Sify Technologies Ltd / Astria Therapeutics Inc / Global Blood Therapeutics Inc / Alibaba Group Holding Ltd / Iovance Biotherapeutics Inc / Bilibili Inc / iQIYI Inc / Triplepoint Venture Growth BDC Corp / Trip.com Group Ltd / Ayala Pharmaceuticals Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / India / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Scenario Analysis for Adu PDUFA</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AXP / BAC.N / C.N / COF / COST.O / CRY.N / GS / HD / JEF / JPM / LOW / MDT / MS / MSFT.O / PNC.N / SCM.N / URI / USB / WFC.N / TME / AMZN.O / SPOT.N / HEAR.O / ARCC.O / ATVI.OQ / INCY.OQ / TTWO.OQ / ISRG.OQ / MGRC.O / SIVB.O / BIIB.O / 478160104 / 0700.HK / OLED.O / 36467W109 / 02043Q107 / FDUS.O / ZNGA.O / EA.O / MRCC.O / 82655M107 / MMD.WA / APL.PS / TWLO.K / AKTS.OQ / CUE.OQ / WSC.OQ / BILI.O / SURF.O / VCNX.OQ / SWAV.O / PRPL.O / VERO.O / ORIC.OQ / NMFC.O / HUYA.K</td><td class="leftalignment">American Express Co / Bank of America Corp / Citigroup Inc / Capital One Financial Corp / Costco Wholesale Corp / CryoLife Inc / Goldman Sachs Group Inc / Home Depot Inc / Jefferies Financial Group Inc / JPMorgan Chase & Co / Lowe's Companies Inc / Medtronic PLC / Morgan Stanley / Microsoft Corp / PNC Financial Services Group Inc / Stellus Capital Investment Corp / United Rentals Inc / US Bancorp / Wells Fargo & Co / Tencent Music Entertainment Group / Amazon.com Inc / Spotify Technology SA / Turtle Beach Corp / Ares Capital Corp / Activision Blizzard Inc / Incyte Corp / Take-Two Interactive Software Inc / Intuitive Surgical Inc / McGrath RentCorp / SVB Financial Group / Biogen Inc / Johnson & Johnson / Tencent Holdings Ltd / Universal Display Corp / GameStop Corp / Alnylam Pharmaceuticals Inc / Fidus Investment Corp / Zynga Inc / Electronic Arts Inc / Monroe Capital Corp / Sify Technologies Ltd / Milestone Medical Inc / Apollo Global Capital Inc / Twilio Inc / Akoustis Technologies Inc / Cue Biopharma Inc / Willscot Mobile Mini Holdings Corp / Bilibili Inc / Surface Oncology Inc / Vaccinex Inc / Shockwave Medical Inc / Purple Innovation Inc / Venus Concept Inc / Oric Pharmaceuticals Inc / New Mountain Finance Corp / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / India / Ireland / Luxembourg / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - May 18 2021 6:50AM</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ACN / AX / CFG / CMA / FITB.O / FRC / G / IBM / KEY / PB / WNS / ZION.O / RF / HBAN.O / PACW.O / TJX.N / ROST.O / WBS / INFY.NS / WIPR.NS / SIVB.O / CATY.O / CVBF.O / BOKF.O / WTFC.O / UMPQ.O / EWBC.O / TCBI.O / BIIB.O / SBNY.O / BKU / EPAM.K / NYCB.K / TSC.O / AGTC.O / BURL.K / GLOB.K / FFWM.O / CUBI.K / HOPE.O / VRNA.O / DAVA.K / VLY.O / PRPL.O / FRLN.O</td><td class="leftalignment">Accenture PLC / Axos Financial Inc / Citizens Financial Group Inc / Comerica Inc / Fifth Third Bancorp / First Republic Bank / Genpact Ltd / International Business Machines Corp / KeyCorp / Prosperity Bancshares Inc / WNS (Holdings) Ltd / Zions Bancorporation NA / Regions Financial Corp / Huntington Bancshares Inc / PacWest Bancorp / TJX Companies Inc / Ross Stores Inc / Webster Financial Corp / Infosys Ltd / Wipro Ltd / SVB Financial Group / Cathay General Bancorp / CVB Financial Corp / BOK Financial Corp / Wintrust Financial Corp / Umpqua Holdings Corp / East West Bancorp Inc / Texas Capital Bancshares Inc / Biogen Inc / Signature Bank / BankUnited Inc / Epam Systems Inc / New York Community Bancorp Inc / TriState Capital Holdings Inc / Applied Genetic Technologies Corp / Burlington Stores Inc / Globant SA / First Foundation Inc / Customers Bancorp Inc / Hope Bancorp Inc / Verona Pharma PLC / Endava PLC / Valley National Bancorp / Purple Innovation Inc / Freeline Therapeutics Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / United Kingdom / India / Ireland / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Record Lows Across Key COVID-19 Metrics Signal New Phase of Pandemic in United States; Early Sign of Waning Outbreak in India</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">FY 3Q21 Financials; Ahem…. ACHM!</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AGTC.O / BIIB.O</td><td class="leftalignment">Applied Genetic Technologies Corp / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Matthew Barcus</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">A Trifecta of Products With a Pipeline Punch; Initiating at Buy and $23 PT</td><td class="leftalignment">English</td><td class="rightalignment">97</td><td class="leftalignment">757468103 / BIIB / 09060J106 / 040047607 / ALLK.OQ / 15671L109 / 23283M101 / 590717104 / 4525EP101 / 617760202 / 45254U101</td><td class="leftalignment">Redhill Biopharma Ltd / Biogen Inc / BioDelivery Sciences International Inc / Arena Pharmaceuticals Inc / Allakos Inc / Avalo Therapeutics Inc / Cytodyn Inc / Mesoblast Ltd / Immunic Inc / MorphoSys AG / Immuron Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Germany / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Raghuram Selvaraju, Ph.D. / Boobalan Pachaiyappan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Have You Read This? Is TRKB the Holy Grail of Antidepressants?</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB / 64125C109 / 6200097 / 78667J108 / 032797300 / 05464T104 / 20451W101 / ADXN.OQ</td><td class="leftalignment">Biogen Inc / Neurocrine Biosciences Inc / Bionomics Ltd / SAGE Therapeutics Inc / Anavex Life Sciences Corp / Axsome Therapeutics Inc / Compass Pathways PLC / Addex Therapeutics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Norway / Singapore / Sweden / Taiwan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">F3Q21 Results; XLRP and ACHM Programs Continue Strong Differentiation</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03820J100 / BIIB</td><td class="leftalignment">Applied Genetic Technologies Corp / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ESALY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ESALY.PK / BIIB.O / EPZM.O / RDHL.O / ABBV.K</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc / Epizyme Inc / Redhill Biopharma Ltd / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Recalibrating Ahead of Adu PDUFA</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Cell Therapy is Coming</td><td class="leftalignment">English</td><td class="rightalignment">330</td><td class="leftalignment">00700210 / 62818Q10 / 09062X103 / 556099109 / 98401F105 / 019770106 / 14757U10 / 03969F109 / 74019P108 / 918640103 / 36251A10 / 52490G10 / 73730P10 / 86877M20</td><td class="leftalignment">Adicet Bio Inc / Mustang Bio Inc / Biogen Inc / MacroGenics Inc / Xencor Inc / Allogene Therapeutics Inc / CASI Pharmaceuticals Inc / Arcus Biosciences Inc / Precision BioSciences Inc / Vaccinex Inc / Celularity Inc / Legend Biotech Corp / Poseida Therapeutics Inc / Surface Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Justin Zelin</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">There's a Lot of Horsepower Under This Hood. Initiating MBIO at Buy with a $11 PT.</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">62818Q10 / 09062X103 / 556099109 / 98401F105 / 019770106 / 74019P108 / 52490G10 / 73730P10 / 00700210</td><td class="leftalignment">Mustang Bio Inc / Biogen Inc / MacroGenics Inc / Xencor Inc / Allogene Therapeutics Inc / Precision BioSciences Inc / Legend Biotech Corp / Poseida Therapeutics Inc / Adicet Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Justin Zelin</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 07, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / TWTR=US / GBT=US / CL=US / AMZN=US / T=US / EBAY=US / INCY=US / GILD=US / VZ=US / IGT=US / VRM=US / BYD=US / SPOT=US / EXPE=US / MGM=US / AKR=US / PENN=US / W=US / DV=US / AMK=US / PATH=US / COLL=US / TREE=US / NOW=US / MCRI=US / REGN=US / SNAP=US / TRIP=US / TRUE=US / VRTX=US / WIX=US / PSA=US / SNOW=US / SGMS=US / NET=US / HIW=US / PYPL=US / BKNG=US / EGP=US / FB=US / MTCH=US / AUTL=US / BDSI=US / RRR=US / PTON=US / BIIB=US / RNG=US / CZR=US / EXR=US / GMS=US / PGTI=US / WH=US / TIL=US / IAC=US / 45665G303 / OLO=US / NLSN=US / ANGI=US / MEIP=US / SSTK=US / ABBV=US / VOYA=US / PTCT=US / FATE=US / GOOGL=US / COUP=US / BABA=US / CMPR=US / VCEL=US / GDDY=US / ETSY=US / ARGX=US / ZG=US / SQ=US / WVE=US / MIME=US / TTD=US / CRSP=US / TRVG=US / GDS=US / CVNA=US / YEXT=US / IOVA=US / RDFN=US / ROKU=US / CARG=US / SFIX=US / ROOT=US / COLD=US / FTDR=US / SVMK=US / EB=US / SITC=US / AMTB=US / LYFT=US / UBER=US / GMAB=US / DKNG=US / CRMD.US / BALY=US / ABNB=US / DASH=US / NGMS=US / COUR-US / KNBE=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Twitter Inc / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / AT&T Inc / eBay Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / International Game Technology PLC / Vroom Inc / Boyd Gaming Corp / Spotify Technology SA / Expedia Group Inc / MGM Resorts International / Acadia Realty Trust / Penn National Gaming Inc / Wayfair Inc / DoubleVerify Holdings Inc / AssetMark Financial Holdings Inc / UiPath Inc / Collegium Pharmaceutical Inc / Lendingtree Inc / ServiceNow Inc / Monarch Casino & Resort Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / TrueCar Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Public Storage / Snowflake Inc. / Scientific Games Corp / Cloudflare Inc / Highwoods Properties Inc / PayPal Holdings Inc / Booking Holdings Inc / Eastgroup Properties Inc / Meta Platforms Inc / Match Group Inc / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Red Rock Resorts Inc / Peloton Interactive Inc / Biogen Inc / RingCentral Inc / Caesars Entertainment Inc / Extra Space Storage Inc / GMS Inc / PGT Innovations Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Olo Inc / Nielsen Holdings PLC / Angi Inc / MEI Pharma Inc / Shutterstock Inc / Abbvie Inc / Voya Financial Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Alphabet Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Cimpress PLC / Vericel Corp / GoDaddy Inc / ETSY Inc / argenx SE / Zillow Group Inc / Block Inc / WAVE Life Sciences Ltd / Mimecast Ltd / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / GDS Holdings Ltd / Carvana Co / Yext Inc / Iovance Biotherapeutics Inc / Redfin Corp / Roku Inc / CarGurus Inc / Stitch Fix Inc / Root Inc / Americold Realty Trust / Frontdoor Inc / Momentive Global Inc / Eventbrite Inc / Site Centers Corp / Amerant Bancorp Inc / Lyft Inc / Uber Technologies Inc / Genmab A/S / DraftKings Inc / CorMedix Inc / Bally's Corp / Airbnb Inc / DoorDash Inc / NeoGames SA / Coursera Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Biogen Fails in XLRP; AGTC Leads The Fray; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.OQ / 03820J100 / BIIB</td><td class="leftalignment">Biogen Inc / Applied Genetic Technologies Corp / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Pantginis, Ph.D. / Ms. Emanuela Branchetti, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 5.16.21</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">ABT / ACAD / 00365410 / 28176E10 / 62855J10 / 01988P10 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 45253H10 / 12665010 / 07181310 / 10113710 / 92532F10 / 88355610 / 35802910 / 94184810 / 04635310 / 43644010 / 76115210 / 64125C10 / 87936910 / 37555810 / 15678210 / 03116210 / 66987V10 / 75886F10 / 46120E60 / M2572210 / 45232710 / 09062X10 / 01625510 / 30063P10 / 478160104 / 98956P10 / 159864107 / 640268108 / 075887109 / 02043Q10 / 67070410 / 207410101 / 205306103 / 45784P10 / 25213110 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 92337F10 / 05463X10 / 45780L10 / 92247510 / 09073M104 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 75046920 / 74587V10 / 00287Y10 / 92346J10 / 98401F10 / 46071F10 / G5960L10 / 46222210 / 18946410 / 04004760 / 04280A10 / 92686J10 / 05337M104 / 23283X20 / 40131M10 / 63230710 / 89853L10 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 90041T10 / 09627Y10 / 68071010 / Y9530810 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 87337910 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 98978L20 / 92857F10 / 04685N10 / 13089P10 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 98887Q10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 80405P10 / N4482110 / 92765F10 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 23306J10 / 34385P10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / H9060V101</td><td class="leftalignment">Abbott Laboratories / ACADIA Pharmaceuticals Inc / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / ImmunoGen Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Vertex Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Fresenius Medical Care AG & Co KGaA / Waters Corp / AstraZeneca PLC / Hologic Inc / Resmed Inc / Neurocrine Biosciences Inc / Teleflex Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Compugen Ltd / Illumina Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Zimmer Biomet Holdings Inc / Charles River Laboratories International Inc / Nektar Therapeutics / Becton Dickinson and Co / Alnylam Pharmaceuticals Inc / NuVasive Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / Veracyte Inc / AxoGen Inc / Inogen Inc / Veeva Systems Inc / Bio-Techne Corp / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Radius Health Inc / Puma Biotechnology Inc / Abbvie Inc / Vericel Corp / Xencor Inc / Intersect Ent Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Viking Therapeutics Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Natera Inc / T2 Biosystems Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Olink Holding AB (publ) / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Tabula Rasa HealthCare Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / Vocera Communications Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Zai Lab Ltd / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Satsuma Pharmaceuticals Inc / InflaRx NV / Viracta Therapeutics Inc / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / DBV Technologies SA / Fluidigm Corp / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / VectivBio Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Biogen Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 547</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">GoodNITE to BIIB’s XLRP Gene Therapy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.OQ / AGTC.O / BIIB.O / AGTC.OQ</td><td class="leftalignment">Biogen Inc / Applied Genetic Technologies Corp / Biogen Inc / Applied Genetic Technologies Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Matthew Barcus</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">ACA / AMN / BSX / CHE / CI / CNC / CVS / HUM / MDT / RAD / SGE.L / SYK / UNH / WMT / NOVN.S / HCA.N / CYH.N / EW.N / ISR / INCY.OQ / BCRX.OQ / ICPT.OQ / UTHR.OQ / NKTR.O / CCRN.O / ICAD.O / LIFE.O / AMED.O / CGEN.O / BIIB.O / 00846U101 / 868168105 / ALNY.OQ / MBRX.OQ / MNKD.O / ATRC.OQ / LHCG.O / CYCC.OQ / B8FGn.DE / INFI.OQ / ALCLS.PA / 02043Q107 / ENSG.OQ / 483548103 / MRNA.O / TMDX.OQ / BBI.O / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / ENTA.O / PRTA.OQ / MRTX.OQ / FATE.OQ / FLXN.OQ / GOOGL.O / 02005N100 / CASI.OQ / XENT.OQ / CBAY.OQ / VBIV.O / CLRB.OQ / OTIC.O / INO.O / VBLT.O / FBIO.OQ / EVH.N / TDOC.N / CFMS.O / APLS.OQ / 100063846 / SSKN.OQ / FLGT.OQ / MDGL.O / SRRA.O / URGN.O / IOVA.OQ / VERU.OQ / CLXT.O / MTEM.O / SVRA.O / SYBX.O / CUE.OQ / FIXX.OQ / 720795103 / BNGO.OQ / ALLO.OQ / MRKR.OQ / ORTX.OQ / SWAV.O / XFOR.OQ / PDSB.OQ / 21833P103 / ORGO.O / IDYA.OQ / BCYC.O / XAIR.OQ / DMTK.O / FREQ.OQ / PNTG.OQ / RLMD.OQ / ETNB.O / HGEN.O / NNOX.O / REGW.M3 / 03823M100 / N69603145</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / IsoRay Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Nektar Therapeutics / Cross Country Healthcare Inc / ICAD Inc / aTyr Pharma Inc / Amedisys Inc / Compugen Ltd / Biogen Inc / Agilent Technologies Inc / Superior Industries International Inc / Alnylam Pharmaceuticals Inc / Moleculin Biotech Inc / MannKind Corp / AtriCure Inc / LHC Group Inc / Cyclacel Pharmaceuticals Inc / Biofrontera AG / Infinity Pharmaceuticals Inc / Cellectis SA / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / Transmedics Group Inc / Brickell Biotech Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Enanta Pharmaceuticals Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Fate Therapeutics Inc / Pacira Biosciences Inc / Alphabet Inc / Ally Financial Inc / CASI Pharmaceuticals Inc / Intersect Ent Inc / Cymabay Therapeutics Inc / VBI Vaccines Inc / Cellectar Biosciences Inc / Otonomy Inc / Inovio Pharmaceuticals Inc / Vascular Biogenics Ltd / Fortress Biotech Inc / Evolent Health Inc / Teladoc Health Inc / Conformis Inc / Apellis Pharmaceuticals Inc / Truist Financial Corp / STRATA Skin Sciences Inc / Fulgent Genetics Inc / Madrigal Pharmaceuticals Inc / Sierra Oncology Inc / Urogen Pharma Ltd / Iovance Biotherapeutics Inc / Veru Inc / Calyxt Inc / Molecular Templates Inc / Savara Inc / Synlogic Inc / Cue Biopharma Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Bionano Genomics Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / Orchard Therapeutics PLC / Shockwave Medical Inc / X4 Pharmaceuticals Inc / PDS Biotechnology Corp / Corbus Pharmaceuticals Holdings Inc / Organogenesis Holdings Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Beyond Air Inc / DermTech Inc / Frequency Therapeutics Inc / Pennant Group Inc / Relmada Therapeutics Inc / 89Bio Inc / Humanigen Inc / Nano-X Imaging Ltd / Regency World Consulting Ltd / Applied Minerals Inc / Pharming Group NV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / India / Ireland / Israel / Nigeria / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">BIIB112 Missed in XLRP; No Change to Model</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Ms. Roanna C. Ruiz</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Mixed Pipeline Updates Unlikely to Shift Sentiment Ahead of Aducanumab PDUFA</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Phase 2/3 study BIIB112 gene therapy for XLRP did not meet endpoint; not in our model</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB - '112 Misses, Not Core Driver but Does Continue to Highlight Pipeline Risk</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 5/7/21</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">NBIX.O / BIIB.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">CI.N / EOG.N / NA / OXB.L / PPG.N / PXD.N / APH.L / GILD.O / TA.TO / DIS.N / NICE.O / MRO.N / PAA.N / DVN.N / EVTG.DE / JAZZ.O / SGMO.O / HCA.N / EXEL.O / CYH.N / ARNA.O / DPH.L / RRC.N / EQT.N / ARE.N / RPM.N / NBIX.O / VTR.N / AJG.N / BMRN.O / OPTN.O / REGN.O / VRTX.O / SWIR.O / SM.N / COP.N / CPE.N / ENDP.O / BLU.N / CHE.N / SWN.N / SGEN.OQ / ONC.TO / HCSG.O / HOOK.O / BLUE.O / BCRX.O / AMED.O / ICPT.O / BIIB.O / TCW.TO / MNKD.OQ / ACAD.O / MPW.N / BLDR.O / LHCG.O / BAM.N / BKD.N / ARWR.O / EHTH.O / 3IN.L / CLR.N / INO.OQ / ENSG.O / NOG.A / AGNC.O / ADUS.OQ / TRGP.N / PCRX.O / MTDR.N / ACHC.O / OPS.TO / VCRA.N / SRPT.O / CLINC.L / FANG.O / ABBV.N / ENTA.O / PTCT.O / PRTA.O / BPY.N / DOC.N / 81762P102 / KPTI.O / XNCR.OQ / ITCI.O / QURE.O / FLXN.O / AGRX.O / HQY.OQ / GUD.TO / CAPL.N / AUPH.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / SGRY.O / RGNX.O / WVE.OQ / MESO.O / IONS.O / TRHC.OQ / RCM.OQ / GOOS.TO / CDEV.O / ESTE.N / OVID.O / ORSTED.CO / EHC.N / WELL.N / AMRX.N / VRCA.OQ / ITRM.O / OPRX.OQ / XERS.O / AQST.O / PRVB.O / NXGN.O / MGTX.O / GMDA.OQ / OSMT.O / HNSA.ST / NBSE.OQ / 269796108 / FIXX.O / KRTX.OQ / MORF.OQ / GMAB.O / APRE.OQ / PNTG.OQ / IGMS.O / PEAK.N / UPR.IR / ETNB.O / OAS.OQ / AZEK.N / SLQT.N / AHCO.O / VMD.OQ / APA.OQ / OTRK.OQ / NRIX.OQ / SPRB.OQ / MTCR.O / GDRX.O / MAX.N / TLMD.OQ / VTRS.OQ / SHC.OQ / PUBM.O / DHT_u.TO / CHK.OQ</td><td class="leftalignment">Cigna Corp / EOG Resources Inc / National Bank of Canada / Oxford BioMedica PLC / PPG Industries Inc / Pioneer Natural Resources Co / Alliance Pharma PLC / Gilead Sciences Inc / TransAlta Corp / Walt Disney Co / Nice Ltd / Marathon Oil Corp / Plains All American Pipeline LP / Devon Energy Corp / Evotec SE / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / HCA Healthcare Inc / Exelixis Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Dechra Pharmaceuticals PLC / Range Resources Corp / EQT Corp / Alexandria Real Estate Equities Inc / RPM International Inc / Neurocrine Biosciences Inc / Ventas Inc / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Sierra Wireless Inc / SM Energy Co / Conocophillips / Callon Petroleum Co / Endo International PLC / BELLUS Health Inc / Chemed Corp / Southwestern Energy Co / Seagen Inc / Oncolytics Biotech Inc / Healthcare Services Group Inc / HOOKIPA Pharma Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Amedisys Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Trican Well Service Ltd / MannKind Corp / ACADIA Pharmaceuticals Inc / Medical Properties Trust Inc / Builders FirstSource Inc / LHC Group Inc / Brookfield Asset Management Inc / Brookdale Senior Living Inc / Arrowhead Pharmaceuticals Inc / eHealth Inc / 3I Infrastructure PLC / Continental Resources Inc / Inovio Pharmaceuticals Inc / Ensign Group Inc / Northern Oil and Gas Inc / AGNC Investment Corp / Addus Homecare Corp / Targa Resources Corp / Pacira Biosciences Inc / Matador Resources Co / Acadia Healthcare Company Inc / Opsens Inc / Vocera Communications Inc / Sarepta Therapeutics Inc / Clinigen Group PLC / Diamondback Energy Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Brookfield Property Partners LP / Physicians Realty Trust / ServiceNow Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Pacira Biosciences Inc / Agile Therapeutics Inc / Healthequity Inc / Knight Therapeutics Inc / Crossamerica Partners LP / Aurinia Pharmaceuticals Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Surgery Partners Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / R1 RCM Inc / Canada Goose Holdings Inc / Centennial Resource Development Inc / Earthstone Energy Inc / Ovid Therapeutics Inc / Orsted A/S / Encompass Health Corp / Welltower Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / NextGen Healthcare Inc / MeiraGTx Holdings PLC / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Hansa Biopharma AB / NeuBase Therapeutics Inc / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Genmab A/S / Aprea Therapeutics Inc / Pennant Group Inc / IGM Biosciences Inc / Healthpeak Properties Inc / Uniphar PLC / 89Bio Inc / Oasis Petroleum Inc / Azek Company Inc / SelectQuote Inc / Adapthealth Corp / Viemed Healthcare Inc / APA Corp (US) / Ontrak Inc / Nurix Therapeutics Inc / Spruce Biosciences Inc / Metacrine Inc / Goodrx Holdings Inc / Mediaalpha Inc / Soc Telemed Inc / Viatris Inc / Sotera Health Co / PubMatic Inc / Dri Healthcare Trust / Chesapeake Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Singapore / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">PRISM Platform Charts Course for ALS and FTD, While Revisiting HD and DMD; Reit Buy and $10 PT</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">Y95308105 / BIIB / 014442107</td><td class="leftalignment">WAVE Life Sciences Ltd / Biogen Inc / Alector Inc</td><td class="leftalignment"></td><td class="leftalignment">Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MUTUAL FUNDS / TRUSTS RESEARCH</td><td class="leftalignment">Andrew S. Fein / Andres Y. Maldonado, PhD / Matthew Caufield / Ananda Ghosh, PhD</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Never Mind The Tape - Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">The Feedback Loop: Catalysts & COVID Edition</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GILD.O / NBIX.O / VRTX.O / HOOK.O / BCRX.O / BIIB.O / SRPT.O / PTCT.O / KPTI.O / 78667J108 / NBSE.OQ / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / SAGE Therapeutics Inc / NeuBase Therapeutics Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FISV=US / MCD=US / OXY=US / WEN=US / DT=US / BLD=US / TXN=US / PEB=US / BC=US / H=US / V=US / MTN=US / DIOD=US / VRM=US / MAR=US / ADS=US / TNL=US / HLT=US / UNM=US / APH=US / CBRL=US / ENV=US / CHH=US / DRI=US / DRH=US / AJG=US / IBP=US / PII=US / WGO=US / SAGE=US / GPN=US / AMSF=US / DIN=US / BIIB=US / APP=US / SHO=US / PLAY=US / DENN=US / BLDR=US / CMG=US / FIS=US / HST=US / MA=US / RPRX=US / EHTH=US / TEL=US / TAST=US / EIG=US / QSR=US / WH=US / JACK=US / HGV=US / NXPI=US / RLJ=US / VAC=US / RHP=US / NDLS=US / MBUU=US / 00770K202 / HTRG=US / LOCO=US / SHAK=US / RLMD=US / WING=US / MCFT=US / AXSM=US / CRSP=US / PK=US / PLYA=US / MPWR-US / EOLS=US / PSNL=US / GOCO=US / ONEM=US / ONEW=US / BIGC=US</td><td class="leftalignment">Fiserv Inc / McDonald's Corp / Occidental Petroleum Corp / Wendys Co / Dynatrace Inc / TopBuild Corp / Texas Instruments Inc / Pebblebrook Hotel Trust / Brunswick Corp / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Diodes Inc / Vroom Inc / Marriott International Inc / Alliance Data Systems Corp / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Unum Group / Amphenol Corp / Cracker Barrel Old Country Store Inc / Envestnet Inc / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Arthur J Gallagher & Co / Installed Building Products Inc / Polaris Inc / Winnebago Industries Inc / SAGE Therapeutics Inc / Global Payments Inc / Amerisafe Inc / Dine Brands Global Inc / Biogen Inc / Applovin Corp / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / Mastercard Inc / Royalty Pharma PLC / eHealth Inc / TE Connectivity Ltd / Carrols Restaurant Group Inc / Employers Holdings Inc / Restaurant Brands International Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Noodles & Co / Malibu Boats Inc / Aemetis Inc / Heritage Insurance Holdings Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Relmada Therapeutics Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Axsome Therapeutics Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Monolithic Power Systems Inc / Evolus Inc / Personalis Inc / Gohealth Inc / 1Life Healthcare Inc / OneWater Marine Inc / Bigcommerce Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ALB.N / CC.N / CCK.N / CE.N / DD.N / EMN.N / F.N / FMC.N / IBE.MC / NA / PPG.N / RWEG.DE / SEE.N / SSE.L / GILD.O / INCY.O / WLK.N / DT.N / EPR.N / OLN.N / SHW.N / OI.N / BLL.N / PCOM.O / NLY.N / RPM.N / SLGN.O / REGN.O / VRTX.O / GPK.N / WES.N / HCC.N / HOOK.O / ICPT.O / BIIB.O / HUN.N / 3IN.L / VMW.N / LYB.N / MSP.N / AMCX.O / WEN.O / SRPT.O / BERY.N / 505440107 / VRNS.O / FLXN.O / AXTA.N / 78667J108 / CRBP.OQ / GLPG.O / RMR.OQ / VNTR.N / ORSTED.CO / STLC.TO / EAF.N / NBSE.OQ / CTVA.N / KRTX.OQ / 260557103 / IGMS.O / ETNB.O / GOCO.O / PTVE.O / 900435207 / ATC.N / CHK.OQ / DSEY.O</td><td class="leftalignment">Albemarle Corp / Chemours Co / Crown Holdings Inc / Celanese Corp / Dupont De Nemours Inc / Eastman Chemical Co / Ford Motor Co / FMC Corp / Iberdrola SA / National Bank of Canada / PPG Industries Inc / Rwe AG / Sealed Air Corp / SSE PLC / Gilead Sciences Inc / Incyte Corp / Westlake Chemical Corp / Dynatrace Inc / EPR Properties / Olin Corp / Sherwin-Williams Co / O-I Glass Inc / Ball Corp / Points International Ltd / Annaly Capital Management Inc / RPM International Inc / Silgan Holdings Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Graphic Packaging Holding Co / Western Midstream Partners LP / Warrior Met Coal Inc / HOOKIPA Pharma Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Huntsman Corp / 3I Infrastructure PLC / VMware Inc / LyondellBasell Industries NV / Datto Holding Corp / AMC Networks Inc / Wendys Co / Sarepta Therapeutics Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / Varonis Systems Inc / Pacira Biosciences Inc / Axalta Coating Systems Ltd / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / RMR Group Inc / Venator Materials PLC / Orsted A/S / Stelco Holdings Inc / GrafTech International Ltd / NeuBase Therapeutics Inc / Corteva Inc / Karuna Therapeutics Inc / Dow Inc / IGM Biosciences Inc / 89Bio Inc / Gohealth Inc / Pactiv Evergreen Inc / Turquoise Hill Resources Ltd / Atotech Ltd / Chesapeake Energy Corp / Diversey Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Top Catalysts in Our Universe to Watch Into Mid-Year</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">NA / GILD.O / INCY.O / VRTX.O / HOOK.O / ICPT.O / BIIB.O / SRPT.O / 78667J108 / CRBP.OQ / GLPG.O / NBSE.OQ / KRTX.OQ / IGMS.O</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / HOOKIPA Pharma Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Sarepta Therapeutics Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Stephen Mallon / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">JPM Global BioPharma : 2021 US Multiple Sclerosis Survey Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">SASY.PA / ROG.S / NOVN.S / MRCG.DE / BIIB.O / TGTX.O / ATRA.O</td><td class="leftalignment">Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / Biogen Inc / TG Therapeutics Inc / Atara Biotherapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Richard B. Vosser / James Scott / Ms. Tessa Romero / Cory W. Kasimov / Mr. Eric Joseph / Anupam Rama / Hannah Adeoye / Mr. Rahul K. Agarwal / James D. Gordon / Ms. Laerke Engkilde / Zain Ebrahim</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Positive data from one of the stroke pipeline drugs</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AAP / INTC.O / MSFT.O / SBH.N / W / AMZN.O / AAPL.O / FIS / NVDA.O / HEAR.O / INTU.O / HRB.N / FISV.O / JKHY.OQ / EGAN.O / GNSS.O / BIIB.O / XPO / 02043Q107 / 771195104 / EA.O / ENTA.O / PRTA.OQ / GOOGL.O / OTIC.O / ZG.OQ / SRRA.O / AKTS.OQ / SONM.O / DKNG.O</td><td class="leftalignment">Advance Auto Parts Inc / Intel Corp / Microsoft Corp / Sally Beauty Holdings Inc / Wayfair Inc / Amazon.com Inc / Apple Inc / Fidelity National Information Services Inc / NVIDIA Corp / Turtle Beach Corp / Intuit Inc / H & R Block Inc / Fiserv Inc / Jack Henry & Associates Inc / eGain Corp / Genasys Inc / Biogen Inc / XPO Logistics Inc / Alnylam Pharmaceuticals Inc / Roche Holding AG / Electronic Arts Inc / Enanta Pharmaceuticals Inc / Prothena Corporation PLC / Alphabet Inc / Otonomy Inc / Zillow Group Inc / Sierra Oncology Inc / Akoustis Technologies Inc / Sonim Technologies Inc / DraftKings Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - 4Q results: A mix of expectations and uncertainties for FY3/22 onward</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - 4Q決算：22/3期以降の業績は期待と不確実性が混在する</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KOL Event Takeaways and 1Q Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PRTA.OQ / BIIB.O / 02043Q107 / 771195104</td><td class="leftalignment">Prothena Corporation PLC / Biogen Inc / Alnylam Pharmaceuticals Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Biogen Inc. (BIIB) - Declining sales of TECFIDERA® and RITUXAN® shows concern</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Vaccinations Reach 46%, Adolescent Approval Likely to Reverse Downward Trend in Administrations; Outbreak in India Continues</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / John Boyle / Sami Corwin, PHD / Lachlan Hanbury-Brown</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AXAF.PA / CCK.N / DD.N / DFDS.CO / RENA.PA / SAND.ST / SSE.L / VOWG_p.DE / CONG.DE / WY.N / CFP.TO / GILD.O / FER.MC / REE.MC / TV.TO / UNP.N / SUN.N / WM.N / MMM.N / CONE.O / OI.N / BLL.N / RSG.N / SLGN.O / ENR.N / VRTX.O / WCN.N / BLU.N / HCC.N / BIIB.O / RUS.TO / MAIN.N / ACAD.O / WEF.TO / 443628102 / PRTS.OQ / DAIGn.DE / GETP.PA / INO.OQ / ABI.BR / PCH.O / CFX.TO / MTOR.N / IFP.TO / RFP.N / PANW.N / BERY.N / 505440107 / PTCT.O / 81762P102 / XNCR.OQ / ITCI.O / QURE.O / RYAM.N / AXTA.N / AENA.MC / RACE.MI / VACN.S / PARR.N / UN01.DE / PVAC.O / OKTA.OQ / STLC.TO / SAIL.N / APTV.N / GTES.N / VCTR.N / ZS.OQ / PRVB.O / 269796108 / MORF.OQ / CRWD.O / CRNC.OQ / GFL.N / MOCORP.HE / RXT.OQ / 900435207 / MAX.N / VTRS.OQ / WFG.N / AFRM.O / ATC.N / TSP.OQ</td><td class="leftalignment">AXA SA / Crown Holdings Inc / Dupont De Nemours Inc / DFDS AS / Renault SA / Sandvik AB / SSE PLC / Volkswagen AG / Continental AG / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Ferrovial SA / Red Electrica Corporacion SA / Trevali Mining Corp / Union Pacific Corp / Sunoco LP / Waste Management Inc / 3M Co / CyrusOne Inc / O-I Glass Inc / Ball Corp / Republic Services Inc / Silgan Holdings Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / Waste Connections Inc / BELLUS Health Inc / Warrior Met Coal Inc / Biogen Inc / Russel Metals Inc / Main Street Capital Corp / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Hudbay Minerals Inc / Carparts.Com Inc / Daimler AG / Getlink SE / Inovio Pharmaceuticals Inc / Anheuser Busch Inbev SA / Potlatchdeltic Corp / Canfor Pulp Products Inc / Meritor Inc / Interfor Corp / Resolute Forest Products Inc / Palo Alto Networks Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / PTC Therapeutics Inc / ServiceNow Inc / Xencor Inc / Intra-Cellular Therapies Inc / Uniqure NV / Rayonier Advanced Materials Inc / Axalta Coating Systems Ltd / Aena SME SA / Ferrari NV / VAT Group AG / Par Pacific Holdings Inc / Uniper SE / Ranger Oil Corp / Okta Inc / Stelco Holdings Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Gates Industrial Corporation PLC / Victory Capital Holdings Inc / Zscaler Inc / Provention Bio Inc / Eagle Pharmaceuticals Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / Cerence Inc / GFL Environmental Inc / Metso Outotec Corp / Rackspace Technology Inc / Turquoise Hill Resources Ltd / Mediaalpha Inc / Viatris Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Atotech Ltd / TuSimple Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Luxembourg / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read & Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / VRTX.O / BLU.N / BIIB.O / ACAD.O / PTCT.O / XNCR.OQ / PRVB.O / MORF.OQ</td><td class="leftalignment">Gilead Sciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / PTC Therapeutics Inc / Xencor Inc / Provention Bio Inc / Morphic Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 546</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Andy T. Hsieh, PHD / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">CH0012221716 / US0079031078 / US0382221051 / US2371941053 / US4581401001 / US5128071082 / US55306N1046 / US5951121038 / US67066G1040 / US8807701029 / US9581021055 / US83088M1027 / US0003752047 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / US5380341090 / US82706C1080 / US64110D1046 / IE00B58JVZ52 / NL0010273215 / US0465131078 / US74736K1016 / US00653A1079 / US74624M1027 / US05464T1043 / US00773U1088 / KYG4740B1059 / US0197701065 / US0144421072 / US55087P1049 / US90353T1007 / US09203E1055 / US26142R1041 / CH0499880968 / US5738741041</td><td class="leftalignment">Abb Ltd / Advanced Micro Devices Inc / Applied Materials Inc / Darden Restaurants Inc / Intel Corp / Lam Research Corp / MKS Instruments Inc / Micron Technology Inc / NVIDIA Corp / Teradyne Inc / Western Digital Corp / Skyworks Solutions Inc / Abb Ltd / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Live Nation Entertainment Inc / Silicon Motion Technology Corp / NetApp Inc / Seagate Technology Holdings PLC / ASML Holding NV / Atara Biotherapeutics Inc / Qorvo Inc / Adaptimmune Therapeutics PLC / Pure Storage Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Ichor Holdings Ltd / Allogene Therapeutics Inc / Alector Inc / Lyft Inc / Uber Technologies Inc / Black Diamond Therapeutics Inc / DraftKings Inc / ADC Therapeutics SA / Marvell Technology Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--May 07, 2021</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / GE / HUM / MDT / RAD / SGE.L / SYK / UNH / WMT / GILD.O / AMGN.O / AAPL.O / NOVN.S / HCA.N / CYH.N / INSP.N / EW.N / DRRX.O / INCY.OQ / NBIX.OQ / EPIX.OQ / ICPT.OQ / UTHR.OQ / EXEL.OQ / BLUE.OQ / VRTX.OQ / CCRN.O / LIFE.O / AMED.O / EXAS.O / BIIB.O / 478160104 / 00846U101 / 868168105 / MNKD.O / ACAD.O / ATRC.OQ / DXCM.O / LHCG.O / ALCLS.PA / BLRX.TA / PODD.O / 02043Q107 / ENSG.OQ / TNDM.O / 483548103 / SPRO.OQ / MRNA.O / TMDX.OQ / MD.N / 771195104 / CSII.O / ADUS.O / USPH.N / GLAXOSM.LG / SRPT.O / ENTA.O / FATE.OQ / AUP.TO / AERI.O / TRVN.O / GLMD.OQ / GOOGL.O / ALDX.OQ / MDWD.O / 02005N100 / AGRX.OQ / CBAY.OQ / APS.TO / VKTX.O / NVRO.N / VCEL.O / VRAY.OQ / EVH.N / TDOC.N / MCRB.OQ / GKOS.K / ZBH.N / CFMS.O / GBT.OQ / 100063846 / EDIT.OQ / NVTA.K / ADAP.O / NTLA.O / SYRS.OQ / TCMD.OQ / FLGT.OQ / IRTC.OQ / MDGL.O / VREX.OQ / SLNO.OQ / IOVA.OQ / VERU.OQ / KALA.O / ATNX.O / FIXX.OQ / 720795103 / PRVB.OQ / ARVN.OQ / ALLO.OQ / MRKR.OQ / CRSP.BN / XFOR.OQ / 21833P103 / DTIL.O / IMUX.O / TPTX.O / ONCT.OQ / KRTX.OQ / PSNL.O / PNTG.OQ / BXRX.OQ / ETNB.O / ORIC.OQ / PHGE.K / HGEN.O / REGW.M3 / 03823M100</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / General Electric Co / Humana Inc / Medtronic PLC / Rite Aid Corp / Sage Group PLC / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / Amgen Inc / Apple Inc / Novartis AG / HCA Healthcare Inc / Community Health Systems Inc / Inspire Medical Systems Inc / Edwards Lifesciences Corp / DURECT Corp / Incyte Corp / Neurocrine Biosciences Inc / ESSA Pharma Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Exelixis Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / aTyr Pharma Inc / Amedisys Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / MannKind Corp / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / LHC Group Inc / Cellectis SA / BioLine RX Ltd / Insulet Corp / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Kaman Corp / Spero Therapeutics Inc / Moderna Inc / Transmedics Group Inc / MEDNAX Inc / Roche Holding AG / Cardiovascular Systems Inc / Addus Homecare Corp / US Physical Therapy Inc / Glaxo Smithkline Consumer Nigeria PLC / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Galmed Pharmaceuticals Ltd / Alphabet Inc / Aldeyra Therapeutics Inc / Mediwound Ltd / Ally Financial Inc / Agile Therapeutics Inc / Cymabay Therapeutics Inc / Aptose Biosciences Inc / Viking Therapeutics Inc / Nevro Corp / Vericel Corp / ViewRay Inc / Evolent Health Inc / Teladoc Health Inc / Seres Therapeutics Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / Conformis Inc / Global Blood Therapeutics Inc / Truist Financial Corp / Editas Medicine Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Intellia Therapeutics Inc / Syros Pharmaceuticals Inc / Tactile Systems Technology Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Madrigal Pharmaceuticals Inc / Varex Imaging Corp / Soleno Therapeutics Inc / Iovance Biotherapeutics Inc / Veru Inc / Kala Pharmaceuticals Inc / Athenex Inc / Homology Medicines Inc / Pieris Pharmaceuticals Inc / Provention Bio Inc / Arvinas Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / CRISPR Therapeutics AG / X4 Pharmaceuticals Inc / Corbus Pharmaceuticals Holdings Inc / Precision BioSciences Inc / Immunic Inc / Turning Point Therapeutics Inc / Oncternal Therapeutics Inc / Karuna Therapeutics Inc / Personalis Inc / Pennant Group Inc / Baudax Bio Inc / 89Bio Inc / Oric Pharmaceuticals Inc / Biomx Inc / Humanigen Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / India / Ireland / Israel / Nigeria / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 4/30/21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">NBIX.O / BIIB.O / ACOR.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Acorda Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator: Key Takeaways From Psychiatric Disorder Expert Call With Sanjay Mathew, M.D.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103 / 78667J108 / 98420N105 / 03836N103 / 05464T104 / 74006W108 / 92840H202</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / Xenon Pharmaceuticals Inc / Aptinyx Inc / Axsome Therapeutics Inc / Praxis Precision Medicines Inc / VistaGen Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : It's the Final Countdown (For Real This Time)...Doc / Buyside Surveys Ahead of the Adu PDUFA</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : Aducanumab Doc Poll #3 and (Previous) Buyside Survey</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Didn’t See That Coming – Positive Fund Flow Continues</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 45790W108 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201 / 49705R105</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Inozyme Pharma Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Mixed ICER Updates Ahead of Aducanumab PDUFA</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Ms. Roanna C. Ruiz</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Simoa Value Proposition Continues to Strengthen for NDD Drug Pipeline Globally and Much More; Reiterate Buy and $92 PT Post-1Q21</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">74766Q101 / 09062X103 / 452327109</td><td class="leftalignment">Quanterix Corp / Biogen Inc / Illumina Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Sung Ji Nam / Janet Zhang</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Today's NeuroNavigator Calls: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">One Up; One Down: HAE Moves into Phase III While ENaC Is Discontinued</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">IONS.OQ / BIIB.O</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter / Zhiqi He, Ph.D., CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BXP-US -  Dividend Quality Analysis, for the period ended April 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BXP / MSFT.O / BIIB.O / MAR.O / PTC.O / GOOGL.O</td><td class="leftalignment">Boston Properties Inc / Microsoft Corp / Biogen Inc / Marriott International Inc / PTC Inc / Alphabet Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended May 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB: Adu ICER Draft Report - Though Readthroughs Limited - Reminds Again On Key Concerns</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Biogen Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">AME / CMI / CRM.N / CSL / CVS / GE / INTC.O / KKR / MDT / MSFT.O / NICE.TA / RXN / SGE.L / T.N / AMZN.O / AMGN.O / AAPL.O / WTS.N / NVDA.O / DISH.O / HEAR.O / OUT / MPWR.O / VECO.O / INSP.N / SMTC.O / GPN / DRRX.O / AOS.N / CSCO.OQ / CRUS.OQ / JKHY.OQ / ATVI.OQ / INCY.OQ / TTWO.OQ / AKAM.OQ / VRTX.OQ / TXN.OQ / LPSN.O / EXAS.O / BIIB.O / 478160104 / AYX / DENN.O / 36467W109 / AIMC.O / 02043Q107 / 514766104 / MRNA.O / TMDX.OQ / NXPI.O / AMRC.K / ZNGA.O / EA.O / ADI.OQ / FB.O / HASI.N / RNG.N / 82655M107 / PAYC.K / SABR.O / AGRX.OQ / ANET.K / APS.TO / MCRB.OQ / ZBH.N / ZG.OQ / TMUS.OQ / NVTA.K / APL.PS / UAA / VREX.OQ / EGHT.K / BILI.O / ARVN.OQ / ZM.OQ / VG.O / REGW.M3 / HUYA.K / 03823M100</td><td class="leftalignment">AMETEK Inc / Cummins Inc / Salesforce.Com Inc / Carlisle Companies Inc / CVS Health Corp / General Electric Co / Intel Corp / KKR & Co Inc / Medtronic PLC / Microsoft Corp / Nice Ltd / Zurn Water Solutions Corp / Sage Group PLC / AT&T Inc / Amazon.com Inc / Amgen Inc / Apple Inc / Watts Water Technologies Inc / NVIDIA Corp / DISH Network Corp / Turtle Beach Corp / OUTFRONT Media Inc / Monolithic Power Systems Inc / Veeco Instruments Inc / Inspire Medical Systems Inc / Semtech Corp / Global Payments Inc / DURECT Corp / A O Smith Corp / Cisco Systems Inc / Cirrus Logic Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Incyte Corp / Take-Two Interactive Software Inc / Akamai Technologies Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / LivePerson Inc / Exact Sciences Corp / Biogen Inc / Johnson & Johnson / Alteryx Inc / Denny's Corp / GameStop Corp / Altra Industrial Motion Corp / Alnylam Pharmaceuticals Inc / Landec Corp / Moderna Inc / Transmedics Group Inc / NXP Semiconductors NV / Ameresco Inc / Zynga Inc / Electronic Arts Inc / Analog Devices Inc / Meta Platforms Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / RingCentral Inc / Sify Technologies Ltd / Paycom Software Inc / Sabre Corp / Agile Therapeutics Inc / Arista Networks Inc / Aptose Biosciences Inc / Seres Therapeutics Inc / Zimmer Biomet Holdings Inc / Zillow Group Inc / T-Mobile US Inc / Invitae Corp / Apollo Global Capital Inc / Under Armour Inc / Varex Imaging Corp / 8x8 Inc / Bilibili Inc / Arvinas Inc / Zoom Video Communications Inc / Vonage Holdings Corp / Regency World Consulting Ltd / HUYA Inc / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / India / Ireland / Israel / Netherlands / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Sage-718 Is Latest Asset to Advance in Rich Pipeline on 1Q Call as We Await WATERFALL; Reiterate Neutral</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">78667J108 / BIIB</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Douglas D. Tsao</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">1Q21 Review: Biotech Jewel on the Cheap; Upgrading to Outperform with $205 PT</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AMGN.O / VRTX.OQ / BIIB.O / 478160104 / 02043Q107 / MRNA.O / REGW.M3 / 03823M100</td><td class="leftalignment">Amgen Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Alnylam Pharmaceuticals Inc / Moderna Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">India / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Hartaj K. Singh / Mr. Justin A. Kim / Yichuan (Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">1Q21 Update, Chasing WATERFALL</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">SGE.L / BIIB.O</td><td class="leftalignment">Sage Group PLC / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BXP-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BXP / MSFT.O / BIIB.O / MAR.O / PTC.O / GOOGL.O</td><td class="leftalignment">Boston Properties Inc / Microsoft Corp / Biogen Inc / Marriott International Inc / PTC Inc / Alphabet Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ALXN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIOb / JNJ / GILD.O / REGN.O / VRTX.O / RARE.O / BIIB.O / SRPT.O / AGIO.O / QGEN.K</td><td class="leftalignment">Bio Rad Laboratories Inc / Johnson & Johnson / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Biogen Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Qiagen NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Biogen Idec</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">First-Dose Vaccinations Continue to Decline; Outbreak in India Continues, Showing Initial Signs of Slowing Growth</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / SUN.BO / NOVOB.CO / NOVN.S / 4768.T / GSK.L / UCB.BR / AMGN.OQ / ALKS.OQ / GILD.OQ / UTHR.OQ / BIIB.OQ / 4568.T / TEVA.N / ALM.MC / BAYGN.DE / 4578.T / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Alkermes Plc / Gilead Sciences Inc / United Therapeutics Corp / Biogen Inc / Daiichi Sankyo Co Ltd / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Otsuka Holdings Co Ltd / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: April 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ALB.N / AN.N / AR.N / AXP.N / BAC.N / BAX.N / BDX.N / BSX.N / C.N / CL.N / CNC.N / COF.N / CRM.N / ED.N / EIX.N / EOG.N / FCX.N / GE.N / GM.N / GPS.N / IBM.N / JPM.N / KMB.N / KO.N / LLY.N / LMT.N / MRK.N / OXY.N / TXT.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / DHR.N / DIS.N / UNH.N / FE.N / URI.N / DE.N / CAT.N / SPOT.N / AMG.N / GS.N / CLX.N / HON.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / RMD.N / NKE.N / LIN.N / OLN.N / TGT.N / AVY.N / PKI.N / VZ.N / NYT.N / KSS.N / HRB.N / ORCL.N / KMX.N / PWR.N / COG.N / V.N / HWM.N / ACN.N / WSM.N / AIV.N / HAE.N / LB.TO / BLK.N / CVX.N / MHK.N / NWS.AX / IRM.N / NCR.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / ADSK.OQ / CSCO.OQ / COHR.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / PII.N / REGN.OQ / SIVB.OQ / XLNX.OQ / QDEL.OQ / QCOM.OQ / GILD.OQ / DFS.N / INCY.OQ / PENN.OQ / TPR.N / CTXS.OQ / VSAT.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / NVDA.OQ / BMRN.OQ / PACW.OQ / EXPE.OQ / TREE.OQ / MRVL.OQ / BLUE.OQ / ARRY.OQ / ALGN.OQ / SGEN.OQ / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / CMCSA.OQ / BIIB.OQ / SNX.N / TPX.N / SBNY.OQ / AGO.N / ACAD.OQ / MOS.N / MKTX.OQ / DXCM.OQ / WAL.N / MS.N / STX.AX / MA.N / AWI.N / FSLR.OQ / IVZ.N / CLR.N / QGEN.N / TDC.N / SATS.OQ / MRNA.OQ / NWSA.OQ / AGCO.N / AVGO.OQ / VRSK.OQ / SCHW.N / FTNT.OQ / GNRC.N / TSLA.OQ / NXPI.OQ / ADSGN.F / LPLA.OQ / AMD.OQ / XYL.N / SLM.OQ / ENPH.OQ / TRIP.OQ / GWRE.N / SPLK.OQ / NOW.N / SRPT.OQ / ALLY.N / FANG.OQ / BFAM.N / PRGO.N / COTY.N / RNG.N / MAR.OQ / PTC.OQ / GOOGL.OQ / PAYC.N / EQC.N / HUBS.N / ETSY.OQ / PYPL.OQ / GBT.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / IONS.OQ / RETA.OQ / TWLO.N / COUP.OQ / CDEV.OQ / AYX.N / CVNA.N / VST.N / IOVA.OQ / ROKU.OQ / PEP.OQ / ZS.OQ / FB.PS / STNE.OQ / CPRI.N / PINS.N / FSLY.N / LHX.N / PTON.OQ / NLOK.OQ / RTX.N / CARR.N / LMND.N / AMWL.N / VTRS.OQ</td><td class="leftalignment">Albemarle Corp / AutoNation Inc / Antero Resources Corp / American Express Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Citigroup Inc / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / Consolidated Edison Inc / Edison International / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Gap Inc / International Business Machines Corp / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Merck & Co Inc / Occidental Petroleum Corp / Textron Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Caterpillar Inc / Spotify Technology SA / Affiliated Managers Group Inc / Goldman Sachs Group Inc / Clorox Co / Honeywell International Inc / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Resmed Inc / Nike Inc / Linde PLC / Olin Corp / Target Corp / Avery Dennison Corp / PerkinElmer Inc / Verizon Communications Inc / New York Times Co / Kohls Corp / H & R Block Inc / Oracle Corp / Carmax Inc / Quanta Services Inc / Coterra Energy Inc / Visa Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Haemonetics Corp / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Mohawk Industries Inc / News Corp / Iron Mountain Inc / NCR Corp / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Autodesk Inc / Cisco Systems Inc / Coherent Inc / Hologic Inc / Lam Research Corp / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / SVB Financial Group / Xilinx Inc / Quidel Corp / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Incyte Corp / Penn National Gaming Inc / Tapestry Inc / Citrix Systems Inc / ViaSat Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / PacWest Bancorp / Expedia Group Inc / Lendingtree Inc / Marvell Technology Inc / bluebird bio Inc / Array Technologies Inc / Align Technology Inc / Seagen Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Comcast Corp / Biogen Inc / TD Synnex Corp / Tempur Sealy International Inc / Signature Bank / Assured Guaranty Ltd / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Dexcom Inc / Western Alliance Bancorp / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Armstrong World Industries Inc / First Solar Inc / Invesco Ltd / Continental Resources Inc / Qiagen NV / Teradata Corp / EchoStar Corp / Moderna Inc / News Corp / AGCO Corp / Broadcom Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Generac Holdings Inc / Tesla Inc / NXP Semiconductors NV / Adidas AG / LPL Financial Holdings Inc / Advanced Micro Devices Inc / Xylem Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Guidewire Software Inc / Splunk Inc / ServiceNow Inc / Sarepta Therapeutics Inc / Ally Financial Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / Perrigo Company PLC / Coty Inc / RingCentral Inc / Marriott International Inc / PTC Inc / Alphabet Inc / Paycom Software Inc / Equity Commonwealth / HubSpot Inc / ETSY Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Centennial Resource Development Inc / Alteryx Inc / Carvana Co / Vistra Corp / Iovance Biotherapeutics Inc / Roku Inc / PepsiCo Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Capri Holdings Ltd / Pinterest Inc / Fastly Inc / L3harris Technologies Inc / Peloton Interactive Inc / NortonLifeLock Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / American Well Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Germany / Ireland / Luxembourg / Netherlands / Philippines / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">1Q21 - Recent Hunter Syndrome Data Leave TV Platform Well-Positioned Ahead of Aducanumab PDUFA</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">24823R105 / 09062X103</td><td class="leftalignment">Denali Therapeutics Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Mr. Julian Harrison / Ms. Kaveri Pohlman</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Things You Might Have Missed: SOBP 2021 Highlights Novel Mechanisms of Action and Use of Big Data to Source Patients</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103 / 78667J108 / 03836N103 / 74006W108 / 92840H202</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / Aptinyx Inc / Praxis Precision Medicines Inc / VistaGen Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Wedbush Monthly Check-Up: May 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">DNLI.O / NBIX.O / UTHR.O / BMRN.O / SWTX.O / RARE.O / ICPT.O / BIIB.O / ACOR.O / LXRX.O / IDRA.O / OMER.O / PCRX.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / ARGX.BR / SAGE.O / PRTK.O / XENE.O / CDTX.O / ABUS.O / GBT.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / SYRS.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / KALA.O / OBSV.O / FENC.O / APLS.O / SURF.O / KNSA.O / SRRK.O / APTX.O / LQDA.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / ALNA.O / ETTX.O / HARP.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BCEL.O / FUSN.O / RCUS.K</td><td class="leftalignment">Denali Therapeutics Inc / Neurocrine Biosciences Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Acorda Therapeutics Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / argenx SE / SAGE Therapeutics Inc / Paratek Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Arbutus Biopharma Corp / Global Blood Therapeutics Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Syros Pharmaceuticals Inc / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Kala Pharmaceuticals Inc / Obseva SA / Fennec Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Aptinyx Inc / Liquidia Corp / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Allena Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Harpoon Therapeutics Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Atreca Inc / Fusion Pharmaceuticals Inc / Arcus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Kenneth Shields / Matthew Barcus / Shveta Dighe / Mr. Andreas Argyrides</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 3 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MOGa / US0116591092 / US0231351067 / US0463531089 / US0758871091 / US1101221083 / US14149Y1082 / US37733W1053 / US4234521015 / US5324571083 / US58155Q1031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US03073E1055 / US4771431016 / US4198791018 / US80105N1054 / US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US5380341090 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US7185461040 / US69318G1067 / US00287Y1091 / US55345K1034 / US8485771021 / US21240E1055 / US02376R1023 / US94419L1017 / US0465131078 / CA0089118776 / US00653A1079 / US05464T1043 / US00773U1088 / GB00BDSFG982 / US7493971052 / US02156B1035 / US5904791358 / US0197701065 / US0144421072 / US5024311095 / US70614W1009 / US09203E1055 / US26142R1041 / CH0499880968 / US15872M1045 / US44891N1090 / US69353Y1038 / US62955J1034</td><td class="leftalignment">Moog Inc / Alaska Air Group Inc / Amazon.com Inc / AstraZeneca PLC / Becton Dickinson and Co / Bristol-Myers Squibb Co / Cardinal Health Inc / GlaxoSmithKline PLC / Helmerich and Payne Inc / Eli Lilly and Co / Mckesson Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Amerisourcebergen Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Live Nation Entertainment Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Phillips 66 / PBF Energy Inc / Abbvie Inc / MRC Global Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Wayfair Inc / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / TechnipFMC PLC / R1 RCM Inc / Alteryx Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / L3harris Technologies Inc / Peloton Interactive Inc / Black Diamond Therapeutics Inc / DraftKings Inc / ADC Therapeutics SA / ChampionX Corp / IAC/Interactivecorp / PMV Pharmaceuticals Inc / Nov Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - May 03 2021 6:54AM</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">7974.T / AMC / AX / CCS / GME / IBM / INTC.O / KBH / MSFT.O / TPH / UBIP.PA / ASND.O / AAPL.O / ATVI.O / DNLI.O / NVDA.O / TTWO.O / SGMO.O / AMD.O / NTAP.O / NBIX.O / UTHR.O / XOMA.O / 5425.TWO / 2454.TW / MU.O / MRVL.O / HPE / AVGO.O / SWTX.O / RARE.O / BLUE.O / SWKS.O / BIIB.O / BLDR.O / STX.O / SIMO.O / VMW / IDRA.O / OMER.O / PCRX.O / ANGI.O / ZNGA.O / EA.O / WDC.O / RGLS.O / TMHC.K / EPZM.O / MGNX.O / FATE.O / LGIH.O / KPTI.O / XNCR.O / GOOGL.O / AGTC.O / DOOR.K / ARGX.BR / SAGE.O / PRTK.O / XENE.O / QRVO.O / CDTX.O / ABUS.O / PSTG.K / NVCR.O / CTMX.O / VYGR.O / KURA.O / IAC.O / BPMC.O / NTLA.O / CLSD.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / APLS.O / SURF.O / KNSA.O / SRRK.O / MGTA.O / AVRO.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / ORTX.O / DELL.K / HARP.O / LYFT.O / IMUX.O / TPTX.O / ISEE.O / UBER.K / AXLA.O / SCPL.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BEAM.O / BCEL.O / GBIO.O / FUSN.O / ITOS.O / FRLN.O / RCUS.K / INZY.O</td><td class="leftalignment">Nintendo Co Ltd / AMC Entertainment Holdings Inc / Axos Financial Inc / Century Communities Inc / GameStop Corp / International Business Machines Corp / Intel Corp / KB Home / Microsoft Corp / Tri Pointe Homes Inc (Delaware) / Ubisoft Entertainment SA / Ascendis Pharma A/S / Apple Inc / Activision Blizzard Inc / Denali Therapeutics Inc / NVIDIA Corp / Take-Two Interactive Software Inc / Sangamo Therapeutics Inc / Advanced Micro Devices Inc / NetApp Inc / Neurocrine Biosciences Inc / United Therapeutics Corp / XOMA Corp / Taiwan Semiconductor Co Ltd / MediaTek Inc / Micron Technology Inc / Marvell Technology Inc / Hewlett Packard Enterprise Co / Broadcom Inc / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / bluebird bio Inc / Skyworks Solutions Inc / Biogen Inc / Builders FirstSource Inc / Seagate Technology Holdings PLC / Silicon Motion Technology Corp / VMware Inc / Idera Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Angi Inc / Zynga Inc / Electronic Arts Inc / Western Digital Corp / Regulus Therapeutics Inc / Taylor Morrison Home Corp / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / LGI Homes Inc / Karyopharm Therapeutics Inc / Xencor Inc / Alphabet Inc / Applied Genetic Technologies Corp / Masonite International Corp / argenx SE / SAGE Therapeutics Inc / Paratek Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Arbutus Biopharma Corp / Pure Storage Inc / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / IAC/Interactivecorp / Blueprint Medicines Corp / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / AVROBIO Inc / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Orchard Therapeutics PLC / Dell Technologies Inc / Harpoon Therapeutics Inc / Lyft Inc / Immunic Inc / Turning Point Therapeutics Inc / Iveric Bio Inc / Uber Technologies Inc / Axcella Health Inc / Sciplay Corp / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Beam Therapeutics Inc / Atreca Inc / Generation Bio Co / Fusion Pharmaceuticals Inc / Iteos Therapeutics Inc / Freeline Therapeutics Holdings PLC / Arcus Biosciences Inc / Inozyme Pharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Wedbush Research</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / GBT=US / CL=US / AMZN=US / DVN=US / GILD=US / EOG=US / REI=US / CHTR=US / XOM=US / WLL=US / PXD=US / HSII=US / SWN=US / VRM=US / MRO=US / EXPE=US / KFRC=US / MANH=US / NWL=US / W=US / DISH=US / KFY=US / AMN=US / B=US / BMRN=US / COLL=US / EXPO=US / GFF=US / LH=US / TREE=US / MAN=US / HZO=US / MHK=US / ASGN=US / RARE=US / RHI=US / SGMO=US / STRA=US / SNAP=US / THO=US / TRIP=US / VRTX=US / WIX=US / WGO=US / CVX=US / SAGE=US / CCRN=US / BKNG=US / CFR=US / FB=US / ENSG=US / AMSF=US / VICI=US / MGP=US / BDSI=US / MRNS=US / PTON=US / PRG=US / BIIB=US / MOG.A=US / APTX=US / NUVA=US / WMG=US / AAWW=US / NSP=US / CPRX=US / EIG=US / QSR=US / CLR=US / TIL=US / NOG=US / CWH=US / RCUS=US / KNSL=US / OLO=US / ESTE=US / ANGI=US / FANG=US / ABBV=US / GLPI=US / CNCE=US / GOOGL=US / FIVN=US / HTRG=US / BABA=US / CMPR=US / WK=US / RLMD=US / GDDY=US / ETSY=US / VKTX=US / ARGX=US / NVCR=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / EVBG=US / CRSP=US / PVAC=US / ANAB=US / JELD=US / CVNA=US / VRNA=US / SBOW=US / IOVA=US / SFIX=US / LAZY=US / FTDR=US / SVMK=US / ARVN=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / LHX=US / OVV=US / ONEW=US / CRMD.US / DASH=US / COUR-US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / Devon Energy Corp / Gilead Sciences Inc / EOG Resources Inc / Ring Energy Inc / Charter Communications Inc / Exxon Mobil Corp / Whiting Petroleum Corp / Pioneer Natural Resources Co / Heidrick & Struggles International Inc / Southwestern Energy Co / Vroom Inc / Marathon Oil Corp / Expedia Group Inc / Kforce Inc / Manhattan Associates Inc / Newell Brands Inc / Wayfair Inc / DISH Network Corp / Korn Ferry / AMN Healthcare Services Inc / Barnes Group Inc / Biomarin Pharmaceutical Inc / Collegium Pharmaceutical Inc / Exponent Inc / Griffon Corp / Laboratory Corporation of America Holdings / Lendingtree Inc / ManpowerGroup Inc / MarineMax Inc / Mohawk Industries Inc / ASGN Inc / Ultragenyx Pharmaceutical Inc / Robert Half International Inc / Sangamo Therapeutics Inc / Strategic Education Inc / Snap Inc / Thor Industries Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Winnebago Industries Inc / Chevron Corp / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Cullen/Frost Bankers Inc / Meta Platforms Inc / Ensign Group Inc / Amerisafe Inc / VICI Properties Inc / MGM Growth Properties LLC / BioDelivery Sciences International Inc / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / PROG Holdings Inc / Biogen Inc / Moog Inc / Aptinyx Inc / NuVasive Inc / Warner Music Group Corp / Atlas Air Worldwide Holdings Inc / Insperity Inc / Catalyst Pharmaceuticals Inc / Employers Holdings Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Camping World Holdings Inc / Arcus Biosciences Inc / Kinsale Capital Group Inc / Olo Inc / Earthstone Energy Inc / Angi Inc / Diamondback Energy Inc / Abbvie Inc / Gaming and Leisure Properties Inc / Concert Pharmaceuticals Inc / Alphabet Inc / Five9 Inc / Heritage Insurance Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / Workiva Inc / Relmada Therapeutics Inc / GoDaddy Inc / ETSY Inc / Viking Therapeutics Inc / argenx SE / Novocure Ltd / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Everbridge Inc / CRISPR Therapeutics AG / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Carvana Co / Verona Pharma PLC / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Stitch Fix Inc / Lazydays Holdings Inc / Frontdoor Inc / Momentive Global Inc / Arvinas Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / L3harris Technologies Inc / Ovintiv Inc / OneWater Marine Inc / CorMedix Inc / DoorDash Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AX / ASND.O / DNLI.O / SGMO.O / AMD.O / NBIX.O / UTHR.O / XOMA.O / SWTX.O / RARE.O / BLUE.O / BIIB.O / IDRA.O / OMER.O / PCRX.O / RGLS.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / AGTC.O / ARGX.BR / SAGE.O / PRTK.O / XENE.O / CDTX.O / ABUS.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / NTLA.O / CLSD.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / APLS.O / SURF.O / KNSA.O / SRRK.O / MGTA.O / AVRO.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / ORTX.O / HARP.O / IMUX.O / TPTX.O / ISEE.O / AXLA.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BEAM.O / BCEL.O / GBIO.O / FUSN.O / ITOS.O / FRLN.O / RCUS.K / INZY.O</td><td class="leftalignment">Axos Financial Inc / Ascendis Pharma A/S / Denali Therapeutics Inc / Sangamo Therapeutics Inc / Advanced Micro Devices Inc / Neurocrine Biosciences Inc / United Therapeutics Corp / XOMA Corp / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / bluebird bio Inc / Biogen Inc / Idera Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Regulus Therapeutics Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / argenx SE / SAGE Therapeutics Inc / Paratek Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Arbutus Biopharma Corp / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / AVROBIO Inc / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Orchard Therapeutics PLC / Harpoon Therapeutics Inc / Immunic Inc / Turning Point Therapeutics Inc / Iveric Bio Inc / Axcella Health Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Beam Therapeutics Inc / Atreca Inc / Generation Bio Co / Fusion Pharmaceuticals Inc / Iteos Therapeutics Inc / Freeline Therapeutics Holdings PLC / Arcus Biosciences Inc / Inozyme Pharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD / Shveta Dighe / Matthew Barcus / Kenneth Shields / Mr. Andreas Argyrides</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator REMINDER: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Pain-Free Genomic Diagnostics for Skin Cancer and Beyond; Initiating at Buy and $53 PT</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">24984k10 / 09062X103 / 30063P105 / 14843C105 / 00650F109 / 92337F107 / 40131M10 / 14167L10 / 71535D10 / 63230710 / 09075X10</td><td class="leftalignment">DermTech Inc / Biogen Inc / Exact Sciences Corp / Castle Biosciences Inc / Adaptive Biotechnologies Corp / Veracyte Inc / Guardant Health Inc / CareDx Inc / Personalis Inc / Natera Inc / Biodesix Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Sung Ji Nam / Janet Zhang</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen's Biotech Thermometer</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US0465131078 / US00653A1079 / US05464T1043 / US00773U1088 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">05/02/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Time for Pivotal Trials. DNL151 HV and Pt Data Support LRRK2 MOA. Treatment Effect Size and Detailed Safety the Remaining Questions.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">24823R105 / 09062X103</td><td class="leftalignment">Denali Therapeutics Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Mr. Julian Harrison / Ms. Kaveri Pohlman</td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Biogen (BIIB:$267.33) drops 3%, trailing 81% of stocks</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 545</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for BIIB. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">BAX / BSX / CHE / CNC / CRY.N / HUM / MDT / SYK / UNH / GILD.O / AMGN.O / NOVN.S / RMD.N / CYH.N / EW.N / IART.OQ / NBIX.OQ / BMRN.OQ / EXEL.OQ / BLUE.OQ / VRTX.OQ / ICAD.O / LIFE.O / MMSI.O / AMED.O / BIIB.O / 478160104 / 881624209 / ALNY.OQ / ACAD.O / ATRC.OQ / DXCM.O / CYCC.OQ / PODD.O / 02043Q107 / ENSG.OQ / TNDM.O / MRNA.O / BBI.O / AGIO.OQ / ALDX.OQ / 02005N100 / CLRB.OQ / INO.O / VKTX.O / TDOC.N / CFMS.O / NVCR.OQ / APLS.OQ / MDGL.O / IOVA.OQ / 720795103 / ALLO.OQ / MRKR.OQ / ORTX.OQ / CRSP.BN / SWAV.O / BWAY.TA / KRTX.OQ / NBSE.O / CRDF.OQ / FMTX.O / REGW.M3 / 03823M100</td><td class="leftalignment">Baxter International Inc / Boston Scientific Corp / Chemed Corp / Centene Corp / CryoLife Inc / Humana Inc / Medtronic PLC / Stryker Corp / UnitedHealth Group Inc / Gilead Sciences Inc / Amgen Inc / Novartis AG / Resmed Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Integra Lifesciences Holdings Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Exelixis Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / ICAD Inc / aTyr Pharma Inc / Merit Medical Systems Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Teva Pharmaceutical Industries Ltd / Alnylam Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / AtriCure Inc / Dexcom Inc / Cyclacel Pharmaceuticals Inc / Insulet Corp / Alnylam Pharmaceuticals Inc / Ensign Group Inc / Tandem Diabetes Care Inc / Moderna Inc / Brickell Biotech Inc / Agios Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Ally Financial Inc / Cellectar Biosciences Inc / Inovio Pharmaceuticals Inc / Viking Therapeutics Inc / Teladoc Health Inc / Conformis Inc / Novocure Ltd / Apellis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Iovance Biotherapeutics Inc / Pieris Pharmaceuticals Inc / Allogene Therapeutics Inc / Marker Therapeutics Inc / Orchard Therapeutics PLC / CRISPR Therapeutics AG / Shockwave Medical Inc / Brainsway Ltd / Karuna Therapeutics Inc / NeuBase Therapeutics Inc / Cardiff Oncology Inc / Forma Therapeutics Holdings Inc / Regency World Consulting Ltd / Applied Minerals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / India / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASGCT abstracts highlights SGMO's gene regulation platform in neurogedenerative diseases</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SGMO=US / PFE=US / BIIB=US</td><td class="leftalignment">Sangamo Therapeutics Inc / Pfizer Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 4/23/21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">NBIX.O / BIIB.O / ACOR.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Acorda Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Three in a Row - Biotech Fund Flows Stay Positive</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / G59665102 / 14888D208 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / MeiraGTx Holdings PLC / Catalyst Biosciences Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from the AAN 2021 Conference</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">64125C10 / 09062X10 / 478160104 / G5087110 / 00287Y10 / 05337M104 / G1119610 / 40422M10 / 98978L20</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Johnson & Johnson / Jazz Pharmaceuticals PLC / Abbvie Inc / Avadel Pharmaceuticals PLC / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Ms. Roanna C. Ruiz</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">2021 Is All about Anti-Tau and Anti-Abeta Vaccines―Our Thoughts</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">H00263105 / BIIB / PRTA.OQ</td><td class="leftalignment">AC Immune SA / Biogen Inc / Prothena Corporation PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CRM.N / FDS / MSFT.O / NOW / ORA / HEAR.O / CSGP.O / ATVI.OQ / SGMS.OQ / CHKP.OQ / TTWO.OQ / BIIB.O / 92343V104 / 833034101 / 36467W109 / MRNA.O / FRPT.O / JACK.O / TSLA.O / NXPI.O / ZNGA.O / EA.O / GOOGL.O / 82655M107 / PAYC.K / SNOW.K / SHOP.K / SPGI.K / CVNA.N / WDAY.O / BILI.O / ZM.OQ / NBSE.O / DDOG.O / DKNG.O / GAN.O / ZI.OQ / HUYA.K</td><td class="leftalignment">Salesforce.Com Inc / Factset Research Systems Inc / Microsoft Corp / ServiceNow Inc / Ormat Technologies Inc / Turtle Beach Corp / CoStar Group Inc / Activision Blizzard Inc / Scientific Games Corp / Check Point Software Technologies Ltd / Take-Two Interactive Software Inc / Biogen Inc / Verizon Communications Inc / Snap-On Inc / GameStop Corp / Moderna Inc / Freshpet Inc / Jack in the Box Inc / Tesla Inc / NXP Semiconductors NV / Zynga Inc / Electronic Arts Inc / Alphabet Inc / Sify Technologies Ltd / Paycom Software Inc / Snowflake Inc. / Shopify Inc / S&P Global Inc / Carvana Co / Workday Inc / Bilibili Inc / Zoom Video Communications Inc / NeuBase Therapeutics Inc / Datadog Inc / DraftKings Inc / Gan Ltd / ZoomInfo Technologies Inc / HUYA Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / India / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Peer Group Analytics - Q1 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Biotechnology Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">65</td><td class="leftalignment">US2312692005 / US68403P2039 / US09061G1013 / US45253H1014 / US45337C1027 / US64125C1099 / US09062X1037 / US0042251084 / US03152W1099 / US09609G1004 / US8036071004 / CA1208311029 / US92337C1045 / US16934W1062 / US29428V1044 / US31189P1021 / CA05156V1022 / US0008991046 / US2060221056 / US00972D1054 / US67576A1007 / US19249H1032 / US31572Q8087 / US92346J1088 / US37890U1088 / US92915B1061 / US68235C1071 / US00773U1088 / US98419J2069 / US12648L6011 / CA44974L1031 / US15117B2025 / US21900C3088 / US6700024010 / US89237H2094 / US81181C1045 / US42237K4094 / US30233G2093</td><td class="leftalignment">Curis Inc / Oramed Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / ImmunoGen Inc / Incyte Corp / Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Amicus Therapeutics Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Burcon NutraScience Corp / Verastem Inc / Chimerix Inc / Epizyme Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / ADMA Biologics Inc / Concert Pharmaceuticals Inc / Akebia Therapeutics Inc / Ocular Therapeutix Inc / Coherus BioSciences Inc / FibroGen Inc / Vericel Corp / Global Blood Therapeutics Inc / Voyager Therapeutics Inc / OncoCyte Corp / Adverum Biotechnologies Inc / XOMA Corp / CTI Biopharma Corp / IMV Inc / Celldex Therapeutics Inc / CorMedix Inc / Novavax Inc / TRACON Pharmaceuticals Inc / Seagen Inc / Heat Biologics Inc / EyePoint Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Right to Try vs. First Do No Harm</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US09062X1037 / US03820J1007 / US00289Y1073 / US7310941080 / US40434H2031</td><td class="leftalignment">Amgen Inc / Biogen Inc / Applied Genetic Technologies Corp / Abeona Therapeutics Inc / PolarityTE Inc / HTG Molecular Diagnostics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Biogen climbs 10% in 2021, outperforming Medical/Biomedical sector</td><td class="leftalignment">English</td><td class="rightalignment">81</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PEP=US / AMGN=US / BMY=US / CAG=US / DIS=US / KO=US / OXY=US / RRC=US / CL=US / PG=US / AMZN=US / DVN=US / EBAY=US / INCY=US / U=US / APA=US / CPE=US / EOG=US / DGX=US / SLG=US / REI=US / MTN=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / MGY=US / SWN=US / MUR=US / SPOT=US / MRO=US / ATVI=US / MANH=US / NWL=US / FLO=US / STZ=US / AIR=US / ATRO=US / CENT=US / CHD=US / CSTR=US / COLL=US / CNX=US / DCO=US / EPC=US / EQT=US / HAIN=US / HEI=US / HXL=US / MAN=US / SMG=US / SHOP=US / TGI=US / CVX=US / POST=US / NET=US / SIVB=US / ABCB=US / BOKF=US / BDN=US / FB=US / SPR=US / RF=US / NLS=US / NFLX=US / COP=US / MGPI=US / SBCF=US / BDSI=US / MNST=US / PTON=US / NOMD=US / BIIB=US / RNG=US / NUVA=US / FRPT=US / THS=US / TDG=US / ELF=US / EIG=US / CLR=US / NOG=US / AAN=US / UTZ=US / OLO=US / AR=US / ESTE=US / BCEI=US / EA=US / MTDR=US / PDCE=US / FANG=US / GOOGL=US / FIVN=US / COUP=US / HUBS=US / ARGX=US / ACBI=US / AXSM=US / CDEV=US / PVAC=US / VRNA=US / SBOW=US / PETQ=US / ROKU=US / IQV=US / KDP=US / OZK=US / ARVN=US / BRBR=US / OVV=US / ARQT=US / REYN=US / DASH=US / HYFM=US / COUR-US</td><td class="leftalignment">PepsiCo Inc / Amgen Inc / Bristol-Myers Squibb Co / Conagra Brands Inc / Walt Disney Co / Coca-Cola Co / Occidental Petroleum Corp / Range Resources Corp / Colgate-Palmolive Co / Procter & Gamble Co / Amazon.com Inc / Devon Energy Corp / eBay Inc / Incyte Corp / Unity Software Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Quest Diagnostics Inc / SL Green Realty Corp / Ring Energy Inc / Vail Resorts Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Spotify Technology SA / Marathon Oil Corp / Activision Blizzard Inc / Manhattan Associates Inc / Newell Brands Inc / Flowers Foods Inc / Constellation Brands Inc / AAR Corp / Astronics Corp / Central Garden & Pet Co / Church & Dwight Co Inc / CapStar Financial Holdings Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Ducommun Inc / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / HEICO Corp / Hexcel Corp / ManpowerGroup Inc / Scotts Miracle-Gro Co / Shopify Inc / Triumph Group Inc / Chevron Corp / Post Holdings Inc / Cloudflare Inc / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / Brandywine Realty Trust / Meta Platforms Inc / Spirit AeroSystems Holdings Inc / Regions Financial Corp / Nautilus Inc / Netflix Inc / Conocophillips / MGP Ingredients Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / Monster Beverage Corp / Peloton Interactive Inc / Nomad Foods Ltd / Biogen Inc / RingCentral Inc / NuVasive Inc / Freshpet Inc / TreeHouse Foods Inc / TransDigm Group Inc / elf Beauty Inc / Employers Holdings Inc / Continental Resources Inc / Northern Oil and Gas Inc / Aaron's Company Inc / UTZ Brands Inc / Olo Inc / Antero Resources Corp / Earthstone Energy Inc / Civitas Resources Inc / Electronic Arts Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Alphabet Inc / Five9 Inc / Coupa Software Inc / HubSpot Inc / argenx SE / Atlantic Capital Bancshares Inc / Axsome Therapeutics Inc / Centennial Resource Development Inc / Ranger Oil Corp / Verona Pharma PLC / SilverBow Resources Inc / PetIQ Inc / Roku Inc / IQVIA Holdings Inc / Keurig Dr Pepper Inc / Bank Ozk / Arvinas Inc / Bellring Brands Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / DoorDash Inc / Hydrofarm Holdings Group Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator Call Miniseries: Hosting Christoph Correll, M.D. and Sanjay Mathew, M.D., May 6 at 10.00 a.m. ET and 2 p.m. ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 74006W108 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Praxis Precision Medicines Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AXP / 0989529 / 2000019 / 2008154 / 2486813 / 2973821 / 2026242 / 2219224 / 2270726 / 2317087 / 2576941 / 2670519 / 2328915 / 2100920 / 2366799 / 2455965 / 2689560 / 2440637 / 2138158 / 2503529 / 7103065 / B125XQ6 / B03PGL4 / B7TL820 / B6RS2B3 / B7VD3F2 / BDZCRX3 / BYY8XK8 / BYNZGK1 / BK0VHF6 / BD8DJ71 / BMQ5T49 / BFZ1K46 / BLGJ610 / BG31GH0 / BGSP7M9 / BJVR9Y9 / BWY52P3 / BMVWYW8 / BN2R582 / BN4RD42 / BLBLMD5 / BMV31Q4</td><td class="leftalignment">American Express Co / AstraZeneca PLC / Amazon.com Inc / Adobe Inc / Kellogg Co / Alliant Energy Corp / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Entergy Corp / Exelixis Inc / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / Gentex Corp / Biogen Inc / PG&E Corp / CenterPoint Energy Inc / Sempra Energy / World Wrestling Entertainment Inc / Novartis AG / Portland General Electric Co / NorthWestern Corp / Meta Platforms Inc / Clovis Oncology Inc / Duke Energy Corp / RingCentral Inc / WEC Energy Group Inc / Block Inc / IDEAYA Biosciences Inc / Snap Inc / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Warner Music Group Corp / Y-mAbs Therapeutics Inc / Zoom Video Communications Inc / iHeartMedia Inc / Blueprint Medicines Corp / Protara Therapeutics Inc / Relay Therapeutics Inc / CureVac NV / Array Technologies Inc / Audacy Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">NeuroNavigator: DSM-VI Beta? Looking at Upstream Targets to Improve Neuropsychiatric Treatments</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / Mr. Rob Andrew, CFA / John Boyle / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Updating our BIIB model- we remain cautious into aducanumab approval</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACA / AMN / BAX / BSX / CHE / CI / CNC / CVS / FDS / HELE.O / HON / HUM / MCO / MDT / RAD / SYK / UNH / WMT / GILD.O / HCA.N / CYH.N / EW.N / INCY.OQ / BMRN.OQ / ISRG.OQ / VRTX.OQ / CCRN.O / AMED.O / BIIB.O / 478160104 / 00846U101 / 868168105 / LHCG.O / CME.O / ENSG.OQ / 483548103 / MRNA.O / MD.N / ADUS.O / USPH.N / FIVE.OQ / GOOGL.O / INO.O / EVH.N / TDOC.N / ZBH.N / CFMS.O / 100063846 / SPGI.K / 720795103 / PNTG.OQ / REGW.M3</td><td class="leftalignment">Arcosa Inc / AMN Healthcare Services Inc / Baxter International Inc / Boston Scientific Corp / Chemed Corp / Cigna Corp / Centene Corp / CVS Health Corp / Factset Research Systems Inc / Helen of Troy Ltd / Honeywell International Inc / Humana Inc / Moody's Corp / Medtronic PLC / Rite Aid Corp / Stryker Corp / UnitedHealth Group Inc / Walmart Inc / Gilead Sciences Inc / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Incyte Corp / Biomarin Pharmaceutical Inc / Intuitive Surgical Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Amedisys Inc / Biogen Inc / Johnson & Johnson / Agilent Technologies Inc / Superior Industries International Inc / LHC Group Inc / CME Group Inc / Ensign Group Inc / Kaman Corp / Moderna Inc / MEDNAX Inc / Addus Homecare Corp / US Physical Therapy Inc / Five Below Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / Evolent Health Inc / Teladoc Health Inc / Zimmer Biomet Holdings Inc / Conformis Inc / Truist Financial Corp / S&P Global Inc / Pieris Pharmaceuticals Inc / Pennant Group Inc / Regency World Consulting Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Oppenheimer Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AX / ASND.O / DNLI.O / SGMO.O / AMD.O / NBIX.O / UTHR.O / XOMA.O / SWTX.O / RARE.O / BLUE.O / BIIB.O / IDRA.O / OMER.O / PCRX.O / RGLS.O / EPZM.O / MGNX.O / FATE.O / KPTI.O / XNCR.O / AGTC.O / ARGX.BR / SAGE.O / PRTK.O / XENE.O / CDTX.O / ABUS.O / NVCR.O / CTMX.O / VYGR.O / KURA.O / BPMC.O / NTLA.O / CLSD.O / ALBO.O / ANAB.O / GTHX.O / MRSN.O / ALPN.O / APLS.O / SURF.O / KNSA.O / SRRK.O / MGTA.O / AVRO.O / AQST.O / REPL.O / YMAB.O / ARVN.O / STRO.O / ORTX.O / HARP.O / IMUX.O / TPTX.O / ISEE.O / AXLA.O / STOK.O / KRTX.O / TCRR.O / IGMS.O / BEAM.O / BCEL.O / GBIO.O / FUSN.O / ITOS.O / FRLN.O / RCUS.K / INZY.O</td><td class="leftalignment">Axos Financial Inc / Ascendis Pharma A/S / Denali Therapeutics Inc / Sangamo Therapeutics Inc / Advanced Micro Devices Inc / Neurocrine Biosciences Inc / United Therapeutics Corp / XOMA Corp / SpringWorks Therapeutics Inc / Ultragenyx Pharmaceutical Inc / bluebird bio Inc / Biogen Inc / Idera Pharmaceuticals Inc / Omeros Corp / Pacira Biosciences Inc / Regulus Therapeutics Inc / Epizyme Inc / MacroGenics Inc / Fate Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / argenx SE / SAGE Therapeutics Inc / Paratek Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Arbutus Biopharma Corp / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Blueprint Medicines Corp / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / G1 Therapeutics Inc / Mersana Therapeutics Inc / Alpine Immune Sciences Inc / Apellis Pharmaceuticals Inc / Surface Oncology Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / AVROBIO Inc / Aquestive Therapeutics Inc / Replimune Group Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Sutro Biopharma Inc / Orchard Therapeutics PLC / Harpoon Therapeutics Inc / Immunic Inc / Turning Point Therapeutics Inc / Iveric Bio Inc / Axcella Health Inc / Stoke Therapeutics Inc / Karuna Therapeutics Inc / TCR2 Therapeutics Inc / IGM Biosciences Inc / Beam Therapeutics Inc / Atreca Inc / Generation Bio Co / Fusion Pharmaceuticals Inc / Iteos Therapeutics Inc / Freeline Therapeutics Holdings PLC / Arcus Biosciences Inc / Inozyme Pharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD / Shveta Dighe / Matthew Barcus / Kenneth Shields / Mr. Andreas Argyrides</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Post 1Q Model Update; Lowering PT to $325</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 544</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Tidbits from speaking with CFO this morning</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 4/16/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX.O / BIIB.O / ACOR.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / Acorda Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Kenneth Shields</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CACI=US / LLY=US / PFE=US / BMY=US / INTC=US / AMD=US / RRC=US / EFX=US / AMZN=US / T=US / GL=US / NVDA=US / DGX=US / TRU=US / MTN=US / VZ=US / CCI=US / VRM=US / EWBC=US / BRO=US / EXPE=US / LSTR=US / HCA=US / CVS=US / UNH=US / AVGO=US / AJG=US / SAFE=US / HZO=US / MAT=US / RARE=US / SNAP=US / TRIP=US / WIX=US / BXS=US / BKNG=US / FAF=US / FB=US / MKL=US / PTON=US / JRVR=US / BIIB=US / NUVA=US / KAR=US / CADE=US / EIG=US / KNSL=US / AR=US / ANGI=US / TMUS=US / GOOGL=US / ASMB=US / BABA=US / CMPR=US / ANTM=US / GDDY=US / LOB=US / WLTW=US / ANAB=US / CVNA=US / SFIX=US / FTDR=US / SVMK=US / SITC=US / LYFT=US / UBER=US / PLMR=US</td><td class="leftalignment">CACI International Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Intel Corp / Advanced Micro Devices Inc / Range Resources Corp / Equifax Inc / Amazon.com Inc / AT&T Inc / Globe Life Inc / NVIDIA Corp / Quest Diagnostics Inc / TransUnion / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Vroom Inc / East West Bancorp Inc / Brown & Brown Inc / Expedia Group Inc / Landstar System Inc / HCA Healthcare Inc / CVS Health Corp / UnitedHealth Group Inc / Broadcom Inc / Arthur J Gallagher & Co / Safehold Inc / MarineMax Inc / Mattel Inc / Ultragenyx Pharmaceutical Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Cadence Bank / Booking Holdings Inc / First American Financial Corp / Meta Platforms Inc / Markel Corp / Peloton Interactive Inc / James River Group Holdings Ltd / Biogen Inc / NuVasive Inc / KAR Auction Services Inc / Cadence Bank / Employers Holdings Inc / Kinsale Capital Group Inc / Antero Resources Corp / Angi Inc / T-Mobile US Inc / Alphabet Inc / Assembly Biosciences Inc / Alibaba Group Holding Ltd / Cimpress PLC / Anthem Inc / GoDaddy Inc / Live Oak Bancshares Inc / Willis Towers Watson PLC / AnaptysBio Inc / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Site Centers Corp / Lyft Inc / Uber Technologies Inc / Palomar Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">AAN 2021 Recap: Oral CGRPs Promising; Waiting for Adu PDUFA Decision; Innovation in Rare Disease; Talent Show Extraordinary</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter / Mr. Hunter Rogers / Mr. Tim F. Lugo / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 0989529 / 0925288 / 2000019 / 2050832 / 2026242 / 2113393 / 2219224 / 2270726 / 2317087 / 2576941 / 2670519 / 2367480 / 2455965 / 2459020 / 2645409 / 2689560 / 2680905 / 2684703 / 2440637 / 2138158 / 2900335 / 2928683 / 2503529 / 7103065 / 7123870 / B121557 / 2769796 / 2857817 / B125XQ6 / B02R1L6 / B03PGL4 / B6RS2B3 / B7VD3F2 / BDZCRX3 / BK0VHF6 / BD8DJ71 / BNFWR44 / BMQ5T49 / BFZ1K46 / BFMXGR0 / BG31GH0 / BGSP7M9 / BZ1LFG7 / BWY52P3 / BKS3RS7 / BDRW1L7 / BLBLMD5 / BMZ9Z11</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Amazon.com Inc / Ameren Corp / American Electric Power Company Inc / Boston Beer Company Inc / CMS Energy Corp / Walt Disney Co / Entergy Corp / Exelixis Inc / Exelon Corp / Genuine Parts Co / Biogen Inc / Intuit Inc / NiSource Inc / PG&E Corp / PPL Corp / Pfizer Inc / CenterPoint Energy Inc / Sempra Energy / Tractor Supply Co / VF Corp / World Wrestling Entertainment Inc / Novartis AG / Nestle SA / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Portland General Electric Co / ALLETE Inc / NorthWestern Corp / Clovis Oncology Inc / Duke Energy Corp / RingCentral Inc / IDEAYA Biosciences Inc / Snap Inc / Worldline SA / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Evergy Inc / Y-mAbs Therapeutics Inc / Zoom Video Communications Inc / Roku Inc / Blueprint Medicines Corp / 10X Genomics Inc / AnaptysBio Inc / Array Technologies Inc / Prometheus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">All Eyes on Aducanumab PDUFA—Our Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB / PRTA.OQ / 24823R105</td><td class="leftalignment">Biogen Inc / Prothena Corporation PLC / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Ananda Ghosh, PhD / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ALB.N / ALTR.O / CSGN.S / DD.N / EOG.N / FMC.N / GPS.N / KMB.N / OXB.L / PD.TO / PERP.PA / RL.N / WY.N / CFP.TO / APH.L / LPX.N / FN.TO / POW.TO / DHR.N / HBAN.O / ADBE.O / UNP.N / MRO.N / DVN.N / WHR.N / NKE.N / SHW.N / HCA.N / DHI.N / AMP.N / VFC.N / TJX.N / DPH.L / ROST.O / ANF.N / GPC.N / GIL.N / PVH.N / SAM.N / AGFb.TO / CIX.TO / NET.N / URBN.O / VRNT.O / COP.N / TSCO.O / GGG.N / PNR.N / RLI.N / DFS.N / X.TO / RGLD.O / SIVB.O / BIIB.O / NESN.S / HCG.TO / SPI.L / IGM.TO / 416515104 / WEF.TO / BAM.N / 35671D857 / MERC.O / AEO.N / IVZ.N / LULU.O / ABCA.L / CVSG.L / SII.TO / VALE.N / IFC.TO / SWI.N / INPP.L / FSZ.TO / PCH.O / BKU.N / FHI.N / IFP.TO / SLM.OQ / EFN.TO / RFP.N / PANW.N / CLINC.L / APAM.N / TPH.N / EQB.TO / BURL.N / CFF.TO / LB.N / COUP.N / ARES.N / RYAM.N / AXTA.N / ASB.N / SHOP.N / MIME.OQ / RMR.OQ / BBU.N / ECN.TO / ONEX.TO / CTEC.L / UAA.N / OKTA.OQ / GOOS.TO / CADE.N / SAIL.N / 05971J102 / VCTR.N / BSIG.N / SMAR.N / DBX.O / ZM.O / CTVA.N / PING.N / DDOG.O / APRE.OQ / NLOK.O / UPR.IR / DCT.O / ASAN.N / BSY.O / WFG.N / ATC.N / OSO.N</td><td class="leftalignment">Albemarle Corp / Altair Engineering Inc / Credit Suisse Group AG / Dupont De Nemours Inc / EOG Resources Inc / FMC Corp / Gap Inc / Kimberly-Clark Corp / Oxford BioMedica PLC / Precision Drilling Corp / Pernod Ricard SA / Ralph Lauren Corp / Weyerhaeuser Co / Canfor Corp / Alliance Pharma PLC / Louisiana-Pacific Corp / First National Financial Corp / Power Corporation of Canada / Danaher Corp / Huntington Bancshares Inc / Adobe Inc / Union Pacific Corp / Marathon Oil Corp / Devon Energy Corp / Whirlpool Corp / Nike Inc / Sherwin-Williams Co / HCA Healthcare Inc / D R Horton Inc / Ameriprise Financial Inc / VF Corp / TJX Companies Inc / Dechra Pharmaceuticals PLC / Ross Stores Inc / Abercrombie & Fitch Co / Genuine Parts Co / Gildan Activewear Inc / PVH Corp / Boston Beer Company Inc / AGF Management Ltd / CI Financial Corp / Cloudflare Inc / Urban Outfitters Inc / Verint Systems Inc / Conocophillips / Tractor Supply Co / Graco Inc / Pentair PLC / Rli Corp / Discover Financial Services / TMX Group Ltd / Royal Gold Inc / SVB Financial Group / Biogen Inc / Nestle SA / Home Capital Group Inc / Spire Healthcare Group PLC / IGM Financial Inc / Hartford Financial Services Group Inc / Western Forest Products Inc / Brookfield Asset Management Inc / Freeport-McMoRan Inc / Mercer International Inc / American Eagle Outfitters Inc / Invesco Ltd / Lululemon Athletica Inc / Abcam PLC / CVS Group PLC / Sprott Inc / Vale SA / Intact Financial Corp / SolarWinds Corp / International Public Partnerships Ltd / Fiera Capital Corp / Potlatchdeltic Corp / BankUnited Inc / Federated Hermes Inc / Interfor Corp / SLM Corp / Element Fleet Management Corp / Resolute Forest Products Inc / Palo Alto Networks Inc / Clinigen Group PLC / Artisan Partners Asset Management Inc / Tri Pointe Homes Inc (Delaware) / Equitable Group Inc / Burlington Stores Inc / Conifex Timber Inc / Bath & Body Works Inc / Coupa Software Inc / Ares Management Corp / Rayonier Advanced Materials Inc / Axalta Coating Systems Ltd / Associated Banc-Corp / Shopify Inc / Mimecast Ltd / RMR Group Inc / Brookfield Business Partners LP / ECN Capital Corp / Onex Corp / ConvaTec Group PLC / Under Armour Inc / Okta Inc / Canada Goose Holdings Inc / Cadence Bank / SailPoint Technologies Holdings Inc / Cadence Bank / Victory Capital Holdings Inc / Brightsphere Investment Group Inc / Smartsheet Inc / Dropbox Inc / Zoom Video Communications Inc / Corteva Inc / Ping Identity Holding Corp / Datadog Inc / Aprea Therapeutics Inc / NortonLifeLock Inc / Uniphar PLC / Duck Creek Technologies Inc / Asana Inc / Bentley Systems Inc / West Fraser Timber Co Ltd / Atotech Ltd / Olo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / France / United Kingdom / Ireland / United States / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Large Cap Medical Devices</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BAX / BSX / CI / HUM / MDT / SYK / UNH / GILD.O / HCA.N / CYH.N / EW.N / INCY.OQ / BMRN.OQ / ISRG.OQ / VRTX.OQ / BIIB.O / ZBH.N / REGW.M3</td><td class="leftalignment">Baxter International Inc / Boston Scientific Corp / Cigna Corp / Humana Inc / Medtronic PLC / Stryker Corp / UnitedHealth Group Inc / Gilead Sciences Inc / HCA Healthcare Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Incyte Corp / Biomarin Pharmaceutical Inc / Intuitive Surgical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Zimmer Biomet Holdings Inc / Regency World Consulting Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / India / Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steven M. Lichtman / David Kuang</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, April 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US4523271090 / US30063P1057 / US09062X1037 / US1281261099 / 632307104 / 83304A106 / 40131M109</td><td class="leftalignment">Illumina Inc / Exact Sciences Corp / Biogen Inc / CalAmp Corp / Natera Inc / Snap Inc / Guardant Health Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Large-Cap Biotechnology: Termination of Coverage</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">BIIB.OQ / ACRX.OQ / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS</td><td class="leftalignment">Biogen Inc / AcelRx Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">- Credit Suisse U Eq. Res.</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB 1Q21 Postview:  Quiet set of results</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">No major updates as waiting game continues on adu and zura; reiterate BUY, $359PT</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sumant Kulkarni / Jia Min, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">1Q Update Outlines Aducanumab Launch Prep</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.O / SGE.L / 02005N100</td><td class="leftalignment">Biogen Inc / Sage Group PLC / Ally Financial Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jay Olson, CFA / Matthew Hershenhorn / Cheng Li, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : 1Q Snapshot - Uneventful Print Ahead of a VERY Eventful Quarter</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Solid 1Q; Stay Tuned for Adu and Key Data Readouts in 2Q</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">09062X10</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Ms. Roanna C. Ruiz</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Here Comes the Sun – Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">1Q21 results; adu labeling questions and approval remain a key focus</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech - Pharma Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / GSK.L / AMGN.OQ / CVM.A / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / UTHR.OQ / BMRN.OQ / ESPR.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / MNKD.OQ / RPRX.OQ / JAZZ.OQ / INO.OQ / MRNA.OQ / OMER.OQ / CYDY.PK / ABBV.N / ZTS.N / SRNE.OQ / HRTX.OQ / NVTA.N / IONS.OQ / EDIT.OQ / MDGL.OQ / KALA.OQ / VXRT.OQ / TLRY.OQ / 6160.HK / IGMS.OQ / OCGN.OQ / BEAM.OQ / PGEN.OQ / NRIX.OQ / 22UAy.DE / IBRX.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / CEL-SCI Corp / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / MannKind Corp / Royalty Pharma PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Moderna Inc / Omeros Corp / Cytodyn Inc / Abbvie Inc / Zoetis Inc / Sorrento Therapeutics Inc / Heron Therapeutics Inc / Invitae Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / Kala Pharmaceuticals Inc / Vaxart Inc / Tilray Brands Inc / Beigene Ltd / IGM Biosciences Inc / Ocugen Inc / Beam Therapeutics Inc / Precigen Inc / Nurix Therapeutics Inc / BioNTech SE / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Two Years of Back and Forth on Aducanumab to End Within Seven Weeks; Have Labeling Discussions Begun?</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">FDA labeling discussions "on track"</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Mgmt won't confirm or comment on CMO's labeling discussion commentary</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Going into 1Q21 Earnings the Question Is: What Questions Will Be Answered?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ALKS.O / HRTX.O / EBS / JAZZ.O / OPTN.O / COLL.O / BDSI.O / US09062X1037 / MNKD.O / AXGN.O / SPNE.O / SRGA.O</td><td class="leftalignment">Alkermes Plc / Heron Therapeutics Inc / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Collegium Pharmaceutical Inc / BioDelivery Sciences International Inc / Biogen Inc / MannKind Corp / AxoGen Inc / SeaSpine Holdings Corp / Surgalign Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brandon Folkes, CFA / Louise Chen / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">1Q21 BIIB Beat But Binary Aducanumab Decision Nears</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">1Q21 - Vumerity Emerging as a Real Drug, Pipeline Efforts Gaining Momentum Ahead of Aducanumab PDUFA.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103 / 92915B106 / 24823R105</td><td class="leftalignment">Biogen Inc / Voyager Therapeutics Inc / Denali Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Mr. Julian Harrison / Ms. Kaveri Pohlman</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Model Update Following 1Q21 Spinraza Revenue Disclosure</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">IONS=US / BIIB=US</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">1Q21: Upside Optionality Not Enough To Chase, Given Risks and Base Business Fragility</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Decent Overall Print, But Tecfidera, Spinraza US Trends No Bueno</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">my top Q for call off 1Q print</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : First Look at 1Q Results</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Apr 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">T.N / ALK.N / DOW.N / FCX.N / LUV.N / DGX.N / NUE.N / DHR.N / FE.N / UNP.N / VLO.N / HCA.N / DHI.N / SNA.N / GPC.N / SAM.N / INTC.OQ / SIVB.OQ / ODFL.OQ / POOL.OQ / VRSN.OQ / BIIB.OQ / BJRI.OQ / MKTX.OQ / TAL.N / STX.OQ / ALLE.N / AAL.OQ / SAFE.N / IQV.N / AEP.OQ / PNT.DE</td><td class="leftalignment">AT&T Inc / Alaska Air Group Inc / Dow Inc / Freeport-McMoRan Inc / Southwest Airlines Co / Quest Diagnostics Inc / Nucor Corp / Danaher Corp / FirstEnergy Corp / Union Pacific Corp / Valero Energy Corp / HCA Healthcare Inc / D R Horton Inc / Snap-On Inc / Genuine Parts Co / Boston Beer Company Inc / Intel Corp / SVB Financial Group / Old Dominion Freight Line Inc / Pool Corp / Verisign Inc / Biogen Inc / BJ's Restaurants Inc / Marketaxess Holdings Inc / TAL Education Group / Seagate Technology Holdings PLC / Allegion PLC / American Airlines Group Inc / Safehold Inc / IQVIA Holdings Inc / American Electric Power Company Inc / Pentair PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Ireland / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Why the stock could be weak may be from CMO's comments on label discussions</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">BIIB Reports Financials; Solid Q1 As Aducanumab's PDUFA Approaches</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - 1Q21; An In-line Quarter Overall, Focus Remains on Upcoming Aducanumab PDUFA Date</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Biogen First-Quarter Quick Take: Revenue Decline Not Quite as Bad as Expected, No Apparent Changes to Aducanumab Language</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103 / 462222100</td><td class="leftalignment">Biogen Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Beat and Raise Out of the Gate but Focus Still on Adu</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q121 First Take: Nice Beat/Raise - Still Waiting to Exhale on Adu's Fate</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Brief of Biogen Inc conference call, Apr. 22, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Apr. 22, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">1Q21 First Take: Reports A Beat, But Aducanumab Matters Most</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">1Q21 First Take: Spinraza Strong, R&D In Check, But Adu/Pipeline Success Needed In Face Of Generics</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">BIIB First Take: 1Q21 top-line in-line with bottom-line beat; FY2021 EPS guidance raised</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BIIB: Our Thoughts Post the 1Q21 Call: Performance remains predicated on aducanumab, despite expected near-term pipeline updates</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BIIB: Biogen, Inc. - 1Q21 First Take: Very modest revenue beat; focus remains on the potential adu approval on June 7th</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for BIIB</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AN=US / AMGN=US / BMY=US / DIS=US / PG=US / T=US / INCY=US / GILD=US / AMT=US / PEB=US / AKAM=US / CHTR=US / H=US / CONE=US / MTN=US / VZ=US / CCI=US / MGY=US / THC=US / MAR=US / SPOT=US / MRO=US / LEG=US / TNL=US / HLT=US / CMCSA=US / UNH=US / DISH=US / WTFC=US / BMRN=US / CHH=US / DRH=US / EQIX=US / HXL=US / MAN=US / PRGO=US / REGN=US / SBAC=US / VRTX=US / SNV=US / JAZZ=US / NFLX=US / PNFP=US / BIIB=US / TPX=US / EXP=US / SHO=US / DLR=US / PLAY=US / GMS=US / CCOI=US / HST=US / RPRX=US / LLNW=US / PRPL=US / LUMN=US / WH=US / CLNY=US / HGV=US / PCRX=US / RLJ=US / VAC=US / BCEI=US / RHP=US / ABBV=US / TMUS=US / SPNE=US / CABO=US / CRSP=US / PK=US / GDS=US / PLYA=US / SBOW=US / ROKU=US / SWCH=US / BHC=US / ARVN=US / AXNX=US / GMAB=US / 96758W101 / HIMS=US</td><td class="leftalignment">AutoNation Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Procter & Gamble Co / AT&T Inc / Incyte Corp / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Akamai Technologies Inc / Charter Communications Inc / Hyatt Hotels Corp / CyrusOne Inc / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Magnolia Oil & Gas Corp / Tenet Healthcare Corp / Marriott International Inc / Spotify Technology SA / Marathon Oil Corp / Leggett & Platt Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Comcast Corp / UnitedHealth Group Inc / DISH Network Corp / Wintrust Financial Corp / Biomarin Pharmaceutical Inc / Choice Hotels International Inc / Diamondrock Hospitality Co / Equinix Inc / Hexcel Corp / ManpowerGroup Inc / Perrigo Company PLC / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Vertex Pharmaceuticals Inc / Synovus Financial Corp / Jazz Pharmaceuticals PLC / Netflix Inc / Pinnacle Financial Partners Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / GMS Inc / Cogent Communications Holdings Inc / Host Hotels & Resorts Inc / Royalty Pharma PLC / Limelight Networks Inc / Purple Innovation Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / DigitalBridge Group Inc / Hilton Grand Vacations Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Ryman Hospitality Properties Inc / Abbvie Inc / T-Mobile US Inc / SeaSpine Holdings Corp / Cable One Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / GDS Holdings Ltd / Playa Hotels & Resorts NV / SilverBow Resources Inc / Roku Inc / Switch Inc / Bausch Health Companies Inc / Arvinas Inc / Axonics Inc / Genmab A/S / WideOpenWest Inc / Hims & Hers Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AAP.N / ALVG.DE / AXAF.PA / FITB.O / FOUG.PA / HEIN.AS / HSX.L / KEY.N / MUVGn.DE / NTRS.O / PNN.L / RIO.L / SCOR.PA / TRV.N / ZURN.S / CMA.N / PG.N / GILD.O / INCY.O / THC.N / DOV.N / CSX.N / MRO.N / SNV.N / HNRGn.DE / IG.MI / NBIX.O / SAM.N / SRG.MI / BLUE.O / WTFC.O / ICPT.O / BIIB.O / DCP.N / ELS.N / ACAD.O / DRX.L / LRE.L / HOG.N / BEZG.L / WRB.N / SMSS.L / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GLPG.O / GBT.OQ / SRENH.S</td><td class="leftalignment">Advance Auto Parts Inc / Allianz SE / AXA SA / Fifth Third Bancorp / Eiffage SA / Heineken NV / Hiscox Ltd / KeyCorp / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / Northern Trust Corp / Pennon Group PLC / Rio Tinto PLC / Scor SE / Travelers Companies Inc / Zurich Insurance Group AG / Comerica Inc / Procter & Gamble Co / Gilead Sciences Inc / Incyte Corp / Tenet Healthcare Corp / Dover Corp / CSX Corp / Marathon Oil Corp / Synovus Financial Corp / Hannover Rueck SE / Italgas SpA / Neurocrine Biosciences Inc / Boston Beer Company Inc / Snam SpA / bluebird bio Inc / Wintrust Financial Corp / Intercept Pharmaceuticals Inc / Biogen Inc / DCP Midstream LP / Equity LifeStyle Properties Inc / ACADIA Pharmaceuticals Inc / Drax Group PLC / Lancashire Holdings Ltd / Harley-Davidson Inc / Beazley PLC / W R Berkley Corp / Smart Metering Systems PLC / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Galapagos NV / Global Blood Therapeutics Inc / Swiss Re AG</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Switzerland / Germany / France / United Kingdom / Italy / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Managing Autoimmunity by Nuanced Kinase Inhibition; Initiate at Buy and $40 PT</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">ACRS.OQ / BHC / BIIB / 53220K504 / CANF / 040047607 / 15671L109 / 19249H103 / N44821101 / 23283M101 / 590717104 / 4525EP101 / 63937X202</td><td class="leftalignment">Aclaris Therapeutics Inc / Bausch Health Companies Inc / Biogen Inc / Ligand Pharmaceuticals Inc / Can Fite Biopharma Ltd / Arena Pharmaceuticals Inc / Avalo Therapeutics Inc / Coherus BioSciences Inc / InflaRx NV / Cytodyn Inc / Mesoblast Ltd / Immunic Inc / Navidea Biopharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Raghuram Selvaraju, Ph.D. / Boobalan Pachaiyappan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, April 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0378331005 / US0970231058 / US28176E1082 / US4282911084 / US64110L1061 / US09062X1037 / US09609G1004 / 82837P408</td><td class="leftalignment">Apple Inc / Boeing Co / Edwards Lifesciences Corp / Hexcel Corp / Netflix Inc / Biogen Inc / bluebird bio Inc / Silvergate Capital Corp</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: 2Q21 - Reimbursement Radar</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GLPG.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Galapagos NV / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Read-Throughs from Roche's 1Q21 Results: Our Thoughts on REGN, BIIB, AMGN, and MRTX</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.OQ / AMGN.OQ / MRTX.OQ / REGN.OQ</td><td class="leftalignment">Biogen Inc / Amgen Inc / Mirati Therapeutics Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">N=54 prescriber poll on JAK inhibitors in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">09062X103 / 031162100 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Biogen Inc / Amgen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">BIIB 1Q21 preview: Still waiting for adu and WATERFALL; reiterate BUY, $359PT</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sumant Kulkarni / Jia Min, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Bringing investors back to Biotech -- What's on tap for 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BIIB=US / AMGN=US / INCY=US / GILD=US / BMRN=US / REGN=US / VRTX=US / CRSP=US</td><td class="leftalignment">Biogen Inc / Amgen Inc / Incyte Corp / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / CRISPR Therapeutics AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Biotechnology Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">65</td><td class="leftalignment">US2312692005 / US68403P2039 / US09061G1013 / US45253H1014 / US45337C1027 / US64125C1099 / US09062X1037 / US0042251084 / US03152W1099 / US09609G1004 / US8036071004 / CA1208311029 / US92337C1045 / US16934W1062 / US29428V1044 / US31189P1021 / CA05156V1022 / US2060221056 / US00972D1054 / US67576A1007 / US13089P1012 / US19249H1032 / US31572Q8087 / US92346J1088 / US37890U1088 / US68235C1071 / US00773U1088 / US98419J2069 / US12648L6011 / CA44974L1031 / US15117B2025 / US21900C3088 / US89237H2094 / US81181C1045 / US42237K4094 / US30233G2093</td><td class="leftalignment">Curis Inc / Oramed Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / ImmunoGen Inc / Incyte Corp / Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Amicus Therapeutics Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Burcon NutraScience Corp / Verastem Inc / Chimerix Inc / Epizyme Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Concert Pharmaceuticals Inc / Akebia Therapeutics Inc / Ocular Therapeutix Inc / Calithera Biosciences Inc / Coherus BioSciences Inc / FibroGen Inc / Vericel Corp / Global Blood Therapeutics Inc / OncoCyte Corp / Adverum Biotechnologies Inc / XOMA Corp / CTI Biopharma Corp / IMV Inc / Celldex Therapeutics Inc / CorMedix Inc / TRACON Pharmaceuticals Inc / Seagen Inc / Heat Biologics Inc / EyePoint Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DE=US / TME=US / MRK=US / LLY=US / MSFT=US / INSP=US / DNLI=US / NVDA=US / RMD=US / SPOT=US / TTWO=US / ATVI=US / HEAR=US / PHG=US / SAGE=US / GME=US / MTCH=US / NFLX=US / BIIB=US / ALNY=US / 700-HK=US / UBI-PAR=US / TCEHY=US / ZNGA=US / EA=US / YY=US / LOVE=US / MOMO=US / SPXC=US / LIVN=US / IQ=US / BILI=US / HUYA=US / DOYU=US / TARA=US / CRSR=US / PLTK=US</td><td class="leftalignment">Deere & Co / Tencent Music Entertainment Group / Merck & Co Inc / Eli Lilly and Co / Microsoft Corp / Inspire Medical Systems Inc / Denali Therapeutics Inc / NVIDIA Corp / Resmed Inc / Spotify Technology SA / Take-Two Interactive Software Inc / Activision Blizzard Inc / Turtle Beach Corp / Koninklijke Philips NV / SAGE Therapeutics Inc / GameStop Corp / Match Group Inc / Netflix Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Tencent Holdings Ltd / Ubisoft Entertainment SA / Tencent Holdings Ltd / Zynga Inc / Electronic Arts Inc / JOYY Inc / Lovesac Co / Hello Group Inc / SPX Corp / LivaNova PLC / iQIYI Inc / Bilibili Inc / HUYA Inc / Douyu International Holdings Ltd / Protara Therapeutics Inc / Corsair Gaming Inc / Playtika Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Machinery / Pharmaceuticals / Retailing / Semiconductors</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Upcoming Biopharma Regulatory Events to Watch Given Tougher Environment</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / INCY=US / GILD=US / MOR=DE / AZN=US / GSK=US / ALKS=US / BMRN=US / ICPT=US / VRTX=US / SGEN=US / SAGE=US / PRVB=US / SNY=US / BIIB=US / ACAD=US / ALNY=US / MNKD=US / FOLD=US / IFRX=US / ASND=US / CCXI=US / FGEN=US / ABBV=US / MRTX=US / MGNX=US / ITCI=US / QURE=US / AUPH=US / BPMC=US / AXSM=US / RETA=US / BHVN=US / BBIO=US / MIRM=US / GMAB=US / TVTX=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Incyte Corp / Gilead Sciences Inc / MorphoSys AG / AstraZeneca PLC / GlaxoSmithKline PLC / Alkermes Plc / Biomarin Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Provention Bio Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Amicus Therapeutics Inc / InflaRx NV / Ascendis Pharma A/S / ChemoCentryx Inc / FibroGen Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Intra-Cellular Therapies Inc / Uniqure NV / Aurinia Pharmaceuticals Inc / Blueprint Medicines Corp / Axsome Therapeutics Inc / Reata Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / BridgeBio Pharma Inc / Mirum Pharmaceuticals Inc / Genmab A/S / Travere Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / Denmark / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Plateau Holds as First Dose Vaccinations Reach ~40% Overall and Breaking 50% in Adults; Outbreak in India Concerning</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107 / 45175G108</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AAP.N / IBE.MC / KBH.N / KO.N / PHM.N / PPG.N / TOL.N / ZION.O / WY.N / CFP.TO / GILD.O / SJRb.TO / RCIb.TO / INCY.O / LEN.N / VLO.N / DHI.N / KMI.N / AZO.N / RRC.N / NBIX.O / MTB.N / GPC.N / DK.N / STL.N / VRTX.O / WBS.N / LTC.N / HOOK.O / ORLY.O / BIIB.O / 02209S103 / CWX.TO / ALNY.O / DRX.L / PRTS.OQ / PBF.N / PCH.O / MPC.N / HFC.N / IFP.TO / PSX.N / RFP.N / TPH.N / TMHC.N / ONB.OQ / ITCI.O / RYAM.N / CRBP.OQ / GLPG.O / TRHC.OQ / PARR.N / OVID.O / IGMS.O / WFG.N</td><td class="leftalignment">Advance Auto Parts Inc / Iberdrola SA / KB Home / Coca-Cola Co / Pultegroup Inc / PPG Industries Inc / Toll Brothers Inc / Zions Bancorporation NA / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Shaw Communications Inc / Rogers Communications Inc / Incyte Corp / Lennar Corp / Valero Energy Corp / D R Horton Inc / Kinder Morgan Inc / Autozone Inc / Range Resources Corp / Neurocrine Biosciences Inc / M&T Bank Corp / Genuine Parts Co / Delek US Holdings Inc / Sterling Bancorp / Vertex Pharmaceuticals Inc / Webster Financial Corp / LTC Properties Inc / HOOKIPA Pharma Inc / O'Reilly Automotive Inc / Biogen Inc / Altria Group Inc / Doman Building Materials Group Ltd / Alnylam Pharmaceuticals Inc / Drax Group PLC / Carparts.Com Inc / PBF Energy Inc / Potlatchdeltic Corp / Marathon Petroleum Corp / HollyFrontier Corp / Interfor Corp / Phillips 66 / Resolute Forest Products Inc / Tri Pointe Homes Inc (Delaware) / Taylor Morrison Home Corp / Old National Bancorp / Intra-Cellular Therapies Inc / Rayonier Advanced Materials Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Tabula Rasa HealthCare Inc / Par Pacific Holdings Inc / Ovid Therapeutics Inc / IGM Biosciences Inc / West Fraser Timber Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Spain / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Adu Clarity Still Elusive – Assessing Top 8 Developments of '21 That Could Read Through To Approvability</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 1Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Considerations Ahead of 1Q Results</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB=US / LLY=US / DNLI=US / SAGE=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Denali Therapeutics Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - JNJ 1Q21 Earnings Readthroughs to our Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / AMGN.OQ / GILD.OQ / INCY.OQ / BIIB.OQ / SAGE.OQ</td><td class="leftalignment">Johnson & Johnson / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LBPS=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / DDDD=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">4D Pharma PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / 4D Pharma PLC / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US09061G1013 / US0028241000 / US0079731008 / US0116591092 / US0311621009 / US0382221051 / US0463531089 / US0556221044 / US1101221083 / US1924461023 / US1925761066 / US30161Q1040 / US30231G1022 / US3755581036 / US37733W1053 / US45337C1027 / US4567881085 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US64125C1099 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91307C1027 / US91347P1057 / US92532F1003 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / RDSa.AS / PAP310761054 / US16115Q3083 / US3020811044 / US29089Q1058 / US92932M1018 / US01748X1028 / US2473617023 / US87874R1005 / US03152W1099 / BMG3922B1072 / CH0102993182 / IE00B4BNMY34 / US58933Y1055 / US46333X1081 / US9100471096 / US03027X1000 / US29414B1044 / US00287Y1091 / NL0010273215 / US98978V1035 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US8485771021 / US21240E1055 / US02376R1023 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / CA0089118776 / US2681582019 / US31572Q8087 / US22822V1017 / IE00BTN1Y115 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / KYG4740B1059 / US2067871036 / US78410G1040 / US23355L1061 / IL0011407140 / US76243J1051 / US89854H1023 / US05351X1019 / US05455M1009 / US29260V1052 / US5904791358 / CA39342L1085 / US28414H1032 / US61775R1059 / US92537N1081 / US39813G1094 / US44891N1090 / US12769G1004 / US81181C1045 / US05875B1061</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Cognizant Technology Solutions Corp / Cohu Inc / Exelixis Inc / Exxon Mobil Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Infosys Ltd / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Neurocrine Biosciences Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / United Therapeutics Corp / Universal Display Corp / Vertex Pharmaceuticals Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Copa Holdings SA / Chart Industries Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / TechTarget Inc / Amicus Therapeutics Inc / Genpact Ltd / TE Connectivity Ltd / Accenture PLC / Merck & Co Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / American Tower Corp / Epam Systems Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Air Canada / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Medtronic PLC / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Conduent Inc / SBA Communications Corp / DXC Technology Co / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / TTEC Holdings Inc / Avaya Holdings Corp / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Morphic Holding Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / IAC/Interactivecorp / Caesars Entertainment Inc / Seagen Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Mexico / Netherlands / Panama / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">1Q21 Preview; Cautious Into 1Q21 Earnings Season</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">ACAD=US / ACIU=US / ALKS=US / NBIX=US / SAGE=US / STSA=US / MRNS=US / BIIB=US / APTX=US / GRAY=US / LUN=US / ZGNX=US / ITCI=US / ALDX=US / XENE=US / RLMD=US / AXSM=US / BHVN=US / EOLS=US / GMTX=US</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / AC Immune SA / Alkermes Plc / Neurocrine Biosciences Inc / SAGE Therapeutics Inc / Satsuma Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Biogen Inc / Aptinyx Inc / Graybug Vision Inc / Lundin Mining Corp / Zogenix Inc / Intra-Cellular Therapies Inc / Aldeyra Therapeutics Inc / Xenon Pharmaceuticals Inc / Relmada Therapeutics Inc / Axsome Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Evolus Inc / Gemini Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Marc Goodman</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Catalysts in 2021 and beyond for our biotechnology coverage: April 2021 edition</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">NBIX.OQ / US09062X1037 / ACAD.N / 78667J108 / G11196105 / 98986X109 / 46116X101 / 92915B106 / 918385105 / 09075P105 / 22053A107 / 20451W101 / 23256X100</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / SAGE Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Zynerba Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Voyager Therapeutics Inc / vTv Therapeutics Inc / BioXcel Therapeutics Inc / Cortexyme Inc / Compass Pathways PLC / Cybin Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Sumant Kulkarni / Jia Min, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Taking Proteomics to New Frontiers; Initiating at Buy and $44 PT</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">68071010 / 09062X103 / 452327109 / 34385P108 / 74766Q101</td><td class="leftalignment">Olink Holding AB (publ) / Biogen Inc / Illumina Inc / Fluidigm Corp / Quanterix Corp</td><td class="leftalignment"></td><td class="leftalignment">Sweden / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Sung Ji Nam / Janet Zhang</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 1Q21 EPS Preview: Biotech Headwinds Led to Underperformance in Q1, but M&A Could Provide Catalysts to Lift Sentiment</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">BIIB.OQ / AMGN.OQ / 4502.T / LLY.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / EXEL.OQ / SGEN.OQ / VRTX.OQ / GLPG.AS / EPZM.OQ / MRTX.OQ / BPMC.OQ / DCPH.OQ / GRTX.OQ</td><td class="leftalignment">Biogen Inc / Amgen Inc / Takeda Pharmaceutical Co Ltd / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Exelixis Inc / Seagen Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Epizyme Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Deciphera Pharmaceuticals Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park / Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: TSHA now pivotal-stage; JNJ C19 safety pause</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009 / US1266501006 / US3755581036 / US4448591028 / US45337C1027 / US75886F1075 / US92532F1003 / US09062X1037 / US15135B1017 / US69366J2006 / US0367521038 / US1255231003</td><td class="leftalignment">Amgen Inc / CVS Health Corp / Gilead Sciences Inc / Humana Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Centene Corp / PTC Therapeutics Inc / Anthem Inc / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">1Q21 Large Cap Preview: We see mostly solid prints across the board in spite of COVID</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US09062X1037 / US0311621009 / US3755581036 / US45337C1027 / US75886F1075 / US92532F1003</td><td class="leftalignment">Biogen Inc / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMD=US / DNLI=US / AX=US / XOMA=US / ACET=US / APLS=US / BLUE=US / ISEE=US / FUSN=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / COGT=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Advanced Micro Devices Inc / Denali Therapeutics Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 543</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">FSTX=US / GANX=US / MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / NVS=US / AZN=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / UCB=BE / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CHE=US / CYH=US / EW=US / ISEE=US / GEN=US / ISRG=US / PHG=US / LH=US / PRVL=US / REGN=US / USPH=US / UHS=US / VRTX=US / SGEN=US / SAGE=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / IGMS=US / BIIB=US / ISR=US / SLP=US / MRNA=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / OSCR=US / FOLD=US / EHC=US / TMDI=US / ADXN=US / SWAV=US / ADUS=US / SRNE=US / RGNX=US / ANVS=US / ACHC=US / PRTA=US / MRTX=US / MGNX=US / AERI=US / XNCR=US / TRVN=US / FLXN=US / CTRE=US / VBIV=US / WBA=US / NVTA=US / EVH=US / TDOC=US / NVCR=US / VYGR=US / MRUS=US / APVO=US / IRTC=US / CRSP=US / IOVA=US / MTEM=US / SYBX=US / NCNA=US / MDNA=US / ALLO=US / IDYA=US / BCYC=US / PSNL=US / ONCT=US / NBSE=US / DMTK=US / BNTX=US / PNTG=US / PASG=US / LYS=US / ORIC=US / INBX=US / TSHA=US / KDNY=US / SIOX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Gain Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Ucb SA / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Iveric Bio Inc / General Electric Co / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Porvair PLC / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / IGM Biosciences Inc / Biogen Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Oscar Health Inc / Amicus Therapeutics Inc / Encompass Health Corp / Titan Medical Inc / Addex Therapeutics Ltd / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Regenxbio Inc / Annovis Bio Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / MacroGenics Inc / Aerie Pharmaceuticals Inc / Xencor Inc / Trevena Inc / Pacira Biosciences Inc / CareTrust REIT Inc / VBI Vaccines Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Merus NV / Aptevo Therapeutics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Molecular Templates Inc / Synlogic Inc / NuCana PLC / Medicenna Therapeutics Corp / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Personalis Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / DermTech Inc / BioNTech SE / Pennant Group Inc / Passage Bio Inc / Lysogene SA / Oric Pharmaceuticals Inc / Inhibrx Inc / Taysha Gene Therapies Inc / Chinook Therapeutics Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">April 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">171</td><td class="leftalignment">09062X103 / 031162100 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Biogen Inc / Amgen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 4/9/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / PEP=US / AMGN=US / BMY=US / DIS=US / PLD=US / AMZN=US / CPE=US / VRM=US / BRO=US / EXPE=US / UNH=US / KIDS=US / AJG=US / MAN=US / REGN=US / SNAP=US / TRIP=US / WIX=US / BKNG=US / FB=US / KIM=US / PTON=US / STRO=US / BIIB=US / AAWW=US / CLNY=US / GDOT=US / PCRX=US / ANGI=US / SPLK=US / PTCT=US / VCYT=US / QURE=US / GOOGL=US / BABA=US / CMPR=US / GDDY=US / WLTW=US / CVNA=US / SFIX=US / FTDR=US / SVMK=US / HARP=US / LYFT=US / UBER=US / TCRR=US / GMAB=US / CRMD.US</td><td class="leftalignment">Merck & Co Inc / PepsiCo Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Prologis Inc / Amazon.com Inc / Callon Petroleum Co / Vroom Inc / Brown & Brown Inc / Expedia Group Inc / UnitedHealth Group Inc / OrthoPediatrics Corp / Arthur J Gallagher & Co / ManpowerGroup Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Booking Holdings Inc / Meta Platforms Inc / Kimco Realty Corp / Peloton Interactive Inc / Sutro Biopharma Inc / Biogen Inc / Atlas Air Worldwide Holdings Inc / DigitalBridge Group Inc / Green Dot Corp / Pacira Biosciences Inc / Angi Inc / Splunk Inc / PTC Therapeutics Inc / Veracyte Inc / Uniqure NV / Alphabet Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / Willis Towers Watson PLC / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Genmab A/S / CorMedix Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / MRNA.OQ / ACRX.OQ / ABBV.N / MGNX.OQ / SAGE.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / MacroGenics Inc / SAGE Therapeutics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Auerbach Grayson & Co., Inc.</td><td class="leftalignment">AUERBACH GRAYSON: CEEMEA & LATAM Daily Morning Note 04-16-21:  (Alumetal, Anadolu Sigorta, Astarta Holding, Baghdad Soft Drinks, Bank Handlowy, CD Projekt, CEZ, CI Games, Clico Investment Fund, Cyfrowy Polsat, Enter Air, Forte, GPW, Grupa Kety)</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">AMT.WA / ANSGR.IS / ASTH.WA / CDR.WA / CEZP.PR / CIF.TTB / CIG.WA / CPS.WA / ENTP.WA / GPW.WA / KTY.WA / CZ0005112300 / GRS014013007 / TLEVICPO@MM / BHW@PW / GRS282183003 / GRS393503008 / PLKETY000011 / HU0000067624 / HU0000068952 / ZW0009011579 / LAMDA@GA / PLPGNIG00014 / AST@PW / TRAANSGR91O1 / PLCFRPT00013 / GPW@PW / IQ000A0M7TT6 / PLJSW0000015 / KRC@PW / AML@PW / FTE@PW / CIG@PW / BIIB@IQ / SLV@PW / CDR@PW / MONET@CP / CIF@TP / ENT@PW</td><td class="leftalignment">Alumetal SA / Anadolu Anonim Turk Sigorta Sti / ASTARTA Holding NV / CD Projekt SA / CEZ as / CLICO Investment Fund / CI Games SA / Cyfrowy Polsat SA / Enter Air SA / Gielda Papierow Wartosciowych w Warszawie SA / Grupa Kety SA / CEZ as / Piraeus Financial Holdings SA / Grupo Televisa SAB / Bank Handlowy w Warszawie SA / Jumbo SA / Mytilineos SA / Grupa Kety SA / Richter Gedeon Vegyeszeti Gyar Nyrt / MOL Magyar Olajes Gazipari Nyrt / TSL Ltd / Lamda Development SA / Polskie Gornictwo Naftowe i Gazownictwo SA / ASTARTA Holding NV / Anadolu Anonim Turk Sigorta Sti / Cyfrowy Polsat SA / Gielda Papierow Wartosciowych w Warszawie SA / Baghdad Soft Drinks Co / Jastrzebska Spolka Weglowa SA / Krynicki Recykling SA / Alumetal SA / Fabryki Mebli Forte SA / CI Games SA / Iraqi Islamic Bank for Investment & Development / Selvita SA / CD Projekt SA / Moneta Money Bank as / CLICO Investment Fund / Enter Air SA</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">Czech Republic / Ghana / Greece / Croatia / Hungary / Iraq / Mexico / Namibia / Nigeria / Poland / Russian Federation / Slovenia / Trinidad and Tobago / Turkey / Ukraine / Zimbabwe / Serbia & Montenegro - Discontinue with effect from December 11, 2006</td><td class="leftalignment">Advertising / Agriculture / Air Transportation / Apparel & Textiles / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Communications / Electrical / Environmental Services / Financial Services / Food / Household Products / Info. Tech./Computers / Info. Tech./Software / Insurance / Leisure & Entertainment / Media / Metals & Minerals / Office Equipment / Pharmaceuticals / Publishing / Real Estate / Retailing / Transportation / Utilities / Wholesale</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Auerbach Grayson</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Small Biotech Inflows Break Up the Bleeding</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 68906L105 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Otonomy Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ABT.N / BAC.N / BK.N / C.N / CCI.N / DOW.N / IBM.N / JNJ.N / JPM.N / KO.N / PM.N / PNC.N / WFC.N / PG.N / UNH.N / GS.N / VZ.N / STT.N / DHI.N / PLD.N / MTB.N / BLK.N / FRC.N / LRCX.OQ / ZION.OQ / NFLX.OQ / BIIB.OQ / MS.N / NEE.N / ANTM.N / IQV.N / PEP.OQ / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Crown Castle International Corp / Dow Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Philip Morris International Inc / PNC Financial Services Group Inc / Wells Fargo & Co / Procter & Gamble Co / UnitedHealth Group Inc / Goldman Sachs Group Inc / Verizon Communications Inc / State Street Corp / D R Horton Inc / Prologis Inc / M&T Bank Corp / BlackRock Inc / First Republic Bank / Lam Research Corp / Zions Bancorporation NA / Netflix Inc / Biogen Inc / Morgan Stanley / Nextera Energy Inc / Anthem Inc / IQVIA Holdings Inc / PepsiCo Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">U.S. High Grade Credit Analyst Focus List : April 2021</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">CB.N / CIT.N / GE.N / GM.N / KO.N / NAB.AX / TAP.N / TEF.MC / AAL.L / VLO.N / KR.N / LXP.N / BKH.N / AMH.N / BIIB.O / DISCA.O / PSEC.O / PSX.N / TMUS.O / PAA.O</td><td class="leftalignment">Chubb Ltd / First-Citizens Bank & Trust Co / General Electric Co / General Motors Co / Coca-Cola Co / National Australia Bank Ltd / Molson Coors Beverage Co / Telefonica SA / Anglo American PLC / Valero Energy Corp / Kroger Co / LXP Industrial Trust / Black Hills Corp / American Homes 4 Rent / Biogen Inc / Discovery Inc / Prospect Capital Corp / Phillips 66 / T-Mobile US Inc / Plains All American Pipeline LP</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Switzerland / Spain / United Kingdom / United States</td><td class="leftalignment">Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Conglomerates / Consumer / Energy / Financial Services / Food / Healthcare / Industrial Materials / Insurance / Manufacturing / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Telecommunications / Utilities / Wholesale / Oil & Gas</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Eric Beinstein / Mr. Matthew A. Anavy / Mr. Kabir Caprihan / Virginia M. Chambless / Mr. Christian D. Crosby / Brett Gibson / Kevin L. Kwan / Mr. Jonathan D. Rau / Mr. Mark S. Streeter</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Michigan Hospitalizations Surge, Confirming We Are Not in the Clear Despite Strong Vaccination Pace; Global Cases Still Grow</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / BLD=US / DVN=US / INCY=US / TEVA=US / AMT=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / CCI=US / MGY=US / SWN=US / MUR=US / CHRS=US / BRO=US / MRO=US / LEG=US / DISH=US / CBRL=US / CNX=US / DRI=US / EQT=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / SBAC=US / CVX=US / SAGE=US / BXS=US / MKL=US / COP=US / DIN=US / JRVR=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / CLR=US / PRPL=US / NMTR=US / TIL=US / NOG=US / IAC=US / JACK=US / TREX=US / KNSL=US / AR=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / TMUS=US / NDLS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / WING=US / 82982L103 / CDEV=US / IRTC=US / CRSP=US / PVAC=US / JELD=US / SBOW=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / FBRX=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / TopBuild Corp / Devon Energy Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / American Tower Corp / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Crown Castle International Corp / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Coherus BioSciences Inc / Brown & Brown Inc / Marathon Oil Corp / Leggett & Platt Inc / DISH Network Corp / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / SBA Communications Corp / Chevron Corp / SAGE Therapeutics Inc / Cadence Bank / Markel Corp / Conocophillips / Dine Brands Global Inc / James River Group Holdings Ltd / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / 9 Meters Biopharma Inc / Instil Bio Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Kinsale Capital Group Inc / Antero Resources Corp / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2050832 / 2026242 / 2219224 / 2270726 / 2455965 / 2471950 / 2689560 / 2680905 / 2684703 / 2440637 / 7103065 / B00FWN1 / B125XQ6 / B3D7K31 / B3D7KG4 / B7TL820 / B3V9F12 / BYVY8G0 / BP4GNK9 / BJLT387 / BMQ5T49 / BKVDFF7 / BFMXGR0 / BYXJQG9 / BKTNTR9 / BJDX8Y8 / BJNQGL0 / BLBLMD5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Ameren Corp / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Biogen Inc / Incyte Corp / PG&E Corp / PPL Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Portland General Electric Co / Discovery Inc / Discovery Inc / Meta Platforms Inc / PVH Corp / Alphabet Inc / SAGE Therapeutics Inc / Avantor Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Evergy Inc / Spire Inc / ViacomCBS Inc / Mirum Pharmaceuticals Inc / Rite Aid Corp / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen & Sage : SAGE-324 Tremor Data is Mixed Overall But Doesn't Shake Up the Near-Term Outlook for Either Company</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O / SAGE.O</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CRNT=US / SAGE=US / NVDA=US / THO=US / URBN=US / BIIB=US / RGNX=US / CNHI=US / TSHA=US / OUST=US</td><td class="leftalignment">Ceragon Networks Ltd / SAGE Therapeutics Inc / NVIDIA Corp / Thor Industries Inc / Urban Outfitters Inc / Biogen Inc / Regenxbio Inc / CNH Industrial NV / Taysha Gene Therapies Inc / Ouster Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Telecommunications</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">SAGE-324 Top Line Data Show Promise in ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SAGE=US / BIIB=US</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Investor focus remains on adu approval; encouraging tremor data adds upside to pipeline</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US / SAGE=US</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">SAGE-324 Phase II KINETIC Study Demonstrates Meaningful Reductions in Tremor but Clear Need for Dose Optimization</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X103 / 78667J108 / BIIB.OQ</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Essential tremor could add upside to our model; sensitivities and quick take below</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">SAGE/BIIB: As We Expected, ET Results Raise More Questions than Answers About '324's Therapeutic Window and Potential Viability</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O / 78667J108 / SAGE.OQ</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: 6-mo MRNA C19 data; DRNA sells ALNY royalties</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ALNY.OQ / MRNA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Moderna Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FOCS=US / GANX=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / CAT=US / DIS=US / MO=US / WM=US / BWA=US / MSFT=US / CL=US / MDT=US / C=US / AMZN=US / A=US / RUN=US / CG=US / CSR=US / DOX=US / GS=US / MPWR=US / TMX=US / FCEL=US / PLUG=US / AXL=US / NVS=US / SMTC=US / MET=US / VRTS=US / TSM=US / UPS=US / ENR=US / CRY=US / RAD=US / CSL=US / JCI=US / JNJ=US / UCB=BE / DE=US / FLO=US / HCC=US / NUAN=US / RSG=US / AAII=US / ALB=US / AMED=US / ECOL=US / AMSC=US / APLS=US / ARRY=US / ATRC=US / AVNT=US / AVT=US / BOX=US / B=US / BL=US / CMI=US / CALM=US / CSV=US / CENX=US / CME=US / CO=US / CRVL=US / CREE=US / DAKT=US / EW=US / EXAS=US / FDS=US / FIVE=US / HTLD=US / ITRI=US / MMS=US / MRCY=US / MS=US / MCO=US / ODFL=US / PZZA=US / PRVL=US / QDEL=US / RBC=US / ROK=US / POOL=US / TRMB=US / UTL=US / VCTR=US / VRTX=US / VG=US / WDFC=US / OSUR=US / PDFS=US / CCRN=US / RHHBY=US / PYPL=US / AGR=US / ACA=US / HR=US / NEP=US / PRA=US / UFCS=US / BIO=US / O=US / SWKS=US / ICAD=US / OSTK=US / ENSG=US / BE=US / AMSF=US / ARES=US / CLH=US / WCN=US / NDAQ=US / BIIB=US / RNG=US / CRI=US / ISR=US / NUVA=US / PBF=US / RMR=US / ENS=US / TWIN=US / ORA=US / WTI=US / FRPT=US / MORN=US / AMRS=US / PDD=US / SPWR=US / ICE=US / ATNI=US / EHTH=US / CSIQ=US / RSI=US / EBS=US / FSLR=US / FOLD=US / MASI=US / DAN=US / WPRT=US / ADXN=US / TBK=US / KKR=US / SWAV=US / AGCO=US / SWI=US / UTZ=US / ADUS=US / SRNE=US / GNRC=US / CBOE=US / TSLA=US / MSCI=US / AMRC=US / 2454-TW=US / HZNP=US / ANVS=US / ZNGA=US / ENPH=US / PRTA=US / HASI=US / CNHI=US / FATE=US / QURE=US / GOOGL=US / DNOW=US / COUP=US / BABA=US / LOVE=US / VCEL=US / BILL=US / ETSY=US / SEDG=US / WING=US / TDOC=US / AQMS=US / VYGR=US / MIME=US / NTNX=US / NGVT=US / WKHS=US / MDGL=US / IRTC=US / CRSP=US / HLNE=US / SNDR=US / IOVA=US / RDFN=US / PETQ=US / SYBX=US / ROKU=US / MDB=US / APTV=US / MDNA=US / VOW3-DE=US / SMAR=US / CWEN=US / FTDR=US / ALLO=US / ESTC=US / FVRR=US / NBSE=US / MPNGF=US / PASG=US / LYS=US / MSGS=US / MSGE=US / ORIC=US / VLDR=US / HYLN=US / SIOX=US / SHLS=US / CHPT=US / AEVA=US</td><td class="leftalignment">Focus Financial Partners Inc / Gain Therapeutics Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Walt Disney Co / Altria Group Inc / Waste Management Inc / Borgwarner Inc / Microsoft Corp / Colgate-Palmolive Co / Medtronic PLC / Citigroup Inc / Amazon.com Inc / Agilent Technologies Inc / Sunrun Inc / Carlyle Group Inc / Centerspace / Amdocs Ltd / Goldman Sachs Group Inc / Monolithic Power Systems Inc / Terminix Global Holdings Inc / Fuelcell Energy Inc / Plug Power Inc / American Axle & Manufacturing Holdings Inc / Novartis AG / Semtech Corp / MetLife Inc / Virtus Investment Partners Inc / Taiwan Semiconductor Manufacturing Co Ltd / United Parcel Service Inc / Energizer Holdings Inc / CryoLife Inc / Rite Aid Corp / Carlisle Companies Inc / Johnson Controls International PLC / Johnson & Johnson / Ucb SA / Deere & Co / Flowers Foods Inc / Warrior Met Coal Inc / Nuance Communications Inc / Republic Services Inc / Alabama Aircraft Industries Inc / Albemarle Corp / Amedisys Inc / US Ecology Inc / American Superconductor Corp / Apellis Pharmaceuticals Inc / Array Technologies Inc / AtriCure Inc / Avient Corp / Avnet Inc / Box Inc / Barnes Group Inc / Blackline Inc / Cummins Inc / Cal-Maine Foods Inc / Carriage Services Inc / Century Aluminum Co / CME Group Inc / Global Cord Blood Corp / CorVel Corp / Wolfspeed Inc / Daktronics Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Factset Research Systems Inc / Five Below Inc / Heartland Express Inc / Itron Inc / Maximus Inc / Mercury Systems Inc / Morgan Stanley / Moody's Corp / Old Dominion Freight Line Inc / Papa John's International Inc / Porvair PLC / Quidel Corp / Regal Rexnord Corp / Rockwell Automation Inc / Pool Corp / Trimble Inc / Unitil Corp / Victory Capital Holdings Inc / Vertex Pharmaceuticals Inc / Vonage Holdings Corp / WD-40 Co / OraSure Technologies Inc / PDF Solutions Inc / Cross Country Healthcare Inc / Roche Holding AG / PayPal Holdings Inc / Avangrid Inc / Arcosa Inc / Healthcare Realty Trust Inc / Nextera Energy Partners LP / ProAssurance Corp / United Fire Group Inc / Bio Rad Laboratories Inc / Realty Income Corp / Skyworks Solutions Inc / ICAD Inc / Overstock.com Inc / Ensign Group Inc / Bloom Energy Corp / Amerisafe Inc / Ares Management Corp / Clean Harbors Inc / Waste Connections Inc / Nasdaq Inc / Biogen Inc / RingCentral Inc / Carter's Inc / IsoRay Inc / NuVasive Inc / PBF Energy Inc / RMR Group Inc / EnerSys / Twin Disc Inc / Ormat Technologies Inc / W&T Offshore Inc / Freshpet Inc / Morningstar Inc / Amyris Inc / Pinduoduo Inc / SunPower Corp / Intercontinental Exchange Inc / ATN International Inc / eHealth Inc / Canadian Solar Inc / Rush Street Interactive Inc / Emergent BioSolutions Inc / First Solar Inc / Amicus Therapeutics Inc / Masimo Corp / Dana Inc / Westport Fuel Systems Inc / Addex Therapeutics Ltd / Triumph Bancorp Inc / KKR & Co Inc / Shockwave Medical Inc / AGCO Corp / SolarWinds Corp / UTZ Brands Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Generac Holdings Inc / Cboe Global Markets Inc / Tesla Inc / MSCI Inc / Ameresco Inc / MediaTek Inc / Horizon Therapeutics PLC / Annovis Bio Inc / Zynga Inc / Enphase Energy Inc / Prothena Corporation PLC / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Fate Therapeutics Inc / Uniqure NV / Alphabet Inc / NOW Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Lovesac Co / Vericel Corp / Bill.com Holdings Inc / ETSY Inc / Solaredge Technologies Inc / Wingstop Inc / Teladoc Health Inc / Aqua Metals Inc / Voyager Therapeutics Inc / Mimecast Ltd / Nutanix Inc / Ingevity Corp / Workhorse Group Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Hamilton Lane Inc / Schneider National Inc / Iovance Biotherapeutics Inc / Redfin Corp / PetIQ Inc / Synlogic Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Medicenna Therapeutics Corp / Volkswagen AG / Smartsheet Inc / Clearway Energy Inc / Frontdoor Inc / Allogene Therapeutics Inc / Elastic NV / Fiverr International Ltd / NeuBase Therapeutics Inc / Meituan / Passage Bio Inc / Lysogene SA / Madison Square Garden Sports Corp / Madison Square Garden Entertainment Corp / Oric Pharmaceuticals Inc / Velodyne Lidar Inc / Hyliion Holdings Corp / Sio Gene Therapies Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Aeva Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States / Jersey / Guernsey</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Machinery / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Apr 12 2021 6:40AM</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CCS=US / NUAN=US / AAPL=US / DELL=US / IBM=US / GM=US / INTC=US / AMD=US / MSFT=US / MU=US / QCOM=US / DNLI=US / NVDA=US / NTAP=US / BC=US / 7974=JP / UBI=FR / XLNX=US / TTWO=US / ATVI=US / IIVI=US / AX=US / XOMA=US / ACET=US / APLS=US / AVGO=US / BLUE=US / ISEE=US / FORD=US / FUSN=US / HZO=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / WDC=US / SAGE=US / ACOR=US / SWKS=US / ALPN=US / STX=US / IGMS=US / STRO=US / BIIB=US / COGT=US / SIMO=US / SCPL=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / 2454=US / 2330=US / VMW=US / 6758=US / IDRA=US / ASND=US / RCUS=US / 8299=US / OMER=US / TSLA=US / NXPI=US / PCRX=US / 981=US / BEAM=US / ZNGA=US / EA=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / QRVO=US / CDTX=US / BPMC=US / ABUS=US / PSTG=US / ARGX=US / NVCR=US / HPE=US / CTMX=US / VYGR=US / KURA=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US / PLTK=US</td><td class="leftalignment">Century Communities Inc / Nuance Communications Inc / Apple Inc / Dell Technologies Inc / International Business Machines Corp / General Motors Co / Intel Corp / Advanced Micro Devices Inc / Microsoft Corp / Micron Technology Inc / Qualcomm Inc / Denali Therapeutics Inc / NVIDIA Corp / NetApp Inc / Brunswick Corp / Nintendo Co Ltd / Ubisoft Entertainment SA / Xilinx Inc / Take-Two Interactive Software Inc / Activision Blizzard Inc / II-VI Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / bluebird bio Inc / Iveric Bio Inc / Forward Industries Inc / Fusion Pharmaceuticals Inc / MarineMax Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / Western Digital Corp / SAGE Therapeutics Inc / Acorda Therapeutics Inc / Skyworks Solutions Inc / Alpine Immune Sciences Inc / Seagate Technology Holdings PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Silicon Motion Technology Corp / Sciplay Corp / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / MediaTek Inc / Taiwan Semiconductor Manufacturing Co Ltd / VMware Inc / Sony Group Corp / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Phison Electronics Corp / Omeros Corp / Tesla Inc / NXP Semiconductors NV / Pacira Biosciences Inc / Semiconductor Manufacturing International Corp / Beam Therapeutics Inc / Zynga Inc / Electronic Arts Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / Pure Storage Inc / argenx SE / Novocure Ltd / Hewlett Packard Enterprise Co / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc / Playtika Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Netherlands / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Building & Building Materials / Electronics / Healthcare / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">An Emerging and Differentiated In-Silico Story; Initiating at Outperform & $30 PT</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">GANX=US / LLY=US / PFE=US / NVS=US / JNJ=US / UCB=BE / PRVL=US / VRTX=US / RHHBY=US / BIIB=US / FOLD=US / ADXN=US / SRNE=US / ANVS=US / PRTA=US / VYGR=US / NBSE=US / PASG=US / LYS=US / SIOX=US</td><td class="leftalignment">Gain Therapeutics Inc / Eli Lilly and Co / Pfizer Inc / Novartis AG / Johnson & Johnson / Ucb SA / Porvair PLC / Vertex Pharmaceuticals Inc / Roche Holding AG / Biogen Inc / Amicus Therapeutics Inc / Addex Therapeutics Ltd / Sorrento Therapeutics Inc / Annovis Bio Inc / Prothena Corporation PLC / Voyager Therapeutics Inc / NeuBase Therapeutics Inc / Passage Bio Inc / Lysogene SA / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biopharma: Latest Short Interest for US Biopharma: Large Caps Stable; ACRX and NBIX See Moderate Increases Among SMid Caps</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BIIB: Biogen, Inc. - SAGE-324 Meets Primary Endpoint for Essential Tremor, but safety concerns could limit usage; still our focus remains on the early June adu PDUFA</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.OQ / SAGE.OQ</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Learnings from Previous Tax Act</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AMGN=US / BIIB=US</td><td class="leftalignment">Amgen Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMD=US / DNLI=US / AX=US / XOMA=US / ACET=US / APLS=US / BLUE=US / ISEE=US / FUSN=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / COGT=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Advanced Micro Devices Inc / Denali Therapeutics Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 542</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / N5749R100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107 / 30315R107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Merus NV / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc / F-Star Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Apr 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMAC=US / ONCT=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / ADCT=US / WMT=US / INCY=US / CMS=US / GILD=US / DGX=US / NVS=US / AZN=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / LH=US / LIFE=US / RKT=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / BIIB=US / ACAD=US / GOOG=US / LHCG=US / CHNG=US / BNGO=US / TPTX=US / EHC=US / ATHX=US / TMDI=US / SWAV=US / ADUS=US / SRNE=US / IRWD=US / SLRX=US / ACHC=US / CCXI=US / TGTX=US / ABBV=US / CTRE=US / OTIC=US / VBLT=US / CLRB=US / WBA=US / SNPHY=US / NVTA=US / EVH=US / GKOS=US / BGNE=US / RETA=US / APVO=US / FLGT=US / IRTC=US / PLXP=US / CYCN=US / TMDX=US / KRTX=US / PNTG=US / NNOX=US / KDNY=US / TVTX=US / EVAX=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Oncternal Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / ADC Therapeutics SA / Walmart Inc / Incyte Corp / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / General Electric Co / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Rocket Companies Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Bionano Genomics Inc / Turning Point Therapeutics Inc / Encompass Health Corp / Athersys Inc / Titan Medical Inc / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Ironwood Pharmaceuticals Inc / Salarius Pharmaceuticals Inc / Acadia Healthcare Company Inc / ChemoCentryx Inc / TG Therapeutics Inc / Abbvie Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Santen Pharmaceutical Co Ltd / Invitae Corp / Evolent Health Inc / Glaukos Corp / Beigene Ltd / Reata Pharmaceuticals Inc / Aptevo Therapeutics Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / PLx Pharma Inc / Cyclerion Therapeutics Inc / Transmedics Group Inc / Karuna Therapeutics Inc / Pennant Group Inc / Nano-X Imaging Ltd / Chinook Therapeutics Inc / Travere Therapeutics Inc / Evaxion Biotech A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 4/2/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMAC=US / FTNT=US / AAPL=US / IBM=US / CSII=US / ALL=US / BMY=US / COST=US / DIS=US / INTC=US / MO=US / AMD=US / MSFT=US / CL=US / GLW=US / K=US / AMZN=US / QCOM=US / T=US / ORCL=US / A=US / WMT=US / TXN=US / RUN=US / CG=US / CSR=US / D=US / ED=US / NTRS=US / AMT=US / DOX=US / GS=US / AKAM=US / MPWR=US / JPM=US / PLUG=US / CHTR=US / NICE=US / V=US / NVS=US / VZ=US / PBR=US / EL=US / SMTC=US / VRTS=US / CHKP=US / SAP=US / URI=US / CCI=US / UPS=US / ENR=US / GSK=US / CTAS=US / CSL=US / TTWO=US / LEG=US / LRCX=US / ATVI=US / CMCSA=US / SRCL=US / CI=US / W=US / UNH=US / DISH=US / INTU=US / NUAN=US / AAII=US / ABMD=US / ALB=US / AMED=US / APPS=US / APLS=US / AVGO=US / BOX=US / B=US / BETA=US / HRB=US / CALM=US / CSV=US / KMX=US / CME=US / CRVL=US / CSGP=US / CYBR=US / DHI=US / EW=US / EGAN=US / EGHT=US / EQIX=US / EXAS=US / FIVE=US / ISRG=US / ITRI=US / LIFE=US / MS=US / MCO=US / TEAM=US / PZZA=US / QUIK=US / QDEL=US / ROK=US / ROP=US / SBAC=US / POOL=US / HSIC=US / SNAP=US / UTL=US / VG=US / WDFC=US / WSC=US / WIX=US / ALGN=US / OSUR=US / PDFS=US / RDWR=US / SNOW=US / PRVB=US / NET=US / CRNT=US / GME=US / ARE=US / FB=US / HR=US / MGRC=US / NEP=US / PRA=US / BIO=US / O=US / SWKS=US / NFLX=US / VRNT=US / ENSG=US / AMSF=US / TWLO=US / ERIC=US / NDAQ=US / PTON=US / RPD=US / BIIB=US / RNG=US / CRI=US / OPEN=US / CEVA=US / MRNA=US / DPZ=US / GOOG=US / DLR=US / OLED=US / VIAC=US / FRPT=US / MORN=US / DISCA=US / FIS=US / CCOI=US / ATNI=US / BIG=US / TEL=US / CSIQ=US / RSI=US / QSR=US / BX=US / LLNW=US / LULU=US / VMW=US / LUMN=US / SPGI=US / TBK=US / SWI=US / ADUS=US / GNRC=US / TCEHY=US / NEE=US / TSLA=US / MSCI=US / AMRC=US / HZNP=US / ZNGA=US / EA=US / SVB=US / CCXI=US / ENPH=US / SPLK=US / PANW=US / QLYS=US / WDAY=US / TMUS=US / FEYE=US / GTT=US / AVYA=US / TME=US / QURE=US / COUP=US / LOVE=US / QRVO=US / BILL=US / ETSY=US / WING=US / ZS=US / SQ=US / MIME=US / RETA=US / DZSI=US / TTD=US / CRSP=US / UAA=US / OKTA=US / CVNA=US / ATUS=US / IOVA=US / RDFN=US / ROKU=US / MDB=US / SAIL=US / PLXP=US / BILI=US / HUYA=US / FOCS=US / FTDR=US / ESTC=US / UBER=US / ZM=US / CYCN=US / TUFN=US / FSLY=US / CRWD=US / CMBM=US / FVRR=US / PING=US / NLOK=US / DKNG=US / KDNY=US / RXT=US / ONDS=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Fortinet Inc / Apple Inc / International Business Machines Corp / Cardiovascular Systems Inc / Allstate Corp / Bristol-Myers Squibb Co / Costco Wholesale Corp / Walt Disney Co / Intel Corp / Altria Group Inc / Advanced Micro Devices Inc / Microsoft Corp / Colgate-Palmolive Co / Corning Inc / Kellogg Co / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Agilent Technologies Inc / Walmart Inc / Texas Instruments Inc / Sunrun Inc / Carlyle Group Inc / Centerspace / Dominion Energy Inc / Consolidated Edison Inc / Northern Trust Corp / American Tower Corp / Amdocs Ltd / Goldman Sachs Group Inc / Akamai Technologies Inc / Monolithic Power Systems Inc / JPMorgan Chase & Co / Plug Power Inc / Charter Communications Inc / Nice Ltd / Visa Inc / Novartis AG / Verizon Communications Inc / Petroleo Brasileiro SA Petrobras / Estee Lauder Companies Inc / Semtech Corp / Virtus Investment Partners Inc / Check Point Software Technologies Ltd / SAP SE / United Rentals Inc / Crown Castle International Corp / United Parcel Service Inc / Energizer Holdings Inc / GlaxoSmithKline PLC / Cintas Corp / Carlisle Companies Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Lam Research Corp / Activision Blizzard Inc / Comcast Corp / Stericycle Inc / Cigna Corp / Wayfair Inc / UnitedHealth Group Inc / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Alabama Aircraft Industries Inc / ABIOMED Inc / Albemarle Corp / Amedisys Inc / Digital Turbine Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / Box Inc / Barnes Group Inc / Beta Drugs Ltd / H & R Block Inc / Cal-Maine Foods Inc / Carriage Services Inc / Carmax Inc / CME Group Inc / CorVel Corp / CoStar Group Inc / Cyberark Software Ltd / D R Horton Inc / Edwards Lifesciences Corp / eGain Corp / 8x8 Inc / Equinix Inc / Exact Sciences Corp / Five Below Inc / Intuitive Surgical Inc / Itron Inc / aTyr Pharma Inc / Morgan Stanley / Moody's Corp / Atlassian Corporation PLC / Papa John's International Inc / QuickLogic Corp / Quidel Corp / Rockwell Automation Inc / Roper Technologies Inc / SBA Communications Corp / Pool Corp / Henry Schein Inc / Snap Inc / Unitil Corp / Vonage Holdings Corp / WD-40 Co / Willscot Mobile Mini Holdings Corp / Wix.Com Ltd / Align Technology Inc / OraSure Technologies Inc / PDF Solutions Inc / Radware Ltd / Snowflake Inc. / Provention Bio Inc / Cloudflare Inc / Ceragon Networks Ltd / GameStop Corp / Alexandria Real Estate Equities Inc / Meta Platforms Inc / Healthcare Realty Trust Inc / McGrath RentCorp / Nextera Energy Partners LP / ProAssurance Corp / Bio Rad Laboratories Inc / Realty Income Corp / Skyworks Solutions Inc / Netflix Inc / Verint Systems Inc / Ensign Group Inc / Amerisafe Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / Nasdaq Inc / Peloton Interactive Inc / Rapid7 Inc / Biogen Inc / RingCentral Inc / Carter's Inc / Opendoor Technologies Inc / CEVA Inc / Moderna Inc / Domino's Pizza Inc / Alphabet Inc / Digital Realty Trust Inc / Universal Display Corp / ViacomCBS Inc / Freshpet Inc / Morningstar Inc / Discovery Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / ATN International Inc / Big Lots Inc / TE Connectivity Ltd / Canadian Solar Inc / Rush Street Interactive Inc / Restaurant Brands International Inc / Blackstone Inc / Limelight Networks Inc / Lululemon Athletica Inc / VMware Inc / Lumen Technologies Inc / S&P Global Inc / Triumph Bancorp Inc / SolarWinds Corp / Addus Homecare Corp / Generac Holdings Inc / Tencent Holdings Ltd / Nextera Energy Inc / Tesla Inc / MSCI Inc / Ameresco Inc / Horizon Therapeutics PLC / Zynga Inc / Electronic Arts Inc / SilverBridge Holdings Ltd / ChemoCentryx Inc / Enphase Energy Inc / Splunk Inc / Palo Alto Networks Inc / Qualys Inc / Workday Inc / T-Mobile US Inc / Mandiant Inc / GTT Communications Inc / Avaya Holdings Corp / Tencent Music Entertainment Group / Uniqure NV / Coupa Software Inc / Lovesac Co / Qorvo Inc / Bill.com Holdings Inc / ETSY Inc / Wingstop Inc / Zscaler Inc / Block Inc / Mimecast Ltd / Reata Pharmaceuticals Inc / DZS Inc / Trade Desk Inc / CRISPR Therapeutics AG / Under Armour Inc / Okta Inc / Carvana Co / Altice USA Inc / Iovance Biotherapeutics Inc / Redfin Corp / Roku Inc / MongoDB Inc / SailPoint Technologies Holdings Inc / PLx Pharma Inc / Bilibili Inc / HUYA Inc / Focus Financial Partners Inc / Frontdoor Inc / Elastic NV / Uber Technologies Inc / Zoom Video Communications Inc / Cyclerion Therapeutics Inc / Tufin Software Technologies Ltd / Fastly Inc / CrowdStrike Holdings Inc / Cambium Networks Corp / Fiverr International Ltd / Ping Identity Holding Corp / NortonLifeLock Inc / DraftKings Inc / Chinook Therapeutics Inc / Rackspace Technology Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / India / Ireland / Israel / Netherlands / Sweden / United States / South Africa / Jersey / Guernsey</td><td class="leftalignment">Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">When It Rains, It Pours - Biotech Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / US09062X1037</td><td class="leftalignment">Biogen Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">DMAC May Have Unlocked Synthetic KLK1's Potential in Stroke and Chronic Kidney Disease; Initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">DMAC=US / PFE=US / BMY=US / NVS=US / BIIB=US / ATHX=US / IRWD=US / CCXI=US / RETA=US / CYCN=US / KDNY=US / TVTX=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Pfizer Inc / Bristol-Myers Squibb Co / Novartis AG / Biogen Inc / Athersys Inc / Ironwood Pharmaceuticals Inc / ChemoCentryx Inc / Reata Pharmaceuticals Inc / Cyclerion Therapeutics Inc / Chinook Therapeutics Inc / Travere Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ANTO.L / BAC.N / BARC.L / BNPP.PA / C.N / CAS.TO / CSGN.S / F.N / GM.N / GPS.N / HSBA.L / JPM.N / RIO.L / RL.N / SGEF.PA / SOGN.PA / SSE.L / WY.N / PXD.N / CFP.TO / GILD.O / LPX.N / TEN.N / INCY.O / UHS.N / AAL.L / SU.TO / GS.N / DBKGn.DE / UNM.N / NKE.N / BOL.ST / VFC.N / TJX.N / ROST.O / NBIX.O / ANF.N / PVH.N / OPTN.O / VRTX.O / CAGR.PA / PRU.N / URBN.O / COP.N / SWN.N / SEM.N / SIGI.O / ICPT.O / BIIB.O / CWX.TO / ACAD.O / WEF.TO / MS.N / ISBC.O / CS.TO / 443628102 / AEO.N / LULU.O / DAN.N / CLW.N / VALE.N / BHPB.L / PCH.O / CFX.TO / MTOR.N / GLEN.L / IFP.TO / ACHC.O / RFP.N / SRPT.O / 505440107 / KPT.TO / ENTA.O / PTCT.O / BURL.N / LB.N / KPTI.O / ITCI.O / RYAM.N / GBT.OQ / UBSG.S / UAA.N / OKTA.OQ / GOOS.TO / ORSTED.CO / EHC.N / NTGY.MC / LUMN.N / WFG.N / WING.N</td><td class="leftalignment">Antofagasta PLC / Bank of America Corp / Barclays PLC / BNP Paribas SA / Citigroup Inc / Cascades Inc / Credit Suisse Group AG / Ford Motor Co / General Motors Co / Gap Inc / HSBC Holdings PLC / JPMorgan Chase & Co / Rio Tinto PLC / Ralph Lauren Corp / Vinci SA / Societe Generale SA / SSE PLC / Weyerhaeuser Co / Pioneer Natural Resources Co / Canfor Corp / Gilead Sciences Inc / Louisiana-Pacific Corp / Tenneco Inc / Incyte Corp / Universal Health Services Inc / Anglo American PLC / Suncor Energy Inc / Goldman Sachs Group Inc / Deutsche Bank AG / Unum Group / Nike Inc / Boliden AB / VF Corp / TJX Companies Inc / Ross Stores Inc / Neurocrine Biosciences Inc / Abercrombie & Fitch Co / PVH Corp / OptiNose Inc / Vertex Pharmaceuticals Inc / Credit Agricole SA / Prudential Financial Inc / Urban Outfitters Inc / Conocophillips / Southwestern Energy Co / Select Medical Holdings Corp / Selective Insurance Group Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Doman Building Materials Group Ltd / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Morgan Stanley / Investors Bancorp Inc / Capstone Mining Corp / Hudbay Minerals Inc / American Eagle Outfitters Inc / Lululemon Athletica Inc / Dana Inc / Clearwater Paper Corp / Vale SA / BHP Group PLC / Potlatchdeltic Corp / Canfor Pulp Products Inc / Meritor Inc / Glencore PLC / Interfor Corp / Acadia Healthcare Company Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Labrador Iron Ore Royalty Corp / KP Tissue Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Burlington Stores Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Rayonier Advanced Materials Inc / Global Blood Therapeutics Inc / UBS Group AG / Under Armour Inc / Okta Inc / Canada Goose Holdings Inc / Orsted A/S / Encompass Health Corp / Naturgy Energy Group SA / Lumen Technologies Inc / West Fraser Timber Co Ltd / Wingstop Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">1Q21 Earnings Preview On Select Biotechs</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / PTCT.O / KPTI.O / ITCI.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - Revisiting our Outperform and addressing investor pushbacks</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">AZN.L / 1093.HK / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / FGEN.PS / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / CSPC Pharmaceutical Group Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / First Gen Corp / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Hong Kong / Philippines / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">You're Gonna Miss This Opportunity When It's Gone, Time To Take Another Look With The Pullback</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">LLY.N / JNJ.N / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Johnson & Johnson / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: BIIB - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">BIIB</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read & Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GILD.O / NBIX.O / BLU.N / BIIB.O / ACAD.O / SRPT.O / PTCT.O / KPTI.O / 03835T200 / IGMS.O</td><td class="leftalignment">Gilead Sciences Inc / Neurocrine Biosciences Inc / BELLUS Health Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Aptose Biosciences Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / David Szeto / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Portfolio Manager's Guide to ESG - April 2021</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">A.N / AAP.N / ABT.N / AIG.N / ALB.N / ALK.N / APD.N / BA.N / BAC.N / BAX.N / BBY.N / BDX.N / BMY.N / BSX.N / CAH.N / CCL.N / CE.N / CF.N / CI.N / CL.N / CNC.N / CVS.N / DAL.N / DD.N / DOW.N / ECL.N / EL.N / EMN.N / EOG.N / F.N / FCX.N / FDX.N / FLS.N / FMC.N / GE.N / GM.N / GPS.N / HLT.N / IP.N / IR.N / KMB.N / KO.N / LMT.N / LUV.N / MAS.N / MO.N / NEM.N / NOC.N / NSC.N / OXY.N / PHM.N / PM.N / PPG.N / RHI.N / RL.N / SEE.N / SGEF.PA / SLB.N / SWK.N / TAP.N / TXT.N / WMB.N / WMT.N / PG.N / DGX.N / PXD.N / NUE.N / ROK.N / CPB.N / HAL.N / AAL.L / ADML.L / ETN.N / DHR.N / BWA.N / CMI.N / GD.N / URI.N / DE.N / DOV.N / IEX.N / PH.N / ROP.N / K.N / WAB.N / CAT.N / MGM.N / LEN.N / UNP.N / RCL.N / CLX.N / MCD.N / CAG.N / TSN.N / SYY.N / YUM.N / VLO.N / HD.N / LOW.N / MRO.N / UPS.N / WM.N / KR.N / ITW.N / MMM.N / GIS.N / EMR.N / VMC.N / XOM.N / HSY.N / DVN.N / WHR.N / NKE.N / LIN.N / TGT.N / AVY.N / SHW.N / PKG.N / BLL.N / GWW.N / PKI.N / MLM.N / HCA.N / JCI.N / COO.N / DHI.N / STZ.N / VFC.N / DVA.N / TJX.N / KMI.N / AZO.N / KMX.N / PWR.N / COG.N / EFX.N / EW.N / OKE.N / HWM.N / LEG.N / RSG.N / SNA.N / CHD.N / AME.N / GPC.N / MKC.N / HRL.N / PVH.N / LB.TO / ABC.N / CVX.N / MHK.N / TDY.N / COP.N / HAYS.L / AOS.N / ABMD.OQ / AMGN.OQ / CERN.OQ / CTAS.OQ / EXPD.OQ / FAST.OQ / HOLX.OQ / JBHT.OQ / PCAR.OQ / PNR.N / ROL.N / ROST.OQ / SJM.N / TT.N / SBUX.OQ / ODFL.OQ / ORLY.OQ / GILD.OQ / COST.OQ / TSCO.OQ / CPRT.OQ / PENN.OQ / DLTR.OQ / HSIC.OQ / POOL.OQ / TPR.N / AMZN.OQ / CHRW.OQ / EBAY.OQ / EXPE.OQ / GRMN.OQ / ALGN.OQ / WYNN.OQ / MNST.OQ / BIIB.OQ / DPZ.N / MOS.N / LVS.N / NDAQ.OQ / NOV.N / DXCM.OQ / CMG.N / TDG.N / HES.N / HBI.N / ULTA.OQ / NVR.N / BIO.N / VRSK.OQ / GNRC.N / TSLA.OQ / LYB.N / CZR.OQ / NLSN.N / HII.N / HFC.N / BKR.N / FBHS.N / XYL.N / PSX.N / LKQ.OQ / MDLZ.OQ / FANG.OQ / ABBV.N / LDOS.N / MAR.OQ / ALLE.N / NCLH.N / CTLT.N / ANTM.N / WBA.OQ / ETSY.OQ / WRK.N / KHC.OQ / CSX.OQ / FTV.N / LW.N / UAA.N / APTV.N / PEP.OQ / BKNG.OQ / UAL.OQ / NWL.OQ / CTVA.N / LHX.N / J.N / RTX.N / CARR.N / OTIS.N / APA.OQ / HON.OQ / 1U1.DE</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Abbott Laboratories / American International Group Inc / Albemarle Corp / Alaska Air Group Inc / Air Products and Chemicals Inc / Boeing Co / Bank of America Corp / Baxter International Inc / Best Buy Co Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Carnival Corp / Celanese Corp / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / Centene Corp / CVS Health Corp / Delta Air Lines Inc / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Eastman Chemical Co / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Flowserve Corp / FMC Corp / General Electric Co / General Motors Co / Gap Inc / Hilton Worldwide Holdings Inc / International Paper Co / Ingersoll Rand Inc / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Masco Corp / Altria Group Inc / Newmont Corporation / Northrop Grumman Corp / Norfolk Southern Corp / Occidental Petroleum Corp / Pultegroup Inc / Philip Morris International Inc / PPG Industries Inc / Robert Half International Inc / Ralph Lauren Corp / Sealed Air Corp / Vinci SA / Schlumberger NV / Stanley Black & Decker Inc / Molson Coors Beverage Co / Textron Inc / Williams Companies Inc / Walmart Inc / Procter & Gamble Co / Quest Diagnostics Inc / Pioneer Natural Resources Co / Nucor Corp / Rockwell Automation Inc / Campbell Soup Co / Halliburton Co / Anglo American PLC / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / Borgwarner Inc / Cummins Inc / General Dynamics Corp / United Rentals Inc / Deere & Co / Dover Corp / IDEX Corp / Parker-Hannifin Corp / Roper Technologies Inc / Kellogg Co / Westinghouse Air Brake Technologies Corp / Caterpillar Inc / MGM Resorts International / Lennar Corp / Union Pacific Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Conagra Brands Inc / Tyson Foods Inc / Sysco Corp / Yum! Brands Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / Waste Management Inc / Kroger Co / Illinois Tool Works Inc / 3M Co / General Mills Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / Hershey Co / Devon Energy Corp / Whirlpool Corp / Nike Inc / Linde PLC / Target Corp / Avery Dennison Corp / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / PerkinElmer Inc / Martin Marietta Materials Inc / HCA Healthcare Inc / Johnson Controls International PLC / Cooper Companies Inc / D R Horton Inc / Constellation Brands Inc / VF Corp / DaVita Inc / TJX Companies Inc / Kinder Morgan Inc / Autozone Inc / Carmax Inc / Quanta Services Inc / Coterra Energy Inc / Equifax Inc / Edwards Lifesciences Corp / ONEOK Inc / Howmet Aerospace Inc / Leggett & Platt Inc / Republic Services Inc / Snap-On Inc / Church & Dwight Co Inc / AMETEK Inc / Genuine Parts Co / McCormick & Company Inc / Hormel Foods Corp / PVH Corp / Laurentian Bank of Canada / Amerisourcebergen Corp / Chevron Corp / Mohawk Industries Inc / Teledyne Technologies Inc / Conocophillips / Hays PLC / A O Smith Corp / ABIOMED Inc / Amgen Inc / Cerner Corp / Cintas Corp / Expeditors International of Washington Inc / Fastenal Co / Hologic Inc / J B Hunt Transport Services Inc / Paccar Inc / Pentair PLC / Rollins Inc / Ross Stores Inc / J M Smucker Co / Trane Technologies PLC / Starbucks Corp / Old Dominion Freight Line Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Costco Wholesale Corp / Tractor Supply Co / Copart Inc / Penn National Gaming Inc / Dollar Tree Inc / Henry Schein Inc / Pool Corp / Tapestry Inc / Amazon.com Inc / CH Robinson Worldwide Inc / eBay Inc / Expedia Group Inc / Garmin Ltd / Align Technology Inc / Wynn Resorts Ltd / Monster Beverage Corp / Biogen Inc / Domino's Pizza Inc / Mosaic Co / Las Vegas Sands Corp / Nasdaq Inc / Nov Inc / Dexcom Inc / Chipotle Mexican Grill Inc / TransDigm Group Inc / Hess Corp / HanesBrands Inc / Ulta Beauty Inc / NVR Inc / Bio Rad Laboratories Inc / Verisk Analytics Inc / Generac Holdings Inc / Tesla Inc / LyondellBasell Industries NV / Caesars Entertainment Inc / Nielsen Holdings PLC / Huntington Ingalls Industries Inc / HollyFrontier Corp / Baker Hughes Co / Fortune Brands Home & Security Inc / Xylem Inc / Phillips 66 / LKQ Corp / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Leidos Holdings Inc / Marriott International Inc / Allegion PLC / Norwegian Cruise Line Holdings Ltd / Catalent Inc / Anthem Inc / Walgreens Boots Alliance Inc / ETSY Inc / Westrock Co / Kraft Heinz Co / CSX Corp / Fortive Corp / Lamb Weston Holdings Inc / Under Armour Inc / Aptiv PLC / PepsiCo Inc / Booking Holdings Inc / United Airlines Holdings Inc / Newell Brands Inc / Corteva Inc / L3harris Technologies Inc / Jacobs Engineering Group Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / APA Corp (US) / Honeywell International Inc / 1&1 AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Liberia / Netherlands / Panama / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Michigan Surge Highlights Race Between Variants and Vaccines; Global Case Growth Continues</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: March 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / AAL.L / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Anglo American PLC / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Apr 05 2021 6:31AM</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">GBT=US / WING=US / AAPL=US / DELL=US / IBM=US / WSM=US / G=US / GM=US / INTC=US / AMD=US / MSFT=US / MU=US / WEN=US / AMZN=US / QCOM=US / U=US / NVDA=US / INFY=US / NTAP=US / HBAN=US / 7974=JP / UBI=FR / FITB=US / XLNX=US / TTWO=US / ATVI=US / IIVI=US / NUAN=US / AVGO=US / KMX=US / CTSH=US / GLOB=US / ICPT=US / NBIX=US / WDC=US / WIX=US / WIT=US / ACN=US / GME=US / PYPL=US / ACOR=US / SWKS=US / DIN=US / STX=US / BIIB=US / SBNY=US / SIMO=US / SCPL=US / FIS=US / WNS=US / HOG=US / EXLS=US / 2454=US / 2330=US / VMW=US / 6758=US / ASND=US / 8299=US / CHWY=US / TSLA=US / NXPI=US / 981=US / ZNGA=US / EA=US / EPAM=US / CUBI=US / QRVO=US / PSTG=US / HPE=US / ALBO=US / DXC=US / BHVN=US / KALA=US / SAIL=US / DAVA=US / AQST=US / LYFT=US / BDTX=US / SKLZ=US / PLTK=US</td><td class="leftalignment">Global Blood Therapeutics Inc / Wingstop Inc / Apple Inc / Dell Technologies Inc / International Business Machines Corp / Williams-Sonoma Inc / Genpact Ltd / General Motors Co / Intel Corp / Advanced Micro Devices Inc / Microsoft Corp / Micron Technology Inc / Wendys Co / Amazon.com Inc / Qualcomm Inc / Unity Software Inc / NVIDIA Corp / Infosys Ltd / NetApp Inc / Huntington Bancshares Inc / Nintendo Co Ltd / Ubisoft Entertainment SA / Fifth Third Bancorp / Xilinx Inc / Take-Two Interactive Software Inc / Activision Blizzard Inc / II-VI Inc / Nuance Communications Inc / Broadcom Inc / Carmax Inc / Cognizant Technology Solutions Corp / Globant SA / Intercept Pharmaceuticals Inc / Neurocrine Biosciences Inc / Western Digital Corp / Wix.Com Ltd / Wipro Ltd / Accenture PLC / GameStop Corp / PayPal Holdings Inc / Acorda Therapeutics Inc / Skyworks Solutions Inc / Dine Brands Global Inc / Seagate Technology Holdings PLC / Biogen Inc / Signature Bank / Silicon Motion Technology Corp / Sciplay Corp / Fidelity National Information Services Inc / WNS (Holdings) Ltd / Harley-Davidson Inc / Exlservice Holdings Inc / MediaTek Inc / Taiwan Semiconductor Manufacturing Co Ltd / VMware Inc / Sony Group Corp / Ascendis Pharma A/S / Phison Electronics Corp / Chewy Inc / Tesla Inc / NXP Semiconductors NV / Semiconductor Manufacturing International Corp / Zynga Inc / Electronic Arts Inc / Epam Systems Inc / Customers Bancorp Inc / Qorvo Inc / Pure Storage Inc / Hewlett Packard Enterprise Co / Albireo Pharma Inc / DXC Technology Co / Biohaven Pharmaceutical Holding Company Ltd / Kala Pharmaceuticals Inc / SailPoint Technologies Holdings Inc / Endava PLC / Aquestive Therapeutics Inc / Lyft Inc / Black Diamond Therapeutics Inc / Skillz Inc / Playtika Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / Luxembourg / Netherlands / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Electronics / Household Products / Info. Tech./Computers / Leisure & Entertainment / Lodging & Restaurants / Pharmaceuticals / Retailing / Technology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AFL.N / AIG.N / AMAT.O / AMD.N / CB.N / CCO.TO / CRM.N / EIX.N / F.N / GM.N / INTC.O / LRCX.O / MMC.N / QCOM.O / RYN.N / SO.N / T.N / TRV.N / WY.N / PXD.N / GILD.O / ASML.O / CMCSA.O / AMGN.O / AAPL.O / MET.N / AAL.L / DIS.N / D.N / NVDA.O / DT.N / DISH.O / UNM.N / AMT.N / KGC.N / GIBa.TO / CONE.O / ADI.O / VZ.N / HCA.N / EXEL.O / XEL.N / PACW.O / CINF.O / LNC.N / KMX.N / FISV.O / SNPS.O / ADSK.O / CHTR.O / AWK.N / NBIX.O / NWN.N / TXN.O / AJG.N / REGN.O / VRTX.O / PFG.N / MU.O / PRU.N / NCR.N / NET.N / CNP.N / CPK.N / MKL.N / BRO.N / RLI.N / GPN.N / SIGI.O / CASY.O / ACGL.O / ICPT.O / FFIV.O / EQIX.O / ATDb.TO / BIIB.O / GOLD.N / FM.TO / NST.AX / 878742204 / NTR.N / MOS.N / DLR.N / ACAD.O / 416515104 / CDNS.O / SJW.N / FIS.N / 025676206 / CS.TO / 443628102 / AON.N / SLR.AX / WRB.N / 759351604 / CLW.N / VALE.N / FTNT.O / SPB.N / NEE.N / PCH.O / CTT.N / GLEN.L / ACHC.O / SPLK.OQ / WDC.O / PANW.N / QLYS.O / FFHu.TO / 505440107 / TSLA.N / ENTA.O / TMUS.N / VOYA.N / PRTA.O / AGIO.O / 81762P102 / 46579R104 / PTC.O / ITCI.O / COUP.N / VRNS.O / CIA.TO / BTG.N / NEP.N / S32.AX / PYPL.OQ / RPD.O / MESO.O / TWLO.N / OR.N / KNSL.OQ / GDS.O / ICHR.O / PBYI.OQ / OKTA.OQ / WPM.N / BHF.O / KL.N / SAIL.N / APTV.N / EHC.N / ZS.OQ / EQH.N / GSHD.O / VNE.N / ESTC.N / CRWD.O / GMAB.O / PING.N / DDOG.O / SBSW.N / IGIC.OQ / FOUR.N</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aflac Inc / American International Group Inc / Applied Materials Inc / Advanced Micro Devices Inc / Chubb Ltd / Cameco Corp / Salesforce.Com Inc / Edison International / Ford Motor Co / General Motors Co / Intel Corp / Lam Research Corp / Marsh & McLennan Companies Inc / Qualcomm Inc / Rayonier Inc / Southern Co / AT&T Inc / Travelers Companies Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Gilead Sciences Inc / ASML Holding NV / Comcast Corp / Amgen Inc / Apple Inc / MetLife Inc / Anglo American PLC / Walt Disney Co / Dominion Energy Inc / NVIDIA Corp / Dynatrace Inc / DISH Network Corp / Unum Group / American Tower Corp / Kinross Gold Corp / CGI Inc / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / HCA Healthcare Inc / Exelixis Inc / Xcel Energy Inc / PacWest Bancorp / Cincinnati Financial Corp / Lincoln National Corp / Carmax Inc / Fiserv Inc / Synopsys Inc / Autodesk Inc / Charter Communications Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Texas Instruments Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Principal Financial Group Inc / Micron Technology Inc / Prudential Financial Inc / NCR Corp / Cloudflare Inc / CenterPoint Energy Inc / Chesapeake Utilities Corp / Markel Corp / Brown & Brown Inc / Rli Corp / Global Payments Inc / Selective Insurance Group Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Barrick Gold Corp / First Quantum Minerals Ltd / Northern Star Resources Ltd / Teck Resources Ltd / Nutrien Ltd / Mosaic Co / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Cadence Design Systems Inc / SJW Group / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Capstone Mining Corp / Hudbay Minerals Inc / Aon PLC / Silver Lake Resources Ltd / W R Berkley Corp / Reinsurance Group of America Inc / Clearwater Paper Corp / Vale SA / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Potlatchdeltic Corp / CatchMark Timber Trust Inc / Glencore PLC / Acadia Healthcare Company Inc / Splunk Inc / Western Digital Corp / Palo Alto Networks Inc / Qualys Inc / Fairfax Financial Holdings Ltd / Labrador Iron Ore Royalty Corp / Tesla Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / Voya Financial Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Ivanhoe Mines Ltd / PTC Inc / Intra-Cellular Therapies Inc / Coupa Software Inc / Varonis Systems Inc / Champion Iron Ltd / B2Gold Corp / Nextera Energy Partners LP / South32 Ltd / PayPal Holdings Inc / Rapid7 Inc / Mesoblast Ltd / Twilio Inc / Osisko Gold Royalties Ltd / Kinsale Capital Group Inc / GDS Holdings Ltd / Ichor Holdings Ltd / Puma Biotechnology Inc / Okta Inc / Wheaton Precious Metals Corp / Brighthouse Financial Inc / Kirkland Lake Gold Ltd / SailPoint Technologies Holdings Inc / Aptiv PLC / Encompass Health Corp / Zscaler Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Veoneer Inc / Elastic NV / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Datadog Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Shift4 Payments Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Netherlands / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 3/26/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ENTA.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / David Szeto / Leonid Timashev / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) update for QURE in hemB; new tech for DRNA</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">UQ1.F / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Uniqure NV / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - April 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US0116591092 / US1264081035 / US22284P1057 / US3021301094 / US31428X1063 / US3695501086 / US4433201062 / US4456581077 / US5150981018 / US6558441084 / US6795801009 / US8308791024 / US8447411088 / US9029251066 / US9078181081 / US9113121068 / US9507551086 / CA1363751027 / CA13645T1003 / US4771431016 / US4198791018 / US09062X1037 / US0042251084 / US02043Q1076 / US0491642056 / US12541W2098 / US31620M1062 / ACOR.OQ / US78709Y1055 / PAP310761054 / US75025X1000 / US8485741099 / NL0000687663 / US01748X1028 / US2473617023 / US92826C8394 / US00922R1059 / US9100471096 / US9837931008 / US00912X3026 / US8485771021 / US21240E1055 / US8086251076 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US00653A1079 / US70450Y1038 / US05464T1043 / US00773U1088 / CA87241L1094 / US23753F1075 / US80689H1023 / US4990491049 / US5904791358 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968 / CA67079A1021</td><td class="leftalignment">Alaska Air Group Inc / CSX Corp / Covenant Logistics Group Inc / Expeditors International of Washington Inc / FedEx Corp / General Dynamics Corp / Hub Group Inc / J B Hunt Transport Services Inc / Landstar System Inc / Norfolk Southern Corp / Old Dominion Freight Line Inc / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / United Parcel Service Inc / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Atlas Air Worldwide Holdings Inc / CH Robinson Worldwide Inc / Fidelity National Information Services Inc / Acorda Therapeutics Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Spirit AeroSystems Holdings Inc / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Visa Inc / Air Transport Services Group Inc / United Airlines Holdings Inc / XPO Logistics Inc / Air Lease Corp / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Science Applications International Corp / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / PayPal Holdings Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / TFI International Inc / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / Nuvei Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 541</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Apr 01 2021 6:58AM</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ITOS=US / MU=US / AAPL=US / GM=US / INTC=US / AMD=US / GBT=US / MSFT=US / AMZN=US / ORCL=US / DNLI=US / NVDA=US / NTAP=US / CRM=US / APLS=US / AVGO=US / BMRN=US / CYBR=US / DOCU=US / FORD=US / FUSN=US / ICPT=US / LC=US / NBIX=US / PRTK=US / RARE=US / SWTX=US / UTHR=US / WDC=US / SAGE=US / ACOR=US / VRNT=US / ALPN=US / STX=US / IGMS=US / STRO=US / BIIB=US / APTX=US / SIMO=US / SURF=US / ALNA=US / LXRX=US / 2330=US / IDRA=US / RCUS=US / OMER=US / TSLA=US / PCRX=US / RTRX=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / VRNS=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / PSTG=US / ARGX=US / NVCR=US / CTMX=US / ZS=US / VYGR=US / KURA=US / VIE=US / SYRS=US / ALBO=US / OBSV=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / REPL=US / AQST=US / LQDA=US / ETTX=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / STOK=US / BCEL=US / KRTX=US / FRLN=US / QS=US</td><td class="leftalignment">Iteos Therapeutics Inc / Micron Technology Inc / Apple Inc / General Motors Co / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Amazon.com Inc / Oracle Corp / Denali Therapeutics Inc / NVIDIA Corp / NetApp Inc / Salesforce.Com Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / Biomarin Pharmaceutical Inc / Cyberark Software Ltd / DocuSign Inc / Forward Industries Inc / Fusion Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / LendingClub Corp / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / Western Digital Corp / SAGE Therapeutics Inc / Acorda Therapeutics Inc / Verint Systems Inc / Alpine Immune Sciences Inc / Seagate Technology Holdings PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Aptinyx Inc / Silicon Motion Technology Corp / Surface Oncology Inc / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Idera Pharmaceuticals Inc / Arcus Biosciences Inc / Omeros Corp / Tesla Inc / Pacira Biosciences Inc / Travere Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Varonis Systems Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / Pure Storage Inc / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Zscaler Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Veolia Environnement SA / Syros Pharmaceuticals Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Replimune Group Inc / Aquestive Therapeutics Inc / Liquidia Corp / Entasis Therapeutics Holdings Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Freeline Therapeutics Holdings PLC / Quantumscape Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Electronics / Financial Services / Info. Tech./Computers / Info. Tech./Software</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US0116591092 / US1271903049 / US30231G1022 / US31428X1063 / US4234521015 / US5951121038 / US6745991058 / US7237871071 / US8308791024 / US8447411088 / US9113121068 / US00508Y1029 / US4771431016 / US4198791018 / US09062X1037 / US0042251084 / US02043Q1076 / US0491642056 / PAP310761054 / US8485741099 / NL0000687663 / US01748X1028 / US2473617023 / US00922R1059 / US9100471096 / US00912X3026 / US25278X1090 / US8485771021 / US21240E1055 / US8086251076 / US02376R1023 / US0465131078 / CA0089118776 / US00653A1079 / US9741551033 / US81750R1023 / US05464T1043 / US00773U1088 / US5904791358 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968 / US74767V1098</td><td class="leftalignment">Alaska Air Group Inc / CACI International Inc / Exxon Mobil Corp / FedEx Corp / Helmerich and Payne Inc / Micron Technology Inc / Occidental Petroleum Corp / Pioneer Natural Resources Co / SkyWest Inc / Southwest Airlines Co / United Parcel Service Inc / Acuity Brands Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Atlas Air Worldwide Holdings Inc / Copa Holdings SA / Spirit AeroSystems Holdings Inc / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Air Transport Services Group Inc / United Airlines Holdings Inc / Air Lease Corp / Diamondback Energy Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Science Applications International Corp / American Airlines Group Inc / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Wingstop Inc / Seres Therapeutics Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / Quantumscape Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Wedbush Monthly Check-Up: April 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">GBT=US / DNLI=US / APLS=US / BMRN=US / FUSN=US / ICPT=US / NBIX=US / PRTK=US / RARE=US / SWTX=US / UTHR=US / SAGE=US / ACOR=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / APTX=US / SURF=US / ALNA=US / LXRX=US / IDRA=US / RCUS=US / OMER=US / PCRX=US / RTRX=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / VIE=US / SYRS=US / ALBO=US / OBSV=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / REPL=US / AQST=US / LQDA=US / ETTX=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / STOK=US / BCEL=US / KRTX=US</td><td class="leftalignment">Global Blood Therapeutics Inc / Denali Therapeutics Inc / Apellis Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Fusion Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Acorda Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Aptinyx Inc / Surface Oncology Inc / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Travere Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Veolia Environnement SA / Syros Pharmaceuticals Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Replimune Group Inc / Aquestive Therapeutics Inc / Liquidia Corp / Entasis Therapeutics Holdings Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Morphomer Platform—AC Immune's Chamber of Secrets Keep Pipeline Energized</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">H00263105 / BIIB / PRTA.OQ</td><td class="leftalignment">AC Immune SA / Biogen Inc / Prothena Corporation PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AIG.N / ALV.N / AXP.N / BAC.N / BATS.L / BK.N / C.N / CI.N / CL.N / COF.N / CP.TO / CWK.L / DANO.PA / DD.N / DGE.L / EL.N / F.N / FITB.O / GE.N / GM.N / IP.N / JPM.N / KEY.N / KGF.L / KMB.N / KO.N / L.TO / NTRS.O / OREP.PA / PB.N / PNC.N / RYN.N / SGEF.PA / STO.AX / TRV.N / ULVR.L / USB.N / VC.N / WFC.N / ZION.O / SSE.L / PEP.N / CMA.N / TRI.N / BFb.N / PG.N / WY.N / HUM.N / CFP.TO / CNQ.TO / GILD.O / LPX.N / TEN.N / MET.N / HBAN.O / BWA.N / LEA.N / K.N / ADBE.O / SU.TO / GS.N / CLX.N / CAG.N / HD.N / GIS.N / EPC.N / BBVA.MC / NKE.N / MRU.TO / NG.L / VLY.N / STT.N / HCA.N / SNV.N / PACW.O / STZ.N / APH.N / EQT.N / V.N / EPD.N / AXL.N / DLTR.O / NBIX.O / MTB.N / GIL.N / PVH.N / STL.N / VRTX.O / JHX.AX / MU.O / SM.N / TEL.N / VRNT.O / RF.N / COP.N / ASC.L / CNP.N / CFR.N / FRC.N / ST.N / WBS.N / FCF.N / DFS.N / LNG.A / PFS.N / EFX.TO / FFBC.O / PBCT.O / SIVB.O / WSBC.O / BPOP.O / CASY.O / BOKF.O / COLB.O / ACGL.O / WTFC.O / TCBI.O / ATDb.TO / EMPA.TO / BIIB.O / MFI.TO / TFC.N / FHN.N / NESN.S / CWX.TO / MOS.N / SCL.TO / 427866108 / WEF.TO / WAL.N / RDSb.L / BAM.N / BVIC.L / MS.N / ISBC.O / CTCa.TO / MERC.O / PPL.TO / CPRI.MI / DAN.N / CLW.N / HOMB.O / AAV.TO / ADN.TO / TOU.TO / PCH.O / CFX.TO / FRU.TO / BKU.N / CTT.N / MTOR.N / IFP.TO / PXT.TO / SMSS.L / SLM.OQ / EFN.TO / SPLK.OQ / RFP.N / WDC.O / SRPT.O / MDLZ.OQ / ALLY.N / NYCB.N / ABBV.N / KPT.TO / COTY.N / PTCT.O / ONB.OQ / CFF.TO / KPTI.O / COUP.N / RYAM.N / SYF.N / CFG.N / GWB.N / FEVR.L / ASB.N / WBA.N / 78667J108 / EVA.N / TDOC.N / WRK.N / RPD.O / TWLO.N / AKERBP.OL / ADNT.N / GDS.O / OKTA.OQ / CADE.N / GRPG.I / ROOT.TO / APTV.N / 05971J102 / COLD.N / SMAR.N / VNE.N / NTGY.MC / ZM.O / KRTX.OQ / CRWD.O / GMAB.O / CRNC.OQ / ETNB.O / REYN.O / NKLA.OQ / AKES.OL / ASAN.N / SUMO.O / MCFE.OQ / WFG.N</td><td class="leftalignment">American International Group Inc / Autoliv Inc / American Express Co / Bank of America Corp / British American Tobacco PLC / Bank of New York Mellon Corp / Citigroup Inc / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / Canadian Pacific Railway Ltd / Cranswick PLC / Danone SA / Dupont De Nemours Inc / Diageo PLC / Estee Lauder Companies Inc / Ford Motor Co / Fifth Third Bancorp / General Electric Co / General Motors Co / International Paper Co / JPMorgan Chase & Co / KeyCorp / Kingfisher PLC / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / Northern Trust Corp / L'Oreal SA / Prosperity Bancshares Inc / PNC Financial Services Group Inc / Rayonier Inc / Vinci SA / Santos Ltd / Travelers Companies Inc / Unilever PLC / US Bancorp / Visteon Corp / Wells Fargo & Co / Zions Bancorporation NA / SSE PLC / PepsiCo Inc / Comerica Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Humana Inc / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Louisiana-Pacific Corp / Tenneco Inc / MetLife Inc / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / Kellogg Co / Adobe Inc / Suncor Energy Inc / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / Home Depot Inc / General Mills Inc / Edgewell Personal Care Co / Banco Bilbao Vizcaya Argentaria SA / Nike Inc / Metro Inc / National Grid PLC / Valley National Bancorp / State Street Corp / HCA Healthcare Inc / Synovus Financial Corp / PacWest Bancorp / Constellation Brands Inc / Amphenol Corp / EQT Corp / Visa Inc / Enterprise Products Partners LP / American Axle & Manufacturing Holdings Inc / Dollar Tree Inc / Neurocrine Biosciences Inc / M&T Bank Corp / Gildan Activewear Inc / PVH Corp / Sterling Bancorp / Vertex Pharmaceuticals Inc / James Hardie Industries PLC / Micron Technology Inc / SM Energy Co / TE Connectivity Ltd / Verint Systems Inc / Regions Financial Corp / Conocophillips / ASOS PLC / CenterPoint Energy Inc / Cullen/Frost Bankers Inc / First Republic Bank / Sensata Technologies Holding PLC / Webster Financial Corp / First Commonwealth Financial Corp / Discover Financial Services / Cheniere Energy Inc / Provident Financial Services Inc / Enerflex Ltd / First Financial Bancorp / People's United Financial Inc / SVB Financial Group / WesBanco Inc / Popular Inc / Caseys General Stores Inc / BOK Financial Corp / Columbia Banking System Inc / Arch Capital Group Ltd / Wintrust Financial Corp / Texas Capital Bancshares Inc / Alimentation Couche-Tard Inc / Empire Company Ltd / Biogen Inc / Maple Leaf Foods Inc / Truist Financial Corp / First Horizon Corp / Nestle SA / Doman Building Materials Group Ltd / Mosaic Co / Shawcor Ltd / Hershey Co / Western Forest Products Inc / Western Alliance Bancorp / Royal Dutch Shell PLC / Brookfield Asset Management Inc / Britvic PLC / Morgan Stanley / Investors Bancorp Inc / Canadian Tire Corporation Ltd / Mercer International Inc / Pembina Pipeline Corp / Davide Campari Milano NV / Dana Inc / Clearwater Paper Corp / Home BancShares Inc / Advantage Energy Ltd / Acadian Timber Corp / Tourmaline Oil Corp / Potlatchdeltic Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / BankUnited Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Parex Resources Inc / Smart Metering Systems PLC / SLM Corp / Element Fleet Management Corp / Splunk Inc / Resolute Forest Products Inc / Western Digital Corp / Sarepta Therapeutics Inc / Mondelez International Inc / Ally Financial Inc / New York Community Bancorp Inc / Abbvie Inc / KP Tissue Inc / Coty Inc / PTC Therapeutics Inc / Old National Bancorp / Conifex Timber Inc / Karyopharm Therapeutics Inc / Coupa Software Inc / Rayonier Advanced Materials Inc / Synchrony Financial / Citizens Financial Group Inc / Great Western Bancorp Inc / Fevertree Drinks PLC / Associated Banc-Corp / Walgreens Boots Alliance Inc / SAGE Therapeutics Inc / Enviva Inc / Teladoc Health Inc / Westrock Co / Rapid7 Inc / Twilio Inc / Aker BP ASA / Adient PLC / GDS Holdings Ltd / Okta Inc / Cadence Bank / Greencoat Renewables PLC / Roots Corp / Aptiv PLC / Cadence Bank / Americold Realty Trust / Smartsheet Inc / Veoneer Inc / Naturgy Energy Group SA / Zoom Video Communications Inc / Karuna Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / Cerence Inc / 89Bio Inc / Reynolds Consumer Products Inc / Nikola Corp / Aker Solutions ASA / Asana Inc / Sumo Logic Inc / Mcafee Corp / West Fraser Timber Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / Spain / France / United Kingdom / Ireland / Netherlands / Norway / Puerto Rico / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ / ABCL.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Angelman Syndrome Primer</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">RARE.OQ / ROG.S / BIIB.OQ</td><td class="leftalignment">Ultragenyx Pharmaceutical Inc / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Martin Auster, M.D. / Mr. Tiago Fauth / Matthew Terwelp / Roger Xu / Mr. Thomas Deal / Mark Connolly / European Pharma Team</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen's Biotech Thermometer</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US0465131078 / US00653A1079 / US05464T1043 / US00773U1088 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US -  Dividend Quality Analysis, for the period ended March 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Biogen gains 14% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Mar. 31, 2021 / 12:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Biogen Inc. MARCH 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Vaccination Ramp-Up Continues to Accelerate as Spring Wave Driven by Variants Likely</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Biotechnology Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US89237H2094 / US09061G1013 / US09058V1035 / US30161Q1040 / US45337C1027 / US64125C1099 / US09062X1037 / US0042251084 / US09609G1004 / US8036071004 / CA1208311029 / US68403P2039 / US92337C1045 / US45845P1084 / US16934W1062 / US29428V1044 / US31189P1021 / CA05156V1022 / US0008991046 / US00972D1054 / US78667J1088 / US13089P1012 / US31572Q8087 / US92346J1088 / US81750R1023 / US37890U1088 / US68235C1071 / US98419J2069 / US12648L6011 / US8177631053 / US03890D1081 / US15117B2025 / US72940R3003 / US74017N1054 / US81181C1045</td><td class="leftalignment">TRACON Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / BioCryst Pharmaceuticals Inc / Exelixis Inc / Incyte Corp / Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Burcon NutraScience Corp / Oramed Pharmaceuticals Inc / Verastem Inc / Intercept Pharmaceuticals Inc / Chimerix Inc / Epizyme Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / ADMA Biologics Inc / Akebia Therapeutics Inc / SAGE Therapeutics Inc / Calithera Biosciences Inc / FibroGen Inc / Vericel Corp / Seres Therapeutics Inc / Global Blood Therapeutics Inc / OncoCyte Corp / XOMA Corp / CTI Biopharma Corp / Sesen Bio Inc / Aravive Inc / Celldex Therapeutics Inc / Pluristem Therapeutics Inc / Precigen Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AMD=US / DNLI=US / AX=US / XOMA=US / ACET=US / APLS=US / BLUE=US / ISEE=US / FUSN=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / COGT=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Advanced Micro Devices Inc / Denali Therapeutics Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">William Blair Biopharma Catalyst Watch Second Quarter 2021</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">00847G705 / 00887A105 / 03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Agenus Inc / Aileron Therapeutics Inc / Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Matt Phipps, PHD / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Have You Read This? TREM2 Tames Tau</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB / 24823R105 / 014442107</td><td class="leftalignment">Biogen Inc / Denali Therapeutics Inc / Alector Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Norway / Singapore / Sweden / Taiwan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Andrew S. Fein / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AEP.N / AES.N / ALV.N / BAC.N / BK.N / CL.N / CP.TO / EIX.N / EL.N / EOG.N / FMS.N / KMB.N / KO.N / MRK.N / NTRS.O / PFE.N / SO.N / T.N / USB.N / WFC.N / PEP.N / BFb.N / PG.N / CPB.N / TEN.N / CMCSA.O / INCY.O / DUK.N / K.N / DT.N / ADBE.O / CLX.N / CAG.N / GIS.N / PCG.N / EPC.N / AMT.N / JAZZ.O / CONE.O / VZ.N / STT.N / STZ.N / APH.N / ADSK.O / AXL.N / AWK.N / NBIX.O / CHD.N / NWN.N / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / NET.N / TEL.N / CNP.N / ENDP.O / CPK.N / ST.N / SGEN.OQ / MNST.O / BLUE.O / BIIB.O / 02209S103 / DLR.N / ACAD.O / 427866108 / MS.N / TEVA.N / ATL.MI / BGS.N / SPB.N / NEE.N / ERF.TO / ACHC.O / SPLK.OQ / PANW.N / MDLZ.OQ / ABBV.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / COTY.N / PTCT.O / PRTA.O / AGIO.O / 81762P102 / LB.N / KPTI.O / ITCI.O / QURE.O / VRNS.O / AGRX.O / ANTM.N / 78667J108 / RGNX.O / WVE.OQ / IONS.O / TWLO.N / OKTA.OQ / VST.N / ATNX.O / SAIL.N / APTV.N / ZS.OQ / AMRX.N / KDP.N / XERS.O / AQST.O / MGTX.O / ESTC.N / NWL.O / NBSE.OQ / KRTX.OQ / CRWD.O / GMAB.O / PING.N / CRNC.OQ / WTRG.N / REYN.O / NKLA.OQ / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Bank of America Corp / Bank of New York Mellon Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Fresenius Medical Care AG & Co KGaA / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Northern Trust Corp / Pfizer Inc / Southern Co / AT&T Inc / US Bancorp / Wells Fargo & Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Campbell Soup Co / Tenneco Inc / Comcast Corp / Incyte Corp / Duke Energy Corp / Kellogg Co / Dynatrace Inc / Adobe Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Edgewell Personal Care Co / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / State Street Corp / Constellation Brands Inc / Amphenol Corp / Autodesk Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Cloudflare Inc / TE Connectivity Ltd / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / Seagen Inc / Monster Beverage Corp / bluebird bio Inc / Biogen Inc / Altria Group Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hershey Co / Morgan Stanley / Teva Pharmaceutical Industries Ltd / Atlantia SpA / B&G Foods Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Enerplus Corp / Acadia Healthcare Company Inc / Splunk Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Coty Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Uniqure NV / Varonis Systems Inc / Agile Therapeutics Inc / Anthem Inc / SAGE Therapeutics Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Ionis Pharmaceuticals Inc / Twilio Inc / Okta Inc / Vistra Corp / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / MeiraGTx Holdings PLC / Elastic NV / Newell Brands Inc / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Italy / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Neuropsych Day – Major Depressive Disorder</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.O / ITCI.O / 78667J108</td><td class="leftalignment">Biogen Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Leonid Timashev / David Szeto / Yinglu Zhang / Lisa Walter / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Neuropsych Day – Multiple Sclerosis</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.O / GMAB.O</td><td class="leftalignment">Biogen Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Leonid Timashev / David Szeto / Yinglu Zhang / Lisa Walter / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Neuropsych Day – Neuromuscular Disorders</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.O / PTCT.O / RGNX.O / IONS.O</td><td class="leftalignment">Biogen Inc / PTC Therapeutics Inc / Regenxbio Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Luca Issi, PHD / Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Lisa Walter / David Szeto / Leonid Timashev / Yinglu Zhang / Edwin Delfin</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Annual CEO information briefing: targeting ecosystem and platform construction</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - 恒例のインフォメーションミーティング、エコシステムとプラットフォーム構築を目指すという趣旨</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) results from PRQR & KRYS; ide-cel approved</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">CERC=US / XFOR=US / BSX=US / CSII=US / LLY=US / ABT=US / MDT=US / WMT=US / DNLI=US / CMS=US / DGX=US / BBI=US / NVS=US / BWAY=US / GSK=US / CRY=US / RAD=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / GEN=US / ICPT=US / PHG=US / LH=US / LIFE=US / USPH=US / UHS=US / SAGE=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / BLFS=US / MD=US / SLF=US / BIIB=US / MBRX=US / GOOG=US / DXCM=US / LHCG=US / CBAY=US / CHNG=US / BNGO=US / PODD=US / EHC=US / NMTR=US / TNDM=US / SWAV=US / ADUS=US / HZNP=US / ACHC=US / XNCR=US / CTRE=US / EKTAY=US / APTO=US / VBLT=US / WBA=US / RLMD=US / CRBP=US / EVH=US / LIVN=US / IONS=US / SSKN=US / VRAY=US / IRTC=US / SYBX=US / NCNA=US / MBIO=US / TMDX=US / IDYA=US / AKRO=US / FREQ=US / ETNB=US / BXRX=US / PNTG=US / TARA=US / ORIC=US / AYLA=US / VRDN=US / SNSE=US</td><td class="leftalignment">Avalo Therapeutics Inc / X4 Pharmaceuticals Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Abbott Laboratories / Medtronic PLC / Walmart Inc / Denali Therapeutics Inc / CMS Energy Corp / Quest Diagnostics Inc / Brickell Biotech Inc / Novartis AG / Brainsway Ltd / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / General Electric Co / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / aTyr Pharma Inc / US Physical Therapy Inc / Universal Health Services Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / BioLife Solutions Inc / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / Moleculin Biotech Inc / Alphabet Inc / Dexcom Inc / LHC Group Inc / Cymabay Therapeutics Inc / Change Healthcare Inc / Bionano Genomics Inc / Insulet Corp / Encompass Health Corp / 9 Meters Biopharma Inc / Tandem Diabetes Care Inc / Shockwave Medical Inc / Addus Homecare Corp / Horizon Therapeutics PLC / Acadia Healthcare Company Inc / Xencor Inc / CareTrust REIT Inc / Elekta AB (publ) / Aptose Biosciences Inc / Vascular Biogenics Ltd / Walgreens Boots Alliance Inc / Relmada Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Evolent Health Inc / LivaNova PLC / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / ViewRay Inc / iRhythm Technologies Inc / Synlogic Inc / NuCana PLC / Mustang Bio Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / Akero Therapeutics Inc / Frequency Therapeutics Inc / 89Bio Inc / Baudax Bio Inc / Pennant Group Inc / Protara Therapeutics Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Viridian Therapeutics Inc / Sensei Biotherapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 540</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 3/19/21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / BMY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Biogen Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Tecfidera's new patents are being misconstrued</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Green Shoots or Eye of the Hurricane? Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SNSE=US / TMDX=US / LLY=US / C=US / DNLI=US / BAC=US / GS=US / JPM=US / MS=US / SAGE=US / JEF=US / BIIB=US / VBLT=US</td><td class="leftalignment">Sensei Biotherapeutics Inc / Transmedics Group Inc / Eli Lilly and Co / Citigroup Inc / Denali Therapeutics Inc / Bank of America Corp / Goldman Sachs Group Inc / JPMorgan Chase & Co / Morgan Stanley / SAGE Therapeutics Inc / Jefferies Financial Group Inc / Biogen Inc / Vascular Biogenics Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Financial Services / Healthcare</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">New Tecfidera Patents Could be Thesis Changing, But a Lot of Unknowns Remain</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Takeaways from Discussion with Management</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB=US / LLY=US / DNLI=US / SAGE=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Denali Therapeutics Inc / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BIIB: Biogen, Inc. - While early, new Tecfidera IP could support share upside outside of Adu</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HD=US / INTC=US / MCD=US / AMD=US / WEN=US / AMZN=US / RUN=US / PLUG=US / V=US / MTN=US / VRM=US / LEG=US / AIR=US / CBRL=US / CENT=US / DRI=US / HEI=US / INFO=US / DOC=US / OKE=US / REGI=US / TRGP=US / EPD=US / NET=US / DCP=US / NHI=US / DIN=US / ECPG=US / PRAA=US / BIIB=US / TPX=US / KAR=US / PLAY=US / DENN=US / SPWR=US / CMG=US / MA=US / GPRE=US / TAST=US / PRPL=US / NMTR=US / JACK=US / HTA=US / ENPH=US / PANW=US / NDLS=US / PTCT=US / CEQP=US / VRNS=US / LOCO=US / SHAK=US / RLMD=US / BWXT=US / WING=US / SPNE=US / ZS=US / SQ=US / WVE=US / IRTC=US / OKTA=US / CVNA=US / SAIL=US / APLT=US / CRWD=US</td><td class="leftalignment">Home Depot Inc / Intel Corp / McDonald's Corp / Advanced Micro Devices Inc / Wendys Co / Amazon.com Inc / Sunrun Inc / Plug Power Inc / Visa Inc / Vail Resorts Inc / Vroom Inc / Leggett & Platt Inc / AAR Corp / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Darden Restaurants Inc / HEICO Corp / IHS Markit Ltd / Physicians Realty Trust / ONEOK Inc / Renewable Energy Group Inc / Targa Resources Corp / Enterprise Products Partners LP / Cloudflare Inc / DCP Midstream LP / National Health Investors Inc / Dine Brands Global Inc / Encore Capital Group Inc / PRA Group Inc / Biogen Inc / Tempur Sealy International Inc / KAR Auction Services Inc / Dave & Buster's Entertainment Inc / Denny's Corp / SunPower Corp / Chipotle Mexican Grill Inc / Mastercard Inc / Green Plains Inc / Carrols Restaurant Group Inc / Purple Innovation Inc / 9 Meters Biopharma Inc / Jack in the Box Inc / Healthcare Trust Of America Inc / Enphase Energy Inc / Palo Alto Networks Inc / Noodles & Co / PTC Therapeutics Inc / Crestwood Equity Partners LP / Varonis Systems Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Relmada Therapeutics Inc / BWX Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Zscaler Inc / Block Inc / WAVE Life Sciences Ltd / iRhythm Technologies Inc / Okta Inc / Carvana Co / SailPoint Technologies Holdings Inc / Applied Therapeutics Inc / CrowdStrike Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Large Cap Modestly Higher / STSA With Greatest Sequential Change Among SMid Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US09062X1037 / US28238P1093 / US69366J2006</td><td class="leftalignment">Biogen Inc / eHealth Inc / PTC Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Conference Call to Discuss the Recent FDA Regulatory Landscape on CRLs and Delays on 3/24 at 10am ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US84763A1088 / US09062X1037</td><td class="leftalignment">Spectrum Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Investor questions we're getting on PTCT and read from competitor data</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PTCT=US / BIIB=US</td><td class="leftalignment">PTC Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">With an End in Sight, Variants and Eagerness to Open Set Up for U.S. Spring Wave as Race to Ramp Up Vaccinations Continues</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / China / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2026242 / 2317087 / 2670519 / 2100920 / 2455965 / 2680905 / 2684703 / 2707677 / 2440637 / 2573083 / 2138158 / 7103065 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BK7Y2V9 / B0SDJB4 / BJFSR88 / BKVDFF7 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BZ1LFG7 / BMG75B4</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / American Electric Power Company Inc / Entergy Corp / Exelon Corp / FirstEnergy Corp / Biogen Inc / PPL Corp / Pfizer Inc / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sangamo Therapeutics Inc / Sempra Energy / Novartis AG / Duke Energy Corp / Eversource Energy / Alphabet Inc / Akero Therapeutics Inc / Zealand Pharma A/S / Uniqure NV / Oric Pharmaceuticals Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Roku Inc / Inventiva SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">New Neurologist Survey Underscores Just How High the Aducanumab Stakes Are</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Invitation: Virtual KOL Call to Review Usher Data | Thurs 3/25 @ 10am ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PRQR.O / US09062X1037</td><td class="leftalignment">ProQR Therapeutics NV / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Emma K. Nealon, III / Ms. Alethia R. Young</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SGMO: Why Tau, Why Now?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2573083 / 2455965</td><td class="leftalignment">Sangamo Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Debjit Chattopadhyay, Ph.D. / Aaron Welch, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Catalysts in 2021 and beyond for our biotechnology coverage: March 2021 edition</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">NBIX.OQ / US09062X1037 / ACAD.N / 78667J108 / G11196105 / 98986X109 / 46116X101 / 92915B106 / 918385105 / 09075P105 / 22053A107 / 20451W101 / 23256X100</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / SAGE Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Zynerba Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Voyager Therapeutics Inc / vTv Therapeutics Inc / BioXcel Therapeutics Inc / Cortexyme Inc / Compass Pathways PLC / Cybin Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Sumant Kulkarni / Jia Min, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Conference Call to Discuss the Recent FDA Regulatory Landscape on CRLs and Delays on 3/24 at 10am ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US84763A1088 / US09062X1037 / US0042251084 / US92915B1061 / US75615P1030 / US85789A1051</td><td class="leftalignment">Spectrum Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Voyager Therapeutics Inc / Reata Pharmaceuticals Inc / Stealth BioTherapeutics Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Mar 22 2021 6:40AM</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PEGA=US / STX=US / FISV=US / AAPL=US / DELL=US / IBM=US / INTC=US / AMD=US / MSFT=US / MU=US / QCOM=US / DNLI=US / NVDA=US / NTAP=US / V=US / XLNX=US / ADS=US / IIVI=US / AX=US / XOMA=US / ACET=US / APLS=US / AVGO=US / BMRN=US / BLUE=US / ISEE=US / FUSN=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / WDC=US / FOUR=US / SAGE=US / GPN=US / PYPL=US / EVOP=US / SWKS=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / COGT=US / SIMO=US / GRAY=US / FIS=US / MA=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / 2454=US / 2330=US / VMW=US / 6758=US / IDRA=US / ASND=US / RCUS=US / 8299=US / OMER=US / TSLA=US / NXPI=US / PCRX=US / 981=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / QRVO=US / CDTX=US / BPMC=US / ABUS=US / PSTG=US / ARGX=US / NVCR=US / HPE=US / CTMX=US / SQ=US / VYGR=US / KURA=US / VIE=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / RPAY=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Pegasystems Inc / Seagate Technology Holdings PLC / Fiserv Inc / Apple Inc / Dell Technologies Inc / International Business Machines Corp / Intel Corp / Advanced Micro Devices Inc / Microsoft Corp / Micron Technology Inc / Qualcomm Inc / Denali Therapeutics Inc / NVIDIA Corp / NetApp Inc / Visa Inc / Xilinx Inc / Alliance Data Systems Corp / II-VI Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / Western Digital Corp / Shift4 Payments Inc / SAGE Therapeutics Inc / Global Payments Inc / PayPal Holdings Inc / EVO Payments Inc / Skyworks Solutions Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Silicon Motion Technology Corp / Graybug Vision Inc / Fidelity National Information Services Inc / Mastercard Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / MediaTek Inc / Taiwan Semiconductor Manufacturing Co Ltd / VMware Inc / Sony Group Corp / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Phison Electronics Corp / Omeros Corp / Tesla Inc / NXP Semiconductors NV / Pacira Biosciences Inc / Semiconductor Manufacturing International Corp / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / Pure Storage Inc / argenx SE / Novocure Ltd / Hewlett Packard Enterprise Co / CytomX Therapeutics Inc / Block Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Veolia Environnement SA / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Repay Holdings Corp / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / China / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Netherlands / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Electronics / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">375</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMD=US / DNLI=US / AX=US / XOMA=US / ACET=US / APLS=US / BLUE=US / ISEE=US / FUSN=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / COGT=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / VIE=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Advanced Micro Devices Inc / Denali Therapeutics Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Veolia Environnement SA / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / France / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: SLDB makes progress in DMD</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">SLDB.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Solid Biosciences Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Catalyst Tracker 3.21.21: Highlights Top Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">MRK=US / ABT=US / AMGN=US / INSP=US / GILD=US / SAN=FR / ATRC=US / BLUE=US / CSTL=US / ILMN=US / TFX=US / PRVB=US / CGEN=US / BIIB=US / ACRS=US / ACAD=US / QTRX=US / FOLD=US / PODD=US / RCUS=US / SRPT=US / MRTX=US / MGNX=US / QURE=US / AFMD=US / NVRO=US / ZBH=US / LNTH=US / WVE=US / MRUS=US / RETA=US / BHVN=US / REPL=US / HARP=US / ETNB=US / KROS=US / FMTX=US / ITOS=US / CGEM=US</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Amgen Inc / Inspire Medical Systems Inc / Gilead Sciences Inc / Sanofi SA / AtriCure Inc / bluebird bio Inc / Castle Biosciences Inc / Illumina Inc / Teleflex Inc / Provention Bio Inc / Compugen Ltd / Biogen Inc / Aclaris Therapeutics Inc / ACADIA Pharmaceuticals Inc / Quanterix Corp / Amicus Therapeutics Inc / Insulet Corp / Arcus Biosciences Inc / Sarepta Therapeutics Inc / Mirati Therapeutics Inc / MacroGenics Inc / Uniqure NV / Affimed NV / Nevro Corp / Zimmer Biomet Holdings Inc / Lantheus Holdings Inc / WAVE Life Sciences Ltd / Merus NV / Reata Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / Replimune Group Inc / Harpoon Therapeutics Inc / 89Bio Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Iteos Therapeutics Inc / Cullinan Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Israel / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 539</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q4 2020: Biogen sequential quarterly profits hit by 49.0% fall</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 3/12/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Mar 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">EBAY=US / PINS=US / FISV=US / WSM=US / SBUX=US / G=US / C=US / AMZN=US / V=US / BBBY=US / ADS=US / W=US / XOMA=US / AZO=US / GPC=US / LC=US / ORLY=US / RH=US / SGMO=US / SHOP=US / THO=US / WIX=US / WGO=US / FOUR=US / SAGE=US / WOOF=US / AAP=US / GPN=US / GME=US / PYPL=US / EVOP=US / OSTK=US / STRO=US / BIIB=US / FIS=US / MA=US / IDRA=US / IAC=US / CHWY=US / GDDY=US / ETSY=US / SQ=US / KNSA=US / IIIV=US / RPAY=US / GBIO=US / BIGC=US / FHTX=US</td><td class="leftalignment">eBay Inc / Pinterest Inc / Fiserv Inc / Williams-Sonoma Inc / Starbucks Corp / Genpact Ltd / Citigroup Inc / Amazon.com Inc / Visa Inc / Bed Bath & Beyond Inc / Alliance Data Systems Corp / Wayfair Inc / XOMA Corp / Autozone Inc / Genuine Parts Co / LendingClub Corp / O'Reilly Automotive Inc / RH / Sangamo Therapeutics Inc / Shopify Inc / Thor Industries Inc / Wix.Com Ltd / Winnebago Industries Inc / Shift4 Payments Inc / SAGE Therapeutics Inc / Petco Health and Wellness Company Inc / Advance Auto Parts Inc / Global Payments Inc / GameStop Corp / PayPal Holdings Inc / EVO Payments Inc / Overstock.com Inc / Sutro Biopharma Inc / Biogen Inc / Fidelity National Information Services Inc / Mastercard Inc / Idera Pharmaceuticals Inc / IAC/Interactivecorp / Chewy Inc / GoDaddy Inc / ETSY Inc / Block Inc / Kiniksa Pharmaceuticals Ltd / I3 Verticals Inc / Repay Holdings Corp / Generation Bio Co / Bigcommerce Holdings Inc / Foghorn Therapeutics Inc.</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Israel / United States</td><td class="leftalignment">Biotechnology / Financial Services / Household Products / Leisure & Entertainment / Lodging & Restaurants / Pharmaceuticals / Retailing</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / AVB=US / AMZN=US / GILD=US / MTN=US / VRM=US / EXPE=US / ESS=US / EQR=US / AIR=US / AMN=US / HOOK=US / SNAP=US / TRIP=US / WIX=US / CCRN=US / BKNG=US / CPT=US / FB=US / MAA=US / UDR=US / NLS=US / PTON=US / BIIB=US / APTS=US / ANGI=US / IBTX=US / GOOGL=US / 00770K202 / BABA=US / CMPR=US / GDDY=US / NXRT=US / CVNA=US / SFIX=US / SYNH=US / BTAI=US / FTDR=US / SVMK=US / LYFT=US / UBER=US / AIRC=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Avalonbay Communities Inc / Amazon.com Inc / Gilead Sciences Inc / Vail Resorts Inc / Vroom Inc / Expedia Group Inc / Essex Property Trust Inc / Equity Residential / AAR Corp / AMN Healthcare Services Inc / HOOKIPA Pharma Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Cross Country Healthcare Inc / Booking Holdings Inc / Camden Property Trust / Meta Platforms Inc / Mid-America Apartment Communities Inc / UDR Inc / Nautilus Inc / Peloton Interactive Inc / Biogen Inc / Preferred Apartment Communities Inc / Angi Inc / Independent Bank Group Inc / Alphabet Inc / Aemetis Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / NexPoint Residential Trust Inc / Carvana Co / Stitch Fix Inc / Syneos Health Inc / BioXcel Therapeutics Inc / Frontdoor Inc / Momentive Global Inc / Lyft Inc / Uber Technologies Inc / Apartment Income REIT Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Notes From The (Virtual) Road... Management Meetings Move Through The LANDSCAPE</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">SAGE=US / BIIB=US</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.OQ / INCY.OQ / LLY.N / MRK.N / AZN.L / SASY.PA / AMGN.OQ / REGN.OQ / ALKS.OQ / STSA.OQ / GILD.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / TEVA.N / MRNA.OQ / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / SAGE.OQ / ZBH.N / GRTX.OQ</td><td class="leftalignment">Biogen Inc / Incyte Corp / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / SAGE Therapeutics Inc / Zimmer Biomet Holdings Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EU Pharma Feedback: Key takeaways from Roche Muscular Dystrophy Association/Neuroscience call</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ROG.S / NOVN.S / BIIB.OQ</td><td class="leftalignment">Roche Holding AG / Novartis AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Transcript from Expert call on donanemab</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">LLY=US / MRK=US / BIIB=US / BTAI=US</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / Biogen Inc / BioXcel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from the AD/PD 2021 Conference</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">BIIB=US / ACIU=US</td><td class="leftalignment">Biogen Inc / AC Immune SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Marc Goodman</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">You’re Going the Wrong Way! Outflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / MDT=US / PD=US / BLD=US / CMA=US / PEB=US / REI=US / H=US / MTN=US / PB=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / TNL=US / VMC=US / HLT=US / MLM=US / WTFC=US / AIR=US / CHH=US / CSTR=US / DRH=US / ENDP=US / IBP=US / PACW=US / REGI=US / WAL=US / HTH=US / SAGE=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / UCBI=US / PNFP=US / SBCF=US / BIIB=US / TCBI=US / FNB=US / FHN=US / SHO=US / RNST=US / BLDR=US / HST=US / CADE=US / WH=US / 45665G303 / HGV=US / RLJ=US / VAC=US / RHP=US / ABBV=US / IBTX=US / SHAK=US / SUM=US / LOB=US / ACBI=US / PK=US / PLYA=US / YEXT=US / MBIN=US / MAXR=US / HWC=US / OZK=US / AMTB=US / UBER=US / FERG=US / AHCO=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Medtronic PLC / PagerDuty Inc / TopBuild Corp / Comerica Inc / Pebblebrook Hotel Trust / Ring Energy Inc / Hyatt Hotels Corp / Vail Resorts Inc / Prosperity Bancshares Inc / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Wintrust Financial Corp / AAR Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Endo International PLC / Installed Building Products Inc / PacWest Bancorp / Renewable Energy Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / SAGE Therapeutics Inc / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / United Community Banks Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Renasant Corp / Builders FirstSource Inc / Host Hotels & Resorts Inc / Cadence Bank / Wyndham Hotels & Resorts Inc / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Shake Shack Inc / Summit Materials Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Yext Inc / Merchants Bancorp / Maxar Technologies Inc / Hancock Whitney Corp / Bank Ozk / Amerant Bancorp Inc / Uber Technologies Inc / Ferguson PLC / Adapthealth Corp / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">SAGE data updates - supportive & odd at the same time</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Beyond Aducanumab, investors should take a closer look at depression drug</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">SHORELINE Data Support Continued Development of Zuranolone; Top-Line Data From Phase III WATERFALL Study Next Milestone</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X103 / 78667J108</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Matt Phipps, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MCD=US / WEN=US / REI=US / PLUG=US / IGT=US / BYD=US / EXPE=US / MGM=US / PENN=US / AIR=US / ARCC=US / CBRL=US / DRI=US / EEFT=US / LEN=US / MAIN=US / MCRI=US / ORCC=US / TRIP=US / SAGE=US / SGMS=US / BKNG=US / DIN=US / RRR=US / BIIB=US / CZR=US / AINV=US / PLAY=US / DENN=US / CMG=US / CPRX=US / TAST=US / PNNT=US / NXGN=US / JACK=US / NDLS=US / GOOGL=US / TSLX=US / 70806A106 / COUP=US / LOCO=US / SHAK=US / GSBD=US / CHCT=US / WING=US / TRVG=US / MAXR=US / SMAR=US / FSK=US / CRWD=US / OPCH=US / SPCE=US / DKNG=US / FSKR=US / BALY=US / ABNB=US</td><td class="leftalignment">McDonald's Corp / Wendys Co / Ring Energy Inc / Plug Power Inc / International Game Technology PLC / Boyd Gaming Corp / Expedia Group Inc / MGM Resorts International / Penn National Gaming Inc / AAR Corp / Ares Capital Corp / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Euronet Worldwide Inc / Lennar Corp / Main Street Capital Corp / Monarch Casino & Resort Inc / Owl Rock Capital Corp / Tripadvisor Inc / SAGE Therapeutics Inc / Scientific Games Corp / Booking Holdings Inc / Dine Brands Global Inc / Red Rock Resorts Inc / Biogen Inc / Caesars Entertainment Inc / Apollo Investment Corp / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Pennantpark Investment Corp / NextGen Healthcare Inc / Jack in the Box Inc / Noodles & Co / Alphabet Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Coupa Software Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Goldman Sachs BDC Inc / Community Healthcare Trust Inc / Wingstop Inc / Trivago NV / Maxar Technologies Inc / Smartsheet Inc / FS KKR Capital Corp / CrowdStrike Holdings Inc / Option Care Health Inc / Virgin Galactic Holdings Inc / DraftKings Inc / FS KKR Capital Corp / Bally's Corp / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">ACI-24-Key Takeaways from the Global Down Syndrome Symposium</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">H00263105 / BIIB / PRTA.OQ</td><td class="leftalignment">AC Immune SA / Biogen Inc / Prothena Corporation PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Revisiting the Current Situation at the FDA and Potential Implications for Biogen's Aducanumab</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.OQ / MRK.N / REGN.OQ / FGEN.PS / ACHC.OQ</td><td class="leftalignment">Biogen Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc / First Gen Corp / Acadia Healthcare Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SYN-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SYN / ABT / MRK / PFE / AZN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Synthetic Biologics Inc / Abbott Laboratories / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083 / US3755581036 / US09062X1037 / US0042251084 / US42226A1079 / US05464T1043 / US0327973006 / US24823R1059</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Healthequity Inc / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Partner company's COO departure should not be viewed as a concern; maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US / SAGE=US</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Improvements Continue, Though Signs of Deceleration as Variants Spread; IHME Warns of Easing Restrictions Too Early</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / TEVA=US / GILD=US / AMT=US / VZ=US / LOW=US / PB=US / CHRS=US / LEG=US / DISH=US / BNL=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / REGI=US / SBAC=US / STOR=US / ABCB=US / ADC=US / BOKF=US / FFIN=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / PRPL=US / EPRT=US / JACK=US / TREX=US / CUBE=US / FBHS=US / TILE=US / TMUS=US / NDLS=US / CNCE=US / LOCO=US / HQY=US / SHAK=US / RLMD=US / WING=US / ZG=US / 82982L103 / ANAB=US / JELD=US / RDFN=US / BTAI=US / OPCH=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / American Tower Corp / Verizon Communications Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / DISH Network Corp / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / STORE Capital Corp / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / First Financial Bankshares Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Trex Company Inc / CubeSmart / Fortune Brands Home & Security Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Concert Pharmaceuticals Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Relmada Therapeutics Inc / Wingstop Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / AnaptysBio Inc / JELD-WEN Holding Inc / Redfin Corp / BioXcel Therapeutics Inc / Option Care Health Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">TRAILBLAZER Results Add Noise to the Din but Are Still Unlikely to Sway Opinion of Investors and Regulators Alike</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">First Few Waves of Innovation Tsunami During 2021 in Alz/Park’s Disease - Post AD/PD’21</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY.N / US1101221083 / BIIB.OQ / US0042251084 / PRTA.OQ / US05464T1043 / US0327973006 / US24823R1059 / SAVA.OQ</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Biogen Inc / ACADIA Pharmaceuticals Inc / Prothena Corporation PLC / Axsome Therapeutics Inc / Anavex Life Sciences Corp / Denali Therapeutics Inc / Cassava Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0311621009 / US75886F1075 / US7665596034 / US09062X1037</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Billy Dunn - BIIB statement</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from Expert call on donanemab</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US / BIIB=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">KOL believes adu could be approved but initial uptake could be small</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US / LLY=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Investor questions about donanemab and read to adu</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US / LLY=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">EVLO=US / ADAP=US / MRK=US / LLY=US / PFE=US / BMY=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / JNJ=US / BMRN=US / BLUE=US / ISEE=US / EXAS=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NESN=US / KLDO=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / DDDD=GB / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / MCRB=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PHGE=US / PASG=US / SIGHT:FP=FR / FBRX=US / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Evelo Biosciences Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Exact Sciences Corp / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Nestle SA / Kaleido Biosciences Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / 4D Pharma PLC / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Seres Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Biomx Inc / Passage Bio Inc / Gensight Biologics SA / Forte Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Mar 15 2021 6:45AM</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">HMPT=US / XENE=US / FISV=US / AAPL=US / DELL=US / IBM=US / INTC=US / AMD=US / MSFT=US / MU=US / QCOM=US / DNLI=US / NVDA=US / NTAP=US / V=US / XLNX=US / ADS=US / IIVI=US / AX=US / XOMA=US / ACET=US / APLS=US / AVGO=US / BLUE=US / ISEE=US / FUSN=US / NBIX=US / PII=US / PRTK=US / RARE=US / RKT=US / SGMO=US / SWTX=US / UTHR=US / WDC=US / FOUR=US / SAGE=US / GPN=US / PYPL=US / EVOP=US / SWKS=US / ALPN=US / STX=US / IGMS=US / STRO=US / BIIB=US / COGT=US / SIMO=US / GRAY=US / FIS=US / MA=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / 2454=US / 2330=US / VMW=US / 6758=US / IDRA=US / ASND=US / RCUS=US / 8299=US / OMER=US / FNMA=US / NXPI=US / PCRX=US / 981=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / QRVO=US / CDTX=US / BPMC=US / ABUS=US / PSTG=US / ARGX=US / NVCR=US / HPE=US / CTMX=US / SQ=US / VYGR=US / KURA=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / IIIV=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / RPAY=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US / UWMC=US</td><td class="leftalignment">Home Point Capital Inc / Xenon Pharmaceuticals Inc / Fiserv Inc / Apple Inc / Dell Technologies Inc / International Business Machines Corp / Intel Corp / Advanced Micro Devices Inc / Microsoft Corp / Micron Technology Inc / Qualcomm Inc / Denali Therapeutics Inc / NVIDIA Corp / NetApp Inc / Visa Inc / Xilinx Inc / Alliance Data Systems Corp / II-VI Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Neurocrine Biosciences Inc / Polaris Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Rocket Companies Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / Western Digital Corp / Shift4 Payments Inc / SAGE Therapeutics Inc / Global Payments Inc / PayPal Holdings Inc / EVO Payments Inc / Skyworks Solutions Inc / Alpine Immune Sciences Inc / Seagate Technology Holdings PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Silicon Motion Technology Corp / Graybug Vision Inc / Fidelity National Information Services Inc / Mastercard Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / MediaTek Inc / Taiwan Semiconductor Manufacturing Co Ltd / VMware Inc / Sony Group Corp / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Phison Electronics Corp / Omeros Corp / Federal National Mortgage Association / NXP Semiconductors NV / Pacira Biosciences Inc / Semiconductor Manufacturing International Corp / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Qorvo Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / Pure Storage Inc / argenx SE / Novocure Ltd / Hewlett Packard Enterprise Co / CytomX Therapeutics Inc / Block Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / I3 Verticals Inc / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Repay Holdings Corp / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc / UWM Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Ireland / Japan / Netherlands / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Financial Services / Healthcare / Info. Tech./Computers / Leisure & Entertainment / Real Estate</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SVRA=US / TRVN=US / MRK=US / BSX=US / CSII=US / FDX=US / ABT=US / AMGN=US / BMY=US / CAT=US / WM=US / BWA=US / MDT=US / QCOM=US / T=US / DT=US / INCY=US / RUN=US / CG=US / BAC=US / GILD=US / FRC=US / MPWR=US / JPM=US / FCEL=US / PLUG=US / NVS=US / TROW=US / CRY=US / JCI=US / JNJ=US / DE=US / RSG=US / ALB=US / AMSC=US / ARNA=US / ARRY=US / ATRC=US / AVNT=US / CMI=US / CREE=US / DRI=US / DRRX=US / EW=US / INSM=US / ITRI=US / MS=US / ROK=US / TER=US / TRMB=US / RHHBY=US / SIVB=US / NEP=US / SWKS=US / ICAD=US / BE=US / CLH=US / WCN=US / BIIB=US / ISR=US / ENS=US / GOOG=US / TWIN=US / ORA=US / AMRS=US / PDD=US / SPWR=US / CSIQ=US / FSLR=US / ARAY=US / BX=US / DAN=US / WPRT=US / SWAV=US / AGCO=US / CPIX=US / TSLA=US / DANA=US / AMRC=US / PCRX=US / ENPH=US / SPLK=US / HASI=US / CNHI=US / HRTX=US / BABA=US / EKTAY=US / NEWR=US / SEDG=US / LIVN=US / AQMS=US / CERC=US / VRAY=US / WKHS=US / IRTC=US / VERU=US / ATXI=US / APTV=US / VOW3-DE=US / CWEN=US / ESTC=US / DDOG=US / BXRX=US / TARA=US / SUMO=US / VLDR=US / SHLS=US / CHPT=US / GOEV=US</td><td class="leftalignment">Savara Inc / Trevena Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / FedEx Corp / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Caterpillar Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Qualcomm Inc / AT&T Inc / Dynatrace Inc / Incyte Corp / Sunrun Inc / Carlyle Group Inc / Bank of America Corp / Gilead Sciences Inc / First Republic Bank / Monolithic Power Systems Inc / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Novartis AG / T Rowe Price Group Inc / CryoLife Inc / Johnson Controls International PLC / Johnson & Johnson / Deere & Co / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Arena Pharmaceuticals Inc / Array Technologies Inc / AtriCure Inc / Avient Corp / Cummins Inc / Wolfspeed Inc / Darden Restaurants Inc / DURECT Corp / Edwards Lifesciences Corp / Insmed Inc / Itron Inc / Morgan Stanley / Rockwell Automation Inc / Teradyne Inc / Trimble Inc / Roche Holding AG / SVB Financial Group / Nextera Energy Partners LP / Skyworks Solutions Inc / ICAD Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Biogen Inc / IsoRay Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Amyris Inc / Pinduoduo Inc / SunPower Corp / Canadian Solar Inc / First Solar Inc / Accuray Inc / Blackstone Inc / Dana Inc / Westport Fuel Systems Inc / Shockwave Medical Inc / AGCO Corp / Cumberland Pharmaceuticals Inc / Tesla Inc / Dana Gas PJSC / Ameresco Inc / Pacira Biosciences Inc / Enphase Energy Inc / Splunk Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Heron Therapeutics Inc / Alibaba Group Holding Ltd / Elekta AB (publ) / New Relic Inc / Solaredge Technologies Inc / LivaNova PLC / Aqua Metals Inc / Avalo Therapeutics Inc / ViewRay Inc / Workhorse Group Inc / iRhythm Technologies Inc / Veru Inc / Avenue Therapeutics Inc / Aptiv PLC / Volkswagen AG / Clearway Energy Inc / Elastic NV / Datadog Inc / Baudax Bio Inc / Protara Therapeutics Inc / Sumo Logic Inc / Velodyne Lidar Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Canoo Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Arab Emirates / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMD=US / DNLI=US / AX=US / XOMA=US / ACET=US / APLS=US / BLUE=US / ISEE=US / FUSN=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / COGT=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Advanced Micro Devices Inc / Denali Therapeutics Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / China / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2516152 / 2000019 / 2023607 / 2008154 / 2050832 / 2026242 / 2175672 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2455965 / 2613990 / 2459020 / 2645409 / 2048804 / 2707677 / 2795393 / 2857817 / B2R3PV1 / B7TL820 / B85KFY9 / B7JYSG3 / BBPK0J0 / B95N910 / BFH3N85 / BYW36M8 / BFM2GV1 / BQT3XY6 / BFZ1K46 / BZ8VJQ8 / BKTNTR9 / BJVR9Y9 / BZ1LFG7 / BL71K91 / BGKG6M3 / BFY7DC4 / 021513106 / BNRQM83</td><td class="leftalignment">Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Adobe Inc / Ameren Corp / American Electric Power Company Inc / Cardinal Health Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Biogen Inc / Illumina Inc / Intuit Inc / NiSource Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Amerisourcebergen Corp / Netflix Inc / American Water Works Company Inc / Meta Platforms Inc / Five Below Inc / Guidewire Software Inc / Mirati Therapeutics Inc / PTC Inc / Veeva Systems Inc / PayPal Holdings Inc / GreenSky Inc / Cyberark Software Ltd / Spotify Technology SA / Vistra Corp / ViacomCBS Inc / iHeartMedia Inc / Roku Inc / Revolution Medicines Inc / StoneCo Ltd / Altimmune Inc / Alto Ingredients Inc / Petco Health and Wellness Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Update from this Weekend’s AD/PD Conference</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB / PRTA.OQ</td><td class="leftalignment">Biogen Inc / Prothena Corporation PLC</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABF.L / AEP.N / ALV.N / AU.N / CAS.TO / CI.N / CL.N / CMS.N / EDP.LS / EIX.N / EL.N / F.N / FGP.L / GM.N / GOG.L / HMb.ST / IBE.MC / IP.N / JD.L / KBH.N / KMB.N / KO.N / MKS.L / MRK.N / NCM.AX / NEM.N / NXT.L / PD.N / PFE.N / PHM.N / RSG.AX / RYN.N / SO.N / T.N / TOL.N / VC.N / PEP.N / BFb.N / PG.N / WY.N / CFP.TO / GILD.O / FNV.N / CPB.N / LPX.N / TEN.N / CMCSA.O / AMGN.O / INCY.O / DUK.N / AGI.N / BWA.N / LEA.N / PNM.N / K.N / DT.N / DISH.O / LEN.N / CLX.N / CAG.N / GIS.N / AEM.N / EPC.N / SBM.AX / AMT.N / KGC.N / NKE.N / JAZZ.O / CONE.O / VZ.N / EXEL.O / DHI.N / STZ.N / APH.N / FISV.O / ADSK.O / V.N / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / ITX.MC / BMRN.O / OPTN.O / REGN.O / ENR.N / JHX.AX / CEY.L / NCR.N / NET.N / TEL.N / GFI.N / ASC.L / CNP.N / ENDP.O / CPK.N / PII.N / ST.N / SEM.N / SGEN.OQ / GPN.N / MNST.O / RGLD.O / BLUE.O / CASY.O / EQIX.O / ATDb.TO / BIIB.O / GOLD.N / RMS.AX / NST.AX / 02209S103 / CWX.TO / RRL.AX / DLR.N / IAG.N / 427866108 / WEF.TO / FIS.N / ARWR.O / TEVA.N / MA.N / HOG.N / MERC.O / AUY.N / ATL.MI / BGS.N / HOCM.L / SLR.AX / ENSG.O / DAN.N / NOG.A / FRES.L / NGD.A / CLW.N / OGC.TO / ADUS.OQ / EGO.N / ADN.TO / SPB.N / NEE.N / GOR.AX / PCH.O / CFX.TO / PCRX.O / CTT.N / MTOR.N / IFP.TO / POLYP.L / EVN.AX / SPLK.OQ / RFP.N / BOSSn.DE / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / TPH.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / TMHC.N / COTY.N / PRTA.O / 81762P102 / CFF.TO / LB.N / KPTI.O / XNCR.OQ / VRNS.O / BOOH.L / BTG.N / AGRX.O / RYAM.N / ZALG.DE / 03835T200 / SHOP.N / WRK.N / SGRY.O / RACE.MI / TWLO.N / OR.N / ADNT.N / CRSP.OQ / GDS.O / SAND.N / AQN.N / OKTA.OQ / VST.N / WPM.N / KL.N / ATNX.O / SAIL.N / APTV.N / EHC.N / SDRY.L / ZS.OQ / AMRX.N / ITRM.O / VNE.N / NTGY.MC / KDP.N / XERS.O / AQST.O / FOCS.O / ESTC.N / GMDA.OQ / OSMT.O / NWL.O / OPI.OQ / CRWD.O / GMAB.O / PING.N / APRE.OQ / CRNC.OQ / IGMS.O / FRAS.L / REYN.O / SBSW.N / IGIC.OQ / NKLA.OQ / FOUR.N / GOCO.O / ALOO.O / MAX.N / WFG.N / AG1G.DE / 120291281 / 120681711</td><td class="leftalignment">Associated British Foods PLC / American Electric Power Company Inc / Autoliv Inc / AngloGold Ashanti Ltd / Cascades Inc / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / H & M Hennes & Mauritz AB / Iberdrola SA / International Paper Co / JD Sports Fashion PLC / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Marks and Spencer Group PLC / Merck & Co Inc / Newcrest Mining Ltd / Newmont Corporation / Next PLC / PagerDuty Inc / Pfizer Inc / Pultegroup Inc / Resolute Mining Ltd / Rayonier Inc / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Alamos Gold Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Lennar Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / Agnico Eagle Mines Ltd / Edgewell Personal Care Co / St Barbara Ltd / American Tower Corp / Kinross Gold Corp / Nike Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Industria de Diseno Textil SA / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / James Hardie Industries PLC / Centamin PLC / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Gold Fields Ltd / ASOS PLC / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Select Medical Holdings Corp / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Royal Gold Inc / bluebird bio Inc / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Barrick Gold Corp / Ramelius Resources Ltd / Northern Star Resources Ltd / Altria Group Inc / Doman Building Materials Group Ltd / Regis Resources Ltd / Digital Realty Trust Inc / IAMGOLD Corp / Hershey Co / Western Forest Products Inc / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Harley-Davidson Inc / Mercer International Inc / Yamana Gold Inc / Atlantia SpA / B&G Foods Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Ensign Group Inc / Dana Inc / Northern Oil and Gas Inc / Fresnillo PLC / New Gold Inc / Clearwater Paper Corp / OceanaGold Corp / Addus Homecare Corp / Eldorado Gold Corp / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Gold Road Resources Ltd / Potlatchdeltic Corp / Canfor Pulp Products Inc / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Polymetal International PLC / Evolution Mining Ltd / Splunk Inc / Resolute Forest Products Inc / Hugo Boss AG / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / Coty Inc / Prothena Corporation PLC / ServiceNow Inc / Conifex Timber Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Xencor Inc / Varonis Systems Inc / boohoo group plc / B2Gold Corp / Agile Therapeutics Inc / Rayonier Advanced Materials Inc / Zalando SE / Aptose Biosciences Inc / Shopify Inc / Westrock Co / Surgery Partners Inc / Ferrari NV / Twilio Inc / Osisko Gold Royalties Ltd / Adient PLC / CRISPR Therapeutics AG / GDS Holdings Ltd / Sandstorm Gold Ltd / Algonquin Power & Utilities Corp / Okta Inc / Vistra Corp / Wheaton Precious Metals Corp / Kirkland Lake Gold Ltd / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Encompass Health Corp / Superdry PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Iterum Therapeutics PLC / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Focus Financial Partners Inc / Elastic NV / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Office Properties Income Trust / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Aprea Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / Frasers Group PLC / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Nikola Corp / Shift4 Payments Inc / Gohealth Inc / Allogene Therapeutics Inc / Mediaalpha Inc / West Fraser Timber Co Ltd / AUTO1 Group SE / Cenovus Energy Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : Quick Thoughts on Donanemab Data and What It Means for BIIB</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / James Scott</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Dona Details Highlight Class Hopes, Uncertainties; Unlikely To Sway FDA Either Way On Adu</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - LLY's Full TRAILBLAZER Results Are Competitive with Aducanumab but Likely Need One More Study; FDA Decision on Adu Coming in June</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965 / LLY.N / 2516152</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Seamus Fernandez / Mr. Eddie Hickman, Ph.D. / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">LLY: Donanemab Results Encouraging but Modest Effect Suggests Confirmatory Study Likely Required; Data Supports Anti-Amyloid Plaque Treatments</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">2516152 / 2455965</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: BNTX/PFE efficacy in C19; (+) LentiGlobin news</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">PFE.N / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Pfizer Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BIIB: Blazing a trail or following in aducanumab's footsteps? Donanemab full phase 2 data demonstrates difficulty of developing an AD Tx</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB.OQ / LLY.N</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Blazing New TRAILs With More Alzheimer's Data, But LLY Needs To Show More Before It Can Cut Down The Competition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/13/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Mar. 13, 2021 / 7:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/13/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Momentum Soon Set for Major Rebalance</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AMGN=US / QCOM=US / INCY=US / CG=US / BAC=US / GILD=US / FRC=US / MPWR=US / JPM=US / TROW=US / MS=US / TER=US / SIVB=US / SWKS=US / BIIB=US / BX=US</td><td class="leftalignment">Amgen Inc / Qualcomm Inc / Incyte Corp / Carlyle Group Inc / Bank of America Corp / Gilead Sciences Inc / First Republic Bank / Monolithic Power Systems Inc / JPMorgan Chase & Co / T Rowe Price Group Inc / Morgan Stanley / Teradyne Inc / SVB Financial Group / Skyworks Solutions Inc / Biogen Inc / Blackstone Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Financial Services</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/13/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Mar. 13, 2021 / 6:45AM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/13/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Global Gene Therapy Market: Current Analysis and Forecast (2020-2027)</td><td class="leftalignment">English</td><td class="rightalignment">302</td><td class="leftalignment">BGT=AU / BMY=US / GILD=US / NOVN=CH / BMRN=US / BLUE=US / null / BIIB=US / ORTX=US / RGNX=US / QURE=US</td><td class="leftalignment">Bio-Gene Technology Ltd / Bristol-Myers Squibb Co / Gilead Sciences Inc / Novartis AG / Biomarin Pharmaceutical Inc / bluebird bio Inc / One 97 Communications Ltd / Biogen Inc / Orchard Therapeutics PLC / Regenxbio Inc / Uniqure NV</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Germany / Spain / France / United Kingdom / India / Italy / Japan / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">OPT=US / VBIV=US / AAPL=US / MRK=US / BSX=US / PFE=US / ABT=US / BMY=US / MDT=US / AMZN=US / WMT=US / INSP=US / CMS=US / GILD=US / DGX=US / BBI=US / RMD=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ISRG=US / LH=US / PHAR=US / REGN=US / USPH=US / UHS=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MRNS=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / EHC=US / NMTR=US / TMDI=US / SPRO=US / ASND=US / ADUS=US / ACHC=US / PRTA=US / OM=US / FLXN=US / CTRE=US / ALDX=US / XENT=US / WBA=US / EVH=US / ZBH=US / CATB=US / LIVN=US / CERC=US / AVDL=US / SRRA=US / SLNO=US / SYNH=US / FIXX=US / MRKR=US / GMDA=US / PDSB=US / TMDX=US / BCYC=US / KRTX=US / BNTX=US / PNTG=US</td><td class="leftalignment">Opthea Ltd / VBI Vaccines Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Amazon.com Inc / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Brickell Biotech Inc / Resmed Inc / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / Pharming Group NV / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Marinus Pharmaceuticals Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Encompass Health Corp / 9 Meters Biopharma Inc / Titan Medical Inc / Spero Therapeutics Inc / Ascendis Pharma A/S / Addus Homecare Corp / Acadia Healthcare Company Inc / Prothena Corporation PLC / Outset Medical Inc / Pacira Biosciences Inc / CareTrust REIT Inc / Aldeyra Therapeutics Inc / Intersect Ent Inc / Walgreens Boots Alliance Inc / Evolent Health Inc / Zimmer Biomet Holdings Inc / Astria Therapeutics Inc / LivaNova PLC / Avalo Therapeutics Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Soleno Therapeutics Inc / Syneos Health Inc / Homology Medicines Inc / Marker Therapeutics Inc / Gamida Cell Ltd / PDS Biotechnology Corp / Transmedics Group Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / BioNTech SE / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 538</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 3/5/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">CSL=US / INTU=US / AAPL=US / IBM=US / CSCO=US / BMY=US / DIS=US / INTC=US / ADI=US / AMD=US / MSFT=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / TXN=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / MPWR=US / CHTR=US / NICE=US / VZ=US / SMTC=US / CCI=US / UPS=US / EXPE=US / CMCSA=US / W=US / DISH=US / NUAN=US / APPS=US / HRB=US / CTL=US / CRUS=US / CME=US / EGAN=US / EGHT=US / EQIX=US / FIVE=US / QUIK=US / SBAC=US / TRIP=US / VG=US / RDWR=US / SNOW=US / NET=US / CRNT=US / RHHBY=US / BKNG=US / FB=US / MTCH=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / BIIB=US / RNG=US / FTCH=US / CEVA=US / GOOG=US / DLR=US / VIAC=US / DISCA=US / CCOI=US / TRIT=US / LLNW=US / PRPL=US / LUMN=US / ULTA=US / SPRO=US / CDXC=US / 005930-KR=US / TCEHY=US / MXL=US / TSLA=US / NXPI=US / YY=US / PRTA=US / TMUS=US / GTT=US / AVYA=US / TME=US / GOOGL=US / FIVN=US / ALDX=US / LOVE=US / ETSY=US / DZSI=US / TEUM=US / CVNA=US / ATUS=US / FIXX=US / HUYA=US / GRWG=US / REZI=US / PDSB=US / ZM=US / FSLY=US / BCYC=US / CMBM=US / DKNG=US / YALA=US / RXT=US / ABNB=US / ONDS=US / CHPT=US</td><td class="leftalignment">Carlisle Companies Inc / Intuit Inc / Apple Inc / International Business Machines Corp / Cisco Systems Inc / Bristol-Myers Squibb Co / Walt Disney Co / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Texas Instruments Inc / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Monolithic Power Systems Inc / Charter Communications Inc / Nice Ltd / Verizon Communications Inc / Semtech Corp / Crown Castle International Corp / United Parcel Service Inc / Expedia Group Inc / Comcast Corp / Wayfair Inc / DISH Network Corp / Nuance Communications Inc / Digital Turbine Inc / H & R Block Inc / Lumen Technologies Inc / Cirrus Logic Inc / CME Group Inc / eGain Corp / 8x8 Inc / Equinix Inc / Five Below Inc / QuickLogic Corp / SBA Communications Corp / Tripadvisor Inc / Vonage Holdings Corp / Radware Ltd / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Roche Holding AG / Booking Holdings Inc / Meta Platforms Inc / Match Group Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / Biogen Inc / RingCentral Inc / Farfetch Ltd / CEVA Inc / Alphabet Inc / Digital Realty Trust Inc / ViacomCBS Inc / Discovery Inc / Cogent Communications Holdings Inc / Triterras Inc / Limelight Networks Inc / Purple Innovation Inc / Lumen Technologies Inc / Ulta Beauty Inc / Spero Therapeutics Inc / Chromadex Corp / Farfetch Ltd / Tencent Holdings Ltd / Maxlinear Inc / Tesla Inc / NXP Semiconductors NV / JOYY Inc / Prothena Corporation PLC / T-Mobile US Inc / GTT Communications Inc / Avaya Holdings Corp / Tencent Music Entertainment Group / Alphabet Inc / Five9 Inc / Aldeyra Therapeutics Inc / Lovesac Co / ETSY Inc / DZS Inc / Pareteum Corp / Carvana Co / Altice USA Inc / Homology Medicines Inc / HUYA Inc / GrowGeneration Corp / Resideo Technologies Inc / PDS Biotechnology Corp / Zoom Video Communications Inc / Fastly Inc / Bicycle Therapeutics PLC / Cambium Networks Corp / DraftKings Inc / Yalla Group Ltd / Rackspace Technology Inc / Airbnb Inc / Ondas Holdings Inc / ChargePoint Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States / Guernsey</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Household Products / Leisure & Entertainment / Machinery / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CACI=US / AMZN=US / GL=US / PEB=US / DGX=US / H=US / CRM=US / MTN=US / VZ=US / VRM=US / MAR=US / EXPE=US / TNL=US / MGM=US / HLT=US / MANH=US / RCL=US / ARCC=US / APH=US / CCL=US / KIDS=US / CHH=US / CHD=US / DRH=US / MAIN=US / ORCC=US / SNAP=US / TRIP=US / WIX=US / BKNG=US / PRI=US / FB=US / SSB=US / UCBI=US / MGP=US / PNFP=US / PTON=US / NOMD=US / BIIB=US / TPX=US / AINV=US / SHO=US / RNST=US / HST=US / PNNT=US / PRPL=US / WH=US / PSN=US / AAN=US / HGV=US / RLJ=US / ESTE=US / VAC=US / RHP=US / HCI=US / NCLH=US / MODN=US / TMUS=US / GOOGL=US / QTWO=US / TSLX=US / FIVN=US / 70806A106 / LOCO=US / BABA=US / CMPR=US / WK=US / RLMD=US / GDDY=US / GSBD=US / ACBI=US / SQ=US / PK=US / PLYA=US / PETQ=US / FNKO=US / SFIX=US / BHC=US / FTDR=US / SVMK=US / FSK=US / HARP=US / LYFT=US / UBER=US / TCRR=US / LSPD=US / OPCH=US / ZI=US / FSKR=US / BIGC=US / NGMS=US</td><td class="leftalignment">CACI International Inc / Amazon.com Inc / Globe Life Inc / Pebblebrook Hotel Trust / Quest Diagnostics Inc / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Verizon Communications Inc / Vroom Inc / Marriott International Inc / Expedia Group Inc / Travel + Leisure Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Manhattan Associates Inc / Royal Caribbean Cruises Ltd / Ares Capital Corp / Amphenol Corp / Carnival Corp / OrthoPediatrics Corp / Choice Hotels International Inc / Church & Dwight Co Inc / Diamondrock Hospitality Co / Main Street Capital Corp / Owl Rock Capital Corp / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Booking Holdings Inc / Primerica Inc / Meta Platforms Inc / SouthState Corp / United Community Banks Inc / MGM Growth Properties LLC / Pinnacle Financial Partners Inc / Peloton Interactive Inc / Nomad Foods Ltd / Biogen Inc / Tempur Sealy International Inc / Apollo Investment Corp / Sunstone Hotel Investors Inc / Renasant Corp / Host Hotels & Resorts Inc / Pennantpark Investment Corp / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Parsons Corp / Aaron's Company Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Hci Group Inc / Norwegian Cruise Line Holdings Ltd / Model N Inc / T-Mobile US Inc / Alphabet Inc / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / Five9 Inc / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / Workiva Inc / Relmada Therapeutics Inc / GoDaddy Inc / Goldman Sachs BDC Inc / Atlantic Capital Bancshares Inc / Block Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / PetIQ Inc / Funko Inc / Stitch Fix Inc / Bausch Health Companies Inc / Frontdoor Inc / Momentive Global Inc / FS KKR Capital Corp / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Lightspeed Commerce Inc / Option Care Health Inc / ZoomInfo Technologies Inc / FS KKR Capital Corp / Bigcommerce Holdings Inc / NeoGames SA</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Ireland / Israel / Liberia / Luxembourg / Netherlands / Panama / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Today@11am ET: Virtual KOL Call to Discuss Emerging Therapies for Alzheimer’s Disease Ahead of AD/PD 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / JNJ.N / LLY.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Johnson & Johnson / Eli Lilly and Co / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">AD/PD Presentations Reflect Leading Platform</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PRTA=US / BMY=US / RHHBY=US / BIIB=US</td><td class="leftalignment">Prothena Corporation PLC / Bristol-Myers Squibb Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Biogen Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Bleeding Continues</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Virtual KOL Call to Discuss Emerging Therapies for Alzheimer’s Disease</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N / BIIB.OQ / PRTA.OQ / AVXL.OQ / DNLI.OQ</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / Prothena Corporation PLC / Anavex Life Sciences Corp / Denali Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 4031976 / 0925288 / 2868165 / 2516152 / 2000019 / 2050832 / 2026242 / 2270726 / 2328915 / 2455965 / 2471950 / 2459020 / 2630513 / 2689560 / 2825933 / B1F76F9 / 2969637 / B2R3PV1 / B5B2106 / 2982924 / B7TL820 / BCBVTX1 / BBFL7S1 / B7VD3F2 / BBPK0J0 / BDZCRX3 / BFLR866 / BJ36RM8 / BYW36M8 / BYZLV46 / BK0VHF6 / BDHF4K6 / BZBY005 / BZ1LFB2 / BKS3SM8 / BMQ5T49 / BGCYWN8 / BKVDFF7 / BZ8VJQ8 / BJXBP30 / BYQHPK7 / BYYWPW6 / BZ1LFG7 / BWY52P3 / BL71K91 / BDD1B07 / BLBLMD5</td><td class="leftalignment">American Express Co / Visa Inc / Adidas AG / GlaxoSmithKline PLC / Sysco Corp / Eli Lilly and Co / Amazon.com Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Nextera Energy Inc / Biogen Inc / Incyte Corp / Intuit Inc / New Jersey Resources Corp / PG&E Corp / South Jersey Industries Inc / Western Union Co / DICK'S Sporting Goods Inc / American Water Works Company Inc / Fortinet Inc / Spectrum Pharmaceuticals Inc / Meta Platforms Inc / Agios Pharmaceuticals Inc / bluebird bio Inc / Duke Energy Corp / Mirati Therapeutics Inc / RingCentral Inc / Twitter Inc / Pacira Biosciences Inc / PayPal Holdings Inc / InflaRx NV / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Merus NV / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Zentalis Pharmaceuticals Inc / Xencor Inc / Oric Pharmaceuticals Inc / Vistra Corp / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Roku Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Rubius Therapeutics Inc / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">ReCode Therapeutics, Inc.: Our Q&A With Management</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Myles R. R. Minter</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Maintaining Our Ground; Believe Amendment Not Impactful For Belumosudil Approvability</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB / 78667J108</td><td class="leftalignment">Biogen Inc / SAGE Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Andres Y. Maldonado, PhD / Matthew Caufield</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH: Previewing LLY's Donanemab Results Ahead of "Amyloid" Showcase at AD/PD</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY.N / 2516152 / 2455965</td><td class="leftalignment">Eli Lilly and Co / Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Yatin Suneja / Tarun Soni / Mr. Evan B. Wang / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Mar. 10, 2021 / 11:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">3/12@11am ET: Virtual KOL Call to Discuss Emerging Therapies for Alzheimer’s Disease Ahead of AD/PD 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DNB / HD=US / MCD=US / WEN=US / PD=US / AMZN=US / T=US / CMA=US / BC=US / VZ=US / LOW=US / PB=US / EWBC=US / TRMK=US / UMPQ=US / EXPE=US / LEG=US / KFRC=US / BKI=US / WTFC=US / KFY=US / AIZ=US / AMN=US / BMRN=US / CBRL=US / CSTR=US / DRI=US / EXPO=US / FCN=US / HAIN=US / MAN=US / MHK=US / PACW=US / REGN=US / STRA=US / THO=US / TRIP=US / WAL=US / HTH=US / CVX=US / POST=US / SNOW=US / BXS=US / BKNG=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / ADC=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / UCBI=US / DIN=US / PNFP=US / SBCF=US / BCO=US / MRNS=US / BIIB=US / TCBI=US / TPX=US / FNB=US / FHN=US / PLAY=US / RNST=US / DENN=US / XM=US / THS=US / CMG=US / CCOI=US / EHTH=US / CADE=US / TAST=US / PRPL=US / IAC=US / JACK=US / CLNY=US / VRSK=US / FBHS=US / ANGI=US / SPLK=US / IBTX=US / TMUS=US / NDLS=US / FEYE=US / GOOGL=US / LOCO=US / OSH=US / SHAK=US / WING=US / LOB=US / EVRI=US / ACBI=US / ZS=US / IBEX=US / TRVG=US / PVAC=US / OKTA=US / RDFN=US / ATNX=US / MBIN=US / HWC=US / OZK=US / FTDR=US / ESTC=US / AMTB=US / GOCO=US / DKNG=US / CRMD.US / ABNB=US / AFRM=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Home Depot Inc / McDonald's Corp / Wendys Co / PagerDuty Inc / Amazon.com Inc / AT&T Inc / Comerica Inc / Brunswick Corp / Verizon Communications Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / East West Bancorp Inc / Trustmark Corp / Umpqua Holdings Corp / Expedia Group Inc / Leggett & Platt Inc / Kforce Inc / Black Knight Inc / Wintrust Financial Corp / Korn Ferry / Assurant Inc / AMN Healthcare Services Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Exponent Inc / FTI Consulting Inc / Hain Celestial Group Inc / ManpowerGroup Inc / Mohawk Industries Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Strategic Education Inc / Thor Industries Inc / Tripadvisor Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Chevron Corp / Post Holdings Inc / Snowflake Inc. / Cadence Bank / Booking Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / United Community Banks Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Brinks Co / Marinus Pharmaceuticals Inc / Biogen Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / First Horizon Corp / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Qualtrics International Inc / TreeHouse Foods Inc / Chipotle Mexican Grill Inc / Cogent Communications Holdings Inc / eHealth Inc / Cadence Bank / Carrols Restaurant Group Inc / Purple Innovation Inc / IAC/Interactivecorp / Jack in the Box Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Fortune Brands Home & Security Inc / Angi Inc / Splunk Inc / Independent Bank Group Inc / T-Mobile US Inc / Noodles & Co / Mandiant Inc / Alphabet Inc / El Pollo Loco Holdings Inc / Oak Street Health Inc / Shake Shack Inc / Wingstop Inc / Live Oak Bancshares Inc / Everi Holdings Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / Ibex Ltd / Trivago NV / Ranger Oil Corp / Okta Inc / Redfin Corp / Athenex Inc / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Elastic NV / Amerant Bancorp Inc / Gohealth Inc / DraftKings Inc / CorMedix Inc / Airbnb Inc / Affirm Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Mar. 10, 2021 / 6:45AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ANA.MC / KBH.N / MRK.N / PFE.N / PHM.N / TOL.N / FER.MC / EPR.N / LEN.N / XOM.N / GWW.N / NG.L / DHI.N / IG.MI / CVX.N / SRG.MI / TT.N / DKS.N / CASY.O / BIIB.O / TRN.MI / ATL.MI / GETP.PA / FTNT.O / CIO.N / PCRX.O / FANG.O / ABBV.N / TPH.N / TMHC.N / AENA.MC / 78667J108 / NTGY.MC / XERS.O / GMDA.OQ / OTRK.OQ / SHC.OQ</td><td class="leftalignment">Acciona SA / KB Home / Merck & Co Inc / Pfizer Inc / Pultegroup Inc / Toll Brothers Inc / Ferrovial SA / EPR Properties / Lennar Corp / Exxon Mobil Corp / W W Grainger Inc / National Grid PLC / D R Horton Inc / Italgas SpA / Chevron Corp / Snam SpA / Trane Technologies PLC / DICK'S Sporting Goods Inc / Caseys General Stores Inc / Biogen Inc / Terna Rete Elettrica Nazionale SpA / Atlantia SpA / Getlink SE / Fortinet Inc / City Office REIT Inc / Pacira Biosciences Inc / Diamondback Energy Inc / Abbvie Inc / Tri Pointe Homes Inc (Delaware) / Taylor Morrison Home Corp / Aena SME SA / SAGE Therapeutics Inc / Naturgy Energy Group SA / Xeris Biopharma Holdings Inc / Gamida Cell Ltd / Ontrak Inc / Sotera Health Co</td><td class="leftalignment"></td><td class="leftalignment">Spain / France / United Kingdom / Ireland / Israel / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">‘324 and ‘718 Readouts Could Validate Neurosteroid Platform, Though Still Overshadowed By WATERFALL</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">78667J108 / BIIB.O</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended March 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">JNJ.N / NCOX.PA / NVAX.OQ / BIIB.OQ / ACAD.OQ / BNFT.OQ / AERI.OQ / AGTC.OQ / ALDX.OQ / GBT.OQ / VYGR.OQ / ADVM.OQ / EYPT.OQ / UBX.OQ / SIBN.OQ / CURA.CD / CL.CD / CCHW.NLB / GOCO.OQ / GRAY.OQ / NEXI.OQ</td><td class="leftalignment">Johnson & Johnson / Nicox SA / Novavax Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Benefitfocus Inc / Aerie Pharmaceuticals Inc / Applied Genetic Technologies Corp / Aldeyra Therapeutics Inc / Global Blood Therapeutics Inc / Voyager Therapeutics Inc / Adverum Biotechnologies Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / SI-BONE Inc / Curaleaf Holdings Inc / Cresco Labs Inc / Columbia Care Inc / Gohealth Inc / Graybug Vision Inc / Neximmune Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">What’s going on at the FDA? Potential impact on Biotech</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMRN=US / BIIB=US / ATNX=US</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Biogen Inc / Athenex Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Progress on Oral Antivirals as Domestic Improvements Continue and Declines in Global New Cases Plateau</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / TEVA=US / GILD=US / LOW=US / CHRS=US / LEG=US / CI=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / AMSF=US / DIN=US / BIIB=US / TPX=US / EXP=US / CRD.B=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / REX=US / RPRX=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / TILE=US / NDLS=US / LOCO=US / SHAK=US / WING=US / 82982L103 / PVAC=US / ANAB=US / JELD=US / SFIX=US / GOCO=US / AZEK=US / VTRS=US / DHT.UN=CA</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Lowe's Companies Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Cigna Corp / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Amerisafe Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Crawford & Co / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Royalty Pharma PLC / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Gohealth Inc / Azek Company Inc / Viatris Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Initiating on small cap royalty player with a Buy, $15 PT</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">DHT.UN=CA / RPRX.OQ / GILD=US / BIIB=US / RPRX=US / DHT_u.TO</td><td class="leftalignment">Dri Healthcare Trust / Royalty Pharma PLC / Gilead Sciences Inc / Biogen Inc / Royalty Pharma PLC / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Relatively Stable for Large Cap and SMid Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Biotechnology Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">65</td><td class="leftalignment">US89237H2094 / US09061G1013 / US09058V1035 / US30161Q1040 / US45337C1027 / US64125C1099 / US7599161095 / US09062X1037 / US40637H1095 / US04744L1061 / US09609G1004 / US8036071004 / CA1208311029 / US68403P2039 / US16934W1062 / US29428V1044 / US31189P1021 / CA05156V1022 / US0008991046 / US00972D1054 / US78667J1088 / US19249H1032 / US92346J1088 / US7207951036 / US81750R1023 / US63016Q1022 / US37890U1088 / US92915B1061 / US28106W1036 / US04280A1007 / US00773U1088 / US98419J2069 / US12648L6011 / US8177631053 / US03890D1081 / US15117B2025 / US74017N1054</td><td class="leftalignment">TRACON Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / BioCryst Pharmaceuticals Inc / Exelixis Inc / Incyte Corp / Neurocrine Biosciences Inc / Repligen Corp / Biogen Inc / Halozyme Therapeutics Inc / Athersys Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Burcon NutraScience Corp / Oramed Pharmaceuticals Inc / Chimerix Inc / Epizyme Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / ADMA Biologics Inc / Akebia Therapeutics Inc / SAGE Therapeutics Inc / Coherus BioSciences Inc / Vericel Corp / Pieris Pharmaceuticals Inc / Seres Therapeutics Inc / Immunitybio Inc / Global Blood Therapeutics Inc / Voyager Therapeutics Inc / Editas Medicine Inc / Arrowhead Pharmaceuticals Inc / Adverum Biotechnologies Inc / XOMA Corp / CTI Biopharma Corp / Sesen Bio Inc / Aravive Inc / Celldex Therapeutics Inc / Precigen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Biogen down 2% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss Hot Topics and Key 2021 Focus Areas in Eye Diseases TODAY @ 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / REGN.OQ / BIIB.OQ / AERI.OQ / AGTC.OQ / ALDX.OQ / ADVM.OQ / EYPT.OQ / UBX.OQ / GRAY.OQ</td><td class="leftalignment">Johnson & Johnson / Regeneron Pharmaceuticals Inc / Biogen Inc / Aerie Pharmaceuticals Inc / Applied Genetic Technologies Corp / Aldeyra Therapeutics Inc / Adverum Biotechnologies Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Graybug Vision Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IVA=FR / PASG=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / PRVL=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / LYS=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Inventiva SA / Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Porvair PLC / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Lysogene SA / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / REGN.OQ / AMRN.OQ / BIIB.OQ / AERI.OQ / AGTC.OQ / AKBA.OQ / ALDX.OQ / ADVM.OQ / TVTY.OQ / EYPT.OQ / UBX.OQ / HGEN.OQ / GRAY.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Regeneron Pharmaceuticals Inc / Amarin Corporation PLC / Biogen Inc / Aerie Pharmaceuticals Inc / Applied Genetic Technologies Corp / Akebia Therapeutics Inc / Aldeyra Therapeutics Inc / Adverum Biotechnologies Inc / Tivity Health Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Humanigen Inc / Graybug Vision Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Mar 08 2021 6:49AM</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BLDR=US / NUVB=US / AAPL=US / DELL=US / IBM=US / INTC=US / AMD=US / MSFT=US / MU=US / AMZN=US / DNLI=US / NVDA=US / NTAP=US / BC=US / 7974=JP / CRM=US / XLNX=US / TTWO=US / ATVI=US / IIVI=US / AX=US / XOMA=US / ACET=US / APLS=US / AVGO=US / BLUE=US / CYBR=US / DOCU=US / ISEE=US / FUSN=US / HZO=US / NBIX=US / PRTK=US / RARE=US / RKT=US / SGMO=US / SWTX=US / UTHR=US / WDC=US / SAGE=US / AMC=US / FB=US / FBC=US / SWKS=US / ALPN=US / PFSI=US / STX=US / IGMS=US / STRO=US / BIIB=US / COGT=US / SIMO=US / SCPL=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / 2454=US / 2330=US / VMW=US / 6758=US / IDRA=US / ASND=US / RCUS=US / 8299=US / OMER=US / NXPI=US / PCRX=US / 981=US / BEAM=US / ZNGA=US / EA=US / PANW=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / GOOGL=US / AGTC=US / XENE=US / QRVO=US / CDTX=US / BPMC=US / ABUS=US / PSTG=US / ARGX=US / NVCR=US / HPE=US / CTMX=US / ZS=US / VYGR=US / KURA=US / CRVS=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / CRWD=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US / SKLZ=US / UWMC=US / PLTK=US / HMPT=US</td><td class="leftalignment">Builders FirstSource Inc / Nuvation Bio Inc / Apple Inc / Dell Technologies Inc / International Business Machines Corp / Intel Corp / Advanced Micro Devices Inc / Microsoft Corp / Micron Technology Inc / Amazon.com Inc / Denali Therapeutics Inc / NVIDIA Corp / NetApp Inc / Brunswick Corp / Nintendo Co Ltd / Salesforce.Com Inc / Xilinx Inc / Take-Two Interactive Software Inc / Activision Blizzard Inc / II-VI Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / bluebird bio Inc / Cyberark Software Ltd / DocuSign Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / MarineMax Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Rocket Companies Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / Western Digital Corp / SAGE Therapeutics Inc / AMC Entertainment Holdings Inc / Meta Platforms Inc / Flagstar Bancorp Inc / Skyworks Solutions Inc / Alpine Immune Sciences Inc / PennyMac Financial Services Inc / Seagate Technology Holdings PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Silicon Motion Technology Corp / Sciplay Corp / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / MediaTek Inc / Taiwan Semiconductor Manufacturing Co Ltd / VMware Inc / Sony Group Corp / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Phison Electronics Corp / Omeros Corp / NXP Semiconductors NV / Pacira Biosciences Inc / Semiconductor Manufacturing International Corp / Beam Therapeutics Inc / Zynga Inc / Electronic Arts Inc / Palo Alto Networks Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Alphabet Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / Pure Storage Inc / argenx SE / Novocure Ltd / Hewlett Packard Enterprise Co / CytomX Therapeutics Inc / Zscaler Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Corvus Pharmaceuticals Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / CrowdStrike Holdings Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc / Skillz Inc / UWM Holdings Corp / Playtika Holding Corp / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Japan / Netherlands / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Building & Building Materials / Healthcare / Info. Tech./Computers / Leisure & Entertainment / Media / Real Estate / Retailing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMD=US / DNLI=US / AX=US / XOMA=US / ACET=US / APLS=US / BLUE=US / ISEE=US / FUSN=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / COGT=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Advanced Micro Devices Inc / Denali Therapeutics Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/06/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 booster developments; 4Q20 & FY20 earnings</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 537</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - March 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0378331005 / US0382221051 / US1727551004 / US2254471012 / US4581401001 / US5370081045 / US5951121038 / US6821891057 / US7392761034 / US7475251036 / US8168501018 / US8610121027 / US8807701029 / US9021041085 / US91347P1057 / US9581021055 / US87157D1090 / US83088M1027 / US09062X1037 / US1572101053 / US0042251084 / US02043Q1076 / ACOR.OQ / US82706C1080 / NL0009538784 / NL0010273215 / US55405Y1001 / US69888T2078 / US0465131078 / US74736K1016 / US00653A1079 / US05464T1043 / US00773U1088 / US11135F1012 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Apple Inc / Applied Materials Inc / Cirrus Logic Inc / Wolfspeed Inc / Intel Corp / Littelfuse Inc / Micron Technology Inc / ON Semiconductor Corp / Power Integrations Inc / Qualcomm Inc / Semtech Corp / STMicroelectronics NV / Teradyne Inc / II-VI Inc / Universal Display Corp / Western Digital Corp / Synaptics Inc / Skyworks Solutions Inc / Biogen Inc / CEVA Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Silicon Motion Technology Corp / NXP Semiconductors NV / ASML Holding NV / MACOM Technology Solutions Holdings Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Qorvo Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Broadcom Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">EVAX=US / SNSE=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INSP=US / CMS=US / DGX=US / CRIS=US / AZN=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / BCRX=US / BMRN=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / GRTS=US / GEN=US / ICPT=US / PHG=US / LH=US / NBIX=US / PHAR=US / HOOK=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / CMPI=US / SLF=US / ONCR=US / BIIB=US / MRNA=US / ACAD=US / GOOG=US / INO=US / LHCG=US / SNSS=US / AGRX=US / CHNG=US / TPTX=US / ORTX=US / EHC=US / CLDX=US / CVAC=US / ADUS=US / ACHC=US / SRPT=US / PRTA=US / MRTX=US / GNCA=US / CTRE=US / EKTAY=US / CLRB=US / WBA=US / NVTA=US / EVH=US / MCRB=US / CFMS=US / LIVN=US / CERC=US / IONS=US / SSKN=US / VRAY=US / SYRS=US / MDGL=US / FLGT=US / IRTC=US / AVDL=US / SLNO=US / VREX=US / ATNX=US / NCNA=US / RCKT=US / FIXX=US / ARVN=US / MRKR=US / XFOR=US / TMDX=US / BCYC=US / NEXI=US / KRTX=US / DMTK=US / BNTX=US / RCEL=US / PNTG=US / NNOX=US / TSHA=US / VIRX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Sensei Biotherapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Curis Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Gritstone bio Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / HOOKIPA Pharma Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Checkmate Pharmaceuticals Inc / Sun Life Financial Inc / Oncorus Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Viracta Therapeutics Inc / Agile Therapeutics Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Encompass Health Corp / Celldex Therapeutics Inc / CureVac NV / Addus Homecare Corp / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Genocea Biosciences Inc / CareTrust REIT Inc / Elekta AB (publ) / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Seres Therapeutics Inc / Conformis Inc / LivaNova PLC / Avalo Therapeutics Inc / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / ViewRay Inc / Syros Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Avadel Pharmaceuticals PLC / Soleno Therapeutics Inc / Varex Imaging Corp / Athenex Inc / NuCana PLC / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Arvinas Inc / Marker Therapeutics Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Bicycle Therapeutics PLC / Neximmune Inc / Karuna Therapeutics Inc / DermTech Inc / BioNTech SE / AVITA Medical Inc / Pennant Group Inc / Nano-X Imaging Ltd / Taysha Gene Therapies Inc / Viracta Therapeutics Inc / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Share of 12% a New High; Teva's Gx Nuvaring Gaining Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">TEVA.TA / MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 2/26/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / A=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.OQ / AMGN.OQ / 4502.T / JNJ.N / LLY.N / MRK.N / AZN.L / SASY.PA / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Biogen Inc / Amgen Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / AstraZeneca PLC / Sanofi SA / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">4Q20 Model Update</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">45782T10 / 09062X103 / 24823R105 / 014442107</td><td class="leftalignment">INmune Bio Inc / Biogen Inc / Denali Therapeutics Inc / Alector Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Mr. Julian Harrison / Ms. Kaveri Pohlman</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Know the Ledge – Biggest Biotech Outflows So Far This Year</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">China-sourced PD1s coming to a market near you!</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X103 / 031162100 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Biogen Inc / Amgen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">2269.HK: Wuxi Biologics - Vir COVID neutrializing antibody trial failure expected to have limited rev impact to WuXi</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2269.HK / LLY.N / GSK.L / BIIB.OQ</td><td class="leftalignment">WuXi Biologics (Cayman) Inc / Eli Lilly and Co / GlaxoSmithKline PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BXP-US -  Dividend Quality Analysis, for the period ended January 28,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BXP / MSFT.O / BIIB.O / MAR.O / PTC.O / GOOGL.O</td><td class="leftalignment">Boston Properties Inc / Microsoft Corp / Biogen Inc / Marriott International Inc / PTC Inc / Alphabet Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Biogen profits hit by 32.1% fall; Institutional Ownership down 4%</td><td class="leftalignment">English</td><td class="rightalignment">75</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Biogen Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Third Vaccine EUA Should Expand Access, New Variant Boosters Developed, Domestic and Global Improvements Slowing</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">EVAX=US / SRCL=US / AAPL=US / MRK=US / BSX=US / PFE=US / AMGN=US / BMY=US / AMD=US / TSM=US / AZN=US / GSK=US / ETN=US / ANGN=US / ACI=US / AZO=US / BCRX=US / KMX=US / GRTS=US / ICPT=US / PHG=US / ORLY=US / PHAR=US / WSC=US / RHHBY=US / BIIB=US / MRNA=US / INO=US / AGRX=US / TPTX=US / PRPL=US / CVAC=US / AMRC=US / 2454-TW=US / PRTA=US / GNCA=US / IONS=US / MDGL=US / IRTC=US / UAA=US / AVDL=US / CVNA=US / CSPR=US / ATNX=US / ZM=US / TMDX=US / BNTX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Stericycle Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Advanced Micro Devices Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / GlaxoSmithKline PLC / Eaton Corporation PLC / Angion Biomedica Corp / Albertsons Companies Inc / Autozone Inc / BioCryst Pharmaceuticals Inc / Carmax Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / O'Reilly Automotive Inc / Pharming Group NV / Willscot Mobile Mini Holdings Corp / Roche Holding AG / Biogen Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Agile Therapeutics Inc / Turning Point Therapeutics Inc / Purple Innovation Inc / CureVac NV / Ameresco Inc / MediaTek Inc / Prothena Corporation PLC / Genocea Biosciences Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / Under Armour Inc / Avadel Pharmaceuticals PLC / Carvana Co / Casper Sleep Inc / Athenex Inc / Zoom Video Communications Inc / Transmedics Group Inc / BioNTech SE / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / Ireland / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Pharmaceuticals / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">CP.TO / EOG.N / NSC.N / SGC.L / STO.AX / BFb.N / PXD.N / CNQ.TO / GILD.O / INCY.O / FER.MC / ETN.N / CNR.TO / CSX.N / SU.TO / UNP.N / MRO.N / DVN.N / RRC.N / EQT.N / ADSK.O / EPD.N / NBIX.O / VTR.N / VRTX.O / SM.N / NET.N / COP.N / CNP.N / CPE.N / BLU.N / SWN.N / LNG.A / EFX.TO / BLUE.O / BCRX.O / ICPT.O / BIIB.O / SCL.TO / ACAD.O / RDSb.L / HICL.L / ATL.MI / PPL.TO / VMW.N / INO.OQ / CLW.N / TOU.TO / FRU.TO / PXT.TO / MTDR.N / AMCX.O / ACHC.O / VCRA.N / SPLK.OQ / SRPT.O / FANG.O / KPT.TO / PRGO.N / ENTA.O / BEP.N / KPTI.O / ITCI.O / QURE.O / VRNS.O / AGRX.O / 78667J108 / EVA.N / CIGI.O / GLPG.O / GBT.OQ / RGNX.O / ADVM.OQ / TWLO.N / AKERBP.OL / OKTA.OQ / CDEV.O / ESTE.N / GRPG.I / ATNX.O / ORSTED.CO / WELL.N / DBX.O / PRVB.O / ESTC.N / GMDA.OQ / ZM.O / KRTX.OQ / CRWD.O / DDOG.O / APA.OQ / JAMF.O / PLTR.N</td><td class="leftalignment">Canadian Pacific Railway Ltd / EOG Resources Inc / Norfolk Southern Corp / Stagecoach Group PLC / Santos Ltd / Brown-Forman Corp / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Incyte Corp / Ferrovial SA / Eaton Corporation PLC / Canadian National Railway Co / CSX Corp / Suncor Energy Inc / Union Pacific Corp / Marathon Oil Corp / Devon Energy Corp / Range Resources Corp / EQT Corp / Autodesk Inc / Enterprise Products Partners LP / Neurocrine Biosciences Inc / Ventas Inc / Vertex Pharmaceuticals Inc / SM Energy Co / Cloudflare Inc / Conocophillips / CenterPoint Energy Inc / Callon Petroleum Co / BELLUS Health Inc / Southwestern Energy Co / Cheniere Energy Inc / Enerflex Ltd / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Shawcor Ltd / ACADIA Pharmaceuticals Inc / Royal Dutch Shell PLC / HICL Infrastructure PLC / Atlantia SpA / Pembina Pipeline Corp / VMware Inc / Inovio Pharmaceuticals Inc / Clearwater Paper Corp / Tourmaline Oil Corp / Freehold Royalties Ltd / Parex Resources Inc / Matador Resources Co / AMC Networks Inc / Acadia Healthcare Company Inc / Vocera Communications Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / KP Tissue Inc / Perrigo Company PLC / Enanta Pharmaceuticals Inc / Brookfield Renewable Partners LP / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Uniqure NV / Varonis Systems Inc / Agile Therapeutics Inc / SAGE Therapeutics Inc / Enviva Inc / Colliers International Group Inc / Galapagos NV / Global Blood Therapeutics Inc / Regenxbio Inc / Adverum Biotechnologies Inc / Twilio Inc / Aker BP ASA / Okta Inc / Centennial Resource Development Inc / Earthstone Energy Inc / Greencoat Renewables PLC / Athenex Inc / Orsted A/S / Welltower Inc / Dropbox Inc / Provention Bio Inc / Elastic NV / Gamida Cell Ltd / Zoom Video Communications Inc / Karuna Therapeutics Inc / CrowdStrike Holdings Inc / Datadog Inc / APA Corp (US) / Jamf Holding Corp / Palantir Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Norway / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: February 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / APD.N / AXP.N / BA.N / BAC.N / BBY.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CMS.N / CRM.N / DAL.N / ED.N / EOG.N / FCX.N / FDX.N / GE.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MRK.N / NEM.N / OXY.N / PNW.N / SGEF.PA / SLB.N / T.N / TMO.N / U.N / WFC.N / WMT.N / AVB.N / EQR.N / SPG.N / PG.N / PXD.N / W.N / ETR.N / DUK.N / DHR.N / DIS.N / UNH.N / D.N / FE.N / URI.N / DE.N / PGR.N / CAT.N / MGM.N / KIM.N / GS.N / CLX.N / MCD.N / HON.N / VLO.N / HD.N / MRO.N / JWN.N / XRX.N / WEC.N / XOM.N / DVN.N / AMT.N / NKE.N / VZ.N / MUR.N / KSS.N / HRB.N / ORCL.N / LNC.N / HP.N / SRE.N / KMI.N / PWR.N / V.N / OKE.N / BXP.N / ACN.N / PLD.N / TWTR.N / AIV.N / LB.TO / CVX.N / FTI.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / REGN.OQ / ROL.N / RGLD.OQ / SIVB.OQ / TT.N / QDEL.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / COST.OQ / AMZN.OQ / ZBRA.OQ / NVDA.OQ / SBAC.OQ / EXPE.OQ / BLUE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / NXST.OQ / SBNY.OQ / VIAC.OQ / WAL.N / DISCA.OQ / CDNS.OQ / LYV.N / MS.N / TDG.N / HES.N / MA.N / SPR.N / M.N / TDC.N / TNDM.OQ / MRNA.OQ / SWI.N / AVGO.OQ / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / GNRC.N / TSLA.OQ / ADSGN.F / HHC.N / LPLA.OQ / MSI.N / MSP.N / SABR.OQ / HFC.N / HZNP.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / FANG.OQ / ABBV.N / WEX.N / COTY.N / MAR.OQ / ESRT.N / AAL.OQ / NCLH.N / GOOGL.OQ / HUBS.N / OUT.N / ETSY.OQ / PYPL.OQ / SQ.N / IAC.OQ / TWLO.N / TTD.OQ / UAA.N / PK.N / AYX.N / CVNA.N / ROKU.OQ / PEP.OQ / XEL.OQ / BKNG.OQ / ZS.OQ / FB.PS / UAL.OQ / LNT.OQ / CPRI.N / PINS.N / ZM.OQ / CRWD.OQ / SPCE.N / RTX.N / CARR.N / APA.OQ / LMND.N / AEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / American Express Co / Boeing Co / Bank of America Corp / Best Buy Co Inc / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / Delta Air Lines Inc / Consolidated Edison Inc / EOG Resources Inc / Freeport-McMoRan Inc / FedEx Corp / General Electric Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Merck & Co Inc / Newmont Corporation / Occidental Petroleum Corp / Pinnacle West Capital Corp / Vinci SA / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Avalonbay Communities Inc / Equity Residential / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Wayfair Inc / Entergy Corp / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / FirstEnergy Corp / United Rentals Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Kimco Realty Corp / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Marathon Oil Corp / Nordstrom Inc / Xerox Holdings Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Nike Inc / Verizon Communications Inc / Murphy Oil Corp / Kohls Corp / H & R Block Inc / Oracle Corp / Lincoln National Corp / Helmerich and Payne Inc / Sempra Energy / Kinder Morgan Inc / Quanta Services Inc / Visa Inc / ONEOK Inc / Boston Properties Inc / Accenture PLC / Prologis Inc / Twitter Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / Chevron Corp / TechnipFMC PLC / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Regeneron Pharmaceuticals Inc / Rollins Inc / Royal Gold Inc / SVB Financial Group / Trane Technologies PLC / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Costco Wholesale Corp / Amazon.com Inc / Zebra Technologies Corp / NVIDIA Corp / SBA Communications Corp / Expedia Group Inc / bluebird bio Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Nexstar Media Group Inc / Signature Bank / ViacomCBS Inc / Western Alliance Bancorp / Discovery Inc / Cadence Design Systems Inc / Live Nation Entertainment Inc / Morgan Stanley / TransDigm Group Inc / Hess Corp / Mastercard Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / SolarWinds Corp / Broadcom Inc / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / LPL Financial Holdings Inc / Motorola Solutions Inc / Datto Holding Corp / Sabre Corp / HollyFrontier Corp / Horizon Therapeutics PLC / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / WEX Inc / Coty Inc / Marriott International Inc / Empire State Realty Trust Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / HubSpot Inc / OUTFRONT Media Inc / ETSY Inc / PayPal Holdings Inc / Block Inc / IAC/Interactivecorp / Twilio Inc / Trade Desk Inc / Under Armour Inc / Park Hotels & Resorts Inc / Alteryx Inc / Carvana Co / Roku Inc / PepsiCo Inc / Xcel Energy Inc / Booking Holdings Inc / Zscaler Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Alliant Energy Corp / Capri Holdings Ltd / Pinterest Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / APA Corp (US) / Lemonade Inc / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Germany / France / United Kingdom / Ireland / Panama / Philippines / United States / Virgin Islands, British / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Looking Ahead to AD/PD-Epitope Matters</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PRTA=US / BMY=US / RHHBY=US / BIIB=US</td><td class="leftalignment">Prothena Corporation PLC / Bristol-Myers Squibb Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Biogen Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read & Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.O / INCY.O / NBIX.O / VRTX.O / BLU.N / BLUE.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / SRPT.O / ENTA.O / KPTI.O / ITCI.O / 78667J108 / GLPG.O / GBT.OQ / PRVB.O / GMDA.OQ / KRTX.OQ</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / bluebird bio Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc / Provention Bio Inc / Gamida Cell Ltd / Karuna Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD / Yinglu Zhang</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AWK / C / CNI / CP / DVN / EOG / JNJ / MGY / NSC / OLN / PVH / PXD / RKT / UNP / WLK / ASND.O / GILD.O / AMGN.O / SGMO.O / ARNA.O / ISRG.O / REGN.O / TSCO.O / CALA.O / BLUE.O / ICPT.O / BIIB.O / INFI.O / HALO.O / MRNA.O / ZIOP.O / ARCT.O / RGLS.O / FANG.O / MEIP.O / RNA.O / FATE.O / QURE.O / AGTC.O / AFMD.O / BLCM.O / TCON.O / ZBH / CYAD.O / GBT.O / VYGR.O / CSX.O / IONS.O / ADAP.O / EDIT.O / AGLE.O / NTLA.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / IOVA.O / CDLX.O / AVRO.O / AUTL.O / KZR.O / STRO.O / CPRI.K / TPTX.O / RTLR.O / MORF.O / BCSF.K / IMV.O / PGEN.O / GHLD.K / GRCL.O / 87975H100</td><td class="leftalignment">American Water Works Company Inc / Citigroup Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Devon Energy Corp / EOG Resources Inc / Johnson & Johnson / Magnolia Oil & Gas Corp / Norfolk Southern Corp / Olin Corp / PVH Corp / Pioneer Natural Resources Co / Rocket Companies Inc / Union Pacific Corp / Westlake Chemical Corp / Ascendis Pharma A/S / Gilead Sciences Inc / Amgen Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Tractor Supply Co / Calithera Biosciences Inc / bluebird bio Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Moderna Inc / ZIOPHARM Oncology Inc / Arcturus Therapeutics Holdings Inc / Regulus Therapeutics Inc / Diamondback Energy Inc / MEI Pharma Inc / Avidity Biosciences Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Affimed NV / Bellicum Pharmaceuticals Inc / TRACON Pharmaceuticals Inc / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Global Blood Therapeutics Inc / Voyager Therapeutics Inc / CSX Corp / Ionis Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Aeglea Bio Therapeutics Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Iovance Biotherapeutics Inc / Cardlytics Inc / AVROBIO Inc / Autolus Therapeutics PLC / Kezar Life Sciences Inc / Sutro Biopharma Inc / Capri Holdings Ltd / Turning Point Therapeutics Inc / Rattler Midstream LP / Morphic Holding Inc / Bain Capital Specialty Finance Inc / IMV Inc / Precigen Inc / Guild Holdings Co / Gracell Biotechnologies Inc / Telus International Cda Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Mar. 01, 2021 / 10:20AM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EDIT=US / MRNA=US / ADAP=US / MRK=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / DRRX=US / ISEE=US / GRTS=US / ICPT=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NK=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / VKTX=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / NTLA=US / ADVM=US / MDGL=US / CRSP=US / ALSEN=FR / 199800=KR / IVA=FR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / CWBR=US / NGM=US / KOD=US / AXLA=US / STOK=US / AKRO=US / NBSE=US / ETNB=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Editas Medicine Inc / Moderna Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / DURECT Corp / Iveric Bio Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Immunitybio Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Inventiva SA / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / CohBar Inc / NGM Biopharmaceuticals Inc / Kodiak Sciences Inc / Axcella Health Inc / Stoke Therapeutics Inc / Akero Therapeutics Inc / NeuBase Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Suspending Coverage: Biotechnology</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.O / BLCM.O / GILD.O / REGN.O / ICPT.O / BIIB.O / IMV.O</td><td class="leftalignment">Amgen Inc / Bellicum Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / IMV Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Mar 01 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMRN=US / OPEN=US / AAPL=US / DELL=US / IBM=US / GM=US / INTC=US / AMD=US / GBT=US / MSFT=US / MU=US / AMZN=US / QCOM=US / U=US / DNLI=US / NVDA=US / NTAP=US / BC=US / 7974=JP / UBI=FR / XLNX=US / TTWO=US / ATVI=US / IIVI=US / AX=US / XOMA=US / ACET=US / APLS=US / AZO=US / AVGO=US / BLUE=US / ISEE=US / FUSN=US / GPC=US / HEAR=US / ICPT=US / NBIX=US / ORLY=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / WDC=US / SAGE=US / LOGI=US / AAP=US / GME=US / ACOR=US / AMC=US / IMAX=US / SWKS=US / NFLX=US / ALPN=US / STX=US / IGMS=US / STRO=US / BIIB=US / TPX=US / APTX=US / COGT=US / SIMO=US / SCPL=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / 2454=US / NCMI=US / ALNA=US / CNK=US / LXRX=US / 2330=US / PRPL=US / VMW=US / 6758=US / IDRA=US / ASND=US / RCUS=US / OMER=US / TSLA=US / NXPI=US / PCRX=US / 981=US / BEAM=US / ZNGA=US / EA=US / RGLS=US / RTRX=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / GOOGL=US / AGTC=US / XENE=US / QRVO=US / CDTX=US / BPMC=US / ABUS=US / PSTG=US / ARGX=US / NVCR=US / HPE=US / CTMX=US / VYGR=US / KURA=US / NTLA=US / CLSD=US / SYRS=US / ALBO=US / OBSV=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / LQDA=US / ETTX=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CRSR=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US / PLTK=US</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Opendoor Technologies Inc / Apple Inc / Dell Technologies Inc / International Business Machines Corp / General Motors Co / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Unity Software Inc / Denali Therapeutics Inc / NVIDIA Corp / NetApp Inc / Brunswick Corp / Nintendo Co Ltd / Ubisoft Entertainment SA / Xilinx Inc / Take-Two Interactive Software Inc / Activision Blizzard Inc / II-VI Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Autozone Inc / Broadcom Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Genuine Parts Co / Turtle Beach Corp / Intercept Pharmaceuticals Inc / Neurocrine Biosciences Inc / O'Reilly Automotive Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / Western Digital Corp / SAGE Therapeutics Inc / Logitech International SA / Advance Auto Parts Inc / GameStop Corp / Acorda Therapeutics Inc / AMC Entertainment Holdings Inc / Imax Corp / Skyworks Solutions Inc / Netflix Inc / Alpine Immune Sciences Inc / Seagate Technology Holdings PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Tempur Sealy International Inc / Aptinyx Inc / Cogent Biosciences Inc / Silicon Motion Technology Corp / Sciplay Corp / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / MediaTek Inc / National Cinemedia Inc / Allena Pharmaceuticals Inc / Cinemark Holdings Inc / Lexicon Pharmaceuticals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Purple Innovation Inc / VMware Inc / Sony Group Corp / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Tesla Inc / NXP Semiconductors NV / Pacira Biosciences Inc / Semiconductor Manufacturing International Corp / Beam Therapeutics Inc / Zynga Inc / Electronic Arts Inc / Regulus Therapeutics Inc / Travere Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Alphabet Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / Pure Storage Inc / argenx SE / Novocure Ltd / Hewlett Packard Enterprise Co / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Syros Pharmaceuticals Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Liquidia Corp / Entasis Therapeutics Holdings Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Corsair Gaming Inc / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc / Playtika Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Netherlands / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Media / Pharmaceuticals / Retailing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AMD=US / DNLI=US / BC=US / AX=US / XOMA=US / ACET=US / APLS=US / BLUE=US / ISEE=US / FUSN=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / COGT=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Advanced Micro Devices Inc / Denali Therapeutics Inc / Brunswick Corp / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / China / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">DE0006231004 / US0116591092 / US0463531089 / US09058V1035 / US1101221083 / US2254471012 / US30231G1022 / US37733W1053 / US4781601046 / US5324571083 / US5370081045 / US66987V1098 / US6701002056 / US6821891057 / US7170811035 / US7392761034 / US7711951043 / US8308791024 / US8447411088 / US8610121027 / US9021041085 / US9311421039 / US1667641005 / US4771431016 / US4198791018 / US80105N1054 / US09062X1037 / US0042251084 / US02043Q1076 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US13100M5094 / NL0009538784 / US9100471096 / US00164V1035 / US00287Y1091 / US55405Y1001 / US8485771021 / US21240E1055 / US8086251076 / US02376R1023 / US70432V1026 / US69888T2078 / US0465131078 / CA0089118776 / US74736K1016 / US00653A1079 / US05464T1043 / US00773U1088 / SE0009414576 / US5904791358 / US0197701065 / US0144421072 / US09203E1055 / US26142R1041 / CH0499880968 / US30233G2093</td><td class="leftalignment">Infineon Technologies AG / Alaska Air Group Inc / AstraZeneca PLC / BioCryst Pharmaceuticals Inc / Bristol-Myers Squibb Co / Wolfspeed Inc / Exxon Mobil Corp / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Littelfuse Inc / Novartis AG / Novo Nordisk A/S / ON Semiconductor Corp / Pfizer Inc / Power Integrations Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / II-VI Inc / Walmart Inc / Chevron Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Calix Inc / NXP Semiconductors NV / United Airlines Holdings Inc / AMC Networks Inc / Abbvie Inc / MACOM Technology Solutions Holdings Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Science Applications International Corp / American Airlines Group Inc / Paycom Software Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Air Canada / Qorvo Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Oncopeptides AB / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / DraftKings Inc / ADC Therapeutics SA / EyePoint Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Wedbush Monthly Check-Up: March 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GBT=US / DNLI=US / APLS=US / BMRN=US / FUSN=US / ICPT=US / NBIX=US / PRTK=US / RARE=US / SWTX=US / UTHR=US / SAGE=US / ACOR=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / APTX=US / SURF=US / ALNA=US / LXRX=US / IDRA=US / RCUS=US / OMER=US / PCRX=US / RTRX=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / SYRS=US / ALBO=US / OBSV=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / REPL=US / AQST=US / LQDA=US / ETTX=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / STOK=US / BCEL=US / KRTX=US</td><td class="leftalignment">Global Blood Therapeutics Inc / Denali Therapeutics Inc / Apellis Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Fusion Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Acorda Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Aptinyx Inc / Surface Oncology Inc / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Travere Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Syros Pharmaceuticals Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Replimune Group Inc / Aquestive Therapeutics Inc / Liquidia Corp / Entasis Therapeutics Holdings Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Attacking Acute Organ Injury and Much More; Initiating at Buy and $100 PT</td><td class="leftalignment">English</td><td class="rightalignment">83</td><td class="leftalignment">ANGN.OQ / BIIB / 91307C102 / FGEN.OQ / 16383L106 / 00771V108 / ALPN.OQ / 140755109 / TFFP.OQ / 717224109 / 09075V102 / 00972D105</td><td class="leftalignment">Angion Biomedica Corp / Biogen Inc / United Therapeutics Corp / FibroGen Inc / ChemoCentryx Inc / Aerie Pharmaceuticals Inc / Alpine Immune Sciences Inc / Cara Therapeutics Inc / TFF Pharmaceuticals Inc / PhaseBio Pharmaceuticals Inc / BioNTech SE / Akebia Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Raghuram Selvaraju, Ph.D. / Boobalan Pachaiyappan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Biotechnology Monthly: The neuro paradigms, they are a-changin' in 2021?</td><td class="leftalignment">English</td><td class="rightalignment">163</td><td class="leftalignment">NBIX.OQ / US09062X1037 / ACAD.N / 78667J108 / G11196105 / 46116X101 / 09075P105 / 22053A107 / 20451W101</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / SAGE Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Intra-Cellular Therapies Inc / BioXcel Therapeutics Inc / Cortexyme Inc / Compass Pathways PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / China / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Canaccord Genui Research / Sumant Kulkarni / Michelle Gilson / Ms. Arlinda A. Lee, PHD / Mr. Edward H. Nash / Mr. John L. Newman, Ph.D., CFA, PHD / Jia Min, CFA / Benedict Shim</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen's Biotech Thermometer</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US0465131078 / US00653A1079 / US05464T1043 / US00773U1088 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">02/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine boosters; BEAM acquires GuideTx</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 536</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 37148K100 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 877619106 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Generation Bio Co / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">ICAD=US / LHCG=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / INCY=US / INSP=US / CMS=US / DGX=US / NVS=US / BWAY=US / SNN=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ARNA=US / ATRC=US / BDX=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ICPT=US / LH=US / NBIX=US / PHAR=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / SAGE=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / MD=US / NKTR=US / SLF=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / GOOG=US / DXCM=US / SNSS=US / CHNG=US / PODD=US / EHC=US / TNDM=US / ADUS=US / BLRX=US / ACHC=US / ALSN=US / ABBV=US / AGIO=US / FATE=US / AERI=US / MDWD=US / CTRE=US / AUPH=US / OTIC=US / EKTAY=US / VBLT=US / VCEL=US / NVRO=US / WBA=US / EVH=US / GKOS=US / TDOC=US / NVCR=US / VYGR=US / IONS=US / EDIT=US / NTLA=US / SRTS=US / TCMD=US / IRTC=US / IOVA=US / KALA=US / ATNX=US / RCKT=US / ALLO=US / TMDX=US / PSNL=US / KRTX=US / PNTG=US / ARQT=US / FBRX=US / FMTX=US / CZMWY=US / BIOVF=US / VPAHF=US</td><td class="leftalignment">ICAD Inc / LHC Group Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / Brainsway Ltd / Smith & Nephew PLC / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / SAGE Therapeutics Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Alphabet Inc / Dexcom Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Insulet Corp / Encompass Health Corp / Tandem Diabetes Care Inc / Addus Homecare Corp / BioLine RX Ltd / Acadia Healthcare Company Inc / Allison Transmission Holdings Inc / Abbvie Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Elekta AB (publ) / Vascular Biogenics Ltd / Vericel Corp / Nevro Corp / Walgreens Boots Alliance Inc / Evolent Health Inc / Glaukos Corp / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Sensus Healthcare Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Athenex Inc / Rocket Pharmaceuticals Inc / Allogene Therapeutics Inc / Transmedics Group Inc / Personalis Inc / Karuna Therapeutics Inc / Pennant Group Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Forma Therapeutics Holdings Inc / Carl Zeiss Meditec AG / Swedish Orphan Biovitrum AB (publ) / Volpara Health Technologies Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / New Zealand / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 2/19/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Feb 26 2021 6:42AM</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">APLS=US / VYGR=US / FISV=US / AAPL=US / MSFT=US / AMZN=US / BBY=US / DNLI=US / CRM=US / V=US / VRM=US / ADS=US / W=US / NBIX=US / PZZA=US / RKT=US / SHOP=US / UFPI=US / FOUR=US / GPN=US / PYPL=US / FB=US / FND=US / EVOP=US / BIIB=US / DPZ=US / FIS=US / MA=US / VMW=US / SEAS=US / NCLH=US / FATE=US / MGNX=US / GOOGL=US / SHAK=US / ETSY=US / NVCR=US / ZS=US / SQ=US / ANAB=US / CVNA=US / SAIL=US / IIIV=US / RPAY=US / NKLA=US / ABNB=US / PLTK=US</td><td class="leftalignment">Apellis Pharmaceuticals Inc / Voyager Therapeutics Inc / Fiserv Inc / Apple Inc / Microsoft Corp / Amazon.com Inc / Best Buy Co Inc / Denali Therapeutics Inc / Salesforce.Com Inc / Visa Inc / Vroom Inc / Alliance Data Systems Corp / Wayfair Inc / Neurocrine Biosciences Inc / Papa John's International Inc / Rocket Companies Inc / Shopify Inc / Ufp Industries Inc / Shift4 Payments Inc / Global Payments Inc / PayPal Holdings Inc / Meta Platforms Inc / Floor & Decor Holdings Inc / EVO Payments Inc / Biogen Inc / Domino's Pizza Inc / Fidelity National Information Services Inc / Mastercard Inc / VMware Inc / SeaWorld Entertainment Inc / Norwegian Cruise Line Holdings Ltd / Fate Therapeutics Inc / MacroGenics Inc / Alphabet Inc / Shake Shack Inc / ETSY Inc / Novocure Ltd / Zscaler Inc / Block Inc / AnaptysBio Inc / Carvana Co / SailPoint Technologies Holdings Inc / I3 Verticals Inc / Repay Holdings Corp / Nikola Corp / Airbnb Inc / Playtika Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States / Jersey</td><td class="leftalignment">Biotechnology / Building & Building Materials / Consumer / Electronics / Financial Services / Household Products / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Real Estate / Retailing</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">DNL310 Remains In Focus, But Pipeline Shouldn't Be Overlooked</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">DNLI=US / BIIB=US</td><td class="leftalignment">Denali Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Denali Pushes the Pedal on TV Platform—Our Insights on the ATV:TREM2 program; Reit Buy and Raising PT to $95</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">24823R105 / BIIB</td><td class="leftalignment">Denali Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MUTUAL FUNDS / TRUSTS RESEARCH</td><td class="leftalignment">Andrew S. Fein / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">4Q20 - Aducanumab Still Front and Center</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">24823R105 / 09062X103</td><td class="leftalignment">Denali Therapeutics Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Mr. Julian Harrison / Ms. Kaveri Pohlman</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ICAD.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BIIB.OQ / ACAD.OQ / MNKD.OQ / MSB.AX / EBS.N / SPRO.OQ / OMER.OQ / ARDX.OQ / ACRX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / FATE.OQ / AUP.TO / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / TDOC.N / SPNE.OQ / GBT.OQ / ACRS.OQ / DRIO.OQ / TVTY.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / RCUS.N / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / ICAD Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / Biogen Inc / ACADIA Pharmaceuticals Inc / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Teladoc Health Inc / SeaSpine Holdings Corp / Global Blood Therapeutics Inc / Aclaris Therapeutics Inc / DarioHealth Corp / Tivity Health Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / Arcus Biosciences Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Consumer / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Biotech Inflows Continue – At Least For Now</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMED=US / SPXC=US / AAPL=US / BSX=US / PFE=US / AMGN=US / COST=US / INTC=US / AMD=US / GBT=US / MSFT=US / MDT=US / QCOM=US / T=US / INCY=US / TXN=US / NVDA=US / CHTR=US / NVS=US / VZ=US / SMTC=US / TSM=US / EXPE=US / CTXS=US / CMCSA=US / UNH=US / AVGO=US / CHE=US / HEAR=US / ITRI=US / Z=US / SAGE=US / CCRN=US / BKNG=US / ACA=US / HPQ=US / CLH=US / BIIB=US / ALNY=US / GOOG=US / ORA=US / DXCM=US / PODD=US / VMW=US / TNDM=US / CDXC=US / 005930-KR=US / CHWY=US / MSCI=US / NXPI=US / 2454-TW=US / TMUS=US / FATE=US / AUPH=US / LOVE=US / NVRO=US / ETSY=US / TDOC=US / HPE=US / IONS=US / NTNX=US / RDFN=US / CWEN=US / ESTC=US / FVRR=US / XPEV=US / ABNB=US / BIOVF=US</td><td class="leftalignment">Amedisys Inc / SPX Corp / Apple Inc / Boston Scientific Corp / Pfizer Inc / Amgen Inc / Costco Wholesale Corp / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Medtronic PLC / Qualcomm Inc / AT&T Inc / Incyte Corp / Texas Instruments Inc / NVIDIA Corp / Charter Communications Inc / Novartis AG / Verizon Communications Inc / Semtech Corp / Taiwan Semiconductor Manufacturing Co Ltd / Expedia Group Inc / Citrix Systems Inc / Comcast Corp / UnitedHealth Group Inc / Broadcom Inc / Chemed Corp / Turtle Beach Corp / Itron Inc / Zillow Group Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Arcosa Inc / HP Inc / Clean Harbors Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Ormat Technologies Inc / Dexcom Inc / Insulet Corp / VMware Inc / Tandem Diabetes Care Inc / Chromadex Corp / Farfetch Ltd / Chewy Inc / MSCI Inc / NXP Semiconductors NV / MediaTek Inc / T-Mobile US Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Lovesac Co / Nevro Corp / ETSY Inc / Teladoc Health Inc / Hewlett Packard Enterprise Co / Ionis Pharmaceuticals Inc / Nutanix Inc / Redfin Corp / Clearway Energy Inc / Elastic NV / Fiverr International Ltd / Xpeng Inc / Airbnb Inc / Swedish Orphan Biovitrum AB (publ)</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / Sweden / Taiwan / United States</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Machinery / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Refocus-and-Extend Thesis Plays Out in 2021 Guidance; Looking to ENaC Data at ATS</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">IONS=US / PFE=US / NVS=US / BIIB=US / ALNY=US / BIOVF=US</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Pfizer Inc / Novartis AG / Biogen Inc / Alnylam Pharmaceuticals Inc / Swedish Orphan Biovitrum AB (publ)</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Sweden / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">2021 Poised as a Year of Readouts in Uneventful 4Q Call; Reiterate Buy, PT to $86</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">78667J108 / BIIB</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Douglas D. Tsao</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / 4502.T / JNJ.N / PFE.N / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Pfizer Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / AERI.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / BDSI.OQ / BIIB.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / NEOS.BO / OMER.OQ / ARDX.OQ / ACRX.OQ / AMRN.NS / ZTS.N / ANIP.OQ / AXGN.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / Aerie Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / BioDelivery Sciences International Inc / Biogen Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Neo Corp International Ltd / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / ADF Foods Ltd / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Veru Inc / TherapeuticsMD Inc / Evolus Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / France / United Kingdom / India / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q Update Highlights Multiple Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SAGE=US / BIIB=US</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AN=US / MCD=US / RRC=US / WEN=US / MDT=US / BLD=US / PEB=US / PXD=US / ENR=US / FMS=US / DIOD=US / MAR=US / MRO=US / VMC=US / TOL=US / MLM=US / ATRO=US / CBRL=US / CENT=US / CSGP=US / DRI=US / EPC=US / ABG=US / HEI=US / SMG=US / SNAP=US / THO=US / WGO=US / PYPL=US / FB=US / JAZZ=US / PRA=US / SPR=US / WRE=US / DIN=US / BCO=US / BIIB=US / HURN=US / PLAY=US / DENN=US / XM=US / CMG=US / ELF=US / AWI=US / TAST=US / CWH=US / EPRT=US / JACK=US / AAN=US / MTDR=US / FANG=US / ABBV=US / NDLS=US / LDOS=US / CEQP=US / VNOM=US / LOCO=US / SHAK=US / SUM=US / BWXT=US / WING=US / ACBI=US / SQ=US / CDEV=US / TRHC=US / FRTA=US / EOLS=US / EQH=US / GMAB=US / BALY=US / VTRS=US</td><td class="leftalignment">AutoNation Inc / McDonald's Corp / Range Resources Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Pebblebrook Hotel Trust / Pioneer Natural Resources Co / Energizer Holdings Inc / Fresenius Medical Care AG & Co KGaA / Diodes Inc / Marriott International Inc / Marathon Oil Corp / Vulcan Materials Co / Toll Brothers Inc / Martin Marietta Materials Inc / Astronics Corp / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / CoStar Group Inc / Darden Restaurants Inc / Edgewell Personal Care Co / Asbury Automotive Group Inc / HEICO Corp / Scotts Miracle-Gro Co / Snap Inc / Thor Industries Inc / Winnebago Industries Inc / PayPal Holdings Inc / Meta Platforms Inc / Jazz Pharmaceuticals PLC / ProAssurance Corp / Spirit AeroSystems Holdings Inc / Washington Real Estate Investment Trust / Dine Brands Global Inc / Brinks Co / Biogen Inc / Huron Consulting Group Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Qualtrics International Inc / Chipotle Mexican Grill Inc / elf Beauty Inc / Armstrong World Industries Inc / Carrols Restaurant Group Inc / Camping World Holdings Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Aaron's Company Inc / Matador Resources Co / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / Leidos Holdings Inc / Crestwood Equity Partners LP / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Summit Materials Inc / BWX Technologies Inc / Wingstop Inc / Atlantic Capital Bancshares Inc / Block Inc / Centennial Resource Development Inc / Tabula Rasa HealthCare Inc / Forterra Inc / Evolus Inc / Equitable Holdings Inc / Genmab A/S / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Continued stability for Large Cap, Some SMid sequentially lower</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / REGN.OQ / NVAX.OQ / HSTM.OQ / BIIB.OQ / CLDX.OQ / AXGN.OQ / PRQR.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novavax Inc / HealthStream Inc / Biogen Inc / Celldex Therapeutics Inc / AxoGen Inc / ProQR Therapeutics NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Not much new from the Q&A at Global Alzheimer's Platform</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Feb. 23, 2021 / 2:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">February 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">09062X103 / 031162100 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Biogen Inc / Amgen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Trends Continue to Improve as Vaccine Rollout Progresses and Real-World Data Supports Efficacy, Safety of Vaccines</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">FDA Alignment With Phase 3 Strategy Clears the Pivotal Pathway for Simufilam; Reiterate Buy and Raise PT to $97</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">14817C107 / BIIB</td><td class="leftalignment">Cassava Sciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Vernon T. Bernardino</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3621</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Where We Think The Stock Could Trade On TRAILBLAZER Data At AD/PD And Key AD Updates Expected In The Next 12-18 Months</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / BIIB.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Biogen profits hit by 32.1% fall; Institutional Ownership down 4%</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">V / 0989529 / 2000019 / 2496113 / 2293819 / 2008154 / 2973821 / 2050832 / 2026242 / 2045623 / 2219224 / 2206657 / 2216850 / 2208073 / 2280220 / 2270726 / 2542049 / 2100920 / 2455965 / 2459202 / 2613990 / 2471950 / 2680905 / 2730190 / 2829601 / 7123870 / B00FWN1 / B121557 / B1Y9TB3 / B125XQ6 / B2R3PV1 / 2679204 / 2949758 / B7TL820 / B87ZMX0 / BFZCHN7 / B95WG16 / BVVN4Q8 / BYVY8G0 / BF4VBS8 / BXDZ9Z0 / BYNZGK1 / BJLT387 / BJ2Z0H2 / BZ8VJQ8 / BP3YM85 / BL95N25 / BZ1LFG7 / BKS3RS7 / BKT6B38 / BMDCDP2 / BMDJ085</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Amazon.com Inc / Kohls Corp / eBay Inc / Adobe Inc / Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / ANSYS Inc / CMS Energy Corp / Coca-Cola Co / Consolidated Edison Inc / Copart Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / FirstEnergy Corp / Biogen Inc / IDEXX Laboratories Inc / Illumina Inc / Incyte Corp / PPL Corp / Regeneron Pharmaceuticals Inc / Southern Co / Nestle SA / Alnylam Pharmaceuticals Inc / Mastercard Inc / Danone SA / Portland General Electric Co / American Water Works Company Inc / Align Technology Inc / Nexstar Media Group Inc / Meta Platforms Inc / Palo Alto Networks Inc / Wix.Com Ltd / Zoetis Inc / Eversource Energy / Alphabet Inc / BioXcel Therapeutics Inc / Shopify Inc / Block Inc / Avantor Inc / Pinterest Inc / Vistra Corp / Trupanion Inc / Phibro Animal Health Corp / Roku Inc / 10X Genomics Inc / SmileDirectClub Inc / Bigcommerce Holdings Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: CTP2021-ALSEN, MGTX, SIGHT; LentiGlobin BLUEs</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">MGTX.OQ / SIGHT.PA / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">MeiraGTx Holdings PLC / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 2.21.21</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">ADAP=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / TMO=US / MDT=US / A=US / INCY=US / INSP=US / TEVA=US / GILD=US / MOR=DE / SAN=FR / GSK=GB / SYK=US / BAX=US / AZN=US / WAT=US / JNJ=US / MDRX=US / IMGN=US / NUAN=US / ABMD=US / ALKS=US / ALC=US / AMRN=US / ARNA=US / ATRC=US / BDX=US / BMRN=US / BLUE=US / CSTL=US / CALA=US / CERN=US / CNMD=US / EW=US / ENDP=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / INGN=US / ISRG=US / MYGN=US / NBIX=US / PRGO=US / PRTK=US / RARE=US / HOOK=US / REGN=US / RGEN=US / SENS=US / SIEN=US / SILK=US / TECH=US / TFX=US / VRTX=US / ALGN=US / SGEN=US / SAGE=US / OPT=US / PRVB=US / CGEN=US / ALVR=US / JAZZ=US / PHR=US / STSA=US / RNA=US / IMTX=US / MREO=US / NTRA=US / CPSI=US / NKTR=US / MRNS=US / AMTI=US / BIIB=US / ACRS=US / ARWR=US / APTX=US / NUVA=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / COGT=US / DXCM=US / CYRX=US / CBAY=US / GRAY=US / EQ=US / QTRX=US / AVRO=US / TPTX=US / AMRX=US / FOLD=US / PODD=US / TNDM=US / IFRX=US / ITRM=US / NXGN=US / FULC=US / LUN=US / ASND=US / AVEO=US / NEO=US / RCUS=US / MOLN / CTSO=US / ZGNX=US / PCRX=US / RGNX=US / CLVS=US / PBYI=US / AXGN=US / VCRA=US / CCXI=US / FGEN=US / SRPT=US / GMED=US / ABBV=US / EPZM=US / MRTX=US / AGIO=US / PINC=US / FATE=US / MGNX=US / VEEV=US / VCYT=US / KPTI=US / OM=US / ITCI=US / XNCR=US / HRTX=US / QURE=US / GNCA=US / TBPH=US / ARDX=US / RDUS=US / MASS=US / XENT=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / AFMD=US / GNFT=US / DBVT=US / VCEL=US / XENE=US / NVRO=US / NVTA=US / RLMD=US / VKTX=US / BPMC=US / HTGM=US / ZBH=US / ABEO=US / TDOC=US / KURA=US / WVE=US / AXSM=US / IONS=US / BGNE=US / NTLA=US / ADVM=US / RETA=US / MDGL=US / PTGX=US / ACIU=US / TRHC=US / MYOV=US / ZYME=US / AVDL=US / OBSV=US / RCM=US / BHVN=US / MRSN=US / KALV=US / ATNX=US / SYBX=US / ZLAB=US / DCPH=US / SCPH=US / SLDB=US / GH=US / RCKT=US / EOLS=US / XERS=US / REPL=US / RUBY=US / CRNX=US / ALLK=US / SBTX=US / TWST=US / AXNX=US / MLND=US / OSMT=US / ORGO=US / HARP=US / GOSS=US / TCRR=US / IMUX=US / AXLA=US / BBIO=US / HCAT=US / BNTX=US / GMAB=US / IPHA=US / ETNB=US / PGNY=US / CNTG=US / IMVT=US / ONEM=US / RVMD=US / IMRA=US / ZNTL=US / KROS=US / FMTX=US / ACCD=US / ITOS=US / KDNY=US / GDRX=US / SPRB=US / SIOX=US / VTRS=US / ABCM=US / GLTO=US / TVTX=US / ABCL=US / KNTE=US / ELDN=US / PRTC=US / CGEM=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Incyte Corp / Inspire Medical Systems Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / MorphoSys AG / Sanofi SA / GlaxoSmithKline PLC / Stryker Corp / Baxter International Inc / AstraZeneca PLC / Waters Corp / Johnson & Johnson / Allscripts Healthcare Solutions Inc / ImmunoGen Inc / Nuance Communications Inc / ABIOMED Inc / Alkermes Plc / Alcon AG / Amarin Corporation PLC / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / Biomarin Pharmaceutical Inc / bluebird bio Inc / Castle Biosciences Inc / Calithera Biosciences Inc / Cerner Corp / Conmed Corp / Edwards Lifesciences Corp / Endo International PLC / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Inogen Inc / Intuitive Surgical Inc / Myriad Genetics Inc / Neurocrine Biosciences Inc / Perrigo Company PLC / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Senseonics Holdings Inc / Sientra Inc / Silk Road Medical Inc / Bio-Techne Corp / Teleflex Inc / Vertex Pharmaceuticals Inc / Align Technology Inc / Seagen Inc / SAGE Therapeutics Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Allovir Inc / Jazz Pharmaceuticals PLC / Phreesia Inc / Satsuma Pharmaceuticals Inc / Avidity Biosciences Inc / Immatics NV / Mereo Biopharma Group PLC / Natera Inc / Computer Programs and Systems Inc / Nektar Therapeutics / Marinus Pharmaceuticals Inc / Applied Molecular Transport Inc. / Biogen Inc / Aclaris Therapeutics Inc / Arrowhead Pharmaceuticals Inc / Aptinyx Inc / NuVasive Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Cogent Biosciences Inc / Dexcom Inc / Cryoport Inc / Cymabay Therapeutics Inc / Graybug Vision Inc / Equillium Inc / Quanterix Corp / AVROBIO Inc / Turning Point Therapeutics Inc / Amneal Pharmaceuticals Inc / Amicus Therapeutics Inc / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Iterum Therapeutics PLC / NextGen Healthcare Inc / Fulcrum Therapeutics Inc / H Lundbeck A/S / Ascendis Pharma A/S / Aveo Pharmaceuticals Inc / Neogenomics Inc / Arcus Biosciences Inc / Molecular Partners AG / Cytosorbents Corp / Zogenix Inc / Pacira Biosciences Inc / Regenxbio Inc / Clovis Oncology Inc / Puma Biotechnology Inc / AxoGen Inc / Vocera Communications Inc / ChemoCentryx Inc / FibroGen Inc / Sarepta Therapeutics Inc / Globus Medical Inc / Abbvie Inc / Epizyme Inc / Mirati Therapeutics Inc / Agios Pharmaceuticals Inc / Premier Inc / Fate Therapeutics Inc / MacroGenics Inc / Veeva Systems Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Intra-Cellular Therapies Inc / Xencor Inc / Heron Therapeutics Inc / Uniqure NV / Genocea Biosciences Inc / Theravance Biopharma Inc / Ardelyx Inc / Radius Health Inc / 908 Devices Inc. / Intersect Ent Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Affimed NV / Genfit SA / DBV Technologies SA / Vericel Corp / Xenon Pharmaceuticals Inc / Nevro Corp / Invitae Corp / Relmada Therapeutics Inc / Viking Therapeutics Inc / Blueprint Medicines Corp / HTG Molecular Diagnostics Inc / Zimmer Biomet Holdings Inc / Abeona Therapeutics Inc / Teladoc Health Inc / Kura Oncology Inc / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Reata Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Protagonist Therapeutics Inc / AC Immune SA / Tabula Rasa HealthCare Inc / Myovant Sciences Ltd / Zymeworks Inc / Avadel Pharmaceuticals PLC / Obseva SA / R1 RCM Inc / Biohaven Pharmaceutical Holding Company Ltd / Mersana Therapeutics Inc / Kalvista Pharmaceuticals Inc / Athenex Inc / Synlogic Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / scPharmaceuticals Inc / Solid Biosciences Inc / Guardant Health Inc / Rocket Pharmaceuticals Inc / Evolus Inc / Xeris Biopharma Holdings Inc / Replimune Group Inc / Rubius Therapeutics Inc / Crinetics Pharmaceuticals Inc / Allakos Inc / Silverback Therapeutics Inc / Twist Bioscience Corp / Axonics Inc / Tempest Therapeutics Inc / Osmotica Pharmaceuticals PLC / Organogenesis Holdings Inc / Harpoon Therapeutics Inc / Gossamer Bio Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / BridgeBio Pharma Inc / Health Catalyst Inc / BioNTech SE / Genmab A/S / Innate Pharma SA / 89Bio Inc / Progyny Inc / Centogene NV / Immunovant Inc / 1Life Healthcare Inc / Revolution Medicines Inc / Imara Inc / Zentalis Pharmaceuticals Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Accolade Inc / Iteos Therapeutics Inc / Chinook Therapeutics Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Sio Gene Therapies Inc / Viatris Inc / Abcam PLC / Galecto Inc / Travere Therapeutics Inc / Abcellera Biologics Inc / Kinnate Biopharma Inc / Eledon Pharmaceuticals Inc / PureTech Health PLC / Cullinan Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AMD=US / GBT=US / U=US / DNLI=US / AX=US / XOMA=US / ACET=US / APLS=US / BMRN=US / BLUE=US / ISEE=US / FUSN=US / ICPT=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / COGT=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / VRNA=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Unity Software Inc / Denali Therapeutics Inc / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Verona Pharma PLC / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Biogen profits hit by 32.1% fall; Institutional Ownership down 4%</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : Model Update</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / Mr. Matthew T. Holt, P.Eng / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Post-4Q20 Model Sweep: ALXN, BIIB, REGN</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">2455965 / 2730190</td><td class="leftalignment">Biogen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Maintains 10% Share; Gx Vascepa Back to 10% Bottle Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Ownership Timelines & Shareholder Analytics (February 2021)</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 535</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 2/12/21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Dominating MS, While Hoping To Expand Elsewhere</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">NBIX.OQ / VRTX.OQ / PFE.N / AZN.L / ROG.S / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues - Website Introduction Slides</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Back in Black; Biotech Inflows Return</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Biogen Inc.(BIIB) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended February 16,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">U.S./Global Declines Continue as Vaccine Rollout Progresses; Big Pharma’s Fourth-Quarter Earnings Review the Year That Was</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ / BSLN.S / IBIO.A / ABEO.OQ / ORTX.OQ / PHGE.A / ARQT.OQ</td><td class="leftalignment">Biogen Inc / Basilea Pharmaceutica AG / Ibio Inc / Abeona Therapeutics Inc / Orchard Therapeutics PLC / Biomx Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">There's More to BIIB than Aducanumab, but We Still View Pipeline as High Risk/High Reward</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Catalysts in 2021 and beyond for our biotechnology coverage: February 2021 edition</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">NBIX.OQ / US09062X1037 / ACAD.N / 78667J108 / G11196105 / 98986X109 / 46116X101 / 92915B106 / 918385105 / 09075P105 / 22053A107 / 20451W101</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / SAGE Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Zynerba Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Voyager Therapeutics Inc / vTv Therapeutics Inc / BioXcel Therapeutics Inc / Cortexyme Inc / Compass Pathways PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Sumant Kulkarni / Jia Min, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Annual Update - Biogen down 5.8% from 3 week high</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALSEN=FR / MGTX=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / REPL=US / KOD=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Sensorion SA / MeiraGTx Holdings PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / Replimune Group Inc / Kodiak Sciences Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">HD=US / AMD=US / U=US / DNLI=US / BC=US / AX=US / XOMA=US / ACET=US / APLS=US / BLUE=US / ISEE=US / FUSN=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / COGT=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / CRVS=US / NTLA=US / CLSD=US / ALBO=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Home Depot Inc / Advanced Micro Devices Inc / Unity Software Inc / Denali Therapeutics Inc / Brunswick Corp / Axos Financial Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Cogent Biosciences Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Corvus Pharmaceuticals Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2020 Was an Excellent Vintage for Biopharma IPO Returns, No Slowdown Yet in '21</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">MRK=US / TEVA=US / GILD=US / AZN=US / BMRN=US / OPT=US / ALVR=US / RNA=US / SNY=US / AMTI=US / BIIB=US / GRAY=US / LUN=US / SBTX=US / BNTX=US / RVMD=US / IMRA=US / ZNTL=US / KROS=US / FMTX=US / ITOS=US / SPRB=US / GLTO=US / ABCL=US / KNTE=US</td><td class="leftalignment">Merck & Co Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / AstraZeneca PLC / Biomarin Pharmaceutical Inc / Opthea Ltd / Allovir Inc / Avidity Biosciences Inc / Sanofi SA / Applied Molecular Transport Inc. / Biogen Inc / Graybug Vision Inc / H Lundbeck A/S / Silverback Therapeutics Inc / BioNTech SE / Revolution Medicines Inc / Imara Inc / Zentalis Pharmaceuticals Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Iteos Therapeutics Inc / Spruce Biosciences Inc / Galecto Inc / Abcellera Biologics Inc / Kinnate Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">2126335 / 2516152 / 2023607 / 2778844 / 2026242 / 2111955 / 2280220 / 2270726 / 2542049 / 2576941 / 2100920 / 2455965 / 2457864 / 2459020 / 2048804 / 2730190 / 2402121 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / B76LYJ2 / BFH3N85 / BYY8XK8 / BP4GNK9 / BYW36M8 / BFZNYB7 / BD9GVY0 / BDHF4K6 / BZBY005 / BKS3SM8 / BQT3XY6 / BZ1HM42 / BR4T3B3 / BMQ5T49 / BWFKZT2 / BZ8VJQ8 / BKTNTR9 / BK6N347 / BJXBP30 / BYQHPK7 / BJ9NFQ3 / BK71LY6 / BM8MM05 / BP8XZL1</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Borgwarner Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / FirstEnergy Corp / Biogen Inc / ImmunoGen Inc / Intuit Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Nuance Communications Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Vocera Communications Inc / Veeva Systems Inc / WEC Energy Group Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Merus NV / IGM Biosciences Inc / Cyberark Software Ltd / Adyen NV / HubSpot Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Vistra Corp / ViacomCBS Inc / Uber Technologies Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Neoleukin Therapeutics Inc / WW International Inc / Madison Square Garden Entertainment Corp / Healthequity Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gvoke Back Above 10% Mkt Share; Viatris' Gx Advair Share Steady</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">VTRS.OQ / MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Viatris Inc / Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Ex vivo GT sees positive readouts</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 534</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">BNGO=US / INO=US / AAPL=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / BMY=US / MDT=US / WMT=US / INCY=US / EPIX=US / CMS=US / DGX=US / NVS=US / AZN=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXEL=US / GEN=US / LH=US / NVAX=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / VRTX=US / SGEN=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / SNY=US / MD=US / SLF=US / BIIB=US / ISR=US / MRNA=US / ALNY=US / GOOG=US / DXCM=US / LHCG=US / CHNG=US / INFI=US / ORTX=US / EHC=US / BAYRY=US / SPRO=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / ARCT=US / ABBV=US / PRTA=US / ENTA=US / CTRE=US / WBA=US / NVTA=US / EVH=US / ZBH=US / IONS=US / EDIT=US / AVDL=US / MTEM=US / VERU=US / GMDA=US / NBSE=US / FREQ=US / RCEL=US / PNTG=US / TSHA=US / SIOX=US</td><td class="leftalignment">Bionano Genomics Inc / Inovio Pharmaceuticals Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exelixis Inc / Genesis Healthcare Inc / Laboratory Corporation of America Holdings / Novavax Inc / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / Sanofi SA / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / IsoRay Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Dexcom Inc / LHC Group Inc / Change Healthcare Inc / Infinity Pharmaceuticals Inc / Orchard Therapeutics PLC / Encompass Health Corp / Bayer AG / Spero Therapeutics Inc / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Arcturus Therapeutics Holdings Inc / Abbvie Inc / Prothena Corporation PLC / Enanta Pharmaceuticals Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Zimmer Biomet Holdings Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Avadel Pharmaceuticals PLC / Molecular Templates Inc / Veru Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Frequency Therapeutics Inc / AVITA Medical Inc / Pennant Group Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">DNL310 WORLD Data - Just Better. Wide Implications for Other Programs</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">24823R105 / 09062X103 / 014442107</td><td class="leftalignment">Denali Therapeutics Inc / Biogen Inc / Alector Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Mr. Julian Harrison / Ms. Kaveri Pohlman</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 2/5/21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">INO=US / TWOU=US / AAPL=US / MRK=US / WSM=US / NKE=US / PFE=US / BMY=US / HD=US / INTC=US / ADI=US / AMD=US / BWA=US / MSFT=US / AMZN=US / QCOM=US / BBY=US / TXN=US / EPIX=US / MPWR=US / NVS=US / SMTC=US / LOW=US / TSM=US / AZN=US / CRY=US / XLNX=US / EXPE=US / JNJ=US / UNH=US / ARCC=US / AVGO=US / BL=US / CRUS=US / IFX=US / FROG=US / MCHP=US / NVAX=US / REGN=US / TSCO=US / UTHR=US / VCTR=US / WTS=US / SGEN=US / RHHBY=US / PYPL=US / SWKS=US / ARES=US / DKS=US / BIIB=US / MRNA=US / ALNY=US / ENS=US / GOOG=US / BJRI=US / PBH=US / DXCM=US / XPO=US / LULU=US / GNRC=US / MXL=US / NXPI=US / ARCT=US / PRTA=US / VRNS=US / GDDY=US / UAA=US / CARG=US / DDOG=US / RCEL=US / SIOX=US</td><td class="leftalignment">Inovio Pharmaceuticals Inc / 2U Inc / Apple Inc / Merck & Co Inc / Williams-Sonoma Inc / Nike Inc / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Borgwarner Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / Best Buy Co Inc / Texas Instruments Inc / ESSA Pharma Inc / Monolithic Power Systems Inc / Novartis AG / Semtech Corp / Lowe's Companies Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / CryoLife Inc / Xilinx Inc / Expedia Group Inc / Johnson & Johnson / UnitedHealth Group Inc / Ares Capital Corp / Broadcom Inc / Blackline Inc / Cirrus Logic Inc / Infineon Technologies AG / Jfrog Ltd / Microchip Technology Inc / Novavax Inc / Regeneron Pharmaceuticals Inc / Tractor Supply Co / United Therapeutics Corp / Victory Capital Holdings Inc / Watts Water Technologies Inc / Seagen Inc / Roche Holding AG / PayPal Holdings Inc / Skyworks Solutions Inc / Ares Management Corp / DICK'S Sporting Goods Inc / Biogen Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / EnerSys / Alphabet Inc / BJ's Restaurants Inc / Prestige Consumer Healthcare Inc / Dexcom Inc / XPO Logistics Inc / Lululemon Athletica Inc / Generac Holdings Inc / Maxlinear Inc / NXP Semiconductors NV / Arcturus Therapeutics Holdings Inc / Prothena Corporation PLC / Varonis Systems Inc / GoDaddy Inc / Under Armour Inc / CarGurus Inc / Datadog Inc / AVITA Medical Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">CCK.N / EDP.LS / ELE.MC / FMC.N / IBE.MC / IP.N / RWEG.DE / T.TO / PEP.N / PXD.N / CFP.TO / GILD.O / INCY.O / FER.MC / BWA.N / REE.MC / MFC.TO / AEM.N / STZ.N / AMP.N / CINF.O / DVA.N / TJX.N / ROST.O / SAM.N / VRTX.O / NET.N / SLF.TO / ORLY.O / BCRX.O / ICPT.O / BIIB.O / DCP.N / DLR.N / RDSb.L / ALNY.O / BAM.N / 025676206 / MERC.O / AUY.N / IVZ.N / BIP.N / EDPR.LS / ABI.BR / CFX.TO / FHI.N / CTT.N / VCRA.N / RFP.N / FFHu.TO / APAM.N / PTCT.O / BPY.N / BURL.N / KPTI.O / RYAM.N / VNOM.O / QSR.N / BSM.N / GLPG.O / PYPL.OQ / OMF.N / BBU.N / CRSP.OQ / SAND.N / KRP.N / OVID.O / ORSTED.CO / NEXA.TO / VCTR.N / NTGY.MC / BHC.N / FLMN.OQ / NBSE.OQ / MNRL.N / DDOG.O / LUMN.N / AFRM.O</td><td class="leftalignment">Crown Holdings Inc / EDP Energias de Portugal SA / Endesa SA / FMC Corp / Iberdrola SA / International Paper Co / Rwe AG / Telus Corp / PepsiCo Inc / Pioneer Natural Resources Co / Canfor Corp / Gilead Sciences Inc / Incyte Corp / Ferrovial SA / Borgwarner Inc / Red Electrica Corporacion SA / Manulife Financial Corp / Agnico Eagle Mines Ltd / Constellation Brands Inc / Ameriprise Financial Inc / Cincinnati Financial Corp / DaVita Inc / TJX Companies Inc / Ross Stores Inc / Boston Beer Company Inc / Vertex Pharmaceuticals Inc / Cloudflare Inc / Sun Life Financial Inc / O'Reilly Automotive Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / DCP Midstream LP / Digital Realty Trust Inc / Royal Dutch Shell PLC / Alnylam Pharmaceuticals Inc / Brookfield Asset Management Inc / American Equity Investment Life Holding Co / Mercer International Inc / Yamana Gold Inc / Invesco Ltd / Brookfield Infrastructure Partners LP / EDP Renovaveis SA / Anheuser Busch Inbev SA / Canfor Pulp Products Inc / Federated Hermes Inc / CatchMark Timber Trust Inc / Vocera Communications Inc / Resolute Forest Products Inc / Fairfax Financial Holdings Ltd / Artisan Partners Asset Management Inc / PTC Therapeutics Inc / Brookfield Property Partners LP / Burlington Stores Inc / Karyopharm Therapeutics Inc / Rayonier Advanced Materials Inc / Viper Energy Partners LP / Restaurant Brands International Inc / Black Stone Minerals LP / Galapagos NV / PayPal Holdings Inc / OneMain Holdings Inc / Brookfield Business Partners LP / CRISPR Therapeutics AG / Sandstorm Gold Ltd / Kimbell Royalty Partners LP / Ovid Therapeutics Inc / Orsted A/S / Nexa Resources SA / Victory Capital Holdings Inc / Naturgy Energy Group SA / Bausch Health Companies Inc / Falcon Minerals Corp / NeuBase Therapeutics Inc / Brigham Minerals Inc / Datadog Inc / Lumen Technologies Inc / Affirm Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Luxembourg / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- Happy Lunar New Year!</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Patent Patrol – Biotechnology: 4Q20</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">GILD.O / INCY.O / VRTX.O / BCRX.O / ICPT.O / BIIB.O / PTCT.O / GLPG.O / CRSP.OQ / OVID.O</td><td class="leftalignment">Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / PTC Therapeutics Inc / Galapagos NV / CRISPR Therapeutics AG / Ovid Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - 4Q20 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / BAYGN.DE</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Small Biotech Outflows End the Four-Week Inflow Streak</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q Update Outlines Key Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PRTA=US / BMY=US / RHHBY=US / BIIB=US</td><td class="leftalignment">Prothena Corporation PLC / Bristol-Myers Squibb Co / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Biogen Inc. (BIIB) - Erosion of TECFIDERA revenue created negative impact on company performance</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Shejal Ajmera / Ms. Rimi Murarka</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Smart Insider</td><td class="leftalignment">Biogen Inc: 1 director bought</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / ECONOMIC INDICATORS / FUNDAMENTAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Company Snapshot</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended February 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 16,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BCLI-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BCLI.O / GILD.O / AGEN.O / SGEN.O / BIIB.O / CYTK.O / IDRA.O / BIEI.PK</td><td class="leftalignment">Brainstorm Cell Therapeutics Inc / Gilead Sciences Inc / Agenus Inc / Seagen Inc / Biogen Inc / Cytokinetics Inc / Idera Pharmaceuticals Inc / Premier Biomedical Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK.N / CERN.OQ / ICAD.OQ / CPSI.OQ / BIIB.OQ / EVGN.TA / WEED.TO / DNLI.OQ / ORTX.OQ</td><td class="leftalignment">Merck & Co Inc / Cerner Corp / ICAD Inc / Computer Programs and Systems Inc / Biogen Inc / Evogene Ltd / Canopy Growth Corp / Denali Therapeutics Inc / Orchard Therapeutics PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Base Camp, Not Summit, On Denali - Establishing Broad Pipeline Potential for Prevalent & Orphan Neurodegenerative Diseases</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">DNLI.O / BIIB.O</td><td class="leftalignment">Denali Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Charles C. Duncan, Ph.D. / Mr. Pete Stavropoulos</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">JACK=US / NUAN=US / MCD=US / WEN=US / AMZN=US / WMT=US / YUM=US / TTWO=US / W=US / INTU=US / FIVE=US / GPN=US / PTON=US / BIIB=US / MRNA=US / ALNY=US / INFI=US / QSR=US / PRPL=US / LULU=US / FICO=US / TSLA=US / EA=US / ABBV=US / ENTA=US / VRNS=US / PAYC=US / CDK=US / LOVE=US / ETSY=US / EDIT=US / CVNA=US / VERU=US / GRWG=US / MWK=US / NBSE=US</td><td class="leftalignment">Jack in the Box Inc / Nuance Communications Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / Walmart Inc / Yum! Brands Inc / Take-Two Interactive Software Inc / Wayfair Inc / Intuit Inc / Five Below Inc / Global Payments Inc / Peloton Interactive Inc / Biogen Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Infinity Pharmaceuticals Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lululemon Athletica Inc / Fair Isaac Corp / Tesla Inc / Electronic Arts Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Varonis Systems Inc / Paycom Software Inc / CDK Global Inc / Lovesac Co / ETSY Inc / Editas Medicine Inc / Carvana Co / Veru Inc / GrowGeneration Corp / Aterian Inc / NeuBase Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Consumer / Financial Services / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Semiconductors</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Domestic Declines Continue as Vaccine Rollout Ramps Up; IMHE Suggests New Variant Bump May Occur in March/April</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DNB / FISV=US / MRK=US / BSX=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / ADI=US / WEN=US / AMZN=US / BLD=US / TEVA=US / NVDA=US / SLG=US / LOW=US / ENR=US / DIOD=US / IGT=US / CHRS=US / BYD=US / TTWO=US / LEG=US / TTMI=US / ATVI=US / KFRC=US / MGM=US / HUM=US / PENN=US / BKI=US / AVGO=US / CBRL=US / DRI=US / EXEL=US / GFF=US / HAS=US / IBP=US / MAS=US / MHK=US / MCRI=US / REGI=US / SGMO=US / SPG=US / SGMS=US / GPN=US / AUTL=US / DIN=US / ECPG=US / PRAA=US / RRR=US / BIIB=US / TPX=US / EXP=US / CZR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / REX=US / FIS=US / PGTI=US / GPRE=US / SAIA=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / NXPI=US / FBHS=US / ZNGA=US / EA=US / ENPH=US / TILE=US / NDLS=US / VRNS=US / GOOGL=US / LOCO=US / HQY=US / OSH=US / SHAK=US / WING=US / TDOC=US / EDIT=US / 82982L103 / IRTC=US / JELD=US / MPWR-US / CARG=US / BTAI=US / ALLO=US / HARP=US / TCRR=US / FERGY=US / OPCH=US / DKNG=US / AZEK=US / BALY=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Fiserv Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Analog Devices Inc / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / SL Green Realty Corp / Lowe's Companies Inc / Energizer Holdings Inc / Diodes Inc / International Game Technology PLC / Coherus BioSciences Inc / Boyd Gaming Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / TTM Technologies Inc / Activision Blizzard Inc / Kforce Inc / MGM Resorts International / Humana Inc / Penn National Gaming Inc / Black Knight Inc / Broadcom Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Exelixis Inc / Griffon Corp / Hasbro Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Simon Property Group Inc / Scientific Games Corp / Global Payments Inc / Autolus Therapeutics PLC / Dine Brands Global Inc / Encore Capital Group Inc / PRA Group Inc / Red Rock Resorts Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / PGT Innovations Inc / Green Plains Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / NXP Semiconductors NV / Fortune Brands Home & Security Inc / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / Varonis Systems Inc / Alphabet Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Oak Street Health Inc / Shake Shack Inc / Wingstop Inc / Teladoc Health Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / JELD-WEN Holding Inc / Monolithic Power Systems Inc / CarGurus Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Ferguson PLC / Option Care Health Inc / DraftKings Inc / Azek Company Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Some SMid incrementally higher, but stable for Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Improvements in Markers of General Housekeeping Function Could Make a WORLD of Difference for the TV Programs. Data This Week.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">24823R105 / 09062X103 / 014442107</td><td class="leftalignment">Denali Therapeutics Inc / Biogen Inc / Alector Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Mr. Julian Harrison / Ms. Kaveri Pohlman</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Deja Vu All Over Again?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">EDIT=US / BIIB=US / ABBV=US</td><td class="leftalignment">Editas Medicine Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Cash Conversion Cycle 2010-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Biogen Inc: Information Content of Earnings Releases 2015-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Industry Veteran Jim Mullen To Take Helm As CEO Effective February 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">EDIT=US / BIIB=US</td><td class="leftalignment">Editas Medicine Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: VYGR deal termination; big pharma engages GRTS</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">GRTS.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Feb 08 2021 6:43AM</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">GDDY=US / ZG=US / AAPL=US / DELL=US / IBM=US / GM=US / INTC=US / AMD=US / GBT=US / MSFT=US / MU=US / AMZN=US / QCOM=US / EBAY=US / DNLI=US / NVDA=US / NTAP=US / 7974=JP / XLNX=US / IIVI=US / XOMA=US / ACET=US / APLS=US / AVGO=US / BMRN=US / BLUE=US / CYBR=US / ISEE=US / FORD=US / FUSN=US / ICPT=US / NBIX=US / PRTK=US / PRVL=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / WDC=US / SAGE=US / FB=US / NIO=US / SWKS=US / GLAD=US / ALPN=US / STX=US / IGMS=US / STRO=US / BIIB=US / TPX=US / SIMO=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / 2454=US / ALNA=US / LXRX=US / 2330=US / PRPL=US / VMW=US / 6758=US / IDRA=US / ASND=US / RCUS=US / 8299=US / OMER=US / TSLA=US / NXPI=US / PCRX=US / 981=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / GOOGL=US / AGTC=US / XENE=US / QRVO=US / CDTX=US / BPMC=US / ABUS=US / PSTG=US / ARGX=US / NVCR=US / HPE=US / CTMX=US / ZS=US / VYGR=US / KURA=US / EIGR=US / CRVS=US / NTLA=US / CLSD=US / ALBO=US / OBSV=US / ANAB=US / VRNA=US / BHVN=US / GTHX=US / MRSN=US / CSPR=US / KALA=US / SNBR=US / FENC=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / LQDA=US / YMAB=US / ARVN=US / MLND=US / HARP=US / LYFT=US / UBER=US / TCRR=US / PINS=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">GoDaddy Inc / Zillow Group Inc / Apple Inc / Dell Technologies Inc / International Business Machines Corp / General Motors Co / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / eBay Inc / Denali Therapeutics Inc / NVIDIA Corp / NetApp Inc / Nintendo Co Ltd / Xilinx Inc / II-VI Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / Biomarin Pharmaceutical Inc / bluebird bio Inc / Cyberark Software Ltd / Iveric Bio Inc / Forward Industries Inc / Fusion Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Porvair PLC / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / Western Digital Corp / SAGE Therapeutics Inc / Meta Platforms Inc / NIO Inc / Skyworks Solutions Inc / Gladstone Capital Corp / Alpine Immune Sciences Inc / Seagate Technology Holdings PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Tempur Sealy International Inc / Silicon Motion Technology Corp / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / MediaTek Inc / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Purple Innovation Inc / VMware Inc / Sony Group Corp / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Phison Electronics Corp / Omeros Corp / Tesla Inc / NXP Semiconductors NV / Pacira Biosciences Inc / Semiconductor Manufacturing International Corp / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Alphabet Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / Pure Storage Inc / argenx SE / Novocure Ltd / Hewlett Packard Enterprise Co / CytomX Therapeutics Inc / Zscaler Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Eiger BioPharmaceuticals Inc / Corvus Pharmaceuticals Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Verona Pharma PLC / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Casper Sleep Inc / Kala Pharmaceuticals Inc / Sleep Number Corp / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Liquidia Corp / Y-mAbs Therapeutics Inc / Arvinas Inc / Tempest Therapeutics Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Pinterest Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Japan / Netherlands / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Electronics / Financial Services / Healthcare / Household Products / Info. Tech./Computers / Retailing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ESALY-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ESALY.PK / BIIB.O / EPZM.O / RDHL.O / ABBV.K</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc / Epizyme Inc / Redhill Biopharma Ltd / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ALXN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIOb / JNJ / GILD.O / REGN.O / VRTX.O / RARE.O / BIIB.O / SRPT.O / AGIO.O / QGEN.K</td><td class="leftalignment">Bio Rad Laboratories Inc / Johnson & Johnson / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Biogen Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Qiagen NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">REGN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">REGN.O / JNJ / NVS / AMGN.O / BIIB.O / ALNY.O / SNY.O</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Johnson & Johnson / Novartis AG / Amgen Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Health Care Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">65</td><td class="leftalignment">US2290503075 / US89237H2094 / US09061H3075 / US30161Q1040 / US5160121019 / US7599101026 / US92532F1003 / US0162551016 / US09062X1037 / US6707041058 / CA87402A1084 / US0043971052 / US45665G3039 / US8036071004 / US74345W1080 / US1635722093 / US29428V1044 / US29664W1053 / CA05156V1022 / US92337F1075 / US48576U1060 / US0008991046 / US00972D1054 / CA4990531069 / US14167L1035 / US5288723027 / US98978L2043 / US37890U1088 / US00461U1051 / US02081G2012 / US98419J2069 / US12648L6011 / US03890D1081 / US15117B2025 / US6406714005 / US23725P2092 / US18507C1036 / US14147L1089 / US97382D3035 / US0547548745</td><td class="leftalignment">Cryoport Inc / TRACON Pharmaceuticals Inc / Biomerica Inc / Exelixis Inc / Lannett Company Inc / Repro Med Systems Inc / Vertex Pharmaceuticals Inc / Align Technology Inc / Biogen Inc / NuVasive Inc / Taiga Building Products Ltd / Accuray Inc / Infinity Pharmaceuticals Inc / Sarepta Therapeutics Inc / Prophase Labs Inc / Chembio Diagnostics Inc / Epizyme Inc / Esperion Therapeutics Inc / Aurinia Pharmaceuticals Inc / Veracyte Inc / Karyopharm Therapeutics Inc / ADMA Biologics Inc / Akebia Therapeutics Inc / Knight Therapeutics Inc / CareDx Inc / Lexicon Pharmaceuticals Inc / Zogenix Inc / Global Blood Therapeutics Inc / Aclaris Therapeutics Inc / Alphatec Holdings Inc / XOMA Corp / CTI Biopharma Corp / Aravive Inc / Celldex Therapeutics Inc / Nephros Inc / DarioHealth Corp / Clearpoint Neuro Inc / Cardiff Oncology Inc / Windtree Therapeutics Inc / Aytu Biopharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Biotechnology Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">65</td><td class="leftalignment">US12648L6011 / US89237H2094 / US09061G1013 / US0718131099 / US30161Q1040 / US45337C1027 / US7599161095 / US09062X1037 / US40637H1095 / US1920051067 / US8036071004 / CA1208311029 / US6024961012 / US45845P1084 / US16934W1062 / US29428V1044 / US29664W1053 / US31189P1021 / CA05156V1022 / US0008991046 / US90400D1081 / US00972D1054 / US0396971071 / US78667J1088 / US92346J1088 / US63016Q1022 / US37890U1088 / US28106W1036 / US04280A1007 / US98419J2069 / US8177631053 / CA64079L1058 / US03890D1081 / US57055L1070 / US15117B2025 / US72940R3003 / US74017N1054 / US97382D3035 / US89422G1076</td><td class="leftalignment">CTI Biopharma Corp / TRACON Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Baxter International Inc / Exelixis Inc / Incyte Corp / Repligen Corp / Biogen Inc / Halozyme Therapeutics Inc / Codexis Inc / Sarepta Therapeutics Inc / Burcon NutraScience Corp / MiMedx Group Inc / Intercept Pharmaceuticals Inc / Chimerix Inc / Epizyme Inc / Esperion Therapeutics Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / ADMA Biologics Inc / Ultragenyx Pharmaceutical Inc / Akebia Therapeutics Inc / Ardelyx Inc / SAGE Therapeutics Inc / Vericel Corp / Immunitybio Inc / Global Blood Therapeutics Inc / Editas Medicine Inc / Arrowhead Pharmaceuticals Inc / XOMA Corp / Sesen Bio Inc / Neptune Wellness Solutions Inc / Aravive Inc / Marker Therapeutics Inc / Celldex Therapeutics Inc / Pluristem Therapeutics Inc / Precigen Inc / Windtree Therapeutics Inc / Travere Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">02/07/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GBT=US / DNLI=US / XOMA=US / ACET=US / APLS=US / BMRN=US / BLUE=US / ISEE=US / FUSN=US / ICPT=US / NBIX=US / PRTK=US / PRVL=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / ALNA=US / LXRX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / EIGR=US / CRVS=US / NTLA=US / CLSD=US / ALBO=US / OBSV=US / ANAB=US / VRNA=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / LQDA=US / YMAB=US / ARVN=US / MLND=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Global Blood Therapeutics Inc / Denali Therapeutics Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Porvair PLC / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Eiger BioPharmaceuticals Inc / Corvus Pharmaceuticals Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Verona Pharma PLC / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Liquidia Corp / Y-mAbs Therapeutics Inc / Arvinas Inc / Tempest Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 533</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">DE0006969603 / US00971T1016 / US22160K1051 / US5002551043 / US5719032022 / US5801351017 / US6541061031 / US7782961038 / US8552441094 / US8725401090 / US87612E1064 / US9182041080 / US9311421039 / US3448491049 / US9884981013 / US20030N1019 / US21036P1084 / US2533931026 / US09062X1037 / US25754A2015 / US0042251084 / US02043Q1076 / US9043111072 / ACOR.OQ / US1696561059 / US5500211090 / US90384S3031 / DE000A1EWWW0 / US8725901040 / US1220171060 / US0465131078 / US00653A1079 / US9741551033 / US70450Y1038 / US05464T1043 / US00773U1088 / US36165L1089 / GB00BDSFG982 / US05722G1004 / CA39342L1085 / US0197701065 / US0144421072 / CA23126M1023 / US09203E1055 / CH0499880968</td><td class="leftalignment">Puma SE / Akamai Technologies Inc / Costco Wholesale Corp / Kohls Corp / Marriott International Inc / McDonald's Corp / Nike Inc / Ross Stores Inc / Starbucks Corp / TJX Companies Inc / Target Corp / VF Corp / Walmart Inc / Foot Locker Inc / Yum! Brands Inc / Comcast Corp / Constellation Brands Inc / DICK'S Sporting Goods Inc / Biogen Inc / Domino's Pizza Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Acorda Therapeutics Inc / Chipotle Mexican Grill Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Adidas AG / T-Mobile US Inc / Burlington Stores Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Wingstop Inc / PayPal Holdings Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / GDS Holdings Ltd / TechnipFMC PLC / Baker Hughes Co / Green Thumb Industries Inc / Allogene Therapeutics Inc / Alector Inc / Curaleaf Holdings Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: Gx Vascepa Cracks 11% Mkt Share After Steady Growth in January</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 1/29/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / BMY=US / ADI=US / RRC=US / T=US / TXN=US / GILD=US / AMT=US / PEB=US / DGX=US / H=US / CRM=US / V=US / MTN=US / VZ=US / MAR=US / ATVI=US / ESS=US / HLT=US / MANH=US / PENN=US / CI=US / RCL=US / AIR=US / ARCC=US / ARW=US / AVT=US / CCL=US / CHH=US / DRH=US / EXPO=US / MAIN=US / MCHP=US / ORCC=US / PCTY=US / SHOP=US / SNAP=US / VSEC=US / POST=US / LCI=US / AVTR=US / BDN=US / CPT=US / OFC=US / OHI=US / PTON=US / BIIB=US / FLT=US / AINV=US / SHO=US / MPW=US / HST=US / MA=US / EHTH=US / PNNT=US / WH=US / WYND=US / IAC=US / RCUS=US / HGV=US / NXPI=US / RLJ=US / VAC=US / ANGI=US / RHP=US / NCLH=US / TMUS=US / PTCT=US / TSLX=US / 70806A106 / NEWR=US / GSBD=US / ZG=US / WLTW=US / VVV=US / PK=US / LGF.B=US / PLYA=US / RDFN=US / MPWR-US / FSK=US / PLMR=US / BRBR=US / GOCO=US / ONEW=US / FSKR=US / BIGC=US</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Analog Devices Inc / Range Resources Corp / AT&T Inc / Texas Instruments Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Quest Diagnostics Inc / Hyatt Hotels Corp / Salesforce.Com Inc / Visa Inc / Vail Resorts Inc / Verizon Communications Inc / Marriott International Inc / Activision Blizzard Inc / Essex Property Trust Inc / Hilton Worldwide Holdings Inc / Manhattan Associates Inc / Penn National Gaming Inc / Cigna Corp / Royal Caribbean Cruises Ltd / AAR Corp / Ares Capital Corp / Arrow Electronics Inc / Avnet Inc / Carnival Corp / Choice Hotels International Inc / Diamondrock Hospitality Co / Exponent Inc / Main Street Capital Corp / Microchip Technology Inc / Owl Rock Capital Corp / Paylocity Holding Corp / Shopify Inc / Snap Inc / VSE Corp / Post Holdings Inc / Lannett Company Inc / Avantor Inc / Brandywine Realty Trust / Camden Property Trust / Corporate Office Properties Trust / Omega Healthcare Investors Inc / Peloton Interactive Inc / Biogen Inc / Fleetcor Technologies Inc / Apollo Investment Corp / Sunstone Hotel Investors Inc / Medical Properties Trust Inc / Host Hotels & Resorts Inc / Mastercard Inc / eHealth Inc / Pennantpark Investment Corp / Wyndham Hotels & Resorts Inc / Travel + Leisure Co / IAC/Interactivecorp / Arcus Biosciences Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Norwegian Cruise Line Holdings Ltd / T-Mobile US Inc / PTC Therapeutics Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / New Relic Inc / Goldman Sachs BDC Inc / Zillow Group Inc / Willis Towers Watson PLC / Valvoline Inc / Park Hotels & Resorts Inc / Lions Gate Entertainment Corp / Playa Hotels & Resorts NV / Redfin Corp / Monolithic Power Systems Inc / FS KKR Capital Corp / Palomar Holdings Inc / Bellring Brands Inc / Gohealth Inc / OneWater Marine Inc / FS KKR Capital Corp / Bigcommerce Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Liberia / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.OQ / AMGN.OQ / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Biogen Inc / Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Mo Money, Mo Problems? 4th Consecutive Week of Inflows</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">4Q20 results; focus remains on adu PDUFA & we could see add'l upside to our model; PT $458 from $443</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Biogen Idec</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REMINDER: If You’re a HZNP Shareholder Wondering About VIE, We’ve Got Answers; Join Our Q&A Session With the Guggenheim Team</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BQPVQZ6 / 0989529 / 2455965</td><td class="leftalignment">Horizon Therapeutics PLC / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Dana C. Flanders, CFA / Mr. Seamus Fernandez / Mr. Yatin Suneja</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">What If Tecfidera Wasn't Really Gone? Revisiting the US Patent Appeals Case</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REMINDER: If You’re a HZNP Shareholder Wondering About VIE, We’ve Got Answers; Join Our Q&A Session with the Guggenheim Team</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BQPVQZ6 / 0989529 / 2455965</td><td class="leftalignment">Horizon Therapeutics PLC / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Dana C. Flanders, CFA / Mr. Seamus Fernandez / Mr. Yatin Suneja</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ACAD=US / MBRX=US / AAPL=US / BSX=US / CSII=US / LLY=US / INTC=US / ADI=US / AMD=US / MDT=US / JNPR=US / QCOM=US / SNE=US / T=US / ORCL=US / ADBE=US / TXN=US / CG=US / NVDA=US / CRM=US / VZ=US / GWW=US / ZEN=US / XLNX=US / IEX=US / HUM=US / APPS=US / AVGO=US / BL=US / CRUS=US / CREE=US / DOCU=US / EGAN=US / PHG=US / LFUS=US / LPSN=US / NOW=US / MCHP=US / NBIX=US / SHOP=US / SAGE=US / APO=US / PYPL=US / SWKS=US / ENSG=US / BIIB=US / RNG=US / MWA=US / ELF=US / BX=US / KKR=US / NXPI=US / WDAY=US / TMUS=US / CNHI=US / COUP=US / HUBS=US / QRVO=US / BILL=US / APTV=US / BILI=US / KRTX=US / 120175706</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Moleculin Biotech Inc / Apple Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Medtronic PLC / Juniper Networks Inc / Qualcomm Inc / Sony Group Corp / AT&T Inc / Oracle Corp / Adobe Inc / Texas Instruments Inc / Carlyle Group Inc / NVIDIA Corp / Salesforce.Com Inc / Verizon Communications Inc / W W Grainger Inc / Zendesk Inc / Xilinx Inc / IDEX Corp / Humana Inc / Digital Turbine Inc / Broadcom Inc / Blackline Inc / Cirrus Logic Inc / Wolfspeed Inc / DocuSign Inc / eGain Corp / Koninklijke Philips NV / Littelfuse Inc / LivePerson Inc / ServiceNow Inc / Microchip Technology Inc / Neurocrine Biosciences Inc / Shopify Inc / SAGE Therapeutics Inc / Apollo Global Management Inc / PayPal Holdings Inc / Skyworks Solutions Inc / Ensign Group Inc / Biogen Inc / RingCentral Inc / Mueller Water Products Inc / elf Beauty Inc / Blackstone Inc / KKR & Co Inc / NXP Semiconductors NV / Workday Inc / T-Mobile US Inc / CNH Industrial NV / Coupa Software Inc / HubSpot Inc / Qorvo Inc / Bill.com Holdings Inc / Aptiv PLC / Bilibili Inc / Karuna Therapeutics Inc / Cisco Systems Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Ireland / Japan / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Machinery / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 04 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">CH0012221716 / US0231351067 / US1011371077 / US1924461023 / US2786421030 / US4448591028 / US45167R1041 / US4824801009 / US5370081045 / US7475251036 / US7711951043 / US8269191024 / US8968181011 / US0003752047 / US3463751087 / US64111Q1040 / US09062X1037 / US82706C1080 / US6247581084 / US01748X1028 / US98138H1014 / US21240E1055 / US74736K1016 / US70450Y1038 / US26856L1035 / US80689H1023 / US8760301072 / US92336X1090 / VGG1890L1076 / US05352A1007 / US15912K1007 / US70614W1009 / US4432011082 / US57667L1070 / US44891N1090</td><td class="leftalignment">Abb Ltd / Amazon.com Inc / Boston Scientific Corp / Cognizant Technology Solutions Corp / eBay Inc / Humana Inc / IDEX Corp / KLA Corp / Littelfuse Inc / Qualcomm Inc / Roche Holding AG / Silicon Laboratories Inc / Triumph Group Inc / Abb Ltd / FormFactor Inc / NETGEAR Inc / Biogen Inc / Silicon Motion Technology Corp / Mueller Water Products Inc / Allegiant Travel Co / Workday Inc / Controladora Vuela Compania de Aviacion SAB de CV / Qorvo Inc / PayPal Holdings Inc / elf Beauty Inc / Schneider National Inc / Tapestry Inc / Veoneer Inc / Capri Holdings Ltd / Avantor Inc / Change Healthcare Inc / Peloton Interactive Inc / Howmet Aerospace Inc / Match Group Inc / IAC/Interactivecorp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Mexico / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">V / 0925288 / 2000019 / 2293819 / 2973821 / 2113434 / 2270726 / 2542049 / 2342034 / 2100920 / 2455965 / 2501578 / 2515030 / 2378534 / 2638625 / 2630513 / 2689560 / 2048804 / 2825933 / B17HG57 / 2857817 / B02R1L6 / B2R3PV1 / 2679204 / B5B1S13 / B5B2106 / B3SWPT2 / B7TL820 / B783TY6 / B7VD3F2 / BDZDRC5 / BYY8XK8 / BYVY8G0 / BYVYD43 / BYW36M8 / BJLT387 / BJ1N1M9 / BD8DJ71 / BKTHM05 / BR4T3B3 / BFZ1K46 / BL95N25 / BYY88Y7 / BFWGXQ7 / BYQCZ35 / 021513106</td><td class="leftalignment">Visa Inc / GlaxoSmithKline PLC / Amazon.com Inc / eBay Inc / Alliant Energy Corp / Boston Scientific Corp / Walt Disney Co / Dominion Energy Inc / Fiserv Inc / FirstEnergy Corp / Biogen Inc / Ligand Pharmaceuticals Inc / Lithia Motors Inc / Mckesson Corp / National Beverage Corp / New Jersey Resources Corp / PG&E Corp / Pinnacle West Capital Corp / South Jersey Industries Inc / Cardiovascular Systems Inc / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Align Technology Inc / Dollar General Corp / Fortinet Inc / Ameresco Inc / Meta Platforms Inc / Aptiv PLC / Duke Energy Corp / Premier Inc / WEC Energy Group Inc / Alphabet Inc / Performance Food Group Co / PayPal Holdings Inc / Avantor Inc / Capri Holdings Ltd / Snap Inc / Passage Bio Inc / HubSpot Inc / Spotify Technology SA / Phibro Animal Health Corp / Alphabet Inc / Container Store Group Inc / Madison Square Garden Sports Corp / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Luxembourg / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, February 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US2537981027 / US7475251036 / US8968181011 / US09062X1037 / 101137107 / 23335Q100 / 25400W102 / 70450Y103 / 98986X109 / L8681T102 / 268150109</td><td class="leftalignment">Digi International Inc / Qualcomm Inc / Triumph Group Inc / Biogen Inc / Boston Scientific Corp / DLH Holdings Corp / Digital Turbine Inc / PayPal Holdings Inc / Zynerba Pharmaceuticals Inc / Spotify Technology SA / Dynatrace Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Suspense Around Aducanumab Intensifies—Our Take on 4Q20; PT to $305</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB / H00263105</td><td class="leftalignment">Biogen Inc / AC Immune SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew S. Fein / Matthew Caufield / Andres Y. Maldonado, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">CB.N / QCOM.O / RYN.N / SVT.L / HUM.N / CHKP.O / DT.N / JAZZ.O / GWW.N / VFC.N / EPD.N / CTSH.O / ENR.N / MKL.N / RGLD.O / BIIB.O / BAM.N / ATL.MI / SLRS.MC / ENSG.O / BIP.N / MTOR.N / GLEN.L / APAM.N / ABBV.N / CIA.TO / PYPL.OQ / MIME.OQ / APTV.N / VNE.N / AVTR.N / ALOO.O</td><td class="leftalignment">Chubb Ltd / Qualcomm Inc / Rayonier Inc / Severn Trent PLC / Humana Inc / Check Point Software Technologies Ltd / Dynatrace Inc / Jazz Pharmaceuticals PLC / W W Grainger Inc / VF Corp / Enterprise Products Partners LP / Cognizant Technology Solutions Corp / Energizer Holdings Inc / Markel Corp / Royal Gold Inc / Biogen Inc / Brookfield Asset Management Inc / Atlantia SpA / Solaria Energia y Medio Ambiente SA / Ensign Group Inc / Brookfield Infrastructure Partners LP / Meritor Inc / Glencore PLC / Artisan Partners Asset Management Inc / Abbvie Inc / Champion Iron Ltd / PayPal Holdings Inc / Mimecast Ltd / Aptiv PLC / Veoneer Inc / Avantor Inc / Allogene Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Spain / United Kingdom / Ireland / Israel / Italy / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : 4Q Snapshot - Soft Guide a Not So Gentle Reminder that BIIB's Fate Rests on the Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / Mr. Matthew T. Holt, P.Eng / James Scott</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">2021 Is A Year Of Investment Whose Success Depends On Aducanumab</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Near-term catalysts crucial for BIIB's medium-to-long term; maintain BUY, $359 PT</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sumant Kulkarni / Jia Min, CFA</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB 4Q20 Postview:  Base erodes…will adu save the day?!</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">High Grade Healthcare : 4Q20 Earnings Highlights — What Mattered for Credit Part III</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ABBV.N / AMGN.O / BSX.N / HUM.N / BIIB.O</td><td class="leftalignment">Abbvie Inc / Amgen Inc / Boston Scientific Corp / Humana Inc / Biogen Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brett Gibson / Mr. Matthew Bonner</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">4Q Print Was Not Pretty; Aducanumab Needs to Work; PT to $380</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q Update Outlines Adu Plan for Success</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">BIIB=US / LLY=US / SAGE=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">lots of nuances on alzh from call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat / Michael DiFiore</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ATO / BP / CB / CCO / DD / DIS / ETM / IFF / IPG / MMP / MRO / OMC / SM / AMZN.O / CHKP.O / WWE / SBGI.O / NVDA.O / GTN / JAZZ.O / SIRI.O / SLAB.O / GPN / NFLX.O / BIIB.O / NXST.O / VIAC.O / DISCA.O / ISBC.O / SCHW.K / AMCX.O / PFSI.K / FOXA.O / HMTV.O / GOOGL.O / AFMD.O / BOOT.K / TGNA.K / GBT.O / PFGC.K / LGFb.N / BOMN.O / ROKU.O / SPOT.K / SSP.O / CPRI.K / IHRT.O / ALGM.O</td><td class="leftalignment">Atmos Energy Corp / BP PLC / Chubb Ltd / Clear Channel Outdoor Holdings Inc / Dupont De Nemours Inc / Walt Disney Co / Audacy Inc / International Flavors & Fragrances Inc / Interpublic Group of Companies Inc / Magellan Midstream Partners LP / Marathon Oil Corp / Omnicom Group Inc / SM Energy Co / Amazon.com Inc / Check Point Software Technologies Ltd / World Wrestling Entertainment Inc / Sinclair Broadcast Group Inc / NVIDIA Corp / Gray Television Inc / Jazz Pharmaceuticals PLC / Sirius XM Holdings Inc / Silicon Laboratories Inc / Global Payments Inc / Netflix Inc / Biogen Inc / Nexstar Media Group Inc / ViacomCBS Inc / Discovery Inc / Investors Bancorp Inc / Charles Schwab Corp / AMC Networks Inc / PennyMac Financial Services Inc / Fox Corp / Hemisphere Media Group Inc / Alphabet Inc / Affimed NV / Boot Barn Holdings Inc / Tegna Inc / Global Blood Therapeutics Inc / Performance Food Group Co / Lions Gate Entertainment Corp / Boston Omaha Corp / Roku Inc / Spotify Technology SA / E W Scripps Co / Capri Holdings Ltd / iHeartMedia Inc / Allegro Microsystems Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">As Base Business Declines, Reset Year Hinges on Much Anticipated Aducanumab Decision</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - BIIB: They just said what?! Highlights from the conference call that just ended</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">All-in on Aducanumab</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">4Q20: Call Reflects Optimism Around Adu, Caution Around Base Biz</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BIIB: Guidance Reflects Transition Year Anchored by Aducanumab</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Jim W. Birchenough, MD</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : First Look at 4Q Results</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / Mr. Matthew T. Holt, P.Eng / James Scott</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Puts & Takes for Prasinezumab and Birtamimab</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PRTA=US / RHHBY=US / BIIB=US</td><td class="leftalignment">Prothena Corporation PLC / Roche Holding AG / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">FY21 Guidance Provides A Reset Button For BIIB</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Feb 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PYPL.OQ / 6758.T / AFL.N / ALL.N / BP.L / BSX.N / ELF.N / IBM.N / SLB.N / AVB.N / HUM.N / HAL.N / XOM.N / AVY.N / LNC.N / LAD.N / HWM.N / GSK.L / MAA.N / CTSH.OQ / AAPL.OQ / KLAC.OQ / MSFT.OQ / SBUX.OQ / QCOM.OQ / AMZN.OQ / EBAY.OQ / ALGN.OQ / BIIB.OQ / 0700.HK / RDSa.L / 9999.HK / APO.N / MTOR.N / BKR.N / ABBV.N / QRVO.OQ / APTV.N / CPRI.N / LYFT.OQ / PINS.N / BYND.OQ / UBER.N / ZM.OQ / CTVA.N / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">PayPal Holdings Inc / Sony Group Corp / Aflac Inc / Allstate Corp / BP PLC / Boston Scientific Corp / elf Beauty Inc / International Business Machines Corp / Schlumberger NV / Avalonbay Communities Inc / Humana Inc / Halliburton Co / Exxon Mobil Corp / Avery Dennison Corp / Lincoln National Corp / Lithia Motors Inc / Howmet Aerospace Inc / GlaxoSmithKline PLC / Mid-America Apartment Communities Inc / Cognizant Technology Solutions Corp / Apple Inc / KLA Corp / Microsoft Corp / Starbucks Corp / Qualcomm Inc / Amazon.com Inc / eBay Inc / Align Technology Inc / Biogen Inc / Tencent Holdings Ltd / Royal Dutch Shell PLC / NetEase Inc / Apollo Global Management Inc / Meritor Inc / Baker Hughes Co / Abbvie Inc / Qorvo Inc / Aptiv PLC / Capri Holdings Ltd / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Corteva Inc / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Japan / United States / Virgin Islands, British / Jersey / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">4Q20 - Filling the TECFIDERA Crater Begins. Aducanumab FDA Decision and Commercial Ramp (We Think) Will Dominate Discussion Long Enough for Key Pipeline Approaches to Emerge.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">09062X103 / 92915B106 / 24823R105</td><td class="leftalignment">Biogen Inc / Voyager Therapeutics Inc / Denali Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Mr. Julian Harrison / Ms. Kaveri Pohlman</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Key takes from BIIB 4Q call that ended: 2021 guide hopefully is the floor for BIIB with or without aducanumab</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.O / LLY</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - In-line 4Q20; Below Consensus 2021 Guide, But Hey, It's All About Aducanumab!</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Weak 4Q and 2021 Guidance</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">BIIB Reports Mixed Financials; Solid Q4 With 2021 Guidance Below Consensus</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD / Ernesto Rodriguez-Dumont, M.D.</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fourth-Quarter Quick Take: 2021 Guidance Shows Impact of Tecfidera Generics, Includes Some Aducanumab Contribution</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">09062X103 / 462222100</td><td class="leftalignment">Biogen Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Myles R. R. Minter / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">BIIB: 4Q20 First Read</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Jim W. Birchenough, MD</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Brief of Biogen Inc conference call, Feb. 03, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">BIIB.OQ - Event Transcript of Biogen Inc conference call, Feb. 03, 2021 / 8:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">4Q20 First Take:  Initial FY21 Guidance Sets Up A Tough Year Ahead</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Q420 First Take - Misses EPS and Guides Down; Wherefore Art Thou Aducanumab?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">4Q20 First Take: Tec, Spinraza Resilient; Guidance Disappointing</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD / David Szeto / Leonid Timashev / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BP.L / EL.N / F.N / FLS.N / GE.N / GM.N / IBE.MC / PFE.N / WMT.N / SSE.L / AMGN.O / FER.MC / ETN.N / DHR.N / WCC.N / DOV.N / IEX.N / ROP.N / HON.N / MMM.N / EMR.N / HCA.N / JCI.N / EPAY.O / AME.N / APT.AX / VRTX.O / GGG.N / MKL.N / PNR.N / ST.N / SKY.N / TT.N / ICPT.O / MMP.N / BIIB.O / NVT.N / HOG.N / EHTH.O / AEO.N / SPB.N / PCH.O / PCRX.O / STAG.N / MPC.N / FBHS.N / XYL.N / MPLX.N / BPY.N / AGIO.O / VRNS.O / CTLT.N / GBT.OQ / RPD.O / TRHC.OQ / ATKR.N / ICHR.O / GOOS.TO / ESTE.N / ORSTED.CO / AQUA.N / SAIL.N / Z1P.AX / GSHD.O / NTGY.MC / NBSE.OQ / CRNC.OQ / IGMS.O / SLQT.N / FOUR.N / RXT.OQ / JAMF.O</td><td class="leftalignment">BP PLC / Estee Lauder Companies Inc / Ford Motor Co / Flowserve Corp / General Electric Co / General Motors Co / Iberdrola SA / Pfizer Inc / Walmart Inc / SSE PLC / Amgen Inc / Ferrovial SA / Eaton Corporation PLC / Danaher Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / Honeywell International Inc / 3M Co / Emerson Electric Co / HCA Healthcare Inc / Johnson Controls International PLC / Bottomline Technologies Inc / AMETEK Inc / Afterpay Ltd / Vertex Pharmaceuticals Inc / Graco Inc / Markel Corp / Pentair PLC / Sensata Technologies Holding PLC / Skyline Champion Corp / Trane Technologies PLC / Intercept Pharmaceuticals Inc / Magellan Midstream Partners LP / Biogen Inc / nVent Electric PLC / Harley-Davidson Inc / eHealth Inc / American Eagle Outfitters Inc / Spectrum Brands Holdings Inc / Potlatchdeltic Corp / Pacira Biosciences Inc / STAG Industrial Inc / Marathon Petroleum Corp / Fortune Brands Home & Security Inc / Xylem Inc / MPLX LP / Brookfield Property Partners LP / Agios Pharmaceuticals Inc / Varonis Systems Inc / Catalent Inc / Global Blood Therapeutics Inc / Rapid7 Inc / Tabula Rasa HealthCare Inc / Atkore Inc / Ichor Holdings Ltd / Canada Goose Holdings Inc / Earthstone Energy Inc / Orsted A/S / Evoqua Water Technologies Corp / SailPoint Technologies Holdings Inc / Zip Co Ltd / Goosehead Insurance Inc / Naturgy Energy Group SA / NeuBase Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / SelectQuote Inc / Shift4 Payments Inc / Rackspace Technology Inc / Jamf Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Denmark / Spain / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BIIB: Our Thoughts Post the 4Q20 Call: 2021 a 'reset' year or the year of aducanumab? It really needs to be both.</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">BIIB.OQ / LLY.N</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BIIB: Biogen, Inc. - 4Q20 First Take: Very challenging guide, place further pressure on the potential approval of aducanumab</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - 3Q FY3/21 results: Negative surprise from full-year guidance downgrade, forecast 4Q loss</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - 3Q決算：会社通期予想を下方修正、4Q赤字転落はネガティブサプライズ</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4523.T / MRK.N / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Merck & Co Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Biogen Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Video: “The Feedback Loop” – Groundhog Day Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">VRTX.O / ICPT.O / BIIB.O / NBSE.OQ / IGMS.O</td><td class="leftalignment">Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / NeuBase Therapeutics Inc / IGM Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">INVITE: If You’re a HZNP Shareholder Wondering About VIE, We’ve Got Answers; Join Our Q&A Session with the Guggenheim Team</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BQPVQZ6 / 0989529 / 2455965</td><td class="leftalignment">Horizon Therapeutics PLC / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Dana C. Flanders, CFA / Mr. Seamus Fernandez / Mr. Yatin Suneja</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read & Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">NA / GILD.O / INCY.O / NBIX.O / VRTX.O / BLU.N / HOOK.O / BCRX.O / ICPT.O / BIIB.O / ACAD.O / INO.OQ / SRPT.O / ENTA.O / PTCT.O / KPTI.O / XNCR.OQ / ITCI.O / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / GBT.OQ / OVID.O / ITRM.O / PRVB.O / GMDA.OQ / NBSE.OQ / MORF.OQ / APRE.OQ / IGMS.O / ETNB.O / SPRB.OQ / MTCR.O</td><td class="leftalignment">National Bank of Canada / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / BELLUS Health Inc / HOOKIPA Pharma Inc / BioCryst Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Sarepta Therapeutics Inc / Enanta Pharmaceuticals Inc / PTC Therapeutics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / Global Blood Therapeutics Inc / Ovid Therapeutics Inc / Iterum Therapeutics PLC / Provention Bio Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Spruce Biosciences Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Broad Domestic Declines Continue as Vaccine Rollout Continues to Ramp Up; IHME Projects Variants May Extend Pandemic Tail</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 517125100 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Larimar Therapeutics Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: January 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / ALB.N / AXP.N / BA.N / BAC.N / BSX.N / C.N / CCL.N / CIT.N / CL.N / CRM.N / CVS.N / DAL.N / DD.N / EL.N / EOG.N / F.N / FCX.N / FDX.N / FLT.N / GM.N / HLT.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / LMT.N / LUV.N / MDT.N / MO.N / MRK.N / OXY.N / SLB.N / T.N / TMO.N / USB.N / WFC.N / WMT.N / CMA.N / PG.N / W.N / RIG.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / MGM.N / RCL.N / SYY.N / HON.N / VLO.N / HD.N / LOW.N / MRO.N / SYK.N / JWN.N / XOM.N / NKE.N / LIN.N / TGT.N / VZ.N / SNV.N / KSS.N / ORCL.N / VFC.N / HP.N / MAC.N / KMI.N / KMX.N / PWR.N / EQT.N / V.N / OKE.N / HWM.N / ACN.N / WSM.N / AIV.N / LB.TO / BLK.N / CVX.N / IRM.N / NCR.N / COP.N / INTC.OQ / ABMD.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / COHR.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / PII.N / REGN.OQ / ROL.N / SIVB.OQ / THO.N / QDEL.OQ / SNPS.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / CREE.OQ / GILD.OQ / COST.OQ / CPRT.OQ / TRU.N / ACGL.OQ / SSNC.OQ / EEFT.OQ / VSAT.OQ / AMZN.OQ / MRCY.OQ / EBAY.OQ / NVDA.OQ / MFA.N / CHTR.OQ / NUAN.OQ / ISRG.OQ / ILMN.OQ / ALGN.OQ / GPN.N / PTEN.OQ / NFLX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / SBNY.OQ / OSH.N / MOS.N / LVS.N / VIAC.OQ / DISCA.OQ / KOS.N / CDNS.OQ / MS.N / FIS.N / MA.N / SIX.N / SPR.N / CNK.N / IVZ.N / M.N / BGCP.OQ / PBF.N / MRNA.OQ / MSCI.N / CHNG.OQ / AVGO.OQ / FICO.N / CLNY.N / VRSK.OQ / SCHW.N / MU.OQ / NEE.N / TSLA.OQ / ADSGN.F / HHC.N / TWO.N / SABR.OQ / MPC.N / HFC.N / HZNP.OQ / AMD.OQ / ENPH.OQ / PSX.N / NOW.N / SRPT.OQ / BERY.N / FANG.OQ / ABBV.N / BFAM.N / COTY.N / FEYE.OQ / MAR.OQ / AAL.OQ / NCLH.N / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / WBA.OQ / SEDG.OQ / ETSY.OQ / TDOC.N / PYPL.OQ / PEN.N / NVCR.OQ / TMUS.OQ / SQ.N / RETA.OQ / TWLO.N / SPG.NZ / TTD.OQ / CDEV.OQ / UAA.N / FTI.PA / CVNA.N / AXON.OQ / ROKU.OQ / PEP.OQ / BKNG.OQ / ZS.OQ / QRTEA.OQ / FB.PS / CDAY.N / UAL.OQ / STNE.OQ / ETRN.N / NWL.OQ / CPRI.N / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / CRWD.OQ / PTON.OQ / SVC.OQ / SPCE.N / RTX.N / CARR.N / LMND.N / CHK.N^F20 / AMWL.N / LUMN.N / CHX.OQ</td><td class="leftalignment">Abbott Laboratories / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Boston Scientific Corp / Citigroup Inc / Carnival Corp / First-Citizens Bank & Trust Co / Colgate-Palmolive Co / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / FedEx Corp / Fleetcor Technologies Inc / General Motors Co / Hilton Worldwide Holdings Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Merck & Co Inc / Occidental Petroleum Corp / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Comerica Inc / Procter & Gamble Co / Wayfair Inc / Transocean Ltd / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / MGM Resorts International / Royal Caribbean Cruises Ltd / Sysco Corp / Honeywell International Inc / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Stryker Corp / Nordstrom Inc / Exxon Mobil Corp / Nike Inc / Linde PLC / Target Corp / Verizon Communications Inc / Synovus Financial Corp / Kohls Corp / Oracle Corp / VF Corp / Helmerich and Payne Inc / Macerich Co / Kinder Morgan Inc / Carmax Inc / Quanta Services Inc / EQT Corp / Visa Inc / ONEOK Inc / Howmet Aerospace Inc / Accenture PLC / Williams-Sonoma Inc / Apartment Investment and Management Co / Laurentian Bank of Canada / BlackRock Inc / Chevron Corp / Iron Mountain Inc / NCR Corp / Conocophillips / Intel Corp / ABIOMED Inc / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Coherent Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Polaris Inc / Regeneron Pharmaceuticals Inc / Rollins Inc / SVB Financial Group / Thor Industries Inc / Quidel Corp / Synopsys Inc / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Wolfspeed Inc / Gilead Sciences Inc / Costco Wholesale Corp / Copart Inc / TransUnion / Arch Capital Group Ltd / SS&C Technologies Holdings Inc / Euronet Worldwide Inc / ViaSat Inc / Amazon.com Inc / Mercury Systems Inc / eBay Inc / NVIDIA Corp / MFA Financial Inc / Charter Communications Inc / Nuance Communications Inc / Intuitive Surgical Inc / Illumina Inc / Align Technology Inc / Global Payments Inc / Patterson-UTI Energy Inc / Netflix Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Signature Bank / Oak Street Health Inc / Mosaic Co / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Kosmos Energy Ltd / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Six Flags Entertainment Corp / Spirit AeroSystems Holdings Inc / Cinemark Holdings Inc / Invesco Ltd / Macy's Inc / BGC Partners Inc / PBF Energy Inc / Moderna Inc / MSCI Inc / Change Healthcare Inc / Broadcom Inc / Fair Isaac Corp / DigitalBridge Group Inc / Verisk Analytics Inc / Charles Schwab Corp / Micron Technology Inc / Nextera Energy Inc / Tesla Inc / Adidas AG / Howard Hughes Corp / Two Harbors Investment Corp / Sabre Corp / Marathon Petroleum Corp / HollyFrontier Corp / Horizon Therapeutics PLC / Advanced Micro Devices Inc / Enphase Energy Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Berry Global Group Inc / Diamondback Energy Inc / Abbvie Inc / Bright Horizons Family Solutions Inc / Coty Inc / Mandiant Inc / Marriott International Inc / American Airlines Group Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Solaredge Technologies Inc / ETSY Inc / Teladoc Health Inc / PayPal Holdings Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Block Inc / Reata Pharmaceuticals Inc / Twilio Inc / Stride Property Ltd / Trade Desk Inc / Centennial Resource Development Inc / Under Armour Inc / TechnipFMC PLC / Carvana Co / Axon Enterprise Inc / Roku Inc / PepsiCo Inc / Booking Holdings Inc / Zscaler Inc / Qurate Retail Inc / San Miguel Food and Beverage Inc / Ceridian HCM Holding Inc / United Airlines Holdings Inc / StoneCo Ltd / Equitrans Midstream Corp / Newell Brands Inc / Capri Holdings Ltd / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / Service Properties Trust / Virgin Galactic Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Lemonade Inc / Chesapeake Energy Corp / American Well Corp / Lumen Technologies Inc / ChampionX Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Liberia / New Zealand / Panama / Philippines / United States / Virgin Islands, British / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">GRAPH -- FDA approvals post PDUFA extension</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat / Michael DiFiore</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Monthly Highlights--February 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">FISV=US / AAPL=US / VECO=US / WSM=US / NKE=US / CSII=US / FDX=US / CAT=US / INTC=US / MCD=US / CHRW=US / BWA=US / AMZN=US / T=US / ADBE=US / INCY=US / CG=US / D=US / USB=US / WFC=US / GILD=US / NVDA=US / EVER=US / TMX=US / JPM=US / FCEL=US / PLUG=US / BBI=US / NICE=US / SBH=US / CRM=US / GE=US / VZ=US / SYK=US / RMD=US / BAX=US / EMR=US / HON=US / HELE=US / CTAS=US / EXPE=US / TTWO=US / LSTR=US / ATVI=US / HCA=US / HUM=US / LECO=US / DOV=US / RSG=US / ALB=US / AMED=US / APPS=US / ACI=US / ATRC=US / ADSK=US / BOX=US / B=US / BL=US / BLUE=US / CHD=US / KMX=US / CRUS=US / COO=US / CYBR=US / DRI=US / DFS=US / DOCU=US / E=US / ECL=US / EGHT=US / EQIX=US / EXEL=US / HEAR=US / HRL=US / ITT=US / ICPT=US / IDCC=US / ITRI=US / TREE=US / LIFE=US / MNRO=US / TEAM=US / NR=US / NDSN=US / OSIS=US / ORLY=US / PZZA=US / PCTY=US / PHAR=US / REGN=US / ROK=US / SHOP=US / SUNS=US / SCM=US / SNAP=US / TWOU=US / UNFI=US / UTHR=US / URBN=US / Z=US / VRTX=US / VG=US / SAGE=US / PRVB=US / AAP=US / CRNT=US / CCRN=US / PYPL=US / JEF=US / AOS=US / FB=US / SWKS=US / ENSG=US / BE=US / ALPN=US / TWLO=US / CLH=US / MIST=US / WCN=US / DKS=US / MD=US / CASI=US / BIIB=US / ISR=US / SFM=US / ALNY=US / MBRX=US / DPZ=US / GOOG=US / BJRI=US / TXRH=US / ORA=US / FRPT=US / AMRS=US / PERI=US / SNSS=US / ICE=US / AXON=US / TH=US / CMG=US / MWA=US / SIX=US / XPO=US / FSLR=US / AIMC=US / NM=US / QSR=US / TRIT=US / M=US / PODD=US / VMW=US / TNDM=US / WH=US / DAN=US / SPRO=US / WYND=US / KLR=US / SPGI=US / AGCO=US / SLRC=US / CBOE=US / BLRX=US / MSCI=US / NXPI=US / WWD=US / ANGI=US / ZNGA=US / ENPH=US / TCPC=US / RXN=US / PANW=US / GMED=US / AMBA=US / HASI=US / MRTX=US / CNHI=US / ARMK=US / MDWD=US / VBIV=US / LOVE=US / VCEL=US / NVRO=US / NEWR=US / RLMD=US / GKOS=US / WING=US / PSTG=US / SPXC=US / AQMS=US / SQ=US / CERC=US / 113875965 / IONS=US / NTNX=US / 100502968 / WKHS=US / TCMD=US / FLGT=US / IRTC=US / UAA=US / AVDL=US / SRRA=US / OKTA=US / YEXT=US / VREX=US / NCNA=US / RCKT=US / CAAP=US / MOTS=US / SMAR=US / FOCS=US / CWEN=US / FTDR=US / MRKR=US / GMDA=US / CPRI=US / XFOR=US / ZM=US / TMDX=US / IDYA=US / CRWD=US / MWK=US / CMBM=US / FVRR=US / KRTX=US / DDOG=US / FREQ=US / ETNB=US / BXRX=US / MSGS=US / ORIC=US / AYLA=US / NNOX=US / TSHA=US / VLDR=US / ASAN=US / ABNB=US / ONDS=US</td><td class="leftalignment">Fiserv Inc / Apple Inc / Veeco Instruments Inc / Williams-Sonoma Inc / Nike Inc / Cardiovascular Systems Inc / FedEx Corp / Caterpillar Inc / Intel Corp / McDonald's Corp / CH Robinson Worldwide Inc / Borgwarner Inc / Amazon.com Inc / AT&T Inc / Adobe Inc / Incyte Corp / Carlyle Group Inc / Dominion Energy Inc / US Bancorp / Wells Fargo & Co / Gilead Sciences Inc / NVIDIA Corp / EverQuote Inc / Terminix Global Holdings Inc / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Brickell Biotech Inc / Nice Ltd / Sally Beauty Holdings Inc / Salesforce.Com Inc / General Electric Co / Verizon Communications Inc / Stryker Corp / Resmed Inc / Baxter International Inc / Emerson Electric Co / Honeywell International Inc / Helen of Troy Ltd / Cintas Corp / Expedia Group Inc / Take-Two Interactive Software Inc / Landstar System Inc / Activision Blizzard Inc / HCA Healthcare Inc / Humana Inc / Lincoln Electric Holdings Inc / Dover Corp / Republic Services Inc / Albemarle Corp / Amedisys Inc / Digital Turbine Inc / Albertsons Companies Inc / AtriCure Inc / Autodesk Inc / Box Inc / Barnes Group Inc / Blackline Inc / bluebird bio Inc / Church & Dwight Co Inc / Carmax Inc / Cirrus Logic Inc / Cooper Companies Inc / Cyberark Software Ltd / Darden Restaurants Inc / Discover Financial Services / DocuSign Inc / Eni SpA / Ecolab Inc / 8x8 Inc / Equinix Inc / Exelixis Inc / Turtle Beach Corp / Hormel Foods Corp / ITT Inc / Intercept Pharmaceuticals Inc / InterDigital Inc / Itron Inc / Lendingtree Inc / aTyr Pharma Inc / Monro Inc / Atlassian Corporation PLC / Newpark Resources Inc / Nordson Corp / OSI Systems Inc / O'Reilly Automotive Inc / Papa John's International Inc / Paylocity Holding Corp / Pharming Group NV / Regeneron Pharmaceuticals Inc / Rockwell Automation Inc / Shopify Inc / SLR Senior Investment Corp / Stellus Capital Investment Corp / Snap Inc / 2U Inc / United Natural Foods Inc / United Therapeutics Corp / Urban Outfitters Inc / Zillow Group Inc / Vertex Pharmaceuticals Inc / Vonage Holdings Corp / SAGE Therapeutics Inc / Provention Bio Inc / Advance Auto Parts Inc / Ceragon Networks Ltd / Cross Country Healthcare Inc / PayPal Holdings Inc / Jefferies Financial Group Inc / A O Smith Corp / Meta Platforms Inc / Skyworks Solutions Inc / Ensign Group Inc / Bloom Energy Corp / Alpine Immune Sciences Inc / Twilio Inc / Clean Harbors Inc / Milestone Pharmaceuticals Inc / Waste Connections Inc / DICK'S Sporting Goods Inc / MEDNAX Inc / CASI Pharmaceuticals Inc / Biogen Inc / IsoRay Inc / Sprouts Farmers Market Inc / Alnylam Pharmaceuticals Inc / Moleculin Biotech Inc / Domino's Pizza Inc / Alphabet Inc / BJ's Restaurants Inc / Texas Roadhouse Inc / Ormat Technologies Inc / Freshpet Inc / Amyris Inc / Perion Network Ltd / Viracta Therapeutics Inc / Intercontinental Exchange Inc / Axon Enterprise Inc / Target Hospitality Corp / Chipotle Mexican Grill Inc / Mueller Water Products Inc / Six Flags Entertainment Corp / XPO Logistics Inc / First Solar Inc / Altra Industrial Motion Corp / Navios Maritime Holdings Inc / Restaurant Brands International Inc / Triterras Inc / Macy's Inc / Insulet Corp / VMware Inc / Tandem Diabetes Care Inc / Wyndham Hotels & Resorts Inc / Dana Inc / Spero Therapeutics Inc / Travel + Leisure Co / Kaleyra Inc / S&P Global Inc / AGCO Corp / SLR Investment Corp / Cboe Global Markets Inc / BioLine RX Ltd / MSCI Inc / NXP Semiconductors NV / Woodward Inc / Angi Inc / Zynga Inc / Enphase Energy Inc / BlackRock TCP Capital Corp / Zurn Water Solutions Corp / Palo Alto Networks Inc / Globus Medical Inc / Ambarella Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Mirati Therapeutics Inc / CNH Industrial NV / Aramark / Mediwound Ltd / VBI Vaccines Inc / Lovesac Co / Vericel Corp / Nevro Corp / New Relic Inc / Relmada Therapeutics Inc / Glaukos Corp / Wingstop Inc / Pure Storage Inc / SPX Corp / Aqua Metals Inc / Block Inc / Avalo Therapeutics Inc / CNH Industrial NV / Ionis Pharmaceuticals Inc / Nutanix Inc / Precision Drilling Corp / Workhorse Group Inc / Tactile Systems Technology Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Under Armour Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Okta Inc / Yext Inc / Varex Imaging Corp / NuCana PLC / Rocket Pharmaceuticals Inc / Corporacion America Airports SA / Motus GI Holdings Inc / Smartsheet Inc / Focus Financial Partners Inc / Clearway Energy Inc / Frontdoor Inc / Marker Therapeutics Inc / Gamida Cell Ltd / Capri Holdings Ltd / X4 Pharmaceuticals Inc / Zoom Video Communications Inc / Transmedics Group Inc / IDEAYA Biosciences Inc / CrowdStrike Holdings Inc / Aterian Inc / Cambium Networks Corp / Fiverr International Ltd / Karuna Therapeutics Inc / Datadog Inc / Frequency Therapeutics Inc / 89Bio Inc / Baudax Bio Inc / Madison Square Garden Sports Corp / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Nano-X Imaging Ltd / Taysha Gene Therapies Inc / Velodyne Lidar Inc / Asana Inc / Airbnb Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / United States / Virgin Islands, British / Marshall Islands</td><td class="leftalignment">Services</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Biotechnology Monthly</td><td class="leftalignment">English</td><td class="rightalignment">164</td><td class="leftalignment">US09061G1013 / US09062X1037 / 46116X101 / 09075P105</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Biogen Inc / Intra-Cellular Therapies Inc / BioXcel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / China / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Canaccord Genui Research / Michelle Gilson / Sumant Kulkarni / Ms. Arlinda A. Lee, PHD / Mr. Edward H. Nash / Mr. John L. Newman, Ph.D., CFA, PHD / Jia Min, CFA / Benedict Shim</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Jan 31 2021 11:07PM</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">EBAY=US / WING=US / AAPL=US / DELL=US / IBM=US / GM=US / INTC=US / AMD=US / GBT=US / MSFT=US / MU=US / AMZN=US / QCOM=US / U=US / DNLI=US / NVDA=US / NTAP=US / UMC=US / XLNX=US / EXPE=US / IIVI=US / XOMA=US / ACET=US / APLS=US / AVGO=US / BMRN=US / BLUE=US / CYBR=US / ISEE=US / FUSN=US / ICPT=US / NBIX=US / PRTK=US / PRVL=US / RARE=US / RKT=US / SGMO=US / SWTX=US / UTHR=US / WDC=US / SAGE=US / NRZ=US / BKNG=US / ACOR=US / MFA=US / FBC=US / MTCH=US / PMT=US / SWKS=US / VRNT=US / ALPN=US / COOP=US / PFSI=US / GPRO=US / STX=US / IGMS=US / STRO=US / BIIB=US / APTX=US / SIMO=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / 2454=US / ALNA=US / LXRX=US / 2330=US / VMW=US / 6758=US / IDRA=US / IAC=US / ASND=US / RCUS=US / 8299=US / OMER=US / TSLA=US / FNMA=US / FMCC=US / NXPI=US / WD=US / PCRX=US / 981=US / BEAM=US / ANGI=US / RGLS=US / RTRX=US / EPZM=US / FATE=US / CHMI=US / MGNX=US / KPTI=US / XNCR=US / GOOGL=US / AGTC=US / BABA=US / XENE=US / QRVO=US / CDTX=US / BPMC=US / ABUS=US / PSTG=US / ARGX=US / NVCR=US / HPE=US / CTMX=US / ZS=US / VYGR=US / KURA=US / EIGR=US / CRVS=US / NTLA=US / CLSD=US / SYRS=US / ALBO=US / OBSV=US / ANAB=US / VRNA=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / LQDA=US / ETTX=US / YMAB=US / ARVN=US / MLND=US / HARP=US / TCRR=US / PINS=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / FUBO=US / NKLA=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / ABNB=US / TELOS=US / KNTE=US / UWMC=US</td><td class="leftalignment">eBay Inc / Wingstop Inc / Apple Inc / Dell Technologies Inc / International Business Machines Corp / General Motors Co / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Unity Software Inc / Denali Therapeutics Inc / NVIDIA Corp / NetApp Inc / United Microelectronics Corp / Xilinx Inc / Expedia Group Inc / II-VI Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / Biomarin Pharmaceutical Inc / bluebird bio Inc / Cyberark Software Ltd / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Porvair PLC / Ultragenyx Pharmaceutical Inc / Rocket Companies Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / Western Digital Corp / SAGE Therapeutics Inc / New Residential Investment Corp / Booking Holdings Inc / Acorda Therapeutics Inc / MFA Financial Inc / Flagstar Bancorp Inc / Match Group Inc / PennyMac Mortgage Investment Trust / Skyworks Solutions Inc / Verint Systems Inc / Alpine Immune Sciences Inc / Mr Cooper Group Inc / PennyMac Financial Services Inc / GoPro Inc / Seagate Technology Holdings PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Aptinyx Inc / Silicon Motion Technology Corp / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / MediaTek Inc / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Taiwan Semiconductor Manufacturing Co Ltd / VMware Inc / Sony Group Corp / Idera Pharmaceuticals Inc / IAC/Interactivecorp / Ascendis Pharma A/S / Arcus Biosciences Inc / Phison Electronics Corp / Omeros Corp / Tesla Inc / Federal National Mortgage Association / Federal Home Loan Mortgage Corp / NXP Semiconductors NV / Walker & Dunlop Inc / Pacira Biosciences Inc / Semiconductor Manufacturing International Corp / Beam Therapeutics Inc / Angi Inc / Regulus Therapeutics Inc / Travere Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / Cherry Hill Mortgage Investment Corp / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Alphabet Inc / Applied Genetic Technologies Corp / Alibaba Group Holding Ltd / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / Pure Storage Inc / argenx SE / Novocure Ltd / Hewlett Packard Enterprise Co / CytomX Therapeutics Inc / Zscaler Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Eiger BioPharmaceuticals Inc / Corvus Pharmaceuticals Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Syros Pharmaceuticals Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Verona Pharma PLC / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Liquidia Corp / Entasis Therapeutics Holdings Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Tempest Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Pinterest Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Fubotv Inc / Nikola Corp / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Airbnb Inc / Telenor ASA / Kinnate Biopharma Inc / UWM Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Greece / Ireland / Israel / Japan / Netherlands / Norway / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Consumer / Electronics / Healthcare / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Real Estate / Retailing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 01 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MOGa / US0079731008 / US0116591092 / US0311621009 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US14149Y1082 / US1925761066 / US22284P1057 / US2910111044 / US3021301094 / US3695501086 / US37733W1053 / US4385161066 / US4433201062 / US4448591028 / US4456581077 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US58155Q1031 / US6558441084 / US6668071029 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US7766961061 / US8308791024 / US8447411088 / US8552441094 / US87612E1064 / US8807701029 / US9029251066 / US9078181081 / US91324P1021 / US91347P1057 / US9311421039 / US9507551086 / CA1363751027 / US03073E1055 / CA13645T1003 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US25754A2015 / US0042251084 / US02043Q1076 / US15135B1017 / US12541W2098 / ACOR.OQ / US1696561059 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US30303M1027 / US9837931008 / US00287Y1091 / NL0010273215 / US8485771021 / US60468T1051 / US21240E1055 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US00653A1079 / US9741551033 / US70450Y1038 / US40434L1052 / US05464T1043 / US00773U1088 / US16119P1084 / IE00BY7QL619 / KYG4740B1059 / CA87241L1094 / US23753F1075 / US80689H1023 / US02156K1034 / US4990491049 / US1010441053 / US05351X1019 / US5904791358 / US0197701065 / US1255231003 / US8740602052 / US24703L2025 / US0144421072 / US55087P1049 / US90353T1007 / US18453H1068 / US70614W1009 / US09203E1055 / US4432011082 / CH0499880968</td><td class="leftalignment">Moog Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cardinal Health Inc / Cohu Inc / Covenant Logistics Group Inc / Emerson Electric Co / Expeditors International of Washington Inc / General Dynamics Corp / GlaxoSmithKline PLC / Honeywell International Inc / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / Mckesson Corp / Norfolk Southern Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / Roper Technologies Inc / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Target Corp / Teradyne Inc / USA Truck Inc / Union Pacific Corp / UnitedHealth Group Inc / Universal Display Corp / Walmart Inc / Werner Enterprises Inc / Canadian National Railway Co / Amerisourcebergen Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / Domino's Pizza Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Centene Corp / CH Robinson Worldwide Inc / Acorda Therapeutics Inc / Chipotle Mexican Grill Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Meta Platforms Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Spirit Airlines Inc / Mirati Therapeutics Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Wingstop Inc / PayPal Holdings Inc / HP Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / Johnson Controls International PLC / Ichor Holdings Ltd / TFI International Inc / Daseke Inc / Schneider National Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Boston Omaha Corp / Avaya Holdings Corp / Mesa Air Group Inc / Allogene Therapeutics Inc / Cigna Corp / Takeda Pharmaceutical Co Ltd / Dell Technologies Inc / Alector Inc / Lyft Inc / Uber Technologies Inc / Clear Channel Outdoor Holdings Inc / Peloton Interactive Inc / Black Diamond Therapeutics Inc / Howmet Aerospace Inc / ADC Therapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">WMB=US / LLY=US / AMGN=US / BMY=US / CL=US / AMZN=US / INCY=US / KMI=US / AMT=US / CHTR=US / CRM=US / PAA=US / CCI=US / BRO=US / MANH=US / CMCSA=US / CHD=US / COLL=US / AJG=US / MPLX=US / OKE=US / SBAC=US / TRGP=US / WIX=US / HTH=US / CVX=US / EPD=US / CGEN=US / CFR=US / SIVB=US / ABCB=US / DCP=US / SSB=US / BDSI=US / MMP=US / BIIB=US / MOG.A=US / EXP=US / BAH=US / EHTH=US / PAGP=US / SMLP=US / MODN=US / PTCT=US / CEQP=US / GOOGL=US / WVE=US / WLTW=US / EVBG=US / IRTC=US / RTLR=US / LHX=US</td><td class="leftalignment">Williams Companies Inc / Eli Lilly and Co / Amgen Inc / Bristol-Myers Squibb Co / Colgate-Palmolive Co / Amazon.com Inc / Incyte Corp / Kinder Morgan Inc / American Tower Corp / Charter Communications Inc / Salesforce.Com Inc / Plains All American Pipeline LP / Crown Castle International Corp / Brown & Brown Inc / Manhattan Associates Inc / Comcast Corp / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / Arthur J Gallagher & Co / MPLX LP / ONEOK Inc / SBA Communications Corp / Targa Resources Corp / Wix.Com Ltd / Hilltop Holdings Inc / Chevron Corp / Enterprise Products Partners LP / Compugen Ltd / Cullen/Frost Bankers Inc / SVB Financial Group / Ameris Bancorp / DCP Midstream LP / SouthState Corp / BioDelivery Sciences International Inc / Magellan Midstream Partners LP / Biogen Inc / Moog Inc / Eagle Materials Inc / Booz Allen Hamilton Holding Corp / eHealth Inc / Plains GP Holdings LP / Summit Midstream Partners LP / Model N Inc / PTC Therapeutics Inc / Crestwood Equity Partners LP / Alphabet Inc / WAVE Life Sciences Ltd / Willis Towers Watson PLC / Everbridge Inc / iRhythm Technologies Inc / Rattler Midstream LP / L3harris Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GBT=US / DNLI=US / XOMA=US / ACET=US / APLS=US / BMRN=US / BLUE=US / ISEE=US / FUSN=US / ICPT=US / NBIX=US / PRTK=US / PRVL=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / ALNA=US / LXRX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / EIGR=US / CRVS=US / NTLA=US / CLSD=US / ALBO=US / OBSV=US / ANAB=US / VRNA=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / MGTA=US / REPL=US / AQST=US / LQDA=US / YMAB=US / ARVN=US / MLND=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / BDTX=US / PASG=US / ZNTL=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US / KNTE=US</td><td class="leftalignment">Global Blood Therapeutics Inc / Denali Therapeutics Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Porvair PLC / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Eiger BioPharmaceuticals Inc / Corvus Pharmaceuticals Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Verona Pharma PLC / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Liquidia Corp / Y-mAbs Therapeutics Inc / Arvinas Inc / Tempest Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Black Diamond Therapeutics Inc / Passage Bio Inc / Zentalis Pharmaceuticals Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc / Kinnate Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Wedbush Monthly Check-Up: February 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GBT=US / DNLI=US / APLS=US / BMRN=US / FUSN=US / ICPT=US / NBIX=US / PRTK=US / PRVL=US / RARE=US / SWTX=US / UTHR=US / SAGE=US / ACOR=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / APTX=US / SURF=US / ALNA=US / LXRX=US / IDRA=US / RCUS=US / OMER=US / PCRX=US / RTRX=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / SYRS=US / ALBO=US / OBSV=US / ANAB=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / REPL=US / AQST=US / LQDA=US / ETTX=US / YMAB=US / ARVN=US / HARP=US / TCRR=US / STOK=US / BCEL=US / KRTX=US</td><td class="leftalignment">Global Blood Therapeutics Inc / Denali Therapeutics Inc / Apellis Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Fusion Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Porvair PLC / Ultragenyx Pharmaceutical Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Acorda Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Aptinyx Inc / Surface Oncology Inc / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Travere Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Syros Pharmaceuticals Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Replimune Group Inc / Aquestive Therapeutics Inc / Liquidia Corp / Entasis Therapeutics Holdings Inc / Y-mAbs Therapeutics Inc / Arvinas Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Ms. Laura K. Chico, PHD / Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">V / 2936921 / 2516152 / 2681511 / 2496113 / 2008154 / 2486813 / 2206657 / 2270726 / 2542049 / 2037170 / 2100920 / 2366799 / 2455965 / 2459202 / 2459020 / 2657802 / 2680905 / 2048804 / 7123870 / B1F76F9 / B121557 / B067BM3 / B1Y9TB3 / B2R3PV1 / B3P93Y7 / B3SWPT2 / B7TL820 / B7VD3F2 / BFLR866 / B95WG16 / BZ07BW4 / BYRY499 / BVVN4Q8 / BYY8XK8 / BD3W133 / BYNZGK1 / BFMXGR0 / BFNR303 / BJXBP30 / BYWMQJ2 / BDH65C8 / BD6D4Y5 / BZ1LFG7 / BMH0MR7 / BDVLM39 / BMDCDP2 / BJRFSB7 / BN7K304 / BLBLMD5 / 021513106</td><td class="leftalignment">Visa Inc / Walmart Inc / Eli Lilly and Co / PepsiCo Inc / Kohls Corp / Adobe Inc / Kellogg Co / Coca-Cola Co / Walt Disney Co / Dominion Energy Inc / 8x8 Inc / FirstEnergy Corp / Gentex Corp / Biogen Inc / IDEXX Laboratories Inc / Intuit Inc / OGE Energy Corp / PPL Corp / Pinnacle West Capital Corp / Nestle SA / Western Union Co / Mastercard Inc / Molson Coors Beverage Co / Danone SA / American Water Works Company Inc / Anheuser Busch Inbev SA / Ameresco Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Zoetis Inc / Monster Beverage Corp / Kraft Heinz Co / Eversource Energy / WEC Energy Group Inc / Keurig Dr Pepper Inc / Block Inc / Evergy Inc / Northwest Natural Holding Co / Turning Point Therapeutics Inc / Alteryx Inc / PetIQ Inc / Altair Engineering Inc / Roku Inc / Zendesk Inc / argenx SE / Bigcommerce Holdings Inc / Immunovant Inc / Academy Sports and Outdoors Inc / Array Technologies Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Efficiently Building a Diverse Pipeline; Initiating With a Buy Rating and $47 PT</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">CGEM.OQ / BIIB / 84763A108 / 556099109 / 189464100 / 74587V107 / 09203E105 / N5749R100 / 68622P109 / 45781K204</td><td class="leftalignment">Cullinan Oncology Inc / Biogen Inc / Spectrum Pharmaceuticals Inc / MacroGenics Inc / Clovis Oncology Inc / Puma Biotechnology Inc / Black Diamond Therapeutics Inc / Merus NV / Oric Pharmaceuticals Inc / Innate Pharma SA</td><td class="leftalignment"></td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Edward P. White, II</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">US Morning Summary, February 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0231351067 / US6153942023 / US09062X1037 / 861012102 / GOOGL.OQ / 83304A106 / 450056106 / L8681T102 / 70614W100 / 11778X104</td><td class="leftalignment">Amazon.com Inc / Moog Inc / Biogen Inc / STMicroelectronics NV / Alphabet Inc / Snap Inc / iRhythm Technologies Inc / Spotify Technology SA / Peloton Interactive Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Canaccord Genui Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (from 1 Feb): Focus on results, major swings in M3 and JCR share prices, ongoing upside signs for pharma stocks</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">2413.T / 4552.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / 4516.T / AZN.L / 4506.T / 4536.T / ROG.S / 4151.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 4568.T / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">M3 Inc / JCR Pharmaceuticals Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（2月1日～）: 決算発表へ突入、M3とJCRが大幅上下振動、医薬品全般に底上げが続くか注目</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">2413.T / 4552.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / 4516.T / AZN.L / 4506.T / 4536.T / ROG.S / 4151.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 4568.T / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">M3 Inc / JCR Pharmaceuticals Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: Eisai - Aducanumab's PDUFA action date extended three months; steppingstone to approval?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4523.T / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4523.T: エーザイ - AD治療薬アデュカヌマブの審査終了目標日3ヵ月延長、承認への踏み絵？</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">4523.T / BIIB.OQ</td><td class="leftalignment">Eisai Co Ltd / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen's Biotech Thermometer</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US0465131078 / US00653A1079 / US05464T1043 / US00773U1088 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968</td><td class="leftalignment">Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Atara Biotherapeutics Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : 4Q20 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">53</td><td class="leftalignment">ACAD.O / ALKS.O / GILD.O / AMGN.O / INCY.O / BMRN.O / REGN.O / VRTX.O / RARE.O / SGEN.O / BIIB.O / MRNA.O / CLVS.O / SAGE.O / NVCR.O / PBYI.O / BNTX.O</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Seagen Inc / Biogen Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Novocure Ltd / Puma Biotechnology Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Matthew T. Holt, P.Eng / James Scott / Mr. Turner Kufe / Manish Jajoo</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Solid 4Q results; PT to $215, maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / BIIB=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccines vs variants; IND cleared for PASG</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PASG.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 4Q20 Biotech Earnings Consensus Cheat Sheet for VRTX, AMGN, BIIB, GILD, NBIX, and REGN</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N / PFE.N / AZN.L / NOVN.S / GSK.L / AMGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ABBV.N</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 532</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">30-sec Biotech Nightcap</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN=US / INCY=US / BIIB=US</td><td class="leftalignment">Amgen Inc / Incyte Corp / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ADS / AIG / AJG / ALL / AMAT.O / AON / ARW / CB / CCI / CE / CP / DVN / EOG / GS / HIG / INTC.O / JNJ / KLAC.O / LNC / LRCX.O / MET / MMC / NSC / OLN / PRU / PSX / RE / RNR / SHW / STZ / TRV / XLNX.O / ASML.O / WWE / BRO / AAPL.O / KMI / NVDA.O / AMD.O / NTAP.O / SYF / AXS / MU.O / HPQ / HPE / AVGO.O / ACGL.O / MKSI.O / SWKS.O / BIIB.O / STX.O / CVLT.O / JNPR.K / NXPI.O / FIBK.O / LNG.N / WDC.O / MDLZ.O / VOYA.K / ANET.K / QRVO.O / PSTG.K / WLTW.O / NTNX.O / HESM.K / EQH / AVT.O / DELL.K / ALGM.O / 120175706</td><td class="leftalignment">Alliance Data Systems Corp / American International Group Inc / Arthur J Gallagher & Co / Allstate Corp / Applied Materials Inc / Aon PLC / Arrow Electronics Inc / Chubb Ltd / Crown Castle International Corp / Celanese Corp / Canadian Pacific Railway Ltd / Devon Energy Corp / EOG Resources Inc / Goldman Sachs Group Inc / Hartford Financial Services Group Inc / Intel Corp / Johnson & Johnson / KLA Corp / Lincoln National Corp / Lam Research Corp / MetLife Inc / Marsh & McLennan Companies Inc / Norfolk Southern Corp / Olin Corp / Prudential Financial Inc / Phillips 66 / Everest Re Group Ltd / Renaissancere Holdings Ltd / Sherwin-Williams Co / Constellation Brands Inc / Travelers Companies Inc / Xilinx Inc / ASML Holding NV / World Wrestling Entertainment Inc / Brown & Brown Inc / Apple Inc / Kinder Morgan Inc / NVIDIA Corp / Advanced Micro Devices Inc / NetApp Inc / Synchrony Financial / AXIS Capital Holdings Ltd / Micron Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Arch Capital Group Ltd / MKS Instruments Inc / Skyworks Solutions Inc / Biogen Inc / Seagate Technology Holdings PLC / Commvault Systems Inc / Juniper Networks Inc / NXP Semiconductors NV / First Interstate BancSystem Inc / Cheniere Energy Inc / Western Digital Corp / Mondelez International Inc / Voya Financial Inc / Arista Networks Inc / Qorvo Inc / Pure Storage Inc / Willis Towers Watson PLC / Nutanix Inc / Hess Midstream LP / Equitable Holdings Inc / Avnet Inc / Dell Technologies Inc / Allegro Microsystems Inc / Cisco Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Alzheimer's Tidbits from Lilly Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY=US / BIIB=US / ACIU=US</td><td class="leftalignment">Eli Lilly and Co / Biogen Inc / AC Immune SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Marc Goodman</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">KOL (former FDA clinical reviewer for neuro) says BIIB delay is positive</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Biogen : So You're Telling Me There's a Chance? Adu PDUFA Extended 3 Mos</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Cory W. Kasimov / Mr. Turner Kufe / Mr. Matthew T. Holt, P.Eng / James Scott</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">BIIB - Two ways to look at an aducanumab PDUFA delay</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">NL0000226223 / DE0006231004 / US09061G1013 / US00738A1060 / US02553E1064 / US0378331005 / US0382221051 / US1005571070 / US1727551004 / US22160K1051 / US30226D1063 / US3156161024 / US3647601083 / US4581401001 / US4663671091 / US48203R1041 / US5002551043 / US5951121038 / US6541061031 / US6549022043 / US6556641008 / US7392761034 / US7475251036 / US7782961038 / US8168501018 / US8610121027 / US8725401090 / US87612E1064 / US8807701029 / US9021041085 / US91347P1057 / US9311421039 / US9581021055 / US3448491049 / US5658491064 / US87157D1090 / US83088M1027 / US2948216088 / US21036P1084 / US2533931026 / US09062X1037 / US1572101053 / US90385V1070 / US9043111072 / US42809H1077 / US82706C1080 / US1717793095 / US55616P1049 / US2120151012 / US13100M5094 / DE000A1EWWW0 / US4361061082 / US56585A1025 / US7185461040 / NL0010273215 / US5017971046 / US09609G1004 / US64051T1007 / US03823U1025 / US0404131064 / US69888T2078 / US74736K1016 / US00773U1088 / US7625441040 / US09857L1089 / US11135F1012 / US05455M1009 / US39874R1014 / US00973J1016 / US0090661010 / 120175706</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Biomarin Pharmaceutical Inc / ADTRAN Inc / American Eagle Outfitters Inc / Apple Inc / Applied Materials Inc / Boston Beer Company Inc / Cirrus Logic Inc / Costco Wholesale Corp / Extreme Networks Inc / F5 Inc / Gap Inc / Intel Corp / Jack in the Box Inc / Juniper Networks Inc / Kohls Corp / Micron Technology Inc / Nike Inc / Nokia Oyj / Nordstrom Inc / Power Integrations Inc / Qualcomm Inc / Ross Stores Inc / Semtech Corp / STMicroelectronics NV / TJX Companies Inc / Target Corp / Teradyne Inc / II-VI Inc / Universal Display Corp / Walmart Inc / Western Digital Corp / Foot Locker Inc / Marathon Oil Corp / Synaptics Inc / Skyworks Solutions Inc / Telefonaktiebolaget LM Ericsson / Constellation Brands Inc / DICK'S Sporting Goods Inc / Biogen Inc / CEVA Inc / Ultra Clean Holdings Inc / Under Armour Inc / Hess Corp / Silicon Motion Technology Corp / Ciena Corp / Macy's Inc / Continental Resources Inc / Calix Inc / Adidas AG / HollyFrontier Corp / Marathon Petroleum Corp / Phillips 66 / ASML Holding NV / Bath & Body Works Inc / bluebird bio Inc / NeoPhotonics Corp / Applied Optoelectronics Inc / Arista Networks Inc / Par Pacific Holdings Inc / Qorvo Inc / Adverum Biotechnologies Inc / Ribbon Communications Inc / Booking Holdings Inc / Broadcom Inc / AVROBIO Inc / Grocery Outlet Holding Corp / Akouos Inc / Airbnb Inc / Cisco Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Finland / United Kingdom / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--Jan. 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">CHE=US / HUM=US / BSX=US / CSII=US / LLY=US / ABT=US / AMGN=US / GBT=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / SYK=US / RMD=US / RAD=US / HCA=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CYH=US / EW=US / GEN=US / LH=US / LIFE=US / PHAR=US / PRVL=US / SILK=US / USPH=US / UTHR=US / UHS=US / SGEN=US / SAGE=US / OPT=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / CASI=US / SLF=US / BIIB=US / MRNA=US / MNKD=US / GOOG=US / LHCG=US / SNSS=US / CHNG=US / EHC=US / NMTR=US / SWAV=US / ADUS=US / IRWD=US / ACHC=US / AGIO=US / CTRE=US / AUPH=US / VBLT=US / NVRO=US / WBA=US / CLLS=US / EVH=US / CATB=US / PEN=US / BGNE=US / IRTC=US / ZEAL=US / ZLAB=US / FIXX=US / BHC=US / NBSE=US / PNTG=US</td><td class="leftalignment">Chemed Corp / Humana Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Abbott Laboratories / Amgen Inc / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Resmed Inc / Rite Aid Corp / HCA Healthcare Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Pharming Group NV / Porvair PLC / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Seagen Inc / SAGE Therapeutics Inc / Opthea Ltd / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / CASI Pharmaceuticals Inc / Sun Life Financial Inc / Biogen Inc / Moderna Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Encompass Health Corp / 9 Meters Biopharma Inc / Shockwave Medical Inc / Addus Homecare Corp / Ironwood Pharmaceuticals Inc / Acadia Healthcare Company Inc / Agios Pharmaceuticals Inc / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Vascular Biogenics Ltd / Nevro Corp / Walgreens Boots Alliance Inc / Cellectis SA / Evolent Health Inc / Astria Therapeutics Inc / Penumbra Inc / Beigene Ltd / iRhythm Technologies Inc / Zealand Pharma A/S / Zai Lab Ltd / Homology Medicines Inc / Bausch Health Companies Inc / NeuBase Therapeutics Inc / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">BIIB:  alzh PDUFA extension = re-dosing study submitted?</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat / Michael DiFiore</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: EpiPen Mkt Growth Strong; Vascepa Gx at High-Single Digit Share</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">We highlight recent examples of drugs approved and still in review following FDA extension</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US / BMY=US / PTCT=US</td><td class="leftalignment">Biogen Inc / Bristol-Myers Squibb Co / PTC Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Major Amendment to Aducanumab Application Results in Three-Month PDUFA Delay; Likely a Slight Positive Despite Scant Details</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Matt Phipps, PHD / Mr. Rob Andrew, CFA / Mr. Hunter Rogers</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Adu's PDUFA Extended 3 Months; A Positive, Though Approval Is Still Unlikely</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Phil M. Nadeau, Ph.D., PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Kicking the Aducanumab Can or Bullish Signal? Still Anyone’s Guess</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">09062X103</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Alive adu can kicked three months down the road; reiterate BUY, $359 PT</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US09062X1037</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sumant Kulkarni / Jia Min, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Another Aducanumab Positive Surprise With Major Amendment</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BIIB: Adu PDUFA Delayed 3mo, Suggesting FDA Remains Amendable, Though Not Yet Completely Convinced</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Brian Abrahams, MD</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BIIB - Aducanumab PDUFA Extension A Bullish Signal? We Think So</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2455965</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">We are not making a real negative or positive read to Alzheimer's disease approval delay but just part of a complicated process</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">FDA Pushes Back Aducanumab Alzheimer's Disease Decision To June</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Aducanumab PDUFA date now June 7th (+ 3 months to prev)</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB=US</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 1/22/21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Jan 29 2021 6:45AM</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AX=US / WDC=US / FISV=US / DELL=US / INTC=US / MCD=US / AMD=US / MU=US / NOK=US / QCOM=US / NVDA=US / NTAP=US / BC=US / V=US / UMC=US / EWBC=US / ADS=US / APLS=US / BZH=US / HZO=US / NBIX=US / RARE=US / TSC=US / TSCO=US / FOUR=US / GPN=US / PYPL=US / ACOR=US / EVOP=US / SWKS=US / STX=US / ERIC=US / CVCO=US / BIIB=US / SIMO=US / FIS=US / MA=US / LXRX=US / 2330=US / PCRX=US / CUBI=US / QRVO=US / PSTG=US / SQ=US / BHVN=US / IIIV=US / RPAY=US / TVTX=US</td><td class="leftalignment">Axos Financial Inc / Western Digital Corp / Fiserv Inc / Dell Technologies Inc / Intel Corp / McDonald's Corp / Advanced Micro Devices Inc / Micron Technology Inc / Nokia Oyj / Qualcomm Inc / NVIDIA Corp / NetApp Inc / Brunswick Corp / Visa Inc / United Microelectronics Corp / East West Bancorp Inc / Alliance Data Systems Corp / Apellis Pharmaceuticals Inc / Beazer Homes USA Inc / MarineMax Inc / Neurocrine Biosciences Inc / Ultragenyx Pharmaceutical Inc / TriState Capital Holdings Inc / Tractor Supply Co / Shift4 Payments Inc / Global Payments Inc / PayPal Holdings Inc / Acorda Therapeutics Inc / EVO Payments Inc / Skyworks Solutions Inc / Seagate Technology Holdings PLC / Telefonaktiebolaget LM Ericsson / Cavco Industries Inc / Biogen Inc / Silicon Motion Technology Corp / Fidelity National Information Services Inc / Mastercard Inc / Lexicon Pharmaceuticals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Pacira Biosciences Inc / Customers Bancorp Inc / Qorvo Inc / Pure Storage Inc / Block Inc / Biohaven Pharmaceutical Holding Company Ltd / I3 Verticals Inc / Repay Holdings Corp / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Finland / Ireland / Sweden / Taiwan / United States / Virgin Islands, British</td><td class="leftalignment">Banks / Biotechnology / Building & Building Materials / Financial Services / Household Products / Info. Tech./Computers / Leisure & Entertainment / Lodging & Restaurants / Pharmaceuticals / Retailing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">With Most Of The Fireworks Already Shot Off, Looking For Quiet 4Q20 Reporting</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">ACOR=US / NBIX=US / RARE=US / BIIB=US / BHVN=US / TVTX=US</td><td class="leftalignment">Acorda Therapeutics Inc / Neurocrine Biosciences Inc / Ultragenyx Pharmaceutical Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Preview Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / BAYGN.DE / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Bayer AG / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BIIB: Biogen, Inc. - Adu PDUFA Pushed to June 7, 2021: Our bias remains positive on the program</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BIIB.OQ / 4523.T / SAGE.OQ</td><td class="leftalignment">Biogen Inc / Eisai Co Ltd / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Three in a Row: Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">BTIG</td><td class="leftalignment">Recent AD Update Demonstration That Systemic Administration of INMB's Soluble TNFa Disrupter XPro1595 Reduced CNS Inflammation. The Stock Reaction Has Us Puzzled. PT to $31 from $23 on Improved Proof of Effect on Established Biomarkers.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">45782T10 / 09062X103 / 24823R105 / 014442107</td><td class="leftalignment">INmune Bio Inc / Biogen Inc / Denali Therapeutics Inc / Alector Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas E. Shrader, PHD / Mr. Julian Harrison / Ms. Kaveri Pohlman</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MPWR=US / NDAQ=US / AAPL=US / IBM=US / BSX=US / LLY=US / ABT=US / INTC=US / ADI=US / MSFT=US / GLW=US / AMZN=US / QCOM=US / T=US / ORCL=US / TXN=US / VZ=US / SYK=US / SMTC=US / SAP=US / URI=US / TSM=US / CCI=US / HELE=US / LSTR=US / SEIC=US / CMCSA=US / DISH=US / AVGO=US / CRUS=US / CREE=US / EW=US / LIFE=US / NOW=US / MNRO=US / MSI=US / PHAR=US / TYL=US / UTHR=US / WDC=US / SAGE=US / OPT=US / FB=US / SWKS=US / BIIB=US / MRNA=US / OLED=US / FRPT=US / SNSS=US / AXON=US / TEL=US / BX=US / OSS=US / MXL=US / TSLA=US / NXPI=US / TMUS=US / QRVO=US / CLLS=US / CATB=US / AKTS=US / FIXX=US / REZI=US / NBSE=US / HXGBY=US</td><td class="leftalignment">Monolithic Power Systems Inc / Nasdaq Inc / Apple Inc / International Business Machines Corp / Boston Scientific Corp / Eli Lilly and Co / Abbott Laboratories / Intel Corp / Analog Devices Inc / Microsoft Corp / Corning Inc / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Texas Instruments Inc / Verizon Communications Inc / Stryker Corp / Semtech Corp / SAP SE / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Crown Castle International Corp / Helen of Troy Ltd / Landstar System Inc / SEI Investments Co / Comcast Corp / DISH Network Corp / Broadcom Inc / Cirrus Logic Inc / Wolfspeed Inc / Edwards Lifesciences Corp / aTyr Pharma Inc / ServiceNow Inc / Monro Inc / Motorola Solutions Inc / Pharming Group NV / Tyler Technologies Inc / United Therapeutics Corp / Western Digital Corp / SAGE Therapeutics Inc / Opthea Ltd / Meta Platforms Inc / Skyworks Solutions Inc / Biogen Inc / Moderna Inc / Universal Display Corp / Freshpet Inc / Viracta Therapeutics Inc / Axon Enterprise Inc / TE Connectivity Ltd / Blackstone Inc / One Stop Systems Inc / Maxlinear Inc / Tesla Inc / NXP Semiconductors NV / T-Mobile US Inc / Qorvo Inc / Cellectis SA / Astria Therapeutics Inc / Akoustis Technologies Inc / Homology Medicines Inc / Resideo Technologies Inc / NeuBase Therapeutics Inc / Hexagon AB</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Germany / France / Ireland / Netherlands / Sweden / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - January 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GB0004544929 / US09061G1013 / US0028241000 / US0079031078 / US0231351067 / US0311621009 / US0378331005 / US0382221051 / US0530151036 / US0970231058 / US1271903049 / US2254471012 / US28176E1082 / US30161Q1040 / US30226D1063 / US3696041033 / US3755581036 / US4364401012 / US45253H1014 / US45337C1027 / US4824801009 / US5128071082 / US55306N1046 / US5951121038 / US64125C1099 / US6558441084 / US75886F1075 / US8168501018 / US8636671013 / US8793601050 / US8807701029 / US8832031012 / US91307C1027 / US9138371003 / US9182041080 / US92532F1003 / US9581021055 / US9839191015 / NL0000200384 / US5658491064 / US83088M1027 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / US12541W2098 / US00206R1023 / ACOR.OQ / US42809H1077 / US82706C1080 / US6247581084 / US29089Q1058 / US0043971052 / US03152W1099 / US64110D1046 / US2120151012 / US46333X1081 / US13100M5094 / IE00B58JVZ52 / US88160R1014 / US4361061082 / US56585A1025 / US7185461040 / US30303M1027 / NL0010273215 / US81762P1021 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US69888T2078 / US2681582019 / US31572Q8087 / US22822V1017 / US74736K1016 / US09627Y1091 / US37890U1088 / US74624M1027 / US4622221004 / US07725L1026 / KYG4740B1059 / IL0011407140 / US4990491049 / US8760301072 / US76243J1051 / CH0371153492 / SE0009414576 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Imperial Brands PLC / Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Micro Devices Inc / Amazon.com Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Automatic Data Processing Inc / Boeing Co / CACI International Inc / Wolfspeed Inc / Edwards Lifesciences Corp / Exelixis Inc / Extreme Networks Inc / General Electric Co / Gilead Sciences Inc / Hologic Inc / ImmunoGen Inc / Incyte Corp / KLA Corp / Lam Research Corp / MKS Instruments Inc / Micron Technology Inc / Neurocrine Biosciences Inc / Norfolk Southern Corp / Regeneron Pharmaceuticals Inc / Semtech Corp / Stryker Corp / Teledyne Technologies Inc / Teradyne Inc / Textron Inc / United Therapeutics Corp / Universal Stainless & Alloy Products Inc / VF Corp / Vertex Pharmaceuticals Inc / Western Digital Corp / Xilinx Inc / Core Laboratories NV / Marathon Oil Corp / Skyworks Solutions Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / CH Robinson Worldwide Inc / AT&T Inc / Acorda Therapeutics Inc / Hess Corp / Silicon Motion Technology Corp / Mueller Water Products Inc / Emergent BioSolutions Inc / Accuray Inc / Amicus Therapeutics Inc / NetApp Inc / Continental Resources Inc / Ironwood Pharmaceuticals Inc / Calix Inc / Seagate Technology Holdings PLC / Tesla Inc / HollyFrontier Corp / Marathon Petroleum Corp / Phillips 66 / Meta Platforms Inc / ASML Holding NV / ServiceNow Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Par Pacific Holdings Inc / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Qorvo Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Pure Storage Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Urogen Pharma Ltd / Knight-Swift Transportation Holdings Inc / Tapestry Inc / Rhythm Pharmaceuticals Inc / Landis+Gyr Group AG / Oncopeptides AB / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4+2021 Preview: Fundamentals Remain Strong, Should Provide Investment Oppy's</td><td class="leftalignment">English</td><td class="rightalignment">226</td><td class="leftalignment">US09061G1013 / US0311621009 / US30161Q1040 / US3755581036 / US45337C1027 / US64125C1099 / US75886F1075 / US91307C1027 / US92532F1003 / US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US29089Q1058 / US03152W1099 / US46333X1081 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / US78667J1088 / US2681582019 / US31572Q8087 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / IL0011407140 / US76243J1051 / US05455M1009 / US61775R1059 / US81181C1045</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Amgen Inc / Exelixis Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / SAGE Therapeutics Inc / Dynavax Technologies Corp / FibroGen Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / AVROBIO Inc / Morphic Holding Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Israel / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Key Considerations Ahead of 4Q Results</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB=US / LLY=US / SAGE=US</td><td class="leftalignment">Biogen Inc / Eli Lilly and Co / SAGE Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Jan 27 2021 6:59AM</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HAFC=US / HOPE=US / SBUX=US / INTC=US / AMD=US / MSFT=US / MU=US / QCOM=US / NVDA=US / NTAP=US / BBBY=US / XLNX=US / EWBC=US / NAVI=US / PII=US / SAGE=US / SWKS=US / STX=US / BIIB=US / SIMO=US / 2330=US / QRVO=US / PSTG=US / PRAX=US</td><td class="leftalignment">Hanmi Financial Corp / Hope Bancorp Inc / Starbucks Corp / Intel Corp / Advanced Micro Devices Inc / Microsoft Corp / Micron Technology Inc / Qualcomm Inc / NVIDIA Corp / NetApp Inc / Bed Bath & Beyond Inc / Xilinx Inc / East West Bancorp Inc / Navient Corp / Polaris Inc / SAGE Therapeutics Inc / Skyworks Solutions Inc / Seagate Technology Holdings PLC / Biogen Inc / Silicon Motion Technology Corp / Taiwan Semiconductor Manufacturing Co Ltd / Qorvo Inc / Pure Storage Inc / Praxis Precision Medicines Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / Ireland / Taiwan / United States</td><td class="leftalignment">Banks / Biotechnology / Financial Services / Household Products / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Retailing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">FISV=US / PFE=US / AMGN=US / INTC=US / ADI=US / AMD=US / BXP=US / PLD=US / T=US / DVN=US / INCY=US / TXN=US / TEVA=US / AMT=US / NVDA=US / EOG=US / BC=US / PLUG=US / H=US / VZ=US / WLL=US / CHKP=US / CCI=US / MGY=US / XLNX=US / BRO=US / MRO=US / DISH=US / DHI=US / ENDP=US / HXL=US / HZO=US / PACW=US / PRGO=US / PII=US / REGN=US / SBAC=US / ST=US / BXS=US / NET=US / GPN=US / FMBI=US / SNV=US / LCI=US / MKL=US / RPD=US / BIIB=US / FIS=US / TEL=US / AMRX=US / CLR=US / EHC=US / NOG=US / SWI=US / NXPI=US / PCRX=US / VAC=US / PANW=US / FANG=US / ABBV=US / TMUS=US / PTCT=US / FEYE=US / MBUU=US / VRNS=US / AJRD=US / MCFT=US / EVRI=US / ZS=US / OKTA=US / SAIL=US / BHC=US / TENB=US / PLMR=US / CRWD=US / ONEW=US / VTRS=US / 100073616</td><td class="leftalignment">Fiserv Inc / Pfizer Inc / Amgen Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Boston Properties Inc / Prologis Inc / AT&T Inc / Devon Energy Corp / Incyte Corp / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / American Tower Corp / NVIDIA Corp / EOG Resources Inc / Brunswick Corp / Plug Power Inc / Hyatt Hotels Corp / Verizon Communications Inc / Whiting Petroleum Corp / Check Point Software Technologies Ltd / Crown Castle International Corp / Magnolia Oil & Gas Corp / Xilinx Inc / Brown & Brown Inc / Marathon Oil Corp / DISH Network Corp / D R Horton Inc / Endo International PLC / Hexcel Corp / MarineMax Inc / PacWest Bancorp / Perrigo Company PLC / Polaris Inc / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Sensata Technologies Holding PLC / Cadence Bank / Cloudflare Inc / Global Payments Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Lannett Company Inc / Markel Corp / Rapid7 Inc / Biogen Inc / Fidelity National Information Services Inc / TE Connectivity Ltd / Amneal Pharmaceuticals Inc / Continental Resources Inc / Encompass Health Corp / Northern Oil and Gas Inc / SolarWinds Corp / NXP Semiconductors NV / Pacira Biosciences Inc / Marriott Vacations Worldwide Corp / Palo Alto Networks Inc / Diamondback Energy Inc / Abbvie Inc / T-Mobile US Inc / PTC Therapeutics Inc / Mandiant Inc / Malibu Boats Inc / Varonis Systems Inc / Aerojet Rocketdyne Holdings Inc / Mastercraft Boat Holdings Inc / Everi Holdings Inc / Zscaler Inc / Okta Inc / SailPoint Technologies Holdings Inc / Bausch Health Companies Inc / Tenable Holdings Inc / Palomar Holdings Inc / CrowdStrike Holdings Inc / OneWater Marine Inc / Viatris Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - January 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">FR0000054470 / US09061G1013 / US0079031078 / US0116591092 / US02553E1064 / US1005571070 / US22160K1051 / US22284P1057 / US2855121099 / US3156161024 / US3647601083 / US4282911084 / US4781601046 / US48203R1041 / US5002551043 / US5398301094 / US5949181045 / US6556641008 / US7739031091 / US7782961038 / US8552441094 / US8581191009 / US8725401090 / US8740541094 / US87612E1064 / US9021041085 / US92343V1044 / US9311421039 / US9839191015 / CA1363751027 / US4198791018 / US21036P1084 / US09062X1037 / US1717793095 / US55616P1049 / US00507V1098 / US13100M5094 / US98986T1088 / US5017971046 / LU0914713705 / US09609G1004 / US38046C1099 / US00847X1046 / US9314271084 / US00773U1088 / US09857L1089 / US05455M1009 / US39874R1014 / US75513E1010 / US00973J1016 / US22041X1028 / US0090661010</td><td class="leftalignment">Ubisoft Entertainment SA / Biomarin Pharmaceutical Inc / Advanced Micro Devices Inc / Alaska Air Group Inc / American Eagle Outfitters Inc / Boston Beer Company Inc / Costco Wholesale Corp / Covenant Logistics Group Inc / Electronic Arts Inc / F5 Inc / Gap Inc / Hexcel Corp / Johnson & Johnson / Juniper Networks Inc / Kohls Corp / Lockheed Martin Corp / Microsoft Corp / Nordstrom Inc / Rockwell Automation Inc / Ross Stores Inc / Starbucks Corp / Steel Dynamics Inc / TJX Companies Inc / Take-Two Interactive Software Inc / Target Corp / II-VI Inc / Verizon Communications Inc / Walmart Inc / Xilinx Inc / Canadian National Railway Co / Hawaiian Holdings Inc / Constellation Brands Inc / Biogen Inc / Ciena Corp / Macy's Inc / Activision Blizzard Inc / Calix Inc / Zynga Inc / Bath & Body Works Inc / Intelsat SA / bluebird bio Inc / Gogo Inc / Agios Pharmaceuticals Inc / Walgreens Boots Alliance Inc / Adverum Biotechnologies Inc / Booking Holdings Inc / AVROBIO Inc / Grocery Outlet Holding Corp / Raytheon Technologies Corp / Akouos Inc / Corsair Gaming Inc / Airbnb Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Notes From The (Virtual) Road... Management Meetings Set Stage For A Busy 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PRAX=US / SAGE=US / BIIB=US</td><td class="leftalignment">Praxis Precision Medicines Inc / SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Trials And Triumphs Of Gene Therapy: A Compendium - Ahead Of The Curve Series</td><td class="leftalignment">English</td><td class="rightalignment">550</td><td class="leftalignment">US09061G1013 / US09062X1037 / US09609G1004 / US00773U1088 / US05455M1009 / US00973J1016</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Biogen Inc / bluebird bio Inc / Adverum Biotechnologies Inc / AVROBIO Inc / Akouos Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Cowen Health Care Team / Joshua T. Jennings, M.D., MD / Mr. Chris Y. Lin, CFA / Mr. Doug A. Schenkel / Mr. Joseph Thome / Ms. Ritu S. Baral / Lyla Youssef, Ph.D. / Mr. Phil M. Nadeau, Ph.D., PHD / Yaron Werber, M.D., MD / Brendan Smith, Ph.D. / Steve M. Scala, R.Ph., CFA, CFA / Mr. Ken C. Cacciatore</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Latest Short Interest for US Biotech: Stable for Large Cap Stocks, SMid incrementally higher</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology 4Q20 Preview: More of the same? Large Cap lethargy, SMid-Cap enthusiasm, against the continuing pandemic backdrop</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">AMGN.OQ / GILD.OQ / BMY.N / LLY.N / PFE.N / REGN.OQ / RARE.OQ / INCY.OQ / NBIX.OQ / ICPT.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / ARNA.OQ / ESPR.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / GLPG.AS / IRWD.OQ / SRPT.OQ / ABBV.N / PTCT.OQ / RNA.OQ / QURE.OQ / FLXN.OQ / ASND.OQ / ANAB.OQ / APLS.OQ / KURA.OQ / NTLA.OQ / ARGX.OQ / IFRX.OQ / SRRK.OQ / CYCN.OQ / ISEE.OQ / STOK.OQ / INBX.OQ / IMVT.OQ / FMTX.OQ / ALXO.OQ / CVAC.OQ / SPRB.OQ / GLTO.OQ / BCAB.OQ / ABCL.OQ</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Incyte Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / Galapagos NV / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / PTC Therapeutics Inc / Avidity Biosciences Inc / Uniqure NV / Pacira Biosciences Inc / Ascendis Pharma A/S / AnaptysBio Inc / Apellis Pharmaceuticals Inc / Kura Oncology Inc / Intellia Therapeutics Inc / argenx SE / InflaRx NV / Scholar Rock Holding Corp / Cyclerion Therapeutics Inc / Iveric Bio Inc / Stoke Therapeutics Inc / Inhibrx Inc / Immunovant Inc / Forma Therapeutics Holdings Inc / ALX Oncology Holdings Inc / CureVac NV / Spruce Biosciences Inc / Galecto Inc / Bioatla Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Denmark / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Dr. Martin Auster, M.D. / Ms. Judah C. Frommer / Mr. Tiago Fauth / Mark Connolly / Jonathan Woo / Yunhee Park / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">30-sec Biotech Nightcap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / INCY=US / REGN=US / BIIB=US / PTCT=US</td><td class="leftalignment">Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Biogen Inc / PTC Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Read-throughs to our large-cap Biotech coverage from NVS' earnings call</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN=US / INCY=US / REGN=US / BIIB=US / PTCT=US</td><td class="leftalignment">Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Biogen Inc / PTC Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Declines in Domestic Cases, Hospitalizations, and Deaths Suggest the Beginning of the End as Threat of New Variant Looms</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 00461U105 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BSX=US / PFE=US / HD=US / MCD=US / WEN=US / BLD=US / RUN=US / GILD=US / BC=US / LOW=US / IART=US / MUR=US / BRO=US / LEG=US / MANH=US / CBRL=US / ELY=US / FUN=US / KIDS=US / DRI=US / GFF=US / HAS=US / HXL=US / IBP=US / HZO=US / MAS=US / MAT=US / MHK=US / PII=US / REGN=US / SGMO=US / STRA=US / THO=US / WW=US / WGO=US / GOLF=US / OPT=US / BXS=US / FBK=US / NLS=US / DIN=US / MGPI=US / BIIB=US / TPX=US / EXP=US / FHN=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / SIX=US / XPO=US / PGTI=US / SAIA=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / PRPL=US / NMTR=US / SEAS=US / CWH=US / IAC=US / JACK=US / TREX=US / FBHS=US / TILE=US / NDLS=US / FOXF=US / MBUU=US / ARCB=US / LOCO=US / VCEL=US / NVRO=US / SHAK=US / WING=US / SPNE=US / TDOC=US / MCFT=US / ACBI=US / 82982L103 / JELD=US / FNKO=US / AXNX=US / KOD=US / FERGY=US / BRBR=US / ONEM=US / ONEW=US / AZEK=US / BALY=US</td><td class="leftalignment">Boston Scientific Corp / Pfizer Inc / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Sunrun Inc / Gilead Sciences Inc / Brunswick Corp / Lowe's Companies Inc / Integra Lifesciences Holdings Corp / Murphy Oil Corp / Brown & Brown Inc / Leggett & Platt Inc / Manhattan Associates Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Cedar Fair LP / OrthoPediatrics Corp / Darden Restaurants Inc / Griffon Corp / Hasbro Inc / Hexcel Corp / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mattel Inc / Mohawk Industries Inc / Polaris Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Strategic Education Inc / Thor Industries Inc / WW International Inc / Winnebago Industries Inc / Acushnet Holdings Corp / Opthea Ltd / Cadence Bank / FB Financial Corp / Nautilus Inc / Dine Brands Global Inc / MGP Ingredients Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / Six Flags Entertainment Corp / XPO Logistics Inc / PGT Innovations Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / 9 Meters Biopharma Inc / SeaWorld Entertainment Inc / Camping World Holdings Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Fox Factory Holding Corp / Malibu Boats Inc / ArcBest Corp / El Pollo Loco Holdings Inc / Vericel Corp / Nevro Corp / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Teladoc Health Inc / Mastercraft Boat Holdings Inc / Atlantic Capital Bancshares Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Funko Inc / Axonics Inc / Kodiak Sciences Inc / Ferguson PLC / Bellring Brands Inc / 1Life Healthcare Inc / OneWater Marine Inc / Azek Company Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - January 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CNR.TO / BB.N / CP.TO / NSC.N / GILD.O / AMGN.O / INCY.O / CSX.N / TV.TO / UNP.N / NBIX.O / VRTX.O / BIIB.O / ALNY.O / 35671D857 / CS.TO / AUY.N / 550372106 / SRPT.O / 505440107 / PTCT.O / CIA.TO / AUPH.O / GLPG.O / GBT.OQ / TFII.TO / NEXA.TO / 900435207</td><td class="leftalignment">Canadian National Railway Co / BlackBerry Ltd / Canadian Pacific Railway Ltd / Norfolk Southern Corp / Gilead Sciences Inc / Amgen Inc / Incyte Corp / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Capstone Mining Corp / Yamana Gold Inc / Lundin Mining Corp / Sarepta Therapeutics Inc / Labrador Iron Ore Royalty Corp / PTC Therapeutics Inc / Champion Iron Ltd / Aurinia Pharmaceuticals Inc / Galapagos NV / Global Blood Therapeutics Inc / TFI International Inc / Nexa Resources SA / Turquoise Hill Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ANA.MC / BB.N / CP.TO / DFDS.CO / F.N / GM.N / KMB.N / NSC.N / SGC.L / GILD.O / AMGN.O / INCY.O / AAPL.O / CNR.TO / CSX.N / TV.TO / UNP.N / NBIX.O / VRTX.O / BRO.N / BIIB.O / 02209S103 / ALNY.O / 35671D857 / CS.TO / AUY.N / 550372106 / NOG.A / SRPT.O / MDLZ.OQ / 505440107 / PTCT.O / PTC.O / CIA.TO / AUPH.O / GLPG.O / GBT.OQ / CADE.N / NEXA.TO / WMG.OQ / 900435207</td><td class="leftalignment">Acciona SA / BlackBerry Ltd / Canadian Pacific Railway Ltd / DFDS AS / Ford Motor Co / General Motors Co / Kimberly-Clark Corp / Norfolk Southern Corp / Stagecoach Group PLC / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Apple Inc / Canadian National Railway Co / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Brown & Brown Inc / Biogen Inc / Altria Group Inc / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Capstone Mining Corp / Yamana Gold Inc / Lundin Mining Corp / Northern Oil and Gas Inc / Sarepta Therapeutics Inc / Mondelez International Inc / Labrador Iron Ore Royalty Corp / PTC Therapeutics Inc / PTC Inc / Champion Iron Ltd / Aurinia Pharmaceuticals Inc / Galapagos NV / Global Blood Therapeutics Inc / Cadence Bank / Nexa Resources SA / Warner Music Group Corp / Turquoise Hill Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Denmark / Spain / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESG Stratify™: Leading The Way On Innovation And Sustainability – Our Biotech ESG Scorecard</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">GILD.O / AMGN.O / INCY.O / NBIX.O / VRTX.O / BIIB.O / ALNY.O / SRPT.O / PTCT.O / GLPG.O / GBT.OQ</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Galapagos NV / Global Blood Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Lisa Walter / James Hong / Sara Mahaffy / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Leonid Timashev / David Szeto / Yinglu Zhang / Edwin Delfin</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Biogen Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for BIIB.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Wolfe Pharma & Biotech* 4Q20 EPS Preview - Model Changes and Updated Perspectives</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">09062X103 / 031162100 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Biogen Inc / Amgen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Mgmt color: SGMO is in clinical execution mode; investors should give it another look</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">SGMO=US / GILD=US / BIIB=US</td><td class="leftalignment">Sangamo Therapeutics Inc / Gilead Sciences Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LSI=US / PEP=US / AMGN=US / CAG=US / KO=US / MCD=US / OXY=US / RRC=US / CL=US / PG=US / WEN=US / BXP=US / AVB=US / AMZN=US / T=US / DVN=US / EBAY=US / INCY=US / AMT=US / APA=US / CPE=US / EOG=US / SLG=US / REI=US / PLUG=US / CHTR=US / CRM=US / VZ=US / XOM=US / CRK=US / WLL=US / PXD=US / CCI=US / ENR=US / MGY=US / SWN=US / SCOR=US / MUR=US / UMPQ=US / MRO=US / ESS=US / CLI=US / MANH=US / AKR=US / TOL=US / NWL=US / CMCSA=US / EQR=US / FLO=US / MAC=US / STZ=US / CBRL=US / CENT=US / CHD=US / CNX=US / DHI=US / DRI=US / EPC=US / EQT=US / HAIN=US / SAFE=US / KBH=US / LEN=US / DOC=US / NTST=US / PDM=US / PHM=US / REGI=US / SBAC=US / SGMO=US / SMG=US / SHOP=US / WAL=US / WIX=US / CVX=US / POST=US / PSA=US / SPG=US / HIW=US / SIVB=US / ADC=US / BDN=US / CPT=US / OFC=US / CUZ=US / PRI=US / EPR=US / FRT=US / KIM=US / MAA=US / NHI=US / OHI=US / UDR=US / VNO=US / WRE=US / COP=US / BRX=US / DIN=US / MGNI=US / MGPI=US / MNST=US / NOMD=US / BIIB=US / EXR=US / TXRH=US / PLAY=US / FRPT=US / DENN=US / THS=US / MPW=US / CMG=US / REX=US / GPRE=US / ELF=US / TAST=US / CLR=US / NMTR=US / NOG=US / JACK=US / AAN=US / HTA=US / AR=US / SBRA=US / APTS=US / ESTE=US / CUBE=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / NDLS=US / GOOGL=US / VNOM=US / LOCO=US / CMPR=US / SHAK=US / DEA=US / NXRT=US / CHCT=US / WING=US / ZG=US / CDEV=US / PVAC=US / SBOW=US / RDFN=US / PETQ=US / COLD=US / SMAR=US / KDP=US / OZK=US / SITC=US / RTLR=US / BRBR=US / OVV=US / OPCH=US / REYN=US / FBRX=US / BIGC=US / AIRC=US / HYFM=US / 100087548</td><td class="leftalignment">Life Storage Inc / PepsiCo Inc / Amgen Inc / Conagra Brands Inc / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Colgate-Palmolive Co / Procter & Gamble Co / Wendys Co / Boston Properties Inc / Avalonbay Communities Inc / Amazon.com Inc / AT&T Inc / Devon Energy Corp / eBay Inc / Incyte Corp / American Tower Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / SL Green Realty Corp / Ring Energy Inc / Plug Power Inc / Charter Communications Inc / Salesforce.Com Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Crown Castle International Corp / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Umpqua Holdings Corp / Marathon Oil Corp / Essex Property Trust Inc / Veris Residential Inc / Manhattan Associates Inc / Acadia Realty Trust / Toll Brothers Inc / Newell Brands Inc / Comcast Corp / Equity Residential / Flowers Foods Inc / Macerich Co / Constellation Brands Inc / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / CNX Resources Corp / D R Horton Inc / Darden Restaurants Inc / Edgewell Personal Care Co / EQT Corp / Hain Celestial Group Inc / Safehold Inc / KB Home / Lennar Corp / Physicians Realty Trust / Netstreit Corp / Piedmont Office Realty Trust Inc / Pultegroup Inc / Renewable Energy Group Inc / SBA Communications Corp / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Shopify Inc / Western Alliance Bancorp / Wix.Com Ltd / Chevron Corp / Post Holdings Inc / Public Storage / Simon Property Group Inc / Highwoods Properties Inc / SVB Financial Group / Agree Realty Corp / Brandywine Realty Trust / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Primerica Inc / EPR Properties / Federal Realty Investment Trust / Kimco Realty Corp / Mid-America Apartment Communities Inc / National Health Investors Inc / Omega Healthcare Investors Inc / UDR Inc / Vornado Realty Trust / Washington Real Estate Investment Trust / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Magnite Inc / MGP Ingredients Inc / Monster Beverage Corp / Nomad Foods Ltd / Biogen Inc / Extra Space Storage Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Medical Properties Trust Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / elf Beauty Inc / Carrols Restaurant Group Inc / Continental Resources Inc / 9 Meters Biopharma Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Aaron's Company Inc / Healthcare Trust Of America Inc / Antero Resources Corp / Sabra Health Care REIT Inc / Preferred Apartment Communities Inc / Earthstone Energy Inc / CubeSmart / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Noodles & Co / Alphabet Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Cimpress PLC / Shake Shack Inc / Easterly Government Properties Inc / NexPoint Residential Trust Inc / Community Healthcare Trust Inc / Wingstop Inc / Zillow Group Inc / Centennial Resource Development Inc / Ranger Oil Corp / SilverBow Resources Inc / Redfin Corp / PetIQ Inc / Americold Realty Trust / Smartsheet Inc / Keurig Dr Pepper Inc / Bank Ozk / Site Centers Corp / Rattler Midstream LP / Bellring Brands Inc / Ovintiv Inc / Option Care Health Inc / Reynolds Consumer Products Inc / Forte Biosciences Inc / Bigcommerce Holdings Inc / Apartment Income REIT Corp / Hydrofarm Holdings Group Inc / APA Corp (US)</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / Luxembourg / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LJPC=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">La Jolla Pharmaceutical Co / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Jan 25 2021 7:03AM</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BKU=US / SIVB=US / FISV=US / AAPL=US / DELL=US / IBM=US / PAYX=US / GM=US / INTC=US / AMD=US / GBT=US / MSFT=US / MU=US / AMZN=US / QCOM=US / ORCL=US / EBAY=US / DNLI=US / USB=US / NVDA=US / NTAP=US / BC=US / HBAN=US / 7974=JP / NICE=US / V=US / ADP=US / XLNX=US / EWBC=US / UMPQ=US / ADS=US / IIVI=US / NUAN=US / XOMA=US / AI=US / ACET=US / APLS=US / AVGO=US / BMRN=US / BLUE=US / DOCU=US / ISEE=US / FUSN=US / HEAR=US / ICPT=US / HZO=US / NBIX=US / PRTK=US / PRVL=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / WDC=US / FOUR=US / SAGE=US / GPN=US / PYPL=US / FB=US / NIO=US / RF=US / EVOP=US / SWKS=US / VRNT=US / ALPN=US / CRNC=US / DKS=US / STX=US / IGMS=US / STRO=US / BIIB=US / TCBI=US / SIMO=US / GRAY=US / FIS=US / MA=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / 2454=US / ALNA=US / LXRX=US / 2330=US / VMW=US / 6758=US / IDRA=US / ASND=US / RCUS=US / 8299=US / OMER=US / TSLA=US / NXPI=US / PCRX=US / 981=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / GOOGL=US / AGTC=US / BABA=US / XENE=US / QRVO=US / CDTX=US / BPMC=US / ABUS=US / PSTG=US / ARGX=US / NVCR=US / HPE=US / CTMX=US / SQ=US / VYGR=US / KURA=US / EIGR=US / CRVS=US / NTLA=US / CLSD=US / ALBO=US / OBSV=US / ANAB=US / VRNA=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / IIIV=US / MGTA=US / AQST=US / LQDA=US / YMAB=US / ARVN=US / MLND=US / HARP=US / UBER=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / RPAY=US / KRTX=US / PASG=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CRSR=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US</td><td class="leftalignment">BankUnited Inc / SVB Financial Group / Fiserv Inc / Apple Inc / Dell Technologies Inc / International Business Machines Corp / Paychex Inc / General Motors Co / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Oracle Corp / eBay Inc / Denali Therapeutics Inc / US Bancorp / NVIDIA Corp / NetApp Inc / Brunswick Corp / Huntington Bancshares Inc / Nintendo Co Ltd / Nice Ltd / Visa Inc / Automatic Data Processing Inc / Xilinx Inc / East West Bancorp Inc / Umpqua Holdings Corp / Alliance Data Systems Corp / II-VI Inc / Nuance Communications Inc / XOMA Corp / C3.ai Inc / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / Biomarin Pharmaceutical Inc / bluebird bio Inc / DocuSign Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Turtle Beach Corp / Intercept Pharmaceuticals Inc / MarineMax Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Porvair PLC / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / Western Digital Corp / Shift4 Payments Inc / SAGE Therapeutics Inc / Global Payments Inc / PayPal Holdings Inc / Meta Platforms Inc / NIO Inc / Regions Financial Corp / EVO Payments Inc / Skyworks Solutions Inc / Verint Systems Inc / Alpine Immune Sciences Inc / Cerence Inc / DICK'S Sporting Goods Inc / Seagate Technology Holdings PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Texas Capital Bancshares Inc / Silicon Motion Technology Corp / Graybug Vision Inc / Fidelity National Information Services Inc / Mastercard Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / MediaTek Inc / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Taiwan Semiconductor Manufacturing Co Ltd / VMware Inc / Sony Group Corp / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Phison Electronics Corp / Omeros Corp / Tesla Inc / NXP Semiconductors NV / Pacira Biosciences Inc / Semiconductor Manufacturing International Corp / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Alphabet Inc / Applied Genetic Technologies Corp / Alibaba Group Holding Ltd / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / Pure Storage Inc / argenx SE / Novocure Ltd / Hewlett Packard Enterprise Co / CytomX Therapeutics Inc / Block Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Eiger BioPharmaceuticals Inc / Corvus Pharmaceuticals Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Verona Pharma PLC / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / I3 Verticals Inc / Magenta Therapeutics Inc / Aquestive Therapeutics Inc / Liquidia Corp / Y-mAbs Therapeutics Inc / Arvinas Inc / Tempest Therapeutics Inc / Harpoon Therapeutics Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Repay Holdings Corp / Karuna Therapeutics Inc / Passage Bio Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Corsair Gaming Inc / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Japan / Netherlands / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Banks / Biotechnology / Electronics / Financial Services / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Retailing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GBT=US / DNLI=US / XOMA=US / ACET=US / APLS=US / BMRN=US / BLUE=US / ISEE=US / FUSN=US / ICPT=US / NBIX=US / PRTK=US / PRVL=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / GRAY=US / AVRO=US / TPTX=US / SURF=US / ORTX=US / ALNA=US / LXRX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / EIGR=US / CRVS=US / NTLA=US / CLSD=US / ALBO=US / OBSV=US / ANAB=US / VRNA=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / MGTA=US / AQST=US / LQDA=US / YMAB=US / ARVN=US / MLND=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US</td><td class="leftalignment">Global Blood Therapeutics Inc / Denali Therapeutics Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Porvair PLC / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Graybug Vision Inc / AVROBIO Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Eiger BioPharmaceuticals Inc / Corvus Pharmaceuticals Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Verona Pharma PLC / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Aquestive Therapeutics Inc / Liquidia Corp / Y-mAbs Therapeutics Inc / Arvinas Inc / Tempest Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fourth Quarter 2020 Biotechnology Earnings Preview: Grace Notes to a Historic Year</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 09061G101 / 45337C102 / 09060J106 / 803607100 / 26979610 / 268158201 / 76133010 / 462222100 / 19459J104 / G11196105 / 69366J200 / 37890U108 / 48576A100 / 04683R106</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Biomarin Pharmaceutical Inc / Incyte Corp / BioDelivery Sciences International Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Dynavax Technologies Corp / Revance Therapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Biohaven Pharmaceutical Holding Company Ltd / PTC Therapeutics Inc / Global Blood Therapeutics Inc / Karuna Therapeutics Inc / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Andy T. Hsieh, PHD / Matt Phipps, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Mr. Rob Andrew, CFA / Lachlan Hanbury-Brown / John Boyle</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Initiating at Outperform, $26 Target; Hard to Ignore Depth of the Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">PASG=US / DNLI=US / BIIB=US</td><td class="leftalignment">Passage Bio Inc / Denali Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">INITIATING COVERAGE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues 2021 Strategic Conclusions. Summary slides</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Ms Jo Walton / Mr Matthew J. Weston / Mr. Trung Huynh / Elizabeth Walton / Mr. Dominic Lunn</td></tr>
<tr class="even"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine from GRTS; TSHA designations</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">GRTS.OQ / TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ACB.TO / IBIO.A / ZTS.N / WEED.TO / TLRY.OQ / OGI.TO / XGN.OQ / IMAB.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Aurora Cannabis Inc / Ibio Inc / Zoetis Inc / Canopy Growth Corp / Tilray Brands Inc / OrganiGram Holdings Inc / Exagen Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">30-sec Biotech Nightcap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">INCY=US / SGMO=US / BIIB=US / NMTR=US / MEIP=US / FBRX=US</td><td class="leftalignment">Incyte Corp / Sangamo Therapeutics Inc / Biogen Inc / 9 Meters Biopharma Inc / MEI Pharma Inc / Forte Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Minh Vong</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Weekly: COVID Vaccine Rollout Driving Recent Growth in the EpiPen Market?</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / GSK=US / ENDP=US / PRGO=US / BIIB=US / AMRX=US / ABBV=US / XERS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Endo International PLC / Perrigo Company PLC / Biogen Inc / Amneal Pharmaceuticals Inc / Abbvie Inc / Xeris Biopharma Holdings Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Ami Fadia</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">Fast Forward No. 531</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 07373V105 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Beam Therapeutics Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Neurology Prescription Sales Tracker -- Week Ending 1/15/21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NBIX=US / ACOR=US / BIIB=US / BHVN=US</td><td class="leftalignment">Neurocrine Biosciences Inc / Acorda Therapeutics Inc / Biogen Inc / Biohaven Pharmaceutical Holding Company Ltd</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Noteworthy Weekly Rx Trends/Forecast</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">GILD.O / AMGN.O / NBIX.O / REGN.O / VRTX.O / ICPT.O / BIIB.O / ACAD.O / ITCI.O</td><td class="leftalignment">Gilead Sciences Inc / Amgen Inc / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Intra-Cellular Therapies Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Brian Abrahams, MD / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / David Szeto</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 Stock Thoughts & 4Q20 Earning Previews</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">ACAD=US / ACIU=US / ALKS=US / NBIX=US / SAGE=US / STSA=US / MRNS=US / BIIB=US / APTX=US / GRAY=US / LUN=US / ZGNX=US / ITCI=US / XENE=US / RLMD=US / AXSM=US / BHVN=US / EOLS=US</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / AC Immune SA / Alkermes Plc / Neurocrine Biosciences Inc / SAGE Therapeutics Inc / Satsuma Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Biogen Inc / Aptinyx Inc / Graybug Vision Inc / H Lundbeck A/S / Zogenix Inc / Intra-Cellular Therapies Inc / Xenon Pharmaceuticals Inc / Relmada Therapeutics Inc / Axsome Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Evolus Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Marc Goodman</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">4Q Large Cap Preview:  We are paying most attention to BIIB and GILD outlooks around 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BIIB.O / GILD.O / AMGN.O / INCY.O / REGN.O / VRTX.O</td><td class="leftalignment">Biogen Inc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Emily Bodnar / Ms. Emma K. Nealon, III</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for BIIB</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BIIB.OQ</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">I'm Hooked On a Feeling... Biotech Inflows Continue</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">031162100 / 766559603 / 09062X103 / 09061G101 / 75886F107 / 00287Y109 / 45773H201 / 90400D108 / 09627Y109 / 039697107 / 03836N103 / 00972D105 / 24344T101 / 00166B105 / 46565G104 / 019818103 / 38942Q103 / 68236R103 / 19240Q201</td><td class="leftalignment">Amgen Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Inovio Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Blueprint Medicines Corp / Ardelyx Inc / Aptinyx Inc / Akebia Therapeutics Inc / Deciphera Pharmaceuticals Inc / ALX Oncology Holdings Inc / Iteos Therapeutics Inc / Allovir Inc / Graybug Vision Inc / Oncorus Inc / Cogent Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">William Blair & Company</td><td class="leftalignment">All the Vectors: New Cases Showing Signs of Slowing as U.S. Mortality Tops 400,000 and Vaccination Rollout Continues</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">03116210 / 64125C109 / 110122108 / 09062X103 / 92532F100 / 09061G101 / 640268108 / 30161Q104 / 45337C102 / 09060J106 / 45253H101 / 04744L106 / 00847G705 / 00287Y109 / 803607100 / 26979610 / 00847L10 / 045396108 / 268158201 / 31572Q80 / 76133010 / 78667J108 / 98978L204 / 15117K103 / 04651310 / 462222100 / 19459J104 / 01345P106 / 690469101 / G11196105 / 00887A105 / 69366J200 / 816212104 / 09609G100 / 67022C106 / 98420N105 / 603380106 / 720795103 / 49372L100 / 05280R100 / 01671P100 / 92686J106 / 54142F102 / 019770106 / H17182108 / 501147102 / 37890U108 / 77313F106 / 03836N103 / 717224109 / 05464T104 / 55234L105 / 74019P108 / 48576A100 / G10830100 / 73730P108 / 81181C104 / 00507W206 / 92840H202 / 00444P108 / 16961L106 / 654405109 / 03890D108 / 192010106 / 13089P101 / 151205200 / 04683R106 / 89422G107</td><td class="leftalignment">Amgen Inc / Neurocrine Biosciences Inc / Bristol-Myers Squibb Co / Biogen Inc / Vertex Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Nektar Therapeutics / Exelixis Inc / Incyte Corp / BioDelivery Sciences International Inc / ImmunoGen Inc / Athersys Inc / Agenus Inc / Abbvie Inc / Sarepta Therapeutics Inc / Eagle Pharmaceuticals Inc / Agile Therapeutics Inc / Assembly Biosciences Inc / Dynavax Technologies Corp / FibroGen Inc / Revance Therapeutics Inc / SAGE Therapeutics Inc / Zogenix Inc / Cellectis SA / Atara Biotherapeutics Inc / Ionis Pharmaceuticals Inc / Collegium Pharmaceutical Inc / Albireo Pharma Inc / Ovid Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aileron Therapeutics Inc / PTC Therapeutics Inc / Selecta Biosciences Inc / bluebird bio Inc / NuCana PLC / Xenon Pharmaceuticals Inc / Minerva Neurosciences Inc / Pieris Pharmaceuticals Inc / Kezar Life Sciences Inc / Autolus Therapeutics PLC / Allakos Inc / Viking Therapeutics Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Krystal Biotech Inc / Global Blood Therapeutics Inc / Rocket Pharmaceuticals Inc / Aptinyx Inc / PhaseBio Pharmaceuticals Inc / Axsome Therapeutics Inc / Lyra Therapeutics Inc / Precision BioSciences Inc / Karuna Therapeutics Inc / Beyondspring Inc / Poseida Therapeutics Inc / Seagen Inc / Actinium Pharmaceuticals Inc / VistaGen Therapeutics Inc / Acer Therapeutics Inc / Chinook Therapeutics Inc / 9 Meters Biopharma Inc / Aravive Inc / Codiak BioSciences, Inc. / Calithera Biosciences Inc / Celyad Oncology SA / Atea Pharmaceuticals Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Tim F. Lugo / Brittany Woods / Mr. Hunter Rogers / Mr. Raju Prasad, PHD / Matt Phipps, PHD / Andy T. Hsieh, PHD / Mr. Myles R. R. Minter / Sami Corwin, PHD / Lachlan Hanbury-Brown / John Boyle / Mr. Rob Andrew, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2936921 / 2126335 / 2516152 / 2050832 / 2270726 / 2542049 / 2415204 / 2455965 / 2657802 / 2684703 / 2048804 / 7103065 / B1F76F9 / B121557 / 2857817 / B02R1L6 / B2R3PV1 / 2679204 / B7TL820 / B7VD3F2 / BFLR866 / BVVN4Q8 / BYY8XK8 / BYW36M8 / BD8DJ71 / BJ2Z0H2 / BLGJ610 / BFMXGR0 / BKC9SX3 / BYTJZL1 / BKT6B38</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Walmart Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Hawaiian Electric Industries Inc / Biogen Inc / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Western Union Co / Mastercard Inc / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Align Technology Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / WEC Energy Group Inc / PayPal Holdings Inc / Snap Inc / Pinterest Inc / Warner Music Group Corp / Evergy Inc / Arcturus Therapeutics Holdings Inc / Zogenix Inc / SmileDirectClub Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: PharmaValues 2021 strategic conclusions</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Ms. Gretel Janu / Mr. Dominic Lunn / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Evan D. Seigerman / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Auerbach Grayson & Co., Inc.</td><td class="leftalignment">AUERBACH GRAYSON: CEEMA & LATAM Daily Morning Note 01-20-21:  (Allegro.eu, Alumetal, AmRest, Arabian Food Industries, Baghdad Soft Drinks, Bank of Palestine, Comp, Cyrela, EFG-Hermes, Emaar Malls Group, Emirates Integrated Telecommunications, Etisalat)</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">AL0.F / AMT.WA / CYRE3.SA / DOMT.CA / EATP.WA / ETISALAT.AD / HRHO.CA / GRS014013007 / PLVSTLA00011 / GRS434003000 / PLLOTOS00025 / BRCYREACNOR7 / EAT@PW / PLPGNIG00014 / EGS69101C011 / HBOR3@BZ / AE000A0LFD04 / CMP@PW / GRS496003005 / EGS655L1C012 / AE000A0JLXY4 / LU0327357389 / IQ000A0M7TT6 / EGS30901C010 / BOP@PS / TTP985721039 / ENG@PW / OPL@PW / MBK@PW / NEU@PW / AML@PW / BIIB@IQ / DOMT@EY / Q*@MM / OLFI@EY / PBX@PW / PLW@PW / IRMC@IQ / MRB@PW / ALE@PW / 100388051</td><td class="leftalignment">Allegro.eu SA / Alumetal SA / Cyrela Brazil Realty SA Empreendimentos e Participacoes / Arabian Food Industries Company SAE / Amrest Holdings SE / Emirates Telecommunications Group Company PJSC / EFG Hermes Holdings SAE / Piraeus Financial Holdings SA / VRG SA / Public Power Corporation SA / Grupa Lotos SA / Cyrela Brazil Realty SA Empreendimentos e Participacoes / Amrest Holdings SE / Polskie Gornictwo Naftowe i Gazownictwo SA / EFG Hermes Holdings SAE / Helbor Empreendimentos SA / Emirates Telecommunications Group Company PJSC / Comp SA / Terna Energy SA / Palm Hills Developments / Emirates Integrated Telecommunications Company PJSC / Kernel Holding SA / Baghdad Soft Drinks Co / Juhayna Food Industries SAE / Bank of Palestine PLC / West Indian Tobacco Company Ltd / Energa SA / Orange Polska SA / mBank SA / Neuca SA / Alumetal SA / Iraqi Islamic Bank for Investment & Development / Arabian Food Industries Company SAE / Qualitas Controladora SAB de CV / Obour Land for Food Industries / Poznanska Korporacja Budowlana Pekabex SA / Playway SA / Ready Made Clothes Co SA / Mirbud SA / Allegro.eu SA / Emaar Properties PJSC</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United Arab Emirates / Brazil / Egypt / Ghana / Greece / Croatia / Iraq / Jamaica / Mexico / Namibia / Nigeria / Peru / Poland / Russian Federation / Saudi Arabia / Slovenia / Trinidad and Tobago / Turkey / Tanzania, United Republic of / Ukraine / United States / Palestine</td><td class="leftalignment">Agriculture / Apparel & Textiles / Appliances / Banks / Beverages & Tobacco / Building & Building Materials / Communications / Electrical / Engineering & Construction / Financial Services / Food / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Insurance / Metals & Minerals / Real Estate / Retailing / Utilities / Wholesale</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Auerbach Grayson</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BAC / CCO / CMA / CNI / CP / CPB / DANO.PA / EOG / ETM / FMC / GIS / HSY / IPG / K / MRO / NSC / OMC / SHW / SJM / SM / TFX / THS / UNP / BYND.O / GILD.O / AMGN.O / AAPL.O / INTU.O / SGMO.O / ARNA.O / ARGX.O / AXS / REGN.O / CALA.O / FAST.O / BLUE.O / ICPT.O / HAIN.O / BIIB.O / INFI.O / HALO.O / NOG.A / MRNA.O / ARCT.O / MDLZ.O / FANG.O / SMPL.O / POST.K / FATE.O / AFMD.O / BLCM.O / KHC.O / CYAD.O / OMF / CSX.O / IONS.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / NOMD.K / KZR.O / STRO.O / IHRT.O / IMV.O / BRBR.K / RAPT.O</td><td class="leftalignment">Bank of America Corp / Clear Channel Outdoor Holdings Inc / Comerica Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Campbell Soup Co / Danone SA / EOG Resources Inc / Audacy Inc / FMC Corp / General Mills Inc / Hershey Co / Interpublic Group of Companies Inc / Kellogg Co / Marathon Oil Corp / Norfolk Southern Corp / Omnicom Group Inc / Sherwin-Williams Co / J M Smucker Co / SM Energy Co / Teleflex Inc / TreeHouse Foods Inc / Union Pacific Corp / Beyond Meat Inc / Gilead Sciences Inc / Amgen Inc / Apple Inc / Intuit Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / argenx SE / AXIS Capital Holdings Ltd / Regeneron Pharmaceuticals Inc / Calithera Biosciences Inc / Fastenal Co / bluebird bio Inc / Intercept Pharmaceuticals Inc / Hain Celestial Group Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Northern Oil and Gas Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Mondelez International Inc / Diamondback Energy Inc / Simply Good Foods Co / Post Holdings Inc / Fate Therapeutics Inc / Affimed NV / Bellicum Pharmaceuticals Inc / Kraft Heinz Co / Celyad Oncology SA / OneMain Holdings Inc / CSX Corp / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Nomad Foods Ltd / Kezar Life Sciences Inc / Sutro Biopharma Inc / iHeartMedia Inc / IMV Inc / Bellring Brands Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / France / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Biogen climbs 8.1% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">BIIB.O</td><td class="leftalignment">Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights - January 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CCO / ETM / IPG / OMC / SHW / TFX / GILD.O / AMGN.O / INTU.O / SGMO.O / ARNA.O / ARGX.O / REGN.O / CALA.O / FAST.O / BLUE.O / ICPT.O / BIIB.O / INFI.O / HALO.O / MRNA.O / ARCT.O / FATE.O / AFMD.O / BLCM.O / CYAD.O / IONS.O / CRSP.O / JNCE.O / CLLS.O / ZYME.K / KZR.O / STRO.O / IHRT.O / IMV.O / RAPT.O</td><td class="leftalignment">Clear Channel Outdoor Holdings Inc / Audacy Inc / Interpublic Group of Companies Inc / Omnicom Group Inc / Sherwin-Williams Co / Teleflex Inc / Gilead Sciences Inc / Amgen Inc / Intuit Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / argenx SE / Regeneron Pharmaceuticals Inc / Calithera Biosciences Inc / Fastenal Co / bluebird bio Inc / Intercept Pharmaceuticals Inc / Biogen Inc / Infinity Pharmaceuticals Inc / Halozyme Therapeutics Inc / Moderna Inc / Arcturus Therapeutics Holdings Inc / Fate Therapeutics Inc / Affimed NV / Bellicum Pharmaceuticals Inc / Celyad Oncology SA / Ionis Pharmaceuticals Inc / CRISPR Therapeutics AG / Jounce Therapeutics Inc / Cellectis SA / Zymeworks Inc / Kezar Life Sciences Inc / Sutro Biopharma Inc / iHeartMedia Inc / IMV Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Anne Bode</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">KRYS=US / ADAP=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / LOGC=US / MGEN=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US</td><td class="leftalignment">Krystal Biotech Inc / Adaptimmune Therapeutics PLC / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / LogicBio Therapeutics Inc / Viridian Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Wedbush Morning Call - Jan 19 2021 6:57AM</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ICPT=US / SAGE=US / AAPL=US / DELL=US / IBM=US / INTC=US / AMD=US / GBT=US / MSFT=US / MU=US / AMZN=US / QCOM=US / DNLI=US / NVDA=US / NTAP=US / 7974=JP / XLNX=US / IIVI=US / XOMA=US / ACET=US / APLS=US / AVGO=US / BMRN=US / BLUE=US / KMX=US / ISEE=US / FUSN=US / HEAR=US / MGEN=US / NBIX=US / PII=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / WDC=US / FB=US / SWKS=US / ALPN=US / STX=US / IGMS=US / STRO=US / BIIB=US / SIMO=US / GRAY=US / HOG=US / TPTX=US / SURF=US / ORTX=US / 2454=US / ALNA=US / LXRX=US / 2330=US / VMW=US / 6758=US / IDRA=US / ASND=US / RCUS=US / 8299=US / OMER=US / NXPI=US / PCRX=US / 981=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / GOOGL=US / AGTC=US / XENE=US / QRVO=US / CDTX=US / BPMC=US / ABUS=US / PSTG=US / ARGX=US / NVCR=US / HPE=US / CTMX=US / VYGR=US / KURA=US / EIGR=US / CRVS=US / NTLA=US / CLSD=US / ALBO=US / OBSV=US / ANAB=US / CVNA=US / VRNA=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / MGTA=US / AQST=US / LQDA=US / YMAB=US / ARVN=US / MLND=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CRSR=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US</td><td class="leftalignment">Intercept Pharmaceuticals Inc / SAGE Therapeutics Inc / Apple Inc / Dell Technologies Inc / International Business Machines Corp / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Micron Technology Inc / Amazon.com Inc / Qualcomm Inc / Denali Therapeutics Inc / NVIDIA Corp / NetApp Inc / Nintendo Co Ltd / Xilinx Inc / II-VI Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Broadcom Inc / Biomarin Pharmaceutical Inc / bluebird bio Inc / Carmax Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Turtle Beach Corp / Viridian Therapeutics Inc / Neurocrine Biosciences Inc / Polaris Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / Western Digital Corp / Meta Platforms Inc / Skyworks Solutions Inc / Alpine Immune Sciences Inc / Seagate Technology Holdings PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Silicon Motion Technology Corp / Graybug Vision Inc / Harley-Davidson Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / MediaTek Inc / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Taiwan Semiconductor Manufacturing Co Ltd / VMware Inc / Sony Group Corp / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Phison Electronics Corp / Omeros Corp / NXP Semiconductors NV / Pacira Biosciences Inc / Semiconductor Manufacturing International Corp / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Alphabet Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Qorvo Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / Pure Storage Inc / argenx SE / Novocure Ltd / Hewlett Packard Enterprise Co / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Eiger BioPharmaceuticals Inc / Corvus Pharmaceuticals Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Carvana Co / Verona Pharma PLC / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Aquestive Therapeutics Inc / Liquidia Corp / Y-mAbs Therapeutics Inc / Arvinas Inc / Tempest Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Corsair Gaming Inc / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / China / Cayman Islands / Denmark / United Kingdom / Ireland / Japan / Netherlands / Taiwan / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Biotechnology / Electronics / Healthcare / Household Products / Info. Tech./Computers / Leisure & Entertainment / Pharmaceuticals / Retailing</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">The Week Ahead in Life Sciences</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">GBT=US / DNLI=US / XOMA=US / ACET=US / APLS=US / BMRN=US / BLUE=US / ISEE=US / FUSN=US / ICPT=US / MGEN=US / NBIX=US / PRTK=US / RARE=US / SGMO=US / SWTX=US / UTHR=US / SAGE=US / ALPN=US / IGMS=US / STRO=US / BIIB=US / GRAY=US / TPTX=US / SURF=US / ORTX=US / ALNA=US / LXRX=US / IDRA=US / ASND=US / RCUS=US / OMER=US / PCRX=US / BEAM=US / RGLS=US / EPZM=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AGTC=US / XENE=US / CDTX=US / BPMC=US / ABUS=US / ARGX=US / NVCR=US / CTMX=US / VYGR=US / KURA=US / EIGR=US / CRVS=US / NTLA=US / CLSD=US / ALBO=US / OBSV=US / ANAB=US / VRNA=US / BHVN=US / GTHX=US / MRSN=US / KALA=US / FENC=US / KNSA=US / SRRK=US / MGTA=US / AQST=US / LQDA=US / YMAB=US / ARVN=US / MLND=US / HARP=US / TCRR=US / IMUX=US / AXLA=US / IDYA=US / STOK=US / BCEL=US / KRTX=US / GBIO=US / ITOS=US / INZY=US / FRLN=US / CDAK=US / PRAX=US / FHTX=US / TVTX=US</td><td class="leftalignment">Global Blood Therapeutics Inc / Denali Therapeutics Inc / XOMA Corp / Adicet Bio Inc / Apellis Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Fusion Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Viridian Therapeutics Inc / Neurocrine Biosciences Inc / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SpringWorks Therapeutics Inc / United Therapeutics Corp / SAGE Therapeutics Inc / Alpine Immune Sciences Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Graybug Vision Inc / Turning Point Therapeutics Inc / Surface Oncology Inc / Orchard Therapeutics PLC / Allena Pharmaceuticals Inc / Lexicon Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Ascendis Pharma A/S / Arcus Biosciences Inc / Omeros Corp / Pacira Biosciences Inc / Beam Therapeutics Inc / Regulus Therapeutics Inc / Epizyme Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Applied Genetic Technologies Corp / Xenon Pharmaceuticals Inc / Cidara Therapeutics Inc / Blueprint Medicines Corp / Arbutus Biopharma Corp / argenx SE / Novocure Ltd / CytomX Therapeutics Inc / Voyager Therapeutics Inc / Kura Oncology Inc / Eiger BioPharmaceuticals Inc / Corvus Pharmaceuticals Inc / Intellia Therapeutics Inc / Clearside Biomedical Inc / Albireo Pharma Inc / Obseva SA / AnaptysBio Inc / Verona Pharma PLC / Biohaven Pharmaceutical Holding Company Ltd / G1 Therapeutics Inc / Mersana Therapeutics Inc / Kala Pharmaceuticals Inc / Fennec Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / Scholar Rock Holding Corp / Magenta Therapeutics Inc / Aquestive Therapeutics Inc / Liquidia Corp / Y-mAbs Therapeutics Inc / Arvinas Inc / Tempest Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / IDEAYA Biosciences Inc / Stoke Therapeutics Inc / Atreca Inc / Karuna Therapeutics Inc / Generation Bio Co / Iteos Therapeutics Inc / Inozyme Pharma Inc / Freeline Therapeutics Holdings PLC / Codiak BioSciences, Inc. / Praxis Precision Medicines Inc / Foghorn Therapeutics Inc. / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / United Kingdom / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. David M. Nierengarten, PHD / Ms. Liana Moussatos, PHD / Mr. Robert Driscoll, PHD / Ms. Laura K. Chico, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Wedbush Securities Inc.</td><td class="leftalignment">Layering in SAGE-324, Raising Target to $98</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">SAGE=US / BIIB=US</td><td class="leftalignment">SAGE Therapeutics Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Laura K. Chico, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">AC.TO / AEP.N / ALTR.O / ALV.N / AMAT.O / AMD.N / BARC.L / BBDb.TO / C.N / CI.N / CL.N / CMS.N / CNA.L / CP.TO / CVS.N / EDP.LS / EIX.N / EL.N / ELE.MC / EOG.N / F.N / GM.N / HSBA.L / HSX.L / INTC.O / IP.N / JPM.N / KBH.N / KMB.N / KO.N / LLOY.L / PD.N / PEG.N / PFE.N / PHM.N / PNC.N / SAN.MC / SGEF.PA / SO.N / T.N / TOL.N / VC.N / WFC.N / SSE.L / PEP.N / BFb.N / PG.N / PXD.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / INCY.O / THC.N / CNR.TO / DUK.N / UNH.N / BWA.N / LEA.N / TRP.TO / NVDA.O / K.N / DT.N / DISH.O / EPR.N / LEN.N / CTXS.O / CLX.N / CAG.N / MRO.N / GIS.N / DVN.N / EPC.N / MGA.N / AMT.N / JAZZ.O / VZ.N / EXEL.O / CYH.N / DHI.N / STZ.N / APH.N / FISV.O / EQT.N / ADSK.O / V.N / AXL.N / AWK.N / CHD.N / BC.N / SAM.N / FRAG.DE / BMRN.O / OPTN.O / REGN.O / ENR.N / MU.O / SM.N / NCR.N / NET.N / TEL.N / COP.N / CNP.N / CPE.N / ENDP.O / CPK.N / PII.N / ST.N / SWN.N / SR.N / NTCT.OQ / GPN.N / MNST.O / NWG.L / IMGN.O / CASY.O / ANSS.O / ICPT.O / FFIV.O / EQIX.O / ATDb.TO / BIIB.O / CHR.TO / 02209S103 / DLR.N / ACAD.O / 427866108 / SJW.N / BKD.N / FIS.N / HICL.L / ADP.PA / TEVA.N / MA.N / HOG.N / CVLT.O / ATL.MI / BGS.N / VMW.N / TDC.N / INO.OQ / DAN.N / EDPR.LS / SWI.N / EIF.TO / FTNT.O / SPB.N / FHZN.S / PCRX.O / MSP.N / MTOR.N / MTDR.N / SPLK.OQ / WDC.O / PANW.N / QLYS.O / MDLZ.OQ / FANG.O / ABBV.N / TPH.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / TMHC.N / DOO.TO / COTY.N / AGIO.O / PTC.O / VRNS.O / AGRX.O / ANTM.N / AENA.MC / SHOP.N / GLPG.O / WRK.N / RPD.O / SGRY.O / MIME.OQ / MESO.O / RACE.MI / MTRO.L / SCWX.O / TWLO.N / ADNT.N / PBYI.OQ / OKTA.OQ / CDEV.O / ESTE.N / SAIL.N / APTV.N / ZS.OQ / AMRX.N / VNE.N / NTGY.MC / KDP.N / XERS.O / AQST.O / PRVB.O / ESTC.N / NWL.O / ZM.O / CRWD.O / GMAB.O / DOCU.N / PING.N / DDOG.O / CRNC.OQ / VMUK.L / NLOK.O / WTRG.N / REYN.O / NKLA.OQ / APA.OQ / FOUR.N / JAMF.O / PLTR.N / ASAN.N / MTCR.O / SUMO.O / BSY.O / MCFE.OQ / 900435207 / 120681711</td><td class="leftalignment">Air Canada / American Electric Power Company Inc / Altair Engineering Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Barclays PLC / Bombardier Inc / Citigroup Inc / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / Centrica PLC / Canadian Pacific Railway Ltd / CVS Health Corp / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Endesa SA / EOG Resources Inc / Ford Motor Co / General Motors Co / HSBC Holdings PLC / Hiscox Ltd / Intel Corp / International Paper Co / JPMorgan Chase & Co / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Lloyds Banking Group PLC / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Pultegroup Inc / PNC Financial Services Group Inc / Banco Santander SA / Vinci SA / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / Wells Fargo & Co / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Canadian National Railway Co / Duke Energy Corp / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / TC Energy Corp / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / EPR Properties / Lennar Corp / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / Marathon Oil Corp / General Mills Inc / Devon Energy Corp / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / Verizon Communications Inc / Exelixis Inc / Community Health Systems Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Brunswick Corp / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Micron Technology Inc / SM Energy Co / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Conocophillips / CenterPoint Energy Inc / Callon Petroleum Co / Endo International PLC / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Spire Inc / Netscout Systems Inc / Global Payments Inc / Monster Beverage Corp / Natwest Group PLC / ImmunoGen Inc / Caseys General Stores Inc / ANSYS Inc / Intercept Pharmaceuticals Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Chorus Aviation Inc / Altria Group Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hershey Co / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / HICL Infrastructure PLC / Aeroports de Paris SA / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Harley-Davidson Inc / Commvault Systems Inc / Atlantia SpA / B&G Foods Inc / VMware Inc / Teradata Corp / Inovio Pharmaceuticals Inc / Dana Inc / EDP Renovaveis SA / SolarWinds Corp / Exchange Income Corp / Fortinet Inc / Spectrum Brands Holdings Inc / Flughafen Zuerich AG / Pacira Biosciences Inc / Datto Holding Corp / Meritor Inc / Matador Resources Co / Splunk Inc / Western Digital Corp / Palo Alto Networks Inc / Qualys Inc / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / BRP Inc / Coty Inc / Agios Pharmaceuticals Inc / PTC Inc / Varonis Systems Inc / Agile Therapeutics Inc / Anthem Inc / Aena SME SA / Shopify Inc / Galapagos NV / Westrock Co / Rapid7 Inc / Surgery Partners Inc / Mimecast Ltd / Mesoblast Ltd / Ferrari NV / Metro Bank PLC / SecureWorks Corp / Twilio Inc / Adient PLC / Puma Biotechnology Inc / Okta Inc / Centennial Resource Development Inc / Earthstone Energy Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / DocuSign Inc / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Virgin Money UK PLC / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Jamf Holding Corp / Palantir Technologies Inc / Asana Inc / Metacrine Inc / Sumo Logic Inc / Bentley Systems Inc / Mcafee Corp / Turquoise Hill Resources Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : Putting a Wrap on The 2021 Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CVS.N / JNJ.N / MCK.N / PFE.N / GILD.O / AMGN.O / INCY.O / ALKS.O / BMRN.O / REGN.O / VRTX.O / RARE.O / BLUE.O / NVAX.O / SGEN.O / BIIB.O / ACAD.O / MRNA.O / CLVS.O / SAGE.O / GBT.O / NVCR.O / EDIT.O / PBYI.O / JNCE.O / ALLO.O / BNTX.O / LEGN.O / BCAB.O</td><td class="leftalignment">CVS Health Corp / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Alkermes Plc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / bluebird bio Inc / Novavax Inc / Seagen Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / Editas Medicine Inc / Puma Biotechnology Inc / Jounce Therapeutics Inc / Allogene Therapeutics Inc / BioNTech SE / Legend Biotech Corp / Bioatla Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Matthew T. Holt, P.Eng / Mr. Turner Kufe</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">RBC Biotech Lit Bits: A Review of Interesting Literature and Science</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">INCY.O / ICPT.O / BIIB.O / ACAD.O / INO.OQ / GLPG.O / PRVB.O / MTCR.O</td><td class="leftalignment">Incyte Corp / Intercept Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Galapagos NV / Provention Bio Inc / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / David Szeto</td></tr>
<tr class="odd"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Canaccord Genuity</td><td class="leftalignment">Catalysts in 2021 and beyond for our biotechnology coverage: January 2021 edition</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">NBIX.OQ / US09062X1037 / ACAD.N / 78667J108 / G11196105 / 98986X109 / 46116X101 / 92915B106 / 918385105 / 09075P105 / 22053A107 / 20451W101</td><td class="leftalignment">Neurocrine Biosciences Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / SAGE Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Zynerba Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Voyager Therapeutics Inc / vTv Therapeutics Inc / BioXcel Therapeutics Inc / Cortexyme Inc / Compass Pathways PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Sumant Kulkarni / Jia Min, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (from 18 Jan): Sector continues to search for direction</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4516.T / 4519.T / 4502.T / 4503.T / 4507.T / 4523.T / 4528.T / 4543.T / MRK.N / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">Nippon Shinyaku Co Ltd / Chugai Pharmaceutical Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Merck & Co Inc / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（1月18日～）: 方向感つかめず</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4503.T / 4519.T / 4502.T / 4507.T / 4523.T / 4528.T / 4543.T / MRK.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Merck & Co Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
</tbody></table>
</body>
</html>